Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),-0.7544014500934447,-2.9093681892794505,0.0,0.0,0.0,67/87,15.94%,RPLP1;RPS16;RPS14;RPL41;RPL6;RPL26;RPL19;RPS11;RPSA;RPS12;RPS23;RPL13;RPS29;RPS25;RPS15;RPL28;RPL30;RPS21;RPS4X;RPS27;RPL27A;RPS9;RPL10;RPS3;RPL37A;RPL38;RPL39;RPL11;RPL18A;RPS28;RPS8;RPL32;RPS10;RPL23;RPL17;RPL14;RPS15A;RPS5;RPL21;RPS24;RPS27A;RPL18;RPS13;RPS19;RPL35;RPL27;RPL23A;RPL29;RPL34;RPL31;RPL35A;RPL8;RPS18;RPL12;RPS20;RPL13A;SEC63;RPL10A;RPS7;RPL36;RPS6;RPL3;RPL15;SEC61B;RPL22;RPL24;SRP19
prerank,cytoplasmic translation (GO:0002181),-0.7457353933178213,-2.8941284526871445,0.0,0.0,0.0,69/91,15.86%,RPLP1;RPS16;RPS14;RPL41;RPL6;RPL26;RPL19;RPS11;RPSA;RPS12;RPS23;RPL13;RPS29;RPS25;RPS15;RPL28;RPL30;RPS21;RPS4X;RPS27;RPL27A;RPS9;RPL10;RPS3;RPL37A;RPL38;RPL39;RPL11;RPL18A;RPS28;RPS8;RPL32;RPS10;RPL23;RPL17;RPL14;RPS15A;RPS5;RPL21;RPS24;RPS27A;RPL18;RPS13;RPS19;RPL35;RPL27;RPL23A;RPL29;RPL34;RPL31;RPL35A;RPL8;RPS18;RPL22L1;RPL12;RPS20;RPL13A;ZC3H15;EIF3I;RPL10A;RPS7;RPL36;RPS6;RPL3;RPL15;EIF4A1;RPL22;EIF2B3;RPL24
prerank,cotranslational protein targeting to membrane (GO:0006613),-0.7342004885750696,-2.8418225868323495,0.0,0.0,0.0,63/91,13.60%,RPLP1;RPS16;RPS14;RPL41;RPL6;RPL26;RPL19;RPS11;RPSA;RPS12;RPS23;RPL13;RPS29;RPS25;RPS15;RPL28;RPL30;RPS21;RPS4X;RPS27;RPL27A;RPS9;RPL10;RPS3;RPL37A;RPL38;RPL39;RPL11;RPL18A;RPS28;RPS8;RPL32;RPS10;RPL23;RPL17;RPL14;RPS15A;RPS5;RPL21;RPS24;RPS27A;RPL18;RPS13;RPS19;RPL35;RPL27;RPL23A;RPL29;RPL34;RPL31;RPL35A;RPL8;RPS18;RPL12;RPS20;RPL13A;SEC63;RPL10A;RPS7;RPL36;RPS6;RPL3;RPL15
prerank,protein targeting to ER (GO:0045047),-0.7185145724775956,-2.796462328175739,0.0,0.0,0.0,68/99,15.94%,RPLP1;RPS16;RPS14;RPL41;RPL6;RPL26;RPL19;RPS11;RPSA;RPS12;RPS23;RPL13;RPS29;RPS25;RPS15;RPL28;RPL30;RPS21;RPS4X;RPS27;RPL27A;RPS9;RPL10;RPS3;RPL37A;RPL38;RPL39;RPL11;RPL18A;RPS28;RPS8;RPL32;RPS10;RPL23;RPL17;RPL14;RPS15A;RPS5;RPL21;RPS24;RPS27A;RPL18;RPS13;RPS19;RPL35;RPL27;RPL23A;RPL29;RPL34;SPCS1;RPL31;RPL35A;RPL8;RPS18;RPL12;RPS20;RPL13A;SEC63;RPL10A;RPS7;RPL36;RPS6;RPL3;RPL15;RPL22;SGTA;RPL24;SRP19
prerank,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",-0.6853911934382467,-2.7517378071548753,0.0,0.0,0.0,71/110,14.63%,RPLP1;RPS16;RPS14;RPL41;RPL6;RPL26;RPL19;RPS11;RPSA;RPS12;RPS23;RPL13;RPS29;RPS25;RPS15;RPL28;RPL30;RPS21;RPS4X;RPS27;RPL27A;RPS9;RPL10;RPS3;RPL37A;RPL38;RPL39;RPL11;RPL18A;RPS28;RPS8;RPL32;RPS10;RPL23;RPL17;RPL14;RPS15A;RPS5;RPL21;RPS24;RPS27A;RPL18;RPS13;RPS19;RPL35;RPL27;PPP2R1A;RPL23A;RPL29;RPL34;RPL31;RPL35A;RPL8;RPS18;PNRC2;RPL12;RPS20;RPL13A;SMG9;RPL10A;UPF3A;RPS7;RPL36;RNPS1;SMG8;PPP2R2A;RPS6;RPL3;RPL15;MAGOH;RPL22
prerank,peptide biosynthetic process (GO:0043043),-0.637161769521316,-2.7092632317991443,0.0,0.0,0.0,80/153,15.20%,EEF1A1;DMD;RPLP1;RPS16;RPS14;RPL41;RPL6;RPL26;RPL19;RPS11;RPSA;RPS12;RPS23;RPL13;RPS29;RPS25;RPS15;RPL28;RPL30;RPS21;RPS4X;RPS27;RPL27A;RPS9;RPL10;RPS3;RPL37A;RPL38;RPL39;RPL11;RPL18A;RPS28;RPS8;RPL32;RPS10;RPL23;RPL17;RPL14;RPS15A;RPS5;SARS1;RPL21;RPS24;RPS27A;RPL18;RPS13;RPS19;RPL35;RPL27;GGTA1;MRPL52;RPL23A;RPL29;RPL34;RPL31;RPL35A;RPL8;MRPL51;HBS1L;RPS18;CARNS1;WARS1;MRPL28;RPL12;RPS20;RPL13A;GGT5;RPS6KB2;RPL10A;RPS7;MRPL43;RPL36;RPS6;RPL3;COPS5;MRPL32;RPL15;RPL22;MRPL24;MRPS17
prerank,translation (GO:0006412),-0.569247959493548,-2.4899935440622767,0.0,0.0,0.0,92/208,15.20%,EEF1A1;RPLP1;RPS16;RPS14;RPL41;RPL6;RPL26;RPL19;RPS11;RPSA;RPS12;RPS23;RPL13;RPS29;RPS25;EEF2;RPS15;RPL28;RPL30;RPS21;RPS4X;RPS27;RPL27A;RPS9;RPL10;RPS3;RPL37A;RPL38;RPL39;RPL11;RPL18A;RPS28;RPS8;RPL32;RPS10;RPL23;RPL17;RPL14;RPS15A;RPS5;SARS1;QRSL1;RPL21;RPS24;RPS27A;RPL18;RPS13;RPS19;RPL35;RPL27;MRPL52;PTCD3;RPL23A;RPL29;RPL34;EEF1D;RPL31;RPL35A;WARS2;RPL8;EEFSEC;MRPL51;HBS1L;RPS18;CARS1;RPL22L1;LARS2;WARS1;MRPL28;RPL12;RPS20;RPL13A;ZC3H15;RPS6KB2;EEF1B2;RPL10A;RPS7;SARS2;MRPL43;RPL36;TSFM;TARS1;RPS6;RPL3;COPS5;GATC;MRPL32;RPL15;RPL22;FARS2;MRPL24;MRPS17
prerank,nuclear-transcribed mRNA catabolic process (GO:0000956),-0.5658446549614908,-2.409959642698733,0.0,0.0,0.0,78/168,14.93%,DDX5;RPLP1;RPS16;RPS14;RPL41;RPL6;RPL26;RPL19;RPS11;RPSA;RPS12;RPS23;RPL13;RPS29;RPS25;RPS15;RPL28;RPL30;RPS21;RPS4X;RPS27;RPL27A;RPS9;RPL10;RPS3;RPL37A;RPL38;RPL39;RPL11;RPL18A;RPS28;RPS8;RPL32;RPS10;RPL23;RPL17;RPL14;RPS15A;RPS5;RPL21;RPS24;RPS27A;RPL18;RPS13;RPS19;CNOT7;RPL35;RPL27;PPP2R1A;RPL23A;DCPS;ERI1;RPL29;RPL34;RPL31;RPL35A;RC3H1;RPL8;RPS18;PNRC2;RPL12;RPS20;RPL13A;SMG9;DIS3L2;RPL10A;UPF3A;RPS7;RPL36;RNPS1;SMG8;PPP2R2A;RPS6;RPL3;RPL15;MAGOH;RPL22;PAN2
prerank,cellular response to copper ion (GO:0071280),-0.8378762752920572,-2.221873497235847,0.0,0.0001270282444829917,0.001,9/16,3.96%,MT1G;MT1A;MT1B;MT1F;MT1E;MT1M;MT1X;MT1H;MT2A
prerank,response to copper ion (GO:0046688),-0.7590779986402596,-2.1614130045926325,0.0,0.0008002779402428479,0.007,10/20,4.92%,MT1G;MT1A;MT1B;MT1F;MT1E;MT1M;MT1X;MT1H;MT2A;ATP5F1D
prerank,membrane lipid biosynthetic process (GO:0046467),-0.587143766256569,-2.120028311113994,0.0,0.0031179660009461605,0.027,20/58,12.89%,SGMS1;ST3GAL4;CERT1;SGMS2;ACER2;SPTLC2;DEGS2;ELOVL7;PLPP1;CSNK1G2;PRKD3;SPTLC1;ST8SIA6;KDSR;SPTSSB;SPNS2;ELOVL5;SGPL1;SPHK2;ACER3
prerank,regulation of bone mineralization (GO:0030500),0.6220808968772598,2.119408903058637,0.0,0.08288565634993213,0.085,15/55,2.10%,BMP6;ENPP1;ADGRV1;WNT4;NELL1;NOTUM;BMP2;PTN;FBN2;DDR2;SLC8A1;BCOR;CYP27B1;KL;AHSG
prerank,rRNA processing (GO:0006364),-0.48878534118121525,-2.1084461365637663,0.0,0.003334491417678532,0.029,87/172,25.93%,RPLP1;RPS16;RPS14;RPL41;RPL6;RPL26;RPL19;RPL13;RPS25;RPS15;NOP14;RPL28;RPL30;RPS27;RPL27A;RPS9;RPL10;RPL37A;RPL38;RPL39;RPL11;RPL18A;RPS28;RPL32;RPL23;RPL17;RPL14;RRP15;RPL21;RPS24;RPL18;RPS19;MTREX;RPL35;RPL27;RPL23A;PRKDC;ERI1;RPL29;RPL34;RPL31;NOP56;RPL35A;THUMPD1;RPL8;NOP2;WDR18;RPL12;RPL13A;UTP14A;NOB1;PELP1;PES1;DHX37;RPL10A;RPS7;RPL36;RPS6;RPL3;DKC1;RPL15;RPL22;MDN1;WDR74;RPL24;EMG1;EXOSC8;RPLP2;HELQ;RPL7;WDR12;DDX10;RPL5;UTP4;PIH1D2;DDX49;NSA2;PWP2;MRM2;TBL3;RSL1D1;WDR55;DDX47;RPL7A;RIOK2;UTP15;DIS3
prerank,positive regulation of synapse assembly (GO:0051965),0.6995101454334641,2.102287485112279,0.002197802197802198,0.06279216390146374,0.125,14/27,10.63%,SRPX2;GRID2;NRXN1;CLSTN2;PTPRD;IL1RAP;SYNDIG1;NLGN2;NLGN3;IL1RAPL1;EPHB1;NLGN1;CUX2;VSTM5
prerank,sequestering of extracellular ligand from receptor (GO:0035581),0.845287838856007,2.101949382069739,0.0,0.042140518884982325,0.126,5/13,0.82%,LTBP1;GREM2;FBN1;BMP2;FBN2
prerank,establishment of endothelial barrier (GO:0061028),-0.678044479410187,-2.0754489870126998,0.0,0.005012729955367288,0.048,13/29,9.53%,PECAM1;RAP1A;RAP1B;F11R;RAPGEF1;PDE4D;PPP1R16B;TJP2;MSN;PDE2A;ROBO4;EZR;SOX18
prerank,regulation of nitric-oxide synthase activity (GO:0050999),-0.6374256102596834,-2.071042523246449,0.0,0.0048996608586296805,0.051,20/36,20.94%,CAV1;NOS3;NOSTRIN;SCARB1;GCH1;CALM1;AKT1;APOE;S100A1;LYPLA1;WASL;EGFR;NPR3;SPR;HSP90AA1;NOSIP;CYGB;NUS1;DNM2;DDAH1
prerank,rRNA metabolic process (GO:0016072),-0.48656707024549634,-2.0686578833163547,0.0,0.004801667641457087,0.054,59/160,15.02%,RPLP1;RPS16;RPS14;RPL41;RPL6;RPL26;RPL19;RPL13;RPS25;RPS15;NOP14;RPL28;RPL30;RPS27;RPL27A;RPS9;RPL10;RPL37A;RPL38;RPL39;RPL11;RPL18A;RPS28;RPL32;RPL23;RPL17;RPL14;RPL21;RPS24;RPL18;RPS19;MTREX;RPL35;RPL27;RPL23A;RPL29;RPL34;RPL31;NOP56;RPL35A;RPL8;WDR18;RPL12;RPL13A;UTP14A;NOB1;PELP1;PES1;DHX37;RPL10A;RPS7;RPL36;RPS6;RPL3;DKC1;RPL15;RPL22;MDN1;WDR74
prerank,cellular response to zinc ion (GO:0071294),-0.793565335943738,-2.044510254827254,0.0,0.006216444714386407,0.075,9/15,3.96%,MT1G;MT1A;MT1B;MT1F;MT1E;MT1M;MT1X;MT1H;MT2A
prerank,negative regulation of reproductive process (GO:2000242),0.7471173968542901,2.0325000191245786,0.0,0.0983743901122932,0.315,4/17,1.53%,IGF1;SULF1;HYAL3;GJA1
prerank,activation of protein kinase A activity (GO:0034199),0.7631767251221602,2.0254517326086177,0.0042643923240938165,0.08757413792124141,0.348,5/16,2.65%,ADCY7;ADCY2;ADCY1;ADCY5;PRKACA
prerank,negative regulation of actin filament polymerization (GO:0030837),-0.6906187855244013,-2.020797036756032,0.0,0.008608031626141556,0.11,9/22,9.03%,TMSB4X;KANK3;CYRIB;SLIT2;KANK4;SSH2;HIP1R;PFN1;TMSB10
prerank,ribosome assembly (GO:0042255),-0.5788759923046889,-2.0160995329640468,0.0,0.008891977113809419,0.121,20/47,15.86%,RPS14;RPL6;RPSA;RPS15;RPS27;RPL10;RPL11;RPS28;RPS5;RPS19;RPL23A;NOP2;RPS27L;DHX37;RPL3;PPAN;MTERF3;MDN1;ERAL1;RPL24
prerank,cellular macromolecule biosynthetic process (GO:0034645),-0.43603520825838377,-2.0048038618828747,0.0,0.01028928780312233,0.145,135/306,25.02%,ST3GAL4;EEF1A1;RPLP1;RPS16;RPS14;RPL41;RPL6;RPL26;RPL19;RPS11;RPSA;RPS12;RPS23;RPL13;RPS29;MEF2A;RPS25;EEF2;RPS15;RPL28;RPL30;RPS21;RPS4X;RPS27;RPL27A;RPS9;RPL10;RPS3;RPL37A;RPL38;RPL39;RPL11;RPL18A;RPS28;RPS8;RPL32;RPS10;RPL23;RPL17;RPL14;RPS15A;NR4A2;RPS5;SARS1;RPL21;ING5;RPS24;RPS27A;RPL18;RPS13;RPS19;PTMA;RPL35;RPL27;MRPL52;RPL23A;RPL29;RPL34;EEF1D;RPL31;RPL35A;RPL8;EEFSEC;RAD1;MRPL51;HBS1L;RPS18;WARS1;MRPL28;FAM111A;RPL12;RPS20;RPL13A;INHBA;XAB2;RPS6KB2;EEF1B2;RPL10A;PPP5C;E2F1;RPS7;APOE;MRPL43;RPL36;TSFM;RNPS1;RPS6;RPL3;COPS5;MRPL32;RPL15;EPC1;PTMS;RAD9B;POLR3A;RPL22;MRPL24;MRPS17;HUS1;RPA3;RAD9A;RPL24;RAD17;MED20;RPS26;RPLP2;CHEK1;TYMS;MRPS18C;RPL7;MRPS18A;MRPL35;ALAS2;RPL5;PWP1;FARSB;MRPS6;RHNO1;EIF4G1;RRAGC;MLF1;TUFM;MRPL13;RFC3;MRPL11;DHPS;POLE3;LARGE1;MCM5;RFC2;POLL;GOLPH3;EXO1;RPL7A;HOXD3
prerank,positive regulation of bone mineralization (GO:0030501),0.6460489963974315,2.0002267696700935,0.0,0.10549083535445906,0.467,9/35,1.96%,BMP6;ADGRV1;WNT4;NELL1;BMP2;PTN;FBN2;SLC8A1;KL
prerank,maintenance of blood-brain barrier (GO:0035633),-0.6381681045793705,-1.9962543218069935,0.0,0.011032403033347831,0.16,15/30,6.76%,PECAM1;ACTB;OCLN;CLDN5;ESAM;SLC12A2;JAM2;LSR;DMD;ACTG1;F11R;TJP2;JAM3;SLC1A1;MFSD2A
prerank,presynapse assembly (GO:0099054),0.7600747467853278,1.994485840700663,0.0,0.09831458805143464,0.499,8/16,10.35%,LRP4;PTPRD;LRRTM3;NLGN2;NLGN3;IL1RAPL1;NLGN1;PTEN
prerank,tight junction assembly (GO:0120192),-0.574502985189298,-1.987397355325651,0.0,0.01257579620381618,0.188,9/49,2.77%,PECAM1;OCLN;CLDN5;ESAM;LSR;ACTG1;PARD3;F11R;RAMP2
prerank,cellular response to mechanical stimulus (GO:0071260),-0.5806112658120595,-1.985942054370555,0.0,0.012419897903768871,0.195,21/46,20.22%,PIEZO2;F11R;MAPK3;PIEZO1;MAP3K1;CRADD;PDE2A;CASP8;TLR3;MAP3K2;FAS;TLR4;BAK1;TNFRSF1A;BAD;CHEK1;PTGER4;GADD45A;SOX9;CASP1;LTBR
prerank,neurotransmitter uptake (GO:0001504),0.8006768404362675,1.9816132445993757,0.0022026431718061676,0.10433964568293225,0.559,7/12,8.62%,SLC1A3;ATP1A2;SLC29A1;SLC22A3;SLC38A1;SNAP25;GLUL
prerank,response to cadmium ion (GO:0046686),-0.6562291615994482,-1.968905942390649,0.001890359168241966,0.014961718013235849,0.237,10/26,3.96%,MT1G;MT1A;MT1B;MT1F;MT1E;MT1M;MT1X;MT1H;MAPK3;MT2A
prerank,positive regulation of biomineral tissue development (GO:0070169),0.6171398705683805,1.9633037223944823,0.0,0.11814229356275398,0.638,9/40,1.96%,BMP6;ADGRV1;WNT4;NELL1;BMP2;PTN;FBN2;SLC8A1;KL
prerank,cellular nitrogen compound biosynthetic process (GO:0044271),-0.6493337373437876,-1.961831188509263,0.0,0.016100829988219198,0.268,13/26,16.86%,ACER2;SPTLC2;NOS3;GCH1;CYP1B1;SPTLC1;AKT1;ASAH2;ABCA2;SPHK2;ACER3;SPR;NQO1
prerank,cellular zinc ion homeostasis (GO:0006882),-0.6586852315095054,-1.9480559534307507,0.0,0.019252400733842222,0.323,11/26,5.47%,SLC39A10;MT1G;MT1A;MT1B;MT1F;MT1E;MT1M;MT1X;MT1H;MT2A;SLC39A8
prerank,cellular response to glucagon stimulus (GO:0071377),0.7298047386881601,1.9475380761286682,0.0020833333333333333,0.13010536360383285,0.71,5/17,2.65%,ADCY7;ADCY2;ADCY1;ADCY5;PRKACA
prerank,regulation of synapse assembly (GO:0051963),0.5837796698175689,1.9456977441591454,0.0,0.12147429525664984,0.721,17/46,10.84%,GPC6;SRPX2;ROBO2;GRID2;NRXN1;CLSTN2;GPC4;PTPRD;IL1RAP;SYNDIG1;NLGN2;NLGN3;IL1RAPL1;EPHB1;NLGN1;CUX2;MUSK
prerank,positive regulation of ossification (GO:0045778),0.6150784605397522,1.9424449519731157,0.0,0.11595619600470303,0.736,9/39,1.96%,BMP6;ADGRV1;WNT4;NELL1;BMP2;PTN;FBN2;SLC8A1;KL
prerank,positive regulation of nervous system development (GO:0051962),0.5838544710527503,1.9348682811495899,0.0,0.11862888810922685,0.772,14/42,9.52%,SRPX2;GRID2;NRXN1;CLSTN2;PTPRD;SERPINF1;IL1RAP;SYNDIG1;NLGN2;NLGN3;IL1RAPL1;EPHB1;NLGN1;CUX2
prerank,skeletal system development (GO:0001501),0.47072927807343373,1.9305381501014938,0.0,0.11643461249157132,0.792,38/148,11.15%,IGF1;BMP6;COL13A1;FBN1;NOTUM;BMP2;TBX3;COL1A2;FGFR2;SULF1;HYAL3;BMP5;SULF2;GJA1;MATN3;TRPS1;AHSG;GLI2;CHD7;SH3PXD2B;MMP16;ANKRD11;EVC;CDH11;ANKH;COL10A1;SPEF2;PAPSS1;TGFBR1;IGF2;HES5;CNMD;SOX5;RAB33B;COL9A2;FRZB;UFD1;EXTL1
prerank,cellular response to cadmium ion (GO:0071276),-0.6572224461373484,-1.9286812913380948,0.0019047619047619048,0.025855133453999698,0.424,10/24,3.96%,MT1G;MT1A;MT1B;MT1F;MT1E;MT1M;MT1X;MT1H;MAPK3;MT2A
prerank,axonal fasciculation (GO:0007413),0.7721305551911571,1.9244998442823975,0.0,0.11576084260589846,0.804,7/12,14.11%,SEMA5A;CNTN4;EPHA3;RTN4;NRCAM;CDK5R1;AMIGO1
prerank,cAMP biosynthetic process (GO:0006171),0.8329023462161446,1.9243849331763272,0.002277904328018223,0.10857811674628104,0.804,4/10,1.26%,ADCY7;ADCY2;ADCY1;ADCY5
prerank,ribosomal small subunit assembly (GO:0000028),-0.72310064044306,-1.9214866368189256,0.0,0.028327298519707153,0.462,10/16,14.99%,RPS14;RPSA;RPS15;RPS27;RPS28;RPS5;RPS19;PRKDC;RPS27L;ERAL1
prerank,regulation of response to cytokine stimulus (GO:0060759),-0.6962943169188369,-1.9201258985940994,0.0,0.02788723638703393,0.47,9/19,12.36%,IFIH1;LIFR;MAP2K5;KLF4;ELF1;IRAK2;CBFB;DHX9;MAVS
prerank,negative regulation of vascular permeability (GO:0043116),-0.7880907206768359,-1.9196246096970104,0.0018083182640144665,0.027162142897897642,0.474,7/12,5.68%,CLDN5;PTPRJ;RAMP2;FERMT2;SLIT2;PDE2A;VEGFA
prerank,positive regulation of protein processing (GO:0010954),0.6719987749106869,1.9162913419386838,0.0,0.11371537760665078,0.835,2/19,0.75%,CCBE1;CLEC3B
prerank,ribosome biogenesis (GO:0042254),-0.438060885730043,-1.9016148969437074,0.0,0.034450059903787356,0.557,60/187,15.02%,RPLP1;RPS16;RPS14;RPL41;RPL6;RPL26;RPL19;RPL13;RPS25;RPS15;NOP14;RPL28;RPL30;RPS27;RPL27A;RPS9;RPL10;RPL37A;RPL38;RPL39;RPL11;RPL18A;RPS28;RPL32;RPL23;RPL17;RPL14;RPL21;RPS24;RPL18;RPS19;MTREX;RPL35;RPL27;RPL23A;RPL29;RPL34;RPL31;NOP56;RPL35A;RPL8;CUL4A;WDR18;RPL12;RPL13A;UTP14A;NOB1;PELP1;PES1;DHX37;RPL10A;RPS7;RPL36;RPS6;RPL3;DKC1;RPL15;RPL22;MDN1;WDR74
prerank,positive regulation of vascular endothelial growth factor production (GO:0010575),0.6626160769607035,1.900537536878365,0.0,0.12972395934902395,0.887,4/24,1.48%,CCBE1;RORA;SULF1;SULF2
prerank,negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),-0.5766078814624134,-1.8977139077534768,0.0,0.03525648437198905,0.576,21/37,25.92%,HSP90AB1;RPL11;RPL23;N4BP1;GIPC1;USP7;CAMLG;DDRGK1;BAG5;UBXN1;RPS7;SDCBP;SGTA;CSNK2A1;CSNK2A2;CCAR2;MAP1A;RPL5;TAF9;TRIM39;PARK7
prerank,regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),-0.7682583028616242,-1.8975423668733058,0.0,0.034154719235364395,0.576,7/12,14.62%,CAV1;PDE4D;CAMK2D;CALM1;GJD3;CALM3;SRI
prerank,gene expression (GO:0010467),-0.40786427395118774,-1.8966244018330567,0.0,0.03370867687689571,0.578,144/348,23.30%,TSPAN5;EEF1A1;RPLP1;RPS16;RPS14;RPL41;RPL6;RPL26;RPL19;RPS11;RPSA;RPS12;RPS23;RPL13;RPS29;MEF2A;RPS25;RPS15;RPL28;RPL30;RPS21;RPS4X;RPS27;RPL27A;RPS9;RPL10;RPS3;HNRNPA2B1;RPL37A;RPL38;RPL39;DDX17;RPL11;RPL18A;RPS28;RPS8;RPL32;RPS10;ADAR;RPL23;RPL17;RPL14;RPS15A;NR4A2;RPS5;SARS1;RPL21;RPS24;RPS27A;RPL18;RPS13;SRSF2;RPS19;PTMA;RPL35;SRSF5;RPL27;MRPL52;RPL23A;RPL29;RPL34;RPL31;RPL35A;NUP93;RPL8;SRSF6;MRPL51;HBS1L;RPS18;WARS1;NDC1;HHEX;NUP54;MRPL28;RPL12;RPS20;U2AF1;HSPD1;TSPAN14;RPL13A;XAB2;RPS6KB2;RPL10A;LMF2;ZC3H11A;PPP5C;E2F1;RPS7;RBMS2;MRPL43;RPL36;RNPS1;RPS6;RPL3;COPS5;DKC1;NUP188;MRPL32;RBM6;RPL15;EPC1;SRSF4;MAGOH;NUP155;POLR3A;RANBP2;RPL22;CHTOP;HNRNPK;MRPL24;MRPS17;ALYREF;AGFG1;RPL24;TSPAN17;NUP37;DDX20;DDX39B;MED20;RPS26;RPLP2;DUSP11;SMG7;CASC3;MRPS18C;RPL7;SYNCRIP;MRPS18A;MRPL35;THOC6;RPL5;CPSF4;PWP1;FARSB;MRPS6;NUP160;EIF4G1;DDX39A;RRAGC;NCBP2;MLF1;MRPL13;MRPL11;DHPS
prerank,ncRNA processing (GO:0034470),-0.42990973873064897,-1.8955294180250757,0.0,0.03338974767483815,0.584,78/200,20.81%,RPLP1;RPS16;RPS14;RPL41;RPL6;RPL26;RPL19;RPL13;RPS25;RPS15;NOP14;RPL28;RPL30;RPS27;RPL27A;RPS9;RPL10;HNRNPA2B1;RPL37A;RPL38;RPL39;RPL11;RPL18A;RPS28;RPL32;ADAR;RPL23;RPL17;RPL14;SARS1;RPL21;RPS24;RPL18;RPS19;MTREX;RPL35;RPL27;RPL23A;RPL29;RPL34;RPL31;NOP56;RPL35A;RPL8;WDR18;RPL12;RPL13A;UTP14A;NOB1;PELP1;PES1;DHX37;INTS8;RPL10A;RPS7;RPL36;RPS6;RPL3;DKC1;INTS1;RPL15;RPL22;FARS2;MDN1;WDR74;RPL24;EMG1;EXOSC8;TRPT1;RPLP2;SMAD2;HELQ;RPP21;RPL7;WDR12;DDX10;RPL5;UTP4
prerank,renal water homeostasis (GO:0003091),0.6571995431461176,1.8922193232143245,0.004338394793926247,0.1370852083490903,0.907,5/23,2.65%,ADCY7;ADCY2;ADCY1;ADCY5;PRKACA
prerank,regulation of protein processing (GO:0070613),0.6609131265820865,1.8897485613673952,0.0022727272727272726,0.13450081507693532,0.913,2/21,1.70%,CCBE1;SERPINE2
prerank,ribosomal small subunit biogenesis (GO:0042274),-0.5792175056770343,-1.8890181540800943,0.001984126984126984,0.03566953105082407,0.613,28/39,33.97%,RPS16;RPS14;RPSA;RPS25;RPS15;NOP14;RPS27;RPS28;RPS5;RPS24;RPS19;NOB1;RPS27L;RPS7;RPS6;ERAL1;EMG1;UTP4;PWP2;NOM1;RIOK2;NPM1;LSM6;RIOK1;LTV1;RIOK3;RRP36;RRP7A
prerank,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),0.5487133360702678,1.8867834282343627,0.002105263157894737,0.13351806787682668,0.918,13/57,12.66%,ADCY7;ADCY2;ADCY1;LPAR1;ADCY5;GNAI1;CHRM2;OPRK1;CHRM3;ADCY8;HTR4;HTR5A;GRM4
prerank,neuron projection fasciculation (GO:0106030),0.7838622469888837,1.8846805808195606,0.0022123893805309734,0.13098825948414433,0.922,6/10,14.11%,SEMA5A;CNTN4;RTN4;NRCAM;CDK5R1;AMIGO1
prerank,positive regulation of cell-substrate adhesion (GO:0010811),-0.5130670018510164,-1.8810849768479365,0.0,0.03814023040601826,0.648,20/67,9.77%,UTRN;FN1;CDK6;LIMS2;RREB1;VIT;DOCK1;PTK2B;FERMT2;RAC1;LIMS1;NEDD9;CRK;MYOC;JUP;NPNT;PPM1F;FBLN2;S100A10;EMP2
prerank,neuron cell-cell adhesion (GO:0007158),0.7482690995533882,1.8792741469736223,0.004545454545454545,0.13246416489126175,0.931,9/14,9.26%,NRXN1;CNTN4;NCAM2;ASTN2;NLGN2;NLGN3;NRXN3;NLGN1;CDK5R1
prerank,diol biosynthetic process (GO:0034312),-0.7274501082427699,-1.8770463569329048,0.0,0.03967401062825547,0.667,9/15,16.60%,ACER2;SPTLC2;GCH1;SPTLC1;ASAH2;ABCA2;SPHK2;ACER3;SPR
prerank,regulation of vascular endothelial growth factor production (GO:0010574),0.6312884161535843,1.869856029045376,0.0,0.1418405213463064,0.95,4/26,1.48%,CCBE1;RORA;SULF1;SULF2
prerank,negative regulation of growth (GO:0045926),-0.4642449551647011,-1.8686772105209624,0.0,0.044165714897612805,0.713,58/121,23.46%,APBB2;PTPRJ;SERTAD2;NOTCH1;OSGIN2;RACK1;BMPR2;SH3BP4;MT1G;MT1A;MT1B;MT1F;MT1E;MT1M;MT1X;MT1H;FHL1;CCN3;SOX17;SLIT2;NPR1;ADAM15;CDKN1B;MT2A;TGFB1;TGFB2;ING5;PPP2R1A;NDUFA13;BCL6;SIPA1;RB1;WFDC1;WNT11;INHBA;CCDC85B;CRLF3;SPHK2;SMARCA4;NDUFS3;CDKN2AIP;OSGIN1;SMAD4;CDKN1A;SMARCA2;HSPA1A;CCAR2;CDKN2C;NME6;TSPYL2;ESR2;MSX1;NDRG3;HSPA1B;SESN2;HYAL1;ENO1;FGFR3
prerank,cell-substrate junction assembly (GO:0007044),-0.5844553219915573,-1.8660819311956938,0.0,0.04476279907512193,0.726,14/33,12.21%,FN1;ITGA6;THSD1;SORBS1;PEAK1;FERMT2;ITGB4;CD151;LAMA3;ACTN1;BCR;LAMC2;TAOK2;RCC2
prerank,response to glucagon (GO:0033762),0.6903552486364867,1.8633727949214662,0.004219409282700422,0.14708436472278866,0.966,5/19,2.65%,ADCY7;ADCY2;ADCY1;ADCY5;PRKACA
prerank,negative regulation of viral life cycle (GO:1903901),-0.713151354731625,-1.8615084031857085,0.001841620626151013,0.046015981563963755,0.745,8/15,19.76%,LY6E;MID2;PPIA;IFITM1;IFITM3;IFITM2;TRIM5;SNX3
prerank,regulation of establishment or maintenance of cell polarity (GO:0032878),-0.6657760724763307,-1.8480975835782476,0.0017889087656529517,0.05498773861180821,0.805,7/18,4.80%,TEK;RAP1B;RACK1;PTK2B;CYRIB;BCAS3;SHTN1
prerank,zinc ion homeostasis (GO:0055069),-0.6158723326707506,-1.8467503182806322,0.0,0.05457677789751393,0.81,11/28,5.47%,SLC39A10;MT1G;MT1A;MT1B;MT1F;MT1E;MT1M;MT1X;MT1H;MT2A;SLC39A8
prerank,regulation of vascular endothelial growth factor signaling pathway (GO:1900746),0.6587858894029964,1.844852068235902,0.0020920502092050207,0.17398259567159413,0.982,3/19,2.16%,CCBE1;ROBO1;DCN
prerank,sphingosine biosynthetic process (GO:0046512),-0.7763185447023738,-1.8321734339330107,0.0017699115044247787,0.06391830301939629,0.862,7/11,12.89%,ACER2;SPTLC2;SPTLC1;ASAH2;ABCA2;SPHK2;ACER3
prerank,sphingoid biosynthetic process (GO:0046520),-0.7763185447023738,-1.8321734339330107,0.0017699115044247787,0.06391830301939629,0.862,7/11,12.89%,ACER2;SPTLC2;SPTLC1;ASAH2;ABCA2;SPHK2;ACER3
prerank,regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),0.7025779371124555,1.8306684730544749,0.002173913043478261,0.19467121233253792,0.987,6/16,6.49%,IGF1;IGFBP2;BMP2;BMP5;PHIP;MYORG
prerank,diterpenoid metabolic process (GO:0016101),0.5293287959715643,1.8290288595843975,0.0020161290322580645,0.19106758444302535,0.989,8/55,4.05%,ALDH1A1;GPC6;AKR1B1;LRP1;DHRS3;GPC4;ABCA4;GPC2
prerank,cAMP metabolic process (GO:0046058),0.7396711802065433,1.8281415709017292,0.006880733944954129,0.18612463479206284,0.99,4/13,1.26%,ADCY7;ADCY2;ADCY1;ADCY5
prerank,regulation of response to biotic stimulus (GO:0002831),-0.5858372394877638,-1.8274792840399683,0.0018587360594795538,0.06702010178922643,0.876,11/28,14.53%,FOXP1;CD55;GATA6;N4BP1;CASP8;ERAP1;TIRAP;LRP8;DHX58;SAMHD1;TRIM5
prerank,negative regulation of signaling receptor activity (GO:2000272),0.6269518281856197,1.826558646336672,0.002105263157894737,0.18285078128106239,0.99,7/25,7.40%,ERRFI1;SLC6A9;CBLB;PPARA;VPS25;CALCR;ZFYVE28
prerank,positive regulation of osteoblast differentiation (GO:0045669),0.5619209478042034,1.8263631112365808,0.0,0.17743850186349105,0.99,8/43,3.61%,IGF1;BMP6;WNT4;NELL1;BMP2;FBN2;DDR2;CCN4
prerank,sodium-independent organic anion transport (GO:0043252),-0.7571379572728147,-1.8260151270134932,0.0,0.06678095731156933,0.882,4/10,1.27%,SLCO3A1;SLCO2A1;SLCO1C1;SLCO2B1
prerank,regulation of cell migration involved in sprouting angiogenesis (GO:0090049),-0.5815556309875941,-1.8242919488055667,0.00186219739292365,0.0665276646372094,0.887,18/32,12.82%,THBS1;NOTCH1;RHOJ;MAP2K5;KDR;STARD13;KLF4;ANXA1;MAP3K3;HDAC7;HDAC9;VEGFA;GATA2;PIK3C2A;JCAD;FOXC2;CIB1;FGF2
prerank,regulation of phospholipase activity (GO:0010517),0.771564883053458,1.8207615444114025,0.0022675736961451248,0.18209727531424486,0.992,4/10,2.25%,FGFR2;LRP1;PLA2G5;PDPK1
prerank,positive regulation of cellular protein catabolic process (GO:1903364),-0.6635344777815417,-1.8202193091875967,0.0018484288354898336,0.06880961218338057,0.902,10/18,16.67%,MSN;CD81;EZR;CTSC;PTTG1IP;APOE;ABCA2;VPS11;ATP5IF1;HSP90AA1
prerank,regulation of cell junction assembly (GO:1901888),-0.6003602633335666,-1.818837669574704,0.0,0.06847859342894339,0.905,10/27,9.23%,PRKCH;MEF2C;OCLN;CLDN5;RAP1A;RAP1B;F11R;RAPGEF1;CBFB;FLOT1
prerank,cellular protein metabolic process (GO:0044267),-0.3856296454617727,-1.8159004987836909,0.0,0.07003575231325265,0.909,126/396,14.63%,FN1;ST3GAL6;ST8SIA4;IGFBP7;GPC3;EEF1A1;IGFBP6;RPLP1;RPS16;RPS14;RPL41;RPL6;RPL26;RPL19;RPS11;RPSA;RPS12;RPS23;RPL13;RPS29;RPS25;RPS15;MANBA;RPL28;RPL30;RPS21;RPS4X;RPS27;RPL27A;RPS9;RPL10;RPS3;PLOD2;RPL37A;DAB2IP;RPL38;RPL39;IGFBP5;RPL11;APP;RPL18A;RPS28;RPS8;RPL32;RPS10;RPL23;RPL17;RPL14;RPS15A;WWP2;RPS5;MSLN;ADAM10;SARS1;SPARCL1;RPL21;IGFBP3;RPS24;RPS27A;RPL18;RPS13;RPS19;RPL35;SFTPA2;SFTPA1;RPL27;LTA4H;MRPL52;GATA6;RPL23A;PRKDC;MSRA;NUCB1;CSNK1G3;RPL29;IDE;RPL34;RIPK1;SPCS1;RPL31;RPL35A;RPL8;QSOX1;DENND3;MFGE8;MRPL51;HBS1L;UBE2L6;RPS18;CST3;PSENEN;SPP1;WARS1;CPE;PNPLA2;ATG3;MRPL28;RPL12;RPS20;RPL13A;UBE2G2;ABL2;RPS6KB2;RPL10A;STK38;CHRDL1;SEC11A;MMP15;RPS7;APOE;MRPL43;RPL36;ICMT;FSTL1;RNF5;RPS6;RPL3;COPS5;MRPL32;RPL15;FBXL2;LOX;FUCA2;APH1A;UBE2G1;RPL22
prerank,regulation of glucose import (GO:0046324),0.6020671336415528,1.814510735633278,0.004246284501061571,0.1890614971287708,0.995,7/30,5.54%,IGF1;ENPP1;PIK3R1;PID1;PRKAG2;OSBPL8;IRS2
prerank,anterograde trans-synaptic signaling (GO:0098916),0.42001543222695753,1.8103131049937775,0.0,0.1917007827344687,0.996,65/224,14.98%,SLC1A3;NOVA1;GRIA4;CACNA1E;NRXN1;PDE7B;PCDHB10;HTR7;CHRNA1;OMP;PRKACA;DLG2;GABRA2;RIT2;GABRR3;UNC13C;CHRNB4;GRIK2;GRM1;GLRB;CHRM2;OPRK1;CAMK4;GABRB3;DLGAP1;PCDHB13;KCND2;NLGN2;CHRM3;NLGN3;GABRR2;SYT1;HRH1;ASIC2;SNAP25;CACNB4;CACNB2;NLGN1;GRIK1;HRH2;CACNB1;MYCBPAP;GABRA5;ATXN3;SLC6A1;CHRNA4;GRIA3;CHRNA7;CHRFAM7A;HTR4;HTR5A;GRM4;AMPH;APBA1;CHRNB1;SLC1A2;DLG4;GLRA3;GRIN2A;PNOC;GABRB1;GRIA1;PCDHB16;GABRG1;HCRTR1
prerank,negative regulation of extracellular matrix organization (GO:1903054),-0.7723948895978561,-1.8079714787357861,0.0,0.07570136146218759,0.93,7/10,13.25%,NOTCH1;DPP4;FAP;TGFB1;TNFRSF1B;CST3;TNFRSF1A
prerank,chemical synaptic transmission (GO:0007268),0.40657907842414026,1.8059672871476575,0.0,0.19476335180408294,0.997,82/284,14.98%,SLC1A3;NOVA1;GRIA4;GRID2;CACNA1E;NRXN1;CDH8;PDE7B;PCDHB10;HTR7;CHRNA1;OMP;RIMS1;PRKACA;DLG2;GABRA2;RIT2;GABRR3;UNC13C;CHRNB4;GRIK5;GRIK2;GRM1;GLRB;CHRM2;OPRK1;CAMK4;GABRB3;DLGAP1;RIMBP2;PCDHB13;KCND2;NLGN2;CHRM3;TBC1D24;NLGN3;GABRR2;SYT1;HRH1;GRID1;ASIC2;SNAP25;CACNB4;CACNB2;NLGN1;GRIK1;HRH2;CACNB1;PDZD11;MYCBPAP;GABRA5;ATXN3;SLC6A1;CHRNA4;GRIA3;PTEN;CBLN2;STAC3;BRSK1;CHRNA7;CHRFAM7A;PTPRN2;HTR4;HTR5A;STXBP3;GRM4;AMPH;APBA1;SNAPIN;CHRNB1;SLC1A2;DLG4;GLRA3;GRIN2A;PNOC;DRD2;GABRB1;GRIA1;PCDHB16;GABRG1;FCHSD2;HCRTR1
prerank,ceramide metabolic process (GO:0006672),-0.5158760023624561,-1.802510836750675,0.0058823529411764705,0.07985190876269295,0.947,14/49,12.89%,SGMS1;ST6GALNAC3;SGMS2;ACER2;SPTLC2;DEGS2;PLPP1;SPTLC1;PPP2R1A;SPTSSB;ASAH2;SGPL1;ABCA2;ACER3
prerank,endothelial cell development (GO:0001885),-0.6056161210189301,-1.7996998682976133,0.001893939393939394,0.08108476488875647,0.95,12/25,9.53%,PECAM1;RAP1A;RAP1B;RAPGEF1;PDE4D;PPP1R16B;COL18A1;MSN;PDE2A;ROBO4;EZR;SOX18
prerank,response to zinc ion (GO:0010043),-0.6091075676746587,-1.7985629323076924,0.0035460992907801418,0.08078996349118273,0.952,10/25,4.64%,MT1G;MT1A;MT1B;MT1F;MT1E;MT1M;MT1X;MT1H;MT2A;CRIP1
prerank,amide transport (GO:0042886),-0.6019455739747177,-1.795329725650438,0.0,0.08281317698513001,0.953,6/26,6.03%,ABCG2;CERT1;PLTP;SLC5A6;SLC38A5;AQP11
prerank,negative regulation of protein polymerization (GO:0032272),-0.5861774954117289,-1.7950609770331567,0.0018484288354898336,0.0815997685497618,0.954,8/27,8.84%,KANK3;CYRIB;SLIT2;KANK4;SSH2;HIP1R;STMN2;PFN1
prerank,regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),-0.7226766347799733,-1.7901248628899011,0.00392156862745098,0.08484149592048236,0.96,6/12,12.43%,FOXP1;MAP2K5;KLF4;TIRAP;CD74;TLR4
prerank,endoderm formation (GO:0001706),-0.5570552920263525,-1.7899501371104758,0.0,0.08359553558053984,0.96,12/35,15.46%,FN1;COL12A1;COL4A2;SOX17;LAMA3;COL6A1;MMP14;SOX7;INHBA;MMP15;ITGA7;ITGA4
prerank,negative regulation of type I interferon production (GO:0032480),-0.5331290481916175,-1.7890621149008115,0.0,0.08293437249974307,0.961,14/40,15.59%,TAX1BP1;IFIH1;TRIM25;REL;NLRC5;RNF125;OTUD5;YY1;UBE2L6;RELB;DHX58;MAVS;ITCH;TNFAIP3
prerank,positive regulation of protein maturation (GO:1903319),0.7303604737575137,1.7880504855706192,0.00909090909090909,0.2274006587513009,0.999,1/11,0.01%,CCBE1
prerank,regulation of steroid biosynthetic process (GO:0050810),0.7564348516109525,1.7853101589233535,0.0022471910112359553,0.22727369161308167,0.999,3/11,1.32%,WNT4;BMP2;BMP5
prerank,regulation of G1/S transition of mitotic cell cycle (GO:2000045),-0.4887285550916315,-1.7835611804102487,0.0,0.08742083785319489,0.969,35/66,26.02%,CDK6;CCND3;KLF4;FHL1;ANXA1;PKD1;RGCC;AKT1;KANK2;RB1;FAM107A;LSM11;CDK4;E2F1;EGFR;PTPN6;CDKN1A;ANKRD17;CDKN2C;CCND1;CDK2AP2;FGF10;E2F7;RBL1;PKD2;EIF4G1;LSM10;HYAL1;AIF1;CCL2;CDKN2B;RPTOR;DCUN1D3;RDX;PLK5
prerank,negative regulation of viral entry into host cell (GO:0046597),-0.7130660467003913,-1.7815758476805177,0.007207207207207207,0.08791812219389225,0.97,7/12,19.76%,LY6E;MID2;IFITM1;IFITM3;IFITM2;TRIM5;SNX3
prerank,diol metabolic process (GO:0034311),-0.6531161334170867,-1.77864907509329,0.00375234521575985,0.08972701514335707,0.974,11/19,20.39%,NOS3;DEGS2;GCH1;CALM1;PLPP1;AKT1;ASAH2;SPHK2;SPR;HSP90AA1;PLPP2
prerank,negative regulation of DNA-dependent DNA replication (GO:2000104),0.731788191085298,1.777200286981243,0.006944444444444444,0.238522093472718,1.0,7/11,23.90%,BLM;FBXO5;SMARCAL1;DONSON;ZRANB3;FBH1;TIMELESS
prerank,retinoid metabolic process (GO:0001523),0.49413499872584454,1.7767414321707087,0.001984126984126984,0.23341511046174876,1.0,9/71,4.05%,ALDH1A1;GPC6;ALDH1A2;AKR1B1;LRP1;DHRS3;GPC4;ABCA4;GPC2
prerank,negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),-0.5783192491735836,-1.7766949815174564,0.0019267822736030828,0.09064372588464908,0.977,19/30,28.04%,HSP90AB1;RPL11;N4BP1;GIPC1;USP7;SVIP;CAMLG;DDRGK1;BAG5;UBXN1;STYX;SDCBP;SGTA;CCAR2;MAP1A;TAF9;TRIM39;PARK7;USP14
prerank,bicellular tight junction assembly (GO:0070830),-0.5216209263420861,-1.775682782994498,0.0,0.09033494517428753,0.977,7/46,2.77%,PECAM1;OCLN;CLDN5;ESAM;PARD3;F11R;RAMP2
prerank,apical junction assembly (GO:0043297),-0.5010002040572608,-1.7736624830100343,0.0,0.09165380981550506,0.981,15/53,19.08%,PECAM1;OCLN;CLDN5;ESAM;PARD3;F11R;CTNNA1;RAMP2;WDR1;VCL;STRN;CLDN11;CLDN10;ECT2;ARL2
prerank,activation of adenylate cyclase activity (GO:0007190),0.5716564617362301,1.7726658328577873,0.0021929824561403508,0.23607760554820312,1.0,5/35,1.26%,ADCY7;ADCY2;ADCY1;LGR4;ADCY5
prerank,synaptic membrane adhesion (GO:0099560),0.7173474984281084,1.7716071911259852,0.0041841004184100415,0.23258625913420225,1.0,4/14,3.62%,GPC6;LRRC4C;GPC4;PTPRD
prerank,positive regulation of epithelial cell migration (GO:0010634),-0.4552289192344515,-1.7700197776135573,0.0,0.09398935289518814,0.981,29/92,13.75%,TEK;FOXP1;RREB1;THBS1;NRP2;DOCK1;PLCG2;FGF1;PTK2B;RAB11A;BMPR2;SCARB1;KDR;GPI;ETS1;TGFB2;RAC1;BCAS3;VEGFA;PPM1F;EDN1;FLT4;AKT1;PFN1;RHOB;FOXC2;PRKCE;FGF2;EMC10
prerank,embryonic digestive tract development (GO:0048566),0.6727026226621476,1.7696174854420186,0.008130081300813009,0.2311947672791036,1.0,6/18,3.86%,SALL1;FGFR2;RARB;GLI2;PDGFRA;GLI3
prerank,regulation of cellular component biogenesis (GO:0044087),-0.5284019228742654,-1.7638588660931076,0.001968503937007874,0.10041867117972621,0.988,24/39,29.98%,RAP1A;TIE1;NOTCH1;RAP1B;RAPGEF1;DAB2IP;MSN;HSPA8;EZR;HCFC1;BAG5;NCLN;APOE;VPS11;HSP90AA1;GFAP;RAPGEF2;TJP1;RDX;ANKRA2;PARP10;CD36;METTL18;IRGM
prerank,positive regulation of carbohydrate metabolic process (GO:0045913),0.6080405028977975,1.7604923924973024,0.008492569002123142,0.24620369380899498,1.0,3/23,3.87%,IGF1;ZBTB20;PFKFB4
prerank,positive regulation of sodium ion transmembrane transporter activity (GO:2000651),-0.686546646194308,-1.759731192718735,0.003629764065335753,0.10438919602873618,0.989,5/14,7.63%,DMD;ACTN4;WNK1;CHP1;ATP1B1
prerank,positive regulation of purine nucleotide metabolic process (GO:1900544),0.6314397135553187,1.7588238785477812,0.011111111111111112,0.23879627368156653,1.0,3/20,3.87%,IGF1;ZBTB20;PFKFB4
prerank,positive regulation of glycolytic process (GO:0045821),0.6314397135553187,1.7588238785477812,0.011111111111111112,0.23879627368156653,1.0,3/20,3.87%,IGF1;ZBTB20;PFKFB4
prerank,retina homeostasis (GO:0001895),-0.603115124221135,-1.7580518032835928,0.0019193857965451055,0.1049971285159198,0.989,7/23,12.91%,ACTB;POTEF;B2M;ACTG1;HSPB1;WHRN;POC1B
prerank,regulation of cell-matrix adhesion (GO:0001952),-0.47960135553699496,-1.7575296602114896,0.0,0.1042647830716396,0.99,18/64,11.89%,UTRN;CDK6;ACER2;THBS1;ACTG1;PTK2B;LIMCH1;PEAK1;PTK2;ADAM15;MINK1;MYOC;JUP;VCL;EMP2;NF1;CIB1;DUSP3
prerank,response to progesterone (GO:0032570),-0.6484699781988235,-1.7566614548269517,0.003787878787878788,0.10384290616953974,0.991,7/18,11.52%,ABHD2;CAV1;THBS1;TGFB1;TGFB2;TGFB3;WBP2
prerank,regulation of cell-cell adhesion mediated by integrin (GO:0033632),-0.7453599704389073,-1.7528610078535027,0.00539568345323741,0.10665608977403192,0.991,4/10,3.16%,PODXL;DPP4;WNK1;PIEZO1
prerank,cyclic purine nucleotide metabolic process (GO:0052652),0.6265819899641852,1.7513731184240537,0.008988764044943821,0.2500038154639147,1.0,4/21,1.26%,ADCY7;ADCY2;ADCY1;ADCY5
prerank,sphingolipid metabolic process (GO:0006665),-0.43436841327110937,-1.7485028136355163,0.0,0.11031619982525674,0.994,28/108,13.77%,SGMS1;CERT1;ST6GALNAC3;SGMS2;ACER2;SPTLC2;ESYT2;DEGS2;ELOVL7;SUMF2;HEXA;PLPP1;CSNK1G2;PRKD3;SPTLC1;PSAP;PPP2R1A;KDSR;SPTSSB;SPNS2;ASAH2;ELOVL5;SGPL1;ABCA2;SPHK2;ACER3;SUMF1;CERKL
prerank,negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),-0.685461962236095,-1.7474017209113204,0.008896797153024912,0.10998414394959137,0.994,5/14,2.59%,THBS1;NOTCH1;MAP2K5;STARD13;KLF4
prerank,angiogenesis involved in wound healing (GO:0060055),-0.7312769133310327,-1.7471577309708748,0.003683241252302026,0.10876158292633752,0.994,8/11,14.82%,ADIPOR2;CD34;KDR;VEGFA;GATA2;PRCP;MCAM;SRF
prerank,regulation of epithelial cell migration (GO:0010632),-0.49989461630421095,-1.7459568132848982,0.0,0.10889496258304465,0.994,15/51,9.77%,PTPRG;BMPER;RREB1;DOCK1;PLCG2;RHOJ;RAB11A;BMPR2;PTK2;DAB2IP;TGFB2;ADIPOR1;PPM1F;PFN1;EMP2
prerank,tryptophan catabolic process (GO:0006569),0.7295155869870904,1.7455872727609438,0.004347826086956522,0.2569401906708405,1.0,5/11,10.07%,IL4I1;AFMID;TDO2;KMO;KYNU
prerank,cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),-0.569205246552888,-1.7440491177817572,0.003703703703703704,0.11010874220484156,0.996,11/26,17.01%,NOD1;IFIH1;IRAK2;UBB;UBC;RPS27A;CASP8;ITCH;NOD2;TNFAIP3;TAB2
prerank,regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),-0.6417733807628745,-1.7440438574381687,0.001890359168241966,0.10869709166375384,0.996,5/18,7.38%,ESR1;DDX5;NCOR1;TGFB1;RIPK1
prerank,granulocyte differentiation (GO:0030851),-0.6288386083779451,-1.7436286487562895,0.0,0.10778426942004939,0.996,8/18,15.87%,LEF1;CBFA2T3;LBR;RARA;TAL1;CDK4;E2F1;CDKN1A
prerank,amyloid fibril formation (GO:1990000),-0.4957703595056898,-1.7427733818305946,0.0,0.10738015076758498,0.996,18/51,10.13%,B2M;TSPAN5;APP;FKBP1A;UBB;ADAM10;UBC;RPS27A;TGFBI;BACE1;RIPK1;MFGE8;UBE2L6;CST3;PSENEN;USP9X;H3-3A;TSPAN14
prerank,positive regulation of histone H3-K4 methylation (GO:0051571),0.6739941359226599,1.7415343486527401,0.006802721088435374,0.261337497704342,1.0,5/14,10.29%,AUTS2;PRDM9;KMT2A;DNMT1;PAXIP1
prerank,cellular biogenic amine catabolic process (GO:0042402),0.7428357975054497,1.7409758164672313,0.011363636363636364,0.2573026384196306,1.0,5/10,10.40%,CHDH;ALDH7A1;SLC44A1;HNMT;COMT
prerank,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),0.547498372217521,1.7395879028869656,0.0,0.2551371203644275,1.0,18/35,19.40%,CDH8;PCDHB10;CDH18;DCHS1;PCDHB13;CDH11;CDH20;CDH19;CDH7;NLGN1;CDH10;CDHR3;CDH12;PCDHGB4;PCDHB16;PCDHB14;CDH9;CDH24
prerank,poly-N-acetyllactosamine metabolic process (GO:0030309),0.6763230262226474,1.7391678146542269,0.016018306636155607,0.2509552443298499,1.0,8/13,17.29%,B3GALT1;GAL3ST3;B3GALNT1;B3GNT7;B3GALT2;B3GALT5;B4GAT1;B3GNT6
prerank,endodermal cell differentiation (GO:0035987),-0.5626801063969941,-1.7391357388536453,0.0037105751391465678,0.11064160094468578,0.997,10/31,15.46%,FN1;COL12A1;COL4A2;LAMA3;COL6A1;MMP14;INHBA;MMP15;ITGA7;ITGA4
prerank,cellular response to vascular endothelial growth factor stimulus (GO:0035924),-0.5477268478802627,-1.7377004505342954,0.001876172607879925,0.1110908471751744,0.997,21/34,21.80%,FLT1;SEMA6A;GAB1;NOTCH1;KDR;MT1G;RAMP2;VEGFC;ANXA1;DAB2IP;VEGFA;HSPB1;FLT4;VEGFD;PIK3CA;RELA;DLL4;PGF;NUS1;PRKD2;EGR3
prerank,negative regulation of glucose transmembrane transport (GO:0010829),0.7273967512587107,1.7355328381501731,0.018561484918793503,0.25427606269123504,1.0,2/10,0.66%,ENPP1;PID1
prerank,negative regulation of interleukin-1 production (GO:0032692),0.6059304125289652,1.7342720023879445,0.010526315789473684,0.25216385216580267,1.0,4/23,8.44%,IGF1;GSTP1;NLRP12;NLRP2B
prerank,regulation of interleukin-8 production (GO:0032677),-0.4685198158305412,-1.7336474707500196,0.0,0.11541357764707093,0.998,35/69,31.60%,TMSB4X;AFAP1L2;LBP;NOD1;MAP2K5;F3;KLF4;ANXA1;TLR3;ANXA4;RIPK1;TIRAP;MAPKBP1;CD74;MAVS;TLR4;SYK;RAB1A;NOD2;HSPA1A;RELA;LGALS9;HSPA1B;PRKD2;PTPN22;BCL10;PARK7;LAMTOR5;TLR6;HYAL2;TLR1;C5AR2;NOS2;TLR5;CD14
prerank,positive regulation of interleukin-6 production (GO:0032755),-0.4652047653496582,-1.7317237392186646,0.0,0.11620362336383391,0.999,31/68,31.22%,LBP;PLCG2;IFIH1;APP;IL33;TLR3;DHX9;TWIST1;HSPD1;TIRAP;CD74;MAVS;TLR4;SPHK2;SYK;NOD2;IL17RA;POU2F2;XBP1;ARHGEF2;LGALS9;AIF1;BCL10;TMEM106A;C1QTNF4;TLR6;HYAL2;TLR1;NOS2;MBP;TYROBP
prerank,regulation of sprouting angiogenesis (GO:1903670),-0.5456393804325231,-1.7311521865740092,0.005484460694698354,0.11550902438328699,0.999,14/33,13.86%,BMPER;SEMA6A;THBS1;RHOJ;FGF1;KLF2;KLF4;PPP1R16B;EPN1;VEGFA;PKM;FGF2;S100A1;EPN2
prerank,cellular response to ketone (GO:1901655),0.5669292371182132,1.728592072089015,0.006263048016701462,0.26082779588008004,1.0,8/35,4.24%,ADCY2;ADCY1;AR;PTGFR;ADCY5;ROCK2;GNAI1;SFRP1
prerank,positive regulation of integrin activation (GO:0033625),-0.7162448321762117,-1.7268583808141782,0.005309734513274336,0.11980240527356385,0.999,4/11,3.56%,RASIP1;RAP1B;PIEZO1;FERMT2
prerank,positive regulation of smooth muscle cell migration (GO:0014911),0.6472328364580777,1.7268552035558375,0.012295081967213115,0.26013461549384576,1.0,5/17,7.84%,IGF1;NRP1;CCN4;PDGFRB;DOCK7
prerank,stress-activated protein kinase signaling cascade (GO:0031098),-0.5704502344942763,-1.7267624018083618,0.0,0.11851735210263126,0.999,12/27,20.35%,MAP3K5;MAPK3;MAP3K20;UBB;UBC;RPS27A;IKBKB;MAP3K8;TAOK2;CUL1;CHUK;MAPK11
prerank,positive regulation of ATP metabolic process (GO:1903580),0.5606635830038841,1.7261812383470185,0.00851063829787234,0.2569246039634891,1.0,7/32,5.08%,IGF1;ZBTB20;PID1;PPARA;PFKFB4;ACTN3;IL4
prerank,negative regulation of heterotypic cell-cell adhesion (GO:0034115),-0.7182679035303641,-1.7248273482477283,0.00945179584120983,0.11862868022700963,0.999,3/10,2.77%,MAP2K5;KLF4;WNK1
prerank,regulation of cell-cell adhesion involved in gastrulation (GO:0070587),-0.7182679035303641,-1.7248273482477283,0.00945179584120983,0.11862868022700963,0.999,3/10,2.77%,MAP2K5;KLF4;WNK1
prerank,negative regulation of protein modification by small protein conjugation or removal (GO:1903321),-0.4924878188423682,-1.7246419963315223,0.0,0.11753923462011225,0.999,23/54,21.43%,CAV1;NXN;RPS3;SMAD7;RPL11;IVNS1ABP;CHP1;SH3RF2;N4BP1;AKT1;DNAJA1;CAMLG;BAG5;UBXN1;SOX4;PRMT3;TNFAIP3;UFL1;HSPA1A;USP4;COPS9;RPL5;HSPA1B
prerank,positive regulation of activated T cell proliferation (GO:0042104),0.6307444223204112,1.7240858785129618,0.009029345372460496,0.25742583965779026,1.0,4/18,8.31%,IGF1;IGFBP2;IGF2;IL18
prerank,positive regulation of cell projection organization (GO:0031346),0.4304776879996549,1.7239640883237783,0.0,0.25326172773590366,1.0,37/115,14.65%,PLXNA2;ROBO1;CAMK1D;ROBO2;PTN;NTRK3;TENM3;MAGI2;PTK7;GRIP1;EPHA3;RIT2;PTPRD;GPC2;LYN;NPTN;IL1RAPL1;CUX1;CAMK2B;DPYSL3;CDKL3;LRRC7;DVL3;CUX2;PRKCI;FUT9;PLXNB2;NGFR;CBFA2T2;ROR1;OBSL1;DLG4;EP300;CAPRIN2;AMIGO1;MAP6;PLPPR5
prerank,proteoglycan metabolic process (GO:0006029),0.5903690181812576,1.7235587703411954,0.012875536480686695,0.24987733652901128,1.0,6/26,1.48%,IGF1;ADAMTS12;CHST8;GAL3ST3;SULF1;SULF2
prerank,mitochondrial ATP synthesis coupled electron transport (GO:0042775),-0.46761145953114436,-1.722526960348977,0.0,0.11897381623390532,0.999,42/69,31.61%,COX4I1;NDUFV2;COX7C;COX6B1;NDUFB2;NDUFB8;NDUFB4;NDUFS4;NDUFA13;CYC1;UQCRQ;COX15;NDUFB7;SDHD;NDUFS2;NDUFA12;NDUFB5;NDUFA9;NDUFB9;NDUFS3;NDUFS6;COX6C;NDUFC1;UQCRB;NDUFA4;UQCR11;NDUFA3;COX10;UQCRH;NDUFA10;NDUFB10;NDUFB3;COX8A;NDUFA7;NDUFA1;COX4I2;UQCC3;NDUFA8;COX7A2L;SDHC;COA6;NDUFA2
prerank,negative regulation of cytokine production involved in inflammatory response (GO:1900016),0.6521586429476636,1.7224523972535248,0.01991150442477876,0.2480150935965814,1.0,3/16,6.04%,ADCY7;PPARA;ABCD2
prerank,purine nucleotide catabolic process (GO:0006195),-0.663204272074553,-1.721506049393182,0.009124087591240875,0.11913454368180407,0.999,6/13,12.56%,NT5E;GPX1;NT5C;GDA;NT5C1A;HINT1
prerank,tetrahydrobiopterin metabolic process (GO:0046146),-0.7330778738664582,-1.7209519704735963,0.0035398230088495575,0.11857881738221981,0.999,6/11,16.67%,NOS3;GCH1;CALM1;AKT1;SPR;HSP90AA1
prerank,intraciliary retrograde transport (GO:0035721),0.7075400802767757,1.7191925588853774,0.015730337078651686,0.2507294535851234,1.0,11/12,26.28%,DYNC2I2;DYNC2H1;IFT122;DYNC2LI1;IFT140;DYNLT2B;IFT43;WDR19;TTC21A;WDR35;TTC21B
prerank,positive regulation of blood vessel endothelial cell migration (GO:0043536),-0.5009505661482239,-1.7183243035140292,0.003738317757009346,0.12067412953023612,0.999,23/48,14.08%,TMSB4X;THBS1;NOS3;RHOJ;KDR;ETS1;ANXA1;TGFB1;MAP3K3;HDAC7;HDAC9;VEGFA;ATP5F1A;GATA2;ATP5F1B;HSPB1;AKT1;PIK3C2A;JCAD;FOXC2;CIB1;FGF2;STAT5A
prerank,response to lipid (GO:0033993),-0.43039090885723075,-1.7182424055476415,0.0,0.11947608106362395,0.999,38/105,20.86%,FOXP1;ACER2;LBP;NOS3;ESR1;PPARD;FOXO1;RPS6KA3;FOXO3;ANXA1;GCH1;SOCS2;TGFB1;MAPKAPK3;SMAD6;RARA;GATA6;OTUD5;TRIM16;TNFRSF11A;ABCG1;SPP1;IFNAR1;TRIB1;TIRAP;GGT5;TLR4;ABCA2;JAK2;STRN3;TAB2;PELI1;HSD17B2;SOX9;GGT1;LGALS9;RXRB;PAQR7
prerank,homotypic cell-cell adhesion (GO:0034109),-0.522242828088687,-1.7172985344042007,0.007434944237918215,0.11942242834457259,0.999,12/39,9.38%,FN1;ACTB;ACTG1;MEGF11;CLIC1;TJP2;PPIA;ACTN1;HSPB1;MYL12A;MYL9;VCL
prerank,positive regulation of tumor necrosis factor production (GO:0032760),-0.46720125884869623,-1.7158826890452064,0.001893939393939394,0.11962917663424012,0.999,24/69,20.77%,LBP;THBS1;PTPRJ;PLCG2;IFIH1;APP;IL33;TLR3;HSPB1;RIPK1;DHX9;TWIST1;TIRAP;MAVS;TLR4;SPHK2;SYK;JAK2;NOD2;OAS2;IFNGR1;ARHGEF2;LGALS9;FZD5
prerank,platelet aggregation (GO:0070527),-0.5438622825018279,-1.714728874788733,0.00929368029739777,0.11985503728943174,0.999,10/33,9.38%,FN1;ACTB;ACTG1;CLIC1;PPIA;ACTN1;HSPB1;MYL12A;MYL9;VCL
prerank,aerobic electron transport chain (GO:0019646),-0.46733088488952285,-1.7143035509695215,0.0,0.11926797354730348,0.999,38/68,28.25%,COX4I1;NDUFV2;COX7C;COX6B1;NDUFB2;NDUFB8;NDUFB4;NDUFS4;NDUFA13;CYC1;UQCRQ;COX15;NDUFB7;SDHD;NDUFS2;NDUFA12;NDUFB5;NDUFA9;NDUFB9;NDUFS3;NDUFS6;COX6C;NDUFC1;UQCRB;NDUFA4;UQCR11;NDUFA3;COX10;UQCRH;NDUFA10;NDUFB10;NDUFB3;COX8A;NDUFA7;NDUFA1;COX4I2;UQCC3;NDUFA8
prerank,pattern recognition receptor signaling pathway (GO:0002221),-0.4751197709970388,-1.7096719197019417,0.0,0.12444321970776283,1.0,18/56,18.78%,LBP;PLCG2;NOD1;RPS6KA3;IRAK2;MAPKAPK3;UBB;UBC;RPS27A;SFTPA2;SFTPA1;TLR3;CTSB;TLR4;S100A1;NOD2;TAB2;IRAK4
prerank,sphingosine metabolic process (GO:0006670),-0.6342758338922758,-1.7088568005975175,0.009025270758122744,0.12444491761004056,1.0,8/17,12.89%,ACER2;SPTLC2;PLPP1;SPTLC1;ASAH2;ABCA2;SPHK2;ACER3
prerank,nucleotide catabolic process (GO:0009166),-0.6338355142306432,-1.705922950635911,0.003745318352059925,0.12721505072487846,1.0,7/16,14.01%,NT5E;GPX1;NT5C;VCP;GDA;NT5C1A;SAMHD1
prerank,tumor necrosis factor-mediated signaling pathway (GO:0033209),-0.4189905861813771,-1.7044944460149496,0.0,0.1278557779980217,1.0,42/114,23.43%,TMSB4X;PTK2B;ACTN4;NFKBIA;TNFRSF11B;FOXO3;CARD14;LIMS1;IKBKB;PSMA6;TNFRSF1B;RIPK1;TNFRSF11A;PSMB5;PSMC4;PSMC5;PSMD14;COMMD7;EDA2R;TRAF1;TNFRSF1A;AIM2;JAK2;PSMD8;TNFSF13;PSMD11;STAT1;PSMB4;PSMD12;PSMC1;RELA;CHUK;LTBR;PSMA1;PSMB1;PSMC3;TXNDC17;PSMA4;TNFSF13B;PSMA2;TNFRSF9;TNFRSF12A
prerank,positive regulation of interleukin-8 production (GO:0032757),-0.4875347309579595,-1.7038736624757949,0.0,0.1273739078790368,1.0,26/49,31.60%,AFAP1L2;LBP;NOD1;F3;TLR3;RIPK1;TIRAP;CD74;MAVS;TLR4;SYK;RAB1A;NOD2;HSPA1A;RELA;LGALS9;HSPA1B;PRKD2;BCL10;PARK7;LAMTOR5;HYAL2;TLR1;NOS2;TLR5;CD14
prerank,negative regulation of GTPase activity (GO:0034260),-0.6029495366041805,-1.7024098271051975,0.001869158878504673,0.12808802297982125,1.0,9/22,13.58%,SH3BP4;F11R;LRCH1;WNK1;DAB2IP;BCAS3;GMIP;RCC2;HRAS
prerank,melanocyte differentiation (GO:0030318),0.7244677599228029,1.701623835678496,0.011061946902654867,0.2864402969199675,1.0,6/11,4.30%,ENPP1;LRMDA;SLC24A5;KIT;MITF;HPS6
prerank,positive regulation of angiogenesis (GO:0045766),-0.4290433561692098,-1.7003212084236003,0.0,0.12977013715636043,1.0,38/108,18.89%,TEK;FLT1;BMPER;THBS1;NOS3;CD34;GAB1;TIE1;FGF1;KDR;HIPK1;F3;KLF4;RAMP2;VEGFC;ETS1;CYP1B1;PIK3R6;VEGFA;GATA6;PKM;GATA2;HSPB1;JUP;TWIST1;RHOB;FOXC2;VEGFD;FGF2;S100A1;EMC10;RAPGEF3;JMJD8;XBP1;NINJ1;SP1;PGF;ANGPTL4
prerank,regulation of histone H3-K4 methylation (GO:0051569),0.6373102869550801,1.6982485961168128,0.013452914798206279,0.2893622384741738,1.0,5/16,10.29%,AUTS2;BCOR;KMT2A;DNMT1;PAXIP1
prerank,regulation of interferon-beta production (GO:0032648),-0.5014514842108991,-1.6973767461399205,0.0019880715705765406,0.1324999564346002,1.0,15/46,16.67%,IFIH1;REL;TLR3;YY1;DHX9;FLOT1;RELB;TIRAP;DHX58;TRIM56;MAVS;TLR4;POLR3A;OAS2;HSP90AA1
prerank,positive regulation of wound healing (GO:0090303),-0.5203813762992615,-1.6947175093863078,0.005703422053231939,0.13514746644286293,1.0,12/36,13.58%,ST3GAL4;OCLN;RREB1;THBS1;ACTG1;PTK2;ANXA1;FERMT2;ENPP4;FOXC2;PRKCE;HRAS
prerank,peptide cross-linking (GO:0018149),-0.5813317453142043,-1.6926374523570296,0.0136986301369863,0.13731636688937568,1.0,5/25,3.46%,FN1;THBS1;TGM2;COL3A1;ANXA1
prerank,sphingolipid biosynthetic process (GO:0030148),-0.45238039459911444,-1.6912112963788717,0.0,0.1380843209619023,1.0,20/71,12.89%,SGMS1;CERT1;SGMS2;ACER2;SPTLC2;DEGS2;ELOVL7;PLPP1;CSNK1G2;PRKD3;SPTLC1;KDSR;A4GALT;SPTSSB;SPNS2;ASAH2;ELOVL5;SGPL1;SPHK2;ACER3
prerank,presynapse organization (GO:0099172),0.7155743587051053,1.6903662398873185,0.02510460251046025,0.304149543897715,1.0,4/10,7.71%,LRRTM3;NLGN2;NLGN3;NLGN1
prerank,positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770),-0.7298558451960444,-1.6902685163687947,0.010309278350515464,0.1382719607176349,1.0,6/10,15.49%,NAMPT;KDR;IL33;TLR4;JAK2;NOD2
prerank,negative regulation of protein ubiquitination (GO:0031397),-0.4873237061010236,-1.68905636256671,0.0018552875695732839,0.1387828938206857,1.0,20/50,18.87%,CAV1;NXN;RPS3;SMAD7;IVNS1ABP;CHP1;SH3RF2;N4BP1;AKT1;DNAJA1;CAMLG;BAG5;UBXN1;SOX4;PRMT3;LIMK1;TNFAIP3;UFL1;HSPA1A;USP4
prerank,negative regulation of Notch signaling pathway (GO:0045746),-0.5588395719622975,-1.688074163962695,0.009523809523809525,0.13900149963333105,1.0,14/28,17.87%,NOTCH3;ZBTB7A;WWP2;GATA2;MMP14;AKT1;ARRDC1;TCIM;LFNG;YTHDF2;HEY1;EGFR;RITA1;DLL4
prerank,positive regulation of nitrogen compound metabolic process (GO:0051173),-0.5951664667106532,-1.687514800979811,0.00390625,0.1386747287929586,1.0,5/19,4.11%,SLCO1C1;MAP2K5;KLF2;KLF4;APP
prerank,cytoplasmic sequestering of transcription factor (GO:0042994),-0.6622434824255893,-1.6836555379551368,0.0055248618784530384,0.14265824152155113,1.0,8/14,21.52%,TMSB4X;NFKBIA;PKD1;MDFI;CCDC22;KEAP1;PKD2;NFKBIE
prerank,regulation of angiogenesis (GO:0045765),-0.38360962295397305,-1.682063794310148,0.0,0.1439416172074728,1.0,63/192,18.89%,TEK;FLT1;CLDN5;BMPER;SEMA6A;THBS1;NOS3;CD34;GAB1;TIE1;RHOJ;FGF1;KDR;HIPK1;F3;KLF4;RAMP2;VEGFC;ETS1;PPP1R16B;COL4A2;DAB2IP;NPR1;TGFB2;STAB1;SARS1;CYP1B1;PTPRM;PIK3R6;AMOT;VEGFA;GATA6;GATA2;HSPB1;RGCC;JUP;TWIST1;WARS1;NAXE;HHEX;EMP2;ISM1;RHOB;PLXND1;EGLN1;NF1;HTATIP2;VEGFD;FGF2;EMC10;ERBB2;EPHA2;TNFAIP3;PGK1;STAT1;RAPGEF3;RNH1;XBP1;NINJ1;SP1;KRIT1;PGF;ANGPTL4
prerank,cellular response to increased oxygen levels (GO:0036295),-0.6885638508151288,-1.6773765904106666,0.018796992481203006,0.14952201515990302,1.0,9/11,25.30%,CAV1;FOXO1;ATP6V0A2;FAS;ATG7;ATP6V1G1;ATP6AP1;CCDC115;ATP6V0D1
prerank,organic anion transport (GO:0015711),-0.4512935173899019,-1.6770558613101607,0.004056795131845842,0.14864242323493668,1.0,13/76,5.47%,ABCG2;SLC4A10;ABCC4;SLC26A7;SLCO3A1;SLCO2A1;SLCO1C1;SLCO2B1;LRRC8C;SLC35A3;LRRC8D;CA4;SLC39A8
prerank,"positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",-0.7148892394156607,-1.6761643644535469,0.007054673721340388,0.14868068911402535,1.0,3/10,5.58%,CD55;TGFBR2;CD81
prerank,regulation of actin filament polymerization (GO:0030833),-0.44294844135436945,-1.6760225426928361,0.005628517823639775,0.14766080709314164,1.0,27/69,23.65%,ESAM;KANK3;BAIAP2L1;PTK2B;CYRIB;SLIT2;KANK4;SSH2;HIP1R;LMOD1;PFN1;DBNL;DBN1;PRKCE;WASHC5;NCKAP1;HCK;CDC42EP3;RASA1;CTTN;NCK1;HCLS1;PLEKHG2;PRKCD;CARMIL1;NCK2;ARHGAP18
prerank,ATP synthesis coupled proton transport (GO:0015986),-0.6159768350413403,-1.6759418974901656,0.0111731843575419,0.1465349536626485,1.0,8/17,13.19%,ATP5PD;ATP5MF;ATP5F1D;ATP5F1A;ATP5F1B;ATP5ME;ATP5MC3;ATP5MC1
prerank,apical protein localization (GO:0045176),-0.7033400171733445,-1.6756282905087485,0.008605851979345954,0.14585861990491716,1.0,6/10,15.89%,ACTB;ATP8B1;JAM3;MAL;CELSR1;SHROOM3
prerank,cellular response to fatty acid (GO:0071398),0.6743329820766693,1.6751146048299823,0.02857142857142857,0.33737746647611067,1.0,3/12,5.80%,PID1;PDK4;PDK3
prerank,positive regulation of cellular component movement (GO:0051272),-0.5765428715053911,-1.6718285057357691,0.008992805755395683,0.14997078473656622,1.0,9/24,14.21%,SPOCK2;ACTN4;ETS1;CAVIN1;RPS19;VEGFA;TWIST1;CSF1R;NTN1
prerank,positive regulation of locomotion (GO:0040017),-0.5594118771988708,-1.6706305062552826,0.00927643784786642,0.15042090547306522,1.0,9/27,14.21%,THBS1;SPOCK2;STX3;TGFB1;CAVIN1;PPM1F;TWIST1;CSF1R;NTN1
prerank,mitochondrial ATP synthesis coupled proton transport (GO:0042776),-0.6225553018237442,-1.6682091724135004,0.014814814814814815,0.15286680563678806,1.0,8/16,13.19%,ATP5PD;ATP5MF;ATP5F1D;ATP5F1A;ATP5F1B;ATP5ME;ATP5MC3;ATP5MC1
prerank,stress-activated MAPK cascade (GO:0051403),-0.4664793806160847,-1.66671434297135,0.006024096385542169,0.15379491028476497,1.0,23/61,20.35%,MAP3K5;NOD1;MAP4K3;MAPK3;IRAK2;MAP3K20;UBB;MINK1;UBC;RPS27A;IKBKB;MAP3K8;MAP3K11;TRIB1;TAOK2;NOD2;TAB2;CUL1;CHUK;PTGER4;ARHGEF6;LGALS9;MAPK11
prerank,positive regulation of epithelial cell proliferation (GO:0050679),0.4223887129042173,1.6665630474326483,0.0019083969465648854,0.3545664188302652,1.0,16/113,4.24%,IGF1;BMP6;TCF7L2;NRP1;BMP2;AREG;PTN;FGFR2;SEMA5A;BMP5;PRKCA;VEGFB;AKT3;TGFA;STXBP4;SFRP1
prerank,receptor clustering (GO:0043113),0.5468581827500423,1.6663818909656496,0.023605150214592276,0.34973673298988395,1.0,9/27,13.19%,PTN;MAGI2;NRXN1;LRP4;DLG2;NLGN1;LRRC7;MUSK;DLG4
prerank,tryptophan metabolic process (GO:0006568),0.6798550009524369,1.665273882918739,0.02850877192982456,0.3480286464711128,1.0,4/11,10.07%,IL4I1;TDO2;KMO;KYNU
prerank,regulation of dendrite development (GO:0050773),0.5271721499501663,1.6634373551647097,0.01882845188284519,0.3476319798602775,1.0,12/37,10.12%,CAMK1D;HECW2;PTN;ADGRB3;BMP5;CSMD3;RAP2A;HECW1;TNIK;BCL11A;DCC;ALK
prerank,indolalkylamine catabolic process (GO:0046218),0.6967935475304365,1.6611437799997675,0.021691973969631236,0.34892110428521933,1.0,4/10,10.07%,IL4I1;TDO2;KMO;KYNU
prerank,lipid transport (GO:0006869),-0.41476210817195497,-1.6589452432009721,0.001890359168241966,0.16445756681998408,1.0,25/97,12.95%,PITPNC1;ABCC4;CERT1;SLCO3A1;SLCO2A1;SLCO1C1;LBP;PLTP;ATP8B1;ATP8A1;SLCO2B1;SCARB1;PPARD;TNFAIP8L3;MFSD2A;PITPNA;ABCG1;SPNS2;CHKA;FABP5;PRELID2;STARD5;APOE;ABCA2;MFSD2B
prerank,regulation of macrophage cytokine production (GO:0010935),-0.6574432726208446,-1.6587202486327457,0.008849557522123894,0.1635746673840124,1.0,6/13,10.73%,SEMA7A;PLCG2;TGFB1;TGFB2;TGFB3;CD74
prerank,"energy coupled proton transport, down electrochemical gradient (GO:0015985)",-0.7012328798243979,-1.6576362031831553,0.007380073800738007,0.16393733486835213,1.0,5/10,13.19%,ATP5PD;ATP5F1D;ATP5F1A;ATP5MC3;ATP5MC1
prerank,regulation of cell growth (GO:0001558),-0.3785786618856128,-1.6568337481372806,0.0,0.16401300643438585,1.0,79/204,22.04%,PLCE1;APBB2;PTPRJ;SERTAD2;NET1;LTBP4;OSGIN2;RACK1;BMPR2;SH3BP4;FHL1;TFRC;CCN3;RPS6KA3;CAMK2D;DCUN1D5;SOX17;SLIT2;NPR1;SOCS2;ADAM15;CDKN1B;TGFB1;TGFB2;ADAM10;PPP2R1A;MFSD2A;EGLN2;PABIR1;MMP14;AKT1;NDUFA13;BCL6;SIPA1;RB1;FAM107A;WFDC1;H3-3A;WNT11;INHBA;CCDC85B;TAOK2;CRLF3;AKAP6;CIB1;KIF26A;ITCH;FXN;SPHK2;SMARCA4;NDUFS3;CISH;CDKN2AIP;LAMTOR2;SDCBP;EGFR;ERBB2;OSGIN1;SMAD4;CDKN1A;CSNK2A1;SMARCA2;OGFR;TMEM97;HSPA1A;CCAR2;DERL2;CDKN2C;SLC25A33;NME6;TSPYL2;ESR2;BRAT1;MSX1;NDRG3;HSPA1B;ADNP2;DDX49;EIF4G1
prerank,regulation of establishment of cell polarity (GO:2000114),-0.6255988797632093,-1.6564909911821428,0.0035398230088495575,0.1632060824479989,1.0,6/16,4.80%,RAP1B;RACK1;PTK2B;CYRIB;BCAS3;SHTN1
prerank,positive regulation of ruffle assembly (GO:1900029),-0.6571625992373176,-1.6559621189698834,0.01773049645390071,0.16275782524938956,1.0,7/13,13.89%,EPS8;PLEKHM1;EPS8L2;PFN1;FAM98A;HRAS;NDEL1
prerank,negative regulation of viral process (GO:0048525),-0.4594500273551251,-1.6554101731294366,0.003875968992248062,0.1624280554116955,1.0,18/57,18.62%,IFIH1;MID2;PPIA;IFITM1;IFITM3;N4BP1;SRPK1;IFITM2;TRIM28;TRIM14;IFIT1;FAM111A;TRIM62;MAVS;TRIM5;OAS2;STAT1;RSAD2
prerank,regulation of keratinocyte proliferation (GO:0010837),0.5868722216346735,1.6543404194516076,0.017130620985010708,0.3626498044367353,1.0,4/22,4.07%,AREG;FGFR2;VDR;STXBP4
prerank,negative regulation of interleukin-1 beta production (GO:0032691),0.6153886047251566,1.6542689796446228,0.015217391304347827,0.35778742427484034,1.0,3/19,8.44%,IGF1;GSTP1;NLRP2B
prerank,positive regulation of type I interferon production (GO:0032481),-0.44241912254354954,-1.6540838832684137,0.00392156862745098,0.16349388239737414,1.0,36/73,34.37%,IFIH1;LRRFIP1;PRKDC;TLR3;GAPDH;DDX41;DHX9;FLOT1;HSPD1;DHX58;TRIM56;MAVS;TLR4;POLR3E;POLR3A;OAS2;STAT1;HSP90AA1;RELA;CHUK;CGAS;PTPN22;POLR3B;SETD2;CTNNB1;MRE11;POLR1C;POLR2F;PQBP1;POLR2L;CD14;RIOK3;CREBBP;TLR2;IRF3;TLR8
prerank,regulation of macrophage migration (GO:1905521),-0.7097215388704825,-1.653861412945331,0.01841620626151013,0.1625876843885972,1.0,5/10,19.17%,MTUS1;PTK2B;CD81;CX3CR1;CD200
prerank,regulation of integrin activation (GO:0033623),-0.6300056501746579,-1.6538024681656154,0.009074410163339383,0.16149306207988812,1.0,12/15,32.37%,RASIP1;RAP1B;PIEZO1;FERMT2;JAM3;PTGER4;SELP;SKAP1;SRC;FARP2;PLEK;FBLIM1
prerank,gliogenesis (GO:0042063),-0.6302512682066249,-1.6530164324656758,0.01717557251908397,0.1617412621249935,1.0,5/15,11.96%,CDK6;ANXA1;TGFB2;CD9;NDUFS2
prerank,odontogenesis (GO:0042476),0.5184099427075507,1.6506052945024723,0.008928571428571428,0.3633114462229349,1.0,7/35,5.19%,BMP2;COL1A2;FGFR2;BCOR;GLI2;ANKRD11;AXIN2
prerank,regulation of ossification (GO:0030278),0.5131409334833231,1.6495901028423765,0.02412280701754386,0.3614226442941007,1.0,11/36,8.08%,ENPP1;NOTUM;BMP2;PTN;DDR2;CYP27B1;AHSG;LRP4;SFRP1;ANKH;RBPJ
prerank,positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),-0.44334704496177757,-1.6495208256887894,0.0018796992481203006,0.1659624014170287,1.0,24/73,20.77%,LBP;THBS1;PTPRJ;PLCG2;IFIH1;APP;IL33;TLR3;HSPB1;RIPK1;DHX9;TWIST1;TIRAP;MAVS;TLR4;SPHK2;SYK;JAK2;NOD2;OAS2;IFNGR1;ARHGEF2;LGALS9;FZD5
prerank,regulation of Notch signaling pathway (GO:0008593),-0.4372290519768468,-1.6492654776842908,0.001949317738791423,0.16521256922567404,1.0,27/76,16.33%,NOS3;TSPAN5;NOTCH3;NOTCH1;CCN3;ZBTB7A;TGFB2;WWP2;NEPRO;JAG2;NOTCH4;GATA2;MMP14;AKT1;ARRDC1;TSPAN14;TCIM;LFNG;YTHDF2;TM2D3;MFNG;POGLUT1;EPN2;HEY1;EGFR;NOD2;RITA1
prerank,regulation of viral entry into host cell (GO:0046596),-0.5306908245216335,-1.6491618292972672,0.0038240917782026767,0.16422846587983583,1.0,15/30,20.27%,LY6E;MID2;TRIM25;IFITM1;IFITM3;IFITM2;TRIM14;CD74;TRIM62;TRIM68;TRIM5;NECTIN2;LGALS1;SNX3;LGALS9
prerank,positive regulation of interferon-beta production (GO:0032728),-0.5194472922652147,-1.646722509885756,0.001941747572815534,0.16717457519682913,1.0,11/33,16.67%,IFIH1;TLR3;DHX9;FLOT1;DHX58;TRIM56;MAVS;TLR4;POLR3A;OAS2;HSP90AA1
prerank,skeletal system morphogenesis (GO:0048705),0.49524645470921375,1.6460706171668622,0.010660980810234541,0.366270878181498,1.0,13/42,12.51%,FBN2;FGFR2;HOXC4;PDGFRA;HOXB3;ANKRD11;HOXC9;SPEF2;TGFBR1;HOXB9;RAB33B;FUZ;FGFR1
prerank,regulation of cellular carbohydrate metabolic process (GO:0010675),0.6271260313788247,1.6451654148909263,0.037037037037037035,0.3637869523715854,1.0,5/16,5.80%,RORA;PDK1;PDK4;PRKN;PDK3
prerank,lamellipodium organization (GO:0097581),-0.535904710817798,-1.643540200178373,0.005597014925373134,0.17111778009981374,1.0,17/29,24.65%,ABLIM1;PARVB;S1PR1;RAC1;ABLIM3;SPATA13;VCL;SPEF1;ABLIM2;ARHGEF4;CTTN;ARHGEF6;PTPRO;DMTN;CARMIL1;GOLPH3;CCDC88A
prerank,regulation of transmembrane transport (GO:0034762),-0.5240205030007462,-1.6430861105772563,0.005952380952380952,0.17067266202102216,1.0,11/31,12.17%,ACTB;OCLN;SLC2A1;CTTNBP2NL;KCNJ2;NEDD4L;WWP2;KCNJ10;ACE2;KCNJ8;KCNJ15
prerank,regulation of Ras protein signal transduction (GO:0046578),-0.43138396542240837,-1.643048492804395,0.0,0.169543010058393,1.0,23/85,9.48%,PLCE1;ARHGEF28;NOTCH1;EPS8;OPHN1;STARD13;STARD8;RAPGEF1;ARHGAP17;SHOC2;DAB2IP;DENND1A;NGF;EPS8L2;TGFB2;ARHGDIA;ARHGDIB;GABARAP;SHC1;BCR;DENND3;KANK2;MAPKAP1
prerank,negative regulation of blood vessel endothelial cell migration (GO:0043537),-0.5245117441178181,-1.640219985995562,0.011538461538461539,0.17289945765108777,1.0,19/33,26.38%,MEF2C;THBS1;NOTCH1;MAP2K5;STARD13;KLF4;TGFB1;RGCC;JUP;CSNK2B;APOE;FGF2;DLL4;GADD45A;PDCD10;TBXA2R;ANGPT4;HDAC5;CARD10
prerank,"mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",-0.5031699581268023,-1.6392191415123691,0.0037313432835820895,0.17341443507454116,1.0,22/38,25.74%,NDUFV2;NDUFB2;NDUFB8;NDUFB4;NDUFS4;NDUFA13;NDUFB7;NDUFS2;NDUFA12;NDUFB5;NDUFA9;NDUFB9;NDUFS3;NDUFS6;NDUFC1;NDUFA4;NDUFA3;NDUFA10;NDUFB10;NDUFB3;NDUFA7;NDUFA1
prerank,cristae formation (GO:0042407),-0.5419920992428499,-1.6391031634366382,0.012844036697247707,0.17243695326593214,1.0,15/27,27.79%,ATP5PD;ATP5MF;ATP5F1D;ATP5F1A;ATP5F1B;CHCHD3;ATP5ME;ATP5MC3;ATP5MC1;CHCHD6;APOO;ATP5F1E;ATP5PO;MICOS13;UQCC3
prerank,regulation of adaptive immune response (GO:0002819),0.6142465908801036,1.638446022362357,0.020089285714285716,0.376970445448268,1.0,4/18,11.53%,ADCY7;IL4I1;TRIM27;AHR
prerank,intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),-0.5261673253536014,-1.6380686573523084,0.010948905109489052,0.17290947311192958,1.0,10/32,17.02%,PPP1R13B;DDX5;HIPK1;DYRK2;RPS27L;HINT1;TMEM109;AEN;PHLDA3;DDIT4
prerank,positive regulation of interferon-alpha production (GO:0032727),-0.5843543150436085,-1.6380189322167407,0.018050541516245487,0.17184875386020193,1.0,8/19,18.03%,IFIH1;TLR3;DHX9;HSPD1;MAVS;TLR4;STAT1;CHUK
prerank,regulation of smooth muscle cell migration (GO:0014910),0.5751222320857305,1.6373052320872212,0.023157894736842106,0.3754864064275221,1.0,7/20,9.35%,IGF1;NRP1;LRP1;CCN4;SERPINE1;PDGFRB;BMPR1A
prerank,negative regulation of hydrolase activity (GO:0051346),-0.472732057944464,-1.6356887344311348,0.005385996409335727,0.1744682126676098,1.0,16/49,19.08%,SH3BP4;F11R;LRCH1;WNK1;DAB2IP;BCAS3;CHP1;SH3RF2;CST3;EGLN1;GMIP;RCC2;HRAS;ATP5IF1;NEIL1;ARL2
prerank,myoblast differentiation (GO:0045445),0.6397833834508357,1.6351246426293082,0.039647577092511016,0.3767317877416427,1.0,4/14,1.40%,IGF1;TCF7L2;EPAS1;NRG1
prerank,negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),0.661964081640141,1.6349861097889433,0.03532008830022075,0.3723261358537292,1.0,4/13,7.40%,ERRFI1;CBLB;VPS25;ZFYVE28
prerank,negative regulation of proteasomal protein catabolic process (GO:1901799),-0.5087790806393775,-1.6343573496851904,0.012121212121212121,0.17557658878175628,1.0,19/36,26.64%,OPHN1;HSP90AB1;RPL11;AQP11;N4BP1;GIPC1;USP7;CAMLG;DDRGK1;BAG5;UBXN1;SDCBP;CCAR2;MAP1A;TAF9;ALAD;TRIM39;PARK7;F8A1
prerank,positive regulation of cardiocyte differentiation (GO:1905209),-0.6801656194926233,-1.6325803925319222,0.017953321364452424,0.1774225219209449,1.0,3/11,4.12%,MEF2C;TGFB1;TGFB2
prerank,positive regulation of response to stimulus (GO:0048584),-0.49692531020354525,-1.6317373207311276,0.003898635477582846,0.17760043028657335,1.0,17/40,23.42%,B2M;IL15;IFIH1;TGFB2;ABI3;DHX9;YPEL3;MAVS;HOMER1;FMR1;CDKN2AIP;NSMCE4A;CGAS;RSAD2;TAF9;IER5;PRKCD
prerank,skeletal muscle contraction (GO:0003009),0.5960580370538668,1.631669862908778,0.02494802494802495,0.37669096645678096,1.0,6/19,14.26%,CHRNA1;TNNC1;TNNI3;TNNI1;STAC3;TNNT3
prerank,positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),-0.6775089770264622,-1.6309474008834781,0.01584507042253521,0.1777092145967838,1.0,4/11,14.66%,DDX5;TGFB1;RIPK1;EGFR
prerank,positive regulation of NF-kappaB transcription factor activity (GO:0051092),-0.38878156572930195,-1.630730858111972,0.0,0.17696837438015342,1.0,49/149,21.58%,PRKCH;CAV1;SLCO3A1;RPS6KA5;NOD1;NFKBIA;TFRC;MID2;RPS3;IRAK2;CARD14;ZBTB7A;TRIM25;APP;UBB;PPIA;PRKCZ;UBC;RPS27A;IKBKB;PSMA6;RIPK1;TNFRSF11A;DHX9;FLOT1;TRIM14;DDRGK1;TIRAP;CIB1;TRIM62;TLR4;EDA2R;TRAF1;AIM2;TRIM68;TRIM5;FLOT2;NOD2;CX3CR1;HSPA1A;TAB2;RELA;CHUK;ARHGEF2;LGALS9;CLOCK;HSPA1B;PRKD2;BTK
prerank,striated muscle cell development (GO:0055002),-0.6282000743652139,-1.6300733320320597,0.014814814814814815,0.17704317289731428,1.0,5/14,8.19%,PGM5;TMOD3;LMOD1;FLII;TMOD1
prerank,regulation of osteoblast proliferation (GO:0033688),0.6156775118621339,1.6291458939679833,0.03275109170305677,0.37836618046511267,1.0,4/17,4.24%,NELL1;BMP2;FGFR2;SFRP1
prerank,endoplasmic reticulum mannose trimming (GO:1904380),-0.5779389782832925,-1.6287819090256677,0.01838235294117647,0.17800540718140503,1.0,10/18,20.87%,SEL1L;UBB;UBC;RPS27A;MAN1B1;RNF185;RNF5;DERL2;AMFR;EDEM2
prerank,positive regulation of extracellular matrix organization (GO:1903055),0.593432768594883,1.6278315630707265,0.029288702928870293,0.3770656833414644,1.0,4/18,2.77%,BMP2;DDR2;EFEMP2;SMAD3
prerank,positive regulation of immune system process (GO:0002684),-0.6167296784768685,-1.6276542647568726,0.019157088122605363,0.1786587940554806,1.0,6/16,20.27%,IL15;ANXA1;TGFB2;VEGFA;RSAD2;LGALS9
prerank,poly-N-acetyllactosamine biosynthetic process (GO:0030311),0.6424386559991563,1.6261547616333292,0.02320185614849188,0.3766632803174946,1.0,7/12,17.29%,B3GALT1;B3GALNT1;B3GNT7;B3GALT2;B3GALT5;B4GAT1;B3GNT6
prerank,leukocyte cell-cell adhesion (GO:0007159),-0.5507698165502278,-1.6254265665420362,0.012987012987012988,0.18125971783990968,1.0,7/24,15.46%,PECAM1;F11R;NT5E;MSN;EZR;SYK;ITGA4
prerank,hemidesmosome assembly (GO:0031581),-0.6718709688350615,-1.6243338867792387,0.01876172607879925,0.1817631271776568,1.0,5/11,9.08%,ITGA6;ITGB4;CD151;LAMA3;LAMC2
prerank,response to ethanol (GO:0045471),0.6263799162720057,1.623713428476935,0.03319502074688797,0.3782895445960182,1.0,2/14,2.71%,ADCY7;GRIN3A
prerank,ketone body metabolic process (GO:1902224),0.6842972317335106,1.6228776492577144,0.0367170626349892,0.37613966459858206,1.0,2/10,0.55%,ACSS3;HMGCLL1
prerank,regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),-0.5515335271145447,-1.6227862275050287,0.014519056261343012,0.18319050845062101,1.0,12/24,14.62%,DMD;PDE4D;CAMK2D;CALM1;FKBP1A;JPH2;JPH4;AKAP6;GSTM2;CALM3;CASQ2;SRI
prerank,regulation of heterotypic cell-cell adhesion (GO:0034114),-0.5580214447927541,-1.6199535667577964,0.021032504780114723,0.1866468338936758,1.0,6/22,14.98%,MAP2K5;KLF4;WNK1;CD44;FLOT1;FLOT2
prerank,negative regulation of stress fiber assembly (GO:0051497),0.5582244176817249,1.618923338522727,0.019522776572668113,0.3825365988118138,1.0,6/24,5.17%,ARHGAP6;PIK3R1;ARHGAP28;PHLDB2;CGNL1;DLC1
prerank,nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),-0.5177573997979715,-1.6189035447075657,0.013011152416356878,0.18738146758569607,1.0,11/28,17.07%,NOD1;IRAK2;UBB;UBC;RPS27A;CASP8;ITCH;NOD2;TNFAIP3;TAB2;RELA
prerank,regulation of bicellular tight junction assembly (GO:2000810),-0.5785238987989889,-1.61874859073186,0.01953125,0.1865874507712549,1.0,6/19,6.72%,PRKCH;OCLN;CLDN5;F11R;IKBKB;CBFB
prerank,regulation of canonical Wnt signaling pathway (GO:0060828),0.3695060736930713,1.618598939400154,0.0,0.379188558251021,1.0,48/248,12.02%,BICC1;TCF7L2;IGFBP2;RNF220;LGR4;NOTUM;BMP2;LRRK1;WLS;RBMS3;DAAM2;CDK14;FGFR2;LYPD6;SEMA5A;TBL1XR1;PRICKLE1;PTK7;LRP4;DKK3;GLI3;ZEB2;ZNRF3;SFRP1;MCC;AXIN2;PRKN;HECW1;CTNND2;FRAT1;SMURF2;TLE1;PSMA3;SOX2;ADGRA2;PSMF1;NPHP3;DVL3;GPC5;DACT3;FRZB;FUZ;SIAH2;NKD2;USP47;BTRC;RNF146;PSME3
prerank,regulation of blood vessel endothelial cell migration (GO:0043535),-0.46333512829608353,-1.6185416522409097,0.005758157389635317,0.18578920077637853,1.0,22/54,15.34%,MEF2C;TMSB4X;THBS1;NOS3;KDR;ETS1;TGFB1;VEGFA;ATP5F1A;GATA2;ATP5F1B;HSPB1;RGCC;JUP;PRCP;AKT1;CSNK2B;NF1;APOE;FGF2;STAT5A;EPHA2
prerank,positive regulation of vasculature development (GO:1904018),-0.41450517855602803,-1.6181442817751284,0.0,0.1854895504695406,1.0,21/94,7.34%,TEK;FLT1;THBS1;NOS3;CD34;GAB1;TIE1;FGF1;KDR;HIPK1;F3;RAMP2;VEGFC;ETS1;CYP1B1;PIK3R6;VEGFA;GATA6;GATA2;HSPB1;JUP
prerank,macrophage activation (GO:0042116),-0.5036513728523856,-1.616985417287346,0.012844036697247707,0.18639835549129394,1.0,11/34,17.22%,FOXP1;LBP;PLCG2;CD93;APP;DYSF;TLR4;SYK;JAK2;C1QA;IFNGR1
prerank,regulation of vasculature development (GO:1901342),-0.5395799093572196,-1.613959276555619,0.012589928057553957,0.19035862944228896,1.0,12/26,16.99%,BMPER;ETS1;WARS1;EMP2;PLXND1;EGLN1;NF1;HTATIP2;FGF2;ERBB2;EPHA2;RNH1
prerank,positive regulation of calcium ion transmembrane transport (GO:1904427),0.5544840372266724,1.6135783883005999,0.0255863539445629,0.38883165583567064,1.0,5/25,7.60%,CEMIP;PDPK1;ANK2;CALCR;CACNB2
prerank,negative regulation of protein binding (GO:0032091),-0.4310872958997441,-1.613205033650668,0.0038240917782026767,0.1905513864814923,1.0,27/71,24.41%,CAV1;ACTB;B2M;RACK1;ADAM15;CTSZ;RALB;ATP2A3;NES;BAX;AKT1;DISC1;IFIT1;CTNNBIP1;CAMK1;STYX;MITD1;ITGA4;CDKN1A;GTF2F1;KDM1A;PIN1;TMBIM6;PPP1CA;ZFPM1;PRKCD;CARD16
prerank,regulation of GTPase activity (GO:0043087),-0.37856055318440995,-1.6108432333060079,0.0,0.19360001129168994,1.0,59/177,20.08%,DOCK9;PKP4;CHN2;FGD5;ITGA6;RAP1A;NET1;PRKG1;RASIP1;RACK1;SIPA1L1;TGM2;SH3BP4;AGRN;F11R;CAV2;LRCH1;SGSM2;WNK1;PTK2;RAPGEF1;ARHGAP27;DAB2IP;FERMT2;PLXNA4;BCAS3;LIMS1;CHN1;CRK;FGD6;GPR137B;RGS6;CCL15;S100A10;ZC3H15;ADAP1;WNT11;PLXNA1;PLXND1;GMIP;NF1;RCC2;ARHGEF5;HRAS;NDEL1;SNX18;RAP1GDS1;ERBB2;BCAR3;RAPGEF3;MAPRE2;TBC1D2;PLXNA3;ECT2;RAB3GAP2;ARL2;PIN1;FGD2;RGS10
prerank,negative regulation of gene silencing by miRNA (GO:0060965),-0.6456322188855451,-1.6099264645967173,0.02819548872180451,0.1940924718729333,1.0,3/12,4.03%,ESR1;NCOR1;TGFB1
prerank,purine-containing compound catabolic process (GO:0072523),-0.629187198456764,-1.607900759781872,0.024390243902439025,0.1962874406421224,1.0,5/13,11.45%,NT5E;GPX1;NT5C;GDA;NT5C1A
prerank,clathrin coat assembly (GO:0048268),-0.6361233452889434,-1.6073418244168007,0.01303538175046555,0.19616391724334184,1.0,9/15,25.64%,HIP1R;PIK3C2A;HIP1;FCHO2;SGIP1;CLTA;NSG2;EPS15;CLTB
prerank,neuronal action potential (GO:0019228),0.5633387839269101,1.606629059578401,0.018518518518518517,0.4041675770410214,1.0,6/22,7.51%,SCN7A;CHRNA1;SCN3A;CACNA1I;SCN2A;CACNA1G
prerank,regulation of amyloid-beta formation (GO:1902003),0.5019513956724603,1.6058607481829918,0.02510460251046025,0.40179624643292666,1.0,8/34,11.12%,IGF1;SLC2A13;ROCK2;LRRTM3;RTN4;CASP3;TMED10;CHRNA7
prerank,"nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",-0.5323047488998703,-1.6047698656400546,0.025878003696857672,0.19950442838697727,1.0,10/24,17.01%,NOD1;IRAK2;UBB;UBC;RPS27A;CASP8;ITCH;NOD2;TNFAIP3;TAB2
prerank,regulation of endothelial cell migration (GO:0010594),-0.41899678893927117,-1.6043101968167452,0.009823182711198428,0.19925940779875184,1.0,31/85,13.75%,TEK;FOXP1;BMPER;THBS1;NRP2;RHOJ;FGF1;PTK2B;BMPR2;SCARB1;KDR;GPI;PTK2;ETS1;DAB2IP;SLIT2;RAC1;BCAS3;PTPRM;VEGFA;PRCP;EDN1;FLT4;AKT1;EMP2;RHOB;FOXC2;NF1;APOE;FGF2;EMC10
prerank,regulation of dendrite morphogenesis (GO:0048814),0.5210077257940368,1.6042540261488272,0.01948051948051948,0.4021701593184618,1.0,15/32,17.48%,HECW2;ADGRB3;RAP2A;PTPRD;HECW1;IL1RAPL1;CUX1;TNIK;CDKL3;CUX2;OBSL1;SARM1;CAPRIN2;NEDD4;CUL7
prerank,MyD88-dependent toll-like receptor signaling pathway (GO:0002755),-0.5225670982224899,-1.6032732153029894,0.024299065420560748,0.20001102319819422,1.0,18/27,31.78%,IRAK2;MAP3K1;UBB;UBC;RPS27A;HSPD1;TIRAP;TLR4;TAB2;IRAK4;BTK;TRAF6;CD36;TLR6;TLR1;TLR5;CD14;LY96
prerank,positive regulation of blood coagulation (GO:0030194),-0.5911287091325282,-1.6030272816349995,0.026929982046678635,0.19939128341643833,1.0,5/17,2.91%,ANO6;ST3GAL4;THBS1;F3;THBD
prerank,cellular response to hydrogen peroxide (GO:0070301),-0.5137487931236016,-1.601901720104089,0.009328358208955223,0.20027501390571814,1.0,23/33,39.61%,MAP3K5;NET1;RPS3;ANXA1;CYP1B1;RIPK1;RHOB;IMPACT;FXN;TNFAIP3;RELA;ECT2;PRKCD;RNF112;PARK7;AQP1;ABL1;MAPK7;ANKZF1;SIGMAR1;OSER1;PLEKHA1;PPIF
prerank,positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),-0.530228738059755,-1.6011161953715345,0.024074074074074074,0.2005165677088923,1.0,17/26,25.75%,CCND3;ANXA1;RGCC;AKT1;LSM11;CDK10;EGFR;MTBP;ANKRD17;CCND1;FGF10;EIF4G1;LSM10;HYAL1;AIF1;RPTOR;RDX
prerank,regulation of cell-substrate adhesion (GO:0010810),-0.4876429226739667,-1.6006390275771858,0.017543859649122806,0.20024732460298814,1.0,13/42,11.33%,VIT;NOTCH1;PTK2;FZD4;RAC1;LIMS1;MINK1;NPNT;PPM1F;FBLN2;FZD7;EMP2;NF1
prerank,histone H2A monoubiquitination (GO:0035518),0.5902662692743396,1.6003027232934353,0.02736842105263158,0.4089277782165001,1.0,9/17,22.65%,BCOR;DDB2;RNF2;PCGF5;PCGF6;SKP1;TRIM37;PCGF2;KDM2B
prerank,chordate embryonic development (GO:0043009),0.45999776639109846,1.5998648361678003,0.01882845188284519,0.40596692633031445,1.0,14/55,9.13%,ARNT2;BMP2;ALDH1A2;FGFR2;SULF1;BMP5;SULF2;CHD7;SIX4;TGFBR1;IGF2;FOXD3;HES5;GATA3
prerank,keratan sulfate catabolic process (GO:0042340),0.6558208588106667,1.598192991787764,0.03896103896103896,0.40633800715856677,1.0,6/11,7.32%,FMOD;OMD;GNS;LUM;GALNS;OGN
prerank,positive regulation of endothelial cell migration (GO:0010595),-0.4215272357394592,-1.5967627308979473,0.001949317738791423,0.20629106178635678,1.0,24/84,8.42%,TEK;FOXP1;TMSB4X;THBS1;NOS3;NRP2;FGF1;PTK2B;BMPR2;SCARB1;KDR;GPI;ETS1;TGFB1;RAC1;BCAS3;VEGFA;ATP5F1A;GATA2;ATP5F1B;HSPB1;EDN1;FLT4;AKT1
prerank,ribosomal large subunit assembly (GO:0000027),-0.5392147622953867,-1.596199752199587,0.019011406844106463,0.20613124496914484,1.0,9/24,15.86%,RPL6;RPL10;RPL11;RPL23A;NOP2;RPL3;PPAN;MDN1;RPL24
prerank,extracellular structure organization (GO:0043062),0.3718673114045944,1.5960975593574667,0.001976284584980237,0.40804441175301187,1.0,36/204,6.84%,COL4A6;LAMA1;COL4A5;ADAMTS6;ITGA9;COL13A1;ADAMTS12;FBN1;LAMA2;LAMC3;FBN2;DDR2;ADAMTS10;COL1A2;NID2;COL22A1;MATN3;ITGA11;ADAMTS5;DCN;NID1;RECK;MIA;COL4A4;TNC;MMP16;DDR1;COL16A1;LUM;ADAM12;SERPINE1;COL4A3;ITGAD;COL10A1;COL8A2;MMP11
prerank,regulation of interleukin-12 production (GO:0032655),-0.4617427639785562,-1.5959499498645175,0.011049723756906077,0.2055233698525309,1.0,13/47,20.35%,FOXP1;THBS1;PLCG2;CMKLR1;TLR3;HSPD1;TIRAP;TLR4;SYK;JAK3;LAPTM5;LGALS9;MAPK11
prerank,regulation of viral release from host cell (GO:1902186),-0.5682423944962989,-1.595093815643914,0.015355086372360844,0.20591623616139923,1.0,8/21,18.15%,MID2;TRIM25;CHMP2B;TRIM28;TRIM62;TSG101;TRIM5;CHMP2A
prerank,neurotransmitter transport (GO:0006836),0.44501191493651343,1.5946045631968941,0.010638297872340425,0.4080239125929752,1.0,21/73,13.99%,SLC1A3;ATP1A2;NRXN1;RIMS1;GABRA2;SLC29A1;SLC22A3;SLC38A1;SYT1;SNAP25;PDZD11;GLUL;GLS2;BRSK1;PTPRN2;STXBP3;GRM4;APBA1;SNAPIN;SLC1A2;PPFIA2
prerank,negative regulation of interleukin-8 production (GO:0032717),-0.5937053449221922,-1.5945795776215677,0.01904761904761905,0.20585373333922394,1.0,6/17,10.63%,TMSB4X;MAP2K5;KLF4;ANXA1;ANXA4;MAPKBP1
prerank,external encapsulating structure organization (GO:0045229),0.3717784625756142,1.594051909064492,0.00196078431372549,0.405261480135202,1.0,36/205,6.84%,COL4A6;LAMA1;COL4A5;ADAMTS6;ITGA9;COL13A1;ADAMTS12;FBN1;LAMA2;LAMC3;FBN2;DDR2;ADAMTS10;COL1A2;NID2;COL22A1;MATN3;ITGA11;ADAMTS5;DCN;NID1;RECK;MIA;COL4A4;TNC;MMP16;DDR1;COL16A1;LUM;ADAM12;SERPINE1;COL4A3;ITGAD;COL10A1;COL8A2;MMP11
prerank,circulatory system development (GO:0072359),-0.3906243561138027,-1.593421982712036,0.001937984496124031,0.2067937866476987,1.0,40/118,16.10%,FN1;TEK;PLCE1;MEF2C;HEG1;CXADR;NXN;NOTCH1;TGFBR2;MEF2A;RAMP2;TBX1;COL3A1;SOX17;CDKN1B;PDLIM1;TGFB1;RBM20;TGFB2;CRIP1;HDAC9;STRA6;PKD1;MICAL2;NOTCH4;CASP8;FLT4;SOX18;SMG9;FOXC2;NF1;TCF25;ACVR1;SOX4;HEY1;SRF;PIK3CA;PDLIM3;CDKN1A;ZFPM2
prerank,regulation of interleukin-6 production (GO:0032675),-0.40854817151910533,-1.5929032146251134,0.00819672131147541,0.20669057756860348,1.0,38/96,31.22%,AFAP1L2;LBP;PLCG2;IFIH1;APP;IL33;TLR3;DHX9;TWIST1;HSPD1;TIRAP;CD74;MAVS;TLR4;SPHK2;SYK;NOD2;IL17RA;PTPN6;TNFAIP3;POU2F2;XBP1;ARHGEF2;CD200;LGALS9;PTPN22;AIF1;BCL10;TREM2;TMEM106A;C1QTNF4;TLR6;HYAL2;TLR1;C5AR2;NOS2;MBP;TYROBP
prerank,response to hydrogen peroxide (GO:0042542),-0.4751936926224833,-1.59210079846705,0.005628517823639775,0.20707495760751865,1.0,28/45,39.61%,MAP3K5;NET1;RPS3;ANXA1;CYP1B1;RIPK1;STK25;GPX1;RHOB;IMPACT;FXN;TNFAIP3;STK26;RELA;ECT2;PDCD10;PRKCD;PARK7;SOD1;AQP1;ABL1;HP;MAPK7;ANKZF1;FYN;OSER1;PLEKHA1;PPIF
prerank,protein localization to cell-cell junction (GO:0150105),-0.6150459820532936,-1.5920879821103946,0.019855595667870037,0.20600956773129755,1.0,5/15,3.37%,ACTB;LSR;ACTG1;F11R;TJP2
prerank,negative regulation of Rho protein signal transduction (GO:0035024),-0.5917252883312942,-1.5917987918379706,0.02,0.2053043858728268,1.0,8/18,16.13%,HEG1;RASIP1;CCDC125;MYOC;TNFAIP1;ABL2;MET;KCTD10
prerank,cyclic-nucleotide-mediated signaling (GO:0019935),0.5071758879297537,1.590765672826225,0.026200873362445413,0.40985312206337216,1.0,5/35,1.87%,IRAG1;ADCY2;ADCY1;KSR1;PDE7B
prerank,lamellipodium assembly (GO:0030032),-0.5295480916745455,-1.5904371691638766,0.01107011070110701,0.20688112527010882,1.0,16/26,24.65%,ABLIM1;PARVB;S1PR1;RAC1;ABLIM3;SPATA13;VCL;SPEF1;ABLIM2;ARHGEF4;ARHGEF6;PTPRO;DMTN;CARMIL1;GOLPH3;CCDC88A
prerank,regulation of vascular associated smooth muscle cell migration (GO:1904752),-0.6579901888245998,-1.5902781133271744,0.01717557251908397,0.20605966071461299,1.0,4/12,5.18%,MEF2C;PRKG1;IGFBP5;DOCK4
prerank,regulation of T cell cytokine production (GO:0002724),-0.6016570880534623,-1.5901888205947872,0.018315018315018316,0.20516377838868272,1.0,4/15,7.20%,B2M;CD55;SMAD7;TNFRSF1B
prerank,regulation of epidermal growth factor-activated receptor activity (GO:0007176),0.550457285956258,1.589619757630418,0.04329004329004329,0.408952805057453,1.0,6/26,7.40%,ERRFI1;AREG;CBLB;TGFA;VPS25;ZFYVE28
prerank,ribonucleoprotein complex biogenesis (GO:0022613),-0.44560345683889546,-1.5893250340353693,0.01968503937007874,0.20558539192424144,1.0,23/57,20.67%,RPS16;RPL26;RPS25;RPS15;NOP14;RPL38;RPL11;RPS28;RPL14;RPS24;RPS19;RPL35A;CUL4A;PES1;DHX37;RPS7;RPS6;WDR74;EMG1;TGS1;RPL7;WDR12;RPL5
prerank,axon guidance (GO:0007411),0.3666348031112751,1.5892440656563822,0.0,0.4059896780728699,1.0,38/201,9.90%,LAMA1;PLXNA2;ROBO1;EPHA7;PIK3R1;NRP1;ROBO2;LAMA2;LRTM1;SEMA5A;NRXN1;GDNF;CNTN4;GLI2;EPHA3;PRKCA;EPHA6;DOK2;SEMA3A;ARTN;RHOH;KIF5C;DAB1;SEMA3D;EFNA3;IRS2;NPTN;NRXN3;EPHB1;ALCAM;UNC5C;RYK;UNC5D;CDK5R1;EPHA8;DCC;NCAM1;EPHA5
prerank,regulation of biomineral tissue development (GO:0070167),0.5315451235012132,1.5890407086213931,0.050997782705099776,0.4025757478053843,1.0,8/26,6.28%,ENPP1;NOTUM;DDR2;CYP27B1;AHSG;ROCK2;CEBPB;ANKH
prerank,positive regulation of epidermal growth factor-activated receptor activity (GO:0045741),0.6851609115397858,1.587468777685621,0.0405727923627685,0.4027477199986699,1.0,2/10,3.55%,AREG;TGFA
prerank,positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),-0.5800793249231231,-1.5870592029828812,0.025974025974025976,0.2086702743525527,1.0,13/18,12.82%,RHOJ;KDR;ANXA1;MAP3K3;HDAC7;HDAC9;VEGFA;GATA2;PIK3C2A;JCAD;FOXC2;CIB1;FGF2
prerank,toll-like receptor signaling pathway (GO:0002224),-0.4118836539604696,-1.585529635372152,0.008048289738430584,0.21025378013114934,1.0,22/84,13.56%,SCARA3;LBP;PLCG2;RPS6KA3;IRAK2;MAP3K1;MAPKAPK3;UBB;UBC;RPS27A;SFTPA2;SFTPA1;IKBKB;CASP8;TLR3;RIPK1;HSPD1;TIRAP;CTSB;PIK3AP1;TLR4;S100A1
prerank,membrane depolarization during action potential (GO:0086010),0.5359085356306431,1.5854513709065337,0.020491803278688523,0.40429298247377055,1.0,8/26,7.51%,ATP1A2;SCN7A;SLC8A1;SCN3B;SCN3A;CACNA1I;SCN2A;CACNA1G
prerank,regulation of wound healing (GO:0061041),-0.4685239067230796,-1.5850831281962978,0.007677543186180422,0.20995254040685823,1.0,17/42,24.19%,CAV1;OCLN;ACTG1;PTK2;ANXA1;CD109;CRK;SRSF6;PRKCE;FGF2;HRAS;TNFAIP3;PLAU;CADM4;TNFRSF12A;DMTN;CLDN1
prerank,regulation of cytokine-mediated signaling pathway (GO:0001959),-0.4186435197262548,-1.58506307834245,0.012987012987012988,0.20894414014118276,1.0,24/72,18.03%,TAX1BP1;RACK1;LIFR;HIPK1;ELF1;IRAK2;HSP90AB1;IKBKB;CBFB;CASP8;RIPK1;CD74;SYK;TRAF1;AGPAT1;TNFRSF1A;JAK2;SIGIRR;MADD;PTPN6;TNFAIP3;STAT1;IFNGR1;CHUK
prerank,regulation of activated T cell proliferation (GO:0046006),0.5282429250908975,1.5840556804053192,0.017817371937639197,0.40422206336313704,1.0,5/30,8.31%,IGF1;IGFBP2;CD274;IGF2;IL18
prerank,phospholipid transport (GO:0015914),-0.452238166374977,-1.5830063341720635,0.005780346820809248,0.21161692698381407,1.0,16/52,14.03%,PITPNC1;ATP10A;PLTP;ATP8B1;ATP8A1;SCARB1;ATP11C;TNFAIP8L3;ATP11A;MFSD2A;PITPNA;ATP9B;ABCG1;PRELID2;APOE;PITPNM1
prerank,regulation of intracellular estrogen receptor signaling pathway (GO:0033146),-0.5092845140980046,-1.5828822432521115,0.016728624535315983,0.21074747929195223,1.0,12/29,20.15%,ESR1;UFM1;CBFB;KANK2;DDRGK1;KMT2D;WBP2;VPS11;STRN3;UFL1;UBA5;SRARP
prerank,membrane depolarization during cardiac muscle cell action potential (GO:0086012),0.5967699837246581,1.5800428384651977,0.05010438413361169,0.41130841951807845,1.0,7/17,7.60%,ATP1A2;SLC8A1;SCN3B;ANK2;CACNA2D1;CACNA1G;CACNB2
prerank,transforming growth factor beta receptor signaling pathway (GO:0007179),-0.40713140971028566,-1.5800111131013086,0.002109704641350211,0.21502279497470234,1.0,31/87,15.00%,CLDN5;PARD3;ID1;PXN;TGFBR2;F11R;NLK;PTK2;COL3A1;SMAD9;FERMT2;SMAD7;TGFB1;TGFB2;FKBP1A;UBB;PRKCZ;UBC;RPS27A;SMAD6;TGFB3;USP9X;ACVR1;NRROS;ZMIZ2;ENG;USP15;SMURF1;ARHGEF18;EID2;SMAD4
prerank,heme catabolic process (GO:0042167),-0.6193279681718955,-1.5787612093752277,0.016666666666666666,0.21516269322292753,1.0,2/14,1.27%,ABCG2;SLCO2B1
prerank,porphyrin-containing compound catabolic process (GO:0006787),-0.6193279681718955,-1.5787612093752277,0.016666666666666666,0.21516269322292753,1.0,2/14,1.27%,ABCG2;SLCO2B1
prerank,positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),-0.48931464247472184,-1.5766342930441155,0.013257575757575758,0.21778992516608928,1.0,11/34,11.58%,LIMS2;RREB1;DOCK1;FERMT2;RAC1;LIMS1;NEDD9;CRK;MYOC;S100A10;CIB1
prerank,response to cAMP (GO:0051591),-0.4794270301405606,-1.5755006405724605,0.014084507042253521,0.21885789189470603,1.0,15/37,23.48%,RAP1A;RAP1B;RAPGEF1;IGFBP5;PDE2A;KCNQ1;EZR;NDUFS4;AKAP6;HCN2;STAT1;RAPGEF3;RAPGEF2;PKD2;DMTN
prerank,regulation of B cell receptor signaling pathway (GO:0050855),-0.5464310339310979,-1.5753291224643038,0.018148820326678767,0.21813956115939928,1.0,6/21,6.72%,PRKCH;FOXP1;SLC39A10;ELF1;CD81;CBFB
prerank,desensitization of G protein-coupled receptor signaling pathway (GO:0002029),0.6598459368120431,1.575296216715672,0.046460176991150445,0.42099309489773884,1.0,3/11,5.95%,GRK3;GTF2H2;ADM
prerank,response to prostaglandin E (GO:0034695),0.671898513041242,1.5752680678818534,0.06329113924050633,0.4171415233997239,1.0,2/10,4.24%,TGFBR3;SFRP1
prerank,positive regulation of glial cell differentiation (GO:0045687),0.5866944926991009,1.5751970643021844,0.03333333333333333,0.4135756909003564,1.0,4/17,1.70%,BMP2;IL34;PTN;SERPINE2
prerank,glycosaminoglycan catabolic process (GO:0006027),0.4523131523846069,1.573753524262803,0.022448979591836733,0.41356821938349514,1.0,13/55,7.32%,CEMIP;GPC6;SPAM1;HYAL3;FMOD;DCN;GPC4;GPC2;OMD;GNS;LUM;GALNS;OGN
prerank,ceramide biosynthetic process (GO:0046513),-0.47411654926608365,-1.573102407351477,0.011494252873563218,0.2212942478236744,1.0,10/40,8.90%,SGMS1;ST6GALNAC3;SGMS2;ST8SIA4;SPTLC2;DEGS2;SPTLC1;ST8SIA6;SPTSSB;ASAH2
prerank,regulation of JNK cascade (GO:0046328),-0.398259340627584,-1.5701322016405976,0.00411522633744856,0.22554536591940427,1.0,32/101,15.49%,MECOM;IGF1R;MAP3K5;PTK2B;NCOR1;TPD52L1;DAB2IP;APP;MFHAS1;MINK1;TAOK3;SH3RF2;RASSF2;RIPK1;AIDA;FLT4;ZMYND11;FZD7;MAP3K11;TIRAP;TAOK2;ULK4;GADD45G;DUSP3;ITCH;EDA2R;COPS5;TRAF1;HRAS;SDCBP;EGFR;NOD2
prerank,regulation of NIK/NF-kappaB signaling (GO:1901222),-0.41590060259385936,-1.5699378718071233,0.0,0.22480534866821814,1.0,38/76,32.30%,TMSB4X;NR3C2;NOD1;ACTN4;NFKBIA;CCN3;RPS3;APP;HDAC7;LIMS1;ADIPOR1;EZR;RASSF2;TLR3;TCIM;TLR4;PHB2;EGFR;NOD2;RELA;ADGRG3;LAPTM5;TRIP6;LGALS9;TSPAN6;PTPN22;TRAF6;PTP4A3;PDCD4;SPI1;CD86;C1QTNF4;TERF2IP;RHOA;CD14;TRIM44;NLRP3;NLRC3
prerank,regulation of gene expression by genetic imprinting (GO:0006349),0.6782696055386612,1.569499788729139,0.0670995670995671,0.421925628406484,1.0,3/10,8.25%,KDM1B;PCGF5;IGF2
prerank,positive regulation of muscle hypertrophy (GO:0014742),0.6057489684024895,1.569226921322187,0.04697986577181208,0.4188536342531924,1.0,3/15,2.64%,IGF1;ROCK2;PRKCA
prerank,regulation of macrophage chemotaxis (GO:0010758),-0.5481762191938271,-1.568148753926281,0.02390438247011952,0.22723538248800318,1.0,6/21,4.89%,MTUS1;THBS1;PTK2B;MAPK3;PTK2;CMKLR1
prerank,cell junction organization (GO:0034330),-0.41420003783394765,-1.566340143980943,0.009487666034155597,0.2296857289426849,1.0,16/71,4.85%,ACTB;OCLN;LIMS2;APBB2;CXADR;ACTG1;OPHN1;AGRN;TJP2;RAB8B;FERMT2;TGFB1;APP;TGFB2;SDK1;LIMS1
prerank,regulation of interferon-alpha production (GO:0032647),-0.5387664752619072,-1.5652053192162743,0.025925925925925925,0.23100745368047756,1.0,13/23,34.37%,IFIH1;TLR3;DHX9;HSPD1;MAVS;TLR4;STAT1;CHUK;SETD2;PTPRS;NLRC3;IRF3;TLR8
prerank,pyruvate metabolic process (GO:0006090),-0.44631074624857536,-1.5647630054639783,0.011090573012939002,0.2308675723921235,1.0,17/52,23.23%,BSG;ME1;GPI;DLD;HK1;PGM1;PKM;GAPDH;GLO1;LDHA;SLC16A1;ME2;PGK1;PGAM1;PGAM4;PFKL;ENO1
prerank,negative regulation of binding (GO:0051100),-0.41499408538900795,-1.564356243202681,0.007736943907156673,0.23057941374380211,1.0,33/81,25.92%,LEF1;CAV1;ACTB;RACK1;NFKBIA;CTSZ;SMO;RALB;NES;BAX;AKT1;DISC1;IFIT1;CTNNBIP1;CAMK1;E2F1;STYX;MITD1;SUMO3;JAK2;CDKN1A;GTF2F1;KDM1A;WAPL;MDFI;PIN1;TMBIM6;PPP1CA;ZFPM1;PRKCD;CARD16;BTAF1;PARK7
prerank,protein targeting to lysosome (GO:0006622),-0.5474704287031928,-1.5634942674856886,0.02142857142857143,0.23132552315205718,1.0,10/20,25.20%,AP3M1;HSPA8;NCOA4;RAB7A;AP4M1;GCC2;LAPTM5;ZFYVE16;GNPTAB;VPS4A
prerank,histone deubiquitination (GO:0016578),-0.5783364000238018,-1.563332171302093,0.02071563088512241,0.23062507070239158,1.0,9/18,19.41%,TRRAP;BRCC3;USP7;UIMC1;USP3;ENY2;USP15;USP22;USP49
prerank,phosphate ion homeostasis (GO:0055062),0.6586012513455253,1.562457167224247,0.05555555555555555,0.4335289541435218,1.0,2/10,8.80%,ENPP1;FGFR4
prerank,negative regulation of stress-activated MAPK cascade (GO:0032873),-0.4905783781645603,-1.5611520018465772,0.018796992481203006,0.23382972891243128,1.0,11/36,12.63%,MECOM;NCOR1;FOXO1;PPIA;TAOK3;EZR;SH3RF2;AIDA;ZMYND11;DUSP3;ITCH
prerank,female gamete generation (GO:0007292),0.5161775909916119,1.559874328342365,0.030864197530864196,0.43756223687125256,1.0,11/29,15.77%,PTN;DMC1;PRDM9;NANOS3;DIAPH2;MCM9;FMN2;PIWIL2;MCM8;PARN;METTL3
prerank,positive regulation of lyase activity (GO:0051349),-0.6064137294224503,-1.5593918466996035,0.02464788732394366,0.236270786643257,1.0,10/14,33.86%,NOS3;ORAI1;NF1;FXN;CACNA1D;CACNA1C;PARK7;NOS2;NOS1;AKAP5
prerank,neutrophil activation involved in immune response (GO:0002283),-0.326879602376496,-1.5592706222964114,0.0,0.23545816188332294,1.0,144/428,24.91%,PTPRB;ANO6;PECAM1;B2M;RAP1A;EEF1A1;PTPRJ;ATP8A1;OSTF1;CD55;ADGRE5;RAP1B;CD93;GPI;IQGAP1;EEF2;MANBA;STK10;CD44;HSP90AB1;VAMP7;RAB27A;CTSZ;RAC1;IGF2R;ANXA2;PGM1;HSPA8;PPIA;ADAM10;ATP11A;VAT1;DIAPH1;RAB18;PSAP;LTA4H;ACLY;PKM;CTSC;FTL;CAP1;TNFRSF1B;JUP;PRCP;SVIP;STOM;ARPC5;QSOX1;IMPDH1;NHLRC3;SPTAN1;CTSD;CST3;TMC6;ENPP4;VCL;COMMD9;ATP6V0C;CSNK2B;LAMP1;ATG7;FCER1G;PGLYRP1;CEP290;TSPAN14;FABP5;VCP;TOLLIP;MOSPD2;RAB4B;LRG1;ILF2;CTSB;SURF4;FRK;RAB24;PDAP1;RAB7A;DBNL;FTH1;TUBB4B;PSMD14;COMMD3;FAF2;SYK;ERP44;CCT2;HRNR;FUCA2;LAMTOR2;SDCBP;GDI2;DYNC1LI1;GUSB;CFP;CAB39;TIMP2;PTPN6;PSMD11;CDK13;SLC15A4;DSP;PSMD12;SLC2A3;HSP90AA1;HMOX2;IST1;HSPA1A;TMEM30A;ATP11B;PLAU;ADGRG3;CCT8;CYBB;PYGL;CPNE3;TMEM179B;CANT1;PSMB1;HSPA1B;PSMC3;C3;PGM2;PGAM1;PFKL;CD68;ARHGAP45;LCN2;NRAS;PSMA2;ABCA13;TOM1;PRKCD;RAB3D;DOK3;CTSS;SLC27A2;STXBP2;DPP7;CYB5R3;ALAD;PLAUR;MLEC;ANXA3
prerank,cellular response to peptide hormone stimulus (GO:0071375),0.4082875892266175,1.5584361240319025,0.004228329809725159,0.43777604634467443,1.0,19/102,10.66%,ADCY7;ENPP1;ADCY2;PIK3R1;ADCY1;TBC1D4;ADCY5;PDPK1;PRKACA;SLC30A10;MYO5A;IRS2;RAB10;PDE3B;C2CD5;INSIG2;PRKCI;LPIN3;ADCY8
prerank,positive regulation of protein metabolic process (GO:0051247),-0.3960689993820562,-1.5583305415078665,0.005917159763313609,0.23626907033169683,1.0,37/110,17.44%,WWP1;GPC3;NEDD4L;MAP2K5;NFKBIA;KLF2;FOXO1;KLF4;DAB2IP;CDKN1B;TGFB1;APP;RNF41;WWP2;EGLN2;IDE;PLK2;AKT1;NDUFA13;ATG7;VCP;PAEP;INHBA;RAB7A;OAZ2;APOE;ABCA2;ITCH;SMURF1;RAB1A;LDB1;SNF8;TNFAIP3;CSNK2A1;NR1H2;FZR1;NSF
prerank,regulation of nitric-oxide synthase biosynthetic process (GO:0051769),-0.6285865867980511,-1.5577417395950086,0.024475524475524476,0.23646221492243422,1.0,7/13,15.49%,NAMPT;KDR;IL33;EDN1;TLR4;JAK2;NOD2
prerank,neutrophil mediated immunity (GO:0002446),-0.3265483477416305,-1.5576433612608571,0.0,0.23562366073276228,1.0,145/432,24.91%,PTPRB;ANO6;PECAM1;B2M;RAP1A;EEF1A1;PTPRJ;ATP8A1;OSTF1;CD55;ADGRE5;RAP1B;CD93;GPI;IQGAP1;EEF2;MANBA;STK10;CD44;HSP90AB1;VAMP7;RAB27A;CTSZ;RAC1;IGF2R;ANXA2;PGM1;HSPA8;PPIA;ADAM10;ATP11A;VAT1;DIAPH1;RAB18;PSAP;LTA4H;ACLY;PKM;CTSC;FTL;CAP1;TNFRSF1B;JUP;PRCP;SVIP;STOM;ARPC5;QSOX1;IMPDH1;NHLRC3;SPTAN1;CTSD;CST3;TMC6;ENPP4;VCL;COMMD9;ATP6V0C;CSNK2B;LAMP1;ATG7;FCER1G;PGLYRP1;CEP290;TSPAN14;FABP5;VCP;TOLLIP;MOSPD2;RAB4B;LRG1;ILF2;CTSB;SURF4;FRK;RAB24;PDAP1;RAB7A;DBNL;FTH1;TUBB4B;PSMD14;COMMD3;FAF2;ERP44;ACE;CCT2;HRNR;FUCA2;LAMTOR2;SDCBP;GDI2;DYNC1LI1;GUSB;CFP;CAB39;TIMP2;PTPN6;PSMD11;CDK13;SLC15A4;DSP;PSMD12;SLC2A3;HSP90AA1;HMOX2;IST1;HSPA1A;TMEM30A;ATP11B;IRAK4;PLAU;ADGRG3;CCT8;CYBB;PYGL;CPNE3;TMEM179B;CANT1;PSMB1;HSPA1B;PSMC3;C3;PGM2;PGAM1;PFKL;CD68;ARHGAP45;LCN2;NRAS;PSMA2;ABCA13;TOM1;PRKCD;RAB3D;DOK3;CTSS;SLC27A2;STXBP2;DPP7;CYB5R3;ALAD;PLAUR;MLEC;ANXA3
prerank,intracellular steroid hormone receptor signaling pathway (GO:0030518),-0.476423049026763,-1.5561665289046516,0.02389705882352941,0.23756617215191111,1.0,14/35,11.52%,NR3C2;ESR1;DDX5;DDX17;PLPP1;PPARGC1B;RBFOX2;KDM3A;SAFB;NR3C1;EGLN2;ARID1A;NCOA4;WBP2
prerank,regulation of membrane repolarization (GO:0060306),-0.626775812284748,-1.5558838025025856,0.03018867924528302,0.23701088640942197,1.0,7/13,14.41%,CAV1;KCNJ2;NEDD4L;KCNQ1;CACNB3;AKAP6;CASQ2
prerank,cardiac muscle tissue development (GO:0048738),0.4629971044360772,1.5551185789385094,0.016494845360824743,0.4434786794167171,1.0,9/50,3.68%,BMP2;SGCZ;GJB6;BMP5;NRG1;GJA1;TBX18;SGCD;CSRP3
prerank,sodium ion transmembrane transport (GO:0035725),0.411842713759903,1.554471344440771,0.006237006237006237,0.44151299290259965,1.0,17/84,9.33%,ATP1A2;NALCN;SLC24A3;SCN7A;SLC6A12;SLC6A9;SLC8A1;SLC6A13;SCN3B;SCN3A;SLC9A7;ASIC2;SCN2A;SLC24A4;SLC24A2;SLC6A11;SLC6A1
prerank,embryonic eye morphogenesis (GO:0048048),0.6420818619157985,1.5539871295999834,0.04719101123595506,0.43909105708542195,1.0,4/11,7.78%,FBN1;FBN2;MFAP2;RARG
prerank,primary alcohol metabolic process (GO:0034308),0.5345213915584797,1.5536335063771487,0.043209876543209874,0.43641433353588743,1.0,2/25,2.06%,IGF1;DHRS3
prerank,ureteric bud development (GO:0001657),0.5843154938167583,1.5532958296143677,0.03648068669527897,0.43385896802361357,1.0,4/17,1.11%,BMP2;ROBO2;SALL1;FGFR2
prerank,positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),0.5537806424458789,1.5529507800819684,0.04821802935010482,0.43127664749071454,1.0,4/21,9.35%,IGF1;GJA1;DNMT1;BMPR1A
prerank,neutrophil degranulation (GO:0043312),-0.3258255572374396,-1.5528907814347428,0.0,0.24186685862539556,1.0,143/425,24.91%,PTPRB;ANO6;PECAM1;B2M;RAP1A;EEF1A1;PTPRJ;ATP8A1;OSTF1;CD55;ADGRE5;RAP1B;CD93;GPI;IQGAP1;EEF2;MANBA;STK10;CD44;HSP90AB1;VAMP7;RAB27A;CTSZ;RAC1;IGF2R;ANXA2;PGM1;HSPA8;PPIA;ADAM10;ATP11A;VAT1;DIAPH1;RAB18;PSAP;LTA4H;ACLY;PKM;CTSC;FTL;CAP1;TNFRSF1B;JUP;PRCP;SVIP;STOM;ARPC5;QSOX1;IMPDH1;NHLRC3;SPTAN1;CTSD;CST3;TMC6;ENPP4;VCL;COMMD9;ATP6V0C;CSNK2B;LAMP1;ATG7;FCER1G;PGLYRP1;CEP290;TSPAN14;FABP5;VCP;TOLLIP;MOSPD2;RAB4B;LRG1;ILF2;CTSB;SURF4;FRK;RAB24;PDAP1;RAB7A;DBNL;FTH1;TUBB4B;PSMD14;COMMD3;FAF2;ERP44;CCT2;HRNR;FUCA2;LAMTOR2;SDCBP;GDI2;DYNC1LI1;GUSB;CFP;CAB39;TIMP2;PTPN6;PSMD11;CDK13;SLC15A4;DSP;PSMD12;SLC2A3;HSP90AA1;HMOX2;IST1;HSPA1A;TMEM30A;ATP11B;PLAU;ADGRG3;CCT8;CYBB;PYGL;CPNE3;TMEM179B;CANT1;PSMB1;HSPA1B;PSMC3;C3;PGM2;PGAM1;PFKL;CD68;ARHGAP45;LCN2;NRAS;PSMA2;ABCA13;TOM1;PRKCD;RAB3D;DOK3;CTSS;SLC27A2;STXBP2;DPP7;CYB5R3;ALAD;PLAUR;MLEC;ANXA3
prerank,cellular response to cAMP (GO:0071320),-0.5017184123732134,-1.5528509883160564,0.018072289156626505,0.24087253098990796,1.0,13/30,23.48%,RAP1A;RAP1B;RAPGEF1;IGFBP5;PDE2A;KCNQ1;EZR;AKAP6;HCN2;RAPGEF3;RAPGEF2;PKD2;DMTN
prerank,positive regulation of cell-matrix adhesion (GO:0001954),-0.4632623649112676,-1.5522463559513144,0.00945179584120983,0.24090430909777305,1.0,16/42,11.58%,UTRN;TEK;CDK6;PTPRJ;PTK2B;KDR;FERMT2;RAC1;LIMS1;VEGFA;MYOC;JUP;PPM1F;S100A10;EMP2;CIB1
prerank,activation of protein kinase B activity (GO:0032148),0.5110924220555504,1.551738435626594,0.02412280701754386,0.4311522711953292,1.0,5/29,3.10%,IGF1;NTRK3;NRG1;PDPK1;OSBPL8
prerank,regulation of substrate adhesion-dependent cell spreading (GO:1900024),-0.45063686112989965,-1.551655524589603,0.020637898686679174,0.24099096545119994,1.0,14/47,12.21%,LIMS2;RREB1;DOCK1;ACTN4;PTK2;FERMT2;RAC1;LIMS1;NEDD9;CRK;MYOC;S100A10;CIB1;RCC2
prerank,muscle tissue morphogenesis (GO:0060415),0.5883844811390894,1.551613454996925,0.0367816091954023,0.42795327141602474,1.0,4/16,6.27%,TGFBR3;BMP2;EFEMP2;MYLK
prerank,heart contraction (GO:0060047),0.4710118019521552,1.5512712265089081,0.036511156186612576,0.42546754927427277,1.0,8/41,4.22%,ATP1A2;SGCZ;SLC8A1;SCN3B;SGCD;TNNC1;CSRP3;TNNI3
prerank,neuromuscular junction development (GO:0007528),0.5376413094876631,1.5490807088145564,0.04842105263157895,0.4279110151825829,1.0,10/24,12.54%,PDZRN3;PPFIBP2;CHRNA1;LRP4;UNC13C;CACNB4;CACNB2;CACNB1;MUSK;DOK7
prerank,positive regulation of cell adhesion mediated by integrin (GO:0033630),-0.5732450065517755,-1.5486749042443413,0.022263450834879406,0.24581962258027187,1.0,7/17,17.85%,PODXL;PIEZO1;TGFB2;FOXC2;CIB1;SYK;RET
prerank,ethanol metabolic process (GO:0006067),0.6456245978425763,1.5485066695492657,0.06666666666666667,0.4261295516576477,1.0,1/12,0.10%,ALDH1A1
prerank,negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),-0.485044079106936,-1.547310599007341,0.027675276752767528,0.24756921174990854,1.0,18/33,26.02%,CDK6;KLF4;FHL1;KANK2;RB1;FAM107A;CDK4;CDKN1A;CDKN2C;CDK2AP2;E2F7;RBL1;PKD2;PLK3;CCL2;CDKN2B;DCUN1D3;PLK5
prerank,membrane depolarization (GO:0051899),0.49865030046265557,1.546784770230523,0.029473684210526315,0.4277777969098143,1.0,11/32,9.65%,SCN7A;CACNA1E;SCN3B;P2RX4;SCN3A;CACNA1I;CACNG4;SCN2A;CACNA1G;CACNB4;CHRNA4
prerank,amyloid precursor protein metabolic process (GO:0042982),-0.5560232770881588,-1.5466481471503941,0.030131826741996232,0.24786344961807238,1.0,7/18,14.31%,ADAM10;BACE1;ADAM19;ABCG1;PSENEN;APOE;APH1A
prerank,activation of protein kinase activity (GO:0032147),0.399210719595985,1.5462009051283447,0.00796812749003984,0.4260579137722442,1.0,13/106,5.08%,IGF1;ADCY7;ADCY2;ADCY1;NRK;NTRK3;ADCY5;NRG1;PDPK1;PRKACA;OSBPL8;GHR;IL4
prerank,positive regulation of cell migration (GO:0030335),-0.346164132520367,-1.5454656097037425,0.0020325203252032522,0.2489682412246884,1.0,52/253,9.90%,FN1;LEF1;PECAM1;PODXL;CAV1;FLT1;IGF1R;ITGA6;RREB1;SEMA6A;SEMA3C;THBS1;GAB1;NOTCH1;ACTG1;SEMA7A;DOCK1;PLCG2;FGF1;RACK1;PTK2B;RAB11A;BMPR2;ACTN4;KDR;F3;PTK2;DAB2IP;FERMT2;TGFB1;TGFB2;SMO;SHTN1;ADAM10;NEDD9;CD151;VEGFA;SH3RF2;MYOC;PPM1F;EDN1;MMP14;ELP6;INSR;PLAA;PFN1;PDGFC;PDGFA;LAMC2;FAM107A;SEMA3G;DDRGK1
prerank,alpha-amino acid catabolic process (GO:1901606),0.5105478488294038,1.5451504644636023,0.03289473684210526,0.4256886853020161,1.0,8/29,10.07%,ALDH4A1;IL4I1;PRODH;ACADSB;TDO2;KMO;DDO;KYNU
prerank,regulation of Wnt signaling pathway (GO:0030111),0.395509736377297,1.5435369180524225,0.010395010395010396,0.42653589899425054,1.0,21/108,7.51%,NOTUM;BMP2;SALL1;WLS;DAAM2;TRABD2B;CDK14;FGFR2;SULF1;SULF2;LRP1;PTK7;SFRP1;RNF43;WIF1;PRKN;SENP2;TAX1BP3;CTNND2;TLE1;CXXC4
prerank,negative regulation of potassium ion transport (GO:0043267),-0.6228146029917863,-1.5429027360966077,0.02112676056338028,0.25314003197467055,1.0,5/13,15.37%,CAV1;NEDD4L;PTK2B;CASQ2;CAB39
prerank,positive regulation of calcineurin-mediated signaling (GO:0106058),0.623062611441447,1.5416695756899486,0.049783549783549784,0.4247921601148113,1.0,2/12,4.83%,IGF1;CAMTA1
prerank,positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),0.623062611441447,1.5416695756899486,0.049783549783549784,0.4247921601148113,1.0,2/12,4.83%,IGF1;CAMTA1
prerank,negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),0.41954564432196056,1.5405652860474086,0.02178217821782178,0.42468905640223065,1.0,16/74,7.96%,IGF1;TCF7L2;AR;BMP5;EYA2;GDNF;BCL2;SH3RF1;PHIP;CFLAR;IL4;SERPINE1;GSTP1;EYA1;SCG2;TGFBR1
prerank,modulation by symbiont of host process (GO:0044003),-0.6553209956498456,-1.5401513734572934,0.03723404255319149,0.2577305366525684,1.0,7/10,23.23%,B2M;UBB;UBC;RPS27A;PGK1;MRC1;ENO1
prerank,positive regulation of cell motility (GO:2000147),-0.35530614143234085,-1.5401044126232584,0.0,0.25670191972555684,1.0,54/205,14.66%,LEF1;PECAM1;PODXL;CAV1;FLT1;IGF1R;ITGA6;SEMA6A;SEMA3C;THBS1;SPOCK2;NOTCH1;ACTG1;SEMA7A;FGF1;RACK1;PTK2B;ACTN4;KDR;F3;PTK2;FERMT2;TGFB1;SMO;CAVIN1;ADAM10;NEDD9;CD151;VEGFA;SH3RF2;MYOC;PPM1F;EDN1;MMP14;ELP6;INSR;PDGFC;PDGFA;TWIST1;LAMC2;FAM107A;SEMA3G;DDRGK1;WNT11;HSPA5;CIB1;ACVR1;CSF1R;PIK3R3;HRAS;NTN1;SDCBP;SPAG9;EGFR
prerank,camera-type eye development (GO:0043010),0.5298865802903625,1.5400407373499656,0.045548654244306416,0.4229255298000079,1.0,4/25,1.47%,LAMA1;FBN1;FBN2;TENM3
prerank,positive regulation of interleukin-2 production (GO:0032743),-0.5199178183111064,-1.5388734569746578,0.036036036036036036,0.2581429230003685,1.0,5/25,3.46%,SPTBN1;PLCG2;PDE4D;RPS3;ANXA1
prerank,regulation of metal ion transport (GO:0010959),0.590534019500302,1.5388089308574442,0.05739514348785872,0.42326569740986664,1.0,5/16,7.17%,ANK2;SLC30A10;CACNA2D1;BCL2;CAMK2B
prerank,negative regulation of transforming growth factor beta production (GO:0071635),-0.6647210192681855,-1.5381296689352815,0.03275529865125241,0.2586552330067601,1.0,10/10,33.58%,FN1;HSP90AB1;GATA6;TSKU;LAPTM4B;LILRB1;CD24;CDH3;TYROBP;FURIN
prerank,positive regulation of nitric-oxide synthase activity (GO:0051000),-0.576201771180022,-1.5379691442556642,0.03874538745387454,0.2579335190833131,1.0,7/16,20.07%,SCARB1;GCH1;AKT1;APOE;S100A1;NPR3;NUS1
prerank,UDP-N-acetylglucosamine metabolic process (GO:0006047),-0.6152084540116933,-1.5375351092855087,0.03136531365313653,0.25763879176018994,1.0,8/13,29.27%,SLC35A3;UAP1L1;GFPT1;AMDHD2;RENBP;PGM3;UAP1;GNPDA1
prerank,T-helper cell differentiation (GO:0042093),-0.5946458593258797,-1.5369795229749443,0.04107142857142857,0.25768949675819697,1.0,2/14,0.18%,LEF1;FOXP1
prerank,interleukin-1-mediated signaling pathway (GO:0070498),-0.38928499827011187,-1.536877041018326,0.001953125,0.2568432040223385,1.0,36/94,23.09%,RPS6KA5;NOD1;NFKBIA;MAPK3;IRAK2;MAP3K3;UBB;UBC;RPS27A;IL1R1;IKBKB;PSMA6;MAP3K8;PSMB5;TOLLIP;PSMC4;PSMC5;PSMD14;RBX1;PSMD8;NOD2;PSMD11;PSMB4;PSMD12;PSMC1;TAB2;RELA;CUL1;CHUK;PELI1;IRAK4;PSMA1;PSMB1;PSMC3;PSMA4;PSMA2
prerank,ribosomal large subunit biogenesis (GO:0042273),-0.427114939923483,-1.5365120293162817,0.005791505791505791,0.2565519115869427,1.0,25/54,27.42%,RPL6;RPL26;RPL10;RPL11;RPL14;RRP15;RPL23A;RPL35A;NOP2;PES1;RPL10A;RPL3;PPAN;MDN1;WDR74;RPL24;RPL7;WDR12;RPL5;NSA2;RSL1D1;RPL7A;RPF2;NPM1;TRAF7
prerank,positive regulation of lymphocyte chemotaxis (GO:0140131),-0.6026371741822394,-1.5354336143544258,0.05027932960893855,0.2575850513127332,1.0,3/14,4.91%,PTK2B;WNK1;ADAM10
prerank,embryonic organ morphogenesis (GO:0048562),0.4726145174259703,1.534185323050093,0.02591792656587473,0.43234251674507823,1.0,11/42,11.03%,FBN1;FBN2;FGFR2;HOXC4;PDGFRA;HOXB3;HOXC9;MFAP2;RARG;HOXB9;FUZ
prerank,axon extension (GO:0048675),0.5294500171205185,1.5339885592082132,0.0447427293064877,0.42968784703062946,1.0,6/23,7.19%,AUTS2;NRP1;SEMA5A;SEMA3A;NLGN3;ALCAM
prerank,regulation of axonogenesis (GO:0050770),0.44503579250427966,1.5332185670674277,0.02636916835699797,0.42868543973694945,1.0,15/51,15.35%,PLXNA2;ROBO1;ROBO2;LRRC4C;KIF13B;LRP4;MCF2;RTN4;PTEN;PLXNB2;BRSK1;NGFR;AMIGO1;MAP6;PAK1
prerank,axonogenesis (GO:0007409),0.35252133501951555,1.533179971892651,0.0019267822736030828,0.42574592932480215,1.0,43/237,9.90%,LAMA1;AUTS2;ROBO1;EPHA7;PIK3R1;NRP1;ROBO2;LAMA2;LRTM1;FGFR2;SEMA5A;NRXN1;GDNF;CNTN4;GLI2;EPHA3;PRKCA;EPHA6;DOK2;SEMA3A;ARTN;CTNNA2;KIF5C;DAB1;SLITRK4;SEMA3D;EFNA3;IRS2;NPTN;NLGN3;NRXN3;EPHB1;UNC5C;DOCK7;NRCAM;RYK;RAB10;UNC5D;CDK5R1;EPHA8;DCC;NCAM1;EPHA5
prerank,positive regulation of JNK cascade (GO:0046330),-0.4199682237030611,-1.532137116196735,0.014084507042253521,0.2630281190363744,1.0,22/70,15.49%,MAP3K5;PTK2B;TPD52L1;DAB2IP;APP;MFHAS1;MINK1;TAOK3;SH3RF2;RASSF2;RIPK1;FLT4;FZD7;MAP3K11;TIRAP;TAOK2;GADD45G;EDA2R;TRAF1;HRAS;SDCBP;NOD2
prerank,cellular response to alcohol (GO:0097306),0.48368055924414877,1.5305321673499515,0.023605150214592276,0.42965986665032996,1.0,7/42,4.24%,ADCY7;ADCY2;ADCY1;PTGFR;ADCY5;GNAI1;SFRP1
prerank,innate immune response (GO:0045087),-0.3478576916864834,-1.529443314074602,0.0,0.2673768262272591,1.0,56/217,18.09%,B2M;LBP;PLCG2;PTK2B;IFIH1;PTK2;MID2;GCH1;RPL39;TRIM25;ADAM15;APP;ADAR;MFHAS1;REL;NLRC5;NCF2;S100B;STYK1;IKBKB;IFITM1;IFITM3;TLR3;SRPK1;IFITM2;TRIM28;TRIM14;CLPB;RELB;IFIT1;FCER1G;PGLYRP1;DHX58;CD74;FRK;TRIM56;TTC4;TRIM62;ZDHHC1;MAVS;TLR4;NRROS;SYK;PHB2;TRIM68;TRIM5;POLR3A;CFP;NOD2;YES1;CX3CR1;ANKRD17;RELA;HCK;CHUK;SLA
prerank,regulation of type I interferon production (GO:0032479),-0.39461691475898175,-1.528092669455095,0.0099601593625498,0.26902723231578385,1.0,39/84,34.35%,TAX1BP1;IFIH1;TRIM25;NLRC5;LRRFIP1;RNF125;PRKDC;GAPDH;OTUD5;DDX41;UBE2L6;DHX9;TIRAP;DHX58;TRIM56;MAVS;ITCH;POLR3E;POLR3A;NLRP4;TNFAIP3;RELA;IRF8;CGAS;PIN1;PTPN22;POLR3B;CTNNB1;MRE11;UBA7;POLR1C;POLR2F;PQBP1;POLR2L;CD14;IKBKE;CREBBP;POLA1;IRF3
prerank,negative regulation of DNA binding (GO:0043392),-0.4968964849590596,-1.526222375106951,0.028680688336520075,0.2720667283254748,1.0,9/28,18.97%,LEF1;NFKBIA;SMO;E2F1;SUMO3;JAK2;HEY1;KDM1A;MDFI
prerank,renal system development (GO:0072001),0.43971309750276755,1.5248530677175043,0.024896265560165973,0.442027144899921,1.0,12/52,9.13%,WNT4;SALL1;GREB1L;SULF1;SULF2;GLI2;TBX18;LRP4;TGFBR1;ITGA8;NPHP3;GATA3
prerank,membrane repolarization during action potential (GO:0086011),-0.6172582758056419,-1.5248157356509955,0.03985507246376811,0.2737356226475824,1.0,7/13,25.60%,KCNJ2;ATP1A1;KCNQ1;ATP1B1;KCND3;KCNIP2;YWHAE
prerank,negative regulation of peptidyl-serine phosphorylation (GO:0033137),-0.53210345414896,-1.524443729197919,0.04504504504504504,0.2735086454404271,1.0,7/21,7.58%,CAV1;DMD;RACK1;PDE4D;SMAD7;RASSF2;PPM1F
prerank,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),-0.5562298695198005,-1.5228342469066551,0.035916824196597356,0.2759449798293367,1.0,7/19,17.02%,HIPK1;DYRK2;RPS27L;TMEM109;AEN;PHLDA3;DDIT4
prerank,natural killer cell mediated cytotoxicity (GO:0042267),-0.575914322222351,-1.5209792268553224,0.029143897996357013,0.2790587852297015,1.0,8/16,29.58%,VAMP7;LYST;PLEKHM2;TUBB4B;ARL8B;KIF5B;VAMP2;CORO1A
prerank,negative regulation of cell cycle G1/S phase transition (GO:1902807),-0.4895488397091938,-1.520778237034914,0.027726432532347505,0.2783823977844763,1.0,16/31,25.13%,CDK6;KLF4;FHL1;KANK2;RB1;FAM107A;CDK4;CDKN1A;CDKN2C;CDK2AP2;E2F7;RBL1;PKD2;CCL2;CDKN2B;DCUN1D3
prerank,negative regulation of JNK cascade (GO:0046329),-0.4887175234935802,-1.5184487553025305,0.03415559772296015,0.2823883062769963,1.0,9/31,12.63%,MECOM;NCOR1;TAOK3;SH3RF2;AIDA;ZMYND11;DNAJA1;DUSP3;ITCH
prerank,regulation of calcineurin-NFAT signaling cascade (GO:0070884),0.5203633115689141,1.5165115021057796,0.034722222222222224,0.4621798062039286,1.0,4/26,4.89%,IGF1;FHL2;CAMTA1;ACTN3
prerank,positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),0.44792277766113503,1.5160493093714666,0.03076923076923077,0.4600250530750312,1.0,13/49,13.71%,IGF1;IL31RA;KIT;LYN;GHR;IL4;IL18;HES5;ERBB4;CNTF;IL6R;PIBF1;TSLP
prerank,"synaptic transmission, glutamatergic (GO:0035249)",0.5524540381269952,1.5138514134777217,0.07625272331154684,0.4630456960592939,1.0,7/18,7.76%,GRID2;CDH8;UNC13C;GRIK5;GRIK2;GRID1;GRIK1
prerank,anterior/posterior axis specification (GO:0009948),0.5769523277410145,1.5133143069133566,0.06564551422319474,0.46124380955775884,1.0,2/15,0.85%,WLS;TBX3
prerank,negative regulation of actin filament bundle assembly (GO:0032232),0.5099261992718339,1.512813265309664,0.0440251572327044,0.45959276420517925,1.0,7/27,5.39%,ARHGAP6;PIK3R1;ARHGAP28;PHLDB2;CGNL1;DLC1;PRKN
prerank,positive regulation of T cell cytokine production (GO:0002726),-0.5382883663991639,-1.5110776326152295,0.04395604395604396,0.2971740760775803,1.0,6/20,6.56%,B2M;CD55;PRKCZ;IL1R1;CD81;DENND1B
prerank,positive regulation of focal adhesion assembly (GO:0051894),-0.549840537064485,-1.5108846576886175,0.028846153846153848,0.29642115572602873,1.0,10/19,9.73%,TEK;PTPRJ;KDR;FERMT2;RAC1;LIMS1;VEGFA;MYOC;PPM1F;S100A10
prerank,aorta development (GO:0035904),0.5977187444587774,1.51053075920462,0.04405286343612335,0.4630445095104674,1.0,5/14,6.77%,ROBO1;ROBO2;LRP1;EFEMP2;PDGFRB
prerank,chaperone cofactor-dependent protein refolding (GO:0051085),-0.5046957297699218,-1.5101106626406517,0.043052837573385516,0.29711658282531755,1.0,15/25,34.57%,HSPA8;DNAJB12;HSPA5;HSPA1A;HSPA9;HSPE1;HSPA1B;DNAJB1;ERO1A;BAG1;SDF2L1;SDF2;HSPA14;DNAJC7;ST13
prerank,regulation of establishment of endothelial barrier (GO:1903140),-0.5562602996242101,-1.509857631916997,0.05162523900573614,0.2964765085234301,1.0,8/17,13.25%,CLDN5;F11R;VEGFA;IKBKB;S1PR3;ADD1;VCL;TNFRSF1A
prerank,positive regulation of nuclear division (GO:0051785),0.514130812442131,1.5098034096319006,0.04086021505376344,0.4621276985079617,1.0,6/25,8.25%,IGF1;TGFA;PHIP;PDGFRB;SIRT2;IGF2
prerank,kidney development (GO:0001822),0.4166169390954463,1.5094775355538987,0.022774327122153208,0.45995892193700383,1.0,13/65,9.13%,WNT4;ROBO2;SALL1;GREB1L;SULF1;SULF2;GDNF;GLI2;LRP4;TGFBR1;ITGA8;NPHP3;GATA3
prerank,negative regulation of viral genome replication (GO:0045071),-0.45724030102567786,-1.5092251207704288,0.024344569288389514,0.2968605761389208,1.0,14/40,21.38%,IFIH1;MPHOSPH8;IFITM1;IFITM3;N4BP1;SRPK1;IFITM2;IFIT1;FAM111A;MAVS;TASOR;OAS2;RSAD2;SETDB1
prerank,Fc-gamma receptor signaling pathway (GO:0038094),-0.4082024482329728,-1.5089044405906233,0.016597510373443983,0.29646038070926717,1.0,26/71,17.97%,ACTB;ACTG1;DOCK1;PLCG2;WASF2;ARPC1B;MAPK3;PTK2;HSP90AB1;RAC1;CRK;ARPC5;FCER1G;PRKCE;ACTR3;SYK;ABI1;WASL;PIK3CA;LIMK1;YES1;PIK3R2;NCKAP1;HSP90AA1;HCK;WIPF1
prerank,negative regulation of cytokine production (GO:0001818),-0.3547020286911151,-1.508665773996972,0.0020491803278688526,0.29582142147130674,1.0,47/163,19.57%,FN1;LEF1;TMSB4X;THBS1;RPS6KA5;CD34;TAX1BP1;SRGN;IFIH1;MAP2K5;KLF4;ANXA1;TRIM25;RAC1;HDAC7;HDAC9;CMKLR1;SARS1;NLRC5;RNF125;RARA;EZR;N4BP1;TNFRSF21;RGCC;ANXA4;OTUD5;TRIB2;UBE2L6;DHX58;MAPKBP1;INHBA;MAVS;TLR4;ITCH;INHBB;SIGIRR;PTPN6;TNFAIP3;CD84;ATP2B1;VSIR;JAK3;PTGER4;CD200;PIN1;LAPTM5
prerank,negative regulation of NF-kappaB transcription factor activity (GO:0032088),-0.40366985576380066,-1.50861330793197,0.007905138339920948,0.2948237948764387,1.0,22/76,19.95%,TMSB4X;TAX1BP1;MAP2K5;NFKBIA;KLF4;IRAK2;DAB2IP;CMKLR1;NLRC5;CYP1B1;CHP1;USP7;ANXA4;COMMD7;ITCH;AIM2;TNFAIP3;UFL1;CHUK;CDK5RAP3;CD200;CCDC22
prerank,positive regulation of protein polymerization (GO:0032273),-0.4131291457139633,-1.5083641364663352,0.014028056112224449,0.2942134139633261,1.0,21/65,23.92%,OCLN;BAIAP2L1;PTK2B;RPS3;RAC1;LMOD1;SLAIN2;PFN1;DCTN1;PRKCE;MET;NCKAP1;HSP90AA1;HCK;CDC42EP3;ARL2;CTTN;NCK1;CARMIL1;NCK2;CLIP1
prerank,positive regulation of catabolic process (GO:0009896),-0.41507429792708334,-1.508354859998086,0.016728624535315983,0.2931164666516851,1.0,24/65,17.44%,WWP1;GPC3;NEDD4L;FOXO1;DAB2IP;CDKN1B;RNF41;WWP2;EGLN2;IDE;PLK2;NDUFA13;ATG7;VCP;RAB7A;OAZ2;ITCH;SMURF1;SNF8;TNFAIP3;CSNK2A1;FZR1;VSIR;NSF
prerank,purine ribonucleotide biosynthetic process (GO:0009152),0.4398409976144705,1.5083499146404111,0.03187250996015936,0.460174466224007,1.0,8/48,8.32%,ADCY7;ADCY2;ADCY1;ADCY5;AMPD3;SLC26A1;PAPSS1;GUCY2F
prerank,positive regulation of cyclin-dependent protein kinase activity (GO:1904031),-0.5285998748996431,-1.5080229452586464,0.031423290203327174,0.292660083763809,1.0,9/20,21.50%,CCND3;CCNY;HSP90AB1;PKD1;RGCC;AKT1;EGFR;CCND1;PKD2
prerank,negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),-0.5073618269625325,-1.507277490863726,0.047058823529411764,0.29322097447162065,1.0,12/25,26.64%,OPHN1;HSP90AB1;RPL11;RPL23;RPS7;SGTA;CSNK2A1;CSNK2A2;RPL5;ALAD;TRIM39;F8A1
prerank,regulation of intracellular protein transport (GO:0033157),-0.48024008509026395,-1.5068124645893768,0.04036697247706422,0.29322321264837836,1.0,14/32,22.97%,PTPN14;TGFB1;BCAS3;PRR5L;CEP290;PCM1;OAZ2;NDEL1;UHMK1;GCC2;RIPOR1;PDCD10;PLK3;PTPN1
prerank,atrial cardiac muscle cell action potential (GO:0086014),0.6069091345243284,1.506458027684489,0.060267857142857144,0.4620228013902933,1.0,6/13,9.45%,GJA1;SCN3B;ANK2;KCNJ3;CACNB2;KCNJ5
prerank,cranial nerve development (GO:0021545),0.630534029044596,1.5059911400659545,0.07488986784140969,0.46013987545301566,1.0,3/11,8.27%,SALL1;CHD7;ERBB3
prerank,regulation of osteoclast differentiation (GO:0045670),0.47958335936654395,1.5059339064230004,0.04337899543378995,0.45731300405866027,1.0,6/33,5.13%,FBN1;OCSTAMP;GPR55;CEBPB;IL4;CAMK4
prerank,regulation of trans-synaptic signaling (GO:0099177),0.4828760571025949,1.5054891546650386,0.04516129032258064,0.4556917037420511,1.0,10/33,7.76%,LRRC4C;NRG3;GRID2;GRIK5;GRIK2;NLGN2;NLGN3;GRID1;NLGN1;GRIK1
prerank,insulin-like growth factor receptor signaling pathway (GO:0048009),0.6151550321002428,1.5042177214380272,0.06465517241379311,0.45605746086265686,1.0,3/11,4.95%,IGF1;PIK3R1;GHR
prerank,positive regulation of cell aging (GO:0090343),-0.631475048563175,-1.504110974232771,0.0481283422459893,0.29833796407929597,1.0,4/11,18.58%,B2M;ABI3;YPEL3;CGAS
prerank,pteridine-containing compound metabolic process (GO:0042558),-0.6137595488477694,-1.5039383583947383,0.04424778761061947,0.2975575008835787,1.0,6/13,16.67%,NOS3;GCH1;CALM1;AKT1;SPR;HSP90AA1
prerank,gonad development (GO:0008406),0.4615714721825055,1.5029451635596958,0.04439746300211417,0.4566278360024135,1.0,9/41,9.13%,WNT4;SALL1;AR;NR2F2;KIT;CSDE1;SIX4;ADAM21;GATA3
prerank,response to chemokine (GO:1990868),-0.6078041130902638,-1.5011211233074162,0.04745166959578207,0.3025968617490734,1.0,3/13,2.77%,SLC12A2;LRCH1;WNK1
prerank,negative regulation of endopeptidase activity (GO:0010951),0.4468641996997501,1.5009555746674645,0.03361344537815126,0.45871608822113885,1.0,9/47,7.28%,TIMP3;SERPINE2;AHSG;SERPINI2;RECK;SERPINF1;SPOCK3;SERPINE1;TIMP4
prerank,inositol phosphate metabolic process (GO:0043647),-0.43897835808142616,-1.4996261688219645,0.020872865275142316,0.304990580728847,1.0,15/46,16.68%,PLCE1;ITPKB;PLCG2;PLCB3;CALM1;INPP5D;IPMK;INPP5A;ISYNA1;NUDT4;FGF2;IP6K1;MINPP1;SYNJ1;IMPA2
prerank,ventricular cardiac muscle tissue development (GO:0003229),0.5085941728313272,1.4993586314914364,0.05319148936170213,0.46007315093507906,1.0,4/23,4.22%,TGFBR3;FGFR2;TNNC1;TNNI3
prerank,negative regulation of DNA-binding transcription factor activity (GO:0043433),-0.3608309123616187,-1.4992337365129529,0.01006036217303823,0.3047932572725646,1.0,42/136,19.39%,TMSB4X;ESR1;TAX1BP1;ID1;ID3;MAP2K5;NFKBIA;FZD6;KLF4;IRAK2;DAB2IP;SMAD7;ZNF431;WWP2;CMKLR1;NLRC5;CYP1B1;PKD1;CHP1;BHLHE40;HEYL;USP7;ANXA4;HDAC4;TRIB1;RB1;CTNNBIP1;EGLN1;COMMD7;ITCH;HES1;AIM2;PHB2;SIGIRR;TNFAIP3;UFL1;KDM1A;CHUK;CDK5RAP3;MDFI;CD200;ADGRG3
prerank,regulation of smoothened signaling pathway (GO:0008589),0.43820636386590944,1.499153830242999,0.02631578947368421,0.45779041757595446,1.0,14/50,11.92%,RORA;FGFR2;IFT81;ZIC1;GLI3;SFRP1;EVC;IFT122;TULP3;KIF7;KCTD21;MGRN1;FUZ;BTRC
prerank,positive regulation of peptidyl-lysine acetylation (GO:2000758),-0.5263055833927968,-1.4990758496424055,0.04701627486437613,0.3040173513429907,1.0,6/20,12.54%,RPS6KA5;MAPK3;PPARGC1A;DIP2B;TADA2B;SOX4
prerank,positive regulation of behavior (GO:0048520),-0.6505345713219686,-1.499074729185591,0.045774647887323945,0.3029079224157282,1.0,4/10,11.50%,MEF2C;STRA6;AGRP;SGIP1
prerank,positive regulation of supramolecular fiber organization (GO:1902905),-0.38479444242409694,-1.4985688739840566,0.018108651911468814,0.30295401817076484,1.0,32/86,23.92%,OCLN;BAIAP2L1;PTK2B;RPS3;APP;RAC1;WDR1;LMOD1;SLAIN2;EDN1;GPX1;STMN2;PFN1;RB1;SYNPO;DCTN1;TRPV4;APOE;PRKCE;KATNB1;LIMK1;MET;NCKAP1;HCK;CDC42EP3;ARL2;CTTN;NCK1;COLGALT1;CARMIL1;NCK2;CLIP1
prerank,positive regulation of programmed cell death (GO:0043068),-0.33027247510453467,-1.4984046708221934,0.0,0.3022140512517082,1.0,81/272,19.61%,ANO6;ITGA6;MAP3K5;MCF2L;ARHGEF3;NET1;RACK1;UNC13B;TGM2;RASGRF2;ARL6IP5;FOXO1;FOXO3;DAB2IP;SLIT2;NGF;MAP3K20;CRADD;CTNNBL1;REST;TRIO;UBB;HTT;CYP1B1;TNFSF10;ING5;IGFBP3;UBC;RPS27A;SOS2;HIP1R;TNFAIP8;ATF4;TGFB3;RASSF2;CASP8;RIPK1;BAX;CTSD;BCL6;MAP3K11;PSENEN;ITSN1;DNAJA1;FAS;ATG7;HSPD1;RHOB;PREX1;NF1;HTATIP2;GADD45G;ABR;E2F1;SOX4;BAK1;RNPS1;SPHK2;RPS6;SYK;RPS6KA2;ARHGEF5;ARHGEF18;APH1A;BNIP3L;TOP2A;PHLDA3;PDCD2;DDX20;BAD;CCAR2;FOXL2;ARHGEF12;CALHM2;ARHGEF17;ARHGEF4;ARHGEF2;ECT2;GADD45A;LAPTM5;ARHGEF6
prerank,regulation of stress fiber assembly (GO:0051492),0.3997581110900435,1.4983648670514604,0.011764705882352941,0.45713218588298105,1.0,12/74,5.17%,ARHGAP6;PIK3R1;PPM1E;NRP1;ARHGAP28;LPAR1;PHLDB2;ROCK2;ASAP3;CGNL1;SFRP1;DLC1
prerank,extracellular matrix organization (GO:0030198),0.33779347328079484,1.4976350933424678,0.001941747572815534,0.45633652596348223,1.0,44/276,6.84%,COL4A6;LAMA1;COL4A5;ADAMTS6;ITGA9;COL13A1;FLRT2;ADAMTS12;FBN1;LAMA2;LAMC3;FBN2;DDR2;ADAMTS10;COL1A2;NID2;COL22A1;DPT;MATN3;ITGA11;SCUBE1;ADAMTS5;DCN;NID1;RECK;MIA;COL4A4;TNC;SH3PXD2B;MMP16;CREB3L1;DDR1;COL16A1;LUM;ADAM12;SERPINE1;COL4A3;PLG;ITGAD;COL10A1;COL8A2;P4HA2;LOXL2;MMP11
prerank,negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),-0.6313885744843148,-1.497448047604829,0.051188299817184646,0.30210389062380466,1.0,7/11,21.50%,CALM1;FKBP1A;GSTM2;CALM3;CASQ2;SRI;PKD2
prerank,negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),-0.6313885744843148,-1.497448047604829,0.051188299817184646,0.30210389062380466,1.0,7/11,21.50%,CALM1;FKBP1A;GSTM2;CALM3;CASQ2;SRI;PKD2
prerank,adenine nucleotide transport (GO:0051503),-0.5605514232936416,-1.4974134019701848,0.047706422018348627,0.3011117717604384,1.0,3/17,2.31%,ABCC4;LRRC8C;LRRC8D
prerank,epithelial tube morphogenesis (GO:0060562),-0.47309694060967666,-1.4969563597891122,0.021526418786692758,0.30090122738306607,1.0,16/32,21.51%,MEF2C;PODXL;RASIP1;SOX17;SLIT2;COL4A1;PKD1;CSNK2B;RHOB;ACVR1;HES1;CSF1R;MET;FGF10;PKD2;PRKD2
prerank,UDP-N-acetylglucosamine biosynthetic process (GO:0006048),-0.6222120972579175,-1.496890700023373,0.04753199268738574,0.2999654038667401,1.0,7/11,29.27%,UAP1L1;GFPT1;AMDHD2;RENBP;PGM3;UAP1;GNPDA1
prerank,Fc receptor mediated stimulatory signaling pathway (GO:0002431),-0.40492943057532577,-1.4962563202822952,0.014644351464435146,0.3003300304669371,1.0,26/73,17.97%,ACTB;ACTG1;DOCK1;PLCG2;WASF2;ARPC1B;MAPK3;PTK2;HSP90AB1;RAC1;CRK;ARPC5;FCER1G;PRKCE;ACTR3;SYK;ABI1;WASL;PIK3CA;LIMK1;YES1;PIK3R2;NCKAP1;HSP90AA1;HCK;WIPF1
prerank,neuron projection extension (GO:1990138),0.48963833622448094,1.495975055581292,0.04697986577181208,0.45788149278534024,1.0,8/32,8.01%,AUTS2;NRP1;SEMA5A;SEMA3A;FLRT1;NLGN3;ALCAM;CDKL3
prerank,negative regulation of cell growth (GO:0030308),-0.3710601406002417,-1.4956437809826693,0.012244897959183673,0.30065963831960524,1.0,48/121,23.23%,APBB2;PTPRJ;SERTAD2;OSGIN2;RACK1;BMPR2;SH3BP4;FHL1;CCN3;SOX17;SLIT2;NPR1;ADAM15;CDKN1B;TGFB1;TGFB2;PPP2R1A;NDUFA13;BCL6;SIPA1;DIP2B;RB1;WFDC1;SEMA3G;WNT11;INHBA;CCDC85B;CRLF3;SPHK2;SMARCA4;NDUFS3;CDKN2AIP;OSGIN1;SMAD4;CDKN1A;SMARCA2;HSPA1A;CCAR2;CDKN2C;NME6;TSPYL2;ESR2;MSX1;NDRG3;HSPA1B;SESN2;HYAL1;ENO1
prerank,regulation of intracellular pH (GO:0051453),-0.46542077817805394,-1.4949424159390632,0.028021015761821366,0.30104751330054147,1.0,11/34,17.65%,SLC4A10;SLC9A2;TMEM165;CHP1;ATP5F1B;SLC4A8;SLC4A2;VPS33A;GPR89B;GPR89A;SLC9B1
prerank,histone lysine methylation (GO:0034968),0.4802632189839384,1.4941289095665757,0.046255506607929514,0.4603115046643253,1.0,14/33,15.53%,PRDM5;WDR5B;PRDM9;SETMAR;MEN1;KMT2A;SMYD1;CXXC1;SMYD3;PAXIP1;EHMT2;DYDC2;EZH2;WDR82
prerank,negative regulation of biosynthetic process (GO:0009890),0.5708316164587287,1.493115012424279,0.059734513274336286,0.4601542502102631,1.0,5/16,6.61%,PPARA;SLC30A10;ABCD2;GSTP1;ASXL3
prerank,regulation of blood coagulation (GO:0030193),-0.4875369525178446,-1.4925185573373256,0.03903345724907063,0.3052448459496701,1.0,8/27,9.15%,CAV1;ST3GAL4;THBS1;CD34;THBD;FAP;EDN1;ENPP4
prerank,peptidyl-tyrosine autophosphorylation (GO:0038083),-0.5693464496346055,-1.4911488114489078,0.0497131931166348,0.3072866719620194,1.0,5/15,3.06%,IGF1R;PTK2B;KDR;MAPK3;BMX
prerank,carboxylic acid transmembrane transport (GO:1905039),0.4598171830341114,1.4906396634347225,0.05263157894736842,0.46364211590564414,1.0,6/40,7.31%,SLC7A11;SLC13A3;SLC38A1;SLC36A2;SLC7A9;SLC25A10
prerank,heterotypic cell-cell adhesion (GO:0034113),-0.4987359877256792,-1.4897812305456715,0.03745318352059925,0.3093022272938591,1.0,11/25,19.70%,CXADR;JAM3;JUP;CTNNA3;ITGA7;DSG2;ITGA4;DSP;NINJ1;CD200;ITGB3
prerank,regulation of actin filament depolymerization (GO:0030834),0.6141645481657532,1.4891123164393174,0.082039911308204,0.4648183628371726,1.0,2/12,1.18%,PLEKHH2;SEMA5A
prerank,cardiac epithelial to mesenchymal transition (GO:0060317),0.5360083514894738,1.4887427422017483,0.06888888888888889,0.4629173683169227,1.0,6/20,8.08%,TGFBR3;BMP2;TBX3;OLFM1;TGFBR1;RBPJ
prerank,regulation of epithelial cell proliferation (GO:0050678),0.3966026687827815,1.4883692109720315,0.023715415019762844,0.4612034603511796,1.0,10/85,4.43%,IGF1;BMP6;TCF7L2;TGFBR3;FGFR2;BMP5;MTSS1;TGFA;SFRP1;MCC
prerank,establishment of epithelial cell polarity (GO:0090162),-0.5300986394734846,-1.487344705706954,0.03816793893129771,0.3135424437752852,1.0,6/19,9.83%,CYTH3;PARD3;OPHN1;MSN;EZR;SIPA1L3
prerank,negative regulation of response to DNA damage stimulus (GO:2001021),-0.4752802100040793,-1.4870287505248792,0.0364963503649635,0.31320401530337644,1.0,11/30,17.32%,ACKR3;TPT1;RPS3;CD44;TWIST1;PTTG1IP;CD74;BCL2L1;DDX39B;CCAR2;KDM1A
prerank,sodium ion transport (GO:0006814),0.3951742778234404,1.4869046967682902,0.018218623481781375,0.46238316510793825,1.0,16/85,9.33%,ATP1A2;NALCN;SLC24A3;SCN7A;SLC6A12;SLC6A9;SLC8A1;SLC6A13;SCN3B;SCN3A;ASIC2;SCN2A;SLC24A4;SLC24A2;SLC6A11;SLC6A1
prerank,negative regulation of peptidyl-threonine phosphorylation (GO:0010801),-0.5442401501121983,-1.486509399414545,0.04553734061930783,0.31322000371996145,1.0,10/17,24.46%,PARD3;SMAD7;CALM1;CALM3;DDIT4;CADM4;EIF4G1;DMTN;SPRED3;PPEF2
prerank,negative regulation of sprouting angiogenesis (GO:1903671),-0.6152651490709353,-1.4864922896773303,0.06007067137809187,0.31218724181197594,1.0,4/11,3.82%,SEMA6A;THBS1;KLF2;EPN1
prerank,interferon-gamma-mediated signaling pathway (GO:0060333),-0.4324382136710786,-1.4863115973634422,0.033663366336633666,0.31154266265742553,1.0,16/45,18.51%,B2M;CAMK2D;TRIM25;CD44;MT2A;MID1;TRIM62;TRIM68;JAK2;TRIM5;IRF9;OAS2;STAT1;IFNGR1;HCK;IRF8
prerank,positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),-0.5523926522334064,-1.4856539096099597,0.03802281368821293,0.31199485432549806,1.0,9/17,25.43%,CCND3;CCNY;PKD1;RGCC;AKT1;EGFR;CCND1;PKD2;SPDYA
prerank,maturation of SSU-rRNA (GO:0030490),-0.45468016591261073,-1.4849104239626438,0.052104208416833664,0.3125219971903993,1.0,8/34,10.81%,RPS16;RPS14;NOP14;RPS28;RPS8;RPS19;NOB1;DHX37
prerank,cellular component maintenance (GO:0043954),-0.6073178491236844,-1.484634384461239,0.04933586337760911,0.31207728773687804,1.0,5/12,25.89%,IGF1R;INSR;CLDN1;TREM2;MTMR2
prerank,regulation of defense response (GO:0031347),-0.3953266425149129,-1.484523852260055,0.023483365949119372,0.3113139319114187,1.0,28/76,20.25%,FOXP1;TMSB4X;SEMA7A;ANXA1;MGLL;IL1R1;BRD4;N4BP1;CASP8;PSMA6;ERAP1;BCL6;ACE2;TIRAP;LRP8;DHX58;PIK3AP1;APOE;SAMHD1;BCL6B;JAK2;NOD2;UFL1;RELA;HCK;DAGLB;CASP1;GGT1
prerank,positive regulation of cellular senescence (GO:2000774),-0.6344779055681121,-1.483176351887246,0.047872340425531915,0.313255513240329,1.0,4/10,18.58%,B2M;ABI3;YPEL3;CGAS
prerank,glycerolipid catabolic process (GO:0046503),-0.534202471905698,-1.4831352564935465,0.04963235294117647,0.31227776768735466,1.0,3/19,3.57%,GPCPD1;ABHD2;MGLL
prerank,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),-0.5549947289558875,-1.4825951878730965,0.05714285714285714,0.3124498383854183,1.0,9/16,25.67%,THBS1;PPP1R16B;VEGFA;GATA2;JCAD;FGF2;DLL4;PDCD10;APLNR
prerank,positive regulation of toll-like receptor signaling pathway (GO:0034123),-0.49100375699988497,-1.4825326967419072,0.05516014234875445,0.31159985887315167,1.0,9/26,18.62%,CAV1;LBP;MFHAS1;TLR3;FLOT1;TIRAP;SLC15A4;NINJ1;RSAD2
prerank,negative regulation of signal transduction (GO:0009968),0.33721756732119673,1.4823689578796053,0.0019157088122605363,0.47205917602220404,1.0,54/249,11.45%,ENPP1;ADAMTS12;LGR4;NOTUM;BMP2;PID1;TRABD2B;SULF1;BMP5;SULF2;LRP1;AHSG;DCN;PIP4K2A;LEPROT;DKK3;BCL2;GLI3;PTPRT;CREB3L1;LYN;SFRP1;RNF43;TMEM25;WIF1;TSPAN15;TAX1BP3;NLRP12;IFT122;SMPDL3B;TLE1;CXXC4;CRY1;TULP3;MAPK8IP2;LRRC14;KIF7;ERBB3;NLRP2B;KCTD21;GPR108;CNMD;GATA3;PRKCB;DCC;MGRN1;PTEN;DACT3;FRZB;PIP4K2B;SIAH2;PTGIR;NKD2;FSTL3
prerank,negative regulation of ubiquitin-protein transferase activity (GO:0051444),-0.5718675610571405,-1.48215199472013,0.05786618444846293,0.31143387671650596,1.0,9/15,25.92%,SMAD7;RPL11;RPL23;BAG5;RPS7;LIMK1;RPL5;DTX3L;PARK7
prerank,purine ribonucleotide transport (GO:0015868),-0.5640077967854509,-1.4819976931024332,0.051756007393715345,0.31076004041190947,1.0,3/16,2.31%,ABCC4;LRRC8C;LRRC8D
prerank,Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),-0.400742700915986,-1.4804482529979826,0.01652892561983471,0.31313808259700987,1.0,25/70,17.97%,ACTB;ACTG1;DOCK1;PLCG2;WASF2;ARPC1B;MAPK3;PTK2;HSP90AB1;RAC1;CRK;ARPC5;PRKCE;ACTR3;SYK;ABI1;WASL;PIK3CA;LIMK1;YES1;PIK3R2;NCKAP1;HSP90AA1;HCK;WIPF1
prerank,negative regulation of cell death (GO:0060548),-0.3805111133486068,-1.4790740259410016,0.006198347107438017,0.31528158739600354,1.0,30/88,22.04%,MECOM;CD34;CCN3;FERMT2;PPARGC1A;PDE8A;DCPS;TNFRSF1B;DUS2;SRSF6;AKT1;KANK2;SPEF1;WNT11;INPP5A;PSMC5;IMPACT;SOX4;CCN5;FGF2;TMEM109;BNIP3L;RAD18;HSPA1A;CHMP2A;CD200;NCK1;HSPA1B;ADNP2;EIF4G1
prerank,I-kappaB phosphorylation (GO:0007252),-0.6294408264303407,-1.4788196612476212,0.04363636363636364,0.3148349075343538,1.0,7/10,34.24%,DAB2IP;TLR3;TLR4;CHUK;PRDX4;ERC1;TLR2
prerank,phosphatidylcholine catabolic process (GO:0034638),0.6332141910797583,1.4787968589184317,0.08968609865470852,0.4791201228124318,1.0,2/10,2.58%,PLA2G5;PLA2G4A
prerank,positive regulation of amyloid precursor protein catabolic process (GO:1902993),0.5140829342735047,1.478586049514345,0.06888888888888889,0.476938124294048,1.0,7/22,11.12%,SLC2A13;ROCK2;LYN;LRRTM3;EFNA3;CASP3;CHRNA7
prerank,inner ear receptor cell stereocilium organization (GO:0060122),0.632777522539562,1.47839526192114,0.09111111111111111,0.4747184380413319,1.0,2/10,2.34%,ADGRV1;STRC
prerank,mitochondrial gene expression (GO:0140053),-0.43962564245678504,-1.4783278169084184,0.03682170542635659,0.31500214175263797,1.0,21/42,32.74%,FOXO3;QRSL1;PTCD3;MRPL51;LARS2;GATC;MRPS17;MRPL16;SLC25A33;MRPL47;MRPS18A;MRPS6;GATB;NDUFA7;MRPS24;MRPL2;MRPS14;MRPS2;IARS2;TWNK;MRPS12
prerank,JNK cascade (GO:0007254),-0.4476550990625524,-1.4767524580589133,0.029354207436399216,0.3174211662139699,1.0,14/40,19.61%,MAP3K5;NOD1;MAP4K3;IRAK2;UBB;MINK1;UBC;RPS27A;MAP3K11;TRIB1;NOD2;TAB2;PTGER4;ARHGEF6
prerank,regulation of glucose metabolic process (GO:0010906),0.47703561492433355,1.4745291315390379,0.05473684210526316,0.48292707449305045,1.0,6/34,5.80%,RORA;PDK1;PDK4;PRKN;IRS2;PDK3
prerank,heme biosynthetic process (GO:0006783),-0.5126191583508749,-1.4744655769715738,0.0616822429906542,0.3214369040949356,1.0,10/22,27.27%,ABCG2;SLC25A38;UROS;COX15;FXN;ATP5IF1;COX10;ALAS2;ALAD;ABCB6
prerank,small GTPase mediated signal transduction (GO:0007264),-0.376471542676719,-1.4738816788767553,0.015779092702169626,0.32168500655475957,1.0,33/103,15.87%,ARHGAP31;RAPGEF5;PLCE1;RREB1;RASGRP3;RGL1;SHOC2;ARHGAP1;RAC1;SHTN1;RALB;CHP1;RAB18;SHC1;BCR;NUCB1;KRAS;USP8;RIT1;RASSF1;GRAP;PLK2;TRIM28;RB1;NF1;ABR;FGF2;GNB1;HRAS;ARHGEF18;NTN1;RGL2;CDKN1A
prerank,regulation of cholesterol biosynthetic process (GO:0045540),-0.5442170319282084,-1.4735909346208322,0.05343511450381679,0.3213617259991367,1.0,7/17,12.63%,FGF1;LPCAT3;MBTPS2;ABCG1;ERLIN2;APOE;ABCA2
prerank,regulation of cell killing (GO:0031341),-0.5510122745712105,-1.4731363566716396,0.05,0.32136875571752077,1.0,4/16,8.56%,CD55;TGFB2;RAC1;FZD7
prerank,positive regulation of stress-activated MAPK cascade (GO:0032874),-0.38214928824600236,-1.4728957018504079,0.014256619144602852,0.3208868244452845,1.0,28/93,15.49%,MAP3K5;PTK2B;ARL6IP5;TPD52L1;DAB2IP;APP;TGFB2;MID1;MFHAS1;MINK1;VEGFA;TAOK3;SH3RF2;RASSF2;RIPK1;FLT4;STK25;FZD7;MAP3K11;TIRAP;TAOK2;GADD45G;EDA2R;TRAF1;HRAS;EMC10;SDCBP;NOD2
prerank,energy reserve metabolic process (GO:0006112),0.5445022672020827,1.4723666691155777,0.060085836909871244,0.4859850356905515,1.0,4/19,2.85%,PID1;PRKAG2;PHKA1;LEPR
prerank,regulation of ventricular cardiac muscle cell action potential (GO:0098911),-0.6017303107524619,-1.4716722920155902,0.06691449814126393,0.32270548370561875,1.0,6/12,19.15%,CAV1;JUP;CTNNA3;DSG2;DSP;CACNA1C
prerank,negative regulation of peptidase activity (GO:0010466),0.43753102802759225,1.4715402723748532,0.040948275862068964,0.48565457493879827,1.0,9/47,7.28%,TIMP3;LRP1;SERPINE2;AHSG;SERPINI2;SERPINF1;SPOCK3;SERPINE1;TIMP4
prerank,myeloid cell activation involved in immune response (GO:0002275),-0.5433229069410908,-1.4715107175913222,0.05008635578583765,0.32202146985682417,1.0,5/18,12.88%,LBP;PLCG2;DYSF;FCER1G;SYK
prerank,carbohydrate derivative transport (GO:1901264),-0.5350792203738214,-1.4711044230267767,0.043151969981238276,0.321851543956266,1.0,8/18,16.27%,LBP;PLTP;SCARB1;MFSD2A;ABCG1;SLC10A7;SLC15A2;SLC15A4
prerank,adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),0.3788453251548614,1.47027266657579,0.02268041237113402,0.48663808770971684,1.0,10/110,1.71%,ADCY7;ADCY2;ADCY1;LGR4;ADGRB3;LPAR1;PTGFR;ADCY5;GPHB5;ABCA1
prerank,regulation of cellular response to heat (GO:1900034),-0.3869746203189073,-1.4701608685373873,0.021235521235521235,0.3230618607475583,1.0,35/77,27.54%,CD34;MAPK3;CAMK2D;HSP90AB1;HSPA8;NUP93;NDC1;HSBP1;NUP54;BAG5;NUP188;HSPB8;NUP155;RANBP2;RPA3;NUP37;HSP90AA1;HSPA1A;CCAR2;CRYAB;FKBP4;HSPA1B;IER5;NUP160;DNAJB1;BAG1;RPTOR;NUP43;SEH1L;YWHAE;SEC13;NUP107;NUP42;CAMK2G;NUP98
prerank,acylglycerol catabolic process (GO:0046464),-0.47003067980000407,-1.4701298168479708,0.04816955684007707,0.32211187094774624,1.0,5/30,13.79%,ABHD2;MGLL;PNPLA2;FABP5;FAAH
prerank,regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),0.510208064332303,1.469910299037979,0.06593406593406594,0.4848542795097068,1.0,7/23,6.87%,TGFBR3;SMAD3;DKK3;TGFBR3L;IL4;NREP;SMURF2
prerank,microvillus assembly (GO:0030033),-0.5628496392107869,-1.4697504648355986,0.056466302367941715,0.3218567124787413,1.0,5/14,6.47%,RAP1A;RAP1B;FXYD5;MINK1;EZR
prerank,negative regulation of potassium ion transmembrane transport (GO:1901380),-0.6287918303777207,-1.4696849957761884,0.05605786618444846,0.32097760459488633,1.0,4/11,15.37%,CAV1;NEDD4L;CASQ2;CAB39
prerank,amino sugar biosynthetic process (GO:0046349),-0.6009647861897573,-1.469514550494887,0.06319702602230483,0.320329792104102,1.0,7/12,29.27%,UAP1L1;GFPT1;AMDHD2;RENBP;PGM3;UAP1;GNPDA1
prerank,intracellular estrogen receptor signaling pathway (GO:0030520),-0.5441388039847644,-1.4694147923280994,0.05805243445692884,0.3195395489969657,1.0,9/16,11.48%,ESR1;DDX5;DDX17;PPARGC1B;RBFOX2;SAFB;EGLN2;ARID1A;NCOA4
prerank,endocrine system development (GO:0035270),0.5202084750212512,1.4693204254232146,0.0625,0.48378731329489755,1.0,8/21,13.61%,WNT4;SALL1;GLI2;DKK3;SOX2;TGFBR1;PAX8;NKX2-1
prerank,positive regulation of immune response (GO:0050778),-0.4005487035817246,-1.468896667754958,0.02111324376199616,0.31974789906151485,1.0,31/64,40.24%,IL15;GBP5;TGFB2;CD81;DHX9;CD74;SPHK2;AKIRIN2;NOD2;SLC15A4;XBP1;RSAD2;LGALS9;IL6ST;POLR3B;STX4;SKAP1;LILRB1;KARS1;NLRP3;RIOK3;SASH3;CCL5;TLR8;FCGR2B;CD226;GRN;MYB;IL12RB1;ITGB2;ADAM8
prerank,regulation of innate immune response (GO:0045088),-0.40735711532182295,-1.4686733278121116,0.022727272727272728,0.31924840972855434,1.0,28/57,35.07%,GBP5;HSP90AB1;N4BP1;CASP8;ERAP1;DHX9;TIRAP;LRP8;DHX58;SAMHD1;AKIRIN2;PTPN6;TNFAIP3;SLC15A4;PTPN22;PTPN1;POLR3B;XIAP;TREM2;MUL1;PARP9;RIOK3;NLRC3;LYAR;CCL5;USP18;TLR8;FCGR2B
prerank,negative regulation of RNA metabolic process (GO:0051253),-0.5312040417289815,-1.468641572970061,0.04204753199268738,0.31835205121301396,1.0,5/18,6.08%,ESR1;NCOR1;TGFB1;RPS13;PTBP3
prerank,microvillus organization (GO:0032528),-0.5757775193199237,-1.4680519297383228,0.04621072088724584,0.3187244510948664,1.0,5/13,6.47%,RAP1A;RAP1B;FXYD5;MINK1;EZR
prerank,regulation of cell communication by electrical coupling (GO:0010649),-0.5790445919495439,-1.4680033230980154,0.057034220532319393,0.3178281854016771,1.0,7/13,14.62%,CAV1;PDE4D;CAMK2D;CALM1;CALM3;CASQ2;SRI
prerank,ubiquitin-dependent ERAD pathway (GO:0030433),-0.39733245161100283,-1.4678640703662833,0.021825396825396824,0.31714783315452205,1.0,34/69,31.15%,SEL1L;TRIM25;FBXO17;DNAJB12;MAN1B1;ERLIN2;RNF185;UBE2G2;VCP;HSPA5;UBXN8;FAF2;RNF5;SEC61B;SGTA;RNF121;TMEM67;DERL2;AMFR;TMEM129;EDEM2;TMUB2;SGTB;TMUB1;FBXO6;UBE2J2;UBE4A;FBXO2;STT3B;UBQLN2;DERL1;PSMC6;EDEM1;SYVN1
prerank,very-low-density lipoprotein particle assembly (GO:0034379),-0.5870979238573832,-1.4675805999776579,0.056776556776556776,0.3167653220612614,1.0,6/12,29.94%,LPCAT3;MFSD2A;APOC1;P4HB;SOAT2;MTTP
prerank,positive regulation of cell cycle G1/S phase transition (GO:1902808),-0.45943639833480004,-1.4669315972810921,0.04158790170132325,0.3172390984718773,1.0,19/33,25.75%,CCND3;PLCG2;ANXA1;RGCC;AKT1;DDRGK1;LSM11;PHB2;EGFR;ANKRD17;GLI1;CCND1;FGF10;EIF4G1;LSM10;HYAL1;AIF1;RPTOR;RDX
prerank,negative regulation of alcohol biosynthetic process (GO:1902931),0.6003592234496103,1.466876184758938,0.08411214953271028,0.48778348300077057,1.0,6/13,12.73%,BMP2;BMP5;CYP27B1;DKK3;SCAP;ERLIN1
prerank,organonitrogen compound biosynthetic process (GO:1901566),-0.3429652899421587,-1.4661877303499504,0.006263048016701462,0.31803663883997463,1.0,48/151,21.70%,SGMS1;ST3GAL4;CERT1;SGMS2;ACER2;SPTLC2;DMD;DEGS2;GCH1;LPCAT3;ELOVL7;PLPP1;CSNK1G2;PRKD3;SPTLC1;CDO1;MFSD2A;KDSR;SPTSSB;SPNS2;GSTA4;CHKA;CSNK2B;ELOVL5;INHBA;CEPT1;GSTM2;APOE;SGPL1;SPHK2;ACER3;GSTA3;GSTM1;TYW1;CSNK2A1;CSNK2A2;GSTO2;ELOVL1;LCAT;MGST3;PLPP2;HACD4;ALAS2;GSTK1;PCYT1A;CHAT;PRKD2;LPCAT2
prerank,sensory perception (GO:0007600),0.44218879728696187,1.465800502061515,0.04791666666666667,0.4881553020388268,1.0,13/45,18.99%,ADGRV1;TTC8;P2RX4;OPRK1;PCDH15;TRPA1;CHRNA4;CHRNA7;PNOC;PTGES;CLRN1;SCN9A;PDYN
prerank,positive regulation of filopodium assembly (GO:0051491),0.49757132623695727,1.4655929078997068,0.05803571428571429,0.4860389495484948,1.0,7/24,7.71%,PIK3R1;NRP1;DOCK11;GPM6A;TENM2;DPYSL3;NLGN1
prerank,fructose 6-phosphate metabolic process (GO:0006002),-0.6308309210676344,-1.4653771134038627,0.06329113924050633,0.318663054110033,1.0,4/10,22.15%,HK1;PFKP;GFPT1;PFKL
prerank,synapse organization (GO:0050808),0.3693330900637853,1.4650278220755604,0.005780346820809248,0.4849339311402222,1.0,39/125,14.68%,GPC6;PDZRN3;PPFIBP2;LRRC4C;SDK2;NRXN1;PCDHB10;CHRNA1;LRP4;GPM6A;GPC4;UNC13C;PTPRD;CTNND2;PCDHB13;KIRREL3;NLGN2;NLGN3;RAB29;CACNB4;CACNB2;NLGN1;CACNB1;NRCAM;RYK;ARHGAP39;SLC6A1;FARP1;PTEN;CBLN2;MUSK;RAB39B;CHRNA7;DOK7;OBSL1;MAPT;PPFIA2;DRD2;PCDHB16
prerank,cellular response to transforming growth factor beta stimulus (GO:0071560),-0.35865499104406073,-1.4648169599832712,0.00641025641025641,0.31907844798262636,1.0,33/112,13.86%,MEF2C;CLDN5;PARD3;ID1;PXN;TGFBR2;F11R;NLK;PTK2;COL3A1;SMAD9;FERMT2;SMAD7;TGFB1;TGFB2;FKBP1A;UBB;PDE2A;LIMS1;PRKCZ;UBC;RPS27A;SMAD6;TGFB3;NR3C1;USP9X;ACVR1;NRROS;ZMIZ2;ENG;USP15;SMURF1;ARHGEF18
prerank,negative regulation of insulin receptor signaling pathway (GO:0046627),0.4945447844892525,1.464054354834892,0.06092436974789916,0.48504671535478505,1.0,4/27,2.24%,ENPP1;PID1;AHSG;PIP4K2A
prerank,endothelial cell proliferation (GO:0001935),-0.5539819874707328,-1.4640293168648553,0.04896421845574388,0.31974960473859565,1.0,4/17,2.11%,TEK;BMPER;CD34;BMPR2
prerank,positive regulation of histone methylation (GO:0031062),0.5018419380460329,1.4639185896552938,0.056433408577878104,0.48280046281080036,1.0,11/24,24.82%,AUTS2;KMT2A;DNMT1;PAXIP1;RIF1;MTF2;PAF1;DNMT3B;CTR9;SIRT1;WDR5
prerank,organophosphate ester transport (GO:0015748),-0.49956814934401506,-1.4638717948521194,0.048327137546468404,0.3191327152950404,1.0,7/24,14.03%,PITPNC1;PLTP;SCARB1;TNFAIP8L3;PITPNA;PRELID2;PITPNM1
prerank,negative regulation of neuroinflammatory response (GO:0150079),0.5863106978817353,1.4637229071771258,0.08425720620842572,0.4807539115050776,1.0,2/14,5.08%,IGF1;IL4
prerank,maturation of LSU-rRNA (GO:0000470),-0.4862626256196396,-1.4636274770170514,0.059782608695652176,0.31863589897034417,1.0,14/26,26.10%,RRP15;RPL35;NOP2;PES1;RPL10A;URB1;RPL7;WDR12;NSA2;RSL1D1;RPL7A;FTSJ3;RPF2;ZNHIT6
prerank,regulation of small GTPase mediated signal transduction (GO:0051056),-0.35105799632891393,-1.4635846242035904,0.006060606060606061,0.3177734772098626,1.0,36/140,11.85%,ARHGAP31;CHN2;PLCE1;MCF2L;ARHGEF3;NET1;RHOJ;OPHN1;TGM2;RASGRF2;ARAP3;STARD13;ARHGAP23;STARD8;ARHGAP17;CYRIB;ARHGAP26;CD2AP;SLIT2;ARAP2;ARHGAP1;ARHGDIA;TRIO;RAC1;ARHGDIB;CHN1;ARHGAP25;SOS2;BCR;ITSN1;RHOT1;RHOB;PREX1;RHOT2;GMIP;ABR
prerank,positive regulation of cyclase activity (GO:0031281),-0.5759563583440322,-1.4632730283178086,0.06457564575645756,0.3174299727939445,1.0,6/14,19.15%,NOS3;MAPK3;ORAI1;NF1;CACNA1D;CACNA1C
prerank,amyloid precursor protein catabolic process (GO:0042987),-0.5794216273234694,-1.463007937476211,0.06204379562043796,0.3170070882831408,1.0,6/14,14.31%,ADAM10;BACE1;ADAM19;ABCG1;PSENEN;APH1A
prerank,regulation of ion transmembrane transport (GO:0034765),-0.4594817145108743,-1.462981783587535,0.04299065420560748,0.3161266984403087,1.0,11/33,14.41%,ANO6;KCNJ2;NEDD4L;WNK1;WWP2;KCNQ1;KCNJ10;KCNJ8;AKAP6;KCNJ15;CASQ2
prerank,cellular response to exogenous dsRNA (GO:0071360),-0.603062826652772,-1.462775848118655,0.06017699115044248,0.3155988630586017,1.0,7/12,12.36%,CAV1;IFIH1;RALB;DHX9;FLOT1;IFIT1;MAVS
prerank,detection of mechanical stimulus (GO:0050982),-0.5307003759093137,-1.4625665986735503,0.05328596802841918,0.31514138283798393,1.0,5/19,7.34%,PIEZO2;PTK2;PIEZO1;PKD1;JUP
prerank,regulation of small molecule metabolic process (GO:0062012),0.49470111064525324,1.462509506849078,0.07048458149779736,0.4815140417424971,1.0,6/28,5.80%,RORA;PPARA;PDK1;PDK4;PRKN;PDK3
prerank,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),-0.4699580887976428,-1.4618270172634082,0.03780718336483932,0.31570914452806137,1.0,19/31,28.98%,PPP1R13B;PPP3CC;HIP1R;CASP8;BAX;BBC3;YWHAZ;E2F1;BAK1;CHCHD10;YWHAG;YWHAH;BAD;SFN;YWHAB;YWHAE;NMT1;PMAIP1;YWHAQ
prerank,embryonic hemopoiesis (GO:0035162),-0.5864925445890912,-1.4615684869388035,0.07243816254416961,0.3153643311717221,1.0,5/12,8.66%,KITLG;TGFBR2;KDR;ATF4;TAL1
prerank,pancreas development (GO:0031016),0.6016561410039234,1.4603787360113334,0.08085106382978724,0.4845818248659555,1.0,3/12,8.90%,TCF7L2;NKX6-1;NPHP3
prerank,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),-0.5308512797218526,-1.4603380529363357,0.07194244604316546,0.3170680534005888,1.0,10/18,29.30%,HIP1R;ACAA2;BAX;BAK1;CHCHD10;HSPA1A;SLC35F6;TMEM14A;MUL1;FZD9
prerank,response to nitric oxide (GO:0071731),-0.5825010029132414,-1.4586278442841891,0.04878048780487805,0.3198220391336793,1.0,4/13,10.80%,MTR;FOXO1;GUCY1B1;EGLN1
prerank,monocarboxylic acid transport (GO:0015718),-0.41330432444227255,-1.4583279799989541,0.04483430799220273,0.31959754015205577,1.0,10/51,3.19%,ABCG2;ABCC4;SLCO3A1;SLCO2A1;SLCO1C1;ATP8B1;SLCO2B1;SLC16A6;SLC16A9;SLC5A6
prerank,negative regulation of cell-cell adhesion (GO:0022408),-0.4360654435819555,-1.457806599952587,0.029906542056074768,0.31990301131499504,1.0,14/39,8.42%,PODXL;CDH1;NOTCH1;MAP2K5;FXYD5;KLF4;WNK1;PTK2;TGFB1;VEGFA;NOTCH4;RGCC;PPM1F;AKT1
prerank,positive regulation of interleukin-12 production (GO:0032735),-0.45958163407394614,-1.4577729281323055,0.0364963503649635,0.31906017295618616,1.0,9/31,20.35%,PLCG2;TLR3;HSPD1;TIRAP;TLR4;SYK;LAPTM5;LGALS9;MAPK11
prerank,response to cholesterol (GO:0070723),-0.538613714600645,-1.4573098475570905,0.07130124777183601,0.3191551790502973,1.0,9/17,19.13%,TGFBR2;TGFB1;SMO;GRAMD1C;GRAMD1A;ABCA2;MLC1;SMAD2;OSBPL7
prerank,negative regulation of bone mineralization (GO:0030502),0.5687312994886953,1.457133779518675,0.1244343891402715,0.49069584336458133,1.0,3/13,2.10%,ENPP1;BCOR;AHSG
prerank,cellular response to organonitrogen compound (GO:0071417),-0.36478311053132345,-1.4570464227666726,0.012072434607645875,0.31890568169677336,1.0,34/99,25.08%,MEF2C;ACTB;RAP1A;CDH1;RAP1B;SH3BP4;CTNNA1;RAPGEF1;CAPN2;SLIT2;IGFBP5;PDE2A;KCNQ1;DIAPH1;EZR;JUP;AKAP6;IMPACT;LAMTOR2;HCN2;RRAGD;RAPGEF3;RELA;XBP1;SOX9;RRAGA;RAPGEF2;PKD2;RRAGC;SESN2;DMTN;NSMF;GOLPH3;RPTOR
prerank,response to acidic pH (GO:0010447),-0.5753924800089337,-1.4562712985753585,0.08235294117647059,0.31962121001127614,1.0,6/13,26.90%,CHP1;GPR4;IMPACT;RAB11B;CTSS;RAB11FIP5
prerank,substantia nigra development (GO:0021762),-0.4498811760390535,-1.455175980176545,0.05197132616487455,0.32115020199432054,1.0,21/37,31.12%,ACTB;CALM1;COX6B1;RAD1;CKB;MAPKAP1;GNB4;HSPA5;CALM3;S100A1;NDUFS3;INA;YWHAH;FGF9;SYNGR3;CDC42;YWHAE;YWHAQ;CNP;MBP;RHOA
prerank,macrophage activation involved in immune response (GO:0002281),-0.583709586304311,-1.4545935833633776,0.0706713780918728,0.3214168243600353,1.0,5/13,15.81%,LBP;PLCG2;DYSF;SYK;CX3CR1
prerank,regulation of pH (GO:0006885),0.6062045384386778,1.454557997352558,0.10284463894967177,0.4953971246752323,1.0,3/11,5.93%,ATP6V0A4;PDK4;SLC9A7
prerank,positive regulation of transforming growth factor beta production (GO:0071636),-0.5999292300062389,-1.4543761244122906,0.07037037037037037,0.32105363210932314,1.0,5/11,20.27%,THBS1;CD34;GATA6;CD200;LGALS9
prerank,regulation of hydrolase activity (GO:0051336),-0.39433870633153556,-1.4535821266845126,0.021526418786692758,0.3217808439547079,1.0,18/71,11.33%,CHN2;FGD5;CAV1;PRKG1;RASIP1;SIPA1L1;PTK2;ARHGAP27;DAB2IP;PLXNA4;CHN1;CRK;FGD6;GPR137B;ADAP1;PLXNA1;PLXND1;NF1
prerank,engulfment of apoptotic cell (GO:0043652),0.5608008823367503,1.4525007136710086,0.06329113924050633,0.49856758967905657,1.0,5/15,4.66%,XKR4;MEGF10;RHOH;XKR6;RHOBTB1
prerank,negative regulation of reactive oxygen species metabolic process (GO:2000378),0.5208518506307651,1.4524259706163434,0.05856832971800434,0.4962107146643795,1.0,5/21,7.11%,PPARA;SLC30A10;PRKN;ABCD2;SIRT2
prerank,negative regulation of mitotic cell cycle phase transition (GO:1901991),-0.37794787356063614,-1.4511022976139987,0.028462998102466792,0.3262171196573018,1.0,37/87,25.25%,CDK6;KLF4;FHL1;PSMA6;RGCC;PSMB5;KANK2;RB1;FAM107A;PSMC4;CDK4;PSMC5;PSMD14;AVEN;FBXL7;RBX1;PSMD8;PSMD11;CDKN1A;PSMB4;PSMD12;PSMC1;CUL1;CDKN2C;CDK2AP2;PSMA1;E2F7;PSMB1;RBL1;PSMC3;PKD2;PSMA4;PSMA2;CCL2;CDKN2B;DCUN1D3;PSMB8
prerank,purine nucleotide metabolic process (GO:0006163),-0.4971421914658587,-1.4510864882183838,0.05805243445692884,0.3253457388683905,1.0,8/24,11.45%,NT5E;PRPS2;GPX1;NT5C;GDA;PRPS1;PRPS1L1;NT5C1A
prerank,negative regulation of cysteine-type endopeptidase activity (GO:2000117),-0.42815690656393757,-1.450598511188371,0.037037037037037035,0.3254623743290151,1.0,24/44,30.92%,THBS1;MAP2K5;KLF4;RPS6KA3;NGF;CD44;CAST;VEGFA;GPX1;AKT1;BEX3;DHCR24;CSNK2A1;IGBP1;SFN;TRIAP1;CARD16;XIAP;YWHAE;LAMTOR5;DNAJB6;SRC;RPS6KA1;AQP1
prerank,vesicle organization (GO:0016050),-0.4243076696553568,-1.4505114851407948,0.04198473282442748,0.3247640290857019,1.0,21/46,25.53%,CAV1;CD34;FNBP1L;SRGN;CAV2;SNX11;PI4K2A;CHMP2B;USP8;ALS2CL;WASL;VPS11;WASHC5;LAPTM4B;DNM1;PLEKHF1;ZFYVE16;ANXA8L1;ANXA8;PHETA2;EPS15
prerank,negative regulation of cell-substrate adhesion (GO:0010812),-0.4373342817216239,-1.4500321746564062,0.04693140794223827,0.32491984975319443,1.0,10/39,14.84%,ACER2;THBS1;NOTCH1;ACTN4;FZD4;ADAM15;MYOC;FZD7;RCC2;NEXMIF
prerank,negative regulation of osteoblast differentiation (GO:0045668),-0.4616591426918245,-1.4494516845589294,0.036328871892925434,0.3252748742353727,1.0,12/31,20.69%,CRIM1;CDK6;NOTCH1;LRP5;HDAC7;SMAD6;TWIST1;LIMD1;GREM1;SKI;SOX9;BAMBI
prerank,protein localization to lysosome (GO:0061462),-0.4738920619032153,-1.4491915009964642,0.056776556776556776,0.3249375456299057,1.0,13/28,26.83%,SH3BP4;AP3M1;CD81;GLMP;NCOA4;RAB7A;AP4M1;MFSD1;GCC2;LAPTM5;ZFYVE16;VPS4A;LAMTOR5
prerank,semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),0.5718637679504648,1.4490164944154944,0.08716707021791767,0.503105132490505,1.0,3/13,2.89%,PLXNA2;NRP1;SEMA3A
prerank,regulation of protein dephosphorylation (GO:0035304),-0.4434523438647186,-1.4489616615911871,0.045275590551181105,0.32455155014600034,1.0,20/37,26.21%,PPP1R16B;CALM1;TGFB1;MFHAS1;PPIA;HTT;PPP2R5A;PPP1R8;CALM3;PPP1R16A;PPP6R3;CDCA2;PIN1;CNEP1R1;CDH5;ARPP19;PRKCD;YWHAB;NSMF;SMPD1
prerank,positive regulation of signal transduction (GO:0009967),0.33448777622582604,1.4487320185788826,0.0039603960396039604,0.5012368299886945,1.0,40/238,9.52%,CCBE1;IGF1;BMP6;ROBO1;PIK3R1;NRP1;BMP2;SALL1;WLS;NTRK3;FGFR2;SULF1;SULF2;NRXN1;CYP27B1;RIMS1;PRKCA;PTGIS;PHIP;SFRP1;EVC;AAK1;AXL;MAML3;NPTN;NLGN2;NLGN3;MYORG;LOXL3;NLGN1;CITED2;TGFBR1;RBPJ;KIF7;IGF2;STX1B;GATA3;PRKCB;MN1;CUX2
prerank,positive regulation of proteolysis (GO:0045862),0.41658177927413276,1.4461927276802256,0.0440251572327044,0.5057549223204665,1.0,14/55,17.44%,CCBE1;SH3D19;AURKAIP1;SNX33;ASPH;FGFR4;SNX9;NKD2;BTRC;NRDC;TANK;TBC1D10A;FADD;CTSH
prerank,negative regulation of cytokine production involved in immune response (GO:0002719),-0.5436571602657483,-1.4461214194372132,0.07378640776699029,0.3300067813243844,1.0,4/15,6.78%,SMAD7;TGFB1;TGFB2;TGFB3
prerank,myelin maintenance (GO:0043217),0.6145566761792842,1.4459167822971115,0.111358574610245,0.5039306089760123,1.0,4/10,13.93%,EPB41L3;ABCD2;PTEN;CXCR4
prerank,regulation of cell adhesion mediated by integrin (GO:0033628),-0.44865462035951054,-1.4453910222541473,0.048582995951417005,0.33089357079436715,1.0,16/33,24.12%,ACER2;DPP4;PTK2;JAM3;TGFB2;CYP1B1;FOXC2;CIB1;SYK;NEXMIF;EPHA2;RET;PLAU;ADA;PIK3CG;SNAI2
prerank,regulation of fatty acid metabolic process (GO:0019217),-0.53204861116364,-1.445363495083569,0.06870229007633588,0.3300496571319358,1.0,5/17,5.35%,CAV1;ADIPOR2;PPARD;NCOR1;ADIPOR1
prerank,modulation by symbiont of entry into host (GO:0052372),-0.5466590321632457,-1.4453409555377508,0.061068702290076333,0.3291916131474356,1.0,8/16,15.28%,CAV1;TRIM25;TRIM14;TRIM62;TRIM68;FUCA2;TRIM5;NECTIN2
prerank,positive regulation of glucose transmembrane transport (GO:0010828),0.49602232498939486,1.444914903092149,0.07157894736842105,0.5043262609718374,1.0,6/26,10.17%,IGF1;PIK3R1;OSBPL8;IRS2;C2CD5;PRKCI
prerank,regulation of cardiac muscle hypertrophy (GO:0010611),0.5100213666410846,1.4448798565748873,0.08823529411764706,0.5018975546429724,1.0,4/22,3.79%,IGF1;ROCK2;PRKCA;P2RX4
prerank,negative regulation of cellular response to insulin stimulus (GO:1900077),0.4868943778262785,1.444362299798542,0.06263498920086392,0.5007974832728197,1.0,4/28,2.24%,ENPP1;PID1;AHSG;PIP4K2A
prerank,membrane raft organization (GO:0031579),-0.5572702093744166,-1.4439221232664021,0.07913669064748201,0.33154683323466927,1.0,7/15,14.98%,ANXA2;FLOT1;NAXE;S100A10;EMP2;NPC1;FLOT2
prerank,regulation of Rho protein signal transduction (GO:0035023),-0.385193499344131,-1.443887051895692,0.03143418467583497,0.330717344140575,1.0,24/72,11.08%,HEG1;ARHGEF28;ARHGEF3;NET1;EPS8;RASIP1;OPHN1;F11R;STARD13;STARD8;COL3A1;EPS8L2;ARHGDIA;RAC1;ARHGDIB;CCDC125;GPR4;MYOC;BCR;ADGRG1;KANK2;LPAR6;TNFAIP1;ABL2
prerank,cell chemotaxis (GO:0060326),0.41406439607739726,1.443275844528755,0.05439330543933055,0.5013033335794658,1.0,14/60,9.85%,NRP1;LPAR1;SEMA5A;KIT;PDGFRA;CCR6;ACKR4;ACKR2;CCR10;PDGFRB;EPHB1;CCR9;HOXB9;CCL25
prerank,digestive tract development (GO:0048565),0.4711566378059097,1.442793579180323,0.051181102362204724,0.5000630477629404,1.0,7/32,3.86%,SALL1;FGFR2;RARB;CLMP;KIT;GLI2;GLI3
prerank,regulation of osteoblast differentiation (GO:0045667),0.3867234112901071,1.442740086525142,0.031683168316831684,0.49772426313102813,1.0,11/82,3.69%,IGF1;BMP6;WNT4;NELL1;BMP2;FBN2;DDR2;FGFR2;PRKACA;CCN4;RANBP3L
prerank,cellular response to dsRNA (GO:0071359),-0.5524170544475658,-1.4423794869908704,0.07142857142857142,0.33313621853144393,1.0,13/15,32.10%,CAV1;IFIH1;RALB;DHX9;FLOT1;IFIT1;MAVS;CGAS;ZCCHC3;NPM1;MUL1;PQBP1;RIOK3
prerank,porphyrin-containing compound biosynthetic process (GO:0006779),-0.48886995816024004,-1.4420120931295508,0.06890130353817504,0.33299904979888784,1.0,10/24,27.27%,ABCG2;SLC25A38;UROS;COX15;FXN;ATP5IF1;COX10;ALAS2;ALAD;ABCB6
prerank,nitric oxide metabolic process (GO:0046209),-0.5653390280204544,-1.4416638323404363,0.06451612903225806,0.3328934359975139,1.0,6/14,16.86%,NOS3;GCH1;CYP1B1;AKT1;SPR;NQO1
prerank,negative regulation of angiogenesis (GO:0016525),-0.38073607670647,-1.4413335413737083,0.018072289156626505,0.3327545841085027,1.0,20/84,10.11%,TEK;CLDN5;SEMA6A;SLC12A2;THBS1;KLF2;KLF4;COL4A2;DAB2IP;NPR1;EPN1;TGFB2;STAB1;SARS1;PTPRM;AMOT;RGCC;NAXE;HHEX;ISM1
prerank,negative regulation of amyloid-beta formation (GO:1902430),0.5330162362278928,1.4411270397136482,0.08705357142857142,0.4998462460559473,1.0,3/17,11.12%,IGF1;RTN4;CHRNA7
prerank,cardiac muscle tissue morphogenesis (GO:0055008),0.4693244491659181,1.440777378216981,0.08597285067873303,0.49840561885761814,1.0,5/29,4.22%,TGFBR3;BMP2;FGFR2;TNNC1;TNNI3
prerank,protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),-0.6089725490095534,-1.4399722523989267,0.08097928436911488,0.33495509055365424,1.0,4/10,5.46%,PARD3;DGKH;PLPP1;PRKD3
prerank,positive regulation of pattern recognition receptor signaling pathway (GO:0062208),-0.5546804034390538,-1.4399285727095514,0.06545454545454546,0.3341634209072857,1.0,7/14,21.90%,TLR3;DHX58;USP15;ANKRD17;ZDHHC5;PUM2;ZCCHC3
prerank,focal adhesion assembly (GO:0048041),-0.5097955204778735,-1.438818381664352,0.06844106463878327,0.33585759728325076,1.0,11/21,20.26%,THSD1;SORBS1;PEAK1;FERMT2;ACTN1;BCR;TAOK2;RCC2;CTTN;TRIP6;PTPRK
prerank,muscle contraction (GO:0006936),-0.3515998680662103,-1.4385825000840342,0.010101010101010102,0.33552078324436846,1.0,21/126,8.19%,UTRN;ITGA1;SORBS3;EDNRA;TMOD3;SORBS1;DMD;VIM;PXN;MYL6;MYOF;CALM1;MYH11;MYOM1;DYSF;ACTA2;LMOD1;MYL12A;MYL9;GJC1;TMOD1
prerank,central nervous system projection neuron axonogenesis (GO:0021952),0.5778159140153921,1.4384050193206837,0.10810810810810811,0.5026150261479895,1.0,3/12,7.13%,MYCBP2;GLI2;EPHB1
prerank,positive regulation of sprouting angiogenesis (GO:1903672),-0.546944223395071,-1.4380839041105284,0.059033989266547404,0.3357194768111593,1.0,8/15,17.07%,BMPER;FGF1;KLF4;VEGFA;PKM;FGF2;S100A1;JMJD8
prerank,oxoacid metabolic process (GO:0043436),0.48645615641726186,1.4376733502964927,0.0653061224489796,0.5020975223657431,1.0,8/27,14.01%,ENPP1;TPST1;SULT6B1;DDO;PPA2;PPA1;ABHD14B;GRHPR
prerank,enzyme linked receptor protein signaling pathway (GO:0007167),0.357735295375249,1.4366604961284182,0.012295081967213115,0.502519317483888,1.0,41/138,12.96%,EPHA7;IL31RA;PTN;NTRK3;DDR2;FGFR2;KIT;EFS;PDGFRA;MTSS1;EPHA3;TNK2;EPHA6;PTPRD;PTPRT;STAP1;LYN;DDR1;AXL;SHC4;PDGFRB;EPHB1;POLR1G;ERBB3;GUCY2F;RYK;FGFR4;EPHA8;AHI1;SH2D6;ERBB4;EPHA5;ALK;MUSK;MST1R;MERTK;GFRA2;FGFR1;ROR1;EPHA1;BCAR1
prerank,pre-miRNA processing (GO:0031054),0.5728460064940291,1.436154849829751,0.09361702127659574,0.5015644845790765,1.0,9/14,23.08%,TUT4;AGO4;LIN28B;DROSHA;AGO3;AGO1;AGO2;MRPL44;DICER1
prerank,negative regulation of canonical Wnt signaling pathway (GO:0090090),0.3446589109159695,1.4358038869553216,0.017475728155339806,0.5000619715564606,1.0,28/161,11.35%,BICC1;TCF7L2;IGFBP2;NOTUM;BMP2;RBMS3;PRICKLE1;TBX18;LRP4;DKK3;GLI3;ZNRF3;SFRP1;MCC;AXIN2;PRKN;HECW1;TLE1;PSMA3;SOX2;PSMF1;NPHP3;DVL3;DACT3;FRZB;FUZ;SIAH2;NKD2
prerank,regulation of membrane protein ectodomain proteolysis (GO:0051043),0.5041672023716873,1.4355782938905126,0.08314606741573034,0.49830665230984444,1.0,6/22,14.07%,SH3D19;TIMP3;SNX33;TIMP4;SNX9;NRDC
prerank,response to molecule of bacterial origin (GO:0002237),-0.3857281941119114,-1.4351520106522244,0.027985074626865673,0.3414488966882702,1.0,23/69,22.08%,FOXP1;LBP;NOS3;CYRIB;RPS6KA3;GCH1;MAPKAPK3;SMAD6;OTUD5;TNFRSF11A;IFNAR1;TRIB1;TIRAP;GGT5;TLR4;JAK2;TNFAIP3;TAB2;PELI1;GGT1;LGALS9;FZD5;PTPN22
prerank,contractile actin filament bundle assembly (GO:0030038),-0.5598285315984948,-1.4345995651855101,0.06593406593406594,0.3409605224350449,1.0,10/15,34.35%,SORBS1;PDLIM1;FAM171A1;TNFAIP1;FHDC1;PDCD10;SRC;RHOA;CUL3;KCTD13
prerank,stress fiber assembly (GO:0043149),-0.5598285315984948,-1.4345995651855101,0.06593406593406594,0.3409605224350449,1.0,10/15,34.35%,SORBS1;PDLIM1;FAM171A1;TNFAIP1;FHDC1;PDCD10;SRC;RHOA;CUL3;KCTD13
prerank,purine ribonucleoside bisphosphate metabolic process (GO:0034035),0.5793956708694981,1.4338898916976326,0.08641975308641975,0.5004009714970865,1.0,3/13,7.11%,ENPP1;TPST1;SULT6B1
prerank,regulation of multicellular organism growth (GO:0040014),0.5599532571396431,1.433803134006339,0.0824295010845987,0.498261744347162,1.0,3/15,4.95%,IGF1;STAT5B;GHR
prerank,ribonucleoprotein complex assembly (GO:0022618),-0.34699846603017415,-1.4335593188659859,0.007722007722007722,0.34237612666557526,1.0,40/132,19.27%,RPS14;RPL6;RPSA;RPS15;RPS27;RPL10;RPL38;HSP90AB1;RPL11;RPS28;RPS5;RPS19;SRSF5;SNRPC;RPL23A;PRKDC;SRPK1;ISY1;SRSF6;NOP2;DHX9;SNRPD3;LUC7L2;RPS27L;XAB2;RPL3;PPAN;ZRSR2;DDX23;MDN1;ERAL1;SMN1;RPL24;HSP90AA1;DDX20;DDX39B;EIF5;SCAF11;SNRPG;TGS1
prerank,fat-soluble vitamin metabolic process (GO:0006775),0.5042237652431049,1.4335539474200387,0.0673469387755102,0.4964924318551229,1.0,3/22,1.77%,ALDH1A2;CYP27B1;VDR
prerank,amino sugar metabolic process (GO:0006040),-0.608497932305629,-1.432895306580909,0.0759493670886076,0.3429463319836497,1.0,4/10,12.61%,CSGALNACT1;SLC35A3;ST6GAL1;GFPT1
prerank,mitochondrial respiratory chain complex I assembly (GO:0032981),-0.4059406909031591,-1.432292197398766,0.03130755064456722,0.34247906361590585,1.0,31/56,31.64%,NDUFV2;NDUFB2;NDUFB8;NDUFB4;NDUFS4;NDUFA13;NDUFB7;NDUFS2;NDUFA12;TIMM21;NDUFB5;NDUFA9;NDUFB9;NDUFS3;NDUFS6;NDUFC1;DMAC2;NDUFA3;ECSIT;NDUFA10;NDUFB10;NDUFB3;NDUFA7;NDUFA1;NDUFAF3;BCS1L;NDUFA8;ACAD9;NDUFAF4;NDUFA2;NDUFAF5
prerank,NADH dehydrogenase complex assembly (GO:0010257),-0.4059406909031591,-1.432292197398766,0.03130755064456722,0.34247906361590585,1.0,31/56,31.64%,NDUFV2;NDUFB2;NDUFB8;NDUFB4;NDUFS4;NDUFA13;NDUFB7;NDUFS2;NDUFA12;TIMM21;NDUFB5;NDUFA9;NDUFB9;NDUFS3;NDUFS6;NDUFC1;DMAC2;NDUFA3;ECSIT;NDUFA10;NDUFB10;NDUFB3;NDUFA7;NDUFA1;NDUFAF3;BCS1L;NDUFA8;ACAD9;NDUFAF4;NDUFA2;NDUFAF5
prerank,canonical glycolysis (GO:0061621),-0.4803777900904905,-1.4318398136370616,0.08,0.34176192274101486,1.0,10/24,23.23%,GPI;HK1;FOXK1;PKM;PFKP;GAPDH;PGK1;PGAM1;PFKL;ENO1
prerank,glucose catabolic process to pyruvate (GO:0061718),-0.4803777900904905,-1.4318398136370616,0.08,0.34176192274101486,1.0,10/24,23.23%,GPI;HK1;FOXK1;PKM;PFKP;GAPDH;PGK1;PGAM1;PFKL;ENO1
prerank,B cell activation (GO:0042113),-0.3910516970625392,-1.431743092344522,0.03564727954971857,0.3411062861794792,1.0,33/68,32.98%,MEF2C;PTPRJ;PLCG2;CTPS1;TPD52;ZBTB7A;HDAC9;CASP8;HDAC4;HHEX;HSPD1;PHB2;CLCF1;ITGA4;TCF3;KLF6;JAK3;ADGRG3;BTK;LAT2;BANK1;DCAF1;NFAM1;HDAC5;PTPN2;LAX1;RASGRP1;CD86;CHRNB2;LYL1;CD40;BLNK;CR2
prerank,platelet degranulation (GO:0002576),-0.35471316825990534,-1.4316488081910426,0.0150093808630394,0.340433403467739,1.0,28/118,9.38%,FN1;VWF;ABCC4;PECAM1;TMSB4X;THBS1;SRGN;ACTN4;CYRIB;VEGFC;CALM1;TGFB1;APP;TGFB2;LHFPL2;FAM3C;CD109;VEGFA;PSAP;WDR1;ISLR;ACTN1;TGFB3;CD9;QSOX1;PDGFA;PCDH7;VCL
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),-0.5363665175587919,-1.4313985534842293,0.075046904315197,0.34015780052018896,1.0,5/16,17.25%,ACKR3;TPT1;RPS3;BCL2L1;CCAR2
prerank,high-density lipoprotein particle remodeling (GO:0034375),-0.5520845653911434,-1.4310307731876075,0.06805293005671077,0.3401620959186083,1.0,5/15,18.26%,PLTP;SCARB1;ABCG1;APOE;LCAT
prerank,positive regulation of glucose import (GO:0046326),0.5141390034758654,1.4307392838855948,0.09368191721132897,0.5019421704918314,1.0,4/21,5.54%,IGF1;PIK3R1;OSBPL8;IRS2
prerank,positive regulation of cell adhesion (GO:0045785),-0.3790842879001413,-1.430571261095139,0.02976190476190476,0.34040905501992264,1.0,20/74,15.65%,FRMD5;PTPRJ;VIT;TGM2;STX3;SMAD7;TGFB2;RAC1;LIMS1;VEGFA;ADGRG1;NPNT;PPM1F;FBLN2;FOXC2;CIB1;SYK;JAK2;ERBB2;ZFHX3
prerank,sphingoid metabolic process (GO:0046519),-0.5755600041520529,-1.4301253870421338,0.08133086876155268,0.340552677857934,1.0,7/12,24.77%,DEGS2;PLPP1;KDSR;ASAH2;SPHK2;PLPP2;SGPP1
prerank,positive regulation of protein localization to Cajal body (GO:1904871),-0.5961874631320115,-1.4298634547387081,0.0782122905027933,0.3393869061806534,1.0,8/11,35.15%,DKC1;CCT2;CCT3;CCT8;MEPCE;CCT7;CCT4;CCT6A
prerank,regulation of protein localization to Cajal body (GO:1904869),-0.5961874631320115,-1.4298634547387081,0.0782122905027933,0.3393869061806534,1.0,8/11,35.15%,DKC1;CCT2;CCT3;CCT8;MEPCE;CCT7;CCT4;CCT6A
prerank,negative regulation of hydrogen peroxide-induced cell death (GO:1903206),-0.5634660017663901,-1.4297217924261632,0.09395973154362416,0.33875634966330337,1.0,6/13,26.64%,RACK1;PDE8A;GPR37L1;MET;PARK7;TXN
prerank,response to metal ion (GO:0010038),-0.391854678867854,-1.429655889020829,0.022304832713754646,0.33803081958591025,1.0,17/67,13.91%,CAV1;THBS1;TRPC3;NEDD4L;MT1A;MT1X;CALM1;ITPR3;MT2A;CRIP1;ATP5F1D;SLC25A12;CALM3;PPP5C;HOMER1;FXN;PEF1
prerank,manganese ion transport (GO:0006828),-0.5478910247628662,-1.429347668312717,0.08610567514677103,0.33775818299821203,1.0,6/14,10.93%,TRPC3;TMEM165;ATP2C1;SLC39A8;TRPC6;TRPC4
prerank,hematopoietic stem cell proliferation (GO:0071425),-0.5916824936972491,-1.429317602041488,0.0711743772241993,0.336987101793215,1.0,2/11,1.19%,MECOM;CD34
prerank,nervous system development (GO:0007399),0.3093606574876782,1.4290205324233791,0.0,0.5042142614753071,1.0,92/429,13.69%,ROBO1;ADGRV1;NELL1;ARNT2;LDB2;ALDH1A2;ROBO2;RBFOX1;PTN;ATXN1;CNTFR;TBX3;LPAR1;SDK2;SEMA5A;CHST8;NRG1;NRXN1;GDNF;CNTN4;ZIC1;TEAD1;PCDHB10;LSAMP;CHD7;GPM6A;DCHS1;ARTN;ZEB2;GLRB;CHRM2;PRKN;PCDHB13;AXL;KIRREL3;GSTP1;NLGN2;CHRM3;NLGN3;RAB29;SCD5;IGF2BP2;ASIC2;APAF1;EPHB1;SCN2A;NLGN1;GRIK1;TGFBR1;ADGRA2;SCIN;NRCAM;ERBB3;HES5;ATXN3;RYK;ATN1;GMFB;TMEM223;AHI1;CYP46A1;FARP1;ERBB4;PTEN;ZIC4;ANKLE2;NFASC;APLP1;RPS6KA6;ST8SIA2;PCDHB15;NAB2;MST1R;SDHA;EDNRB;MERTK;COX7B;GFRA2;KALRN;APBA1;OBSL1;ATXN10;DLG4;PAX8;GBA2;EP300;VCAN;NAV3;YAP1;CNTN6;TENM1;POU6F2
prerank,aromatic amino acid family catabolic process (GO:0009074),0.5501537072340261,1.42853682401955,0.07777777777777778,0.5031784161232294,1.0,5/15,14.42%,IL4I1;TDO2;KMO;KYNU;GSTZ1
prerank,oogenesis (GO:0048477),0.5536394894118359,1.428390660763114,0.10869565217391304,0.501203001154135,1.0,6/15,19.12%,PTN;NANOS3;FMN2;PIWIL2;METTL3;MARF1
prerank,regulation of ruffle assembly (GO:1900027),-0.4886804877638167,-1.4282430442820302,0.06,0.33834307202898745,1.0,9/23,13.89%,CAV1;EPS8;PLEKHM1;EPS8L2;ABI3;PFN1;FAM98A;HRAS;NDEL1
prerank,positive regulation of microtubule polymerization or depolymerization (GO:0031112),-0.4791184620694101,-1.4279693671900942,0.06165703275529865,0.338034543823078,1.0,10/26,19.08%,OCLN;RPS3;RAC1;SLAIN2;STMN2;DCTN1;TRPV4;KATNB1;MET;ARL2
prerank,cellular response to fluid shear stress (GO:0071498),-0.5789701996478762,-1.4274410911508688,0.07692307692307693,0.33832911709518615,1.0,4/12,2.59%,MEF2C;MAP2K5;KLF2;KLF4
prerank,negative regulation of cell junction assembly (GO:1901889),0.4930199338343072,1.4269611228620018,0.08423326133909287,0.502682956150617,1.0,5/25,5.17%,ARHGAP6;ROBO2;PHLDB2;ROCK2;DLC1
prerank,regulation of natural killer cell mediated cytotoxicity (GO:0042269),-0.49462877119786536,-1.4264283720635966,0.08396946564885496,0.3398650160862181,1.0,17/23,45.09%,PIK3R6;PVR;LAMP1;NECTIN2;LGALS9;RASGRP1;LILRB1;AP1G1;CADM1;SLAMF6;CD226;IL12A;CRTAM;NCR1;KLRD1;CD160;KLRK1
prerank,regulation of axon guidance (GO:1902667),0.6033085209141684,1.425521028096038,0.10747663551401869,0.5042908451997554,1.0,3/10,7.97%,NRP1;MYCBP2;ZSWIM5
prerank,regulation of presynapse assembly (GO:1905606),0.5382130162711847,1.4254325555341425,0.09297520661157024,0.4999165454359611,1.0,4/18,7.06%,GPC6;GPC4;PTPRD;IL1RAPL1
prerank,regulation of presynapse organization (GO:0099174),0.5382130162711847,1.4254325555341425,0.09297520661157024,0.4999165454359611,1.0,4/18,7.06%,GPC6;GPC4;PTPRD;IL1RAPL1
prerank,response to exogenous dsRNA (GO:0043330),-0.5249912255254969,-1.42537052496919,0.08483754512635379,0.34153513570264776,1.0,9/18,13.81%,CAV1;IFIH1;RALB;TLR3;DHX9;FLOT1;IFIT1;MAVS;SLC3A2
prerank,positive regulation of hydrolase activity (GO:0051345),-0.345216139951135,-1.4252782361985021,0.01764705882352941,0.34090198948810163,1.0,41/137,20.08%,DOCK9;PKP4;ITGA6;RAP1A;NET1;RACK1;TGM2;AGRN;F11R;CAV2;SGSM2;RAPGEF1;ARHGAP27;RPS3;FERMT2;CALM1;BCAS3;LIMS1;PSAP;RGS6;NDUFA13;CCL15;S100A10;ZC3H15;WNT11;NF1;CALM3;HRAS;NDEL1;SNX18;RAP1GDS1;ERBB2;BCAR3;RAPGEF3;MAPRE2;TBC1D2;MAPK12;ECT2;CD200;PIN1;RGS10
prerank,regulation of apoptotic process (GO:0042981),-0.2879390429204329,-1.4251915526540522,0.0,0.34024374142275465,1.0,194/676,20.37%,LEF1;TEK;ANO6;MEF2C;PPP1R13B;IGF1R;ITGA6;MAP3K5;ACER2;THBS1;MCF2L;TPT1;ARHGEF3;NET1;TAX1BP1;RACK1;PTK2B;UNC13B;TGM2;ACTN4;RASGRF2;NFKBIA;KDR;ARL6IP5;FOXO1;EGLN3;TFRC;PTK2;RNF144B;RPS6KA3;RPL10;FOXO3;RPS3;ANXA1;DAB2IP;CARD14;SLIT2;ZBTB7A;NGF;MAP3K20;CD44;SOCS2;TMBIM4;CRADD;CTNNBL1;REST;ARHGDIA;TRIO;UBB;PPIA;HTT;ADAM10;CYP1B1;TNFSF10;ING5;IGFBP3;CD38;UBC;RPS27A;SMAD6;VEGFA;SPTLC1;PTMA;SOS2;HIP1R;TNFAIP8;RHBDD1;UFM1;IKBKB;TMEM219;GATA6;SH3RF2;ATF4;ANP32A;ACTN1;SHC1;TGFB3;PRKDC;RASSF2;CASP8;HSPB1;TOX3;EGLN2;ANXA4;RIPK1;FLT4;PLK2;BAX;AKT1;PERP;GLO1;CTSD;BCL6;MAP3K11;PSENEN;ITSN1;DNAJA1;FAS;PIM3;ATG7;DDRGK1;HSPD1;HIP1;RHOB;TCIM;VCP;WNT11;LRP8;CD74;PREX1;CFL1;HSPA5;CTSB;RTKN;NF1;HTATIP2;CIB1;GADD45G;ABR;GRK5;SERPINB9;YWHAZ;BCL2L1;E2F1;AVEN;SOX4;ITCH;BAK1;FXN;FSTL1;RNPS1;SPHK2;HIGD2A;RPS6;COPS5;RPS6KA2;ARHGEF5;DHCR24;ARHGEF18;PHB2;NUAK2;APH1A;JAK2;BNIP3L;EGFR;OSGIN1;HNRNPK;TOP2A;OPN3;MADD;HYPK;PTPN6;STK26;LGALS1;OPA1;STAT1;GREM1;PHLDA3;PDCD2;HSP90AA1;DDX20;HSPA1A;RELA;BAD;XBP1;BABAM2;CCAR2;JAK3;HCK;FOXL2;ARHGEF12;CALHM2;HSPA9;ARHGEF17;CRYAB;ASNS;ARHGEF4;ARHGEF2;ECT2;ANGPTL4;RASA1;GADD45A;SRA1;SOX9;LCMT1;FAIM2;GCLC;ARHGEF6;FGD2;MCL1;CASP1;HIGD1A;DNM2;TMBIM6
prerank,protein-containing complex disassembly (GO:0032984),-0.4128296230104118,-1.4249648619647535,0.04990757855822551,0.33987032566323366,1.0,21/54,25.20%,CAV1;MAP1LC3B;VAMP7;RPL23;HSPA8;GABARAP;LIX1L;TECPR1;VCP;MAP1LC3A;TSG101;VPS16;VPS33A;VTI1B;WIPI2;FZD5;RUBCNL;PPP1CA;PYM1;GABARAPL1;VPS4A
prerank,positive regulation of gene silencing by miRNA (GO:2000637),-0.46943297231282516,-1.4243223167485606,0.05321100917431193,0.3404257077357361,1.0,10/27,22.04%,DDX5;TGFB1;RIPK1;DHX9;WTIP;LIMD1;FMR1;EGFR;PUM2;EIF4G1
prerank,synapse assembly (GO:0007416),0.39915596221962657,1.424157736888873,0.04684317718940937,0.501055068825734,1.0,26/67,17.65%,SDK2;GRID2;NRXN1;PCDHB10;GPM6A;GABRA2;LRRTM3;GABRB3;PCDHB13;KIRREL3;NLGN2;NLGN3;RAB29;NLGN1;NRCAM;RYK;FARP1;PTEN;PLXNB2;OBSL1;DRD2;PCDHB16;PCDHB14;ACHE;FLRT3;GABRG2
prerank,negative regulation of fatty acid metabolic process (GO:0045922),-0.5434940669617894,-1.4236451069892977,0.08152173913043478,0.3410708364368328,1.0,8/16,25.17%,NCOR1;ERLIN2;ACADL;WDTC1;ACADVL;SOX9;TRIB3;APOC1
prerank,myeloid cell differentiation (GO:0030099),-0.4107861835968285,-1.4231854710301421,0.03461538461538462,0.34125159545465455,1.0,24/47,28.12%,RPS14;MFHAS1;ZBTB16;RPS19;SLC25A38;TAL1;TIRAP;INHBA;JAK2;ATP5IF1;UFL1;JAK3;HSPA9;UBA5;RASGRP4;SNRK;ALAS2;HCLS1;ZFPM1;CDKN2B;ACIN1;INHA;PTPN2;SPI1
prerank,positive regulation of establishment of protein localization to telomere (GO:1904851),-0.6071138183457847,-1.4231533956742672,0.0661764705882353,0.3404778314125877,1.0,8/10,35.15%,DKC1;CCT2;CCT3;CCT8;CCT7;WRAP53;CCT4;CCT6A
prerank,nitric oxide biosynthetic process (GO:0006809),-0.576873494891259,-1.423073697118877,0.06751824817518248,0.3398524779459521,1.0,6/13,16.86%,NOS3;GCH1;CYP1B1;AKT1;SPR;NQO1
prerank,positive regulation of Ras protein signal transduction (GO:0046579),0.40529964656239525,1.422659491820074,0.04426559356136821,0.5029492766954731,1.0,8/61,5.54%,IGF1;AUTS2;ROBO1;LPAR1;GPR55;GPR174;LYN;IRS2
prerank,regulation of glycogen metabolic process (GO:0070873),-0.5780244258220085,-1.4226027269164665,0.08807339449541285,0.34014309860273245,1.0,6/12,23.46%,PPP1R3B;AKT1;PPP1R3F;PPP1R3C;RUBCNL;PPP1R3E
prerank,positive regulation of leukocyte activation (GO:0002696),-0.5257526820696543,-1.421871774506013,0.061855670103092786,0.34105791831027515,1.0,6/18,15.28%,LBP;THBS1;IL33;HSPD1;TLR4;NECTIN2
prerank,positive regulation of T-helper cell differentiation (GO:0045624),-0.5643837987522682,-1.42185526704492,0.08243727598566308,0.34027000619987474,1.0,4/14,7.13%,ANXA1;PRKCZ;RARA;NFKBIZ
prerank,myotube differentiation (GO:0014902),0.5303690003198008,1.4218409790782471,0.09913793103448276,0.5028867426458477,1.0,5/17,7.46%,IGF1;ADGRB3;ADAMTS5;ADAM12;SIX4
prerank,regulation of focal adhesion assembly (GO:0051893),-0.4021579250437815,-1.4217554347571337,0.0425531914893617,0.339728316243333,1.0,20/54,12.21%,TEK;THBS1;PTPRJ;ACTG1;LIMCH1;PEAK1;KDR;PTK2;FERMT2;RAC1;BCAS3;LIMS1;VEGFA;MYOC;PPM1F;VCL;FAM107A;S100A10;DUSP3;RCC2
prerank,carbohydrate catabolic process (GO:0016052),-0.4315949268766324,-1.4217077062224928,0.060550458715596334,0.3390325827543232,1.0,18/38,29.48%,GPI;MANBA;HK1;PGM1;PKM;GAPDH;LDHA;PGK1;NEU3;PGAM1;PGAM4;PFKL;ENO1;NEU1;NEU2;NAGA;PFKFB1;PFKFB2
prerank,steroid hormone mediated signaling pathway (GO:0043401),-0.5622525793265227,-1.4206655788044127,0.08288288288288288,0.34048413044432857,1.0,5/13,6.98%,ABHD2;NR3C2;ESR1;PLPP1;NR3C1
prerank,positive regulation of cell junction assembly (GO:1901890),0.40626942658749454,1.4203159687032534,0.035864978902953586,0.5045773635180021,1.0,16/56,7.71%,NRP1;SRPX2;GRID2;NRXN1;CLSTN2;CNTNAP2;PTPRD;SFRP1;IL1RAP;COL16A1;SYNDIG1;NLGN2;NLGN3;IL1RAPL1;EPHB1;NLGN1
prerank,negative regulation of metabolic process (GO:0009892),0.4057968364166405,1.4202154922807853,0.06031128404669261,0.502607743540017,1.0,12/54,9.62%,ALDH1A1;LGR4;PLCL1;NOVA1;ADAMTS5;ACTN3;GSTP1;PLCL2;ACOT11;DOCK7;RBPJ;HOXC10
prerank,inner ear morphogenesis (GO:0042472),0.5037428606612726,1.4199421811109483,0.1032258064516129,0.5011275708440341,1.0,7/22,13.23%,FGFR2;ZIC1;TBX18;CHD7;TMIE;TTC39C;PAX8
prerank,receptor metabolic process (GO:0043112),-0.4017493629176455,-1.4199079592071495,0.03639846743295019,0.3413871914667533,1.0,16/53,13.59%,CAV1;DNM3;ACKR3;RAMP2;TFRC;TGFB1;CD81;CD9;AP2M1;FCER1G;LMTK2;KIF16B;REP15;RAB11B;SYK;SMURF1
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",-0.39502114139502753,-1.4179860509554303,0.03244274809160305,0.3448289321853081,1.0,20/54,22.40%,RPL26;CRADD;CDKN1B;CNOT7;RGCC;PLK2;BAX;PLAGL1;PCBP4;E2F1;SOX4;CDKN1A;E2F4;GADD45A;SFN;CNOT11;E2F7;CNOT3;TRIAP1;PLK3
prerank,positive regulation of JUN kinase activity (GO:0043507),-0.4916154865041777,-1.4170606243077555,0.06126482213438735,0.3460358261069108,1.0,8/23,13.54%,MAP3K5;RPS3;DAB2IP;TAOK3;EDN1;TNFRSF11A;MAP3K11;ARHGEF5
prerank,dicarboxylic acid transport (GO:0006835),0.4760371731919212,1.4169744671711197,0.08639308855291576,0.5067658111921288,1.0,7/28,7.31%,SLC1A3;SLC13A3;GJA1;ABCC2;SLC26A1;SLC25A13;SLC25A10
prerank,triglyceride biosynthetic process (GO:0019432),0.5216894817182324,1.416943050136918,0.09381663113006397,0.5046661967083755,1.0,6/18,16.50%,AGMO;MOGAT3;LPIN3;MOGAT2;DGAT2;LPIN1
prerank,cellular response to interferon-gamma (GO:0071346),-0.36405866182950747,-1.4168505083365277,0.03125,0.3456185079352832,1.0,30/88,24.96%,B2M;CAMK2D;GBP5;TRIM25;CD44;MT2A;MID1;GBP7;GAPDH;CCL15;RPL13A;TRIM62;TLR4;TRIM68;JAK2;TRIM5;IRF9;OAS2;STAT1;IFNGR1;HCK;IRF8;AQP4;SYNCRIP;CASP1;LGALS9;PRKCD;AIF1;CCL2;ICAM1
prerank,regulation of interleukin-2 production (GO:0032663),-0.4222350213058372,-1.4166793368910529,0.04823747680890538,0.3451787853763099,1.0,8/43,6.47%,CD34;SPTBN1;PLCG2;PDE4D;RPS3;ANXA1;HDAC7;EZR
prerank,mitotic G1 DNA damage checkpoint signaling (GO:0031571),-0.3847169842619176,-1.415951392955212,0.037037037037037035,0.34594385611348877,1.0,23/63,22.40%,RPL26;CRADD;CDKN1B;CNOT7;PRKDC;RGCC;PLK2;BAX;PLAGL1;PCBP4;RPS27L;E2F1;SOX4;CDKN1A;E2F4;GADD45A;CCND1;SFN;CNOT11;E2F7;CNOT3;TRIAP1;PLK3
prerank,ion homeostasis (GO:0050801),-0.45584483875248993,-1.4159255378955309,0.07074569789674952,0.34518187787738847,1.0,8/30,13.02%,SLC4A10;NEDD4L;FHL1;WNK1;CAMK2D;SLC4A8;SLC4A2;KLHL3
prerank,regulation of protein localization to nucleus (GO:1900180),-0.42030000114959626,-1.4155105945673352,0.05084745762711865,0.34533270876173383,1.0,19/43,31.36%,LIMK2;CTNNA1;TFRC;FERMT2;TGFB1;MFHAS1;AKT1;SUMO3;CDK5RAP3;PIN1;SESN2;DTX3L;PARK7;CARD10;LAMTOR5;PLK1;ATP13A2;PARP9;CDK1
prerank,negative regulation of inflammatory response (GO:0050728),0.3359371541680295,1.4154124618568649,0.01968503937007874,0.5064142517085005,1.0,28/182,11.33%,IGF1;ADCY7;RORA;ADCY2;ADCY1;ADCY5;GPHB5;PPARA;HTR7;PRKACA;PTGIS;LYN;IL4;PTGDR;ADM;GSTP1;NLRP12;MC5R;SMPDL3B;IAPP;CALCR;HRH2;GLP2R;GATA3;TNFAIP6;ADCY8;HTR4;PTGIR
prerank,regulation of hydrogen peroxide-induced cell death (GO:1903205),-0.611867723283062,-1.4151686861266541,0.08858603066439523,0.3452278804657938,1.0,6/10,26.64%,PDE8A;RIPK1;GPR37L1;STK26;PARK7;TXN
prerank,odontogenesis of dentin-containing tooth (GO:0042475),0.5387184034589813,1.415156863196495,0.11085450346420324,0.5049359825835625,1.0,3/15,3.98%,BMP2;GLI2;ANKRD11
prerank,regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),0.5087311196727837,1.414759713360468,0.09482758620689655,0.5038096791928476,1.0,6/20,4.22%,ATP1A2;SLC8A1;ANK2;PRKACA;ATP2A2;TNNI3
prerank,response to laminar fluid shear stress (GO:0034616),-0.6095101907063132,-1.4133653513346656,0.0797872340425532,0.34857204764207544,1.0,5/10,5.65%,MAP2K5;KLF2;KLF4;SMAD7;SMAD6
prerank,positive regulation of lipid kinase activity (GO:0090218),-0.4644052211585873,-1.4127848404941683,0.06605504587155964,0.3489730023465516,1.0,7/29,5.58%,TEK;FLT1;PTK2B;PTK2;TNFAIP8L3;TGFB1;CD81
prerank,regulation of cholesterol metabolic process (GO:0090181),-0.49940169615344343,-1.412664768073234,0.08801498127340825,0.34842603828521856,1.0,7/20,13.36%,LPCAT3;MBTPS2;ACADL;ACADVL;APOE;ABCA2;FMO5
prerank,adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),0.3428999427360225,1.4122412409657645,0.025145067698259187,0.5085069332671498,1.0,25/152,12.27%,ADCY7;ADCY2;ADCY1;LGR4;ADGRB3;LPAR1;PTGFR;ADCY5;GPHB5;ABCA1;GNAI1;CHRM2;OPRK1;ADM;MC5R;IAPP;CALCR;GLP2R;ADRA1D;ADCY8;ADRA1B;PTGIR;GPR161;GNA15;CRHR1
prerank,'de novo' posttranslational protein folding (GO:0051084),-0.45118216558736274,-1.4112304227208317,0.06704980842911877,0.3508434442408836,1.0,18/30,35.82%,HSPA8;DNAJB12;HSPA5;CHCHD4;CCT2;HSPA1A;HSPA9;HSPE1;HSPA1B;DNAJB1;ERO1A;BAG1;SDF2L1;SDF2;HSPA14;DNAJC7;ST13;UGGT1
prerank,negative chemotaxis (GO:0050919),0.4451194251453038,1.4112219360880298,0.09808102345415778,0.5091281674558682,1.0,6/33,7.40%,ROBO1;EPHA7;LRTM1;SEMA3A;SEMA3D;UNC5C
prerank,cell communication by electrical coupling involved in cardiac conduction (GO:0086064),0.5400045334168169,1.410918042079841,0.09719222462203024,0.5077454533281593,1.0,4/17,2.65%,ATP1A2;SLC8A1;GJA1;PRKACA
prerank,autophagosome maturation (GO:0097352),-0.4572384349772,-1.4106848708180115,0.066543438077634,0.3512389905775827,1.0,15/32,20.97%,MAP1LC3B;CALM1;VAMP7;GABARAP;LIX1L;TECPR1;VCP;VMP1;MAP1LC3A;TSG101;VPS16;VPS33A;VTI1B;WIPI2;RUBCNL
prerank,negative regulation of RNA splicing (GO:0033119),-0.5052619191847165,-1.4102888417683257,0.09074410163339383,0.3513415992876347,1.0,9/19,20.37%,RPS13;PTBP3;SRSF6;PCBP4;RNPS1;SRSF4;SFSWAP;RPS26;TMBIM6
prerank,positive regulation of NIK/NF-kappaB signaling (GO:1901224),-0.40331790230070685,-1.4091807253648394,0.03838771593090211,0.35291438668630815,1.0,25/50,31.99%,NR3C2;NOD1;ACTN4;RPS3;APP;LIMS1;TLR3;TCIM;TLR4;PHB2;EGFR;NOD2;RELA;LAPTM5;TRIP6;LGALS9;TRAF6;PTP4A3;PDCD4;CD86;C1QTNF4;TERF2IP;RHOA;CD14;TRIM44
prerank,regulation of cellular component organization (GO:0051128),-0.3386930271377707,-1.4088848245320384,0.006109979633401222,0.3527492395586562,1.0,52/135,25.92%,PLCE1;RAP1A;MLLT3;NET1;LTBP4;RAP1B;OPHN1;TFRC;RAPGEF1;CAMK2D;DCUN1D5;DAB2IP;SOCS2;HSPA8;HIP1R;HCFC1;EGLN2;FAM107A;WFDC1;HIP1;RAB4B;BAG5;ABL2;TAOK2;NCLN;RUFY1;RAB4A;APOE;ITCH;CISH;LAMTOR2;SETD1A;STK38L;OGFR;TMEM97;HSP90AA1;PACSIN1;TSC2;GFAP;PACSIN3;PACSIN2;RAPGEF2;MKI67;CAMSAP3;PTPN1;ANGPTL7;ZFYVE16;TJP1;RPTOR;RAB5C;ANKRA2;PARK7
prerank,cellular response to metal ion (GO:0071248),-0.3432395781838917,-1.4088386310596224,0.020202020202020204,0.35203556407786124,1.0,22/123,4.75%,MEF2C;ITPKB;B2M;CLIC4;SLC12A2;CDH1;PLCG2;MEF2A;MT1G;MT1A;MT1B;MT1F;MT1E;MT1M;MT1X;MT1H;MAPK3;IQGAP1;CAMK2D;CDKN1B;MT2A;CARF
prerank,chaperone-mediated protein complex assembly (GO:0051131),-0.49204412477330384,-1.4085838109455577,0.07078039927404718,0.3518548351553958,1.0,10/20,24.81%,HSP90AB1;HSPD1;HSPA4;CCT2;HSP90AA1;HSPA1A;PTGES3L;PFDN6;PSMG2;MKKS
prerank,metal ion homeostasis (GO:0055065),-0.42875624252780364,-1.4081281108327992,0.046153846153846156,0.3520804354294948,1.0,7/40,8.00%,SLC12A7;CAV1;TMTC2;SLC12A2;FAM20A;LETM2;JPH2
prerank,negative regulation of Wnt signaling pathway (GO:0030178),0.3302435713794612,1.4080807911123643,0.01727447216890595,0.5133099757849995,1.0,33/186,11.35%,BICC1;TCF7L2;IGFBP2;NOTUM;BMP2;RBMS3;TRABD2B;LRP1;PRICKLE1;LRP4;DKK3;GLI3;ZNRF3;SFRP1;MCC;RNF43;AXIN2;WIF1;PRKN;HECW1;TAX1BP3;TLE1;CXXC4;PSMA3;SOX2;PSMF1;NPHP3;DVL3;DACT3;FRZB;FUZ;SIAH2;NKD2
prerank,cellular protein catabolic process (GO:0044257),-0.3885567670868681,-1.4076060945869349,0.03518518518518519,0.3524068021722362,1.0,20/59,15.15%,FAP;CAPN2;DAB2IP;CTSZ;CTSO;CTSC;CASP8;PSMA6;IDE;RIPK1;DENND3;AP2M1;CTSF;UBE2G2;CTSB;RAB7A;RNF5;BNIP3L;UBE2G1;AP2A1
prerank,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),0.33955020432842686,1.4075800626183248,0.019157088122605363,0.512546557550682,1.0,27/159,7.85%,ROBO1;GPC6;ROBO2;LRRC4C;SDK2;TENM3;GRID2;CDH8;CNTN4;PCDHB10;GPC4;CDH18;DCHS1;PTPRD;TENM2;PTPRT;PCDHB13;KIRREL3;CDH11;NPTN;CDH20;CDH19;CDH7;IL1RAPL1;ALCAM;NLGN1;TRO
prerank,negative regulation of epithelial cell proliferation (GO:0050680),0.3914763417568989,1.4072850785921696,0.04563492063492063,0.5111739451456302,1.0,16/66,9.93%,ROBO1;TGFBR3;FGFR2;NR2F2;SULF1;VDR;APOH;MTSS1;SFRP1;MCC;SCG2;SOX2;ATOH8;CNMD;GATA3;AIMP1
prerank,negative regulation of protein dephosphorylation (GO:0035308),-0.49800038642783717,-1.4058534107811882,0.08333333333333333,0.3557161224004265,1.0,13/21,35.38%,PPP1R16B;FKBP1A;MFHAS1;PPP1R8;BOD1;ARPP19;YWHAB;YWHAE;STYXL1;PPP1R1B;CRY2;FKBP1B;PTPA
prerank,mitochondrial respiratory chain complex assembly (GO:0033108),-0.3621969695884537,-1.4058144085951008,0.035849056603773584,0.3550064122577282,1.0,45/87,31.64%,NDUFV2;UQCC2;NDUFB2;NDUFB8;NDUFB4;COA8;NDUFS4;NDUFA13;IMMP2L;NDUFB7;NDUFS2;NDUFA12;TIMM21;NDUFB5;COA3;CHCHD4;NDUFA9;NDUFB9;NDUFS3;SURF1;NDUFS6;NDUFC1;FASTKD3;DMAC2;NDUFA3;SLC25A33;ECSIT;LYRM7;NDUFA10;NDUFB10;SDHAF4;NDUFB3;SCO1;NDUFA7;PET100;NDUFA1;NDUFAF3;BCS1L;UQCC3;SDHAF1;NDUFA8;ACAD9;NDUFAF4;NDUFA2;NDUFAF5
prerank,negative regulation of androgen receptor signaling pathway (GO:0060766),-0.5724038417634694,-1.4056711965977657,0.1073943661971831,0.35450472139419725,1.0,4/12,5.49%,FOXP1;NCOR1;ZBTB7A;HEYL
prerank,positive regulation of Wnt signaling pathway (GO:0030177),0.3441237193663368,1.4056556406305003,0.015625,0.5135400638006572,1.0,22/152,8.56%,RNF220;LGR4;BMP2;LRRK1;SALL1;WLS;DAAM2;FGFR2;LYPD6;SEMA5A;SULF1;TBL1XR1;SULF2;PTK7;ZEB2;SFRP1;AXIN2;FRAT1;SMURF2;PSMA3;ADGRA2;PSMF1
prerank,"synaptic transmission, GABAergic (GO:0051932)",0.5971002351306635,1.4052802223342367,0.12643678160919541,0.5123805689823939,1.0,6/10,21.66%,GABRA2;GABRA5;GABRG1;GABRG3;GABRG2;GABRB2
prerank,positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),-0.5045988620521633,-1.4052671358411013,0.08108108108108109,0.3545691680813512,1.0,5/21,5.58%,PRKCH;FOXP1;SLC39A10;RPS3;CD81
prerank,cellular response to chemical stress (GO:0062197),-0.358063927320868,-1.4049090871753096,0.025440313111545987,0.35455848324438693,1.0,46/96,33.91%,CAV1;LRRC8D;FOXO1;FOXO3;PPIA;PRR5L;PPARGC1A;NCF2;ATF4;CHCHD2;MSRA;GPX1;FAS;ATG7;TRPV4;STX2;ETV5;PIK3CA;VKORC1L1;GSR;HSPA1A;CCS;CYBB;GPX8;KEAP1;HSPA1B;PKD2;ADNP2;ERO1A;SESN2;SRXN1;NUDT2;AIF1;GPX3;PARK7;STX4;SOD1;NOX1;RAD52;LRRC8E;ATP13A2;RBM11;ABL1;NCF1;SLC4A11;HTRA2
prerank,eye morphogenesis (GO:0048592),0.5091599587992063,1.404854691445327,0.10652173913043478,0.5114704010538647,1.0,6/19,7.78%,FBN1;FBN2;TENM3;IFT122;MFAP2;RARG
prerank,positive regulation of protein modification process (GO:0031401),-0.32064022000747394,-1.4037466106602818,0.012738853503184714,0.35642237144239214,1.0,69/203,21.55%,TEK;PECAM1;SLCO3A1;CCND3;FGF1;RACK1;LIMCH1;LIMK2;KDR;MAPK3;TFRC;PTK2;NIBAN1;TBX1;VEGFC;PPP1R16B;CARD14;CALM1;TGFB1;APP;FAM20A;RAC1;PPIA;RALB;CHP1;VEGFA;PDE8A;PPP2R5A;RIPK1;KRAS;SVIP;FLT4;AKT1;INSR;FLOT1;FAS;ATG7;CD74;CAMK1;CIB1;VEGFD;CALM3;MAVS;FGF2;FMR1;CSF1R;ENG;PIK3R3;HRAS;ACE;EGFR;ERBB2;HSP90AA1;RAPGEF3;RAMP1;CDCA2;PGF;FGF9;RAB3GAP2;WDFY2;CCND1;SOX9;PIN1;ITGB3;BRAT1;FGF10;CNEP1R1;CDH5;C3
prerank,sulfur compound transport (GO:0072348),-0.4584171156531007,-1.403339919974218,0.08522727272727272,0.35650519632661,1.0,5/27,3.19%,ABCG2;SLC26A7;SLC6A6;LRRC8D;SLC5A6
prerank,positive regulation of inflammatory response (GO:0050729),-0.36275560813177665,-1.4030832481621252,0.03718199608610567,0.3562749210713419,1.0,19/86,15.55%,LBP;IL15;NFKBIA;ETS1;VAMP7;APP;PDE2A;CD81;IL33;RPS19;GPR4;TLR3;NFKBIZ;RIPK1;DHX9;TLR4;TNFRSF1A;FEM1A;IL17RA
prerank,negative regulation of small GTPase mediated signal transduction (GO:0051058),-0.5022380413701032,-1.4030175663600901,0.07857142857142857,0.35564157285601944,1.0,7/21,9.48%,CYRIB;DAB2IP;CD2AP;SLIT2;TGFB2;ARHGAP25;MAPKAP1
prerank,cellular response to acid chemical (GO:0071229),-0.45801002478881747,-1.4028230468851,0.05730129390018484,0.3553581113989064,1.0,18/27,35.88%,SH3BP4;KLF2;CAPN2;VEGFA;LAMTOR2;RRAGD;XBP1;RRAGA;RRAGC;SESN2;NSMF;RPTOR;LAMTOR5;CPEB4;LAMTOR1;LAMTOR3;GLRA1;IPO5
prerank,morphogenesis of a polarized epithelium (GO:0001738),-0.573890345032154,-1.4026663179899952,0.08118081180811808,0.35494605519501504,1.0,4/12,5.29%,ACTB;ACTG1;LAMA5;LAMA3
prerank,regulation of glycogen biosynthetic process (GO:0005979),0.481880413303894,1.4025127925232532,0.10677618069815195,0.5155046377025622,1.0,4/24,8.25%,IGF1;ENPP1;IRS2;IGF2
prerank,ceramide transport (GO:0035627),-0.5609310217818868,-1.4022460153359275,0.10973451327433628,0.3550769706735274,1.0,7/12,24.77%,CERT1;PLTP;PSAP;ABCA2;GLTP;ABCA13;SGPP1
prerank,regulation of hematopoietic progenitor cell differentiation (GO:1901532),-0.3710753363502011,-1.4013678389137163,0.03932584269662921,0.35618325430320735,1.0,27/73,23.09%,KITLG;LMO2;CBFB;GATA2;PRKDC;PSMA6;PSMB5;TAL1;PSMC4;PSMC5;YTHDF2;PSMD14;ITCH;SETD1A;PSMD8;LDB1;PSMD11;PSMB4;PSMD12;PSMC1;TCF3;PDCD2;PSMA1;PSMB1;PSMC3;PSMA4;PSMA2
prerank,bone development (GO:0060348),0.4312305978584004,1.4009755863882591,0.08315565031982942,0.5176244898800662,1.0,7/39,3.83%,NOTUM;FGFR2;SULF1;SULF2;GJA1;RANBP3L;SH3PXD2B
prerank,defense response to virus (GO:0051607),-0.35842368116840734,-1.4005958325605263,0.03054989816700611,0.357155647376522,1.0,29/100,18.62%,IFIH1;ABCC9;NLRC5;LYST;CNOT7;IFITM1;IFITM3;TLR3;IFITM2;ZMYND11;CLPB;IFIT1;ATG7;TRIM56;TTC4;BCL2L1;ZDHHC1;MAVS;PHB2;SAMHD1;BNIP3L;TRIM5;OAS2;MLKL;STAT1;DDIT4;RELA;CGAS;RSAD2
prerank,myeloid leukocyte differentiation (GO:0002573),-0.3874976358313204,-1.4005845166703024,0.05731225296442688,0.3563975091933601,1.0,19/65,15.87%,LEF1;FOXP1;CBFA2T3;IL15;TGFBR2;MT1G;VEGFA;RARA;CASP8;OSTM1;TNFRSF11A;PIR;GLO1;CDK4;E2F1;CSF1R;GAB2;EPHA2;CDKN1A
prerank,"protein alpha-1,2-demannosylation (GO:0036508)",-0.4836614162839752,-1.4005486358703423,0.0838095238095238,0.3556855199039695,1.0,11/22,20.87%,SEL1L;UBB;EDEM3;UBC;RPS27A;MAN1B1;RNF185;RNF5;DERL2;AMFR;EDEM2
prerank,regulation of interleukin-4 production (GO:0032673),-0.49581207539473476,-1.4003047757416283,0.0875,0.3554565757373154,1.0,6/21,12.88%,LEF1;SLC7A5;PRKCZ;RARA;FCER1G;SYK
prerank,regulation of early endosome to late endosome transport (GO:2000641),-0.5112164379016491,-1.3994585839056521,0.09248554913294797,0.3566226035525169,1.0,9/18,31.46%,MAPK3;MSN;EZR;VPS11;SNX3;RDX;MTMR2;SRC;SNX12
prerank,endocytic recycling (GO:0032456),-0.4013792872079863,-1.3991834957296123,0.040229885057471264,0.35648267023027685,1.0,30/50,39.44%,EHD4;VPS53;DENND1A;DENND1B;EHD2;LMTK2;RAB11B;RAB7A;RAB11FIP3;SNF8;EHD1;VPS29;EHD3;SNX3;CCDC22;ANKRD50;ARL4C;MICALL2;EPS15;VPS26C;ENTR1;SNX12;CMTM6;DENND1C;SNX27;WASHC1;SNX17;ANKRD27;RAB17;EIPR1
prerank,mesonephric tubule development (GO:0072164),0.5384862917570981,1.3991158176185596,0.12831858407079647,0.5203480253274904,1.0,3/15,1.11%,ROBO2;SALL1;FGFR2
prerank,cGMP metabolic process (GO:0046068),-0.5666630741081509,-1.398892878038198,0.09908256880733946,0.35627844707710987,1.0,5/12,15.32%,NPR1;PDE2A;GUCY1B1;GUCY1A1;GUCY2C
prerank,regulation of protein phosphorylation (GO:0001932),-0.31009236015892244,-1.3987393671563542,0.006369426751592357,0.3558409832953453,1.0,61/256,13.58%,FN1;TEK;PLCE1;PECAM1;OCLN;BMPER;SLCO3A1;CCND3;FGF1;RACK1;LIMCH1;LIMK2;KDR;MAPK3;TFRC;PTK2;NIBAN1;TBX1;VEGFC;DAB2IP;CARD14;SLIT2;FNIP2;TGFB1;APP;FAM20A;RAC1;PPIA;RALB;PRR5L;CHP1;IGFBP3;VEGFA;BRD4;ATF4;PDE8A;PRKDC;HSPB1;PPP2R5A;RIPK1;KRAS;FLT4;NDUFS4;AKT1;INSR;PDGFA;WARS1;FLOT1;FAS;CD74;IMPACT;CIB1;VEGFD;MAVS;SMG8;FGF2;FMR1;CSF1R;ENG;PIK3R3;HRAS
prerank,response to ketone (GO:1901654),-0.48100034284610427,-1.39872344315388,0.05813953488372093,0.3550997252981913,1.0,7/24,6.78%,ABHD2;CAV1;THBS1;SLIT2;TGFB1;TGFB2;TGFB3
prerank,COPII-coated vesicle cargo loading (GO:0090110),0.5493814514855391,1.3987018246762895,0.10515021459227468,0.519256168543745,1.0,7/14,17.90%,SEC24D;SCAP;SEC24A;SEC31A;SEC23A;TBC1D20;MIA3
prerank,sister chromatid segregation (GO:0000819),-0.43978792293604557,-1.3985280279844061,0.07196969696969698,0.3547535143284758,1.0,15/31,32.82%,SMC4;ZW10;RB1;TOP2A;KIF18A;KNSTRN;KIF18B;NSL1;NDC80;CDCA8;SGO1;TOP2B;TUBG2;PLK1;ESPL1
prerank,smooth muscle cell differentiation (GO:0051145),-0.577725129919999,-1.3985151441871568,0.0962962962962963,0.354017819069333,1.0,6/12,14.51%,MEF2C;MRTFB;GATA6;TMEM204;MRTFA;HEY1
prerank,nucleotide-sugar metabolic process (GO:0009225),-0.5652285391163123,-1.3975876409539176,0.09671848013816926,0.35529772545986843,1.0,5/12,19.53%,CSGALNACT1;SLC35A3;FUT8;GFPT1;GALT
prerank,amide biosynthetic process (GO:0043604),-0.4042875426409349,-1.3973789934965222,0.05973025048169557,0.35502477958618206,1.0,8/47,8.90%,SGMS1;SGMS2;SPTLC2;DMD;DEGS2;SPTLC1;SPTSSB;ASAH2
prerank,calcium-mediated signaling (GO:0019722),0.36567782423983464,1.3972227140790578,0.03807615230460922,0.5211545401662461,1.0,17/93,8.81%,RCAN2;PTGFR;SLC8A1;PDPK1;ANK2;PRKACA;DMPK;P2RX4;ATP2A2;TNNI3;CCR6;ACKR4;ACKR2;CCR10;CHRM3;PPP1R9A;CCR9
prerank,nucleoside triphosphate metabolic process (GO:0009141),0.557273684401176,1.3971023530300346,0.11161731207289294,0.5193700034440907,1.0,1/14,0.21%,ENPP1
prerank,cellular response to lipid (GO:0071396),0.3259910179759184,1.3968792329127635,0.009652509652509652,0.517869931970346,1.0,42/191,15.40%,RORA;ADCY2;ADCY1;ATP1A2;PID1;AR;ADCY5;PTK7;EPHA3;ROCK2;GNAI1;PDK4;STAP1;LYN;SFRP1;TICAM1;ZNF35;BRINP1;AXL;SERPINE1;PDK3;BRINP3;GSTP1;PPBP;CD274;ABCB4;NUGGC;PABPN1;TNIP3;PDE4B;ADCY8;AHR;FZD10;ATP1A3;BRINP2;ATM;CD180;WNT6;CXCL1;WNT5B;KAT5;NCOA3
prerank,cellular amino acid catabolic process (GO:0009063),0.36962090430437144,1.3964881630703587,0.044897959183673466,0.5168291037908429,1.0,20/87,11.00%,HMGCLL1;ASPA;ALDH4A1;IL4I1;ABAT;PRODH;ACADSB;GLDC;ALDH7A1;ALDH6A1;BCKDHB;TDO2;KMO;DDO;GLUL;GLS2;HIBADH;KYNU;HNMT;DBT
prerank,positive regulation of DNA-binding transcription factor activity (GO:0051091),-0.31093884091243074,-1.396468975225039,0.004210526315789474,0.35618146077088053,1.0,65/234,17.32%,PRKCH;CAV1;SLCO3A1;RPS6KA5;ESR1;PLCG2;NOD1;NFKBIA;TFRC;MID2;FZD4;RPS3;IRAK2;CARD14;ZBTB7A;TRIM25;APP;SMO;UBB;PPARGC1B;PPIA;PRKCZ;PPARGC1A;UBC;RPS27A;VEGFA;IKBKB;PSMA6;RGCC;JUP;RIPK1;EDN1;MBTPS2;TNFRSF11A;HDAC4;AKT1;DHX9;FLOT1;TRIM14;DDRGK1;TIRAP;LRP8;STK36;CIB1;TRIM62;MAVS;TLR4;EDA2R;COPS5;TRAF1;AIM2;ARHGEF5;PHB2;TRIM68;SMARCA4;TRIM5;SRF;FLOT2;NOD2;CX3CR1;TCF3;HSPA1A;TAB2;RELA;KDM1A
prerank,positive regulation of cytokine production involved in immune response (GO:0002720),-0.4621874320492679,-1.3962980418053612,0.09124767225325885,0.3558145631736387,1.0,4/25,1.79%,B2M;PLCG2;CD55;SLC7A5
prerank,histone H4 acetylation (GO:0043967),-0.40908597241021555,-1.3954443924898816,0.05905511811023622,0.35713106906854425,1.0,14/47,18.10%,LEF1;MSL2;PHF20;TRRAP;JADE2;ING5;HCFC1;TRIM16;KANSL2;EPC1;NAA60;MCRS1;BRCA2;EP400
prerank,cellular response to reactive oxygen species (GO:0034614),-0.3917597143573805,-1.3949730358278738,0.04807692307692308,0.3574623656768496,1.0,31/59,34.49%,MAP3K5;NET1;PXN;MAPK3;RPS3;ANXA1;CYP1B1;RIPK1;AKT1;RHOB;IMPACT;FXN;EGFR;TNFAIP3;RELA;CHUK;ECT2;PTPRK;PKD2;PRKCD;PARK7;CAMKK2;ROMO1;AQP1;TPM1;ABL1;MAPK9;FOS;NCF1;JUN;MAPK7
prerank,cellular response to interferon-beta (GO:0035458),-0.5408873946110843,-1.3943660249761733,0.07904411764705882,0.3580774536459736,1.0,5/14,16.32%,IFITM2;NDUFA13;UBE2G2;AIM2;STAT1
prerank,fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),-0.5982005460145455,-1.3943511004375926,0.08566433566433566,0.35735450601524926,1.0,5/10,15.42%,ACAD11;ACADL;ACADVL;ETFDH;ETFB
prerank,vascular endothelial growth factor receptor signaling pathway (GO:0048010),-0.37898855473242404,-1.393790883632204,0.04990403071017274,0.35778759159137474,1.0,19/67,7.83%,FLT1;NRP2;DOCK1;WASF2;PXN;CLEC14A;PTK2B;KDR;SHB;PTK2;VEGFC;DAB2IP;MAPKAPK3;RAC1;CRK;VEGFA;NCF2;HSPB1;FLT4
prerank,positive regulation of protein catabolic process (GO:0045732),-0.36509199443274426,-1.3932740269608603,0.04331450094161959,0.35819704272056085,1.0,30/84,17.44%,WWP1;GPC3;NEDD4L;FOXO1;DAB2IP;CDKN1B;RNF41;MSN;WWP2;EZR;TNFRSF1B;EGLN2;IDE;PLK2;NDUFA13;PTTG1IP;ATG7;VCP;RAB7A;OAZ2;APOE;ITCH;SMURF1;VPS11;SNF8;TNFAIP3;CSNK2A1;HSP90AA1;FZR1;NSF
prerank,regulation of cysteine-type endopeptidase activity (GO:2000116),0.5014222639244008,1.3932608972323735,0.11850311850311851,0.5233852445514805,1.0,8/21,17.49%,EPHA7;NLRP12;SOX2;NGFR;BIRC2;DELE1;PSMB9;GRIN2B
prerank,mesenchymal to epithelial transition (GO:0060231),0.5992562904077932,1.3929928987441158,0.12669683257918551,0.5219671589971077,1.0,3/10,13.23%,SALL1;GATA3;PAX8
prerank,negative regulation of chemotaxis (GO:0050922),0.43866054303140806,1.3924729255880115,0.1019522776572668,0.5214374249825836,1.0,6/31,4.77%,ROBO1;ROBO2;ANGPT2;SEMA5A;SEMA3A;SEMA3D
prerank,hepatocyte growth factor receptor signaling pathway (GO:0048012),0.5765909984944119,1.3919894970259847,0.11397849462365592,0.5207000894720114,1.0,5/11,15.35%,NRP1;SIRT2;MST1R;BCAR1;PAK1
prerank,negative regulation of amyloid precursor protein catabolic process (GO:1902992),0.4959740635643827,1.3914091817666967,0.08888888888888889,0.5202025882902366,1.0,3/19,11.12%,IGF1;RTN4;CHRNA7
prerank,endocardial cushion development (GO:0003197),-0.4793367758306832,-1.3905880629285154,0.08932038834951456,0.36333005211490527,1.0,10/21,14.51%,NOS3;NOTCH1;BMPR2;TGFB2;TBX2;HEYL;CRELD1;ACVR1;ENG;HEY1
prerank,response to amyloid-beta (GO:1904645),0.4165977875571731,1.3902826278154519,0.08108108108108109,0.5211142202497475,1.0,10/44,13.97%,IGF1;LRP1;GJA1;CACNA2D1;CALCR;CACNB1;CHRNA7;NGFR;ATP1A3;GRIN2A
prerank,negative regulation of cell development (GO:0010721),0.476677279185569,1.3900820255354485,0.10786516853932585,0.51958226330819,1.0,2/25,0.45%,IGF1;FBN1
prerank,modulation of chemical synaptic transmission (GO:0050804),0.35882565434326913,1.3899943278401623,0.03346456692913386,0.5177983545256577,1.0,25/107,11.12%,ATP1A2;LRRC4C;NRG3;GRID2;CLSTN2;RIMS1;CHRNB4;GRIK5;GRIK2;GRM1;DLGAP1;NLGN2;NLGN3;SYT1;GRID1;CPLX2;NLGN1;GRIK1;MAPK8IP2;STX1B;MCTP2;PTEN;CNTNAP4;BAIAP3;CHRNA7
prerank,cytokine-mediated signaling pathway (GO:0019221),-0.2855647303937947,-1.3898856598097886,0.0,0.3641698775269646,1.0,142/532,18.78%,FN1;ADIPOR2;TMSB4X;B2M;LBP;ACKR3;RPS6KA5;PTPRJ;VIM;IL15;RAP1B;NOD1;PTK2B;LIFR;ACTN4;NFKBIA;TNFRSF11B;MAOA;F3;FOXO1;MAPK3;STX3;RAPGEF1;LAMA5;CAMK2D;FOXO3;S1PR1;IRAK2;HNRNPA2B1;ANXA1;CARD14;TRIM25;CD44;SOCS2;CDKN1B;MT2A;TGFB1;MID1;MAP3K3;MSN;ADAR;UBB;ANXA2;HSPA8;PPIA;LIMS1;INPP5D;ADIPOR1;UBC;RPS27A;IL1R1;IL33;CRK;VEGFA;STX1A;IKBKB;IFITM1;IFITM3;SHC1;PITPNA;PSMA6;MAP3K8;TNFRSF1B;RIPK1;IL20RB;TNFRSF11A;PSMB5;IFITM2;AKT1;BCL6;CCL15;TWIST1;IFNAR1;CSNK2B;IFIT1;FCER1G;TALDO1;JUNB;LRP8;HNRNPDL;GRB10;TOLLIP;PSMC4;CFL1;ABL2;PSMC5;IL17RE;PSMD14;YWHAZ;TRIM62;BCL2L1;COMMD7;POU2F1;FGF2;EDA2R;SYK;TRAF1;IL18BP;CSF1R;TNFRSF1A;AIM2;TRIM68;SMARCA4;SAMHD1;STAT5A;CISH;RBX1;JAK2;TRIM5;F13A1;PSMD8;GAB2;IRF9;PIK3CA;SMAD4;CLCF1;TNFSF13;NOD2;IL17RA;PTPN6;PSMD11;NDN;CDKN1A;OAS2;STAT1;PSMB4;PSMD12;PSMC1;HSP90AA1;TAB2;RELA;IFNGR1;JAK3;HCK;CUL1;CHUK;SLA;PELI1;HSPA9;IRF8;RSAD2;IRAK4
prerank,regulation of apoptotic signaling pathway (GO:2001233),-0.42678939487057443,-1.38976583647595,0.07954545454545454,0.3636631440029867,1.0,16/36,16.04%,SGMS1;RPS3;TPD52L1;DAB2IP;CRADD;NR4A2;PPIA;ING5;ASAH2;FAS;RB1;TRAF1;MADD;CX3CR1;CSNK2A1;CSNK2A2
prerank,ureteric bud morphogenesis (GO:0060675),0.5306888930506994,1.389126557981852,0.10652173913043478,0.5180694254543091,1.0,3/16,1.69%,BMP2;SALL1;GDNF
prerank,negative regulation of Ras protein signal transduction (GO:0046580),-0.4394053481602091,-1.3890152274162355,0.07262569832402235,0.36466686658166814,1.0,12/35,18.55%,HEG1;RASIP1;DAB2IP;TGFB2;CCDC125;MYOC;MAPKAP1;TNFAIP1;ABL2;MET;KCTD10;SPRY1
prerank,regulation of extrinsic apoptotic signaling pathway (GO:2001236),0.39485808727457306,1.3887025452002968,0.06756756756756757,0.5172458033565516,1.0,12/63,7.96%,IGF1;TCF7L2;AR;DEPTOR;SH3RF1;PHIP;CFLAR;IL4;BCL2L12;GSTP1;SCG2;TGFBR1
prerank,regulation of protein metabolic process (GO:0051246),-0.40630281964633835,-1.3883821363066045,0.05029013539651837,0.3654123241909698,1.0,8/44,4.23%,LTBP4;NEDD4L;MAP2K5;KLF2;KLF4;HSP90AB1;APP;FKBP1A
prerank,necroptotic process (GO:0070266),-0.5219823211526882,-1.3872831077292704,0.09694793536804308,0.3671855049072399,1.0,7/16,16.20%,TRPM7;IPMK;TLR3;RIPK1;TLR4;PGAM5;MLKL
prerank,in utero embryonic development (GO:0001701),0.474689673511999,1.3871238924367202,0.11206896551724138,0.5196776087814218,1.0,7/25,8.48%,ARNT2;BMP2;FGFR2;CHD7;TGFBR1;IGF2;FOXD3
prerank,positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),-0.46560647375069203,-1.386681677210825,0.07259528130671507,0.36783189526569116,1.0,6/27,4.03%,TEK;FLT1;PTK2B;PTK2;TNFAIP8L3;TGFB1
prerank,negative regulation of smoothened signaling pathway (GO:0045879),0.47897681765663136,1.386610202108394,0.09267241379310345,0.5189984861442362,1.0,10/23,13.72%,ENPP1;GLI3;IFT122;TULP3;KIF7;KCTD21;MGRN1;GPR161;BTRC;SUFU
prerank,glycolytic process through glucose-6-phosphate (GO:0061620),-0.4611907623860557,-1.3862012437993634,0.08571428571428572,0.36828266818467364,1.0,10/25,23.23%,GPI;HK1;FOXK1;PKM;PFKP;GAPDH;PGK1;PGAM1;PFKL;ENO1
prerank,negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),-0.564371297406908,-1.385945369824947,0.09057301293900184,0.3680613013316482,1.0,3/12,4.03%,ESR1;NCOR1;TGFB1
prerank,inner mitochondrial membrane organization (GO:0007007),-0.4061741383093161,-1.3858037816361042,0.055865921787709494,0.3675918038617548,1.0,25/47,30.90%,ATP5PD;ATP5MF;ATP5F1D;ATP5F1A;ATP5F1B;NDUFA13;CHCHD3;ATP5ME;ATP5MC3;TIMM29;ATP5MC1;OPA1;TIMM13;HSPA9;CHCHD6;TIMM10;APOO;ATP5F1E;TIMM8B;ATP5PO;TIMM10B;MICOS13;UQCC3;ROMO1;LETM1
prerank,regulation of neuroinflammatory response (GO:0150077),0.512269245863719,1.385404642534224,0.10572687224669604,0.5200820891325663,1.0,3/19,8.31%,IGF1;IL4;IL18
prerank,global genome nucleotide-excision repair (GO:0070911),-0.454710332088918,-1.3853878486680995,0.0873015873015873,0.367746767778261,1.0,12/26,19.11%,UBB;UBC;RPS27A;ERCC1;CUL4A;GTF2H3;CHD1L;RNF111;RBX1;CETN2;GTF2H4;ERCC4
prerank,negative regulation of cold-induced thermogenesis (GO:0120163),0.41569891752939714,1.384587352782955,0.07723577235772358,0.5202119880333432,1.0,11/46,9.62%,ALDH1A1;LGR4;PLCL1;NOVA1;ADAMTS5;ACTN3;PLCL2;ACOT11;DOCK7;RBPJ;HOXC10
prerank,"Wnt signaling pathway, calcium modulating pathway (GO:0007223)",-0.4211905322361711,-1.3841979484677593,0.06976744186046512,0.369667938748541,1.0,12/36,13.50%,LEF1;TNRC6C;FZD6;NLK;FZD4;PLCB3;CALM1;FZD3;NFATC1;WNT11;PPP3CB;GNB1
prerank,regulation of erythrocyte differentiation (GO:0045646),-0.42592181956926145,-1.3839677894604965,0.060218978102189784,0.3694196118968442,1.0,18/35,30.77%,CDK6;FOXO3;ETS1;PRKDC;TAL1;INHBA;LDB1;STAT1;HSPA1A;FAM210B;HSPA9;MAPK11;HSPA1B;ZFPM1;SPI1;HMGB2;ANKRD54;ABCB10
prerank,cellular response to oxygen levels (GO:0071453),-0.5732936466048008,-1.3837217830397468,0.12477396021699819,0.3691981830902241,1.0,7/10,30.68%,ATP6V0A2;NDUFS2;ATP6V1G1;ATP6AP1;CCDC115;ATP6V0D1;CPEB4
prerank,regulation of leukocyte migration (GO:0002685),-0.520654773320388,-1.3836004889027846,0.08286252354048965,0.3687100435624,1.0,4/16,5.68%,ANXA1;RAC1;CD81;VEGFA
prerank,regulation of fibroblast migration (GO:0010762),-0.5026521531730258,-1.3817001183386908,0.09213051823416507,0.3721784396272834,1.0,8/20,12.82%,THBS1;PTK2;TGFB1;RAC1;PRR5L;HAS1;PRKCE;FGF2
prerank,negative regulation of response to stimulus (GO:0048585),-0.38475613812712467,-1.381300502502321,0.055449330783938815,0.3723618675563486,1.0,15/60,11.97%,CDK6;CD34;MAP2K5;KLF4;COL3A1;SLIT2;KLF7;LPCAT3;MAP3K3;IGFBP3;AQP11;TWIST1;PIM3;KIF26A;ACVR1
prerank,response to nutrient levels (GO:0031667),-0.520591004219959,-1.3810452788746594,0.0998185117967332,0.3721502407594612,1.0,8/17,30.00%,KCNB1;ATF4;FAM107A;EIF4G1;CD68;MEAK7;RPTOR;RPS6KB1
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),-0.3707851233407007,-1.3808475697041322,0.047058823529411764,0.37181839814826784,1.0,36/70,35.74%,B2M;NCF2;TAPBP;IKBKB;PSMA6;PSMB5;FCER1G;PSMC4;PSMC5;PSMD14;LNPEP;PSMD8;PSMD11;PSMB4;PSMD12;PSMC1;CHUK;TAP2;CYBB;PSMA1;PSMB1;PSMC3;PSMA4;PSMA2;PSMB8;CD36;PSMC6;PSMD6;PSMA8;NCF1;SEC22B;IKBKG;PSMD2;ITGAV;PSMB2;SNAP23
prerank,regulation of endothelial cell chemotaxis (GO:2001026),-0.5178256793746188,-1.3805830034731965,0.10622710622710622,0.37167379948270474,1.0,7/15,15.81%,TMSB4X;THBS1;NOTCH1;FGF1;HSPB1;FGF2;MET
prerank,negative regulation of receptor-mediated endocytosis (GO:0048261),-0.45996821285948436,-1.3803755823257515,0.1033210332103321,0.3713836920599596,1.0,11/25,29.00%,RIN3;APP;RAC1;ANKRD13A;ABCA2;SDCBP;NEU3;ITGB3;APOC1;MTMR2;UBQLN2
prerank,signal release from synapse (GO:0099643),0.4242394953486709,1.3803470478106539,0.06918238993710692,0.5291984035473359,1.0,12/43,12.98%,NRXN1;RIMS1;SYT1;CPLX2;SNAP25;OTOF;PDZD11;BRSK1;PTPRN2;STXBP3;GRM4;SNAPIN
prerank,transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),-0.336748162049302,-1.3802450850845382,0.012448132780082987,0.37090035966153917,1.0,38/128,14.15%,CLDN5;DDX5;PARD3;ID1;PXN;TGFBR2;BMPR2;F11R;NLK;MAPK3;PTK2;COL3A1;SMAD9;FERMT2;SMAD7;TGFB1;TGFB2;FKBP1A;UBB;PRKCZ;UBC;RPS27A;SMAD6;TGFB3;USP9X;INHBA;HIVEP1;ACVR1;NRROS;RNF111;ZMIZ2;TMEM100;ENG;USP15;SMURF1;INHBB;ARHGEF18;EID2
prerank,positive regulation of T cell chemotaxis (GO:0010820),-0.5947314407841713,-1.3794014619474844,0.1308411214953271,0.37218120831294,1.0,2/10,4.91%,WNK1;ADAM10
prerank,cytoplasmic sequestering of protein (GO:0051220),-0.5416589601221261,-1.3792029829879677,0.10128913443830571,0.3718503435067912,1.0,8/13,24.02%,NFKBIA;PKD1;DBN1;MDFI;KEAP1;PKD2;NFKBIE;YWHAB
prerank,negative regulation of cell adhesion (GO:0007162),-0.370607192811399,-1.3791688583914503,0.04291044776119403,0.37116426205790304,1.0,19/72,10.56%,PODXL;ACER2;SEMA6A;CDH1;NOTCH1;PTK2;FZD4;TGFB1;JAM3;PLXNA4;ARHGDIA;ADAM10;CYP1B1;ARHGDIB;TGFBI;FZD7;SIPA1;PLXNA1;PLXND1
prerank,myelination in peripheral nervous system (GO:0022011),-0.5553869918822052,-1.3782375352521947,0.11195445920303605,0.3725585364608457,1.0,8/13,29.51%,ADGRG6;PARD3;MYOC;NF1;SKI;SOD1;CNTNAP1;LGI4
prerank,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",-0.44217608737396275,-1.3781699624092958,0.08139534883720931,0.3719814668703944,1.0,12/29,24.44%,RPS16;RPS14;NOP14;RPS21;RPS8;RPS19;DHX37;UTP4;PWP2;TBL3;ABT1;TSR1
prerank,potassium ion transport (GO:0006813),0.34769596778894407,1.3770825805004818,0.046370967741935484,0.5362277032706282,1.0,34/120,20.15%,SLC1A3;KCNK2;ATP1A2;NALCN;SLC24A3;ABCB8;CCDC51;KCND2;SLC9A7;KCNJ16;KCNJ3;KCND1;SLC24A4;SLC24A2;KCNJ5;KCNJ14;KCNMA1;KCNK10;KCNH7;ATP1B3;KCNQ4;KCNS3;KCNJ6;KCNS1;KCNG2;KCNC2;KCNN1;KCNG4;KCNH5;KCNH1;KCNK13;KCNS2;SLC9A9;KCNH4
prerank,response to interferon-beta (GO:0035456),-0.471425883125831,-1.3765756057208172,0.08118081180811808,0.37475186734852006,1.0,7/22,16.32%,IFITM1;IFITM3;IFITM2;NDUFA13;UBE2G2;AIM2;STAT1
prerank,striated muscle contraction (GO:0006941),0.40789502626685015,1.3759408475092412,0.072,0.5374222360743472,1.0,9/53,8.07%,ATP1A2;SLC8A1;SCN3B;CHRNA1;TNNC1;CSRP3;TNNI3;KLHL41;TNNI1
prerank,negative regulation of fat cell differentiation (GO:0045599),0.43529304364137994,1.375749037999613,0.09267241379310345,0.535895450441346,1.0,4/34,2.77%,RORA;ENPP1;RUNX1T1;SMAD3
prerank,regulation of protein binding (GO:0043393),-0.33596193475579117,-1.3754816346439849,0.02610441767068273,0.3765139985920991,1.0,27/114,11.06%,CAV1;ACTB;CLDN5;B2M;RACK1;RPL11;APP;FKBP1A;CTSZ;RALB;PKD1;CRK;HIP1R;IDE;NMD3;NES;HDAC4;BAX;AKT1;DISC1;PRMT8;ADD1;FLOT1;IFIT1;CTNNBIP1;CAMK1;GAS8
prerank,I-kappaB kinase/NF-kappaB signaling (GO:0007249),-0.3794974980461742,-1.375081480489145,0.0616822429906542,0.37662255005612044,1.0,19/59,19.19%,NFKBIA;IRAK2;DAB2IP;UBB;REL;UBC;RPS27A;IKBKB;TLR3;RIPK1;FAIM;AKT1;RELB;TLR4;TNFRSF1A;TAB2;RELA;CHUK;NKIRAS2
prerank,embryonic skeletal system development (GO:0048706),0.4294833844530609,1.3747284107979476,0.07575757575757576,0.5366761900975252,1.0,8/35,11.03%,SULF1;SULF2;HOXC4;PDGFRA;HOXB3;HOXC9;HOXB9;FUZ
prerank,regulation of monooxygenase activity (GO:0032768),-0.4765950405834463,-1.3742368050987792,0.10163339382940109,0.37789210707371873,1.0,14/23,20.94%,CAV1;NOS3;NOSTRIN;CALM1;AKT1;LYPLA1;WASL;EGFR;SPR;HSP90AA1;NOSIP;CYGB;DNM2;DDAH1
prerank,organelle fusion (GO:0048284),-0.47937213732861883,-1.3741198273971302,0.09262759924385633,0.3773782307438821,1.0,15/22,41.33%,EEA1;MIEF1;BAX;CHCHD3;MIEF2;VPS11;OPA1;FIS1;STX4;MFF;THG1L;MIGA1;CYP26C1;GDAP1;MFN1
prerank,endocardial cushion morphogenesis (GO:0003203),-0.4910573296725894,-1.373472893701197,0.09867172675521822,0.3780322824652106,1.0,9/18,14.51%,NOS3;NOTCH1;TGFBR2;TGFB2;TBX2;HEYL;ACVR1;ENG;HEY1
prerank,positive regulation of phosphorylation (GO:0042327),0.3166868497169338,1.3733316421652324,0.015625,0.5385840294668002,1.0,55/240,13.40%,IGF1;EPHA7;NRP1;ZBTB20;BMP2;IL34;AR;NTRK3;DDR2;FGFR2;PELI2;KIT;PDGFRA;EPHA3;ROCK2;EPHA6;VEGFB;LEPR;RAP2A;LMO4;PFKFB4;LYN;FNIP1;DDR1;AXIN2;GLMN;AXL;NPTN;PDGFRB;EPHB1;TNIK;THPO;IGF2;ERBB3;RYK;FGFR4;DVL3;EPHA8;MYDGF;ERBB4;AKTIP;EPHA5;ALK;ANG;MUSK;CHRNA7;FXR2;MST1R;MERTK;FGFR1;NBN;ROR1;EPHA1;P2RY1;DAXX
prerank,positive regulation of neuron projection development (GO:0010976),0.36701762379491054,1.3728721872426404,0.05454545454545454,0.5377520916521354,1.0,25/85,14.65%,CAMK1D;PTN;NTRK3;BMP5;TENM3;MAGI2;PTK7;EPHA3;RIT2;GPC2;LYN;NPTN;CAMK2B;DPYSL3;LRRC7;CUX2;ALK;PRKCI;FUT9;PLXNB2;CBFA2T2;ROR1;EP300;CAPRIN2;PLPPR5
prerank,positive regulation of apoptotic process (GO:0043065),-0.29719022054775623,-1.3716086467690345,0.0021321961620469083,0.3817294143419244,1.0,81/293,18.67%,ANO6;ITGA6;MAP3K5;MCF2L;ARHGEF3;NET1;RACK1;UNC13B;TGM2;RASGRF2;ARL6IP5;FOXO1;FAP;FOXO3;RPS3;TPD52L1;DAB2IP;SLIT2;NGF;MAP3K20;CRADD;CTNNBL1;REST;TGFB2;TRIO;UBB;HTT;CYP1B1;TNFSF10;ING5;IGFBP3;UBC;RPS27A;SOS2;BACE1;HIP1R;TNFAIP8;ATF4;TGFB3;RASSF2;CASP8;RIPK1;BAX;CTSD;BCL6;MAP3K11;PSENEN;ITSN1;DNAJA1;FAS;ATG7;HSPD1;RHOB;PREX1;NF1;GADD45G;ABR;E2F1;SOX4;BAK1;RNPS1;SPHK2;RPS6;RPS6KA2;ARHGEF5;ARHGEF18;APH1A;BNIP3L;TOP2A;PHLDA3;PDCD2;DDX20;BAD;CCAR2;FOXL2;ARHGEF12;CALHM2;ARHGEF17;ARHGEF4;ARHGEF2;ECT2
prerank,bicarbonate transport (GO:0015701),-0.45617526783805595,-1.3714505195047382,0.07664233576642336,0.3813553261591165,1.0,7/25,12.98%,SLC4A10;SLC26A7;CA4;SLC39A8;SLC4A8;SLC4A2;CYB5R1
prerank,negative regulation of lipid biosynthetic process (GO:0051055),0.4947820381527837,1.3708734556192643,0.12,0.5413163386136665,1.0,3/20,1.32%,WNT4;BMP2;BMP5
prerank,phosphatidylserine acyl-chain remodeling (GO:0036150),0.4938227534344214,1.3703289157415939,0.1,0.5407297945618548,1.0,4/21,3.10%,PLA2G5;OSBPL10;PLA2G4A;OSBPL8
prerank,negative regulation of toll-like receptor signaling pathway (GO:0034122),0.43835308905964804,1.3702626632149273,0.0772626931567329,0.5389085715059689,1.0,9/34,8.87%,LGR4;LYN;TICAM1;BPIFB1;SMPDL3B;CD300LF;LRRC14;NLRP2B;GPR108
prerank,negative regulation of leukocyte activation (GO:0002695),0.540647506382913,1.3701698219337284,0.11316872427983539,0.5371739759630767,1.0,3/15,8.03%,IL31RA;IL4;CD300LF
prerank,negative regulation of inflammatory response to antigenic stimulus (GO:0002862),0.3456610426986356,1.3697359672319585,0.05128205128205128,0.5363653362263358,1.0,18/116,11.33%,ADCY7;ADCY2;ADCY1;ADCY5;GPHB5;HTR7;PRKACA;LYN;PTGDR;ADM;MC5R;IAPP;CALCR;HRH2;GLP2R;ADCY8;HTR4;PTGIR
prerank,positive regulation of telomerase activity (GO:0051973),-0.42521963480374547,-1.3695654267431194,0.07505070993914807,0.3848625734443472,1.0,10/33,16.67%,HMBOX1;KLF4;MAPK3;NEK7;HSP90AB1;PNKP;DKC1;CCT2;GREM1;HSP90AA1
prerank,glycolipid metabolic process (GO:0006664),-0.39493041099262244,-1.3693727758968477,0.07061068702290077,0.38452872121688336,1.0,25/47,32.56%,ST3GAL6;ST3GAL4;ST6GALNAC3;ESYT2;SUMF2;HEXA;PSAP;ST8SIA6;ABCA2;SUMF1;ESYT3;NEU3;PIGW;SCCPDH;GLTP;SMPD1;NEU1;NEU2;NAGA;B4GALNT1;ARSA;SMPD2;FUCA1;ST3GAL2;HEXB
prerank,regulation of cell migration (GO:0030334),-0.2923434503991235,-1.3687739580341043,0.007984031936127744,0.3851892401957109,1.0,95/382,14.97%,LEF1;PECAM1;PODXL;CAV1;TMSB4X;FLT1;FRMD5;IGF1R;ITGA6;CLDN5;DACH1;SEMA6A;CLIC4;SEMA3C;CDH1;THBS1;PTPRJ;NOTCH1;ACTG1;SEMA7A;FGF1;RACK1;PTK2B;LIMCH1;ACTN4;KDR;F3;PTK2;CYRIB;FOXO3;ANXA1;FERMT2;SMAD7;SLIT2;IGFBP5;ADAM15;TGFB1;RNF41;PLXNA4;SMO;RAC1;ADAM10;ROBO4;PRR5L;CYP1B1;NEDD9;CD151;MINK1;AMOT;VEGFA;IFITM1;SH3RF2;MYOC;SPATA13;ABI3;PPM1F;EDN1;MMP14;AKT1;ELP6;INSR;PDGFC;PDGFA;TMSB10;LAMC2;ZMYND8;VCL;FAM107A;SEMA3G;DDRGK1;RHOB;WNT11;PLXNA1;PLXND1;CD74;HSPA5;NF1;ULK4;CIB1;DUSP3;ACVR1;RCC2;SRCIN1;FGF2;CSF1R;ENG;PIK3R3;HRAS;ACE;RNF20;SDCBP;SPAG9;EGFR;OSGIN1;LDB1
prerank,regulation of protein autophosphorylation (GO:0031952),0.4266548491643299,1.368631676942099,0.09051724137931035,0.5372764485941764,1.0,6/36,7.92%,EPHA7;ENPP1;ERRFI1;RAP2A;NLRP12;PDGFD
prerank,positive regulation of CREB transcription factor activity (GO:0032793),0.5074629631559291,1.3680229280434566,0.11233480176211454,0.5369961676958535,1.0,5/18,10.66%,CAMK1D;ADCY1;LPAR5;EPHA5;ADCY8
prerank,regulation of ubiquitin-dependent protein catabolic process (GO:2000058),-0.4094021053795529,-1.3678348692076205,0.07751937984496124,0.3866212756429579,1.0,20/40,28.58%,PTK2B;PTK2;RPL11;RPL23;FOXF2;RPS7;SMURF1;SGTA;CSNK2A1;CSNK2A2;UFL1;CDK5RAP3;LAPTM5;CCDC22;RPL5;UBE3A;RAD23A;TRIM39;RAD23B;XPO1
prerank,cellular response to ionizing radiation (GO:0071479),-0.40211348899926447,-1.3676521958162864,0.05394990366088632,0.3862680812687772,1.0,24/47,29.47%,NET1;RPL26;MAP3K20;EEF1D;RAD1;RHOB;HRAS;TMEM109;RAD9B;HUS1;RAD9A;CDKN1A;KDM1A;CRYAB;ECT2;GADD45A;NIPBL;CLOCK;RHNO1;RAD51AP1;LIG4;TNKS1BP1;TSPYL5;SWI5
prerank,artery development (GO:0060840),0.4810896863538061,1.3676106242752484,0.1291759465478842,0.5361155802917491,1.0,4/23,2.13%,ROBO1;NRP1;ROBO2;EFEMP2
prerank,regulation of triglyceride biosynthetic process (GO:0010866),-0.5257240915931441,-1.3675861108705243,0.11385199240986717,0.3856666645131336,1.0,11/15,39.87%,SCARB1;MFSD2A;NR1H2;CNEP1R1;C3;SIK1;SREBF1;SLC27A1;LDLR;CTDNEP1;PLIN5
prerank,epithelial to mesenchymal transition (GO:0001837),0.40469960842882274,1.3671326120412681,0.09333333333333334,0.5354693676817724,1.0,11/47,8.08%,TGFBR3;WNT4;BMP2;TBX3;ROCK2;OLFM1;TGFBR3L;LOXL2;LOXL3;TGFBR1;RBPJ
prerank,amino acid import across plasma membrane (GO:0089718),0.47544623952583465,1.3666967578118425,0.09777777777777778,0.5347888995365949,1.0,5/24,1.76%,SLC1A3;SLC6A9;SLC7A2;SLC6A13;SLC22A4
prerank,positive regulation of cardiac muscle hypertrophy (GO:0010613),0.5165509432061368,1.36637878244763,0.1394335511982571,0.5337140266587473,1.0,3/16,2.64%,IGF1;ROCK2;PRKCA
prerank,atrial septum morphogenesis (GO:0060413),-0.5832788117908585,-1.3661917037717692,0.1206581352833638,0.38811700717808706,1.0,4/10,12.54%,BMPR2;TGFB2;ACVR1;SOX4
prerank,positive regulation of heart contraction (GO:0045823),0.5045992570446077,1.365543405835557,0.1148936170212766,0.5339323092372124,1.0,4/19,5.95%,ATP1A2;SCN3B;ATP2A2;ADM
prerank,protein catabolic process (GO:0030163),-0.38046275898116444,-1.365205694755849,0.06346153846153846,0.38968762881029123,1.0,30/59,33.91%,MANBA;TPP1;DAB2IP;RNF41;HSPA8;FBXO17;IDE;RIPK1;DENND3;CTSD;UBE2G2;VCP;APOE;RNF5;UBE2G1;UCHL3;HSP90AA1;OGA;USE1;FBXO6;NEU2;FBXO2;STT3B;MAGEC2;PMAIP1;CAPN3;PRPF19;PSMA8;TRIM24;HTRA2
prerank,regulation of myotube differentiation (GO:0010830),-0.46472678746676616,-1.3650129081734304,0.10476190476190476,0.38934673909450557,1.0,7/24,8.40%,NOTCH1;CCN3;PIEZO1;HDAC9;ATP11A;HDAC4;MMP14
prerank,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),-0.33774671988006355,-1.3641718492713704,0.034,0.39058163036533217,1.0,34/104,19.47%,CRIM1;CAV1;BMPER;NOTCH1;TGFBR2;BMPR2;CCN3;SMAD9;SMAD7;ZBTB7A;TGFB1;FKBP1A;PRDM16;UBB;UBC;RPS27A;CD109;SMAD6;ASPN;IL17RD;HTRA3;HTRA4;SKIL;ACVR1;SMURF1;EID2;SMAD4;GREM1;HSPA1A;SMAD2;SPRY1;SKI;BMPR1B;PIN1
prerank,mitochondrion morphogenesis (GO:0070584),0.5594709751642342,1.3639133043058487,0.1543340380549683,0.5363530615315699,1.0,3/11,10.47%,PID1;NUBPL;PNPT1
prerank,negative regulation of dephosphorylation (GO:0035305),-0.49600538550660084,-1.3632866073342131,0.12639405204460966,0.3919088641115906,1.0,8/18,24.02%,PPP1R16B;MFHAS1;CHP1;SH3RF2;PPP1R8;PPP1R26;ARPP19;YWHAB
prerank,purinergic nucleotide receptor signaling pathway (GO:0035590),-0.4850134995767985,-1.3624880437504188,0.0890909090909091,0.39300189187648354,1.0,5/20,4.11%,ANO6;ENTPD1;NT5E;HSP90AB1;APP
prerank,positive regulation of phospholipase activity (GO:0010518),0.4829991444161511,1.3620847170195263,0.11920529801324503,0.5394790235588713,1.0,6/22,2.25%,NTRK3;FGFR2;KIT;PLA2G5;PDGFRA;PDPK1
prerank,regulation of G2/M transition of mitotic cell cycle (GO:0010389),-0.32737897116872383,-1.362013418043864,0.03244274809160305,0.3933673875501382,1.0,55/145,25.79%,RAB11A;DCTN2;FHL1;TUBA1A;CEP164;PPP2R1A;BRD4;PRKAR2B;CEP192;CEP57;PSMA6;PSMB5;CEP70;DCTN3;CEP290;CNTRL;DCTN1;PSMC4;CDK4;PSMC5;PCM1;TUBB4B;PSMD14;RCC2;AVEN;FBXL7;HAUS1;NDE1;RBX1;PSMD8;CETN2;CEP72;YWHAG;PSMD11;PSMB4;PSMD12;PSMC1;HSP90AA1;CEP41;CUL1;CCND1;TPX2;PSMA1;PSMB1;PSMC3;TUBA4A;CENPF;PSMA4;DTL;PSMA2;PSMB8;HAUS4;YWHAE;CEP63;NEDD1
prerank,neutrophil activation (GO:0042119),-0.5541039625303061,-1.3616053300004558,0.12212389380530973,0.3935734872664565,1.0,4/12,12.88%,IL15;FCER1G;PREX1;SYK
prerank,negative regulation of immune effector process (GO:0002698),-0.5350819823002582,-1.3615375811985029,0.13768115942028986,0.39297939544530497,1.0,3/13,7.75%,CD55;RPS19;RC3H1
prerank,positive regulation of natural killer cell mediated immunity (GO:0002717),-0.5168912128665859,-1.361459629118677,0.12683823529411764,0.39244003839365743,1.0,13/16,45.09%,PVR;LAMP1;NECTIN2;RASGRP1;AP1G1;CADM1;SLAMF6;CD226;IL12A;CRTAM;KLRD1;CD160;KLRK1
prerank,neurotransmitter secretion (GO:0007269),0.4139335908554708,1.3614347992091698,0.0794979079497908,0.5392987617945504,1.0,12/44,12.98%,NRXN1;RIMS1;SYT1;CPLX2;SNAP25;OTOF;PDZD11;BRSK1;PTPRN2;STXBP3;GRM4;SNAPIN
prerank,regulation of postsynaptic membrane potential (GO:0060078),0.4272699836001624,1.3607201591840181,0.08528784648187633,0.5393422409962507,1.0,14/34,18.84%,GRID2;MPP2;GABRA2;NLGN3;MAPK8IP2;GABRA5;CHRNA4;GRIN2A;DRD2;GABRG1;GABRG3;GRIN2B;GABRG2;RAB3GAP1
prerank,positive regulation of granulocyte chemotaxis (GO:0071624),0.5083490330666798,1.360104436075997,0.13305613305613306,0.5391753807005686,1.0,3/19,5.08%,CAMK1D;DAPK2;IL4
prerank,hemopoiesis (GO:0030097),-0.35443248440962744,-1.3599177577993913,0.038461538461538464,0.3953848653455537,1.0,33/87,24.03%,MECOM;KITLG;TEK;FLT1;CD34;TGFBR2;KDR;HIPK1;TGFB1;TGFB2;ZBTB16;NOTCH4;ATF4;FLT4;TAL1;TIRAP;INHBA;YTHDF2;GLRX5;CSF1R;CDK13;BMI1;L3MBTL1;RASGRP4;SNRK;ARMC6;ETV6;WNT10B;ZFPM1;PGM3;MKNK2;ASH2L;PLD4
prerank,mitotic nuclear membrane organization (GO:0101024),-0.38210047728714286,-1.3599055948045524,0.07303370786516854,0.39389888873511963,1.0,29/51,32.17%,LBR;PPP2R1A;CHMP2B;CC2D1B;NUP93;NDC1;VRK1;PPP2R2A;NUP188;NUP155;NUP37;IST1;REEP4;CHMP2A;RANGAP1;RCC1;NUP160;VPS4A;NUP43;SEH1L;SEC13;NUP107;NUP98;CHMP7;CDK1;BANF1;UBE2I;CHMP4B;CHMP4A
prerank,mitotic nuclear membrane reassembly (GO:0007084),-0.38210047728714286,-1.3599055948045524,0.07303370786516854,0.39389888873511963,1.0,29/51,32.17%,LBR;PPP2R1A;CHMP2B;CC2D1B;NUP93;NDC1;VRK1;PPP2R2A;NUP188;NUP155;NUP37;IST1;REEP4;CHMP2A;RANGAP1;RCC1;NUP160;VPS4A;NUP43;SEH1L;SEC13;NUP107;NUP98;CHMP7;CDK1;BANF1;UBE2I;CHMP4B;CHMP4A
prerank,lipid oxidation (GO:0034440),-0.5600437329105445,-1.3594121788534281,0.09225092250922509,0.3943207390676659,1.0,3/12,5.35%,ADIPOR2;PPARGC1A;ADIPOR1
prerank,regulation of organelle organization (GO:0033043),-0.35393795191594335,-1.3591133722252682,0.05991735537190083,0.3942516440404707,1.0,35/80,28.21%,CLIC4;F11R;MAPK3;PTK2;CAPN2;MSN;PDE2A;DIAPH1;EZR;CPLANE2;RHOT1;SPEF1;MIEF2;RHOT2;SURF4;MAVS;ARHGEF5;VPS11;MTM1;TBC1D25;ARMH3;EHD3;TMEM33;FIS1;PDCD10;STX5;CAMSAP3;GOLPH3;TJP1;PLXNB1;RDX;CAPN6;CENPV;MFF;MUL1
prerank,regulation of kinase activity (GO:0043549),0.3626235419799666,1.3582743531027066,0.05845511482254697,0.5422684761816408,1.0,29/89,12.88%,EPHA7;LDB2;NTRK3;DDR2;FGFR2;KIT;PDGFRA;EPHA3;EPHA6;LMO4;DDR1;IRS2;AXL;PDGFRB;EPHB1;ERBB3;RYK;FGFR4;EPHA8;ERBB4;EPHA5;ALK;MUSK;MST1R;MERTK;FGFR1;NBN;ROR1;EPHA1
prerank,homeostasis of number of cells (GO:0048872),-0.5526153984062887,-1.3581883435001616,0.11753371868978806,0.39554866403156214,1.0,6/12,15.81%,NOS3;NOTCH1;CCN3;LPCAT3;OCIAD1;CX3CR1
prerank,double-strand break repair via break-induced replication (GO:0000727),0.5452124252871836,1.3580373101413514,0.13863636363636364,0.5409338509883742,1.0,6/12,23.13%,MCM3;GINS2;MCM2;CDC7;MCMDC2;MCM7
prerank,positive regulation of ERAD pathway (GO:1904294),-0.5505207102344413,-1.3580276791399268,0.10825688073394496,0.3951733641418038,1.0,5/13,14.67%,CAV1;TMEM259;RNF185;BCAP31;SGTA
prerank,polyol metabolic process (GO:0019751),-0.3963275330467795,-1.3568379412620555,0.08045977011494253,0.3972883701943818,1.0,14/46,16.68%,PLCE1;ITPKB;PLCG2;PLCB3;CALM1;INPP5D;IPMK;INPP5A;ISYNA1;NUDT4;IP6K1;MINPP1;SYNJ1;IMPA2
prerank,collagen fibril organization (GO:0030199),0.3606586912573069,1.3567531648982813,0.04819277108433735,0.542558940061144,1.0,21/88,11.06%,COL4A6;COL4A5;COL13A1;DDR2;COL1A2;COL22A1;DPT;COL4A4;COL16A1;LUM;COL4A3;COL10A1;COL8A2;P4HA2;LOXL2;LOXL3;TGFBR1;COL20A1;COL26A1;COL9A2;COL6A3
prerank,regulation of chemokine production (GO:0032642),-0.4154689785160283,-1.3567352914853443,0.08499095840867993,0.39674359110535595,1.0,12/36,25.40%,FOXP1;APP;IL33;TLR3;CD74;TLR4;CSF1R;SIGIRR;LGALS9;AIF1;SNAI2;TREM2
prerank,regulation of sensory perception of pain (GO:0051930),-0.5654081644140803,-1.3563402609001718,0.12432432432432433,0.39686793324425873,1.0,6/11,25.04%,CCN3;MGLL;ZFHX2;TMEM100;SPX;ATPSCKMT
prerank,high-density lipoprotein particle assembly (GO:0034380),0.5822472851834777,1.355831186515227,0.15632183908045977,0.5430623091510097,1.0,2/10,2.65%,ABCA1;PRKACA
prerank,regulation of stress-activated MAPK cascade (GO:0032872),-0.396380343851477,-1.3556429973869761,0.08921161825726141,0.3976576375030679,1.0,18/47,16.62%,IGF1R;ARL6IP5;FOXO1;MAPK3;DAB2IP;TGFB2;MID1;PPIA;TAOK3;STK25;FAS;TAOK2;ULK4;COPS5;EGFR;NOD2;GREM1;IGBP1
prerank,positive regulation of macrophage activation (GO:0043032),-0.5036803075638822,-1.3555128862297852,0.11703958691910499,0.3971857415141726,1.0,5/17,12.43%,LBP;THBS1;IL33;HSPD1;TLR4
prerank,regulation of ubiquitin-protein transferase activity (GO:0051438),-0.4373542719491385,-1.355490877875019,0.11010830324909747,0.39648951501546575,1.0,15/29,30.24%,DCUN1D5;SMAD7;DCUN1D1;BAG5;FEM1A;LIMK1;BMI1;PIN1;TRIB3;DTX3L;DCUN1D3;PARK7;MAGEC2;RPS2;PLK1
prerank,negative regulation of macrophage activation (GO:0043031),0.5285910953899882,1.355429587454598,0.1392931392931393,0.5422375738990509,1.0,2/16,5.08%,IL31RA;IL4
prerank,positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),-0.43693557814936224,-1.3547459057101439,0.102803738317757,0.39751821421709044,1.0,13/28,21.45%,PTK2;DAB2IP;CTSC;DDRGK1;PSMC5;FMR1;SMURF1;ATP5IF1;CDK5RAP3;OSBPL7;LAPTM5;CCDC22;PSMC3
prerank,dendritic cell differentiation (GO:0097028),0.4859456084312705,1.3544436909697464,0.15074309978768577,0.5429872007981591,1.0,5/22,5.75%,PRTN3;LYN;IL4;CAMK4;AXL
prerank,cellular response to chemokine (GO:1990869),-0.39984249087976026,-1.3543250384911083,0.08571428571428572,0.39775046134597786,1.0,5/46,2.77%,SLC12A2;ACKR3;PTK2B;LRCH1;WNK1
prerank,mammary gland development (GO:0030879),0.4885008448512551,1.3542705563545265,0.1403118040089087,0.5415760062864613,1.0,4/21,2.15%,WNT4;TBX3;NRG1;GLI2
prerank,sensory perception of smell (GO:0007608),0.5751827338733194,1.3537602223873884,0.1351931330472103,0.5410768835170197,1.0,4/11,14.15%,OMP;SLC24A4;UBR3;DRD2
prerank,regulation of JUN kinase activity (GO:0043506),-0.4278638813596095,-1.3536843416320017,0.080078125,0.39847605492091925,1.0,9/33,8.98%,MAP3K5;RPS3;DAB2IP;TAOK3;AIDA;EDN1;TNFRSF11A;MAP3K11;DNAJA1
prerank,regulation of lymphocyte migration (GO:2000401),-0.5726715263513424,-1.3534333872116038,0.13297872340425532,0.3983521061490298,1.0,5/10,14.29%,JAM2;STK10;MSN;AKT1;WASL
prerank,regulation of mitotic sister chromatid separation (GO:0010965),0.52268952805393,1.3532179169679837,0.13406593406593406,0.5406179033847914,1.0,4/15,9.25%,HECW2;ANAPC1;CDC23;CDC16
prerank,negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),-0.5394584421382882,-1.3532106865717144,0.11363636363636363,0.39810393538032574,1.0,7/13,22.97%,RACK1;DDRGK1;HSPA5;UFL1;NCK1;BFAR;PTPN1
prerank,amino acid transport (GO:0006865),0.4018388207706714,1.3524225437080752,0.08836206896551724,0.5409372259278824,1.0,11/49,11.88%,SLC7A11;SLC6A12;SLC43A1;SLC7A2;SLC38A1;SLC36A2;SLC7A9;SLC25A47;SLC1A5;SLC38A3;SLC38A9
prerank,negative regulation of smooth muscle cell migration (GO:0014912),-0.5283966576887318,-1.3522792976002773,0.1252236135957066,0.39951671921902104,1.0,6/14,9.62%,MEF2C;PRKG1;SLIT2;IGFBP5;IGFBP3;TRIB1
prerank,regulation of receptor binding (GO:1900120),0.5751604629740366,1.3520343833294668,0.14132762312633834,0.540228940497573,1.0,2/10,3.83%,GREM2;ATP2A2
prerank,regulation of tyrosine phosphorylation of STAT protein (GO:0042509),0.38925077236226885,1.3517016263716786,0.07905982905982906,0.5392789842708854,1.0,12/57,12.15%,IGF1;IL31RA;KIT;LYN;GHR;IL4;IL18;HES5;ERBB4;CNTF;IL6R;PIBF1
prerank,negative regulation of innate immune response (GO:0045824),-0.42125982867756095,-1.3505651251090125,0.08932038834951456,0.4029055189598325,1.0,21/34,40.04%,NLRC5;RPS19;CNOT7;DHX58;YTHDF2;USP15;SAMHD1;TNFAIP3;TTLL12;FAM3A;PTPN2;MUL1;A2M;YTHDF3;NLRC3;LYAR;USP18;GRN;SUSD4;OAS3;CACTIN
prerank,mitochondrial fission (GO:0000266),-0.5159436598304014,-1.3504639245922179,0.11962616822429907,0.40237714240702954,1.0,10/16,28.21%,DNM3;MIEF1;MTFR1;OPA1;DNM1;DNM2;FIS1;MTFR2;MFF;MUL1
prerank,positive regulation of endothelial cell apoptotic process (GO:2000353),-0.5291766298932827,-1.3503213174972215,0.12177121771217712,0.4019660791278499,1.0,3/14,7.21%,ANO6;THBS1;RGCC
prerank,membrane repolarization during cardiac muscle cell action potential (GO:0086013),-0.5213641454161098,-1.350202232946841,0.12014787430683918,0.40151045638740784,1.0,6/15,14.95%,KCNJ2;ATP1A1;KCNQ1;ATP1B1;KCNJ8;KCND3
prerank,phosphatidylglycerol acyl-chain remodeling (GO:0036148),0.5074199954315499,1.3499980240354994,0.12606837606837606,0.541982888117674,1.0,2/17,2.58%,PLA2G5;PLA2G4A
prerank,protein phosphorylation (GO:0006468),-0.2797355912858346,-1.3495565297567698,0.0022172949002217295,0.40224364467306806,1.0,121/478,16.04%,PRKCH;TEK;ERG;FLT1;IGF1R;CDK6;MAP3K5;RPS6KA5;PRKG1;CDK17;TGFBR2;MAP4K3;PTK2B;BMPR2;PEAK1;LIMK2;KDR;HIPK1;NLK;MAPK3;WNK1;PTK2;STK10;BMX;NEK7;RPS6KA3;CAMK2D;DAB2IP;SMAD7;MAP3K1;RICTOR;MAP3K20;FNIP2;TGFB1;MAPKAPK3;APP;TGFB2;FAM20A;MAP3K3;CSNK1G2;ADAM10;PRKCZ;PKD1;CTBP1;IGFBP3;MINK1;TAOK3;NRBP1;IKBKB;RARA;PRKDC;ABI3;BCR;TLR3;CSNK1G3;SRPK1;RIPK1;TRIB2;FLT4;STK25;PLK2;DYRK2;AKT1;INSR;GTF2H3;MAP3K11;CDC42BPB;VRK3;TRIB1;CSNK2B;STK32B;PIM3;LMTK2;WNT11;CAMK1;CDK4;ABL2;TAOK2;ULK3;RPS6KB2;FRK;HTATIP2;STK36;VRK1;STK38;GRK5;ACVR1;PKN3;YWHAZ;PRKCE;CDK10;PPP3CB;TLR4;SYK;CSF1R;FASTK;USP15;RPS6KA2;CDKL4;ABI1;TBCK;NUAK1;CAD;NUAK2;MAST4;JAK2;EGFR;UHMK1;ERBB2;PRKAG1;COQ8A;LMTK3;LIMK1;CAB39;NEK3;PTPN6;STK38L;STK26;CDK13;CSNK2A1;CSNK2A2
prerank,embryonic heart tube morphogenesis (GO:0003143),-0.4022883091144288,-1.3492446141197683,0.07465618860510806,0.4022460627169538,1.0,13/43,14.82%,MEF2C;NOTCH1;TGFBR2;SOX17;TBX2;SMO;MICAL2;SOX18;ZIC3;ACVR1;HES1;ENG;SRF
prerank,plasma membrane bounded cell projection assembly (GO:0120031),-0.29710429212976247,-1.3481087840828607,0.006,0.4042246982472539,1.0,64/259,15.75%,FGD5;ANO6;ABLIM1;ABCC4;DNM3;RAP1A;EXOC4;PARVB;NOTCH1;EXOC6;FNBP1L;RAP1B;RAB11A;OPHN1;CDC14A;FXYD5;EHD4;S1PR1;RAB8B;CD2AP;IFT20;CEP164;RAC1;SHTN1;ABLIM3;PKD1;MINK1;FGD6;EZR;SPATA13;EHD2;CEP162;BBIP1;INPP5E;NUDCD3;DISC1;TMEM237;CPLANE2;IFT46;VCL;EMP2;RAB8A;CEP290;SPEF1;EXOC1;FHDC1;STK36;PCM1;CC2D2A;ACTR3;POC1B;CDC14B;ABLIM2;EMP1;ARL6;RFX2;NTN1;RAB11FIP3;RAB1A;SDCBP;CCDC28B;KIF24;STK26;DNAH5
prerank,negative regulation of protein localization to nucleus (GO:1900181),-0.4824053899424945,-1.3477776043182057,0.11796733212341198,0.4042983367666861,1.0,4/18,6.15%,CTNNA1;MFHAS1;CHP1;UFM1
prerank,immunoglobulin mediated immune response (GO:0016064),-0.575930831192419,-1.3476560729976672,0.14800759013282733,0.4038343162753583,1.0,3/10,10.73%,CD81;FCER1G;CD74
prerank,positive regulation of cell differentiation (GO:0045597),0.310630233565994,1.3474049624471707,0.01717557251908397,0.5472027643116262,1.0,36/237,9.73%,IGF1;BMP6;TCF4;WNT4;NELL1;BMP2;AR;PTN;FBN2;DDR2;RIN2;ZEB1;GJA1;GDNF;PLA2G5;SMAD3;CCN4;RANBP3L;CTNNA2;SFRP1;SP7;OLFM1;CEBPB;AXIN2;BRINP1;BRINP3;MEDAG;LOXL2;RRAS;TGFBR1;NRCAM;IL18;SMYD1;BMPR1A;SOX5;KCTD11
prerank,mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),-0.3366820222456002,-1.347396354358407,0.054474708171206226,0.4036515772297362,1.0,48/96,34.81%,HNRNPA2B1;SRSF2;SRSF5;NUP93;SRSF6;NDC1;HHEX;NUP54;U2AF1;ZC3H11A;RNPS1;NUP188;SRSF4;MAGOH;NUP155;RANBP2;CHTOP;ALYREF;AGFG1;NUP37;DDX39B;SMG7;CASC3;THOC6;CPSF4;NUP160;DDX39A;NCBP2;SMG1;EIF4E;NUP43;SEH1L;SEC13;NUP107;NUP42;THOC7;NUP98;SRSF9;GLE1;UPF1;SMG6;U2AF1L4;RAE1;SRSF1;UPF3B;RBM15B;NUP88;NUP214
prerank,positive regulation of synaptic transmission (GO:0050806),0.37121006749952556,1.3473651827135726,0.05731225296442688,0.5454961813052192,1.0,20/72,13.97%,ADCY1;NRXN1;CLSTN2;RIMS1;MPP2;GRIK2;NPTN;NLGN2;NLGN3;SYT1;CACNG4;NLGN1;STX1B;SLC24A2;ADCY8;BAIAP3;CHRNA7;ZDHHC2;DLG4;GRIN2A
prerank,mitochondrion localization (GO:0051646),-0.49064513007870836,-1.3471018055281583,0.11844660194174757,0.4035749348248174,1.0,7/19,21.48%,TRAK1;MEF2A;TRAK2;MTM1;NECTIN2;BRAT1;TLE6
prerank,insulin receptor signaling pathway (GO:0008286),-0.36576206776097586,-1.3462690102358885,0.06910569105691057,0.4048729505105861,1.0,22/69,16.30%,IGF1R;GAB1;SORBS1;NAMPT;GRB14;CAV2;FOXO1;ATP6V0B;ATP6V0A2;SHC1;IDE;AKT1;INSR;PIK3C2A;ATP6V0C;GRB10;FOXC2;PIK3R3;PIK3CA;ATP6V1G1;BCAR3;PIK3R2
prerank,response to muramyl dipeptide (GO:0032495),-0.5440558319650054,-1.3451498971429745,0.11754068716094032,0.40676984448343606,1.0,5/12,22.08%,VIM;NOD1;NOD2;ARHGEF2;PTPN22
prerank,positive regulation of innate immune response (GO:0045089),-0.436303372204665,-1.3451159750641744,0.07977736549165121,0.4060999304214342,1.0,9/30,16.27%,LBP;GBP5;NLRC5;RPS19;DHX9;TRIM62;MAVS;AKIRIN2;SLC15A4
prerank,positive regulation of leukocyte proliferation (GO:0070665),0.548012506362518,1.3445545229432627,0.14435146443514643,0.5512143447541957,1.0,3/12,4.13%,IL34;OCSTAMP;LYN
prerank,positive regulation of catalytic activity (GO:0043085),-0.40869161836164203,-1.3444457523924431,0.08853118712273642,0.4069800226344513,1.0,11/37,15.49%,CAV1;MAPK3;BCAS3;PSENEN;PHACTR4;ABL2;CIB1;FXN;APH1A;CHTOP;NOD2
prerank,sulfur amino acid metabolic process (GO:0000096),-0.4513776758894632,-1.3444150325231004,0.09515260323159784,0.40634696335986686,1.0,10/24,24.95%,MTR;TXN2;CDO1;MSRA;SMS;CTH;ADI1;GCLC;AHCY;MTRR
prerank,regulation of myeloid cell differentiation (GO:0045637),-0.37677316953748147,-1.3442476764367626,0.06533575317604355,0.4059943131904637,1.0,12/62,11.27%,MEF2C;CDK6;THBS1;TNRC6C;PTK2B;KMT2C;RBBP5;ZBTB16;CBFB;MYL9;H3-3A;KMT2D
prerank,positive regulation of growth (GO:0045927),-0.3762901447408763,-1.3436769909658086,0.07385229540918163,0.40656569194765985,1.0,28/64,25.08%,RPS6KA3;TGFB2;ADAM10;MFSD2A;PPM1F;PABIR1;MMP14;AKT1;INSR;H3-3A;AKAP6;CIB1;FXN;CDKN2AIP;SDCBP;EGFR;ERBB2;CSNK2A1;DERL2;SLC25A33;ZPR1;BRAT1;ADNP2;DDX49;EIF4G1;HYAL1;CDC42;RPTOR
prerank,muscle tissue development (GO:0060537),-0.5417913961412922,-1.3436748142583492,0.12607944732297063,0.40584708957805804,1.0,6/13,13.24%,PGM5;SMO;STRA6;NF1;POGLUT1;ENG
prerank,positive regulation of calcium ion transmembrane transporter activity (GO:1901021),-0.46329393270106584,-1.3430322442616083,0.11560693641618497,0.4067075961230613,1.0,8/22,11.93%,CALM1;HTT;ATP1B1;JPH2;AKAP6;GSTM2;VMP1;CALM3
prerank,regulation of establishment of protein localization to telomere (GO:0070203),-0.5632587380271641,-1.342996092769566,0.11278195488721804,0.4060623671061699,1.0,8/11,35.15%,DKC1;CCT2;CCT3;CCT8;CCT7;WRAP53;CCT4;CCT6A
prerank,actin cytoskeleton reorganization (GO:0031532),0.3771090769919113,1.3424315092701662,0.07945736434108527,0.5551323016499142,1.0,11/63,7.54%,AUTS2;NRP1;NRK;PTK7;ANTXR1;KIT;EFS;RAP2A;THSD7B;THSD7A;TNIK
prerank,T cell homeostasis (GO:0043029),-0.5746423895055718,-1.3423310361235017,0.11423220973782772,0.4069174134653248,1.0,5/10,17.47%,AKT1;FAS;ZC3H8;PPP2R3C;JAK3
prerank,negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),0.4786674912630738,1.3419780512332742,0.14858490566037735,0.5545666665145799,1.0,6/20,10.59%,GRK3;CRY1;GPRASP1;BICD1;MGRN1;APLP1
prerank,regulation of calcium ion transmembrane transporter activity (GO:1901019),-0.4400755883539913,-1.3418078851555608,0.08118081180811808,0.4074052105346023,1.0,9/27,11.12%,AHNAK;DMD;PDE4D;CAMK2D;CALM1;FKBP1A;JPH2;JPH4;CACNB3
prerank,positive regulation of neural precursor cell proliferation (GO:2000179),-0.4694085182860916,-1.3411619627579856,0.12815884476534295,0.4081538688263296,1.0,12/21,31.14%,VEGFA;FZD3;NES;DISC1;CX3CR1;KDM1A;DLL4;TOX;LRP2;CTNNB1;FZD9;SMARCD3
prerank,cellular modified amino acid biosynthetic process (GO:0042398),-0.4732106456635583,-1.3406799741118456,0.1111111111111111,0.40856920964814436,1.0,10/20,29.73%,GATM;PLOD2;GCLM;CNDP2;GCLC;GGT1;GGCT;MTHFS;SLC27A1;MGST2
prerank,protein mono-ADP-ribosylation (GO:0140289),0.5653787021403388,1.3406770407889177,0.14578587699316628,0.5561662015209646,1.0,6/11,16.52%,PARP16;PARP11;PARP12;TIPARP;PARP4;PARP3
prerank,negative regulation of cell adhesion mediated by integrin (GO:0033629),-0.5688950466822859,-1.3405792959881737,0.1523809523809524,0.40806325143615246,1.0,4/10,5.14%,ACER2;WNK1;JAM3;CYP1B1
prerank,regulation of tumor necrosis factor production (GO:0032680),-0.3349426808017224,-1.3401614662593453,0.03682170542635659,0.4084049591903646,1.0,28/112,17.36%,FOXP1;LBP;THBS1;PTPRJ;CD34;PLCG2;IFIH1;APP;IL33;RARA;TLR3;HSPB1;RIPK1;DHX9;TWIST1;TIRAP;MAVS;TLR4;SPHK2;SYK;JAK2;NOD2;PTPN6;TNFAIP3;CX3CR1;OAS2;IFNGR1;VSIR
prerank,positive regulation of cation channel activity (GO:2001259),-0.4014835470431752,-1.3394853212101445,0.07481751824817519,0.4091526269220539,1.0,14/40,25.04%,TMSB4X;SHANK3;CALM1;HTT;JPH2;AKAP6;GSTM2;CALM3;PKD2;KCNIP2;CTSS;CCL2;CASQ1;ATPSCKMT
prerank,response to iron ion (GO:0010039),0.5566420534310048,1.3393884691655833,0.18403547671840353,0.5579134896329011,1.0,2/12,3.67%,BMP6;BCL2
prerank,negative regulation of blood pressure (GO:0045776),-0.5334640142249034,-1.3391090923547746,0.14744801512287334,0.4093430674226407,1.0,8/13,33.71%,NOS3;BMPR2;PRCP;GPR37L1;SCPEP1;APLN;NOS2;NOS1
prerank,bile acid and bile salt transport (GO:0015721),-0.4514393688590338,-1.338944166616021,0.11721611721611722,0.40900918365488487,1.0,4/24,1.27%,ABCC4;SLCO1C1;ATP8B1;SLCO2B1
prerank,cAMP-mediated signaling (GO:0019933),0.4731584031138306,1.3380200496836834,0.12723214285714285,0.5598478658291673,1.0,4/24,1.87%,ADCY2;ADCY1;KSR1;PDE7B
prerank,positive regulation of developmental growth (GO:0048639),-0.3867029179524494,-1.3375752527938614,0.07649253731343283,0.41157949295700724,1.0,14/49,15.29%,SEMA7A;NEDD4L;AGRN;ITSN2;NGF;SHTN1;INSR;PLAA;DBNL;DBN1;SYT2;SMURF1;NTN1;LIMK1
prerank,cardiac conduction system development (GO:0003161),0.4658495570732897,1.3373833028393274,0.12525667351129363,0.5597105181421735,1.0,6/24,12.23%,GJB6;GJA1;TBX18;CACNA1G;BMPR1A;MAML1
prerank,positive regulation of GTPase activity (GO:0043547),-0.3080845907081575,-1.3373187477283421,0.036,0.41144204954123015,1.0,49/188,15.69%,DOCK9;PKP4;ITGA6;ARHGAP42;RAP1A;NET1;RACK1;SIPA1L1;TGM2;AGRN;F11R;CAV2;SGSM2;RALGAPA2;RAPGEF1;TBC1D8;ARHGAP27;ARHGEF15;GRTP1;FERMT2;BCAS3;LIMS1;TBC1D1;ARHGAP25;CCDC125;TBC1D12;BCR;TBC1D22A;RALGAPB;RGS6;SIPA1;CCL15;S100A10;SIPA1L3;ZC3H15;WNT11;GMIP;NF1;ABR;TBC1D9B;ARHGEF5;TBCK;HRAS;NDEL1;SNX18;RAP1GDS1;ERBB2;EPHA2;BCAR3
prerank,positive regulation of protein kinase B signaling (GO:0051897),0.3287880144430971,1.337198051327618,0.03434343434343434,0.5583506221500478,1.0,31/150,9.82%,TCF7L2;PIK3R1;AREG;FGFR2;SEMA5A;NRG1;KL;KIT;PDGFRA;PDPK1;OSBPL8;TGFA;P2RX4;NRG4;NRG2;IRS2;AXL;RTN4;MYORG;IAPP;PDGFRB;CALCR;THPO;TGFBR1;IGF2;ERBB3;IL18;FGFR4;GATA3;MYDGF;ERBB4
prerank,regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),-0.3484700417564557,-1.3366416846863396,0.05048543689320388,0.41229325347224266,1.0,33/86,23.09%,KLF2;EGLN3;UBB;UBC;RPS27A;VEGFA;ATF4;PSMA6;EGLN2;PSMB5;PSMC4;EGLN1;PSMC5;LIMD1;IMPACT;PSMD14;RBX1;PSMD8;PSMD11;PSMB4;PSMD12;PSMC1;HSPA1A;CHEK1;ELOB;HIGD1A;PSMA1;PSMB1;PSMC3;DNAJB1;ATF3;PSMA4;PSMA2
prerank,positive regulation of cell communication (GO:0010647),0.44572727768627834,1.3363988359673167,0.12473118279569892,0.5587789192870833,1.0,10/28,19.22%,WLS;CLSTN2;RIMS1;GRIK2;SYT1;GATA3;DLG4;HCRT;RIMS2;LGI1
prerank,cellular response to epidermal growth factor stimulus (GO:0071364),-0.44403155802002775,-1.3356151380762227,0.11355311355311355,0.4140922288513525,1.0,11/26,19.97%,EEF1A1;IQGAP1;DAB2IP;PDE8A;DUSP3;PTPN12;EGFR;ERBB2;ZPR1;SOX9;KNSTRN
prerank,positive regulation of muscle cell differentiation (GO:0051149),-0.4576379596227976,-1.3343616147134854,0.10614525139664804,0.41628520665283997,1.0,5/24,2.97%,MEF2C;CDON;CTNNA1;MEF2A;BOC
prerank,plasma membrane repair (GO:0001778),-0.5320525943390714,-1.334110567861814,0.14124293785310735,0.41607530073075816,1.0,8/13,31.52%,AHNAK2;MYOF;DYSF;ARL8B;MYH9;SMPD1;SYT7;RAB3A
prerank,positive regulation of defense response (GO:0031349),-0.34416545668089416,-1.3336820864185486,0.058823529411764705,0.4163735746728097,1.0,21/89,18.87%,MEF2C;IL15;NFKBIA;ETS1;GBP5;APP;PDE2A;IL33;GPR4;TLR3;NFKBIZ;RIPK1;DHX9;TLR4;TNFRSF1A;FEM1A;AKIRIN2;IL17RA;SLC15A4;NINJ1;PTGER4
prerank,positive regulation of cardiac muscle tissue growth (GO:0055023),0.5055706417436456,1.332728727574069,0.13025210084033614,0.5665624244945147,1.0,6/16,9.82%,IGF1;TGFBR3;FGFR2;RBPJ;BMPR1A;ERBB4
prerank,cellular response to BMP stimulus (GO:0071773),0.37284176211997166,1.3324686563740085,0.07231404958677685,0.5654023100745346,1.0,7/66,4.24%,BMP6;TGFBR3;ADAMTS12;BMP2;BMP5;SMAD3;SFRP1
prerank,translational elongation (GO:0006414),-0.3343358731772565,-1.332307674861195,0.046065259117082535,0.4188331474250278,1.0,39/101,25.95%,EEF1A1;RACK1;EEF2;MRPL52;PTCD3;EEF1D;EEFSEC;MRPL51;MRPL38;MRPL28;EEF1B2;MRPL43;TSFM;MRPL32;MRPL14;MRPS30;ERAL1;MRPL24;MRPS17;MRPL50;MRPL16;MRPL47;MRPL54;MRPS18C;MRPS18A;MRPL35;MRPS6;LTN1;MRPL58;MRPL48;MRPL49;TUFM;MRPL13;MRPL11;MRPL21;MRPL30;MRPS24;MRPL2;MRPL42
prerank,negative regulation of viral transcription (GO:0032897),-0.5256142157735791,-1.331598382194934,0.13703703703703704,0.4198733872905794,1.0,4/13,12.16%,MID2;IFITM3;TRIM14;TRIM62
prerank,regulation of microtubule depolymerization (GO:0031114),-0.4486051020642336,-1.3315357806308596,0.11195445920303605,0.41928749580008684,1.0,11/25,22.33%,STMN2;SPEF1;TRPV4;CIB1;KATNB1;MAP1B;ARHGEF2;TPX2;MAP1A;APC2;CAMSAP3
prerank,cellular divalent inorganic cation homeostasis (GO:0072503),-0.33468837612021357,-1.330327952937627,0.05242718446601942,0.4213627097618266,1.0,22/107,8.87%,ATP13A5;CAV1;SLC39A10;TPT1;MT1G;MT1A;MT1B;MT1F;MT1E;MT1M;MT1X;MT1H;MT2A;TMEM165;ATP2C1;SLC39A8;ATP2A3;ATP1B1;EDN1;STIM2;CCL15;SLC10A7
prerank,regulation of inflammatory response to antigenic stimulus (GO:0002861),0.33850526851949403,1.3302150892939548,0.06858407079646017,0.5696569101154957,1.0,15/117,8.40%,ADCY7;ADCY2;ADCY1;ADCY5;GPHB5;HTR7;PRKACA;LYN;PTGDR;ADM;MC5R;IAPP;CALCR;HRH2;GLP2R
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),-0.43999893839313525,-1.3300054383788742,0.1206581352833638,0.42135377452066985,1.0,10/24,24.12%,ACKR3;TPT1;CD44;CD74;BCL2L1;CCAR2;KDM1A;TAF9;TRIAP1;SNAI2
prerank,regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),-0.4393604920822904,-1.3297524536103287,0.1050656660412758,0.4212197958635474,1.0,8/24,15.22%,PTK2B;UBB;PKD1;CTSC;GPX1;PSMD14;APOE;ATP5IF1
prerank,organelle fission (GO:0048285),-0.4562778390067962,-1.3296807583803447,0.11302681992337164,0.42068828154165283,1.0,15/24,28.21%,DNM3;MIEF1;MTFR1;WASHC5;ACOT8;OPA1;DNM1;DNM2;FIS1;MTFR2;PEX11G;PEX11A;SEC16B;MFF;MUL1
prerank,regulation of systemic arterial blood pressure (GO:0003073),-0.5094437237896995,-1.3288289593421019,0.12897196261682242,0.4220536145205782,1.0,7/16,20.94%,BMPR2;PLCB3;PRCP;ACE;GPR37L1;SPX;DDAH1
prerank,negative regulation of supramolecular fiber organization (GO:1902904),-0.3504222084818654,-1.3276862883370335,0.07364341085271318,0.42385566184902895,1.0,29/72,25.40%,SHANK3;KANK3;CYRIB;SLIT2;HSPA8;PFDN5;KANK4;SSH2;HIP1R;STMN2;PFN1;SPEF1;CIB1;APOE;KATNB1;PIK3CA;SMAD4;CRYAB;ARHGEF2;TPX2;SHANK1;CDH5;APC2;PFDN6;CAMSAP3;PRKCD;PFDN4;STMN1;TREM2
prerank,mitochondrion organization (GO:0007005),-0.3140746830315055,-1.327657026581879,0.029723991507430998,0.4232117420730774,1.0,51/165,20.82%,DNM3;CXADR;NOS3;VPS13D;TRAK1;CAV2;MEF2A;ATP5F1D;PPARGC1A;MIEF1;TMEM70;CHCHD2;ATP5F1B;HCFC1;TRAK2;BAX;CHCHD3;RHOT1;IMMP2L;ESRRA;HSPD1;MIEF2;GABPA;RHOT2;TIMM17A;BCL2L1;AGTPBP1;MTFR1;HIGD2A;TOMM22;CHCHD4;PHB2;BCAP31;BNIP3L;MTM1;CHCHD10;NIPSNAP2;ADCK1;OPA1;TIMM13;DNM1;HSD17B10;SLC25A33;RAB32;BIK;PTCD2;HIGD1A;DNM2;TOMM5;HIGD1B;TIMM50
prerank,defense response to symbiont (GO:0140546),-0.3452837095423064,-1.3274049767147604,0.07113821138211382,0.42313775673823345,1.0,26/92,18.62%,IFIH1;ABCC9;NLRC5;LYST;CNOT7;IFITM1;IFITM3;TLR3;IFITM2;ZMYND11;IFIT1;ATG7;TRIM56;TTC4;BCL2L1;MAVS;SAMHD1;BNIP3L;TRIM5;OAS2;MLKL;STAT1;DDIT4;RELA;CGAS;RSAD2
prerank,regulation of protein modification process (GO:0031399),-0.3810005803877663,-1.3270909705787521,0.08851224105461393,0.4232071703568505,1.0,20/50,24.65%,FN1;PTK2;PPP1R16B;FNIP2;HSPB1;NDUFS4;WARS1;ATG7;HPF1;ABCA2;CCAR2;PPP1R16A;PIN1;ROPN1L;CDH5;CADM4;SESN2;PPIB;SPRED3;CCDC88A
prerank,iron ion transmembrane transport (GO:0034755),-0.5614697672803713,-1.3268276281996365,0.16545454545454547,0.4230986815875128,1.0,6/10,35.33%,SLC39A8;SLC40A1;SLC25A28;ABCB6;SLC11A2;ABCB7
prerank,cellular response to amyloid-beta (GO:1904646),0.4285280024270024,1.3263457512515227,0.1314655172413793,0.5785782941329156,1.0,4/35,3.32%,IGF1;LRP1;GJA1;CACNA2D1
prerank,negative regulation of apoptotic process (GO:0043066),-0.27788495480523706,-1.3262840186884994,0.0022727272727272726,0.4236826805676914,1.0,138/444,22.71%,PRKCH;LEF1;TEK;MEF2C;CAV1;IGF1R;THBS1;TPT1;NOTCH1;TAX1BP1;PTK2B;MAP2K5;NFKBIA;KDR;FOXO1;KLF4;MAPK3;TFRC;PTK2;TBX1;RNF144B;RPS6KA3;RPL10;ANXA1;CARD14;NGF;CD44;SOCS2;TMBIM4;SIX1;ARHGDIA;UBB;NR4A2;ADAM10;PPARGC1A;CD38;UBC;RPS27A;SMAD6;VEGFA;PTMA;TNFAIP8;RHBDD1;UFM1;IKBKB;GATA6;SH3RF2;SHC1;TGFB3;PRKDC;HSPB1;TOX3;ANXA4;RIPK1;FOXQ1;FLT4;GPX1;PLK2;FZD3;AKT1;GLO1;ASAH2;DNAJA1;FAS;PIM3;RB1;DDRGK1;HSPD1;TCIM;WNT11;CD74;CFL1;MAEA;HSPA5;SFPQ;HTATIP2;BEX3;CIB1;GRK5;SERPINB9;YWHAZ;BCL2L1;APOE;AVEN;ITCH;FXN;FSTL1;HIGD2A;COPS5;DHCR24;PHB2;NUAK2;BNIP3L;EGFR;PIK3CA;HNRNPK;OPN3;CLCF1;HYPK;CX3CR1;CSNK2A1;CSNK2A2;OPA1;GREM1;IGBP1;HSPA1A;RELA;XBP1;BABAM2;HCK;AGAP2;HSPA9;CRYAB;ASNS;ANGPTL4;RASA1;SOX9;FAIM2;GCLC;PTRH2;MCL1;HIGD1A;TMBIM6;SFN;THOC6;HCLS1;IL6ST;HSPA1B;TAF9;BFAR;PDCD10;EGR3;TMEM14A;TRIAP1;API5;PLK3;DSTYK;BAG1
prerank,cardiac muscle contraction (GO:0060048),0.4239262675366912,1.3258566581486602,0.11316872427983539,0.5780561826100192,1.0,6/34,4.22%,ATP1A2;SLC8A1;SCN3B;TNNC1;CSRP3;TNNI3
prerank,regulation of NMDA receptor activity (GO:2000310),0.42347582721610166,1.325529697355429,0.1336116910229645,0.5771781755009119,1.0,13/32,14.41%,SLC6A9;GRIA4;DLG2;DAPK1;CAMK2B;NLGN1;MAPK8IP2;LRRC7;GRIA3;ACTN2;DLG4;GRIN2A;GRIA1
prerank,negative regulation of programmed cell death (GO:0043069),-0.28559595649094016,-1.3254339383310856,0.008492569002123142,0.4249498958733974,1.0,114/355,22.71%,MECOM;LEF1;TEK;IGF1R;THBS1;TPT1;TAX1BP1;PTK2B;NFKBIA;KDR;FOXO1;TFRC;PTK2;RNF144B;RPS6KA3;RPL10;ANXA1;CARD14;NGF;CD44;SOCS2;TMBIM4;ARHGDIA;UBB;ADAM10;CD38;UBC;RPS27A;SMAD6;VEGFA;PTMA;TNFAIP8;RHBDD1;UFM1;IKBKB;GATA6;SH3RF2;SHC1;DCPS;PRKDC;HSPB1;ANXA4;RIPK1;FLT4;PLK2;AKT1;GLO1;KANK2;DNAJA1;FAS;PIM3;DDRGK1;HSPD1;TCIM;WNT11;CD74;CFL1;HSPA5;PSMC5;HTATIP2;CIB1;RAB7A;GRK5;SERPINB9;YWHAZ;BCL2L1;AVEN;ITCH;FXN;FSTL1;HIGD2A;COPS5;DHCR24;PHB2;NUAK2;BNIP3L;EGFR;HNRNPK;OPN3;GPX4;HYPK;MET;OPA1;GREM1;HSPA1A;RELA;XBP1;BABAM2;HCK;HSPA9;CRYAB;ASNS;ANGPTL4;RASA1;SOX9;FAIM2;GCLC;LAPTM5;MCL1;HIGD1A;TMBIM6;THOC6;IL6ST;HSPA1B;TAF9;BFAR;PDCD10;EGR3;TMEM14A;TRIAP1;API5;PLK3;DSTYK;BAG1
prerank,heart development (GO:0007507),-0.3176321799221678,-1.3253733080972985,0.029850746268656716,0.4243970949607179,1.0,30/150,5.81%,FN1;TEK;PLCE1;MEF2C;HEG1;CXADR;GPC3;NOTCH1;TGFBR2;BMPR2;MEF2A;RAMP2;PTK2;TBX1;COL3A1;SOX17;CDKN1B;PDLIM1;TGFB1;RBM20;TGFB2;FKBP1A;TBX2;CRIP1;HDAC9;NDUFV2;STRA6;PKD1;VEGFA;MICAL2
prerank,negative regulation of sodium ion transmembrane transporter activity (GO:2000650),0.5683736109650366,1.3249073101140805,0.1613588110403397,0.5770928961936035,1.0,3/10,5.49%,HECW2;ATP1A2;HECW1
prerank,response to unfolded protein (GO:0006986),-0.3808558965952735,-1.324649568830093,0.09542743538767395,0.4253749638458604,1.0,21/48,22.97%,DAB2IP;HSP90AB1;HSPA8;RHBDD1;HSPB1;BAX;DNAJA1;HSPD1;HSPA5;BAK1;ERP44;HSPA4;HSPB8;HSP90AA1;HSPA1A;HSPA9;HSPE1;TMBIM6;HSPA1B;DNAJB1;PTPN1
prerank,positive regulation of neuron migration (GO:2001224),-0.5628163894813836,-1.324529708483678,0.12754158964879853,0.4249171377902495,1.0,8/11,24.49%,SEMA6A;DAB2IP;SHTN1;PLAA;ARHGEF2;NIPBL;RAPGEF2;NSMF
prerank,regulation of neuron projection development (GO:0010975),0.32238558473171297,1.3242894647098167,0.040169133192389,0.5770317724295012,1.0,39/163,14.65%,CAMK1D;PTN;LPAR1;NTRK3;LRRC4C;CSMD3;TENM3;MAGI2;PTK7;KIF13B;EPHA3;SEMA3A;RIT2;CTNNA2;GPC2;LYN;NPTN;RAB29;IL1RAPL1;CAMK2B;DPYSL3;STX1B;LRRC7;CDK5R1;DCC;PRKCI;FUT9;PTEN;PLXNB2;BRSK1;FBXO7;KIF1A;CBFA2T2;ROR1;FRMD7;EP300;PPFIA2;PDLIM5;PLPPR5
prerank,endothelial cell migration (GO:0043542),-0.40136808068465357,-1.3240536839805095,0.10961538461538461,0.425324974862846,1.0,16/37,16.32%,NOS3;ID1;DPP4;PXN;STARD13;CCN3;FAP;CYP1B1;VEGFA;GIPC1;SOX18;EMP2;PLXND1;FSTL1;PIK3CA;STAT1
prerank,negative regulation of release of cytochrome c from mitochondria (GO:0090201),0.5080092780515932,1.3237177825064694,0.1415929203539823,0.5767983522381956,1.0,2/15,5.39%,IGF1;PRKN
prerank,intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),-0.3896953447516662,-1.3234387659028306,0.08139534883720931,0.4259948376541447,1.0,18/48,20.47%,HIPK1;FNIP2;CRIP1;PRKDC;TNFRSF1B;BAX;DYRK2;RPS27L;BCL2L1;E2F1;BAK1;TMEM109;AEN;EPHA2;PHLDA3;DDIT4;MCL1;SFN
prerank,regulation of viral genome replication (GO:0045069),-0.3697111890714095,-1.3232697551662616,0.08863198458574181,0.42567926895717423,1.0,15/56,16.17%,IFIH1;ADAR;PPIA;CNOT7;IFITM1;IFITM3;N4BP1;SRPK1;IFITM2;IFIT1;FAM111A;STAU1;MAVS;NR5A2;OAS2
prerank,regulation of insulin receptor signaling pathway (GO:0046626),0.401853848910103,1.3227462834485157,0.1111111111111111,0.5776905160830365,1.0,8/43,12.95%,ENPP1;PID1;AHSG;PIP4K2A;IGF2;PRKCB;PIP4K2B;GKAP1
prerank,negative regulation of cyclase activity (GO:0031280),0.5273333227907312,1.3227404725188927,0.16241299303944315,0.5759068465157229,1.0,4/14,17.14%,ADGRV1;EDNRB;DRD2;LTB4R2
prerank,regulation of neuron differentiation (GO:0045664),0.36512496482068746,1.3226854582355185,0.07276507276507277,0.5742638233314917,1.0,16/76,10.12%,TCF4;BMP2;ZEB1;CNTN4;BRINP1;NREP;HES3;BRINP3;DTX1;NLGN1;SOX2;NRCAM;HES5;CDK5R1;KCTD11;ALK
prerank,3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),0.48963695473574576,1.3224657842655336,0.15811088295687886,0.5731141576833597,1.0,5/19,7.88%,ENPP1;TPST1;SLC26A1;SULT6B1;PAPSS1
prerank,positive regulation of alpha-beta T cell proliferation (GO:0046641),-0.5180780665405806,-1.3224148393850104,0.1332116788321168,0.4270463422743478,1.0,6/14,22.08%,CD55;TGFBR2;CD81;SYK;LGALS9;PTPN22
prerank,cGMP-mediated signaling (GO:0019934),0.5341831836771976,1.322097591252836,0.15898617511520738,0.5723116106191133,1.0,1/13,0.05%,IRAG1
prerank,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),-0.45677223275329465,-1.321528616640422,0.1050656660412758,0.4277363302213407,1.0,15/23,28.98%,PPP1R13B;PPP3CC;CASP8;BBC3;YWHAZ;E2F1;YWHAG;YWHAH;BAD;SFN;YWHAB;YWHAE;NMT1;PMAIP1;YWHAQ
prerank,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),-0.45677223275329465,-1.321528616640422,0.1050656660412758,0.4277363302213407,1.0,15/23,28.98%,PPP1R13B;PPP3CC;CASP8;BBC3;YWHAZ;E2F1;YWHAG;YWHAH;BAD;SFN;YWHAB;YWHAE;NMT1;PMAIP1;YWHAQ
prerank,glycolytic process (GO:0006096),-0.42849771176152496,-1.3206522840161972,0.1111111111111111,0.4289834250205742,1.0,11/28,23.23%,GPI;HK1;PGM1;PKM;GAPDH;LDHA;PGK1;PGAM1;PGAM4;PFKL;ENO1
prerank,positive regulation of histone acetylation (GO:0035066),-0.44543867177087193,-1.3203339111233094,0.1200750469043152,0.42904345978837694,1.0,7/23,15.00%,RPS6KA5;MAPK3;PPARGC1A;TADA2B;WBP2;SPHK2;SMAD4
prerank,negative regulation of myotube differentiation (GO:0010832),-0.53017958747843,-1.3202682466352376,0.14766355140186915,0.42848639192738575,1.0,4/12,17.15%,NOTCH1;CCN3;HDAC4;XBP1
prerank,positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),-0.49097371017855473,-1.3201280625141785,0.14522058823529413,0.4280931362524767,1.0,14/17,47.78%,PVR;LAMP1;NECTIN2;RASGRP1;AP1G1;CADM1;SLAMF6;CD226;IL12A;CRTAM;KLRD1;CD160;KLRK1;IL12B
prerank,gastrulation (GO:0007369),-0.4979899584777563,-1.3196612000247157,0.1343570057581574,0.4285134863767448,1.0,5/15,24.81%,GPC3;LRP5;TASOR;SMAD2;MKKS
prerank,regulation of intracellular signal transduction (GO:1902531),-0.2750449570877137,-1.3195997723044004,0.006711409395973154,0.42794501481032154,1.0,108/420,18.68%,ARHGAP31;TEK;CHN2;VWF;SGMS1;PPP1R13B;TMSB4X;MCF2L;ARHGEF3;NET1;PLCG2;RHOJ;FGF1;PIP5K1B;OPHN1;RASGRF2;NFKBIA;ARAP3;HIPK1;STARD13;ARHGAP23;MAPK3;STARD8;ARHGAP17;ARHGAP26;PPP1R16B;DAB2IP;RICTOR;PHF20;TMBIM4;ARAP2;RPL11;RNF41;ARHGAP1;ARHGDIA;TRIO;PDE2A;RAC1;CMKLR1;ING5;ARHGDIB;MINK1;CHN1;MOB3B;CRK;VEGFA;ARHGAP25;SOS2;TAOK3;EZR;PRKAR2B;MYOC;USP7;RASSF2;BCR;HSPB1;RAD1;DYRK2;AKT1;NOP2;ITSN1;PIP4P1;RHOT1;MAPKAP1;CSNK2B;MTA2;RHOB;PREX1;RHOT2;MBD3;TAOK2;GMIP;AKAP6;ULK4;ABR;SPHK2;TRAF1;ARHGEF5;TBCK;FBXL2;NUAK1;ARHGEF18;SLC15A2;RAD9B;SMYD2;EGFR;PRKAG1;HUS1;RPA3;RAD9A;CSNK2A1;CSNK2A2;UFL1;SLC15A4;PIK3R2;RBBP4;RAD17;DDIT4;PRKAR2A;RELA;ARHGEF12;ARHGEF17;L3MBTL1;CHD4;ARHGEF4;ARHGEF2;ECT2;CHEK1
prerank,sphingolipid catabolic process (GO:0030149),-0.5035906144320613,-1.31930661414157,0.1392857142857143,0.427974398619051,1.0,5/15,12.89%,ACER2;ASAH2;SMPDL3A;SGPL1;ACER3
prerank,neuromuscular synaptic transmission (GO:0007274),0.49195368299471853,1.3178313462049633,0.1352549889135255,0.582015302420009,1.0,7/18,14.82%,CHRNA1;CHRNB4;RIMBP2;TBC1D24;STAC3;CHRNB1;FCHSD2
prerank,basement membrane organization (GO:0071711),0.5259846457715811,1.317792948525607,0.15757575757575756,0.5803506540894917,1.0,3/14,2.52%,FLRT2;NID2;NID1
prerank,regulation of filopodium assembly (GO:0051489),0.4004440087703673,1.3174287961974622,0.12040816326530612,0.5795691202835224,1.0,7/38,7.71%,PIK3R1;NRP1;DOCK11;GPM6A;TENM2;DPYSL3;NLGN1
prerank,calcium ion transport (GO:0006816),0.33400847660947025,1.3172527770767888,0.05,0.5782503017423912,1.0,23/113,9.65%,NALCN;SLC24A3;SLC8A1;CACNA1E;CYP27B1;ITPR1;SLC24A5;ANK2;GRIN3A;CACNA2D1;TRPM3;P2RX4;ATP2A2;TRPM1;ORAI2;CACNA1I;TRPM5;TRPA1;CACNA1G;CACNB2;SLC24A4;SLC24A2;CHRNA4
prerank,regulation of stem cell proliferation (GO:0072091),0.49233288625997584,1.316882060312677,0.16228070175438597,0.5775027027231711,1.0,2/17,1.53%,FBLN1;GJA1
prerank,filopodium assembly (GO:0046847),-0.4913014153503697,-1.3168348677086972,0.13653136531365315,0.43314552346695545,1.0,6/16,10.18%,FGD5;DNM3;FGD6;EZR;SPATA13;SPEF1
prerank,heart process (GO:0003015),0.511995731040623,1.31676918046325,0.16519823788546256,0.5760260971509381,1.0,3/14,4.22%,SGCZ;SGCD;TNNI3
prerank,regulation of lamellipodium organization (GO:1902743),-0.5036936683551941,-1.316491802217259,0.13773584905660377,0.43320554299779795,1.0,9/14,38.26%,CD44;RAC1;EPHA2;DMTN;CARMIL1;CDC42;CAPZB;TWF2;VIL1
prerank,atrioventricular valve morphogenesis (GO:0003181),-0.4737996013059307,-1.3162417051540316,0.1366223908918406,0.4331161655056561,1.0,10/19,15.00%,NOTCH1;TGFBR2;BMPR2;TGFB2;HEYL;SMAD6;ACVR1;SOX4;HEY1;SMAD4
prerank,positive regulation of response to wounding (GO:1903036),-0.44212594117459914,-1.316108228076796,0.11368015414258188,0.4327198528537863,1.0,5/24,3.46%,OCLN;ACTG1;SCARF1;PTK2;ANXA1
prerank,positive regulation of cellular protein metabolic process (GO:0032270),-0.33430092251761406,-1.3159353196766468,0.05736137667304015,0.4324029049201576,1.0,33/101,17.09%,THBS1;VIM;RPL26;NFKBIA;KLF4;EEF2;NIBAN1;RPS4X;TGFB1;MSN;EZR;PRKDC;CASP8;AKT1;PERP;PTTG1IP;ATG7;RPS27L;EIF3D;INHBA;LARP4B;CIRBP;UPF3A;SOX4;BAK1;FMR1;VPS11;ERBB2;NR1H2;HSP90AA1;IST1;PCIF1;BAD
prerank,regulation of plasminogen activation (GO:0010755),0.524738478710908,1.315699582716169,0.1759465478841871,0.5772188579944433,1.0,3/12,5.80%,CLEC3B;SERPINE2;SERPINE1
prerank,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",-0.3582777592751297,-1.3156762060207654,0.0650887573964497,0.4323208334883325,1.0,34/67,35.74%,B2M;NCF2;TAPBP;IKBKB;PSMA6;PSMB5;PSMC4;PSMC5;PSMD14;PSMD8;PSMD11;PSMB4;PSMD12;PSMC1;CHUK;TAP2;CYBB;PSMA1;PSMB1;PSMC3;PSMA4;PSMA2;PSMB8;CD36;PSMC6;PSMD6;PSMA8;NCF1;SEC22B;IKBKG;PSMD2;ITGAV;PSMB2;SNAP23
prerank,regulation of defense response to virus by host (GO:0050691),-0.42093215312170806,-1.3155934531099935,0.1233644859813084,0.4318091496875983,1.0,17/30,31.99%,DHX9;ZDHHC1;MAVS;AIM2;TNFAIP3;STAT1;HSP90AA1;CGAS;PTPN22;DTX3L;IFNLR1;MUL1;LILRB1;PARP9;PQBP1;TRAF3IP2;TRIM44
prerank,cellular transition metal ion homeostasis (GO:0046916),-0.3360688820715438,-1.315573054388085,0.05905511811023622,0.4311640772314858,1.0,18/91,7.01%,ABCG2;SLC39A10;MT1G;MT1A;MT1B;MT1F;MT1E;MT1M;MT1X;MT1H;ATOX1;TFRC;MT2A;APP;SLC39A8;SLC40A1;ATP6V0A2;FTL
prerank,renal absorption (GO:0070293),-0.5573414888624302,-1.3140632843450166,0.1623134328358209,0.43396378017821485,1.0,6/10,35.98%,KCNQ1;KLHL3;SLC15A2;HAS2;HYAL2;WNK4
prerank,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),-0.3308553100326868,-1.313914562726182,0.051587301587301584,0.43363263027481347,1.0,31/108,14.41%,MAP3K5;ACER2;NOD1;RACK1;ARL6IP5;F3;EGLN3;RPS3;NGF;CRADD;REST;TNFSF10;HIP1R;ATP2A3;CASP8;RIPK1;PPM1F;BAX;NDUFA13;CTSD;SOX7;FAS;HSPD1;HIP1;VCP;RPS27L;BEX3;BBC3;SYK;BCAP31;JAK2
prerank,negative regulation of adenylate cyclase activity (GO:0007194),0.5384644818331874,1.3138296108975331,0.16745283018867924,0.5806471221842381,1.0,4/13,17.14%,ADGRV1;EDNRB;DRD2;LTB4R2
prerank,sprouting angiogenesis (GO:0002040),0.3828928822743817,1.3136559220880049,0.08658008658008658,0.5793799123099729,1.0,6/51,2.72%,CCBE1;ROBO1;NRP1;SEMA5A;RECK;VEGFB
prerank,acylglycerol metabolic process (GO:0006639),-0.40022829686223044,-1.3132488864368363,0.12092130518234165,0.43457467031061753,1.0,8/37,12.33%,ABHD2;CAV1;DGKH;SEL1L;MGLL;PNPLA2;PLAAT3;APOE
prerank,regulation of cellular component size (GO:0032535),-0.4248784926158655,-1.3131747527416866,0.10163339382940109,0.43408369451371814,1.0,15/30,32.66%,EPS8;RIN3;MSN;RAC1;EZR;AP2M1;PPP1CA;PEX11G;PEX11A;RPTOR;RDX;LAMTOR5;ATP13A2;RAB3B;VAV3
prerank,positive regulation of triglyceride metabolic process (GO:0090208),-0.48777729966373734,-1.3120257504867285,0.14671814671814673,0.4361597352877317,1.0,8/16,28.36%,SCARB1;MFSD2A;PNPLA2;NR1H2;DAGLB;CNEP1R1;SREBF1;SLC27A1
prerank,positive regulation of protein secretion (GO:0050714),0.36034906326526117,1.3111275765132946,0.08531746031746032,0.5846281601981177,1.0,4/69,0.72%,IGF1;BMP6;TCF7L2;WLS
prerank,intestinal absorption (GO:0050892),-0.5220634569380147,-1.3103107612778409,0.15145985401459855,0.439506122369588,1.0,3/13,5.13%,F11R;TJP2;KCNQ1
prerank,cell migration involved in sprouting angiogenesis (GO:0002042),0.482457437139302,1.3098333592511047,0.13537117903930132,0.5864115335212055,1.0,2/17,0.36%,ROBO1;NRP1
prerank,inorganic cation transmembrane transport (GO:0098662),0.2978675387938951,1.3097730643791043,0.025390625,0.5848602512043873,1.0,40/268,10.32%,SLC1A3;KCNK2;ATP1A2;NALCN;SLC24A3;ATP6V0A4;SCN7A;SLC6A12;SLC6A9;SLC8A1;SLC6A13;SLC24A5;SCN3B;SLC30A10;ABCB8;TRPM3;P2RX4;ATP2A2;TRPM1;CCDC51;SCN3A;SLC39A6;SLC36A2;KCND2;SLC9A7;TRPM5;KCNJ16;TRPA1;ASIC2;SCN2A;CACNA1G;KCND1;SLC24A4;SLC24A2;SLC41A1;SLC6A11;SLC6A1;DMAC2L;ATP6V1H;KCNJ14
prerank,regulation of T cell chemotaxis (GO:0010819),-0.5486467781565101,-1.3093128872900588,0.17690875232774675,0.4412997797473543,1.0,2/11,4.91%,WNK1;ADAM10
prerank,modified amino acid transport (GO:0072337),0.5152223725476418,1.3091753741971686,0.18223234624145787,0.5846359165618531,1.0,5/15,11.57%,SLC16A12;SLC6A13;SLC7A9;CTNS;SLC46A1
prerank,regulation of secretion (GO:0051046),0.5255713262452519,1.308629307413726,0.15320910973084886,0.584422784234048,1.0,4/13,8.27%,NRG1;OPRK1;SCIN;ERBB3
prerank,adipose tissue development (GO:0060612),-0.5390833950692707,-1.3086284897327196,0.1621129326047359,0.442236657936435,1.0,4/11,6.33%,SPTLC2;NAMPT;LRP5;PGRMC2
prerank,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),-0.48709627337520567,-1.3084462565450603,0.16353383458646617,0.44193794825340627,1.0,4/16,24.19%,CLDN5;CLDN11;CLDN10;CLDN1
prerank,positive regulation of erythrocyte differentiation (GO:0045648),-0.43314666189394146,-1.3081116357793594,0.11559633027522936,0.4420406929389162,1.0,13/25,30.77%,FOXO3;ETS1;PRKDC;TAL1;INHBA;STAT1;HSPA1A;FAM210B;MAPK11;HSPA1B;HMGB2;ANKRD54;ABCB10
prerank,leukocyte adhesion to vascular endothelial cell (GO:0061756),-0.47857425794416775,-1.3073558302595343,0.14942528735632185,0.4431936688460947,1.0,7/18,26.19%,JAM2;SLC39A8;ITGA4;CX3CR1;GOLPH3;SELP;ITGB7
prerank,regulation of amyloid precursor protein biosynthetic process (GO:0042984),-0.5431609462940514,-1.3071136958812224,0.1651376146788991,0.4430527404861923,1.0,5/11,24.58%,ITM2A;BACE2;ABCA2;NECAB3;NECAB2
prerank,osteoclast differentiation (GO:0030316),-0.4486468620128701,-1.3067784686038466,0.1452513966480447,0.443194901685678,1.0,8/22,15.34%,FOXP1;ANXA2;OSTM1;TNFRSF11A;GLO1;CSF1R;GAB2;EPHA2
prerank,negative regulation of cellular process (GO:0048523),-0.2704871422714265,-1.3067655102254219,0.002188183807439825,0.4425243960206784,1.0,116/521,15.00%,ZBTB7C;PODXL;PTPN14;PPP1R13B;CDK6;ITGA1;APBB2;JAM2;CTTNBP2NL;IGFBP7;NOS3;PTPRJ;CD34;SERTAD2;IGFBP6;NOTCH1;CBFA2T3;OSGIN2;RACK1;PTK2B;BMPR2;SH3BP4;KLF4;FHL1;CCN3;TBX1;ETS1;SOX17;DAB2IP;FERMT2;SLIT2;NPR1;NGF;ADAM15;CDKN1B;TGFB1;LPCAT3;REST;APP;TGFB2;RNF41;COL18A1;PLXNA4;ARHGDIA;TES;PLPP1;ADAM10;CYP1B1;ING5;ARHGDIB;CTBP1;IGFBP3;TGFBI;DYSF;SMAD6;CNOT7;AQP11;PPP2R1A;WNT9A;NOTCH4;IFITM1;ACTN1;PDE8A;TGFB3;TNFRSF21;CD9;TNFRSF1B;RGCC;DUS2;ADGRG1;SRSF6;NDUFA13;BCL6;SIPA1;KANK2;SOX7;WARS1;CSNK2B;RB1;WFDC1;SPEF1;RHOB;WNT11;MYBL1;PLXNA1;PLXND1;DIS3L2;INHBA;CCDC85B;GAS8;CRLF3;FRK;IMPACT;CIB1;FTH1;TMEM115;CDK10;SOX4;CCN5;FGF2;SPHK2;RPS6KA2;ABI1;HRAS;TMEM109;P3H2;SMARCA4;NDUFS3;CDKN2AIP;JAK2;BNIP3L;RAD18;SMYD2;STRN;OSGIN1;SMAD4
prerank,positive regulation of phospholipase C activity (GO:0010863),0.4038633964964311,1.306527429529141,0.11041666666666666,0.5884438362041171,1.0,11/40,12.51%,ARHGAP6;LPAR1;NTRK3;KIT;PDGFRA;GPR55;PDGFRB;ANG;GNA15;ITK;FGFR1
prerank,positive regulation of triglyceride biosynthetic process (GO:0010867),-0.5515238216491332,-1.3064090633564205,0.14942528735632185,0.44265971836592255,1.0,9/11,39.87%,SCARB1;MFSD2A;NR1H2;CNEP1R1;SREBF1;SLC27A1;LDLR;CTDNEP1;PLIN5
prerank,T cell proliferation (GO:0042098),-0.5138903155721795,-1.3061668761528227,0.17744916820702403,0.4425133083768693,1.0,11/13,37.82%,CTPS1;MSN;PPP3CB;PIK3CG;RASGRP1;LILRB1;DOCK8;CADM1;LMBR1L;SLC11A1;CRTAM
prerank,positive regulation of canonical Wnt signaling pathway (GO:0090263),0.3263162897979094,1.3061122056532115,0.05325443786982249,0.5879286162271127,1.0,18/129,8.56%,RNF220;LGR4;LRRK1;WLS;DAAM2;FGFR2;LYPD6;SEMA5A;TBL1XR1;PTK7;ZEB2;SFRP1;AXIN2;FRAT1;SMURF2;PSMA3;ADGRA2;PSMF1
prerank,positive regulation of kinase activity (GO:0033674),0.33578810160437944,1.3055981916001314,0.08113590263691683,0.587484954284642,1.0,31/107,13.81%,EPHA7;NTRK3;DDR2;FGFR2;KIT;PRKAG2;PDGFRA;EPHA3;EPHA6;LMO4;DDR1;AXL;PDGFRB;EPHB1;ERBB3;RYK;FGFR4;EPHA8;ERBB4;EPHA5;ALK;MUSK;SNX9;MST1R;MERTK;FGFR1;NBN;ROR1;EPHA1;DAXX;MAPT
prerank,gland development (GO:0048732),0.36594074672088467,1.305393868915356,0.10526315789473684,0.5863311363628574,1.0,11/59,7.96%,TGFBR3;WNT4;SALL1;TBX3;FGFR2;NRG1;GLI2;DKK3;SOX2;CITED2;TGFBR1
prerank,negative regulation of multicellular organismal process (GO:0051241),0.3028003233164052,1.3049001360679362,0.03578528827037773,0.5860115203176138,1.0,33/199,10.71%,ALDH1A1;ROBO1;LGR4;BMP2;PLCL1;LDLRAD4;NOVA1;BMP5;GJA1;ADAMTS5;TBX18;ROCK2;LRP4;WWC1;SFRP1;MCC;ACTN3;IL4;ADM;NLRP12;PLCL2;NPTN;FOXA2;LOXL2;ACOT11;DOCK7;RBPJ;SFMBT1;GATA3;HOXC10;BBS2;PTEN;RPS6KA6
prerank,regulation of chromatin binding (GO:0035561),-0.5531390188682515,-1.3048136730618227,0.1474820143884892,0.44512557280499654,1.0,6/10,36.33%,HMBOX1;WAPL;DTX3L;BTAF1;PARP9;MED25
prerank,protein auto-ADP-ribosylation (GO:0070213),0.5417715386459145,1.3043330679348222,0.1771058315334773,0.5859097378953275,1.0,10/12,28.14%,PARP16;PARP11;PARP12;TIPARP;PARP3;PARP1;TNKS;PARP8;TNKS2;PARP6
prerank,extrinsic apoptotic signaling pathway (GO:0097191),-0.35344752250378375,-1.3034982718775197,0.08057851239669421,0.4477026590226497,1.0,20/70,14.41%,HIPK1;DAB2IP;NGF;CRADD;TGFB1;TGFB2;RNF41;GABARAP;CASP8;TLR3;TNFRSF1B;RIPK1;BAX;FAS;INHBA;CIB1;BCL2L1;BAK1;TNFRSF1A;JAK2
prerank,regulation of developmental growth (GO:0048638),0.42381015787812965,1.3032039724631914,0.1351931330472103,0.5873136199551242,1.0,7/29,10.84%,IGF1;STAT5B;OLFM1;GHR;SIX4;NRCAM;MUSK
prerank,ventricular cardiac muscle tissue morphogenesis (GO:0055010),0.41809438615341643,1.3028890499663281,0.1400437636761488,0.5864100470866955,1.0,8/31,9.35%,TGFBR3;FGFR2;NRG1;TNNC1;TNNI3;TGFBR1;RBPJ;BMPR1A
prerank,regulation of actin cytoskeleton reorganization (GO:2000249),-0.40085970281487227,-1.3028639144968779,0.13559322033898305,0.4486833023207702,1.0,14/35,17.47%,TEK;ESAM;BAIAP2L1;PTK2B;F11R;ARHGDIA;BCAS3;ARHGDIB;ABI3;ABL2;CSF1R;HRAS;RAPGEF3;HCK
prerank,RNA export from nucleus (GO:0006405),-0.32533434106799397,-1.3028384209910546,0.07509881422924901,0.4480320030566469,1.0,49/100,34.81%,HNRNPA2B1;SRSF2;SRSF5;NUP93;SRSF6;NDC1;HHEX;NUP54;U2AF1;ZC3H11A;RNPS1;NUP188;SRSF4;MAGOH;NUP155;RANBP2;CHTOP;ALYREF;AGFG1;NUP37;DDX39B;HNRNPA1;SMG7;CASC3;THOC6;CPSF4;NUP160;DDX39A;NCBP2;SMG1;EIF4E;NUP43;SEH1L;SEC13;NUP107;NUP42;THOC7;NUP98;SRSF9;GLE1;UPF1;SMG6;U2AF1L4;RAE1;SRSF1;UPF3B;RBM15B;NUP88;NUP214
prerank,positive regulation of axonogenesis (GO:0050772),0.38801273462929775,1.3027102455417001,0.13800424628450106,0.5851700393008821,1.0,3/43,0.57%,PLXNA2;ROBO1;ROBO2
prerank,entry into host (GO:0044409),-0.5131589075817804,-1.30252860998495,0.15985790408525755,0.4480715574164074,1.0,8/13,35.14%,CDH1;PPIA;MET;CBLL1;CTNNB1;SRC;CBL;ITGAV
prerank,phospholipid translocation (GO:0045332),-0.42519663144938735,-1.3022417949330263,0.1350844277673546,0.4480556117934645,1.0,8/28,8.51%,ANO6;ATP10A;ATP8B1;ATP8A1;ATP11C;ATP11A;MFSD2A;ATP9B
prerank,negative regulation of protein phosphorylation (GO:0001933),0.3179455374950995,1.3019435860864503,0.04904051172707889,0.5855732122962977,1.0,27/150,8.96%,ENPP1;PPM1E;ERRFI1;PID1;PTPN13;LDLRAD4;NTRK3;FBLN1;PRKAG2;PDPK1;DEPTOR;LYN;SFRP1;GPD1L;PMEPA1;PRKN;CEP85;GSTP1;NLRP12;PLPP3;SIRT2;IBTK;MEN1;CEP43;TRIM27;NLRP2B;PPP1R15B
prerank,cellular response to growth factor stimulus (GO:0071363),-0.3085669987349603,-1.3010904494224445,0.03382663847780127,0.4501228998635808,1.0,33/151,8.42%,MEF2C;FLT1;SEMA6A;RAP1A;EEF1A1;NOTCH1;TGFBR2;RACK1;BMPR2;MAP2K5;KDR;KLF4;MT1G;IQGAP1;RAMP2;RAPGEF1;TBX1;SMAD9;ANXA1;DAB2IP;SMAD7;CD44;TGFB1;PDE2A;LIMS1;VEGFA;SHC1;PDE8A;NR3C1;HSPB1;FLT4;STMN2;AKT1
prerank,negative regulation of voltage-gated potassium channel activity (GO:1903817),-0.5582751914943301,-1.3007937280501036,0.1675485008818342,0.4501091509873663,1.0,1/10,0.34%,CAV1
prerank,anterior/posterior pattern specification (GO:0009952),0.3824164558301105,1.2991384746178298,0.12629399585921325,0.5913490906759905,1.0,11/53,9.95%,BMP2;WLS;HOXC4;HOXB3;HOXC5;HES3;HOXC9;TGFBR1;HES5;HOXB9;HOXC6
prerank,positive regulation of cysteine-type endopeptidase activity (GO:2001056),-0.36672046573472633,-1.2982287727935025,0.10384615384615385,0.4556588078508689,1.0,17/57,17.57%,MAP3K5;NOD1;ARL6IP5;REST;TNFSF10;CASP8;PPM1F;PERP;NDUFA13;CTSD;SOX7;BAK1;SYK;AIM2;BCAP31;BAD;FOXL2
prerank,"alternative mRNA splicing, via spliceosome (GO:0000380)",-0.4939617266715972,-1.2980147577465146,0.1527001862197393,0.45545720635901793,1.0,13/16,34.99%,DDX5;DDX17;SRSF6;DHX9;SFPQ;CDK13;RBM17;SRSF9;PQBP1;SRSF1;RSRC1;HNRNPM;PUF60
prerank,vascular transport (GO:0010232),0.34782890074171624,1.2978168615975865,0.1014799154334038,0.5932613186479831,1.0,16/81,5.34%,SLC1A3;ATP1A2;SLC24A3;SLC13A3;SLC6A9;SLC16A12;LRP1;SLC7A2;SLC6A13;SLC2A13;SLC5A3;LEPR;ABCC2;SLC29A1;SLC22A3;SLC38A1
prerank,regulation of smooth muscle cell proliferation (GO:0048660),0.3873715591159198,1.2976388760084572,0.1040339702760085,0.592053993876983,1.0,10/46,11.33%,IGF1;TCF7L2;CCN4;PDGFRB;OGN;IL18;HES5;ANG;IL6R;PTGIR
prerank,negative regulation of reactive oxygen species biosynthetic process (GO:1903427),0.5554326877475095,1.2975433475063713,0.1774891774891775,0.5905926166295519,1.0,3/11,6.04%,PPARA;SLC30A10;ABCD2
prerank,mitotic G2/M transition checkpoint (GO:0044818),-0.3871835159698254,-1.2975310060276835,0.09792843691148775,0.4558624205873256,1.0,24/43,32.38%,BRCC3;TAOK3;FOXN3;UIMC1;PABIR1;BABAM1;TAOK2;CDC14B;HUS1;CDKN1A;RAD17;FZR1;BABAM2;CHEK1;CDK5RAP3;DTL;MRNIP;TRIM39;MRE11;PLK1;INTS3;CDK1;CDC6;TICRR
prerank,programmed necrotic cell death (GO:0097300),-0.47241530757174643,-1.2973016231174035,0.13537906137184116,0.45572129933240824,1.0,7/18,16.20%,TRPM7;IPMK;TLR3;RIPK1;TLR4;PGAM5;MLKL
prerank,hyaluronan catabolic process (GO:0030214),0.48174705599602896,1.2970924801089563,0.17307692307692307,0.5901777541293846,1.0,3/18,1.32%,CEMIP;SPAM1;HYAL3
prerank,Rap protein signal transduction (GO:0032486),-0.5588563084602762,-1.2965555000246631,0.15328467153284672,0.45682635497664753,1.0,4/10,8.12%,RAP1A;RAP1B;RAPGEF1;PLK2
prerank,regulation of response to external stimulus (GO:0032101),-0.32072732138681936,-1.2965523199889077,0.06339468302658487,0.4561249045961291,1.0,31/121,18.31%,FOXP1;CAV1;TMSB4X;SEMA7A;CD55;CYRIB;ANXA1;MGLL;CALM1;IL1R1;BRD4;GATA6;N4BP1;CASP8;PSMA6;ERAP1;BCL6;ACE2;TIRAP;LRP8;DHX58;PIK3AP1;SAMHD1;BCL6B;JAK2;TRIM5;NOD2;UFL1;RELA;HCK;DAGLB
prerank,regulation of oligodendrocyte differentiation (GO:0048713),0.48716159998985104,1.2965213553485615,0.16519823788546256,0.590109553988077,1.0,3/18,0.98%,IL34;PTN;DAAM2
prerank,limb development (GO:0060173),0.43205367332845196,1.296301699305913,0.16523605150214593,0.5890210703594272,1.0,6/28,6.38%,SALL1;CHD7;LRP4;GLI3;ZNRF3;IFT122
prerank,vasculogenesis (GO:0001570),-0.414768546396683,-1.2962950235035886,0.14206642066420663,0.45599460060617014,1.0,9/32,5.68%,CAV1;NOTCH1;TGFBR2;RASIP1;KDR;RAMP2;SOX17;TGFB1;VEGFA
prerank,regulation of cellular pH (GO:0030641),-0.4233534057202823,-1.2962918700409194,0.1146384479717813,0.4552983470092391,1.0,12/29,28.71%,SLC4A10;SLC9A2;CHP1;ATP5F1B;SLC4A8;SLC4A2;SLC9B1;ATP6AP1;SLC9A5;SLC9A4;SLC4A3;SLC26A6
prerank,response to interleukin-6 (GO:0070741),0.5466113784631143,1.2959020938315433,0.17857142857142858,0.588381923482287,1.0,4/10,6.59%,PID1;PTGIS;PTPRT;FOXA2
prerank,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),0.43346878384795773,1.2955036309147745,0.1419753086419753,0.58787029454624,1.0,8/27,14.15%,LPAR1;GPR55;GPR174;GRM1;LPAR4;C3AR1;GNA15;DRD2
prerank,positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),-0.4671336646760083,-1.295386126775267,0.17235188509874327,0.4568573739748873,1.0,7/17,15.49%,ARL6IP5;TGFB2;MID1;TAOK3;STK25;TAOK2;NOD2
prerank,negative regulation of response to cytokine stimulus (GO:0060761),-0.5459659631735889,-1.2947332999658376,0.18285714285714286,0.4577558255956565,1.0,3/10,14.68%,MAP2K5;KLF4;SIGIRR
prerank,regulation of protein kinase B signaling (GO:0051896),0.3080313219461403,1.2946296816364702,0.046875,0.5885345691490173,1.0,36/193,10.35%,TCF7L2;PIK3R1;AREG;NTRK3;FGFR2;SEMA5A;NRG1;MAGI2;KL;PPARA;KIT;PDGFRA;PDPK1;OSBPL8;TGFA;P2RX4;NRG4;NRG2;IRS2;AXL;RTN4;MYORG;IAPP;PDGFRB;CALCR;RRAS;THPO;TGFBR1;IGF2;ERBB3;IL18;FGFR4;GATA3;MYDGF;ERBB4;PTEN
prerank,positive regulation of glycoprotein biosynthetic process (GO:0010560),0.5207137146289734,1.294590360955389,0.17970401691331925,0.5870206839577838,1.0,1/13,0.08%,IGF1
prerank,synaptic vesicle cycle (GO:0099504),0.42937797398788174,1.2944210746707805,0.14107883817427386,0.5859256831908993,1.0,9/30,16.14%,RIMS1;SYNDIG1;CPLX2;SNAP25;OTOF;NLGN1;BRSK1;SNAPIN;PLD2
prerank,regulation of type I interferon-mediated signaling pathway (GO:0060338),-0.4219550832775178,-1.2935378023656523,0.122568093385214,0.4599856138127852,1.0,19/29,42.79%,HSP90AB1;NLRC5;CNOT7;YTHDF2;MAVS;SAMHD1;PTPN6;TTLL12;PTPN1;PTPN2;MUL1;YTHDF3;USP18;IFNAR2;CDC37;OAS3;CACTIN;STAT2;ZBP1
prerank,organic acid transport (GO:0015849),0.3398306958624146,1.2929491018537242,0.09812108559498957,0.5882596567403758,1.0,21/94,11.57%,SLC7A11;SLC13A3;SLC6A12;SLC43A1;SLC7A2;SLC6A13;NCOA2;SFXN5;ABCC2;ACSL1;SLC26A1;SLC38A1;SLC36A2;SLC7A9;SLC25A10;NCOA1;SLC10A1;SLC25A47;SLC1A5;SLC38A3;SLC46A1
prerank,mRNA export from nucleus (GO:0006406),-0.3209336409969255,-1.2924311860898268,0.059880239520958084,0.4619463688395681,1.0,50/102,34.81%,HNRNPA2B1;SRSF2;SRSF5;NUP93;SRSF6;ENY2;NDC1;HHEX;NUP54;U2AF1;ZC3H11A;RNPS1;NUP188;SRSF4;MAGOH;NUP155;RANBP2;CHTOP;ALYREF;AGFG1;NUP37;DDX39B;SMG7;CASC3;THOC6;CPSF4;NUP160;DDX39A;NCBP2;SMG1;EIF4E;NUP43;SEH1L;SEC13;NUP107;NUP42;THOC7;NUP98;SRSF9;GLE1;UPF1;SMG6;U2AF1L4;RAE1;SRSF1;UPF3B;RBM15B;DDX19A;NUP88;NUP214
prerank,branching involved in ureteric bud morphogenesis (GO:0001658),0.4909831831975709,1.2923717788469742,0.18085106382978725,0.5882328398808858,1.0,3/16,1.69%,BMP2;SALL1;GDNF
prerank,negative regulation of viral release from host cell (GO:1902187),-0.5151976500424824,-1.2921138558177865,0.169921875,0.46201258561470354,1.0,3/13,14.53%,MID2;TRIM28;TRIM5
prerank,phosphorylation (GO:0016310),-0.2738766536053748,-1.2913809246512318,0.011286681715575621,0.4630057517816596,1.0,105/384,18.84%,PRKCH;ERG;CDK6;MAP3K5;RPS6KA5;DGKH;PRKG1;CDK17;TGFBR2;MAP4K3;PTK2B;BMPR2;PEAK1;LIMK2;HIPK1;NLK;MAPK3;WNK1;STK10;BMX;NEK7;CAMK2D;HK1;MAP3K1;MAP3K20;FNIP2;TGFB1;APP;TGFB2;FAM20A;CSNK1G2;ADAM10;PRKCZ;CTBP1;IGFBP3;MINK1;TAOK3;NRBP1;IKBKB;RARA;PRKDC;BCR;SRPK1;TRIB2;STK25;PLK2;DYRK2;AKT1;INSR;MAP3K11;CDC42BPB;TRIB1;PIM3;LMTK2;WNT11;TOLLIP;CAMK1;CDK4;TAOK2;FRK;LIMD1;STK36;VRK1;STK38;GRK5;ACVR1;PKN3;YWHAZ;PRKCE;CDK10;PPP3CB;PNKP;SPHK2;SYK;FASTK;CDKL4;TBCK;NUAK1;CERKL;NUAK2;JAK2;ERBB2;PIK3CA;PRKAG1;COQ8A;LMTK3;LIMK1;NEK3;STK38L;STK26;CDK13;CSNK2A1;PGK1;MAP3K9;JAK3;HCK;DGKZ;RET;CHUK;POMK;MAP3K6;TXK;CHEK1;NADK;FAM20B
prerank,reticulophagy (GO:0061709),-0.5243300264847665,-1.291027674562959,0.17028985507246377,0.46317804153081216,1.0,5/12,19.01%,UFM1;DDRGK1;UFL1;UFC1;UBA5
prerank,muscle cell development (GO:0055001),0.4225636219163265,1.2904946607271222,0.12472160356347439,0.5915435853785366,1.0,6/30,3.63%,IGF1;SGCZ;SLC8A1;EFEMP2;ANK2;MEGF10
prerank,type I interferon signaling pathway (GO:0060337),-0.38115941667798264,-1.2903866948139544,0.1198501872659176,0.46346033326658737,1.0,24/41,39.84%,ADAR;IFITM1;IFITM3;IFITM2;IFNAR1;IFIT1;SAMHD1;IRF9;OAS2;STAT1;IRF8;RSAD2;PSMB8;EGR1;IP6K2;ISG20;IRF6;XAF1;IRF3;IFNAR2;IRF2;TYK2;OAS3;IRF5
prerank,cellular response to type I interferon (GO:0071357),-0.38115941667798264,-1.2903866948139544,0.1198501872659176,0.46346033326658737,1.0,24/41,39.84%,ADAR;IFITM1;IFITM3;IFITM2;IFNAR1;IFIT1;SAMHD1;IRF9;OAS2;STAT1;IRF8;RSAD2;PSMB8;EGR1;IP6K2;ISG20;IRF6;XAF1;IRF3;IFNAR2;IRF2;TYK2;OAS3;IRF5
prerank,regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),0.48579453254474464,1.2895431326761686,0.1552511415525114,0.5925653499049692,1.0,2/17,2.64%,BMP6;PRKCA
prerank,positive regulation of biosynthetic process (GO:0009891),0.3991411518985921,1.2892163754966115,0.11956521739130435,0.5918521730620587,1.0,6/40,3.98%,WNT4;ZBTB20;PPARA;SLC5A3;LARP6;CREB3L1
prerank,negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),-0.43558210554452825,-1.2892108758911505,0.13108614232209737,0.46557121885461294,1.0,8/26,15.84%,FOXP1;NCOR1;ZBTB7A;HEYL;KANK2;SMARCA4;VPS11;STRN3
prerank,cell junction assembly (GO:0034329),-0.32610732236120155,-1.2891648133245186,0.07172131147540983,0.46496200215592076,1.0,15/100,4.85%,FN1;PKP4;ACTB;SHANK3;DNM3;ITGA6;CLDN5;LIMS2;CDH1;SPOCK2;ACTG1;OPHN1;FERMT2;SDK1;LIMS1
prerank,positive regulation of chemokine production (GO:0032722),-0.37940809220311644,-1.2886224117525693,0.10760667903525047,0.46553241959323166,1.0,11/44,15.55%,APP;IL33;TLR3;TWIST1;TIRAP;CD74;MAVS;TLR4;SYK;CSF1R;IL17RA
prerank,regulation of protein localization to membrane (GO:1905475),0.4321661597694795,1.2883160083643055,0.16,0.592630275688365,1.0,8/28,10.07%,GPC6;AR;SLC5A3;GPC4;GPC2;PRKN;STX7;GPC5
prerank,"regulation of retrograde protein transport, ER to cytosol (GO:1904152)",-0.5122649579892946,-1.288233428355871,0.18198198198198198,0.46580624984632824,1.0,9/13,34.79%,SVIP;UBE2G2;BCAP31;DERL2;ERLEC1;EDEM2;BRSK2;EDEM1;OS9
prerank,positive regulation of cellular component organization (GO:0051130),-0.3219955869805862,-1.288156296041584,0.068762278978389,0.46527002417371827,1.0,32/107,12.88%,SHANK3;IGF1R;ATP10A;GPC3;NEDD4L;RACK1;TFRC;RPS3;DAB2IP;FNIP2;TGFB1;TGFB2;CD151;VEGFA;TGFB3;PLEKHM2;GPX1;BAX;INSR;TAL1;WARS1;ADD1;FLOT1;RB1;DCTN1;TIRAP;VCP;CAMK1;SURF4;APOE;BAK1;SYK
prerank,regulation of protein kinase C signaling (GO:0090036),0.5103670353844713,1.2879449428139236,0.1963882618510158,0.5920277270627028,1.0,3/14,4.33%,ADGRV1;DGKD;GPD1L
prerank,"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",-0.3464721084533964,-1.2876776781847414,0.08806262230919765,0.46576176122133744,1.0,23/72,22.81%,ACER2;RPL26;CRADD;CDKN1B;CNOT7;RGCC;PLK2;BAX;PLAGL1;PCBP4;RPS27L;E2F1;SOX4;CDKN1A;E2F4;GADD45A;SFN;CNOT11;E2F7;CNOT3;TRIAP1;PLK3;SESN2
prerank,positive regulation of neutrophil chemotaxis (GO:0090023),0.5010287780777439,1.2874574394006437,0.15604395604395604,0.5916689490483288,1.0,2/17,1.65%,CAMK1D;DAPK2
prerank,mitotic recombination (GO:0006312),0.4832842237282495,1.2867975395653268,0.18160919540229886,0.5917872943176111,1.0,6/15,18.37%,DMC1;GEN1;TEP1;SMC6;SMC5;NSMCE2
prerank,positive regulation of cell killing (GO:0031343),-0.5133400154012857,-1.2865672994215553,0.17221135029354206,0.46777292731912484,1.0,5/13,30.85%,RAC1;FZD7;SYK;NOX1;NOS2
prerank,negative regulation of protein localization to cell surface (GO:2000009),0.5409263642302057,1.2865629528318365,0.18863636363636363,0.5908285645115516,1.0,6/11,17.39%,LEPROT;SNX33;TAX1BP3;ACTN2;LEPROTL1;GOPC
prerank,negative regulation of receptor binding (GO:1900121),-0.555487012209835,-1.286049544156293,0.1773308957952468,0.46832114228874067,1.0,3/10,6.17%,B2M;ADAM15;ATP2A3
prerank,TOR signaling (GO:0031929),-0.427942246558175,-1.28578749409209,0.17105263157894737,0.4682088044184273,1.0,14/26,30.72%,RICTOR;PRR5L;AKT1;MAPKAP1;RPS6KB2;RPS6;EIF4EBP1;MEAK7;SMG1;CCDC88A;RPTOR;CARD11;RPS6KB1;RHEBL1
prerank,glutamate receptor signaling pathway (GO:0007215),0.39585233136481807,1.2856737713011086,0.13987473903966596,0.5916439727089852,1.0,14/37,18.62%,GRIA4;GRID2;GRIN3A;TRPM1;GRIK2;GRM1;GRIK1;CDK5R1;GRIA3;GRM4;GRIN2A;CLN3;GRIN2B;HOMER2
prerank,regulation of protein transport (GO:0051223),-0.4167444980600513,-1.2854721082274232,0.15456238361266295,0.4683275039065405,1.0,14/27,31.46%,HSPA8;WWP2;CHP1;PPM1F;DNAJA1;NDEL1;SNX3;PTPN1;RHBDF2;NDFIP2;P3H1;ATP13A2;NDFIP1;SNX12
prerank,regulation of cell division (GO:0051302),-0.34397234142788724,-1.2848476424214825,0.08829568788501027,0.46917787302595615,1.0,35/72,31.40%,MLLT3;FGF1;RACK1;RAB11A;CALM1;ZFYVE26;PLK2;TAL1;PRDM15;CIB1;CALM3;BCL2L1;RAB11FIP3;CETN2;KLHL9;KLHL21;PIN1;CDK2AP2;PRPF40A;SFN;KIF18B;TLE6;KIF13A;PLK3;PLK5;MYO19;SETD2;CSPP1;ENTR1;HTR2B;PLK1;MYC;DLL1;AURKA;PIK3R4
prerank,negative regulation of apoptotic signaling pathway (GO:2001234),0.3501092334679132,1.2847640214876048,0.10772357723577236,0.5925784607200011,1.0,13/77,7.96%,IGF1;TCF7L2;AR;BCL2;SH3RF1;PHIP;CFLAR;IL4;PRKN;GSTP1;SCG2;MAPK8IP2;TGFBR1
prerank,protein mannosylation (GO:0035268),0.43755178301160985,1.2843080408154621,0.1799163179916318,0.5922700168294426,1.0,9/22,19.50%,TMTC1;TMTC3;TMTC4;CRPPA;POMT2;DPY19L1;B4GAT1;DPM1;DPY19L4
prerank,regulation of leukocyte chemotaxis (GO:0002688),0.4702100428595888,1.2841504726788397,0.1729490022172949,0.5911594782750283,1.0,3/18,4.13%,CAMK1D;PTN;LYN
prerank,phosphatidylinositol 3-kinase signaling (GO:0014065),0.41818699186556535,1.2839895881896157,0.1652542372881356,0.5899724599588697,1.0,7/33,10.35%,IGF1;PIK3R1;MYO16;SIRT2;ERBB3;GATA3;PTEN
prerank,regulation of nitric oxide biosynthetic process (GO:0045428),-0.3845654905864915,-1.2839734856378555,0.1252302025782689,0.4705641103854176,1.0,13/38,16.67%,CAV1;CD34;KLF2;KLF4;HSP90AB1;RAC1;EDN1;AKT1;INSR;TLR4;JAK2;CX3CR1;HSP90AA1
prerank,anion transmembrane transport (GO:0098656),0.3576781849827661,1.283828352585801,0.10576923076923077,0.5888161672501502,1.0,11/67,7.31%,SLC1A3;SLC13A3;SLC6A9;SLC16A12;SLC7A2;SLC6A13;SLC13A4;MFSD12;SLC25A13;SLC25A42;SLC25A10
prerank,outflow tract septum morphogenesis (GO:0003148),0.44096467031257236,1.2837684321398213,0.15546218487394958,0.5874489331602654,1.0,4/24,1.11%,ROBO1;NRP1;ROBO2;FGFR2
prerank,negative regulation of calcineurin-NFAT signaling cascade (GO:0070885),0.5151280053534804,1.283728425342116,0.19221967963386727,0.584482680997751,1.0,2/12,4.89%,FHL2;ACTN3
prerank,negative regulation of calcineurin-mediated signaling (GO:0106057),0.5151280053534804,1.283728425342116,0.19221967963386727,0.584482680997751,1.0,2/12,4.89%,FHL2;ACTN3
prerank,negative regulation of neuron projection development (GO:0010977),0.36376694091104,1.2833500172455872,0.1315240083507307,0.584016566932354,1.0,14/56,12.61%,LPAR1;LRP4;SEMA3A;MCF2;RTN4;RAB29;DPYSL3;BCL11A;NLGN1;STX1B;DCC;PTEN;NGFR;CBFA2T2
prerank,vitamin D metabolic process (GO:0042359),0.5097610756099827,1.283345562023338,0.2,0.5824943028475993,1.0,2/13,1.77%,CYP27B1;VDR
prerank,"mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",-0.47492352544674665,-1.2830446853125952,0.16991150442477876,0.4721724910989375,1.0,11/17,34.05%,COX4I1;COX7C;COX6B1;COX15;COX6C;NDUFA4;COX10;COX8A;COX4I2;COX7A2L;COX5B
prerank,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),-0.3701272313208978,-1.2824002083159702,0.11871227364185111,0.473043933741467,1.0,26/50,30.92%,THBS1;MAP2K5;KLF4;RPS6KA3;NGF;CD44;VEGFA;GPX1;AKT1;BEX3;DHCR24;CSNK2A1;IGBP1;SFN;TRIAP1;CARD16;PLAUR;XIAP;YWHAE;PARK7;LAMTOR5;DNAJB6;SRC;RPS6KA1;PAK2;AQP1
prerank,glutathione biosynthetic process (GO:0006750),-0.5317975895335618,-1.2823258548856022,0.17540687160940324,0.47252528021015544,1.0,6/11,29.73%,GCLM;CNDP2;GCLC;GGT1;GGCT;MGST2
prerank,negative regulation of oxidative stress-induced neuron death (GO:1903204),-0.528448237063442,-1.2821873872327267,0.16666666666666666,0.47218092184254457,1.0,3/11,6.53%,RACK1;REST;ATF4
prerank,negative regulation of cytoskeleton organization (GO:0051494),-0.4097092043147382,-1.2820912250535041,0.13346228239845262,0.4717107419537936,1.0,8/29,8.84%,SHANK3;KANK3;CYRIB;SLIT2;KANK4;SSH2;HIP1R;PFN1
prerank,positive regulation of cellular metabolic process (GO:0031325),-0.32486292622581847,-1.281706334646106,0.08559498956158663,0.4719427642111599,1.0,27/98,17.44%,SLCO1C1;THBS1;TGFBR2;NFKBIA;PPARD;KLF4;TGFB1;RNF41;ANXA2;VEGFA;ACLY;CHCHD2;RIPK1;AKT1;INSR;IFNAR1;ACE2;INHBA;APOE;AGPAT1;FMR1;RAB1A;CDKN1A;NR1H2;GREM1;CBR1;NSF
prerank,transport across blood-brain barrier (GO:0150104),0.34242704333845936,1.2814074689344044,0.10638297872340426,0.5860733122703511,1.0,16/83,5.34%,SLC1A3;ATP1A2;SLC24A3;SLC13A3;SLC6A9;SLC16A12;LRP1;SLC7A2;SLC6A13;SLC2A13;SLC5A3;LEPR;ABCC2;SLC29A1;SLC22A3;SLC38A1
prerank,DNA replication initiation (GO:0006270),0.40632580689079995,1.2811007195444029,0.13814432989690723,0.5853777676879268,1.0,14/37,23.13%,MCM3;ORC4;RPA2;MCM2;MCM8;ORC1;POLE4;RPA1;ORC3;ORC5;CDC7;PRIM1;PRIM2;MCM7
prerank,regulation of cellular protein metabolic process (GO:0032268),-0.37333201178888614,-1.281086210430325,0.10609037328094302,0.4727625912936093,1.0,13/47,17.00%,NFKBIA;KLF4;RPL10;FOXO3;TGFB1;APP;EDN1;AKT1;INHBA;APOE;RBM4B;NR1H2;PCIF1
prerank,positive regulation of exosomal secretion (GO:1903543),-0.49488310846086025,-1.28091363673995,0.15328467153284672,0.4724973637295375,1.0,8/15,30.80%,RAB7A;SDCBP;TSG101;SNF8;CHMP2A;VPS4A;STAM;ATP13A2
prerank,cellular response to thyroid hormone stimulus (GO:0097067),-0.5214788305742992,-1.2803449385879644,0.17228464419475656,0.4731794634741765,1.0,5/12,25.75%,LMO2;CTSB;GAS2L1;CTSS;RDX
prerank,phospholipid biosynthetic process (GO:0008654),-0.3992146716424738,-1.2801216153292305,0.14048059149722736,0.473067172349428,1.0,13/36,27.46%,SGMS1;SGMS2;SPHK2;FAR1;MBOAT1;PCYT2;AGPAT5;NUS1;CPNE3;FDPS;DHDDS;IDI1;PIP5K1A
prerank,"mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",-0.5403590258599046,-1.2796875701868475,0.171875,0.473439668682377,1.0,11/11,46.01%,CYC1;UQCRQ;UQCRB;UQCR11;UQCRH;UQCC3;UQCRFS1;UQCRC1;UQCRC2;CYCS;UQCR10
prerank,Ras protein signal transduction (GO:0007265),-0.30831172617289365,-1.2789573293388041,0.061507936507936505,0.47458775060287367,1.0,43/137,16.94%,PLCE1;RREB1;RAP1A;RASGRP3;ARHGEF3;EPS8;RAP1B;RAPGEF1;SHOC2;EPS8L2;ARHGAP1;ARHGDIA;RAC1;SHTN1;RALB;ARHGDIB;SHC1;ADGRG1;KRAS;USP8;RIT1;RASSF1;GRAP;PLK2;TRIM28;RB1;GDI1;PHACTR4;RHOB;CFL1;RTKN;NF1;DBNL;FGF2;GNB1;HRAS;NTN1;CELSR1;LIMK1;RGL2;CDKN1A;NCKAP1;RAPGEF3
prerank,regulation of cell cycle (GO:0051726),-0.28493131278635137,-1.2788194186172932,0.032119914346895075,0.4742816792927532,1.0,81/271,21.50%,MECOM;PPP1R13B;CDK6;APBB2;AFAP1L2;THBS1;TTC28;NOTCH1;RACK1;JUND;CDC14A;IQGAP1;FAP;NEK7;DAB2IP;MAP3K20;HSP90AB1;CDKN1B;RPRD1B;TGFB1;TGFB2;RPL23;RPS15A;ADAM10;PKD1;CTBP1;RARA;GATA6;HCFC1;RGCC;RASSF1;PLAGL1;SIPA1;ASAH2;PIM3;RB1;JUNB;PHACTR4;RHOB;PES1;INHBA;MAEA;CDK4;CRLF3;GADD45G;GRK5;CDK10;CDC14B;RPS6KA2;HRAS;DHCR24;RNF20;SDCBP;GAS2L1;UHMK1;MADD;CDKN1A;CSNK2A1;CSNK2A2;LIN54;RBBP4;ANKRD17;FBXL3;TSC2;CDKN2C;L3MBTL1;MAPK12;CHEK1;CDK5RAP3;GADD45A;TTLL12;CCND1;SRA1;SOX9;TSPYL2;PTPRK;WDR12;FGF10;ZBTB49;TBRG4;PKD2
prerank,regulated exocytosis (GO:0045055),-0.298756825399107,-1.2784432424880876,0.05747126436781609,0.474428796348931,1.0,38/173,12.98%,FN1;VWF;ABCC4;PECAM1;TMSB4X;THBS1;SRGN;ACTN4;ARHGAP17;CYRIB;VEGFC;CALM1;VAMP7;TGFB1;APP;TGFB2;LHFPL2;FAM3C;CD109;RAB11FIP1;VEGFA;PSAP;STX1A;WDR1;ISLR;ACTN1;TGFB3;CD9;QSOX1;PDGFA;PCDH7;VCL;RAB11B;VEGFD;PPP3CB;SYT2;CDC37L1;CYB5R1
prerank,mitotic G2 DNA damage checkpoint signaling (GO:0007095),-0.4038287477732889,-1.2783587480305028,0.1408199643493761,0.47392219637792443,1.0,20/32,34.13%,BRCC3;TAOK3;FOXN3;UIMC1;BABAM1;TAOK2;CDC14B;CDKN1A;FZR1;BABAM2;CHEK1;CDK5RAP3;DTL;MRNIP;TRIM39;MRE11;PLK1;CDK1;TICRR;CLSPN
prerank,ceramide catabolic process (GO:0046514),-0.5106529474952366,-1.277736813622725,0.17495395948434622,0.4747400509763764,1.0,8/14,26.89%,ACER2;HEXA;ASAH2;ACER3;NEU3;NEU1;NEU2;NAGA
prerank,regulation of inflammatory response (GO:0050727),-0.290613315941728,-1.2775580534145308,0.04771784232365145,0.4744704336242126,1.0,49/190,20.25%,TEK;FOXP1;TMSB4X;SEMA7A;IL15;NFKBIA;PPARD;KLF4;CCN3;ETS1;ANXA1;MGLL;LPCAT3;APP;MFHAS1;PDE2A;IL1R1;IL33;GPR4;BRD4;TLR3;PSMA6;NFKBIZ;TNFRSF1B;RIPK1;BCL6;DHX9;RB1;ACE2;PIK3AP1;APOE;TLR4;TNFRSF1A;FEM1A;BCL6B;JAK2;NOD2;IL17RA;TNFAIP3;UFL1;RELA;HCK;NINJ1;DAGLB;PTGER4;CD200;METRNL;CASP1;GGT1
prerank,selective autophagy (GO:0061912),-0.35726538461610846,-1.2774822469959861,0.10420475319926874,0.4739593418474534,1.0,17/56,19.74%,VIM;MAP1LC3B;UBB;DYNC1LI2;UBC;RPS27A;UFM1;DDRGK1;RAB7A;KLHL3;PHB2;DYNC1LI1;UFL1;AMBRA1;UFC1;UBA5;DYNLL2
prerank,positive regulation of peptidase activity (GO:0010952),-0.4426621155355256,-1.2768393448711777,0.17647058823529413,0.4749061379339674,1.0,7/20,18.46%,NDUFA13;PSENEN;DDRGK1;VCP;APH1A;VSIR;MAPK12
prerank,regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),-0.3265441576732355,-1.2767952336308863,0.08253358925143954,0.47432640621918964,1.0,34/100,21.46%,CBFA2T3;RACK1;RNF144B;SMAD7;HSP90AB1;RPL11;GABARAP;SH3RF2;N4BP1;GIPC1;USP7;TRIB2;PABIR1;CAMLG;FOXF2;TRIB1;DDRGK1;VCP;USP5;BAG5;UBXN1;RBX1;SDCBP;HECTD1;UFL1;HSPA1A;CCAR2;RNF19A;ELOB;MAP1A;KEAP1;TRIB3;HSPA1B;TAF9
prerank,heart looping (GO:0001947),-0.3865318321257748,-1.2766612440306688,0.1436893203883495,0.4739647753189712,1.0,11/39,14.82%,MEF2C;NOTCH1;TGFBR2;SOX17;TBX2;SMO;MICAL2;SOX18;ZIC3;ENG;SRF
prerank,regulation of cAMP-dependent protein kinase activity (GO:2000479),-0.49375370571720234,-1.276414879064477,0.16635514018691588,0.4739242332739731,1.0,7/14,33.13%,HTT;PRKAR2B;PRKAR2A;RAPGEF2;PKIG;PKIB;ADRB2
prerank,mitochondrial fusion (GO:0008053),-0.4660466810273438,-1.2761246679214853,0.16789667896678967,0.4739299335945365,1.0,12/18,41.33%,MIEF1;BAX;CHCHD3;MIEF2;OPA1;FIS1;MFF;THG1L;MIGA1;STOML2;GDAP1;MFN1
prerank,glycoprotein biosynthetic process (GO:0009101),0.3447408655945377,1.2760482928169319,0.11538461538461539,0.5972442691044053,1.0,12/79,5.53%,IGF1;B3GALT1;CHST8;GAL3ST3;GAL3ST2;B3GALNT1;ST6GALNAC1;ST3GAL5;B3GNT7;ST8SIA1;ALG5;FUT4
prerank,pulmonary valve development (GO:0003177),-0.4650880229945605,-1.275892137143856,0.1621129326047359,0.47381059978579426,1.0,12/18,14.51%,NOS3;NOTCH1;BMPR2;SLIT2;TGFB2;STRA6;HEYL;SMAD6;TNFRSF1B;NFATC1;TNFRSF1A;HEY1
prerank,regulation of cytokine production involved in inflammatory response (GO:1900015),0.39380035267459756,1.2748941510722305,0.1530398322851153,0.5987964861003419,1.0,4/37,6.04%,ADCY7;PPARA;TICAM1;ABCD2
prerank,cellular response to tumor necrosis factor (GO:0071356),-0.2969124992213569,-1.2745532726873732,0.048582995951417005,0.47645775842101995,1.0,57/175,24.36%,TMSB4X;PTK2B;ACTN4;NFKBIA;TNFRSF11B;FOXO3;RPS3;DAB2IP;CARD14;LIMS1;IKBKB;TNFRSF21;PSMA6;TNFRSF1B;RIPK1;NPNT;YBX3;TNFRSF11A;PSMB5;AKT1;CCL15;DHX9;PSMC4;PSMC5;CIB1;PSMD14;COMMD7;EDA2R;TRAF1;TNFRSF1A;AIM2;JAK2;PSMD8;TNFSF13;PSMD11;STAT1;PSMB4;PSMD12;PSMC1;RELA;CHUK;ARHGEF2;HAS2;LTBR;PSMA1;ADAMTS7;PSMB1;PSMC3;TXNDC17;PSMA4;TNFSF13B;PSMA2;HYAL1;TNFRSF9;TNFRSF12A;TRAF6;CCL2
prerank,regulation of MAPK cascade (GO:0043408),0.30859321525926875,1.2744900333855038,0.07068607068607069,0.5983308993817614,1.0,26/157,9.40%,IGF1;EPHA7;TGFBR3;NRK;BMP2;KSR1;LPAR1;NTRK3;FGFR2;PELI2;KIT;ROCK2;RIT2;WWC1;LYN;GSTP1;IAPP;EPHB1;RRAS;TNIK;THPO;SOX2;IGF2;RYK;EPHA8;MYDGF
prerank,protein modification process (GO:0036211),-0.3342851160492369,-1.2734119980722054,0.08481262327416174,0.4786462524617465,1.0,23/76,19.46%,ST3GAL6;ST8SIA4;MANBA;PLOD2;WWP2;PRKDC;MSRA;CSNK1G3;UBE2L6;CPE;ATG3;ABL2;STK38;MMP15;ICMT;FBXL2;LOX;YES1;PHEX;MCRS1;FBXW2;UBL5;LCMT1
prerank,regulation of cell differentiation (GO:0045595),-0.30127670643381294,-1.2733561220513492,0.05443548387096774,0.4781161133450864,1.0,39/148,16.55%,SLC6A6;CDK6;SMOC1;SPOCK2;DDX5;LTBP4;KLF4;PTK2;TBX1;RPS6KA3;SMAD7;NGF;HSP90AB1;DDX17;SIX1;TGFB1;REST;PPP2R1A;UQCC2;NOTCH4;ATF4;CBFB;PHLDB1;BCL6;MCRIP1;EMP2;CAMK1;NF1;OCIAD1;ZFHX2;BCL6B;HEY1;SRF;FLOT2;YWHAG;ZFHX3;GREM1;YWHAH;PDCD2
prerank,monocyte chemotaxis (GO:0002548),-0.4008775581301919,-1.2732177912115936,0.137546468401487,0.4777984779052189,1.0,5/32,8.72%,FLT1;ANXA1;RPS19;TNFRSF11A;CCL15
prerank,potassium ion transmembrane transport (GO:0071805),0.31746881163591556,1.2730670702624145,0.08617234468937876,0.6004570801782857,1.0,32/135,17.85%,SLC1A3;KCNK2;KCNT2;ATP1A2;NALCN;SLC24A3;ABCB8;CCDC51;KCND2;SLC9A7;KCNJ16;KCNJ3;KCND1;SLC24A4;SLC24A2;KCNJ5;KCNJ14;KCNK10;ATP1A3;SLC12A3;KCNH7;ATP1B3;KCNQ4;KCNS3;KCNJ6;KCNS1;KCNG2;KCNC2;KCNN1;KCNJ9;KCNG4;KCNH5
prerank,glucose import (GO:0046323),-0.5119136968304375,-1.27301144193673,0.17938931297709923,0.477594442194928,1.0,6/13,28.36%,SLC2A1;RAB4B;SLC2A3;SLC2A4;SLC2A10;SLC27A1
prerank,positive regulation of brown fat cell differentiation (GO:0090336),-0.5037304563424996,-1.2728677622312483,0.19694072657743786,0.47730944409006276,1.0,3/13,5.34%,RREB1;SIX1;SOX13
prerank,positive regulation of mitotic cell cycle phase transition (GO:1901992),-0.35937659913562964,-1.2726551490951015,0.12380952380952381,0.47712134341259077,1.0,25/56,25.75%,CCND3;RAB11A;ANXA1;BRD4;RGCC;ANAPC11;AKT1;RB1;LSM11;CDK4;RCC2;PHB2;EGFR;ANAPC7;CDC27;ANKRD17;CCND1;FGF10;EIF4G1;LSM10;DTL;HYAL1;AIF1;RPTOR;RDX
prerank,ERBB2 signaling pathway (GO:0038128),0.4158648945778743,1.2724036344171248,0.17162471395881007,0.6007622794166058,1.0,7/31,9.82%,PIK3R1;NRG1;PRKCA;NRG4;NRG2;ERBB3;ERBB4
prerank,regulation of keratinocyte differentiation (GO:0045616),0.4427179052879251,1.2722689004951921,0.16842105263157894,0.5995760755221611,1.0,4/24,2.62%,ERRFI1;CYP27B1;VDR;ROCK2
prerank,actin filament network formation (GO:0051639),-0.5255297689111622,-1.2721176950293143,0.17889087656529518,0.47768022691622014,1.0,3/11,6.60%,COBL;PLS3;ACTN1
prerank,response to steroid hormone (GO:0048545),-0.4174008344260754,-1.2720469570511281,0.14340344168260039,0.4771770894541765,1.0,10/31,12.63%,ABHD2;CAV1;THBS1;ATP1A1;TGFB1;TGFB2;TGFB3;NR3C1;WBP2;ABCA2
prerank,regulation of protein catabolic process (GO:0042176),-0.32180418978047776,-1.2715947155983753,0.09533073929961089,0.47762403707316403,1.0,29/99,19.76%,WWP1;GPC3;EEF1A1;NEDD4L;FOXO1;DAB2IP;CDKN1B;RNF41;WWP2;EGLN2;IDE;PLK2;NDUFA13;ATG7;VCP;RAB7A;OAZ2;ITCH;SMURF1;EGFR;SNF8;TNFAIP3;CSNK2A1;FZR1;NSF;AGAP2;GFAP;PIN1;SNX3
prerank,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),0.48816965827239284,1.2713274943872253,0.18421052631578946,0.6006613819428713,1.0,4/16,2.65%,ATP1A2;SLC8A1;ANK2;PRKACA
prerank,fatty acid derivative biosynthetic process (GO:1901570),0.41298442615701136,1.2712687472166253,0.1590909090909091,0.5992785876512859,1.0,6/35,6.78%,ACSS3;HMGCLL1;PAM;ALOX12;GGT7;SCD5
prerank,positive regulation of interleukin-17 production (GO:0032740),-0.436144497053785,-1.2709440650384385,0.1678082191780822,0.47860733950699186,1.0,3/22,4.03%,IL15;SLC7A5;TGFB1
prerank,negative regulation of myeloid cell differentiation (GO:0045638),-0.45989844403664254,-1.270896737310275,0.15384615384615385,0.4780338754749059,1.0,6/20,18.22%,CDK6;PTK2B;ZBTB16;CIB1;LDB1;HSPA9
prerank,positive regulation of neutrophil migration (GO:1902624),0.48950903372172216,1.2705595158162102,0.17920353982300885,0.5996923272637197,1.0,2/18,1.65%,CAMK1D;DAPK2
prerank,embryonic skeletal system morphogenesis (GO:0048704),0.4050971288156865,1.270004005607193,0.14012738853503184,0.5995812298791442,1.0,8/31,11.03%,FGFR2;HOXC4;PDGFRA;HOXB3;HOXC9;TGFBR1;HOXB9;FUZ
prerank,early endosome to late endosome transport (GO:0045022),-0.4470945104381,-1.2692548297258681,0.19029850746268656,0.4815199379026164,1.0,6/20,15.29%,EEA1;EMP2;LMTK2;KIF16B;RAB7A;SNF8
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),-0.3321705817782218,-1.2691280133401706,0.10810810810810811,0.48117295684107747,1.0,26/80,17.57%,MAP3K5;THBS1;NOD1;MAP2K5;ARL6IP5;KLF4;RPS6KA3;NGF;CD44;REST;TNFSF10;VEGFA;PPM1F;GPX1;AKT1;NDUFA13;CTSD;SOX7;BEX3;SYK;DHCR24;BCAP31;CSNK2A1;IGBP1;BAD;FOXL2
prerank,"positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",-0.5143889902510239,-1.2688918798270377,0.1918819188191882,0.4810362814248457,1.0,8/12,35.15%,DKC1;CCT2;CCT3;CCT8;CCT7;WRAP53;CCT4;CCT6A
prerank,positive regulation of protein phosphorylation (GO:0001934),-0.27304318609069134,-1.2688362209689197,0.008602150537634409,0.4804819228282235,1.0,84/348,15.87%,TEK;PECAM1;CAV1;SLCO3A1;RAP1A;RPS6KA5;PTPRJ;CCND3;PLCG2;IL15;FGF1;RACK1;PTK2B;LIMCH1;BMPR2;LIMK2;KDR;MAPK3;IQGAP1;TFRC;PTK2;NIBAN1;TBX1;VEGFC;CSPG4;CARD14;NGF;CD44;HSP90AB1;CALM1;FNIP2;TGFB1;APP;TGFB2;FAM20A;RAC1;PPIA;RALB;CD81;VEGFA;PDE8A;TGFB3;RASSF2;RIPK1;KRAS;FLT4;AKT1;INSR;PDGFC;PDGFA;FLOT1;FAS;CSNK2B;DDRGK1;LRP8;CD74;CAMK1;INHBA;TAOK2;CIB1;VEGFD;MTCP1;CALM3;ACVR1;MAVS;FGF2;FMR1;CSF1R;ENG;PIK3R3;HRAS;INHBB;JAK2;SDCBP;EGFR;LCP2;MMD;ERBB2;PRKAG1;SMAD4;CAB39;BCAR3;CX3CR1;CDKN1A
prerank,regulation of ATP metabolic process (GO:1903578),-0.3544742086573237,-1.2686721010837487,0.12878787878787878,0.4802358089920779,1.0,23/54,27.54%,ZBTB7A;UQCC2;NUP93;NDC1;NUP54;SPHK2;NUP188;NUP155;RANBP2;PRKAG1;ATP5IF1;NUP37;JMJD8;SLC25A33;FIS1;NUP160;PGAM1;NUP43;SEH1L;SEC13;NUP107;NUP42;NUP98
prerank,mesenchymal cell differentiation (GO:0048762),0.3684218039622741,1.2678305327924415,0.1568627450980392,0.6038942307450341,1.0,11/51,8.08%,TGFBR3;WNT4;BMP2;FGFR2;ROCK2;RANBP3L;TGFBR3L;LOXL2;LOXL3;TGFBR1;RBPJ
prerank,negative regulation of blood vessel morphogenesis (GO:2000181),-0.3395454457574288,-1.2677239442087067,0.11259541984732824,0.481917722892944,1.0,17/75,10.11%,TEK;CLDN5;SEMA6A;THBS1;KLF4;COL4A2;DAB2IP;NPR1;TGFB2;STAB1;SARS1;PTPRM;AMOT;RGCC;NAXE;HHEX;ISM1
prerank,regulation of Rac protein signal transduction (GO:0035020),0.4903956931754581,1.2669559098318575,0.18831168831168832,0.6046991094424596,1.0,2/16,6.54%,AUTS2;ARHGAP24
prerank,positive regulation of T cell mediated immunity (GO:0002711),-0.43671024962384025,-1.2665588256068008,0.14842300556586271,0.48396640310568523,1.0,4/22,10.02%,B2M;CD55;CYRIB;HSPD1
prerank,mRNA transport (GO:0051028),-0.31561559840199405,-1.2665492881240232,0.09664694280078895,0.48331511032820257,1.0,49/101,34.81%,HNRNPA2B1;SRSF2;SRSF5;NUP93;SRSF6;NDC1;HHEX;NUP54;U2AF1;ZC3H11A;RNPS1;NUP188;FMR1;SRSF4;MAGOH;NUP155;RANBP2;CHTOP;ALYREF;AGFG1;NUP37;DDX39B;SMG7;CASC3;THOC6;CPSF4;NUP160;DDX39A;NCBP2;SMG1;EIF4E;NUP43;SEH1L;SEC13;NUP107;NUP42;THOC7;NUP98;SRSF9;GLE1;UPF1;SMG6;U2AF1L4;RAE1;SRSF1;UPF3B;RBM15B;NUP88;NUP214
prerank,blood vessel morphogenesis (GO:0048514),0.37249953601191726,1.2664040809915964,0.13793103448275862,0.6046605955945484,1.0,10/54,8.08%,CCBE1;LAMA1;TGFBR3;NRP1;TNNI3;TGFBR3L;GLMN;ADM;TGFBR1;RBPJ
prerank,positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),0.5159989231863104,1.266161128088324,0.2163355408388521,0.6037450782200134,1.0,2/12,1.22%,PIK3R1;BCL2L11
prerank,positive regulation of toll-like receptor 4 signaling pathway (GO:0034145),-0.5483492480603547,-1.2659536110408458,0.18579234972677597,0.4840404159474428,1.0,4/10,22.08%,LBP;TIRAP;NINJ1;PTPN22
prerank,histone H2A ubiquitination (GO:0033522),0.4762191060000478,1.2658204081812086,0.2086021505376344,0.6032013555418506,1.0,3/17,5.22%,BCOR;DDB2;RNF2
prerank,regulation of tube diameter (GO:0035296),-0.5023902504738907,-1.265287853716284,0.17744916820702403,0.4843321582795632,1.0,7/13,22.67%,NOS3;NPR1;ACE2;ACE;GCLM;GCLC;SCPEP1
prerank,vascular process in circulatory system (GO:0003018),-0.5023902504738907,-1.265287853716284,0.17744916820702403,0.4843321582795632,1.0,7/13,22.67%,NOS3;NPR1;ACE2;ACE;GCLM;GCLC;SCPEP1
prerank,embryonic digit morphogenesis (GO:0042733),0.45662169293508015,1.2650502941696544,0.18834080717488788,0.603840844158426,1.0,3/18,3.86%,SALL1;TBX3;GLI3
prerank,positive regulation of macrophage chemotaxis (GO:0010759),-0.4851487171147402,-1.2647289590815007,0.18026565464895636,0.4850085013363295,1.0,4/14,4.89%,THBS1;MAPK3;PTK2;CMKLR1
prerank,protein localization to mitochondrion (GO:0070585),-0.5203686443405131,-1.264323981749285,0.18716577540106952,0.48529394166365347,1.0,3/11,8.98%,HK1;AKT1;DNAJA1
prerank,response to histamine (GO:0034776),0.5307454958817189,1.2633348828301392,0.21158129175946547,0.606953336369171,1.0,7/10,25.55%,GABRB3;HRH1;DRD2;GABRB1;GABRG2;GABRB2;DRD3
prerank,intraciliary transport involved in cilium assembly (GO:0035735),0.39502970218549455,1.263086151259055,0.1575492341356674,0.6060641345321875,1.0,11/37,12.33%,IFT81;DYNLL1;DYNC2I2;DYNC2H1;IFT122;DYNC2LI1;IFT140;IFT74;KIF3C;KIF3A;IFT43
prerank,positive regulation of cell morphogenesis involved in differentiation (GO:0010770),-0.3671116632270447,-1.2629466339258002,0.1301775147928994,0.4882329695786696,1.0,13/48,11.58%,LIMS2;RREB1;DOCK1;FERMT2;RAC1;LIMS1;NEDD9;CRK;MYOC;PRKDC;S100A10;CAPRIN1;CIB1
prerank,protein O-linked mannosylation (GO:0035269),0.451480668542963,1.262842431713897,0.19254658385093168,0.6051710356437547,1.0,7/18,17.57%,TMTC1;TMTC3;TMTC4;CRPPA;POMT2;B4GAT1;DPM1
prerank,interleukin-35-mediated signaling pathway (GO:0070757),-0.5240733535612311,-1.262762537288226,0.1906474820143885,0.4880286160913077,1.0,8/11,37.52%,JAK2;STAT1;IL6ST;IL12RB2;STAT4;IL27RA;CANX;IL12A
prerank,ciliary basal body-plasma membrane docking (GO:0097711),-0.3226586137026636,-1.262503498803299,0.10231660231660232,0.4879892794003646,1.0,26/94,16.82%,RAB11A;DCTN2;TUBA1A;CEP164;PPP2R1A;PRKAR2B;CEP192;CEP57;CEP162;CEP70;DCTN3;CEP290;CNTRL;DCTN1;PCM1;TUBB4B;CC2D2A;HAUS1;NDE1;CETN2;CEP72;KIF24;YWHAG;HSP90AA1;CEP41;TMEM67
prerank,aminoglycan biosynthetic process (GO:0006023),0.36906398189243034,1.2622614174900821,0.12747252747252746,0.6052729406885945,1.0,18/49,18.11%,GPC6;B3GALT1;B3GALNT1;GPC4;GPC2;B3GNT7;PXYLP1;GPC5;B3GALT2;HS2ST1;HS6ST2;B3GALT5;HS3ST6;HS3ST5;HSPG2;B4GAT1;B3GNT6;B4GALT7
prerank,B cell differentiation (GO:0030183),-0.3788095975577407,-1.2620617050937677,0.11275415896487985,0.48839219388273514,1.0,23/46,33.98%,PTPRJ;PLCG2;TPD52;ZBTB7A;HDAC9;IRF2BP2;HDAC4;HHEX;CLCF1;ITGA4;TCF3;KLF6;JAK3;ADGRG3;DCAF1;NFAM1;HDAC5;PTPN2;SYVN1;LYL1;BLNK;CR2;MS4A1
prerank,cGMP biosynthetic process (GO:0006182),-0.5434519758603195,-1.2617491667472636,0.17857142857142858,0.4884786164078172,1.0,4/10,15.32%,NPR1;GUCY1B1;GUCY1A1;GUCY2C
prerank,negative regulation of type I interferon-mediated signaling pathway (GO:0060339),-0.47782725167505524,-1.2616260133173398,0.19548872180451127,0.4880845081117477,1.0,12/15,42.56%,NLRC5;CNOT7;YTHDF2;SAMHD1;TTLL12;PTPN2;MUL1;YTHDF3;USP18;OAS3;CACTIN;STAT2
prerank,positive regulation of membrane protein ectodomain proteolysis (GO:0051044),0.48674005869703607,1.261213867948761,0.19305856832971802,0.6064327651461363,1.0,4/15,14.07%,SH3D19;SNX33;SNX9;NRDC
prerank,cardiac muscle cell membrane repolarization (GO:0099622),-0.5309148546051208,-1.2610501317713556,0.2,0.48886933463363147,1.0,7/11,25.60%,KCNJ2;ATP1A1;KCNQ1;ATP1B1;KCND3;KCNIP2;YWHAE
prerank,positive regulation of protein-containing complex assembly (GO:0031334),-0.31053234702770366,-1.2608576723694005,0.08888888888888889,0.48870505135351944,1.0,30/113,14.34%,ESR1;RASIP1;RAP1B;RACK1;UNC13B;TFRC;PIEZO1;RPS3;GBP5;DAB2IP;FERMT2;FNIP2;TGFB1;VEGFA;ERCC1;CUL4A;BAX;TAL1;GTF2H3;WARS1;CHD1L;TIRAP;VCP;PSMC4;PSMC5;TLR4;BAK1;SYK;SLF1;RBX1
prerank,embryonic organ development (GO:0048568),0.35983113025429775,1.2602753217812037,0.14910536779324055,0.6075394469620242,1.0,15/61,9.35%,COL13A1;SALL1;FGFR2;GDNF;RARB;TEAD1;KIT;GLI2;GLI3;PBX4;IFT122;KMT2A;RBPJ;GATA3;BMPR1A
prerank,regulation of neurogenesis (GO:0050767),-0.3538080022836353,-1.260070076433933,0.13528336380255943,0.4900341927171529,1.0,13/55,15.81%,B2M;NOTCH1;TGM2;REST;BHLHE40;HEYL;FAIM;PRUNE1;YTHDF2;PCM1;HES1;HEY1;CX3CR1
prerank,positive regulation of amyloid-beta formation (GO:1902004),0.45179976373442415,1.259723989077789,0.21397379912663755,0.6075504416643933,1.0,5/18,11.12%,SLC2A13;ROCK2;LRRTM3;CASP3;CHRNA7
prerank,proteolysis involved in cellular protein catabolic process (GO:0051603),-0.33818895312168445,-1.2593854779087406,0.1095890410958904,0.49116706209534805,1.0,17/71,11.24%,FAP;CAPN2;RNF41;CTSZ;UBB;UBC;RPS27A;CTSO;RHBDD1;CTSC;CASP8;PSMA6;IDE;USP9X;CTSF;VCP;CTSB
prerank,protein localization to cell periphery (GO:1990778),-0.3082212790069899,-1.2592558484945204,0.08757637474541752,0.4907844833880552,1.0,48/133,21.37%,CAV1;BSG;RAP1A;CDH1;TSPAN5;SPTBN1;EFR3B;RAB11A;F11R;RAMP2;EHD4;KCNB1;RAB8B;PACS1;CD81;IKBKB;EZR;EHD2;JUP;ATP1B1;FLOT1;S100A10;EMP2;RAB8A;TSPAN14;FCHO2;CACNB3;SLMAP;TNFRSF1A;SMURF1;AP4M1;TMEM88;FLOT2;EPHA2;TSPAN17;PACSIN1;RABEP1;RAB40B;PIGW;PRAM1;RAMP1;EHD1;PLEKHF1;FYB2;EHD3;RAPGEF2;ZDHHC23;KCNB2
prerank,natural killer cell mediated immunity (GO:0002228),-0.4770101231590923,-1.259224217381104,0.17647058823529413,0.4901889802708811,1.0,4/15,19.41%,LYST;PLEKHM2;TUBB4B;ARL8B
prerank,response to ionizing radiation (GO:0010212),-0.34097275493919943,-1.2590262558786722,0.11583011583011583,0.48994759237268765,1.0,35/70,32.43%,NET1;ANXA1;BRCC3;EEF1D;UIMC1;RAD1;BABAM1;RHOB;MTA1;RAD9B;AEN;HUS1;RAD9A;CDKN1A;BABAM2;ECT2;GADD45A;BRAT1;IKBIP;CLOCK;RHNO1;COP1;MRNIP;DCUN1D3;SMPD1;FANCD2;RAD51AP1;LIG4;TNKS1BP1;RNF8;SWI5;MYC;INTS3;TICRR;FIGNL1
prerank,regulation of programmed cell death (GO:0043067),-0.296112604175152,-1.2589805899758364,0.05152671755725191,0.48939223366703677,1.0,39/161,16.67%,MECOM;PPP1R13B;ACER2;TPT1;TGM2;ACTN4;RPS3;ZBTB7A;CRADD;IGFBP3;TMEM219;ANP32A;ACTN1;DCPS;TOX3;RIPK1;BAX;AKT1;PERP;BCL6;KANK2;FAS;HIP1;VCP;LRP8;CTSB;RTKN;PSMC5;HTATIP2;ACER3;JAK2;BNIP3L;OSGIN1;MADD;PTPN6;STK26;LGALS1;STAT1;HSP90AA1
prerank,negative regulation of protein autophosphorylation (GO:0031953),0.5364910839705739,1.258774101110174,0.1943231441048035,0.6087146241741895,1.0,3/10,6.09%,ENPP1;ERRFI1;NLRP12
prerank,regulation of interleukin-10 production (GO:0032653),-0.36842570815197306,-1.2587443521385984,0.1297709923664122,0.48925369072860214,1.0,11/44,17.47%,CD34;PLCG2;PRKCZ;TNFRSF21;TRIB2;HSPD1;TLR4;SYK;NOD2;VSIR;JAK3
prerank,regulation of T cell receptor signaling pathway (GO:0050856),-0.40253925518755207,-1.2585826926088577,0.1596330275229358,0.48894776413831903,1.0,15/33,28.16%,PTPRJ;RPS3;CD81;EZR;RC3H1;DUSP3;NECTIN2;RELA;DGKZ;LAPTM5;PRKD2;PTPN22;BCL10;PTPN2;CARD11
prerank,regulation of cell development (GO:0060284),-0.39124011028461264,-1.2585818108866307,0.13059701492537312,0.48828743678996395,1.0,11/36,15.81%,FOXO1;HDAC9;BHLHE40;HEYL;RPS19;AKT1;PRUNE1;YTHDF2;HES1;HEY1;CX3CR1
prerank,blood vessel diameter maintenance (GO:0097746),-0.394473628830249,-1.2577606027385597,0.13944954128440368,0.48965050698381685,1.0,9/34,19.56%,EDNRA;NOS3;KLF2;NPR1;EDN1;ACE2;ACE;GCLM;GCLC
prerank,negative regulation of transmembrane transport (GO:0034763),-0.5363972636222409,-1.256876645919447,0.2109090909090909,0.4911491208010034,1.0,3/10,8.42%,CTTNBP2NL;THBS1;AKT1
prerank,nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),0.44507848501188185,1.2565595910597038,0.1825726141078838,0.6131667598817359,1.0,2/21,1.99%,SAMD4A;TUT4
prerank,negative regulation of epithelial cell apoptotic process (GO:1904036),0.4108761503574849,1.2549405247319805,0.1870824053452116,0.6160513675102728,1.0,8/33,9.13%,TCF7L2;SEMA5A;PPARA;PDPK1;IL4;SERPINE1;SCG2;GATA3
prerank,cellular response to drug (GO:0035690),-0.4202618534886374,-1.2549400834206357,0.14814814814814814,0.4952638993427224,1.0,7/25,8.70%,MEF2C;ACER2;TFRC;REST;KCNQ1;PPM1F;RBM22
prerank,regulation of integrin-mediated signaling pathway (GO:2001044),-0.49608024436623954,-1.2545770660855025,0.1929203539823009,0.4955088960866666,1.0,4/14,10.20%,LIMS2;LIMS1;EMP2;PHACTR4
prerank,regulation of RNA metabolic process (GO:0051252),-0.34944113648546726,-1.2543374420902638,0.13293650793650794,0.495440455369481,1.0,15/59,13.27%,AHNAK;NOVA2;AHNAK2;MBNL1;HNRNPLL;RBM20;PTBP3;ZNF326;TNFRSF1B;RC3H1;FUS;PCBP4;YTHDF2;CLK1;FASTK
prerank,negative regulation of programmed necrotic cell death (GO:0062099),-0.5130604718494612,-1.2542386866187865,0.2017857142857143,0.4950336848506239,1.0,7/11,29.30%,CASP8;RIPK1;YBX3;PELI1;ARHGEF2;SLC25A4;FZD9
prerank,positive regulation of hormone secretion (GO:0046887),-0.46351689969791576,-1.2536588132536612,0.19444444444444445,0.49583119064884923,1.0,14/17,51.99%,VAMP7;EDN1;SPP1;RASL10B;EDN3;C1QTNF3;HFE;VAMP8;TFR2;CYP19A1;HCAR2;NMB;SOX11;GRP
prerank,response to calcium ion (GO:0051592),-0.3179083455478475,-1.2532500328572012,0.07809523809523809,0.4961615809647905,1.0,21/102,14.41%,MEF2C;CAV1;ITPKB;CLIC4;THBS1;PLCG2;TRPC3;MEF2A;IQGAP1;CAMK2D;CALM1;ITPR3;CARF;CPNE8;ADD1;SLC25A12;CALM3;HOMER1;SYT2;PEF1;CASQ2
prerank,positive regulation of transport (GO:0051050),-0.3289237302106707,-1.25303745609404,0.09664694280078895,0.4960297993036054,1.0,23/85,15.09%,ACTB;GPC3;IL15;NEDD4L;ANXA1;RAB27A;ANXA2;CHP1;CD151;HIP1R;GATA2;BAX;PLAA;FLOT1;FCER1G;APOE;BAK1;FMR1;CAPN10;TUB;MLC1;LMAN2;CHCHD10
prerank,regulation of mesenchymal cell proliferation (GO:0010464),-0.5211981250140665,-1.25297532129976,0.2158273381294964,0.4955019811302819,1.0,7/11,19.37%,TGFBR2;LRP5;TBX1;PDGFA;CTNNBIP1;STAT1;SOX9
prerank,positive regulation of myeloid leukocyte mediated immunity (GO:0002888),0.516121652642886,1.2526539918446897,0.2412280701754386,0.620730841331842,1.0,3/11,5.13%,STAP1;TICAM1;CAMK4
prerank,regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),-0.37045297188750337,-1.2526395446116594,0.13513513513513514,0.49566488926805874,1.0,10/43,6.98%,DDX5;PPARD;KLF4;FOXO3;ETS1;TGFB1;REST;TGFB2;GATA2;NR3C1
prerank,posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),-0.5096199740903509,-1.251634853062164,0.19444444444444445,0.49750179479102247,1.0,8/12,32.17%,SEC63;HSPA5;SEC61B;SGTA;SGTB;SEC61A1;CHMP4B;CHMP4A
prerank,UV protection (GO:0009650),-0.5272122953959079,-1.2514175230404965,0.2036697247706422,0.4973552099631912,1.0,2/10,8.01%,SCARA3;GPX1
prerank,mesenchyme morphogenesis (GO:0072132),-0.45763680953611946,-1.2512033883792524,0.1941747572815534,0.49719227010666744,1.0,10/17,19.37%,NOS3;NOTCH1;TGFB2;TBX2;HEYL;ACVR1;ENG;HEY1;SMAD2;SOX9
prerank,pyrimidine nucleoside catabolic process (GO:0046135),-0.527271480990619,-1.2508395451709946,0.19715808170515098,0.49747520705920567,1.0,4/10,11.45%,NT5E;UPP2;NT5C;NT5C1A
prerank,regulation of membrane depolarization (GO:0003254),-0.4612073884050847,-1.2506709155717353,0.1864406779661017,0.49722144466695306,1.0,4/18,3.59%,NEDD4L;FHL1;CAMK2D;SMAD7
prerank,regulation of peptidyl-serine phosphorylation (GO:0033135),-0.3162336403562878,-1.2506173777340959,0.11089108910891089,0.49668784871730026,1.0,34/93,27.00%,CAV1;DMD;RACK1;TFRC;PDE4D;SMAD7;NGF;CD44;HSP90AB1;FNIP2;TGFB1;APP;VEGFA;RASSF2;PPM1F;AKT1;CAMK1;MTCP1;EGFR;BCAR3;HSP90AA1;RAPGEF3;DDIT4;NCK1;HCLS1;PRKD2;PDCD10;EIF4G1;DMTN;NCK2;RPTOR;PARK7;TXN;TNKS1BP1
prerank,glucan biosynthetic process (GO:0009250),-0.5137044379260923,-1.249953703444358,0.20218579234972678,0.49700859222674537,1.0,5/12,27.20%,GBE1;PGM1;PPP1R3C;PGM2;GYG1
prerank,glycogen biosynthetic process (GO:0005978),-0.5137044379260923,-1.249953703444358,0.20218579234972678,0.49700859222674537,1.0,5/12,27.20%,GBE1;PGM1;PPP1R3C;PGM2;GYG1
prerank,regulation of necroptotic process (GO:0060544),-0.4267818374356659,-1.2498040620154118,0.18,0.49673262322576867,1.0,10/23,18.57%,CASP8;RIPK1;YBX3;FLOT1;SDCBP;FLOT2;MLKL;HSP90AA1;PELI1;ARHGEF2
prerank,positive regulation of signal transduction by p53 class mediator (GO:1901798),-0.43929913619415123,-1.2493524408990042,0.18772563176895307,0.49720095008069315,1.0,12/22,30.15%,DDX5;RPS15;RPL23;UBB;RPS20;RPS7;CDK5RAP3;MSX1;SPRED3;PMAIP1;RPL37;SPRED1
prerank,regulation of cytokinesis (GO:0032465),-0.3258607511663734,-1.248895949819005,0.09856262833675565,0.4976364113336186,1.0,39/78,32.08%,PKP4;RAB11A;CDC14A;CALM1;GIPC1;ZFYVE26;PLK2;KIF23;CALM3;BCL2L1;PRKCE;CDC14B;RAB11FIP3;CETN2;KLHL9;ECT2;KLHL21;PIN1;PRPF40A;E2F7;KIF13A;PLK3;CDC42;CIT;VPS4A;PLK5;MYO19;SETD2;RACGAP1;CENPV;CSPP1;ENTR1;PLK1;AURKA;RHOA;PIK3R4;CDC6;E2F8;OPN1MW
prerank,positive regulation of establishment of protein localization to mitochondrion (GO:1903749),-0.3532529542387074,-1.248786933797504,0.1267056530214425,0.49726142300458026,1.0,25/52,28.98%,PPP1R13B;ABLIM3;PPP3CC;CASP8;SAE1;BBC3;YWHAZ;E2F1;VPS11;YWHAG;CSNK2A2;YWHAH;BAD;UBL5;SFN;FZD5;NPEPPS;MICALL2;YWHAB;YWHAE;UBE2J2;ATG13;NMT1;PMAIP1;YWHAQ
prerank,lymphocyte proliferation (GO:0046651),-0.4351229360033879,-1.2487608906087058,0.15722120658135283,0.4966620744214107,1.0,5/22,12.38%,MEF2C;CTPS1;MSN;HSPD1;PPP3CB
prerank,regulation of mononuclear cell migration (GO:0071675),-0.4291584166957818,-1.248744750112313,0.17567567567567569,0.4960522962628652,1.0,7/23,4.89%,THBS1;MAPK3;PTK2;STK10;SLIT2;MSN;CMKLR1
prerank,negative regulation of DNA metabolic process (GO:0051053),-0.42720426169918974,-1.2486284332782371,0.17077464788732394,0.4957033340059935,1.0,4/24,7.84%,DACH1;BMPR2;RPS3;ERCC1
prerank,phosphatidylserine metabolic process (GO:0006658),0.4080104058366438,1.2483657974574556,0.17436974789915966,0.6308702289764827,1.0,4/32,3.10%,PLA2G5;OSBPL10;PLA2G4A;OSBPL8
prerank,regulation of phosphatidylinositol 3-kinase activity (GO:0043551),-0.39286177254263993,-1.2482565640351797,0.17100371747211895,0.4959403800172492,1.0,13/34,16.64%,TEK;FLT1;PTK2B;PTK2;DAB2IP;TNFAIP8L3;TGFB1;PIK3IP1;FGF2;PIK3R3;NOD2;PIK3R2;AMBRA1
prerank,mitotic sister chromatid cohesion (GO:0007064),-0.46425144929844686,-1.2477748330406073,0.19600725952813067,0.49653995763459874,1.0,9/16,28.86%,RB1;POGZ;BOD1;RAD21;NIPBL;REC8;SGO1;DSCC1;NAA50
prerank,regulation of protein ubiquitination (GO:0031396),-0.31211837112055413,-1.247741179105552,0.08812260536398467,0.4959797905852331,1.0,31/108,19.57%,CAV1;NXN;RPS3;SMAD7;HSP90AB1;FKBP1A;IVNS1ABP;UBB;CHP1;SH3RF2;N4BP1;DCUN1D1;FBXO4;AKT1;DNAJA1;CAMLG;FOXF2;FAM107A;PTTG1IP;BAG5;UBXN1;SOX4;SPRTN;PRMT3;TNFAIP3;UFL1;HSP90AA1;HSPA1A;CDK5RAP3;USP4;LAPTM5
prerank,axonal transport of mitochondrion (GO:0019896),-0.5320088598268602,-1.2475564956101917,0.19152854511970535,0.4957847791538379,1.0,4/11,16.25%,TRAK1;NEFL;TRAK2;OPA1
prerank,negative regulation of ossification (GO:0030279),0.42671897352742155,1.2474616206097364,0.1891891891891892,0.6317489709095836,1.0,5/23,4.24%,ENPP1;BCOR;AHSG;LRP4;SFRP1
prerank,leukocyte tethering or rolling (GO:0050901),-0.46353544223889337,-1.2468326394648817,0.18702290076335878,0.49694937853986393,1.0,11/17,43.59%,JAM2;ITGA4;CX3CR1;GOLPH3;SELP;ITGB7;ADD2;ROCK1;TNF;GCNT1;SELE
prerank,nonribosomal peptide biosynthetic process (GO:0019184),-0.5013899274326663,-1.2466472709990946,0.20634920634920634,0.49674915341836096,1.0,7/12,34.16%,GCLM;CNDP2;GCLC;GGT1;GGCT;MGST2;BDH2
prerank,extracellular transport (GO:0006858),-0.5060097932337164,-1.2466304670346984,0.21495327102803738,0.4961455975277004,1.0,8/12,27.29%,WWP2;ARRDC1;TSG101;CABYR;ROPN1L;ADCY10;SPAG17;SPA17
prerank,regulation of megakaryocyte differentiation (GO:0045652),-0.3623937034964986,-1.2465456941557254,0.14933837429111532,0.4956859579989265,1.0,10/49,11.58%,MEF2C;THBS1;TNRC6C;KMT2C;RBBP5;CBFB;MYL9;H3-3A;KMT2D;CIB1
prerank,alpha-amino acid metabolic process (GO:1901605),0.3737040698233723,1.2465101068369544,0.14775160599571735,0.6329005217046664,1.0,19/45,23.75%,ASPA;ALDH18A1;SLC25A13;KMO;GLUL;GLS2;FOLH1;MTHFD1;ASS1;DDAH2;ASPG;NOX4;GPT2;GOT1;GOT2;MMUT;KYAT1;CBS;MTHFR
prerank,negative regulation of protein transport (GO:0051224),-0.4116262214445263,-1.2463138272567684,0.1651376146788991,0.49563475653252687,1.0,12/25,31.77%,WWP2;PPM1F;DPH3;APOE;RSAD2;SNX3;CSK;RHBDF2;NDFIP2;NDFIP1;SNX12;HMGCR
prerank,hyaluronan metabolic process (GO:0030212),0.4371188984597592,1.2462626971188022,0.18683651804670912,0.6321178703693375,1.0,3/23,1.32%,CEMIP;SPAM1;HYAL3
prerank,positive regulation of cellular process (GO:0048522),-0.25719523027218066,-1.2458359746533518,0.015086206896551725,0.49623591923855387,1.0,122/565,15.77%,FN1;KITLG;LEF1;CAV1;SLC6A6;FLT1;FRMD5;IGF1R;CLDN5;ACER2;LBP;THBS1;PTPRJ;NOTCH1;PARD3;IL15;DPP4;NAMPT;TRPC3;FGF1;TGFBR2;LRP5;PTK2B;TGM2;LIFR;ACTN4;KDR;STX3;PTK2;TBX1;TBC1D8;RPS4X;RPS9;RPS6KA3;VEGFC;ETS1;HSP90AB1;CDKN1B;RPRD1B;TGFB1;CNBP;TGFB2;RAB27A;TBX2;RPL23;RAC1;RPS15A;DNAJA2;ADAM10;CD81;RPS19;VEGFA;CNOT7;S100B;AQP11;ACLY;RARA;SHC1;GATA2;MFSD2A;TGFB3;HCFC1;TNFRSF1B;ADGRG1;KRAS;EDN1;FLT4;S1PR3;TNFRSF11A;HDAC4;PABIR1;MMP14;AKT1;INSR;FZD7;TAL1;NOP2;PDGFC;PDGFA;LAMC2;FLOT1;EMP2;FCER1G;DDRGK1;H3-3A;CDK4;KMT2D;S100A13;AKAP6;CIB1;VEGFD;FAM98A;GRK5;TLR4;SOX4;FXN;FGF2;HES1;RPS6;ACER3;AGPAT1;FMR1;CSF1R;CAPN10;HRAS;TUB;CDKN2AIP;MLC1;SDCBP;RAD18;EGFR;CHTOP;LMAN2;SRF;ERBB2;GAB2;CLCF1;TNFSF13;PTPN6;ZFHX3;NSMCE4A;CDK13
prerank,phosphatidylinositol-mediated signaling (GO:0048015),0.3452171319854572,1.2457786682528036,0.15267175572519084,0.6318421241197671,1.0,14/69,11.08%,IGF1;PIK3R1;PLCL1;PDGFRA;MYO16;IRS2;PLCL2;PDGFRB;SIRT2;PLCH1;ERBB3;GATA3;PTEN;PLCD4
prerank,T cell differentiation in thymus (GO:0033077),0.48466503061990784,1.2455855976273793,0.22871046228710462,0.6308348741807772,1.0,6/14,22.29%,GLI3;CCR6;FADD;RABL3;SHH;ZFP36L2
prerank,striated muscle tissue development (GO:0014706),-0.40063696268405236,-1.2449099245080202,0.16029143897996356,0.4978635710893218,1.0,8/29,4.68%,MEF2C;CAV1;PGM5;MYL6;BMPR2;SIX1;TBX2;NDUFV2
prerank,V(D)J recombination (GO:0033151),-0.5114142406400815,-1.243746821331794,0.1969178082191781,0.49999743022991994,1.0,5/11,28.60%,PRKDC;TCF3;DCAF1;LIG4;HMGB2
prerank,ventricular septum development (GO:0003281),0.3911542831495953,1.2433155883072895,0.1711340206185567,0.6354266545852525,1.0,4/37,0.61%,ROBO1;TGFBR3;ROBO2;SALL1
prerank,response to organophosphorus (GO:0046683),-0.46191620948195405,-1.2431863491248438,0.21818181818181817,0.5006466309485728,1.0,7/16,23.08%,TRPC3;ABCC9;TRIM16;NDUFS4;STAT1;TYMS;RFC3
prerank,endothelial cell differentiation (GO:0045446),-0.5039055183917847,-1.243115026930396,0.1916376306620209,0.5001906334024929,1.0,5/12,12.73%,TIE1;BMPR2;KDR;SOX18;FSTL1
prerank,cardiac left ventricle morphogenesis (GO:0003214),-0.49872458829186295,-1.242928963069639,0.21100917431192662,0.5000311732463382,1.0,4/13,15.00%,NOTCH1;TGFBR2;CPE;SMAD4
prerank,positive regulation of apoptotic signaling pathway (GO:2001235),-0.3543608682781892,-1.2425171198393168,0.12619502868068833,0.5004620944879392,1.0,13/55,12.16%,CAV1;RACK1;RPS3;TPD52L1;DAB2IP;CRADD;TNFSF10;ING5;RIPK1;BAX;FAS;BBC3;BCL2L1
prerank,negative regulation of catalytic activity (GO:0043086),-0.42343399200572795,-1.242251155395802,0.1774193548387097,0.5005020318067513,1.0,7/24,17.61%,NOTCH1;NES;IFIT1;ATP5IF1;APBA3;CCAR2;NOSIP
prerank,negative regulation of cardiac muscle hypertrophy (GO:0010614),-0.5128722583551367,-1.241862217214548,0.20695970695970695,0.5007292375801174,1.0,2/11,2.58%,NOTCH1;FOXO1
prerank,regulation of extracellular matrix organization (GO:1903053),0.4789446059206027,1.241843603290505,0.2017738359201774,0.6379364146860499,1.0,6/15,8.80%,DDR2;LRP1;EFEMP2;DDR1;AEBP1;FGFR4
prerank,heparan sulfate proteoglycan biosynthetic process (GO:0015012),-0.44645306248270233,-1.2412749579137703,0.17345132743362832,0.5015625764501553,1.0,6/19,16.48%,CSGALNACT1;EXTL3;NDST1;NDST3;HS3ST3B1;XYLT2
prerank,purine ribonucleotide catabolic process (GO:0009154),-0.43775783748001734,-1.2407538232620952,0.189873417721519,0.5021806129051347,1.0,6/21,12.56%,PDE4D;NT5E;PDE2A;NT5C1A;NUDT4;HINT1
prerank,positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),-0.43159375791973625,-1.240331040186312,0.18832391713747645,0.5025272997428002,1.0,8/22,22.43%,ESR1;MED24;PSMC4;PSMC5;SRF;MED14;PSMC3;MED13
prerank,regulation of stem cell population maintenance (GO:2000036),0.45533081742313936,1.2401573476864303,0.21868365180467092,0.6410322441568572,1.0,5/18,15.40%,PTN;TAF6L;LOXL2;TAF5L;NCOA3
prerank,response to glucose (GO:0009749),0.3695466179242828,1.2400651927475395,0.18253968253968253,0.6397323329627227,1.0,6/46,5.80%,TCF7L2;ZBTB20;PRKACA;NKX6-1;IRS2;PDK3
prerank,regulation of chondrocyte differentiation (GO:0032330),0.4340840198807348,1.239934669243931,0.19206680584551147,0.6385496839441837,1.0,6/24,9.57%,ADAMTS12;TRPS1;LOXL2;TGFBR1;SCIN;SOX5
prerank,positive regulation of interleukin-10 production (GO:0032733),-0.3944832851696134,-1.2398779060524399,0.17790262172284643,0.5030289354030921,1.0,7/30,15.49%,CD34;PLCG2;PRKCZ;HSPD1;TLR4;SYK;NOD2
prerank,sympathetic nervous system development (GO:0048485),0.4749901419013899,1.2398614426114247,0.21923937360178972,0.6372222025504285,1.0,3/15,2.89%,NRP1;GDNF;SEMA3A
prerank,regulation of acute inflammatory response (GO:0002673),0.4483760678558239,1.2398442366287652,0.19469026548672566,0.6357647357132729,1.0,5/18,16.61%,IL4;GSTP1;OSMR;PTGES;KLKB1
prerank,regulation of cardiac muscle cell action potential (GO:0098901),-0.4143871501372645,-1.2398409398902208,0.19615384615384615,0.5024849479244914,1.0,10/25,19.15%,CAV1;CXADR;CAMK2D;CALM1;JUP;CTNNA3;CALM3;DSG2;DSP;CACNA1C
prerank,positive regulation of mitotic nuclear division (GO:0045840),0.3950187193933983,1.2397281114523873,0.1747787610619469,0.6345820407762325,1.0,7/34,9.25%,IGF1;TGFA;PHIP;PDGFRB;CDC23;IGF2;CDC16
prerank,ameboidal-type cell migration (GO:0001667),-0.3552684933207134,-1.2397200735798943,0.1519230769230769,0.5020861575752319,1.0,14/51,12.52%,SEMA6A;SEMA3C;GPC3;SEMA7A;CCN3;TBX1;PDLIM1;AMOT;AKT1;SEMA3G;PHACTR4;FAT2;PKN3;SGPL1
prerank,positive regulation of microtubule polymerization (GO:0031116),-0.40118326256145154,-1.239575386228108,0.1741472172351885,0.5018247574233469,1.0,10/28,23.92%,OCLN;RPS3;RAC1;SLAIN2;DCTN1;MET;HSPA1A;ARL2;HSPA1B;CLIP1
prerank,male gonad development (GO:0008584),0.39690536913722696,1.238655352743004,0.17755102040816326,0.6360246778805445,1.0,7/34,9.13%,WNT4;AR;KIT;CSDE1;SIX4;ADAM21;GATA3
prerank,"nucleotide-excision repair, DNA damage recognition (GO:0000715)",-0.4231726139562061,-1.2385791175441783,0.19065420560747665,0.5035404441277065,1.0,14/23,27.65%,UBB;UBC;RPS27A;CUL4A;COPS6;COPS5;RBX1;CETN2;COPS7A;COPS4;COPS7B;XPC;GPS1;RAD23B
prerank,cell morphogenesis involved in neuron differentiation (GO:0048667),-0.32859585946407766,-1.2385625256319335,0.13562753036437247,0.5029522545057875,1.0,17/75,11.10%,MEF2C;ACTB;PARD3;OPHN1;MEF2A;KLF7;APP;SHTN1;MINK1;S100B;MFSD2A;BTBD3;RB1;S100A6;RAB8A;LMTK2;TAOK2
prerank,regulation of muscle cell differentiation (GO:0051147),-0.394801884323433,-1.2385405519954016,0.16539923954372623,0.5023698880720417,1.0,12/31,20.35%,MEF2C;CDON;CTNNA1;MEF2A;BOC;HDAC9;CAMK1;SPAG9;SRF;TCF3;MAPK12;MAPK11
prerank,regulation of translation (GO:0006417),-0.2904846279502055,-1.2383488870970258,0.06560636182902585,0.5022408086301848,1.0,52/173,23.02%,THBS1;VIM;RPL26;RACK1;EEF2;NIBAN1;RPS4X;RPS6KA3;RPL10;FOXO3;RPS3;IGFBP5;APP;EIF4G3;EIF5B;CNOT7;PRKDC;HSPB1;GAPDH;NCL;DHX9;RPL13A;CAPRIN1;RPS27L;EIF3D;LARP4B;IMPACT;CIRBP;UPF3A;SOX4;TSFM;FMR1;RBM4B;ERBB2;PCIF1;LSM14A;GIGYF2;EIF5;ZCCHC4;TYMS;PAIP2B;SYNCRIP;EIF1;RPL5;YTHDF1;LTN1;PAIP1;EIF4G1;EIF4A2;NCBP2;PYM1;MRPL13
prerank,positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),0.3722866001718685,1.2382342602249916,0.17463617463617465,0.6356802211397924,1.0,3/45,1.32%,BMP6;BMP2;BMP5
prerank,chromatin-mediated maintenance of transcription (GO:0048096),-0.5095183371686314,-1.238191991393535,0.19750889679715303,0.5019794199480404,1.0,5/11,18.68%,SERTAD2;ARID1A;ZMIZ2;CDCA4;CHEK1
prerank,regulation of glucose transmembrane transport (GO:0010827),-0.4503326409173358,-1.2379876214684213,0.21666666666666667,0.5018425182162661,1.0,2/18,0.48%,OCLN;SLC2A1
prerank,positive regulation of sodium ion transport (GO:0010765),0.4981288190582779,1.2378489260166712,0.2205240174672489,0.6353295494412678,1.0,2/12,4.33%,SCN3B;GPD1L
prerank,negative regulation of lyase activity (GO:0051350),0.48181577042690665,1.2377227655862324,0.22911694510739858,0.6342135406904202,1.0,4/16,17.14%,ADGRV1;EDNRB;DRD2;LTB4R2
prerank,positive regulation of neuron differentiation (GO:0045666),0.37642387530490806,1.2371894875704506,0.18421052631578946,0.634130761826475,1.0,10/40,14.31%,TCF4;BMP2;ZEB1;BRINP1;BRINP3;NRCAM;KCTD11;FGFR1;BRINP2;GPRC5B
prerank,positive regulation of excitatory postsynaptic potential (GO:2000463),0.4510827742847636,1.2358244477227591,0.1975560081466395,0.6363871687990945,1.0,10/18,13.19%,NRXN1;RIMS1;NLGN2;NLGN3;NLGN1;STX1B;CUX2;PTEN;CHRNA7;DLG4
prerank,positive regulation of collagen biosynthetic process (GO:0032967),0.4712629943169697,1.2355448071951047,0.21123595505617979,0.635586546676066,1.0,3/16,3.98%,WNT4;LARP6;CREB3L1
prerank,cell part morphogenesis (GO:0032990),0.49310597142522083,1.2354464200778743,0.2423580786026201,0.634397111128756,1.0,3/13,10.47%,PID1;NUBPL;PNPT1
prerank,myotube cell development (GO:0014904),0.5394775205881485,1.2352616946873625,0.24053452115812918,0.6334562232921581,1.0,2/10,6.49%,IGF1;MYORG
prerank,negative regulation of immune response (GO:0050777),0.2998045361461736,1.234959232052464,0.09453781512605042,0.632785265012461,1.0,21/154,11.33%,ADCY7;ADCY2;ADCY1;ADCY5;GPHB5;HTR7;PRKACA;LYN;PTGDR;ADM;MC5R;IAPP;CALCR;SIRT2;TRIM27;HRH2;GLP2R;RNF26;ADCY8;HTR4;PTGIR
prerank,positive regulation of signaling receptor activity (GO:2000273),0.38929616061051103,1.2349487352605466,0.1558139534883721,0.6313569656574421,1.0,4/36,6.45%,NRP1;AREG;TGFA;NLGN3
prerank,signal transduction by p53 class mediator (GO:0072331),-0.4056559987003052,-1.2346678823535011,0.18861209964412812,0.5093880538954565,1.0,3/30,1.42%,PPP1R13B;ACER2;DDX5
prerank,estrogen metabolic process (GO:0008210),-0.4746039117450426,-1.2345833376912623,0.20765027322404372,0.5089721739976659,1.0,4/15,18.42%,SULT1A1;CYP1B1;HSD17B10;HSD17B2
prerank,negative regulation of MAPK cascade (GO:0043409),-0.32020989880963524,-1.2342471360757228,0.13,0.5091841910200098,1.0,31/87,27.92%,CAV1;SEMA6A;PTPRJ;FOXO1;DAB2IP;PPIA;PEBP1;EZR;PRDM15;UCHL1;NF1;STK38;DUSP3;APOE;TLR4;SMAD4;PIK3R2;IGBP1;SPRY1;CDK5RAP3;PIN1;PTPN1;DUSP4;PRKCD;SPRED3;PPEF2;SMPD1;SPRY4;DUSP6;PTPN2;DUSP1
prerank,negative regulation of endothelial cell migration (GO:0010596),-0.38656841726488267,-1.2339837923955594,0.1821705426356589,0.5092208934477583,1.0,12/36,12.82%,MEF2C;THBS1;NOTCH1;DAB2IP;SLIT2;TGFB1;PTPRM;RGCC;JUP;CSNK2B;APOE;FGF2
prerank,actin filament depolymerization (GO:0030042),0.5186376718707987,1.2336245033280526,0.22429906542056074,0.633500610220772,1.0,1/11,0.13%,MICAL3
prerank,intermediate filament organization (GO:0045109),-0.45406278756622787,-1.233623185571696,0.20216606498194944,0.5094606856021575,1.0,6/17,22.79%,VIM;NEFL;MTM1;DSP;GFAP;KLHL24
prerank,nucleoside catabolic process (GO:0009164),-0.5068680878793315,-1.2334475922454535,0.2111913357400722,0.5092611544767874,1.0,4/11,11.45%,NT5E;UPP2;NT5C;NT5C1A
prerank,semaphorin-plexin signaling pathway (GO:0071526),0.38246660777443975,1.2333279215940172,0.18082788671023964,0.6328379691685054,1.0,5/35,4.77%,PLXNA2;NRP1;SEMA5A;SEMA3A;SEMA3D
prerank,calcium ion import across plasma membrane (GO:0098703),0.4891831438950817,1.2331421631074184,0.23218390804597702,0.6319018135343748,1.0,3/14,8.94%,SLC8A1;CACNA2D1;SLC24A2
prerank,regulation of astrocyte differentiation (GO:0048710),0.491418055386855,1.2330373334800386,0.23178807947019867,0.6307453835973578,1.0,3/12,8.54%,BMP2;SERPINE2;HES5
prerank,regulation of toll-like receptor signaling pathway (GO:0034121),0.4213086385027925,1.232996188783562,0.1958997722095672,0.6294252336876519,1.0,5/26,8.87%,LGR4;SMPDL3B;LRRC14;NLRP2B;GPR108
prerank,membrane protein intracellular domain proteolysis (GO:0031293),-0.43013349918505855,-1.2329249220561733,0.19055944055944055,0.5098585458308736,1.0,7/20,17.07%,TGFB1;ADAM10;RHBDD1;MBTPS2;PSENEN;APH1A;RELA
prerank,inositol lipid-mediated signaling (GO:0048017),0.3646035808847233,1.2321169579203766,0.17857142857142858,0.6304712092291582,1.0,8/50,7.70%,IGF1;PIK3R1;PLCL1;PDGFRA;IRS2;PLCL2;PDGFRB;PLCH1
prerank,cellular response to interleukin-4 (GO:0071353),-0.5215574777735074,-1.232097936637281,0.2066420664206642,0.5112242195858065,1.0,5/10,27.84%,LEF1;XBP1;JAK3;SHPK;TCF7
prerank,positive regulation of glycogen metabolic process (GO:0070875),0.4927602400767733,1.231924885467572,0.226215644820296,0.6295129408056089,1.0,3/13,8.25%,IGF1;IRS2;IGF2
prerank,positive regulation of cell growth (GO:0030307),-0.31482300114268397,-1.2316644022447827,0.12180746561886051,0.5116397122812867,1.0,40/96,25.08%,SEMA7A;NEDD4L;RPS6KA3;ITSN2;NGF;TGFB2;SHTN1;ADAM10;MFSD2A;EDN1;PABIR1;MMP14;AKT1;PLAA;H3-3A;AKAP6;CIB1;DBNL;DBN1;SYT2;FXN;SMURF1;CDKN2AIP;NTN1;SDCBP;EGFR;ERBB2;LIMK1;CSNK2A1;DERL2;SLC25A33;BRAT1;UNC13A;ADNP2;DDX49;EIF4G1;HYAL1;CDC42;ZFYVE27;RPTOR
prerank,response to growth factor (GO:0070848),-0.365504961933641,-1.231496611512291,0.15264187866927592,0.5114612149432649,1.0,12/41,15.34%,TGFBR2;RACK1;BMPR2;MAP2K5;KLF4;GATA6;SHC1;AKT1;CIB1;ACVR1;ERBB2;EPHA2
prerank,chondroitin sulfate biosynthetic process (GO:0030206),-0.4285389233092569,-1.231120717668638,0.21454545454545454,0.5117646060134339,1.0,3/21,3.48%,CHST11;CSGALNACT1;CSPG4
prerank,"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",-0.49032380432087513,-1.2311168314610492,0.19548872180451127,0.5111395913402191,1.0,10/14,34.08%,RPL35;PES1;URB1;RPL7;WDR12;FTSJ3;RPF2;ZNHIT6;DDX18;ZNHIT3
prerank,regulation of fat cell differentiation (GO:0045598),0.3376850250797508,1.2307922125326947,0.16122448979591836,0.6311781575449024,1.0,11/74,9.31%,RORA;ENPP1;BMP2;RUNX1T1;SMAD3;SFRP1;CEBPB;MEDAG;SIRT2;GATA3;FTO
prerank,carboxylic acid transport (GO:0046942),0.3494399405750562,1.2307483842094502,0.14767932489451477,0.6299121741279781,1.0,13/55,11.30%,SLC13A3;SLC6A12;SLC6A9;SLC16A12;SLC6A13;SLC17A1;SLC16A14;SLC38A1;SLC36A2;SLC25A10;SLC6A11;SLC1A5;SLC38A3
prerank,regulation of cardiac muscle contraction (GO:0055117),0.3887013466861207,1.230431510470515,0.18144329896907216,0.6293520614030653,1.0,6/34,4.22%,SLC8A1;ANK2;PRKACA;P2RX4;ATP2A2;TNNI3
prerank,cation transport (GO:0006812),-0.2910207436046219,-1.229774550196168,0.08860759493670886,0.5138835546887779,1.0,19/167,5.22%,SLC47A1;PIEZO2;ANO6;SLC6A6;SLC12A2;KCNK5;ANO1;KCNJ2;NEDD4L;SLC9B2;SLC7A1;TRPM7;ABCC9;TRPM6;PIEZO1;SLC5A6;SLC38A5;SLC1A1;CHP1
prerank,activation of phospholipase C activity (GO:0007202),0.40953934338457904,1.2295955282747653,0.1646090534979424,0.6301879632001934,1.0,3/29,2.42%,ARHGAP6;LPAR1;GPR55
prerank,regulation of cellular component movement (GO:0051270),0.36326337078225096,1.229589529425914,0.1826086956521739,0.628799981783497,1.0,12/49,9.82%,TGFBR3;MYCBP2;NRG1;ROCK2;LYN;NRG4;NRG2;TGFBR1;ZSWIM5;MEMO1;ERBB3;ERBB4
prerank,tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),-0.3785260487564436,-1.2295563402217105,0.1725417439703154,0.5131882980140727,1.0,17/32,34.81%,NUP93;NDC1;NUP54;NUP188;NUP155;RANBP2;NUP37;NUP160;NUP43;SEH1L;SEC13;NUP107;NUP42;NUP98;RAE1;NUP88;NUP214
prerank,tRNA export from nucleus (GO:0006409),-0.3785260487564436,-1.2295563402217105,0.1725417439703154,0.5131882980140727,1.0,17/32,34.81%,NUP93;NDC1;NUP54;NUP188;NUP155;RANBP2;NUP37;NUP160;NUP43;SEH1L;SEC13;NUP107;NUP42;NUP98;RAE1;NUP88;NUP214
prerank,mesoderm development (GO:0007498),-0.4444452485572982,-1.229325166185429,0.20036429872495445,0.5131122450648419,1.0,13/18,31.82%,TIE1;TBX1;BMX;MESD;VEGFA;FOXC2;JAK2;HCK;BTK;MEST;GDF11;TCF15;TBX6
prerank,negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),0.3352070781073387,1.2289487581698382,0.17307692307692307,0.6290926406161256,1.0,7/65,2.77%,LTBP1;FBN1;LDLRAD4;FBN2;PPARA;PDPK1;SMAD3
prerank,regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),-0.40797011982182124,-1.2284487670558903,0.18421052631578946,0.5146349619911867,1.0,8/25,28.45%,BRD4;ZMYND11;NELFE;LDB1;CDK13;EAPP;ELL;RNF8
prerank,response to interferon-alpha (GO:0035455),-0.4591932724929486,-1.228297101662148,0.2131782945736434,0.5144151119578256,1.0,5/16,9.14%,ADAR;IFITM1;IFITM3;IFITM2;IFNAR1
prerank,neuron migration (GO:0001764),0.36129244794605064,1.2282833731795189,0.16334661354581673,0.6294342324739526,1.0,11/48,13.82%,AUTS2;NRP1;SEMA3A;GPM6A;SH3RF1;ASTN2;NRCAM;CDK5R1;LRP12;FGFR1;TUBGCP2
prerank,response to fatty acid (GO:0070542),0.4548510443204752,1.228237116881018,0.23788546255506607,0.6281462613895694,1.0,4/17,5.80%,PID1;PDK4;GLDC;PDK3
prerank,regulation of hemopoiesis (GO:1903706),0.5089186651273885,1.2279600149843317,0.2579908675799087,0.6275011723124062,1.0,2/10,9.16%,PTN;PRKCB
prerank,positive regulation of neurogenesis (GO:0050769),0.3388624409682644,1.2273815903179692,0.14042553191489363,0.627618536295584,1.0,17/68,14.58%,PLXNA2;ROBO1;ROBO2;PTPRD;SERPINF1;NPTN;IL1RAPL1;CUX1;CDKL3;CUX2;PLXNB2;NGFR;OBSL1;CAPRIN2;AMIGO1;DRD2;MAP6
prerank,response to UV (GO:0009411),-0.3117051121374772,-1.2273781693183765,0.1237721021611002,0.5160337280252273,1.0,28/95,23.42%,SCARA3;RPL26;MAP4K3;USP1;RHBDD1;ATF4;N4BP1;GPX1;YY1;AKT1;CIRBP;SPRTN;BAK1;FMR1;EGFR;RELA;CCAR2;KDM1A;POLK;ERCC4;CCND1;COPS9;PTPRK;UBE2B;RHNO1;TRIAP1;DTL;PRKCD
prerank,amino acid transmembrane transport (GO:0003333),0.3750332204559914,1.2272911145692726,0.19361702127659575,0.626505357608578,1.0,8/45,7.15%,SLC7A11;SLC6A13;SLC22A4;MFSD12;SLC38A1;SLC36A2;SLC7A9;SLC25A13
prerank,regulation of IRE1-mediated unfolded protein response (GO:1903894),-0.47766121795938943,-1.2272629354074176,0.19680851063829788,0.5157115765564948,1.0,11/14,26.68%,DAB2IP;BAX;DDRGK1;HSPA5;BAK1;COPS5;UFL1;TMEM33;BFAR;PTPN1;FICD
prerank,receptor internalization (GO:0031623),-0.3658202581802821,-1.2272234717716042,0.18269230769230768,0.5151643703352246,1.0,9/44,9.89%,CAV1;DNM3;ACKR3;RAMP2;TFRC;CD81;CD9;AP2M1;FCER1G
prerank,regulation of cell population proliferation (GO:0042127),-0.24939584405869006,-1.2270459249949086,0.02040816326530612,0.5149743711964673,1.0,155/691,16.41%,FN1;KITLG;LEF1;ZBTB7C;PTPN14;FLT1;IGF1R;CDK6;CLDN5;ITGA1;ACER2;IGFBP7;THBS1;NOS3;PTPRJ;IGFBP6;NOTCH1;CBFA2T3;IL15;DPP4;NAMPT;FGF1;TGFBR2;LRP5;PTK2B;BMPR2;LIFR;SH3BP4;JUND;KDR;KLF4;EGLN3;STX3;TFRC;PTK2;TBX1;TBC1D8;RPS4X;RPS9;VEGFC;ETS1;DAB2IP;NGF;SIX1;CDKN1B;RPRD1B;TGFB1;CNBP;REST;APP;TGFB2;RNF41;COL18A1;TBX2;RPL23;RPS15A;DNAJA2;TES;PLPP1;LIMS1;ADAM10;CYP1B1;ING5;CTBP1;IGFBP3;CD81;SMAD6;VEGFA;CNOT7;S100B;AQP11;JAG2;RBFOX2;WNT9A;RARA;IFITM1;SHC1;TGFB3;PRKDC;RGCC;ADGRG1;JUP;KRAS;EDN1;FLT4;S1PR3;TNFRSF11A;HDAC4;AKT1;INSR;BCL6;NOP2;KANK2;SOX7;PDGFC;PDGFA;WARS1;LAMC2;HHEX;CSNK2B;EMP2;DDRGK1;ACE2;JUNB;DIS3L2;INHBA;CDK4;GAS8;KMT2D;S100A13;FRK;CIB1;VEGFD;FTH1;TMEM115;FAM98A;GRK5;CDK10;SOX4;FXN;FGF2;HES1;RPS6;ACER3;CSF1R;ENG;RPS6KA2;ABI1;HRAS;NUAK1;P3H2;STAT5A;EID2;BCL6B;JAK2;SDCBP;SMYD2;EGFR;CHTOP;ERBB2;STRN;GAB2;OSGIN1;CLCF1;TNFSF13;PTPN6;CDK13;CDKN1A;CSNK2A1;NPR3;SMARCA2;UFL1;STAT1;GREM1;RBBP4
prerank,ribonucleoside monophosphate biosynthetic process (GO:0009156),-0.48409481164718027,-1.2270244596006858,0.21335807050092764,0.5144000208865742,1.0,4/14,8.25%,RFK;PAICS;ADSS2;IMPDH1
prerank,determination of heart left/right asymmetry (GO:0061371),-0.36705935284957747,-1.226894485334366,0.18235294117647058,0.5141010086254438,1.0,11/42,14.82%,MEF2C;NOTCH1;TGFBR2;SOX17;TBX2;SMO;MICAL2;SOX18;ZIC3;ENG;SRF
prerank,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),0.31181190339160997,1.2267289478288208,0.102880658436214,0.6265618321538848,1.0,23/121,14.31%,IGF1;BMP6;IL31RA;NRP1;IL34;KIT;TNK2;LYN;GHR;IL4;IGF2;ERBB3;IL18;HES5;ERBB4;CNTF;IL6R;PIBF1;TEC;DOK7;DLG4;TSLP;GPRC5B
prerank,protein localization to plasma membrane (GO:0072659),-0.30133566931253974,-1.2261026891083935,0.10420841683366733,0.5154820120267549,1.0,46/129,21.37%,BSG;RAP1A;CDH1;TSPAN5;SPTBN1;EFR3B;RAB11A;F11R;RAMP2;EHD4;KCNB1;RAB8B;PACS1;GORASP2;CD81;IKBKB;EZR;EHD2;JUP;ATP1B1;FLOT1;S100A10;EMP2;RAB8A;TSPAN14;FCHO2;CACNB3;SLMAP;TNFRSF1A;SMURF1;TMEM88;FLOT2;EPHA2;TSPAN17;PACSIN1;RAB40B;PIGW;PRAM1;RAMP1;EHD1;PLEKHF1;FYB2;EHD3;RAPGEF2;ZDHHC23;KCNB2
prerank,ERAD pathway (GO:0036503),-0.3225281189927015,-1.2260902394438893,0.12474849094567404,0.5148784712506322,1.0,36/83,31.15%,SEL1L;TRIM25;RHBDD1;FBXO17;DNAJB12;MAN1B1;ERLIN2;RNF185;UBE2G2;VCP;HSPA5;UBXN8;FAF2;RNF5;SEC61B;SGTA;RNF121;TMEM67;DERL2;AMFR;ERLEC1;TMEM129;TMUB2;SGTB;TMUB1;BRSK2;FBXO6;UBE2J2;UBE4A;FBXO2;STT3B;UBQLN2;DERL1;PSMC6;EDEM1;SYVN1
prerank,positive regulation of protein tyrosine kinase activity (GO:0061098),0.38037459585680394,1.2254797706802798,0.18604651162790697,0.628549560653652,1.0,10/41,15.68%,IL34;AREG;TGFA;STAP1;ERBB3;DOK7;DLG4;BTC;GPRC5B;FCGR1A
prerank,peptidyl-proline modification (GO:0018208),-0.40881328704106884,-1.2254683975196943,0.17635658914728683,0.5157817086378804,1.0,11/25,25.21%,FKBP5;FKBP1A;PPIA;PPIC;P3H2;PPIG;PIN1;NTMT1;FKBP4;PPIB;PPID
prerank,regulation of isotype switching (GO:0045191),0.49234675554150037,1.2254007450838633,0.22494432071269488,0.627384859903824,1.0,7/14,16.52%,SHLD2;IL4;KMT5C;PAXIP1;RIF1;KMT5B;PARP3
prerank,histone H4-K16 acetylation (GO:0043984),-0.4305279479048403,-1.2247583417805243,0.19852941176470587,0.5168162671059785,1.0,5/19,8.18%,MSL2;PHF20;JADE2;HCFC1;KANSL2
prerank,regulation of cell-substrate junction assembly (GO:0090109),-0.43156739303182784,-1.2245872113977696,0.2148014440433213,0.5166078181404851,1.0,7/21,14.97%,ACTG1;LIMCH1;PEAK1;PTK2;VCL;DUSP3;LDB1
prerank,cellular response to nutrient levels (GO:0031669),-0.34075722034379624,-1.224577651567908,0.13962264150943396,0.5160072283488176,1.0,28/62,25.23%,BMPR2;FOXO1;KCNB1;MAP1LC3B;HSPA8;RALB;MFSD2A;FAM107A;ATG7;MAP1LC3A;INHBB;GAS2L1;STK26;RRAGD;XBP1;WIPI2;RIPOR1;RRAGA;KLF10;TFEB;VPS41;EIF4G1;CD68;RRAGC;NUPR2;CDKN2B;RPTOR;SREBF1
prerank,postsynaptic membrane organization (GO:0001941),0.4655087075318318,1.2245739398145343,0.22958057395143489,0.6280770199151213,1.0,8/17,13.19%,NRXN1;LRP4;NLGN2;NLGN3;NLGN1;MUSK;CHRNB1;DLG4
prerank,actin filament organization (GO:0007015),-0.28844484452628666,-1.2245570793082863,0.08565737051792828,0.5154302667350762,1.0,53/151,26.41%,NEBL;SHROOM4;MYO1D;BAIAP2L1;TMOD3;COBL;EPS8;VILL;ARHGAP17;PLS3;CD2AP;MPRIP;RAC1;NEDD9;ARHGAP25;HIP1R;ACTN1;LMOD1;FLII;TMOD1;EMP2;HIP1;RHOB;TRPV4;DBN1;ABI1;WASL;GAS2L1;SHROOM1;SHROOM3;TPM3;MYO1F;MARCKSL1;ARHGEF2;CAPG;TPM2;TPM4;RND2;TLE6;GAS2;AVIL;DMTN;CARMIL1;RFLNB;CORO7;AIF1;CDC42;MCU;ELMO3;INPPL1;MYO7A;TMOD2;MYO19
prerank,negative regulation of cell differentiation (GO:0045596),0.2915499711260998,1.2238931648151894,0.1111111111111111,0.6284724954706501,1.0,27/181,9.13%,RORA;ENPP1;ADGRV1;ADAMTS12;RUNX1T1;LDLRAD4;TBX3;BMP5;ABCA1;CNTN4;PPARA;SMAD3;RANBP3L;SFRP1;HOXB8;HES3;DTX1;FOXA2;SIRT2;MEN1;SOX2;TGFBR1;ABCA5;IGF2;HES5;NPHP3;GATA3
prerank,"nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",-0.42030286691464325,-1.2223545325745235,0.19646365422396855,0.5202692425971032,1.0,9/22,17.81%,UBB;UBC;RPS27A;CUL4A;GTF2H3;CHD1L;RBX1;CETN2;GTF2H4
prerank,regulation of cardiac conduction (GO:1903779),0.35965028348195865,1.2215876353361654,0.18695652173913044,0.6333399657373809,1.0,10/54,6.07%,ATP1A2;SLC8A1;ITPR1;ANK2;PRKACA;DMPK;CORIN;ATP2A2;FXYD1;ASPH
prerank,erythrocyte development (GO:0048821),-0.5173888766979793,-1.2215640718653706,0.23689320388349513,0.521605927277026,1.0,5/10,32.94%,ZBTB7A;ALAS2;DMTN;ABCB10;LYAR
prerank,retinoic acid metabolic process (GO:0042573),0.4890654566427204,1.221538095964881,0.21549636803874092,0.632124128306553,1.0,1/14,0.56%,ALDH1A2
prerank,negative regulation of epithelial to mesenchymal transition (GO:0010719),0.3968270948552275,1.2214356018462622,0.19230769230769232,0.631011412158995,1.0,9/29,13.61%,LDLRAD4;BMP5;SFRP1;FOXA2;GATA3;PTEN;FUZ;ZNF750;NKX2-1
prerank,negative regulation of endothelial cell proliferation (GO:0001937),-0.37799160195587467,-1.2213024586684151,0.16236162361623616,0.5216166326172239,1.0,14/35,18.39%,MEF2C;CAV1;FLT1;THBS1;CAV2;PTPRM;ATP5F1A;RGCC;NF1;APOE;ATP5IF1;STAT1;DLL4;KRIT1
prerank,positive regulation of establishment of protein localization (GO:1904951),-0.4402936434277192,-1.2206964472569952,0.21062271062271062,0.5224782021684398,1.0,11/18,35.15%,CHP1;DKC1;CCT2;CCT3;CCT8;CCT7;TREM2;PTP4A3;WRAP53;CCT4;CCT6A
prerank,positive regulation of vascular endothelial cell proliferation (GO:1905564),0.49254776317415655,1.220622387259192,0.240990990990991,0.6319034488032916,1.0,5/13,14.73%,PDPK1;AKT3;IGF2;FGFR1;SIRT6
prerank,chloride transmembrane transport (GO:1902476),0.3596228911368746,1.2204713739431643,0.18163672654690619,0.6309313323878454,1.0,16/48,14.70%,SLC1A3;ANO7;GABRA2;GABRR3;GLRB;GABRB3;ANO3;GABRR2;GABRA5;CLCN1;SLC6A1;SLC12A3;GLRA3;ANO5;GABRB1;GABRG1
prerank,regulation of monocyte differentiation (GO:0045655),-0.482556751338858,-1.2197668311667835,0.2349624060150376,0.5241848056884637,1.0,4/14,10.73%,FOXP1;CDK6;CTNNBIP1;CD74
prerank,regulation of protein-containing complex assembly (GO:0043254),-0.300479302420699,-1.2197310728805126,0.11394891944990176,0.5236475692022243,1.0,27/110,12.88%,RACK1;TFRC;RPS3;DAB2IP;FNIP2;TGFB1;HSPA8;RALB;PRKCZ;NAPA;VEGFA;HCFC1;AIDA;SVIP;KIF9;BAX;TAL1;WARS1;RB1;TIRAP;VCP;HSPA5;NCLN;IMPACT;APOE;BAK1;SYK
prerank,amino acid import (GO:0043090),-0.41911642516361614,-1.219279539288826,0.21359223300970873,0.5241023528499065,1.0,7/21,5.91%,SLC47A1;SLC6A6;SLC7A5;SLC7A1;SH3BP4;SLC1A1;SLC25A38
prerank,negative regulation of leukocyte chemotaxis (GO:0002689),-0.5066432491776166,-1.2191719729561254,0.22363636363636363,0.5237161027185877,1.0,3/11,3.59%,RIN3;CCN3;SLIT2
prerank,cortical cytoskeleton organization (GO:0030865),0.37734633893978614,1.2185819231322632,0.2,0.63459606343278,1.0,12/41,15.56%,EPB41L3;ROCK2;RHOH;RHOBTB1;FHOD3;FMNL3;NLGN1;RHOBTB3;RHOF;LLGL1;RND1;RHOQ
prerank,protein localization to synapse (GO:0035418),0.49232053832757716,1.2185026507359447,0.24774774774774774,0.6334606444884059,1.0,5/12,17.08%,NRXN1;NLGN2;NLGN1;DLG4;ZDHHC15
prerank,cardiocyte differentiation (GO:0035051),0.529297932882989,1.2182886751250572,0.2657952069716776,0.6326205187172993,1.0,2/10,1.40%,BMP2;NRG1
prerank,positive regulation of signaling (GO:0023056),0.38015781954658984,1.2180710506096148,0.19873150105708245,0.6318555412488059,1.0,12/37,19.22%,WLS;CLSTN2;RIMS1;GRIK2;RAB29;SYT1;GATA3;DLG4;HCRT;VAMP3;RIMS2;LGI1
prerank,positive regulation of smooth muscle cell proliferation (GO:0048661),0.3703555635837039,1.2179372882729647,0.16770186335403728,0.6308867501515337,1.0,9/43,11.20%,IGF1;GJA1;CCN4;PDGFRB;IL18;DNMT1;HES5;BMPR1A;IL6R
prerank,inositol phosphate-mediated signaling (GO:0048016),-0.4412958956742445,-1.2176743780055488,0.20415879017013233,0.5267015966866884,1.0,9/19,23.08%,PLCE1;PPP3CC;EDN1;NFATC1;INPP5A;PPP3CB;ADGRB2;NFATC3;NMUR2
prerank,cellular response to starvation (GO:0009267),-0.2897458041814971,-1.2175704179071227,0.11067193675889328,0.5263268505055844,1.0,51/147,25.89%,MAP3K5;BMPR2;FOXO1;MAPK3;FOXO3;DAPL1;MAP1LC3B;ATP6V0B;HSPA8;RALB;GABARAP;ATF4;MFSD2A;FAS;ATP6V0C;ATG7;HSPA5;XPR1;IMPACT;MAP1LC3A;NUAK1;INHBB;NUAK2;LAMTOR2;GAS2L1;PRKAG1;ATP6V1G1;STK26;CDKN1A;RRAGD;XBP1;HNRNPA1;ASNS;WIPI2;RIPOR1;RRAGA;KLF10;TFEB;VPS41;RRAGC;SESN2;BRSK2;NUPR2;SIK1;CASTOR2;RPTOR;GABARAPL1;SREBF1;ATP6V0D1;SEH1L;SEC13
prerank,apoptotic process (GO:0006915),-0.27769189334545313,-1.2175515200612959,0.07707509881422925,0.5257547091490162,1.0,56/203,20.16%,SEMA6A;TGFBR2;PTK2B;NFKBIA;PPARD;FOXO1;EGLN3;FAP;TBX1;ADAM15;RFK;APP;PPIA;MAGI3;ZBTB16;DPF2;PPP2R1A;CASP7;TNFRSF21;CASP8;RIPK1;GAPDH;DDX41;BAX;AKT1;PLAGL1;MAL;FAS;HSPD1;HIP1;RHOB;TNFAIP1;PAEP;TAOK2;PRUNE2;CIB1;BBC3;BCL2L1;PRKCE;BAK1;DHCR24;JAK2;MRPS30;PIK3CA;NCKAP1;DDIT4;BAD;TSC2;TRAIP;CHEK1;MAGEH1;GADD45A;ARHGEF6;BIK;BRAT1;CASP1
prerank,sulfur compound catabolic process (GO:0044273),0.3732851927364257,1.2175165610952674,0.17338709677419356,0.630704088944115,1.0,8/38,7.32%,FMOD;DCN;OMD;GNS;LUM;GGT7;GALNS;OGN
prerank,aorta morphogenesis (GO:0035909),0.4518175252402825,1.2171865192892386,0.24429223744292236,0.6302431270841437,1.0,7/17,11.84%,LRP1;EFEMP2;MYLK;PDGFRB;RBPJ;BMPR1A;ADAMTS9
prerank,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),-0.3139754745864662,-1.2170307353249739,0.1374764595103578,0.526353141123643,1.0,34/88,27.47%,FBXO17;PSMA6;CUL4A;PSMB5;FBXO4;PSMC4;PSMC5;FBXL14;PSMD14;FBXW5;FBXL7;FBXL2;RBX1;PSMD8;PSMD11;CCNF;PSMB4;PSMD12;PSMC1;FBXL3;FBXL16;CUL1;DMAC2;PSMA1;PSMB1;PSMC3;PSMA4;PSMA2;FBXL18;FBXO6;PSMB8;FBXO38;FBXL8;FBXO2
prerank,skin development (GO:0043588),-0.3321091875813624,-1.2164940856234376,0.1525096525096525,0.527036093564466,1.0,18/65,16.29%,ITGA6;CLIC4;LSR;COL5A2;COL3A1;ANXA1;ITGB4;PKD1;GATA6;BCR;PDGFA;COL5A3;DHCR24;HRNR;OPN3;EPHA2;MET;DSP
prerank,inorganic anion transport (GO:0015698),-0.3440457375479685,-1.2161646052462174,0.158,0.527205065690376,1.0,7/53,2.99%,SLC4A10;ANO6;SLC26A7;CLIC4;ANO1;CLIC1;CLIC5
prerank,regulation of exit from mitosis (GO:0007096),-0.36894416594680496,-1.2158186854526847,0.18045112781954886,0.5274239931271919,1.0,12/38,16.23%,CDC14A;ZW10;UBB;UBC;RPS27A;ANAPC15;RGCC;ANAPC11;CDC14B;PHB2;ANAPC7;CDC27
prerank,positive regulation of glycogen biosynthetic process (GO:0045725),0.5001368580615021,1.215641745045792,0.24295010845986983,0.6328279419906669,1.0,3/12,8.25%,IGF1;IRS2;IGF2
prerank,regulation of plasma membrane bounded cell projection assembly (GO:0120032),-0.32564535209179024,-1.2155262353497158,0.15399239543726237,0.5275159758606714,1.0,25/67,26.20%,PODXL;CAV1;ATP8B1;TBC1D8;PPP1R16B;IFT20;RAC1;TBC1D1;TBC1D22A;ATG3;FMR1;TBC1D9B;EPHA2;TBC1D2;RABEP2;DCDC2;TBC1D15;DMTN;FSCN1;CDC42;ODAD3;MYO10;TBC1D17;RDX;CDKL5
prerank,ERBB signaling pathway (GO:0038127),0.34132367700490673,1.2154534895105058,0.18410041841004185,0.6320599921986154,1.0,10/64,4.45%,PIK3R1;AREG;NRG1;PDPK1;PRKCA;SLC30A10;DGKD;TGFA;NRG4;NRG2
prerank,positive regulation of T cell proliferation (GO:0042102),0.3544275658223242,1.2154247477892084,0.15368421052631578,0.6308024834400463,1.0,6/55,8.31%,IGF1;IGFBP2;IL4;CD274;IGF2;IL18
prerank,actin polymerization or depolymerization (GO:0008154),0.3546718960818434,1.2152648297649107,0.18126272912423624,0.6299274630853705,1.0,3/50,0.25%,MICAL3;SVIL;ARHGAP6
prerank,positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),-0.3267166465398438,-1.2146243158844408,0.12595419847328243,0.5291121648750506,1.0,25/76,21.43%,CBFA2T3;RACK1;PTK2;RNF144B;SMAD7;GABARAP;SH3RF2;TRIB2;PABIR1;TRIB1;DDRGK1;VCP;USP5;SMURF1;RBX1;HECTD1;HSPA1A;CDK5RAP3;RNF19A;ELOB;LAPTM5;CCDC22;KEAP1;TRIB3;HSPA1B
prerank,mitotic sister chromatid segregation (GO:0000070),-0.30824766722721997,-1.2145572188950458,0.1326530612244898,0.528639114832304,1.0,46/98,32.82%,RAB11A;DCTN2;SMC4;ZW10;CHMP2B;KIF23;CSNK2B;RB1;DIS3L2;POGZ;CSNK2A1;CSNK2A2;SMC2;KIF18A;CHMP2A;BOD1;RAD21;KNSTRN;NCAPH;KIF18B;NIPBL;NSL1;NDC80;KIF22;NCAPG;REC8;SPDL1;CDCA8;CEP55;VPS4A;KMT5A;SEH1L;SGO1;EML3;NCAPH2;CHMP7;NAA50;TUBG2;TTN;PLK1;CDK1;NCAPD2;PSRC1;CHMP4B;CHMP4A;ESPL1
prerank,positive regulation of protein binding (GO:0032092),-0.3329913671832254,-1.2143517038115639,0.16569200779727095,0.5285843922703538,1.0,13/56,9.23%,CAV1;CLDN5;B2M;RPL11;APP;FKBP1A;RALB;PKD1;HIP1R;IDE;NMD3;ADD1;FLOT1
prerank,aromatic amino acid family metabolic process (GO:0009072),0.5283741235832493,1.2141837171375256,0.2535211267605634,0.6314288539955762,1.0,4/10,23.20%,IL4I1;KYNU;PCBD1;KYAT1
prerank,positive regulation of immune effector process (GO:0002699),-0.3962881125103897,-1.2141472785862546,0.19439252336448598,0.528504092921797,1.0,8/27,20.27%,LBP;PTPRJ;CD81;RPS19;DHX58;ANKRD17;XBP1;LGALS9
prerank,positive regulation of type 2 immune response (GO:0002830),-0.4790153147583095,-1.2140969780043998,0.22968197879858657,0.527992898193555,1.0,7/14,18.62%,PRKCZ;CD81;RARA;DENND1B;CD74;NOD2;RSAD2
prerank,mitotic DNA damage checkpoint signaling (GO:0044773),-0.3398030358896784,-1.213602443035062,0.150093808630394,0.5286774559526373,1.0,20/57,19.30%,BRCC3;TAOK3;FOXN3;PRKDC;UIMC1;BABAM1;RPS27L;TAOK2;CDC14B;RAD9B;HUS1;EME2;RAD9A;CDKN1A;RAD17;FZR1;BABAM2;CHEK1;CDK5RAP3;CCND1
prerank,membrane organization (GO:0061024),-0.2726781195403268,-1.2131126774436347,0.07551020408163266,0.5292727676757044,1.0,63/227,22.03%,CERT1;ACTB;DNM3;SPTBN1;ACTG1;FNBP1L;TFRC;MYOF;FZD4;EPN1;VAMP7;LPCAT3;ATP2C1;UBB;IGF2R;HSPA8;CHP1;UBC;RPS27A;NAPA;DYSF;HIP1R;REPS2;CHMP2B;A4GALT;NUP93;ARPC5;AP2M1;ITSN1;PIK3C2A;HIP1;FCHO2;SGIP1;TOR1AIP1;SYT2;ACTR3;TMEM43;MITD1;EPN2;NPC1;NUP155;WASL;EGFR;AP2A1;AGFG1;SLC2A8;OPA1;SYNJ1;RABEP1;REEP4;VTI1B;DNM1;CHMP2A;TOR1AIP2;CTTN;SNX3;PACSIN2;DNM2;TMEM33;TIMM50;LPCAT2;CLTA;GLTP
prerank,regulation of collagen biosynthetic process (GO:0032965),0.4407675185608172,1.2130870603487158,0.23178807947019867,0.6328554970922616,1.0,3/19,3.98%,WNT4;LARP6;CREB3L1
prerank,intra-Golgi vesicle-mediated transport (GO:0006891),-0.38939523976343177,-1.213009700115232,0.18861209964412812,0.5289038657630895,1.0,12/29,20.30%,NAPA;RAB6B;GOSR1;COPG1;COPB2;COG8;COG3;GOLGA5;COG5;VTI1B;NSF;COG2
prerank,regulation of mitotic cell cycle phase transition (GO:1901990),-0.2797611892276681,-1.2125897527801606,0.07099391480730223,0.5293293847705096,1.0,65/184,26.49%,CDC14A;DCTN2;TUBA1A;CEP164;ZW10;UBB;PKD1;UBC;RPS27A;PPP2R1A;PRKAR2B;CEP192;CEP57;ANAPC15;PSMA6;RGCC;ANAPC11;PSMB5;CEP70;DCTN3;CEP290;CNTRL;DCTN1;PSMC4;PSMC5;PCM1;TUBB4B;PSMD14;E2F1;CDC14B;HAUS1;NDE1;PSMD8;CETN2;CEP72;YWHAG;PTPN6;PSMD11;ANAPC7;CDC27;PSMB4;PSMD12;PSMC1;HSP90AA1;CEP41;FZR1;CUL1;TPX2;PSMA1;ANAPC2;PSMB1;PSMC3;TUBA4A;CENPF;PSMA4;PSMA2;ANLN;PSMB8;HAUS4;RIOK2;YWHAE;CEP63;NEDD1;PLK5;XPC
prerank,regulation of actin cytoskeleton organization (GO:0032956),-0.31754966950893815,-1.2125691445628535,0.1440162271805274,0.5287584262215586,1.0,24/87,14.95%,ESAM;EPS8;PTK2B;F11R;IQGAP1;ARHGAP17;RICTOR;ARHGDIA;RAC1;ARHGDIB;CRK;HIP1R;EZR;ABI3;PDGFA;FAM107A;RHOB;ABL2;TAOK2;CDK10;CSF1R;ARHGEF5;CELSR1;PIK3CA
prerank,supramolecular fiber organization (GO:0097435),-0.261188544487831,-1.2123649335321618,0.04852320675105485,0.5286624801723967,1.0,71/333,12.53%,SHROOM4;COL25A1;PGM5;ITGA6;MYO1D;TLL1;B2M;TSPAN5;COL12A1;TMOD3;COL5A2;VIM;COL6A2;ARHGAP17;COL3A1;TNXB;PLOD2;COL4A2;CD2AP;ITGB4;HSP90AB1;MYH11;MPRIP;APP;TGFB2;COL18A1;FKBP1A;UBB;COL4A1;RAC1;ADAM10;CYP1B1;CHP1;CD151;LAMA3;UBC;RPS27A;TGFBI;COL6A1;ARHGAP25;BACE1;HIP1R;ACTN1;LMOD1;FLII;NEFL;COLGALT2;SLAIN2;RIPK1;MFGE8;STMN2;TMOD1;UBE2L6;CST3;PSENEN;LAMC2;USP9X;EMP2;H3-3A;TSPAN14;HIP1;DCTN1;COL5A3;RHOB;TRPV4;NF1;CIB1;PCM1;DBN1;PLOD3;KATNB1
prerank,regulation of smooth muscle contraction (GO:0006940),-0.42478707486342493,-1.2122957577605304,0.22003577817531306,0.5282571556611225,1.0,2/20,0.34%,PLCE1;CAV1
prerank,negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),-0.38560044738289284,-1.2117574305784364,0.18618042226487524,0.5289853249467056,1.0,19/30,39.33%,CAV1;PRKCZ;PPP2R1A;SRCIN1;PTPN6;CADM4;PRKCD;DMTN;PTPN2;PARP14;MVP;HYAL2;NF2;SH3BP5;NTF3;PPP2CA;INPP5F;SFRP2;SOCS3
prerank,mitochondrion distribution (GO:0048311),-0.4906715480598697,-1.211723715401329,0.2413793103448276,0.5284455198857392,1.0,4/12,15.08%,TRAK1;MEF2A;TRAK2;MTM1
prerank,negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),0.48231353598056803,1.2117090447141385,0.2211764705882353,0.6352097336867151,1.0,5/14,11.03%,SULF1;SULF2;CREB3L1;GATA3;FUZ
prerank,regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),-0.33779958150185047,-1.2107571006988478,0.14942528735632185,0.5301654373281707,1.0,18/54,22.12%,TAX1BP1;RACK1;HIPK1;IKBKB;CASP8;RIPK1;SYK;TRAF1;TNFRSF1A;MADD;TNFAIP3;HSPA1A;CHUK;TRAIP;LAPTM5;CASP1;HSPA1B;CCDC3
prerank,growth hormone receptor signaling pathway (GO:0060396),0.4745860658812428,1.2107490114927772,0.25934065934065936,0.6364669664833709,1.0,4/14,4.95%,PIK3R1;STAT5B;LYN;GHR
prerank,embryonic heart tube development (GO:0035050),-0.47736004546499144,-1.209177899540314,0.23495145631067962,0.5333567658682672,1.0,5/14,12.83%,SOX17;TBX2;SOX18;ACVR1;HES1
prerank,positive regulation of lamellipodium assembly (GO:0010592),0.41234086575749107,1.2087246043649138,0.2119205298013245,0.6403579759206771,1.0,2/24,0.26%,AUTS2;PIK3R1
prerank,regulation of immune response (GO:0050776),-0.2899260664093945,-1.2084887394761343,0.10869565217391304,0.534410045313451,1.0,26/135,15.46%,FOXP1;CXADR;B2M;CD34;IL15;CLEC2D;COL3A1;TGFB2;FKBP1A;CD81;IFITM1;DENND1B;N4BP1;CASP8;ERAP1;PVR;BCL6;TIRAP;LRP8;DHX58;ICAM2;SYK;SAMHD1;JAML;NECTIN2;ITGA4
prerank,growth hormone receptor signaling pathway via JAK-STAT (GO:0060397),0.5133917017386105,1.2084474092328448,0.2847682119205298,0.6398099405932096,1.0,4/10,12.65%,STAT5B;LYN;GHR;PRLR
prerank,histone H4-K8 acetylation (GO:0043982),-0.4546419708032376,-1.208425444455038,0.2153558052434457,0.5333334019232376,1.0,4/15,8.18%,PHF20;JADE2;HCFC1;KANSL2
prerank,histone H4-K5 acetylation (GO:0043981),-0.4546419708032376,-1.208425444455038,0.2153558052434457,0.5333334019232376,1.0,4/15,8.18%,PHF20;JADE2;HCFC1;KANSL2
prerank,regulation of vascular associated smooth muscle cell proliferation (GO:1904705),0.3820120633366253,1.208246205200319,0.20042194092827004,0.6390574775422247,1.0,8/37,10.35%,IGF1;GJA1;EFEMP2;TAFA5;DNMT1;BMPR1A;SOD2;PTEN
prerank,renal filtration (GO:0097205),0.5152750680801259,1.2082181276037867,0.2657952069716776,0.6378002461112403,1.0,5/10,15.04%,SULF1;SULF2;JCHAIN;TBC1D8B;MYO1E
prerank,negative regulation of establishment of protein localization (GO:1904950),-0.5244414103484647,-1.207896589937975,0.2504472271914132,0.5340431162700716,1.0,7/10,31.46%,WWP2;PPM1F;DNAJA1;SNX3;NDFIP2;NDFIP1;SNX12
prerank,"regulation of DNA-templated transcription, elongation (GO:0032784)",-0.4088887426186998,-1.2077104146009083,0.23180076628352492,0.5338877750332403,1.0,9/25,17.25%,ZNF326;ZMYND11;HMGN1;TSFM;LDB1;ALYREF;CCNK;DDX39B;CCAR2
prerank,peptidyl-proline hydroxylation (GO:0019511),-0.505936988374011,-1.2072914497977831,0.2361904761904762,0.5343077327598205,1.0,5/11,16.40%,EGLN3;EGLN2;EGLN1;P3H2;CRTAP
prerank,regulation of ion transmembrane transporter activity (GO:0032412),-0.3646073444923068,-1.20722349186893,0.19202898550724637,0.5338586920247332,1.0,13/39,18.07%,UTRN;NEDD4L;FXYD5;FHL1;WWP2;RIPK1;TRPC6;HOMER1;SPHK2;PHB2;CACNA1D;YWHAH;SCN2B
prerank,response to lipopolysaccharide (GO:0032496),-0.2906837501819029,-1.207098405962034,0.11214953271028037,0.5335798647221484,1.0,56/138,34.11%,FOXP1;MEF2C;LBP;NOS3;VIM;SCARB1;RPS6KA3;DAB2IP;GCH1;MAPKAPK3;SMAD6;TNFRSF1B;OTUD5;TNFRSF11A;PLAA;IFNAR1;TRIB1;TIRAP;GGT5;TLR4;JAK2;NOD2;TNFAIP3;CX3CR1;TAB2;RELA;XBP1;PELI1;CASP1;GGT1;LGALS9;PTPN22;CD68;TRAF6;CCL2;CARD16;BCL10;SELP;SHPK;NOCT;PDCD4;LILRB1;HMGB2;CD86;IRGM;UPF1;NOS2;RHOA;CD14;LY96;NLRP3;TNIP2;SRR;NOS1;CXCL5;SLC11A1
prerank,positive regulation of epithelial cell apoptotic process (GO:1904037),-0.4311214032316512,-1.2066488812831422,0.21305182341650672,0.5341003751168094,1.0,3/20,7.21%,ANO6;THBS1;RGCC
prerank,negative regulation of focal adhesion assembly (GO:0051895),0.4543157189517829,1.2065924874952974,0.23931623931623933,0.639485754642841,1.0,3/16,5.17%,ARHGAP6;PHLDB2;DLC1
prerank,negative regulation of cell-substrate junction organization (GO:0150118),0.4543157189517829,1.2065924874952974,0.23931623931623933,0.639485754642841,1.0,3/16,5.17%,ARHGAP6;PHLDB2;DLC1
prerank,negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),-0.3314822590150377,-1.2063609464609495,0.1780821917808219,0.5341766243441052,1.0,25/65,25.25%,FHL1;PSMA6;PSMB5;PABIR1;PSMC4;PSMC5;PSMD14;AVEN;FBXL7;RBX1;PSMD8;PSMD11;PSMB4;PSMD12;PSMC1;CUL1;CHEK1;CDK5RAP3;PSMA1;PSMB1;PSMC3;PSMA4;PSMA2;VPS4A;PSMB8
prerank,immune response-regulating cell surface receptor signaling pathway (GO:0002768),0.5122128341221629,1.2060614191822197,0.27230046948356806,0.6396083890806875,1.0,4/10,18.79%,KIT;LYN;BTLA;FGR
prerank,positive regulation of neuroblast proliferation (GO:0002052),-0.5256066733326509,-1.2060267366603714,0.2631578947368421,0.5344028487792175,1.0,7/10,31.14%,VEGFA;FZD3;DISC1;CX3CR1;KDM1A;CTNNB1;SMARCD3
prerank,positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),-0.3715551686207081,-1.2059352829036551,0.19001919385796545,0.5339983813721707,1.0,14/37,21.54%,CAV1;RACK1;RPS3;UBB;BAX;SFPQ;BBC3;BCL2L1;RPS7;BCAP31;BAD;MSX1;NCK1;FIS1
prerank,negative regulation of osteoclast differentiation (GO:0045671),0.43507529223443,1.2057657170669256,0.25225225225225223,0.6390445767406461,1.0,3/18,5.08%,FBN1;GPR55;IL4
prerank,inhibitory synapse assembly (GO:1904862),0.50634717115221,1.2053683481263686,0.2616822429906542,0.638802182825104,1.0,2/11,5.56%,GABRA2;GABRB3
prerank,negative regulation of MAP kinase activity (GO:0043407),-0.35393914327308473,-1.2050100403936015,0.1806083650190114,0.5356461309094407,1.0,17/44,27.92%,PTPRJ;DAB2IP;AIDA;DNAJA1;UCHL1;NF1;STK38;APOE;SPRY1;CDK5RAP3;PTPN22;PTPN1;PRKCD;SMPD1;SPRY4;PDCD4;DUSP1
prerank,cardiac cell development (GO:0055006),-0.5043005904853253,-1.2048921715991963,0.23972602739726026,0.5352949804655375,1.0,4/11,5.68%,CXADR;NOTCH1;MYH11;VEGFA
prerank,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),0.32227005831963434,1.2048182696970018,0.16535433070866143,0.6389905235306009,1.0,7/86,4.95%,IGF1;BMP6;EPHA7;NRP1;TNK2;SFRP1;GHR
prerank,cellular modified amino acid catabolic process (GO:0042219),0.47212646480278464,1.2046606240363946,0.22494432071269488,0.6381324137486549,1.0,3/15,6.00%,ALDH4A1;PRODH;GGT7
prerank,regulation of interleukin-13 production (GO:0032656),-0.4921843849890551,-1.2040738047441877,0.22794117647058823,0.5367499806348975,1.0,5/13,12.85%,LEF1;PRKCZ;RARA;TNFRSF21;SPHK2
prerank,heart morphogenesis (GO:0003007),0.3554065701974579,1.203412953179823,0.1875,0.6401833756233386,1.0,7/50,5.17%,TGFBR3;FLRT2;BMP2;TBX3;CHD7;OLFM1;DLC1
prerank,regulation of sodium ion transmembrane transport (GO:1902305),-0.40054510379139324,-1.2031461670798582,0.2332089552238806,0.5384072498868643,1.0,4/27,3.29%,UTRN;NEDD4L;FXYD5;CAMK2D
prerank,cellular response to heat (GO:0034605),-0.37159741381348654,-1.2030098894010632,0.2003853564547206,0.5381548670697127,1.0,9/35,10.66%,THBS1;ANO1;FGF1;HSP90AB1;CLPB;HSBP1;TCIM;VCP;TRPV4
prerank,maintenance of protein localization in organelle (GO:0072595),-0.43211148369353125,-1.2029304027493626,0.22794117647058823,0.537735819370264,1.0,6/19,19.08%,HK1;AKT1;ARL2BP;HSPA5;CHCHD10;ARL2
prerank,transition metal ion homeostasis (GO:0055076),0.3966262239920556,1.2027838019195298,0.21956521739130436,0.6405872779284204,1.0,4/28,5.39%,CP;HEPH;NEO1;PRKN
prerank,cellular component assembly (GO:0022607),-0.2655200667163943,-1.202170990659669,0.0728051391862955,0.5390547961412041,1.0,53/253,16.41%,ACTB;OCLN;SLC2A1;LIMS2;BAIAP2L1;PARVB;SPTBN1;ACTG1;PARD3;RHOJ;EPS8;PTK2B;OPHN1;PLS3;FERMT2;CD2AP;TGFB1;ZW10;RAC1;LIMS1;GORASP2;RP1;NEDD9;PPARGC1A;PPP2R1A;TAPBP;REPS2;EZR;STK25;QSOX1;PDGFA;ADD1;FAS;FAM107A;CEP290;SPEF1;CD74;GAS8;TEAD2;YTHDF2;HAS1;VMP1;YWHAZ;HES1;TRAF1;CDAN1;WASL;MDN1;CHCHD10;SHROOM1;SKAP2;NCKAP1;RBBP4
prerank,regulation of epidermal cell differentiation (GO:0045604),0.43386215146733914,1.2021626761115687,0.21982758620689655,0.6409504823263893,1.0,2/21,2.62%,ERRFI1;ROCK2
prerank,BMP signaling pathway (GO:0030509),0.33918699186284107,1.2018560927423394,0.1908713692946058,0.640473292613942,1.0,5/62,2.77%,BMP6;TGFBR3;BMP2;BMP5;SMAD3
prerank,calcium ion import into cytosol (GO:1902656),0.4645206198370651,1.2017877221278364,0.25555555555555554,0.6393654580303222,1.0,3/15,8.94%,SLC8A1;CACNA2D1;SLC24A2
prerank,regulation of endopeptidase activity (GO:0052548),0.33583324798271635,1.2016470624195734,0.17777777777777778,0.6384629579276652,1.0,9/59,7.69%,TIMP3;SERPINE2;AHSG;SERPINI2;SERPINF1;SPOCK3;SERPINE1;TIMP4;PSMA3
prerank,cellular response to steroid hormone stimulus (GO:0071383),0.4524571696933898,1.2013103042497952,0.23554603854389722,0.6380593517539802,1.0,2/17,0.70%,ATP1A2;AR
prerank,cellular glucose homeostasis (GO:0001678),-0.36192812747009917,-1.201274767585794,0.19230769230769232,0.5407214324632861,1.0,9/41,5.37%,IGF1R;RACK1;UNC13B;LRRC8D;FOXO1;HK1;KCNB1;PPARGC1A;FOXK1
prerank,acylglycerol homeostasis (GO:0055090),0.43127912453712297,1.201007353597427,0.23660714285714285,0.6375396837182591,1.0,3/20,11.15%,RORA;IL18;PLA2G12B
prerank,establishment of protein localization to extracellular region (GO:0035592),0.3732870693479484,1.2009667307495648,0.1797520661157025,0.6363358728681,1.0,8/39,10.14%,STEAP3;TANGO2;ABCA1;RAB3C;MON1A;SCG2;RAB10;LTBP2
prerank,negative regulation of synaptic transmission (GO:0050805),0.4212344672986315,1.200959647578466,0.2323008849557522,0.6350816201571082,1.0,12/23,25.67%,TMEM25;SLC24A2;PTEN;DRD2;SYT11;ACHE;PRRT1;GRIK3;STXBP1;SHANK2;DRD3;SLC24A1
prerank,positive regulation of dendritic spine development (GO:0060999),-0.4280865636505433,-1.2004058974904572,0.2383612662942272,0.5422892181825555,1.0,8/20,13.09%,SHANK3;CAPRIN1;LRP8;CAMK1;DBNL;DBN1;APOE;FMR1
prerank,positive regulation of cellular component biogenesis (GO:0044089),-0.3119818482595889,-1.2001926129986569,0.1384928716904277,0.5422029366075373,1.0,26/88,15.29%,RACK1;TFRC;RPS3;DAB2IP;FNIP2;TGFB1;VEGFA;RGCC;ERCC1;BAX;TAL1;PFN1;WARS1;FLOT1;SYNPO;TIRAP;VCP;RAB7A;BAK1;SLX4;SYK;SLF1;SDCBP;TSG101;LIMK1;SNF8
prerank,production of small RNA involved in gene silencing by RNA (GO:0070918),0.4308370337089368,1.199729845645616,0.2192622950819672,0.6369757426478543,1.0,10/20,23.08%,HENMT1;AGO4;SNIP1;DROSHA;AGO3;AGO1;AGO2;MRPL44;ZC3H7B;DICER1
prerank,negative regulation of cell motility (GO:2000146),0.30333095665503695,1.1994754593105577,0.1492842535787321,0.6364256826728993,1.0,28/108,14.27%,ROBO1;LDLRAD4;PODN;FBLN1;SULF1;MAGI2;MITF;RECK;RAP2A;PTPRT;SFRP1;SPOCK3;DLC1;SRGAP2;SRGAP3;SERPINE1;DPYSL3;CITED2;GATA3;PTEN;FUZ;AFDN;NGFR;EPHA1;NAV3;NKX2-1;DRD2;ARPIN
prerank,regulation of transcription regulatory region DNA binding (GO:2000677),0.39817894527722275,1.1994570271101617,0.23284823284823286,0.635207028050998,1.0,3/25,9.13%,IGF1;NSD1;GATA3
prerank,negative regulation of nucleic acid-templated transcription (GO:1903507),-0.2543348778852279,-1.1990931976833459,0.049783549783549784,0.544415051900205,1.0,89/417,14.15%,MECOM;LEF1;FOXP1;ELK3;DACH1;WWP1;ATP8B1;RPS6KA5;NOTCH1;CBFA2T3;ID1;ZHX3;HMBOX1;ID3;PPARD;NCOR1;FOXO1;KLF4;DAB2IP;ZBTB7A;CDKN1B;TGFB1;REST;KDM5C;PRDM16;TBX2;HDAC9;HSPA8;WWP2;LIMS1;PFDN5;KCTD1;FOXD1;RLIM;CTBP1;PHC2;BHLHE40;SOX13;FOXK1;CD38;HEYL;ZBTB16;DPF2;CNOT7;MPHOSPH8;DPF3;RBFOX2;RARA;GATA6;SHC1;FOXN3;NR3C1;CBX5;PPM1F;CIC;UIMC1;HDAC4;ZMYND11;NDUFA13;BCL6;SOX7;TWIST1;TRIM28;HHEX;SOX18;RB1;ZC3H8;FOXP2;WNT11;ZBTB18;CCDC85B;SP3;SFPQ;LIMD1;PHC1;CIPC;E2F1;ZNF423;COMMD7;POU2F1;HES1;CIART;MTERF3;PHF12;EPC1;MLX;PHB2;SMARCA4;EID2
prerank,regulation of mitotic nuclear division (GO:0007088),0.35017420371470437,1.1989637478875013,0.19254658385093168,0.6352905818470947,1.0,12/55,13.30%,IGF1;AURKAIP1;TGFA;PHIP;CUL9;PDGFRB;IGF2;BORA;TOM1L2;TOM1L1;OBSL1;BTC
prerank,positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),-0.28024859180040085,-1.1987250330722807,0.10736842105263159,0.5446860099879888,1.0,49/158,21.16%,NOD1;TFRC;MID2;TRIM25;ATP2C1;FKBP1A;MAP3K3;REL;TNFSF10;S100B;IKBKB;BRD4;LURAP1;CASP8;RIPK1;EEF1D;GAPDH;PLK2;TRIM14;TIRAP;CD74;S100A13;PPP5C;TRIM62;MAVS;MIB2;EDA2R;TNFRSF1A;TRIM68;TRIM5;NOD2;TMEM101;LGALS1;ANKRD17;MIER1;TAB2;JMJD8;RELA;GPR89A;CHUK;PELI1;ECT2;IRAK4;CCDC22;CASP1;LTBR;LGALS9;TSPAN6;CANT1
prerank,response to thyroid hormone (GO:0097066),-0.47625693449155604,-1.1982792882998075,0.24118738404452691,0.5451391187856062,1.0,5/13,25.75%,LMO2;CTSB;GAS2L1;CTSS;RDX
prerank,positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),-0.391529802863402,-1.1973711038228563,0.2054794520547945,0.5468613398742147,1.0,15/29,34.63%,CAV1;THBS1;TNFSF10;RIPK1;INHBA;PPP2R1B;RET;LTBR;TNFRSF12A;BCL10;PMAIP1;PAK2;HYAL2;HTRA2;TNFSF12
prerank,positive regulation of myelination (GO:0031643),-0.4875719947456063,-1.1973340543017874,0.2491349480968858,0.5463474736415833,1.0,2/11,7.20%,PARD3;TNFRSF1B
prerank,regulation of mitochondrial fusion (GO:0010635),0.4964014704008642,1.1973097547216691,0.24472573839662448,0.6383430658736367,1.0,3/11,5.39%,PID1;OMA1;PRKN
prerank,regulation of mRNA polyadenylation (GO:1900363),0.44838287072405897,1.1971053076053169,0.24489795918367346,0.6376027180920408,1.0,11/17,23.41%,VIRMA;ZC3H3;CPEB3;CPSF7;CCNT1;CDK9;CPEB1;HSF1;CPSF6;NUDT21;CTR9
prerank,protein localization to vacuole (GO:0072665),-0.468681467738272,-1.1970456214796392,0.2332155477031802,0.5464871340797322,1.0,4/13,14.70%,SH3BP4;CD81;GLMP;MFSD1
prerank,regulation of hematopoietic stem cell differentiation (GO:1902036),-0.32164681993730254,-1.19698485116928,0.1657142857142857,0.5460458196747293,1.0,25/70,23.09%,LMO2;CBFB;GATA2;PRKDC;PSMA6;PSMB5;TAL1;PSMC4;PSMC5;YTHDF2;PSMD14;ITCH;SETD1A;PSMD8;LDB1;PSMD11;PSMB4;PSMD12;PSMC1;TCF3;PSMA1;PSMB1;PSMC3;PSMA4;PSMA2
prerank,phosphatidylinositol acyl-chain remodeling (GO:0036149),0.4521390482631154,1.1969690021444679,0.23333333333333334,0.6367117162913629,1.0,2/17,2.58%,PLA2G5;PLA2G4A
prerank,cellular response to inorganic substance (GO:0071241),-0.4227506720537279,-1.1967205283048024,0.2222222222222222,0.5460927044991979,1.0,3/21,4.92%,MTR;FOXO1;GUCY1B1
prerank,NIK/NF-kappaB signaling (GO:0038061),-0.31898906396671245,-1.1965326499066569,0.15939278937381404,0.5459540911541856,1.0,27/72,26.38%,CARD14;REL;TLR3;PSMA6;PSMB5;AKT1;RELB;TIRAP;PSMC4;PSMC5;PSMD14;PSMD8;PSMD11;PSMB4;PSMD12;PSMC1;RELA;CUL1;CHUK;PSMA1;PSMB1;PSMC3;PSMA4;PSMA2;TRAF6;PSMB8;CARD10
prerank,positive regulation of ERK1 and ERK2 cascade (GO:0070374),-0.28530120458316177,-1.1964975427026154,0.1194331983805668,0.5454287035823856,1.0,33/151,14.66%,TEK;BMPER;RAP1A;ACKR3;NOTCH1;SEMA7A;PTK2B;KDR;MAPK3;FERMT2;TNFAIP8L3;CD44;TGFB1;APP;MFHAS1;PRKCZ;SHC1;PDE8A;NPNT;FLT4;TNFRSF11A;CCL15;PDGFC;PDGFA;TIRAP;CD74;CIB1;APOE;FGF2;CSF1R;HRAS;PHB2;EGFR
prerank,histone monoubiquitination (GO:0010390),0.40650299641264626,1.1958414725030342,0.227765726681128,0.638477644520907,1.0,12/24,27.47%,BCOR;DDB2;RNF2;SKP1;TRIM37;WAC;PAF1;KDM2B;CTR9;RNF168;RYBP;LEO1
prerank,negative regulation of lymphocyte migration (GO:2000402),-0.5175217784168433,-1.1957312694271456,0.26556776556776557,0.546772240035808,1.0,4/10,19.17%,LRCH1;AKT1;WASL;CD200
prerank,positive regulation of protein serine/threonine kinase activity (GO:0071902),-0.3021860360569304,-1.1947969595737695,0.13690476190476192,0.5484296897491394,1.0,30/101,15.49%,FLT1;CCND3;FGF1;CCNY;TPD52L1;DAB2IP;FERMT2;CALM1;TGFB1;RALB;PKD1;PIK3R6;VEGFA;RGCC;EDN1;AKT1;PDGFC;PDGFA;TCIM;CAMK1;CIB1;MTCP1;CALM3;FGF2;CSF1R;HRAS;EGFR;ERBB2;CAB39;NOD2
prerank,regulation of fatty acid oxidation (GO:0046320),0.45758716149413226,1.194769786156742,0.25,0.6399422057151455,1.0,3/16,3.91%,PPARA;PRKAG2;PDK4
prerank,cardiac ventricle development (GO:0003231),-0.4245223626584166,-1.194177386588965,0.23497267759562843,0.5494015720476599,1.0,10/20,17.87%,NOTCH1;PDE2A;STRA6;HEYL;HES1;ENG;HEY1;HECTD1;TMEM65;DLL4
prerank,cellular response to interleukin-1 (GO:0071347),-0.28302578786717786,-1.1940985200423362,0.10515873015873016,0.5489770964640138,1.0,46/143,24.36%,RPS6KA5;NOD1;NFKBIA;MAPK3;IRAK2;DAB2IP;MAP3K3;UBB;UBC;RPS27A;IL1R1;IKBKB;PSMA6;MAP3K8;RC3H1;PSMB5;CCL15;TOLLIP;PSMC4;PSMC5;PSMD14;RBX1;PSMD8;NOD2;PSMD11;PSMB4;PSMD12;PSMC1;TAB2;RELA;CUL1;CHUK;PELI1;IRAK4;SOX9;HAS2;MAPK11;PSMA1;ADAMTS7;PSMB1;PSMC3;PSMA4;PSMA2;HYAL1;TRAF6;CCL2
prerank,iron ion transport (GO:0006826),0.35305725715582364,1.1939021417096063,0.2,0.6409233105989405,1.0,4/47,1.49%,CP;STEAP3;ATP6V0A4;HEPH
prerank,positive regulation of SMAD protein signal transduction (GO:0060391),0.4696071720226255,1.1936959004290364,0.2435344827586207,0.6402113721242232,1.0,3/13,9.35%,BMP6;TGFBR1;BMPR1A
prerank,establishment of endothelial intestinal barrier (GO:0090557),-0.5046659462735434,-1.1931037705915755,0.25693160813308685,0.5508937888197438,1.0,5/11,24.98%,F11R;TJP2;RAB1A;RAPGEF2;TJP1
prerank,regulation of protein serine/threonine kinase activity (GO:0071900),-0.302098204863545,-1.1929222504099835,0.13972055888223553,0.5507636690513774,1.0,28/104,19.30%,ACTB;CCND3;LRP5;DAB2IP;CALM1;CDKN1B;HTT;RALB;TRIB2;AKT1;CCNG2;TRIB1;RB1;CAMK1;CIB1;MTCP1;CALM3;CSF1R;TSG101;SNF8;CAB39;CCNF;CDKN1A;CCNK;CDKN2C;CDK5RAP3;GADD45A;CCND1
prerank,ventricular septum morphogenesis (GO:0060412),0.40036936904085485,1.1926862779228447,0.21729957805907174,0.6416459783798714,1.0,3/27,0.57%,ROBO1;TGFBR3;ROBO2
prerank,pinocytosis (GO:0006907),0.5018601075447487,1.1925419138196822,0.24761904761904763,0.6407722042793579,1.0,2/10,2.92%,AHSG;SNX33
prerank,membrane assembly (GO:0071709),0.3839408646884461,1.1921456359970337,0.21841541755888652,0.640559885440356,1.0,11/34,11.06%,NRXN1;LRP4;PTPRD;UBXN2B;NLGN2;NLGN3;UBXN2A;IL1RAPL1;NLGN1;PTEN;TLCD2
prerank,muscle organ development (GO:0007517),0.34538901045113163,1.1919639004108824,0.20392156862745098,0.6398005345907666,1.0,7/54,4.40%,IGF1;LAMA2;VAMP5;ITGA11;SGCD;SGCE;EVC
prerank,extracellular matrix assembly (GO:0085029),-0.4063585969078933,-1.1919330758892177,0.2277992277992278,0.5525720128654482,1.0,7/23,11.70%,RAMP2;TNXB;MYH11;TGFB1;NTN4;QSOX1;HAS1
prerank,development of primary male sexual characteristics (GO:0046546),0.37995468145842126,1.1918752857881392,0.23045267489711935,0.6387780309697972,1.0,7/34,9.13%,WNT4;AR;KIT;CSDE1;SIX4;ADAM21;GATA3
prerank,activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),-0.31592559281421395,-1.191315654126617,0.16829745596868884,0.5535109182295037,1.0,20/73,11.91%,ACER2;NOD1;RACK1;F3;EGLN3;NGF;CRADD;TNFSF10;HIP1R;ATP2A3;CASP8;RIPK1;BAX;FAS;HSPD1;HIP1;VCP;RPS27L;BEX3;BBC3
prerank,modulation of excitatory postsynaptic potential (GO:0098815),0.3939681274542749,1.191231513604796,0.2361111111111111,0.6391456877058312,1.0,11/26,13.19%,NRXN1;RIMS1;TMEM25;NLGN2;NLGN3;NLGN1;STX1B;CUX2;PTEN;CHRNA7;DLG4
prerank,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),0.25994310458451353,1.1910956076264696,0.0694980694980695,0.6383045697972114,1.0,71/390,12.96%,COL4A6;IGF1;EPHA7;PIK3R1;IL31RA;NRP1;FLRT2;ATP6V0A4;NTRK3;DDR2;ANGPT2;FGFR2;SULF1;NRG1;SULF2;KL;KIT;EFS;PDGFRA;MTSS1;EPHA3;TNK2;ROCK2;EPHA6;VEGFB;FLRT1;PDK4;PTPRT;STAP1;PHIP;LYN;DDR1;EFNA3;GHR;IRS2;AXL;SHC4;CASP3;PDGFRB;SIRT2;EPHB1;POLR1G;PDGFD;IGF2;ERBB3;RYK;POLR2G;FGFR4;CDK5R1;SH2D2A;EPHA8;AHI1;SH2D6;ERBB4;ESRP1;EPHA5;ATP6V1H;ALK;BRK1;MUSK;MST1R;NGFR;MERTK;GFRA2;ANKS1B;FGFR1;PRLR;KALRN;ROR1;EPHA1;BCAR1
prerank,regulation of protein kinase A signaling (GO:0010738),0.4244284107123483,1.1907599015021078,0.23739495798319327,0.6379587062926053,1.0,3/20,6.91%,ADGRV1;IAPP;CALCR
prerank,tRNA aminoacylation (GO:0043039),-0.36443768543199223,-1.1904258721658192,0.19120458891013384,0.5551224816285879,1.0,17/37,30.43%,SARS1;QRSL1;WARS2;CARS1;LARS2;WARS1;SARS2;TARS1;GATC;FARS2;FARSB;IARS1;GATB;GARS1;KARS1;NARS1;IARS2
prerank,positive regulation of gene expression (GO:0010628),-0.2501856282601659,-1.1903717255879778,0.05422993492407809,0.5546385207936689,1.0,87/442,13.26%,FN1;LEF1;MEF2C;ACTB;OCLN;CLDN5;THBS1;NOS3;CD34;TNRC6C;NOTCH1;DDX5;ACTG1;PLCG2;VIM;IL15;RPL26;FGF1;F3;KLF4;MAPK3;EEF2;RAMP2;TFRC;NIBAN1;RPS4X;RPS3;ETS1;NGF;RPL11;HNRNPLL;TGFB1;RBM20;APP;RAB27A;MSN;RPL23;SMO;PDE2A;LIMS1;FOXD1;PPARGC1A;MYOM1;IL33;VEGFA;ACTA2;EZR;ATF4;ADAM19;GATA2;PRKDC;LURAP1;TLR3;HCFC1;RGCC;RIPK1;KRAS;GAPDH;PPM1F;AKT1;RBM22;TWIST1;WARS1;FLOT1;DDRGK1;WNT11;RPS27L;GABPA;EIF3D;CD74;INHBA;LARP4B;S100A13;WBP2;CIRBP;FAM98A;SERPINB9;UPF3A;E2F1;RPS7;TLR4;SOX4;FGF2;SPHK2;AGPAT1;FMR1;PIK3R3
prerank,positive regulation of DNA biosynthetic process (GO:2000573),-0.3309288375568345,-1.190253824642953,0.18181818181818182,0.5543080693206516,1.0,32/60,37.80%,HMBOX1;KLF4;MAPK3;NEK7;HSP90AB1;RGCC;FBXO4;PNKP;FGF2;DKC1;CCT2;GREM1;HSP90AA1;CCT3;HNRNPA1;CCT8;PRKD2;RFC3;RFC2;CCT7;DSCC1;CTNNB1;CHTF18;MYC;PKIB;WRAP53;CCT4;MAP2K7;CCT6A;MAPK15;NVL;GRHL2
prerank,granulocyte chemotaxis (GO:0071621),-0.33505173761644047,-1.1900553920553396,0.19161676646706588,0.5541737577475226,1.0,10/55,14.21%,BSG;CXADR;ANXA1;TGFB2;PPIA;EDN1;CCL15;FCER1G;SYK;JAML
prerank,positive regulation of cell-substrate junction organization (GO:0150117),-0.40693274384999456,-1.1895734961494586,0.22179732313575526,0.5548002234951859,1.0,11/24,11.89%,TEK;PTPRJ;KDR;FERMT2;RAC1;LIMS1;VEGFA;MYOC;PPM1F;S100A10;DUSP3
prerank,positive regulation of collagen metabolic process (GO:0010714),0.44783511644613433,1.1891450511541775,0.24444444444444444,0.6409389376080561,1.0,3/17,3.98%,WNT4;LARP6;CREB3L1
prerank,positive regulation of interleukin-4 production (GO:0032753),-0.4504977927023966,-1.1891168610332408,0.24500907441016334,0.555346805863096,1.0,5/17,12.88%,SLC7A5;PRKCZ;RARA;FCER1G;SYK
prerank,carbohydrate derivative catabolic process (GO:1901136),-0.429497444512122,-1.1890736689761467,0.2545454545454545,0.5548500977157168,1.0,12/18,35.86%,MANBA;FBXO17;SAMHD1;OGA;FBXO6;NEU2;NAGA;FBXO2;STT3B;FUCA1;AOAH;NEU4
prerank,heterochromatin organization (GO:0070828),-0.4627507250189981,-1.189036956924231,0.2641843971631206,0.5543380648298738,1.0,2/14,4.27%,MECOM;PRDM16
prerank,neuron projection morphogenesis (GO:0048812),0.2927885265119424,1.1889868307130598,0.14559386973180077,0.6401233255278507,1.0,28/137,10.85%,NRK;EPB41L3;FGFR2;CNTN4;CNTNAP2;LRP4;GPM6A;FLRT1;DOCK10;CTNNA2;SLITRK4;MYO16;SRGAP2;CTNND2;EPHB1;ALCAM;GAS7;TNIK;NLGN1;MAPK8IP2;DOCK7;NRCAM;RYK;RAB10;DCC;FARP1;PTEN;BRSK1
prerank,mesenchyme development (GO:0060485),0.45728913005341715,1.1887157643890955,0.25773195876288657,0.6396572779231178,1.0,3/15,7.96%,BMP2;FGFR2;TGFBR1
prerank,tRNA transport (GO:0051031),-0.36413003058635907,-1.1886816571258407,0.21361058601134217,0.5546208784758077,1.0,17/35,34.81%,NUP93;NDC1;NUP54;NUP188;NUP155;RANBP2;NUP37;NUP160;NUP43;SEH1L;SEC13;NUP107;NUP42;NUP98;RAE1;NUP88;NUP214
prerank,regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),-0.485039321627349,-1.1885313960939061,0.25321100917431194,0.5543295506791288,1.0,3/12,3.87%,PTPRJ;F3;IFT20
prerank,membrane protein proteolysis (GO:0033619),-0.36271652785686914,-1.1882350352489939,0.1973929236499069,0.5544417735429173,1.0,12/37,17.85%,BACE2;TGFB1;ADAM10;BACE1;RHBDD1;ADAM19;ERAP1;MBTPS2;PSENEN;APH1A;RELA;RET
prerank,regulation of clathrin-dependent endocytosis (GO:2000369),0.46708351861312414,1.1880409271213324,0.27901785714285715,0.6402479528971426,1.0,4/15,6.18%,TNK2;DGKD;AAK1;SNAP91
prerank,"regulation of synaptic transmission, GABAergic (GO:0032228)",0.45864921986727936,1.1872408558550245,0.2488986784140969,0.6411095911989295,1.0,7/15,16.40%,NLGN2;NLGN1;CNTNAP4;BAIAP3;DRD2;ADRA1A;CLN3
prerank,nerve growth factor signaling pathway (GO:0038180),-0.5013626876396049,-1.187003488836113,0.24645390070921985,0.5569157202158632,1.0,3/10,3.71%,RAP1A;RAPGEF1;NGF
prerank,positive regulation of cellular catabolic process (GO:0031331),0.2913399413681631,1.1869158844565955,0.14147286821705427,0.6407129011518726,1.0,14/132,6.12%,IGF1;SH3D19;ZBTB20;PPARA;DCN;TRIM38;SNX33;PIM2;PFKFB4;TICAM1;IRS2;DAPK1;ABCD2;LIN28B
prerank,cell-cell junction assembly (GO:0007043),0.336117887985899,1.1868007416645108,0.1936842105263158,0.6397781365786932,1.0,14/63,6.72%,EPB41L3;TLN2;GJB6;GJA1;CDH8;PRKCA;CDH18;DCHS1;ARVCF;CTNND2;CDH11;CDH20;CDH19;CDH7
prerank,regulation of dendritic spine morphogenesis (GO:0061001),-0.3851850012308463,-1.1865211427104358,0.2205607476635514,0.55746833661532,1.0,9/31,12.32%,SHANK3;SIPA1L1;ABI3;CAPRIN1;LRP8;CFL1;DBNL;DBN1;SRCIN1
prerank,regulation of spindle organization (GO:0090224),0.44003126137132875,1.1864016807335693,0.26954732510288065,0.6396396656038137,1.0,7/18,19.01%,GNAI1;MAP9;BORA;FSD1;PARP3;NUMA1;NUP62
prerank,negative regulation of biomineral tissue development (GO:0070168),0.41854026974655234,1.1861757275508586,0.24774774774774774,0.6389863794112135,1.0,4/21,2.62%,ENPP1;BCOR;AHSG;ROCK2
prerank,potassium ion import across plasma membrane (GO:1990573),-0.3502966443176377,-1.1861245038359935,0.2189239332096475,0.5577775355686014,1.0,10/41,12.17%,SLC12A7;SLC12A2;KCNJ2;ABCC9;ATP1A1;KCNJ10;ATP1B1;KCNJ8;KCNK9;KCNJ15
prerank,vesicle transport along actin filament (GO:0030050),-0.42557501533862746,-1.1860950196453672,0.25,0.5572449121903703,1.0,3/19,2.18%,MYO1D;FNBP1L;ACTN4
prerank,calcium ion import (GO:0070509),0.3963626304723812,1.1859289731304905,0.23917525773195877,0.6384321055671167,1.0,7/28,7.60%,SLC8A1;CACNA1E;ATP2A2;CACNA1I;MICU3;CACNA1G;CACNB2
prerank,positive regulation of response to endoplasmic reticulum stress (GO:1905898),0.43378084211866885,1.1857335283458532,0.27741935483870966,0.6376919417499971,1.0,2/18,1.22%,PIK3R1;BCL2L11
prerank,cellular protein modification process (GO:0006464),-0.23355846239322184,-1.1850304441414132,0.016706443914081145,0.5594232059384341,1.0,217/982,17.51%,FN1;PTPRB;PRKCH;ST3GAL6;PTPRG;ERG;ST3GAL4;PTPN14;CDK6;MAP3K5;ST8SIA4;CTTNBP2NL;IGFBP7;THBS1;GPC3;RPS6KA5;PTPRJ;PRKG1;CDK17;TGFBR2;MAP4K3;PTK2B;RAB11A;BMPR2;TGM2;PEAK1;LIMK2;HIPK1;NLK;MAPK3;EGLN3;WNK1;LMO7;MANBA;STK10;BMX;COL3A1;NEK7;CAMK2D;PLOD2;ANXA1;MAP3K1;MAP3K20;SOCS2;IGFBP5;FNIP2;TGFB1;APP;TGFB2;RBBP5;FAM20A;SUMF2;KLHL5;WWP2;CSNK1G2;MSLN;ADAM10;SPARCL1;PRKCZ;CTDSP1;CTBP1;PTPRM;IGFBP3;MINK1;SSH2;DCAF6;ZBTB16;PPP3CC;RHBDD1;TAOK3;NRBP1;PTP4A2;PPP2R1A;KLHL2;IKBKB;RARA;ST8SIA6;PRKDC;FBXO17;BCR;MSRA;MGAT1;NUCB1;PSMA6;CSNK1G3;SRPK1;PPP2R5A;DCUN1D1;PPM1F;WSB2;TRIB2;STK25;QSOX1;MFGE8;CUL4A;PSMB5;FBXO4;PLK2;UBE2L6;DYRK2;AKT1;INSR;CST3;MAP3K11;SPP1;CDC42BPB;CPE;PNPLA2;ATG3;TRIB1;PIM3;ART3;PPP1CB;ATG7;RAB8A;LMTK2;ASB8;COPS6;WNT11;UBE2F;DAD1;PSMC4;CAMK1;WDTC1;CDK4;ABL2;TAOK2;PSMC5;FRK;STK36;FBXL14;VRK1;RAB11B;PPP2R1B;STK38;CHRDL1;GRK5;ACVR1;MMP15;PKN3;PPP5C;PSMD14;YWHAZ;FBXW5;FBXW10;APOE;PRKCE;CDK10;PPP3CB;ICMT;FSTL1;PPP2R2A;SYK;COPS5;KLHL3;FBXL7;CDC14B;FASTK;SUMF1;PIGT;ST6GALNAC2;CDKL4;TBCK;SERP2;FBXL2;NUAK1;NPC1;LOX;NUAK2;FUCA2;CISH;FEM1A;PTPN12;RBX1;RAB1A;JAK2;F13A1;COG3;PSMD8;ERBB2;PRKAG1;COQ8A;WSB1;MTM1;LMTK3;PARP2;GLRX;LIMK1;NEK3;PTPN6;PSMD11;YES1;CCNF;STK38L;STK26;CDK13;UCHL3;CSNK2A1;LGALS1;UFL1;DSP;PSMB4;PSMD12;PSMC1;PHEX;FBXL3;FBXL16;F5;PPP2R5E;GAN;CTH;RCE1;MAP3K9;JAK3;HCK;CUL1;MCRS1
prerank,regulation of microtubule-based process (GO:0032886),0.3673748790659191,1.1848941152474466,0.242152466367713,0.6386873614281763,1.0,9/36,14.58%,PHLDB2;EPHA3;ATF5;KLHL42;MEMO1;BICD1;MAP10;MAPT;MAP6
prerank,response to insulin (GO:0032868),0.3170819037198065,1.1840614226810655,0.17672413793103448,0.6396475641582414,1.0,12/80,10.60%,ENPP1;PIK3R1;TBC1D4;PDPK1;MYO5A;IRS2;RAB10;PDE3B;C2CD5;INSIG2;PRKCI;LPIN3
prerank,positive regulation of leukocyte apoptotic process (GO:2000108),-0.4918869772101867,-1.183644624712218,0.25,0.5622271490622952,1.0,2/11,3.46%,MEF2C;ANXA1
prerank,positive regulation of lymphocyte proliferation (GO:0050671),-0.3261733127221817,-1.1831481589222133,0.19881889763779528,0.562924624211259,1.0,18/63,23.82%,MEF2C;IL15;SLC7A1;TFRC;ANXA1;CD38;CD81;TIRAP;CD74;CLCF1;JAK3;CD320;NCK1;FGF10;IL6ST;TNFSF13B;NCK2;AIF1
prerank,response to interleukin-4 (GO:0070670),-0.5005539215594789,-1.1831274039072084,0.26,0.5623587533483795,1.0,5/10,27.84%,LEF1;XBP1;JAK3;SHPK;TCF7
prerank,platelet-derived growth factor receptor signaling pathway (GO:0048008),0.4441260964758582,1.1829784653579989,0.2708333333333333,0.6412324782116605,1.0,4/16,7.92%,NRP1;PDGFRA;PDGFRB;PDGFD
prerank,regulation of lamellipodium morphogenesis (GO:2000392),-0.5005444988481884,-1.1827080151894134,0.2433392539964476,0.5628002302296718,1.0,2/11,3.73%,RREB1;CD44
prerank,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),-0.4273347774980576,-1.1825119452305344,0.23985239852398524,0.5627089701857891,1.0,4/17,13.51%,CD55;TLR4;IL18BP;BTN3A3
prerank,regulation of cellular senescence (GO:2000772),-0.3892862355060678,-1.1823928929581267,0.24610051993067592,0.5623765689071083,1.0,6/28,9.25%,CDK6;B2M;MAP3K3;ABI3;TWIST1;YPEL3
prerank,regulation of cell-cell adhesion (GO:0022407),-0.3586332453760506,-1.1818081390951765,0.1948529411764706,0.5633795152520469,1.0,8/39,5.31%,PTPRG;PODXL;CDH1;DPP4;PTK2;SMAD7;TGFB1;MINK1
prerank,toll-like receptor 4 signaling pathway (GO:0034142),-0.434619575619812,-1.1815473994068781,0.24953095684803,0.5634393643368847,1.0,5/19,12.43%,LBP;TIRAP;PIK3AP1;PRKCE;TLR4
prerank,glomerular visceral epithelial cell differentiation (GO:0072112),-0.4819983399145848,-1.1811613621756132,0.25,0.5638363559860661,1.0,3/12,2.73%,PODXL;PROM1;IQGAP1
prerank,negative regulation of interferon-beta production (GO:0032688),-0.5102383492044734,-1.1811482156908866,0.2568306010928962,0.5632465390471926,1.0,6/10,32.30%,REL;YY1;RELB;LILRB1;PTPRS;NLRC3
prerank,regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),-0.3160985188508456,-1.1810462513133988,0.18497109826589594,0.5628522529993714,1.0,29/74,25.25%,NOTCH1;EGLN3;UBB;UBC;RPS27A;VEGFA;PSMA6;EGLN2;PSMB5;PSMC4;EGLN1;PSMC5;LIMD1;PSMD14;RBX1;PSMD8;PSMD11;PSMB4;PSMD12;PSMC1;ELOB;HIGD1A;PSMA1;PSMB1;PSMC3;PSMA4;PSMA2;HIF1AN;PSMB8
prerank,lysosome localization (GO:0032418),-0.35551780915620507,-1.1809031849271567,0.22396856581532418,0.562608369470834,1.0,20/37,31.97%,PLEKHM1;PLEKHM2;BORCS5;PIP4P1;S100A13;FAM98A;NDEL1;SPAG9;VPS33A;ARL8B;TFEB;MILR1;BORCS6;PIK3CG;MYH9;KXD1;KIF5B;VPS33B;RAB3A;LAMTOR1
prerank,ganglion development (GO:0061548),0.4942201751276997,1.1807276203136312,0.2557603686635945,0.645840531429864,1.0,3/11,7.40%,NRP1;SEMA3A;UNC5C
prerank,positive regulation of telomere maintenance via telomere lengthening (GO:1904358),-0.36972043788976516,-1.1805925373750177,0.20408163265306123,0.5627749051232602,1.0,10/35,19.52%,HMBOX1;MAPK3;NEK7;HNRNPA2B1;FBXO4;PNKP;CCT2;CCT3;HNRNPA1;CCT8
prerank,cellular macromolecule catabolic process (GO:0044265),-0.3383069048519722,-1.1805838754350417,0.2032967032967033,0.5621924781317649,1.0,23/49,31.18%,MANBA;DAB2IP;MTREX;FBXO17;IDE;RIPK1;DENND3;PPP1R8;UBE2G2;RNF5;UBE2G1;OGA;DNASE1L2;RNASEH2C;DFFB;FBXO6;NEU2;FBXO2;STT3B;MAGEC2;XRN2;ISG20;SIDT2
prerank,anion transport (GO:0006820),-0.373345449531466,-1.1805485884447378,0.24606299212598426,0.5616815278034188,1.0,5/33,2.31%,ABCG2;SLC26A7;SLCO2B1;LRRC8C;LRRC8D
prerank,negative regulation of secretion by cell (GO:1903531),-0.3564404297032703,-1.180287421501877,0.21511627906976744,0.5617168460557083,1.0,7/38,13.25%,STXBP6;NOTCH1;ANXA1;TNFRSF1B;DPH3;APOE;TNFRSF1A
prerank,positive regulation of actin filament polymerization (GO:0030838),-0.34452075096111845,-1.180247028096101,0.2055888223552894,0.5612197990335304,1.0,12/44,23.65%,BAIAP2L1;PTK2B;LMOD1;PFN1;PRKCE;NCKAP1;HCK;CDC42EP3;CTTN;NCK1;CARMIL1;NCK2
prerank,regulation of carbohydrate catabolic process (GO:0043470),-0.3486072421961417,-1.1802253400654845,0.20917431192660552,0.5606747003744357,1.0,18/41,27.54%,ZBTB7A;NUP93;NDC1;NUP54;NUP188;NUP155;RANBP2;PRKAG1;NUP37;JMJD8;NUP160;PGAM1;NUP43;SEH1L;SEC13;NUP107;NUP42;NUP98
prerank,muscle cell differentiation (GO:0042692),-0.37355502737171387,-1.180219782144362,0.20430107526881722,0.560084158086269,1.0,6/32,2.95%,MEF2C;NEBL;MRTFB;SYNE1;DMD;TBX1
prerank,regulation of endothelial cell apoptotic process (GO:2000351),-0.35950993342955406,-1.1802005333765782,0.20952380952380953,0.5595206141076239,1.0,7/39,7.21%,TEK;ANO6;THBS1;KDR;RAMP2;GATA2;RGCC
prerank,endothelial tube morphogenesis (GO:0061154),-0.5066728025324151,-1.1792357131715903,0.271304347826087,0.5612802824480531,1.0,7/10,31.12%,STARD13;CSNK2B;RHOB;PRKD2;CTNNB1;ACVRL1;RHOA
prerank,modification-dependent macromolecule catabolic process (GO:0043632),-0.5008643694530626,-1.1791045889283072,0.27941176470588236,0.5610064520620046,1.0,4/10,10.66%,UBB;UBC;RPS27A;DIS3L2
prerank,nuclear membrane reassembly (GO:0031468),-0.32907014049149674,-1.1786314925629329,0.19734345351043645,0.5615307975879203,1.0,29/54,32.17%,LBR;PPP2R1A;CHMP2B;CC2D1B;NUP93;NDC1;VRK1;PPP2R2A;NUP188;NUP155;NUP37;IST1;REEP4;CHMP2A;RANGAP1;RCC1;NUP160;VPS4A;NUP43;SEH1L;SEC13;NUP107;NUP98;CHMP7;CDK1;BANF1;UBE2I;CHMP4B;CHMP4A
prerank,positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),-0.31917508556589996,-1.178614999485874,0.1785028790786948,0.5609632349535778,1.0,27/78,24.42%,CAV1;CBFA2T3;RACK1;RNF144B;SMAD7;GABARAP;SH3RF2;TRIB2;PABIR1;TRIB1;DDRGK1;VCP;USP5;BCAP31;RBX1;SGTA;HECTD1;FZR1;HSPA1A;RNF19A;ELOB;KEAP1;TRIB3;HSPA1B;PLK3;RAD23A;COP1
prerank,"positive regulation of DNA-templated transcription, elongation (GO:0032786)",-0.4066328957197795,-1.1785632990509498,0.23962264150943396,0.5604748870250892,1.0,8/22,25.57%,BRD4;HMGN1;ALYREF;CDK13;CCNK;DDX39B;EAPP;ELL
prerank,cell-cell junction organization (GO:0045216),-0.31213052436765026,-1.1785515876436976,0.15831663326653306,0.5599120928084593,1.0,19/79,10.88%,PKP4;OCLN;CLDN5;LIMS2;CXADR;CDH1;CTNNA1;TJP2;TGFB1;TGFB2;SDK1;LIMS1;CDH4;TGFB3;JUP;GJC1;PVR;TRPV4;CDH6
prerank,divalent inorganic cation homeostasis (GO:0072507),-0.40257802835902556,-1.1784884075534452,0.25961538461538464,0.5595037407382945,1.0,5/25,8.00%,CAV1;TMTC2;TRPM7;FAM20A;JPH2
prerank,lipid translocation (GO:0034204),-0.41783506750951366,-1.1784710354471186,0.23738317757009345,0.558948034461645,1.0,6/21,8.51%,ATP10A;ATP8B1;ATP8A1;ATP11C;ATP11A;ATP9B
prerank,positive regulation of protein exit from endoplasmic reticulum (GO:0070863),-0.46251256371001936,-1.178461364993527,0.25486725663716814,0.5583801579263431,1.0,7/13,31.00%,CD81;BCAP31;TMEM30A;EDEM2;SEC16B;TMEM30B;EDEM1
prerank,sensory perception of chemical stimulus (GO:0007606),0.46350992040554634,1.178411782339683,0.2611464968152866,0.650675484824663,1.0,4/15,14.15%,OMP;SLC24A4;UBR3;DRD2
prerank,regulation of cell motility (GO:2000145),-0.29044846714626166,-1.1782738870082854,0.16338582677165353,0.558251147265268,1.0,34/121,14.97%,TMSB4X;FRMD5;CDK6;SPOCK2;FGF1;CYRIB;TGFB1;PLXNA4;RAC1;CAVIN1;ROBO4;MINK1;AMOT;DIAPH1;CRK;CCDC125;SPATA13;ABI3;AKT1;TWIST1;TMSB10;RHOB;PLXNA1;PLXND1;ABL2;RCC2;SRCIN1;FGF2;CSF1R;NTN1;EGFR;ERBB2;OSGIN1;LDB1
prerank,L-amino acid transport (GO:0015807),0.396511999340773,1.1781713967511689,0.24061810154525387,0.6500972696342662,1.0,10/28,15.99%,SLC1A3;SLC7A2;SLC36A2;SLC7A9;SLC25A13;SLC38A3;CTNS;SLC1A2;SLC7A3;SLC25A18
prerank,amyloid-beta metabolic process (GO:0050435),-0.4423891144338966,-1.1779964924221287,0.25932504440497334,0.5583391922431592,1.0,6/16,14.31%,BACE2;BACE1;IDE;PSENEN;ACE;APH1A
prerank,leukotriene metabolic process (GO:0006691),0.43312492393289337,1.1779199843068158,0.25840336134453784,0.6495243261162805,1.0,4/19,7.34%,PLA2G5;ALOX12;PLA2G4A;DPEP2
prerank,regulation of dephosphorylation (GO:0035303),-0.4465558685104493,-1.1778394058059662,0.2743682310469314,0.5581403299877827,1.0,8/15,30.99%,PPP1R16B;IGBP1;PPP1R16A;SMG7;CDK5RAP3;MTMR2;SRC;SMG6
prerank,neutrophil migration (GO:1990266),-0.3295308781667024,-1.1776802527765133,0.19207920792079208,0.5579600158693154,1.0,10/58,14.21%,PECAM1;BSG;CXADR;TGFB2;PPIA;EDN1;CCL15;FCER1G;SYK;JAML
prerank,nucleoside diphosphate metabolic process (GO:0009132),-0.44773884719411267,-1.1768438707164715,0.24057450628366248,0.5595305773778173,1.0,3/15,12.49%,ENTPD1;ENTPD7;ENTPD6
prerank,negative regulation of nuclear division (GO:0051784),0.4943438984001113,1.176785528835458,0.27546296296296297,0.6511928662508824,1.0,4/11,16.63%,AURKAIP1;TOM1L2;TOM1L1;FBXO5
prerank,positive regulation of transferase activity (GO:0051347),0.2958647709704021,1.1766126039433618,0.1686746987951807,0.6504724525092929,1.0,37/142,13.39%,EPHA7;NTRK3;DDR2;FGFR2;KIT;PDGFRA;EPHA3;EPHA6;LMO4;DDR1;MAPKAPK5;AXL;PDGFRB;EPHB1;IGF2;ERBB3;RYK;FGFR4;EPHA8;RFC5;PABPN1;ERBB4;EPHA5;TOPORS;ALK;MUSK;HNRNPD;CHRNA7;MST1R;DCUN1D4;MERTK;FGFR1;NBN;ROR1;EPHA1;SERINC1;PARN
prerank,xenobiotic transport (GO:0042908),-0.43738357950841467,-1.1764138422392212,0.25493716337522443,0.5599847203737273,1.0,3/17,1.79%,ABCG2;SLC47A1;SLC7A5
prerank,response to endoplasmic reticulum stress (GO:0034976),-0.29574848339528925,-1.1759952023316516,0.145748987854251,0.5604872987081224,1.0,41/107,23.34%,MAP3K5;THBS1;RASGRF2;NIBAN1;SEL1L;DAB2IP;TMEM259;GORASP2;RHBDD1;UFM1;ATP2A3;ATF4;MBTPS2;DNAJB12;BAX;FLOT1;DDRGK1;RNF185;VCP;HSPA5;BBC3;BAK1;RNF5;ERP44;BCAP31;UFL1;PIK3R2;UFC1;CDK5RAP3;UBA5;ERLEC1;CREB3L2;NCK1;TMEM33;PDIA4;TRIB3;SELENOK;THBS4;ERO1A;ATF3;BRSK2
prerank,positive regulation of myoblast differentiation (GO:0045663),-0.44410652821362795,-1.1758920123653605,0.2640144665461121,0.5601488280019795,1.0,3/16,5.28%,MEF2C;BOC;IGFBP3
prerank,positive regulation of posttranscriptional gene silencing (GO:0060148),-0.4899219942268577,-1.1755481838990673,0.26256983240223464,0.5603977232171634,1.0,5/11,19.76%,DHX9;WTIP;LIMD1;FMR1;PUM2
prerank,regulation of dopamine secretion (GO:0014059),0.39743015753830446,1.1751931004669012,0.23768736616702354,0.6530354037276227,1.0,9/25,18.08%,GDNF;PRKN;SYT1;CHRNA4;SYT13;DRD2;SYT11;SYT12;SYT6
prerank,negative regulation of cell migration (GO:0030336),0.2870630434459319,1.1750115372011012,0.14516129032258066,0.6523096047798417,1.0,19/137,5.80%,ROBO1;LDLRAD4;PODN;SULF1;PHLDB2;LRP1;GJA1;MAGI2;MITF;RECK;RAP2A;PTPRT;SFRP1;MCC;IL4;DLC1;SRGAP2;SRGAP3;SERPINE1
prerank,regulation of axon extension involved in axon guidance (GO:0048841),0.3963841627394508,1.1748527290398507,0.255863539445629,0.6514953465988991,1.0,4/24,4.77%,NRP1;SEMA5A;SEMA3A;SEMA3D
prerank,chloride transport (GO:0006821),-0.3123131261153257,-1.1747675415815044,0.2,0.561795354229933,1.0,10/74,4.60%,SLC4A10;ANO6;SLC12A7;SLC26A7;CLIC4;SLC12A2;ANO1;CLIC1;CLIC5;SLC1A1
prerank,mitotic cell cycle phase transition (GO:0044772),-0.26994054477274754,-1.174044968052375,0.12673267326732673,0.5630544931265801,1.0,68/203,25.79%,CDK6;CCND3;EPS8;CCNY;DCTN2;TPD52L1;TUBA1A;CDKN1B;CEP164;PPP2R1A;PRKAR2B;CEP192;CEP57;CUL4A;PLK2;NES;CEP70;DCTN3;CCNG2;RB1;PPP1CB;CEP290;CNTRL;DCTN1;INHBA;E2F3;CDK4;CRLF3;PPP1R12B;PCM1;TUBB4B;ACVR1;E2F1;PPP2R2A;FBXL7;HAUS1;NDE1;CETN2;CEP72;YWHAG;CCNF;CDKN1A;ANAPC7;CDC27;HSP90AA1;CEP41;FBXL3;CUL1;CHMP2A;CDKN2C;CCND1;LCMT1;RCC1;DNM2;PPP2R2D;TUBA4A;EIF4EBP1;PLK3;ARPP19;PPP1R12A;BRSK2;CDKN2B;EIF4E;SPDYA;HAUS4;YWHAE;CEP63;NEDD1
prerank,positive regulation of heterotypic cell-cell adhesion (GO:0034116),-0.47590030010546075,-1.173804958474116,0.25627240143369173,0.5630634790878452,1.0,2/12,9.23%,CD44;FLOT1
prerank,ruffle organization (GO:0031529),-0.43658424526505374,-1.1736068817633698,0.2560296846011132,0.5629251998778377,1.0,11/16,39.25%,RAC1;CSF1R;CARMIL1;AIF1;PIP5K1A;PLEK;TPM1;LIMA1;CYFIP1;PLEKHA1;INPP5K
prerank,proteoglycan biosynthetic process (GO:0030166),0.38182145755636754,1.1733412459123282,0.26359832635983266,0.6542997443559815,1.0,4/31,4.91%,IGF1;CHST8;GAL3ST3;PXYLP1
prerank,fluid transport (GO:0042044),-0.4815140292511455,-1.1731172627394741,0.2469982847341338,0.5635645271413089,1.0,9/12,51.87%,AQP11;AQP4;SLC26A6;AQP1;SLC4A11;AQP9;AQP6;PDPN;AQP7
prerank,positive regulation of protein export from nucleus (GO:0046827),0.45735162002904195,1.172961005602209,0.27157894736842103,0.6540881186874973,1.0,5/15,17.96%,TCF7L2;XPO4;EMD;BAG3;TP53
prerank,mononuclear cell differentiation (GO:1903131),0.40234995640567756,1.1728545591239976,0.24946695095948826,0.653158328154044,1.0,4/24,5.75%,IL31RA;LYN;IL4;AXL
prerank,positive regulation of T cell activation (GO:0050870),-0.32137112182889904,-1.1727554984980022,0.19439252336448598,0.5639038625504295,1.0,17/62,24.36%,IL15;SLC7A1;TFRC;CYRIB;ANXA1;CD81;HSPD1;FLOT2;NOD2;XBP1;JAK3;LGALS9;NCK1;IL6ST;NCK2;AIF1;CCL2
prerank,regulation of gene expression (GO:0010468),-0.2336311535991768,-1.1722363714994797,0.01991150442477876,0.564644657244204,1.0,174/903,14.98%,BNC2;FN1;LEF1;FOXP1;MEF2C;PRDM6;OCLN;CDK6;CLDN5;AHNAK;APBB2;RREB1;CDH1;NOS3;RPS6KA5;CD34;TNRC6C;ESR1;NOTCH1;ACTG1;PLCG2;NOVA2;RPL6;SLC7A5;FGF1;AHNAK2;MBNL1;RACK1;HMG20B;KDR;JMJD1C;F3;KLF4;NLK;MAPK3;RAMP2;TFRC;RPS3;ETS1;SOX17;NGF;VSX1;RPL11;SIX1;HNRNPLL;TGFB1;RBM20;CNBP;REST;APP;TGFB2;RAB27A;TRRAP;AFF4;MSN;RPL23;SMO;PDE2A;NFYA;ZNF431;CRIP1;REL;WWP2;ASCC2;PPARGC1B;LIMS1;ADAM10;PFDN5;FOXD1;RLIM;PRDM2;PPARGC1A;BHLHE40;MYOM1;SOX13;SLC39A8;IL33;VEGFA;CNOT7;ACTA2;PTBP3;PPP2R1A;TAPBP;PRDM4;EZR;ATF4;ADAM19;FOXN3;ZNF326;GATA2;CASP8;NR3C1;TLR3;HCFC1;NFKBIZ;RGCC;KRAS;UBAP2;PPM1F;ATP1B1;YBX3;RC3H1;GPX1;NR2C2;YY1;HDAC4;ATXN1L;AKT1;SPIN1;INSR;FZD7;BCL6;FUS;SOX7;PCBP4;TWIST1;WARS1;TRIM14;SOX18;RB1;ESRRA;TDRD7;DDRGK1;ACE2;PRRX2;WNT11;MYBL1;HNRNPDL;GABPA;WTIP;CD74;INHBA;MTA1;CDK4;SP3;SOX12;KMT2D;SFPQ;LIMD1;TEAD2;YTHDF2;FAM98A;SERPINB9;E2F1;RPS7;ZNF423;APOE;CLK1;TLR4;SOX4;HINT1;TOB2;FGF2;TSKU;ENG;PIK3R3;FASTK;PHF12;BTN3A3;HRAS;POGZ;HCFC2;MLX;TRIM68;RNF20;CAVIN4;BCL6B;NR5A2;HEY1;TRIM5;HNRNPK;LDB1;FLOT2;PRKAG1
prerank,negative regulation of calcium ion transport (GO:0051926),0.45006936610873866,1.1718182577902843,0.27702702702702703,0.6545458231860931,1.0,2/15,7.92%,ATP1A2;TRIM27
prerank,regulation of purine nucleotide metabolic process (GO:1900542),-0.3466798184874529,-1.1716786586065244,0.21521335807050093,0.565385099137992,1.0,18/41,27.54%,ZBTB7A;NUP93;NDC1;NUP54;NUP188;NUP155;RANBP2;PRKAG1;NUP37;JMJD8;NUP160;PGAM1;NUP43;SEH1L;SEC13;NUP107;NUP42;NUP98
prerank,regulation of transforming growth factor beta production (GO:0071634),0.4348737473336676,1.1712237006972321,0.26961770623742454,0.6549104074747107,1.0,3/18,5.04%,LTBP1;SMAD3;LRRC32
prerank,L-glutamate transmembrane transport (GO:0015813),0.5107435777009879,1.1711666209504354,0.27293064876957496,0.6538680944778626,1.0,2/10,7.15%,SLC1A3;SLC25A13
prerank,regulation of brown fat cell differentiation (GO:0090335),-0.4382180959201164,-1.1710045998291525,0.26425855513307983,0.5664681655943972,1.0,3/16,5.34%,RREB1;SIX1;SOX13
prerank,cell-matrix adhesion (GO:0007160),-0.2974517598916587,-1.170906851419971,0.17131474103585656,0.5661047422150751,1.0,23/95,12.81%,FN1;ITGA1;THSD1;CD34;SORBS1;PEAK1;COL3A1;FERMT2;ITGB4;CD44;ADAM15;RAC1;MSLN;PKD1;BCAM;ACTN1;BCR;NPNT;VCL;EMP2;TAOK2;RCC2;ITGA7
prerank,positive regulation of MAP kinase activity (GO:0043406),-0.31521469833273436,-1.1702840438773499,0.1865079365079365,0.5671206345521368,1.0,21/66,15.49%,FLT1;MAP3K5;FGF1;RPS3;TPD52L1;DAB2IP;TGFB1;PIK3R6;VEGFA;TAOK3;EDN1;TNFRSF11A;MAP3K11;PDGFC;PDGFA;FGF2;ARHGEF5;HRAS;EGFR;ERBB2;NOD2
prerank,production of miRNAs involved in gene silencing by miRNA (GO:0035196),0.3833681140647886,1.1700470684229318,0.2402464065708419,0.6555806912716099,1.0,14/29,23.08%,TUT4;SMAD3;AGO4;LIN28B;SNIP1;METTL3;DROSHA;AGO3;AGO1;AGO2;MRPL44;ZC3H7B;PUS10;DICER1
prerank,negative regulation of protein tyrosine kinase activity (GO:0061099),0.40977397348964395,1.1698949972323234,0.25957446808510637,0.6547829850559761,1.0,4/23,7.40%,ERRFI1;CBLB;VPS25;ZFYVE28
prerank,negative regulation of small molecule metabolic process (GO:0062014),0.43221169501641793,1.1698671482982395,0.2863070539419087,0.6536569295167327,1.0,3/20,13.45%,WNT4;CRY1;EP300
prerank,mitochondrial protein processing (GO:0034982),0.48726292788717396,1.1695430789691936,0.27705627705627706,0.6532887631994677,1.0,5/11,20.83%,OMA1;IMMP1L;YME1L1;PMPCA;AFG3L2
prerank,regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),0.4193583386889883,1.1695256903668079,0.2757009345794392,0.6521664542700452,1.0,4/20,6.23%,SULF1;SULF2;CREB3L1;NPTN
prerank,import into cell (GO:0098657),0.36097873741330355,1.169446745483288,0.22764227642276422,0.6511781639311145,1.0,9/41,8.62%,SLC1A3;ATP1A2;SLC6A13;SLC22A4;SLC5A3;SLC29A1;SLC38A1;SNAP25;GLUL
prerank,actin filament bundle organization (GO:0061572),-0.3574628805433408,-1.1694115809612804,0.2381852551984877,0.568769558262523,1.0,7/33,9.68%,BAIAP2L1;EPS8;PLS3;NEDD9;EZR;ADD1;FAM107A
prerank,positive regulation of translation (GO:0045727),-0.3028954487869128,-1.1693996842517203,0.18452380952380953,0.5682080111074874,1.0,29/94,17.00%,THBS1;VIM;RPL26;EEF2;NIBAN1;RPS4X;RPS9;CNBP;UQCC2;PKM;PRKDC;YBX3;DHX9;RPS27L;EIF3D;LARP4B;RPS6KB2;YTHDF2;CIRBP;UPF3A;SOX4;FMR1;COA3;TRMT10C;UHMK1;ERBB2;RPUSD4;FASTKD3;PCIF1
prerank,potassium ion homeostasis (GO:0055075),-0.4018065308306471,-1.169331773973754,0.2391713747645951,0.5677850552286698,1.0,5/23,7.63%,SLC12A7;SLC12A2;KCNJ2;ATP1A1;ATP1B1
prerank,regulation of generation of precursor metabolites and energy (GO:0043467),-0.33515958361521914,-1.1690782022189061,0.224105461393597,0.5678635925574138,1.0,25/48,35.33%,ZBTB7A;PRDM16;NUP93;NDC1;NUP54;NUP188;NUP155;RANBP2;PRKAG1;NUP37;JMJD8;RUBCNL;NUP160;PGAM1;NUP43;SEH1L;SEC13;NUP107;NUP42;NUP98;NOS2;RAE1;NUP88;NUP214;GCGR
prerank,regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),0.3373239539993513,1.1685913731289115,0.20588235294117646,0.6522269205709228,1.0,4/56,1.32%,BMP6;BMP2;LDLRAD4;BMP5
prerank,histone H3-K36 demethylation (GO:0070544),0.4944349410261861,1.1685441132909495,0.27056277056277056,0.651184855803935,1.0,6/10,26.09%,KDM7A;KDM2A;PHF8;KDM4C;KDM2B;KDM4B
prerank,positive regulation of insulin receptor signaling pathway (GO:0046628),-0.47328358430178197,-1.1682551796103078,0.27205882352941174,0.5693583258089686,1.0,2/12,5.01%,SORBS1;PRKCZ
prerank,protein secretion (GO:0009306),0.3400912659056205,1.168057381549751,0.22083333333333333,0.6512543202891417,1.0,13/56,16.11%,WLS;STEAP3;TANGO2;ABCA1;RAB3C;MON1A;SCG2;RAB10;LTBP2;CYB5R4;COPG2;PORCN;SVBP
prerank,positive regulation of fatty acid oxidation (GO:0046321),0.47958666373536274,1.1680470194729344,0.29336188436830835,0.6501172060539289,1.0,3/12,6.04%,PPARA;IRS2;ABCD2
prerank,cellular biogenic amine biosynthetic process (GO:0042401),0.45200863279625814,1.1678659539149858,0.2710084033613445,0.649360089440053,1.0,3/15,7.03%,MOXD1;SAT1;TPH2
prerank,organelle transport along microtubule (GO:0072384),-0.37295937758189557,-1.166915234765854,0.24609375,0.5721668389849901,1.0,11/31,14.39%,TRAK1;UBB;HTT;TRAK2;BORCS5;RHOT1;COPG1;RHOT2;NDE1;NDEL1;RAB1A
prerank,positive regulation of protein autophosphorylation (GO:0031954),-0.4074319298853914,-1.1666217942513182,0.2572992700729927,0.5723161202488009,1.0,9/22,16.40%,CALM1;VEGFA;RASSF2;PDGFC;PDGFA;TAOK2;CALM3;ACE;GREM1
prerank,positive regulation of cholesterol efflux (GO:0010875),-0.4071693209649756,-1.1663861324021125,0.25794392523364484,0.5723448752332682,1.0,3/21,2.33%,CAV1;PLTP;NFKBIA
prerank,positive regulation of cytokine production (GO:0001819),-0.2531189551410584,-1.1659498219163877,0.09421841541755889,0.5728221599194484,1.0,114/292,32.07%,FOXP1;AFAP1L2;LBP;CD34;SPTBN1;PLCG2;IL15;SLC7A5;NOD1;IFIH1;F3;PDE4D;CYRIB;RPS3;ANXA1;GBP5;TGFB1;APP;PRKCZ;CYP1B1;IL1R1;LRRFIP1;IL33;RARA;ATF4;PRKDC;LURAP1;TLR3;RGCC;RIPK1;GAPDH;DDX41;FLT4;DHX9;TWIST1;FLOT1;FCER1G;HSPD1;TIRAP;DHX58;PAEP;CD74;S100A13;MAVS;TLR4;SPHK2;SYK;AGPAT1;POLR3E;CSF1R;RAB1A;POLR3A;NOD2;IL17RA;POU2F2;HSPA1A;RELA;XBP1;ARHGEF2;CGAS;TXK;PTGER4;CD200;LAPTM5;LGALS9;MAPK11;FZD5;IL6ST;HSPA1B;PRKD2;C3;PTPN22;POLR3B;PIK3CG;ZFPM1;AIF1;HILPDA;IL12RB2;TRAF6;BCL10;NFAM1;TMEM106A;PARK7;LAMTOR5;SOD1;CTNNB1;RASGRP1;CARD11;LILRB1;CD86;C1QTNF4;MRE11;NOX1;TLR6;POLR1C;POLR2F;EGR1;HTR2B;LY9;HYAL2;TLR1;SCRIB;NOS2;PLCB1;MBP;TLR5;PQBP1;TYROBP;POLR2L;CD14;CADM1;SLAMF6;KAT2A;NLRP3
prerank,TRIF-dependent toll-like receptor signaling pathway (GO:0035666),-0.3764671454513189,-1.165739182565703,0.25806451612903225,0.5727609448742182,1.0,7/29,7.38%,UBB;UBC;RPS27A;IKBKB;CASP8;TLR3;RIPK1
prerank,aggrephagy (GO:0035973),-0.3827490390740283,-1.1655522508494227,0.2532588454376164,0.5725929326017106,1.0,5/27,5.40%,VIM;UBB;DYNC1LI2;UBC;RPS27A
prerank,regulation of nucleocytoplasmic transport (GO:0046822),-0.4750445814522076,-1.1655029265832813,0.2921146953405018,0.5721283009368592,1.0,2/12,4.03%,PTPN14;TGFB1
prerank,T cell activation involved in immune response (GO:0002286),-0.46921668229849217,-1.1654564585242153,0.2854609929078014,0.5716669674994235,1.0,10/12,50.20%,FCER1G;CD74;ICAM1;LILRB1;SLC11A1;LCP1;ITGAL;F2RL1;IFNK;TNFSF18
prerank,positive regulation of T cell migration (GO:2000406),-0.4114188404216653,-1.1652557066053109,0.26838235294117646,0.5715568181529496,1.0,3/20,4.91%,WNK1;APP;ADAM10
prerank,chromatin organization involved in regulation of transcription (GO:0034401),-0.4548101554000273,-1.1652389346384266,0.27797202797202797,0.5710232934514781,1.0,5/13,18.68%,SERTAD2;ARID1A;ZMIZ2;CDCA4;CHEK1
prerank,negative regulation of intracellular protein transport (GO:0090317),-0.4013949952738892,-1.1652286108539547,0.26459143968871596,0.5704698183142158,1.0,13/22,39.25%,CHP1;UFM1;GDI1;RANGAP1;RAB23;DMTN;PARK7;BARD1;INSIG1;SIAH3;APOD;CABP1;INPP5K
prerank,actin filament bundle assembly (GO:0051017),-0.3598976412546385,-1.1652139365196983,0.2380038387715931,0.5699338227572185,1.0,7/33,9.68%,BAIAP2L1;EPS8;PLS3;NEDD9;EZR;ADD1;FAM107A
prerank,membrane protein ectodomain proteolysis (GO:0006509),-0.404981503200249,-1.1648125670375675,0.2560296846011132,0.5703461888347067,1.0,6/21,8.83%,BACE2;ADAM10;BACE1;ADAM19;ERAP1;PSENEN
prerank,anterograde synaptic vesicle transport (GO:0048490),-0.4455805642167362,-1.16463827935535,0.2697768762677485,0.5696025390182659,1.0,11/15,38.38%,AP3M1;AP3B1;DTNBP1;AP3M2;BLOC1S2;BLOC1S6;AP3D1;AP3S1;BLOC1S1;AP3B2;BLOC1S4
prerank,synaptic vesicle transport along microtubule (GO:0099517),-0.4455805642167362,-1.16463827935535,0.2697768762677485,0.5696025390182659,1.0,11/15,38.38%,AP3M1;AP3B1;DTNBP1;AP3M2;BLOC1S2;BLOC1S6;AP3D1;AP3S1;BLOC1S1;AP3B2;BLOC1S4
prerank,positive regulation of monooxygenase activity (GO:0032770),0.3928382475193667,1.1641059584620954,0.25900900900900903,0.6579676894414878,1.0,4/26,3.41%,GDNF;CYP27B1;VDR;POR
prerank,ERK1 and ERK2 cascade (GO:0070371),0.419414527781122,1.1637601378205684,0.2606837606837607,0.6576738571855126,1.0,1/21,0.08%,IGF1
prerank,peptidyl-threonine phosphorylation (GO:0018107),-0.32499828384015084,-1.1637439367747107,0.19961612284069097,0.571204921867536,1.0,16/59,16.04%,TGFBR2;HIPK1;NLK;WNK1;CAMK2D;PRKDC;DYRK2;AKT1;CDC42BPB;CSNK2B;LMTK2;ACVR1;CDK10;CAD;CSNK2A1;CSNK2A2
prerank,detection of light stimulus involved in sensory perception (GO:0050962),0.5041737274838388,1.163356338463935,0.26595744680851063,0.6564602871480415,1.0,10/10,49.61%,TULP1;CEP250;RPE65;GRM6;CNGB1;CACNA1F;GNAT2;CACNA2D4;REEP6;GNAT1
prerank,detection of light stimulus involved in visual perception (GO:0050908),0.5041737274838388,1.163356338463935,0.26595744680851063,0.6564602871480415,1.0,10/10,49.61%,TULP1;CEP250;RPE65;GRM6;CNGB1;CACNA1F;GNAT2;CACNA2D4;REEP6;GNAT1
prerank,neuron projection regeneration (GO:0031102),0.5019622809695764,1.1632294828136736,0.289760348583878,0.6556155068573255,1.0,2/10,5.48%,PTN;NREP
prerank,positive regulation of transcription regulatory region DNA binding (GO:2000679),0.41884975370901606,1.162785505782093,0.26991150442477874,0.6556079821493854,1.0,1/20,0.08%,IGF1
prerank,positive regulation of DNA binding (GO:0043388),0.374074973538946,1.1625348171498002,0.2752688172043011,0.6551227014877591,1.0,5/31,9.13%,IGF1;PRKN;SIRT2;PINX1;GATA3
prerank,pathway-restricted SMAD protein phosphorylation (GO:0060389),0.49118588704304034,1.1623312870695568,0.2909090909090909,0.654481137006304,1.0,2/11,0.54%,TGFBR3;BMP2
prerank,organic hydroxy compound transport (GO:0015850),-0.35498427549064027,-1.161956815839562,0.23047619047619047,0.5751207641779782,1.0,5/36,5.09%,ABCC4;SLCO1C1;ATP8B1;SLCO2B1;STRA6
prerank,"regulation of synaptic transmission, glutamatergic (GO:0051966)",0.34688015739045314,1.1619381516574814,0.23221757322175732,0.6542368620693986,1.0,10/46,7.83%,ATP1A2;NRXN1;GRM1;NLGN2;NLGN3;SYT1;CACNG4;NLGN1;GRIK1;MAPK8IP2
prerank,detection of mechanical stimulus involved in sensory perception (GO:0050974),0.4463702438544844,1.161871678226338,0.27692307692307694,0.6532665721886903,1.0,2/15,2.06%,ADGRV1;KIT
prerank,hepaticobiliary system development (GO:0061008),0.42069501098555334,1.1614549185172591,0.25806451612903225,0.6532059503456267,1.0,5/20,11.25%,TGFBR3;WNT4;CITED2;PRKCSH;ARID5B
prerank,negative regulation of stem cell differentiation (GO:2000737),-0.4682036233247333,-1.1614362155999454,0.2617801047120419,0.5758693276884557,1.0,4/12,12.83%,NOTCH1;REST;YTHDF2;HES1
prerank,regulation of lipid kinase activity (GO:0043550),0.478527927820469,1.160827232152066,0.2822966507177033,0.6535795508911513,1.0,1/11,0.26%,PIK3R1
prerank,ncRNA export from nucleus (GO:0097064),-0.35251514193494565,-1.1606145369461636,0.23191094619666047,0.5772935132333972,1.0,16/36,27.54%,NUP93;NDC1;NUP54;NUP188;NUP155;RANBP2;NUP37;NUP160;NCBP2;NUP43;SEH1L;SEC13;NUP107;NUP42;NPM1;NUP98
prerank,metanephric mesenchyme development (GO:0072075),0.5003579451631789,1.1604670041871217,0.29004329004329005,0.653402962589476,1.0,2/10,7.46%,WNT4;SIX4
prerank,negative regulation of calcium ion transmembrane transport (GO:1903170),0.5019527386832172,1.1601694611190998,0.2794759825327511,0.6530078207953058,1.0,1/10,0.47%,ATP1A2
prerank,negative regulation of T cell receptor signaling pathway (GO:0050860),-0.43412670854620433,-1.1600268828211107,0.27060931899641577,0.578181989251237,1.0,7/17,27.17%,PTPRJ;EZR;DUSP3;DGKZ;LAPTM5;PTPN22;PTPN2
prerank,negative regulation of transcription regulatory region DNA binding (GO:2000678),-0.46180402052317326,-1.1597384572863865,0.28136200716845877,0.5783246257924992,1.0,1/13,0.49%,TMSB4X
prerank,phosphatidylinositol biosynthetic process (GO:0006661),-0.2841724433996864,-1.1594199796821913,0.18016194331983806,0.578549047748465,1.0,35/119,17.68%,ITPKB;EFR3B;PLCG2;PIP5K1B;BMX;SOCS2;PI4K2A;INPP5D;PIK3R6;PIGL;CDS1;MTMR14;MTMR12;CDIPT;INPP5E;PIK3C2A;PIGF;PITPNM2;MBOAT7;RUFY1;PITPNM3;RAB4A;FGF2;PIK3R3;PITPNM1;IP6K1;CISH;PIGC;PIK3CA;MTM1;SYNJ1;PIK3R2;FIG4;PIK3C2B;PIGW
prerank,regulation of cardiac muscle cell proliferation (GO:0060043),0.41313215015511806,1.1589069730284511,0.25806451612903225,0.655224926263685,1.0,6/19,9.82%,TGFBR3;FGFR2;TGFBR1;RBPJ;BMPR1A;ERBB4
prerank,regulation of epithelial to mesenchymal transition (GO:0010717),0.3076793355780807,1.1586326599624548,0.1945031712473573,0.654785764788133,1.0,14/74,10.35%,BMP2;LDLRAD4;BMP5;PHLDB2;EPHA3;SMAD3;SFRP1;OLFM1;AXIN2;FOXA2;LOXL2;TGFBR1;GATA3;PTEN
prerank,regulation of protein exit from endoplasmic reticulum (GO:0070861),-0.45413632822221217,-1.1581665896654223,0.2906764168190128,0.5809821529785237,1.0,7/13,31.36%,CD81;GCC2;TMEM30A;BRSK2;SEC16B;TMEM30B;INSIG1
prerank,regulation of nucleic acid-templated transcription (GO:1903506),-0.2507492776922659,-1.1579954956485061,0.10039370078740158,0.5808458129030009,1.0,75/327,17.62%,BNC2;MEF2C;APBB2;RREB1;RPS6KA5;ESR1;NOTCH1;RPL6;ACTN4;JMJD1C;NLK;SOX17;VSX1;SIX1;CNBP;REST;TRRAP;NFYA;ZNF431;ASCC2;PPARGC1B;PFDN5;PRDM2;PPARGC1A;BHLHE40;SOX13;SLC39A8;PPP2R1A;ATF4;FOXN3;NR3C1;HCFC1;NR2C2;ATXN1L;SPIN1;INSR;FZD7;FUS;SOX7;SOX18;RB1;ESRRA;PRRX2;MYBL1;WTIP;SP3;SOX12;KMT2D;SFPQ;LIMD1;TEAD2;E2F1;ZNF423;SOX4;HINT1;ENG;PHF12;HCFC2;MLX;RNF20;NR5A2;LDB1;ZFHX3;SOX6;DRAP1;CELSR2;SMARCA2;LIN54;SAP30L;TCF3;RELA;ZNF22;CCAR2;BRCA2;SP1
prerank,cell morphogenesis involved in differentiation (GO:0000904),-0.31734606662202175,-1.1579876075924715,0.21887550200803213,0.5802821798555245,1.0,13/70,6.60%,FN1;TEK;MEF2C;PARVB;PXN;OPHN1;PEAK1;LAMA5;FERMT2;RAC1;NTN4;ATF4;ACTN1
prerank,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),0.37703060591992565,1.157686483057839,0.2543103448275862,0.6561010760877317,1.0,6/30,6.87%,TGFBR3;SMAD3;DKK3;TGFBR3L;NREP;SMURF2
prerank,positive regulation of macromolecule metabolic process (GO:0010604),-0.24852955249810504,-1.1576775883693817,0.09473684210526316,0.5805048777554115,1.0,67/348,13.26%,FN1;LEF1;MEF2C;OCLN;CLDN5;NOS3;CD34;TNRC6C;NOTCH1;ACTG1;PLCG2;FGF1;MAP2K5;F3;KLF2;KLF4;MAPK3;RAMP2;TFRC;RPS3;ETS1;NGF;RPL11;TGFB1;APP;RAB27A;MSN;RPL23;SMO;PDE2A;ANXA2;LIMS1;FOXD1;PPARGC1A;MYOM1;IL33;VEGFA;ACTA2;MPHOSPH8;EZR;ATF4;ADAM19;GATA2;TLR3;HCFC1;RGCC;KRAS;PPM1F;AKT1;INSR;TWIST1;WARS1;TRIM28;DDRGK1;WNT11;GABPA;CD74;INHBA;FAM98A;SERPINB9;E2F1;RPS7;TLR4;ITCH;FGF2;FMR1;PIK3R3
prerank,atrioventricular valve development (GO:0003171),-0.45244682172184725,-1.1576502411163143,0.2704761904761905,0.5800071304589031,1.0,5/14,5.49%,NOTCH1;TGFBR2;BMPR2;TGFB2;HEYL
prerank,regulation of cardiac muscle cell contraction (GO:0086004),-0.37808910119540134,-1.1574666452476419,0.25349301397205587,0.5799148313765807,1.0,9/27,19.15%,CAV1;PDE4D;CAMK2D;JUP;CTNNA3;DSG2;SRI;DSP;CACNA1C
prerank,positive chemotaxis (GO:0050918),0.43786841307895835,1.1569274456498069,0.26681614349775784,0.6569155851516459,1.0,3/17,7.29%,NRP1;SEMA5A;SCG2
prerank,hematopoietic progenitor cell differentiation (GO:0002244),-0.37199758477683176,-1.1566894817903417,0.24817518248175183,0.5813068819721833,1.0,13/30,24.03%,FLT1;MLLT3;KDR;TGFB1;FLT4;INHBA;CSF1R;ACE;UFL1;HOXB4;ARMC6;MLF1;PLD4
prerank,positive regulation of response to cytokine stimulus (GO:0060760),-0.4709054442277235,-1.1564882480268357,0.30319148936170215,0.5812214912409679,1.0,5/13,13.01%,IFIH1;DHX9;CD74;MAVS;AGPAT1
prerank,acute inflammatory response (GO:0002526),-0.4044047971287934,-1.156367959527206,0.2631578947368421,0.5809312190263863,1.0,3/23,2.55%,ANO6;LBP;F3
prerank,positive regulation of proteasomal protein catabolic process (GO:1901800),-0.3068613578024224,-1.1558586881808224,0.20948616600790515,0.5816394435156402,1.0,27/85,21.45%,CBFA2T3;RACK1;RNF144B;DAB2IP;TMEM259;SMAD7;GABARAP;SH3RF2;TRIB2;PABIR1;TRIB1;DDRGK1;RNF185;VCP;USP5;PSMC5;FMR1;RBX1;HECTD1;HSPA1A;RNF19A;OSBPL7;ELOB;KEAP1;TRIB3;HSPA1B;PSMC3
prerank,response to hexose (GO:0009746),0.3981669544276196,1.1551745281328787,0.28661087866108786,0.6602259259657433,1.0,2/25,5.54%,TCF7L2;IRS2
prerank,regulation of gene silencing by miRNA (GO:0060964),-0.31143339023407807,-1.155100152481139,0.23214285714285715,0.5829544627905,1.0,29/62,34.81%,TGFB1;NUP93;DHX9;NDC1;NUP54;H3-3A;WTIP;LIMD1;NUP188;FMR1;NUP155;RANBP2;NUP37;PUM2;NUP160;EIF4G1;NUP43;SEH1L;SEC13;NUP107;NUP42;NUP98;POLR2F;POLR2L;POLR2I;RAE1;POLR2C;NUP88;NUP214
prerank,regulation of microtubule polymerization (GO:0031113),-0.34414647455525915,-1.1548166444779848,0.241635687732342,0.5830607842890202,1.0,13/40,25.21%,OCLN;RPS3;RAC1;SLAIN2;STMN2;DCTN1;PRUNE1;MET;ARL2;CDH5;CAMSAP3;CLIP1;STMN1
prerank,interleukin-12-mediated signaling pathway (GO:0035722),-0.33592343270151515,-1.154725222511367,0.210727969348659,0.5826762754989713,1.0,20/46,30.96%,RAP1B;HNRNPA2B1;MSN;ANXA2;PPIA;PITPNA;TALDO1;HNRNPDL;CFL1;JAK2;HSPA9;IL12RB2;CDC42;STAT4;SOD1;GSTO1;PDCD4;P4HB;PAK2;PLCB1
prerank,myelin assembly (GO:0032288),0.49354692506089315,1.1544685430429702,0.30414746543778803,0.6608656544473845,1.0,1/10,0.51%,EPB41L3
prerank,regulation of programmed necrotic cell death (GO:0062098),-0.40425402136906763,-1.1543056117421804,0.2735191637630662,0.5831462696138476,1.0,8/20,18.19%,CASP8;RIPK1;FLOT1;SDCBP;FLOT2;MLKL;HSP90AA1;PELI1
prerank,purine-containing compound salvage (GO:0043101),0.4714117230595184,1.1539713363133897,0.30357142857142855,0.6610744580565895,1.0,2/12,6.90%,AMPD3;GMPR
prerank,skeletal muscle organ development (GO:0060538),-0.37937100070527763,-1.1537511238874272,0.24677716390423574,0.5839819886931481,1.0,5/26,5.09%,MEF2C;CAV1;MYL6;SIX1;STRA6
prerank,cellular polysaccharide biosynthetic process (GO:0033692),0.38745164084777467,1.152972585595922,0.27901785714285715,0.6624324716773144,1.0,10/25,17.29%,B3GALT1;B3GALNT1;B3GNT7;NDST4;FUT9;B3GALT2;HS2ST1;B3GALT5;B4GAT1;B3GNT6
prerank,B cell proliferation (GO:0042100),-0.42774942496914004,-1.152883082399896,0.25788497217068646,0.5856032405769078,1.0,3/17,10.02%,MEF2C;CTPS1;HSPD1
prerank,acidic amino acid transport (GO:0015800),0.4401813721190791,1.1527255446506737,0.2818181818181818,0.661951683212874,1.0,3/17,1.59%,SLC1A3;GJA1;SLC6A13
prerank,RNA destabilization (GO:0050779),0.4206549310112692,1.1526915706196543,0.29515418502202645,0.6608880635891828,1.0,7/18,15.77%,ROCK2;LIN28B;FTO;RIDA;METTL16;RBM24;METTL3
prerank,regulation of fatty acid biosynthetic process (GO:0042304),-0.38496835356432657,-1.1526683484491893,0.26591760299625467,0.5855904842287935,1.0,7/26,11.07%,ADIPOR2;ADIPOR1;ERLIN2;ELOVL5;ACADL;WDTC1;ACADVL
prerank,actin crosslink formation (GO:0051764),-0.4740289592306357,-1.152576241542614,0.2907801418439716,0.5852530553994446,1.0,5/12,23.82%,BAIAP2L1;EPS8;GAS2L1;GAS2;AIF1
prerank,peptidyl-serine phosphorylation (GO:0018105),-0.2729429974529339,-1.1525732078043114,0.17418032786885246,0.5846781181133358,1.0,37/153,16.04%,PRKCH;RPS6KA5;TGFBR2;HIPK1;NLK;WNK1;RPS6KA3;CAMK2D;RICTOR;MAPKAPK3;CSNK1G2;PRKCZ;PKD1;IKBKB;PRKDC;CSNK1G3;RIPK1;PLK2;DYRK2;AKT1;VRK3;STK32B;LMTK2;CAMK1;ULK3;RPS6KB2;VRK1;STK38;PKN3;PRKCE;RPS6KA2;MAST4;UHMK1;CAB39;STK38L;CSNK2A1;CSNK2A2
prerank,regulation of viral life cycle (GO:1903900),-0.40292906526196154,-1.1525705777351094,0.27902621722846443,0.5841054535019272,1.0,8/21,15.28%,TRIM25;PPIA;TRIM14;TRIM62;TRIM68;TSG101;TRIM5;NECTIN2
prerank,negative regulation of double-strand break repair via homologous recombination (GO:2000042),0.445212960048456,1.1525256940962667,0.29910714285714285,0.6601520825952928,1.0,5/16,14.46%,SHLD2;UBQLN4;RADX;SMCHD1;RIF1
prerank,negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),0.4666417987711645,1.1522181859377054,0.3076923076923077,0.6598021687711958,1.0,2/12,2.16%,ADAMTS12;DCN
prerank,glucose 6-phosphate metabolic process (GO:0051156),-0.40521041847440414,-1.1517391424978858,0.2644787644787645,0.5856110233329537,1.0,7/21,26.41%,GPI;HK1;PGLS;TALDO1;RPIA;PGM2;SHPK
prerank,regulation of cell cycle G1/S phase transition (GO:1902806),-0.3604630149255611,-1.1509322388071896,0.258252427184466,0.587122661308333,1.0,10/33,18.08%,PLCG2;CDKN1B;PKD1;DDRGK1;TCIM;E2F1;PHB2;PTPN6;CDKN1A;GLI1
prerank,regulation of RIG-I signaling pathway (GO:0039535),-0.41825150677173295,-1.1508509210009807,0.27977315689981097,0.5867627916519687,1.0,7/18,21.90%,SEC14L1;RNF125;DHX58;USP15;ANKRD17;PUM2;ZCCHC3
prerank,telomere maintenance (GO:0000723),0.33973599984597797,1.1506737914837704,0.25481798715203424,0.6627009256097074,1.0,21/50,21.96%,STN1;BLM;RPA2;TEP1;NBN;ATM;RIF1;RPA1;SMC6;PARP3;PARP1;SP100;SMC5;POLD4;NSMCE2;POLD1;RTEL1;PCNA;POLD3;POLD2;DCLRE1B
prerank,negative regulation of oxidative stress-induced cell death (GO:1903202),-0.38469764879225954,-1.1504767888595748,0.2571428571428571,0.5871010965613764,1.0,8/26,15.08%,REST;PPIA;ATF4;PDE8A;HSPB1;AKT1;BAG5;GPR37L1
prerank,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),-0.24011041450332676,-1.1502334386000708,0.07142857142857142,0.5871162778898001,1.0,121/497,18.45%,MECOM;LEF1;FOXP1;ELK3;DACH1;WWP1;ATP8B1;RPS6KA5;NOTCH1;CBFA2T3;ID1;ZHX3;RACK1;HMBOX1;BMPR2;ID3;PPARD;NCOR1;FOXO1;KLF4;RPS3;DAB2IP;ZBTB7A;IGFBP5;CDKN1B;TGFB1;REST;KDM5C;PRDM16;TBX2;HDAC9;HSPA8;WWP2;LIMS1;PFDN5;KCTD1;FOXD1;RLIM;CTBP1;PHC2;BHLHE40;SOX13;FOXK1;CD38;HEYL;ZBTB16;DPF2;CNOT7;MPHOSPH8;DPF3;RBFOX2;RARA;GATA6;SHC1;FOXN3;NR3C1;CBX5;GAPDH;PPM1F;CIC;UIMC1;HDAC4;ZMYND11;NDUFA13;BCL6;SOX7;NCL;TWIST1;TRIM28;HHEX;SOX18;DBI;RB1;ZC3H8;FOXP2;RPL13A;CAPRIN1;WNT11;ZBTB18;CCDC85B;SP3;SFPQ;LIMD1;PHC1;CIPC;E2F1;ZNF423;COMMD7;POU2F1;HES1;FMR1;CIART;MTERF3;PHF12;CDAN1;EPC1;MLX;PHB2;SMARCA4;EID2;HEY1;LDB1;SMAD4;CDKN1A;ZFPM2;SMARCA2;NR1H2;RAD17;PCIF1;RELA;LSM14A;GIGYF2;CCAR2;KDM1A;FOXL2;WAPL;SCML2;SMAD2;CRYAB;ZNF568;L3MBTL1
prerank,organelle organization (GO:0006996),-0.2438666478703067,-1.1501177752762894,0.08843537414965986,0.5868250597057594,1.0,98/388,20.30%,PLCE1;FGD5;CAV1;CXADR;SYNE1;SEMA6A;NOS3;ATP8B1;VPS13D;FNBP1L;ARAP3;CAV2;SNX11;PI4K2A;ZW10;BCAS3;PPIA;HTT;GORASP2;BRWD3;NEDD9;PPARGC1A;DIAPH1;RAB18;FAM174B;FGD6;MICAL2;TTC17;PDZD8;CHMP2B;CHCHD2;ATP5F1B;HCFC1;PLEKHM2;MREG;ATL3;TRIP11;SPTSSB;KIF9;SIPA1;ATL2;CDC42BPB;RHOT1;ESRRA;SIPA1L3;PLAAT3;TRAPPC11;MIEF2;GABPA;WTIP;RHOT2;BAG5;CFL1;SURF4;LIMD1;YTHDF2;RAB7A;VMP1;AGTPBP1;MTFR1;APOE;FAF2;PHB2;WASL;MAST4;RAB1A;DOP1B;COG3;GOLGA5;GOLGA8B;VPS11;LMAN2;CHCHD10;NIPSNAP2;NECTIN2;TNFAIP3;ADCK1;OPA1;HPS3;PACSIN1;HSD17B10;RANBP10;CHMP2A;SLC25A33;TMED1;PLEKHF1;TOR1AIP2;RAB32;PRPF40A;PACSIN3;IQCG;TMED5;PACSIN2;FGD2;PTCD2;STRIP2;ATP8B2;COG2
prerank,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),0.3560006042627831,1.1492405341103518,0.2478448275862069,0.6652489239996505,1.0,8/37,7.71%,TENM3;GRID2;DCHS1;PTPRD;TENM2;IL1RAPL1;ALCAM;NLGN1
prerank,substrate adhesion-dependent cell spreading (GO:0034446),0.3465447859506908,1.149017073973837,0.21314741035856574,0.6647226881801074,1.0,7/46,5.18%,PIK3R1;NRP1;ATRNL1;LAMC3;ANTXR1;RADIL;SRGAP2
prerank,regulation of oxidoreductase activity (GO:0051341),-0.45270944797340884,-1.1489861225171345,0.2783687943262411,0.5890977347350634,1.0,5/13,33.43%,ABL2;NOD2;ECSIT;ABL1;HP
prerank,lipoprotein transport (GO:0042953),0.47521673163093514,1.1488972029528577,0.3145539906103286,0.6638869436221038,1.0,5/10,18.82%,LRP1;PRKCB;MIA3;UNC119B;PPARG
prerank,autonomic nervous system development (GO:0048483),0.4235959842496248,1.1484965936923632,0.30598669623059865,0.6637592909769303,1.0,6/17,11.99%,NRP1;GDNF;SEMA3A;PHOX2A;GATA3;EDNRB
prerank,T cell mediated immunity (GO:0002456),-0.4537327455424821,-1.1477645897231619,0.2851985559566787,0.5915525482571887,1.0,3/13,13.51%,CD55;EMP2;BTN3A3
prerank,establishment of protein localization to membrane (GO:0090150),-0.3112637426105598,-1.1476139632620421,0.23031496062992127,0.5913162285039955,1.0,17/66,14.66%,PARD3;RAB11A;GORASP2;AQP11;ATG3;NACA;SEC63;ZDHHC9;TAOK2;RAB11B;ZDHHC1;ICMT;ARL6;NPC1;ZDHHC20;SDCBP;EGFR
prerank,defense response to protozoan (GO:0042832),-0.4699899233998457,-1.1474985124765713,0.3176043557168784,0.5910265195828824,1.0,9/12,45.74%,LYST;GBP7;GBP4;CD40;SLC11A1;BATF;PF4;MYD88;IRF4
prerank,miRNA metabolic process (GO:0010586),0.416682912067617,1.1467845252706939,0.2733050847457627,0.6670234846549802,1.0,7/20,16.06%,TUT4;LIN28B;KHSRP;XPO5;PARN;BCDIN3D;DROSHA
prerank,cellular protein-containing complex assembly (GO:0034622),-0.2692869924227073,-1.1463491472586886,0.16216216216216217,0.593316425693966,1.0,60/159,26.07%,STXBP6;DMD;PXN;POMP;RPL38;HSP90AB1;TGFB1;FKBP1A;HIP1R;NUP93;AP2M1;DNAJB12;DHX9;NDC1;PIK3C2A;IMMP2L;CSNK2B;HSPD1;HIP1;FCHO2;SGIP1;TTC12;HIGD2A;CHCHD4;HSPA4;POGZ;ARL6;CCT2;EID2;CASQ2;SMAD4;GPX4;PSMD11;SRP19;HSP90AA1;HSPA1A;PTGES3L;CHMP2A;SMAD2;ARL2;HIGD1A;NCK1;HIGD1B;CLTA;PFDN6;CENPF;NSG2;NCK2;ANLN;PSMG2;CENPA;CASQ1;SMAD1;MKKS;EIF4B;TBCE;EPS15;CLTB;EIF4H;NUP107
prerank,cellular response to amino acid starvation (GO:0034198),-0.3028345058096896,-1.1459540863365811,0.24366471734892786,0.5937643533966348,1.0,23/71,27.35%,MAP3K5;MAPK3;DAPL1;ATP6V0B;ATF4;FAS;ATP6V0C;IMPACT;LAMTOR2;ATP6V1G1;CDKN1A;RRAGD;RRAGA;TFEB;RRAGC;SESN2;CASTOR2;RPTOR;ATP6V0D1;SEH1L;SEC13;LAMTOR5;SESN1
prerank,positive regulation of DNA replication (GO:0045740),0.43639192203376853,1.1456445306468548,0.3039647577092511,0.668745030978143,1.0,4/16,7.91%,GLI2;STN1;ATAD5;BRPF3
prerank,positive regulation of protein localization to nucleus (GO:1900182),-0.3129345597276493,-1.1453810005789158,0.22873345935727787,0.5946096418037244,1.0,34/66,31.36%,CDH1;LIMK2;TFRC;FERMT2;TGFB1;JUP;NMD3;AKT1;RBM22;TRIM28;MAVS;DKC1;CCT2;PIK3R2;CCT3;MCRS1;ECT2;CDK5RAP3;ZPR1;CCT8;MEPCE;HCLS1;SESN2;PRKCD;DTX3L;CCT7;PARK7;CARD10;LAMTOR5;HDAC3;PLK1;HYAL2;PARP9;CDK1
prerank,electron transport chain (GO:0022900),-0.43414392324658485,-1.1453138339139743,0.31899641577060933,0.5942116789953699,1.0,7/15,20.23%,PDIA5;ENOX2;PPARGC1A;ETFDH;ETFB;CYB561;SDHB
prerank,positive regulation of chemotaxis (GO:0050921),0.34616533279273864,1.1445175406748394,0.23706896551724138,0.6705031266654107,1.0,5/43,3.79%,NRP1;PTN;NTRK3;SEMA5A;P2RX4
prerank,positive regulation of transcription by RNA polymerase II (GO:0045944),0.23412167475715584,1.1444234260129034,0.07590132827324478,0.6696308581879732,1.0,100/834,9.65%,IGF1;AUTS2;BMP6;TCF7L2;TCF4;RORA;PIK3R1;ARNT2;LDB2;BMP2;SALL1;PID1;AR;CDK8;TBX3;GLIS3;EPAS1;HLF;FGFR2;NFIA;NR2F2;BMP5;TBL1XR1;GDNF;VDR;RARB;NCOA2;TEAD1;PPARA;HOXC4;GLI2;DCN;MITF;NFAT5;IL4I1;SMAD3;TFEC;KDM1B;STAT5B;NKX6-1;HOXB3;ZNF462;CSRP3;KLF15;AKAP8L;GLI3;WWC1;TFCP2;ZEB2;PHIP;SP7;TFDP1;PHOX2A;CEBPB;IL4;PRKN;ZNF513;MLLT10;HNF4G;SERPINE1;MAML3;BCL2L12;TAF6L;ATF5;GABPB1;GABPB2;FOXA2;ASXL3;ZNF296;PCGF5;SIRT2;LHX4;MEN1;KMT2A;NFIX;RARG;SOX2;CITED2;ZSCAN21;RBPJ;IGF2;IL18;SENP1;RGMA;KAT8;FOXD3;NCOA1;ATOH8;CREB3L4;CREB3;GLIS1;GATA3;DVL3;BMPR1A;NPAT;MLXIP;MYDGF;AHI1;HOXC10;HDAC8
prerank,integrin-mediated signaling pathway (GO:0007229),-0.31057308674827666,-1.1443667577848124,0.24897959183673468,0.5959927053183566,1.0,13/73,5.29%,FN1;SEMA7A;DOCK1;PTK2B;PTK2;COL3A1;LAMA5;FERMT2;ITGB4;ADAM15;ADAM10;NEDD9;LAMA3
prerank,positive regulation of cytosolic calcium ion concentration (GO:0007204),0.27963621656168125,1.1443092335265326,0.19305019305019305,0.6688051420321617,1.0,31/140,14.15%,LPAR1;PTGFR;SLC8A1;ADCY5;PDGFRA;GPR55;CACNA2D1;P2RX4;TRPM1;GPR174;CCR6;GRM1;ACKR4;ACKR2;CCR10;PTGDR;NPTN;IAPP;CALCR;LPAR4;CCR9;ADRA1D;C3AR1;ADCY8;ADRA1B;PTGIR;GNA15;DLG4;P2RY1;CXCR4;DRD2
prerank,positive regulation of cellular response to insulin stimulus (GO:1900078),-0.45388582623373186,-1.144251751889768,0.2975970425138632,0.5957168603872118,1.0,2/13,5.01%,SORBS1;PRKCZ
prerank,regulation of aerobic respiration (GO:1903715),-0.4407698445408097,-1.144124413873042,0.29213483146067415,0.5954604959738725,1.0,4/15,10.41%,CBFA2T3;UQCC2;IDE;VCP
prerank,mitochondrion transport along microtubule (GO:0047497),-0.4514782493139693,-1.1433414860357323,0.299625468164794,0.5968276732868548,1.0,5/13,16.25%,UBB;NEFL;RHOT1;RHOT2;OPA1
prerank,neutrophil chemotaxis (GO:0030593),-0.3243911095757426,-1.1432381247803676,0.2593320235756385,0.5964951032609701,1.0,9/53,14.21%,BSG;CXADR;TGFB2;PPIA;EDN1;CCL15;FCER1G;SYK;JAML
prerank,Notch signaling involved in heart development (GO:0061314),-0.4810665420896402,-1.1431562777104773,0.3120567375886525,0.5961076279192782,1.0,5/11,24.12%,NOTCH1;HEYL;HEY1;DLL4;SNAI2
prerank,response to amino acid starvation (GO:1990928),-0.3019726899935005,-1.1430281985284847,0.2406311637080868,0.5958774086872293,1.0,23/72,27.35%,MAP3K5;MAPK3;DAPL1;ATP6V0B;ATF4;FAS;ATP6V0C;IMPACT;LAMTOR2;ATP6V1G1;CDKN1A;RRAGD;RRAGA;TFEB;RRAGC;SESN2;CASTOR2;RPTOR;ATP6V0D1;SEH1L;SEC13;LAMTOR5;SESN1
prerank,water transport (GO:0006833),-0.4638754629339024,-1.143006033353025,0.30272108843537415,0.5953571097635929,1.0,9/12,53.63%,AQP11;AQP4;AQP1;AQP9;AQP6;CFTR;PDPN;AQP7;SLC5A1
prerank,regulation of neuron death (GO:1901214),-0.3008916082008142,-1.142852305001079,0.20817120622568094,0.595184561966464,1.0,12/82,8.42%,MEF2C;MAP3K5;CD34;EGLN3;REST;CTSZ;UBB;PPARGC1A;CHP1;TNFRSF1B;EGLN2;AKT1
prerank,cellular response to amino acid stimulus (GO:0071230),-0.3625739297012321,-1.1424291811444658,0.2755905511811024,0.5956520393613921,1.0,19/33,36.47%,SH3BP4;CAPN2;LAMTOR2;RRAGD;XBP1;RRAGA;RRAGC;SESN2;CASTOR2;NSMF;RPTOR;LAMTOR5;SESN1;CPEB4;LAMTOR1;LAMTOR3;GLRA1;IPO5;FYN
prerank,positive regulation of stem cell differentiation (GO:2000738),0.42443709204302216,1.1424075160091514,0.26899383983572894,0.6726937161481374,1.0,5/16,14.52%,PTN;SP7;SOX5;LTBP3;RBM24
prerank,negative regulation of histone methylation (GO:0031061),0.48101999867186407,1.1421072259151084,0.31390134529147984,0.6723087921055413,1.0,5/10,24.82%,BCOR;DNMT1;MTF2;DNMT3B;WDR5
prerank,regulation of glycolytic process (GO:0006110),0.3164912308323543,1.1414527286709792,0.226890756302521,0.6729233898348101,1.0,6/68,4.89%,IGF1;ZBTB20;PPARA;PRKAG2;PFKFB4;ACTN3
prerank,positive regulation of nucleocytoplasmic transport (GO:0046824),0.3515636814908672,1.1409946466054592,0.2643171806167401,0.6729810442423588,1.0,4/46,2.77%,TCF7L2;PIK3R1;ZIC1;SMAD3
prerank,positive regulation of nitric oxide biosynthetic process (GO:0045429),-0.37974698450551947,-1.1406794068003838,0.2859744990892532,0.599497514707452,1.0,10/25,21.50%,KLF2;KLF4;HSP90AB1;EDN1;AKT1;INSR;TLR4;HSP90AA1;DDAH1;PKD2
prerank,regulation of histone modification (GO:0031056),0.4499296133991464,1.139442252625338,0.3162393162393162,0.6758055478244737,1.0,6/13,18.13%,AKAP8L;IGF2;SETD5;CDK9;AKAP8;UBE2N
prerank,very long-chain fatty acid biosynthetic process (GO:0042761),-0.46471580567155585,-1.139431516799738,0.2814814814814815,0.6020752180793206,1.0,6/13,26.94%,ELOVL7;ELOVL5;TECRL;ELOVL1;HACD4;HACD2
prerank,negative regulation of oxidoreductase activity (GO:0051354),0.4752765253962335,1.1392735615985812,0.32407407407407407,0.675150540462254,1.0,4/10,25.80%,PRKN;AOC3;HDAC6;SNCA
prerank,macrophage migration (GO:1905517),0.45389718388881883,1.1391652170983215,0.2903981264637002,0.6742932696008279,1.0,4/13,19.88%,P2RX4;EDNRB;CKLF;TAFA4
prerank,Fc-epsilon receptor signaling pathway (GO:0038095),-0.28185381813275057,-1.1383320139731279,0.21330724070450097,0.6042252942644359,1.0,40/109,25.25%,PLCG2;MAPK3;MAP3K1;CALM1;RAC1;IKBKB;SHC1;PSMA6;PSMB5;NFATC1;FCER1G;PSMC4;PSMC5;PSMD14;PPP3CB;SYK;LCP2;PSMD8;GAB2;PIK3CA;PSMD11;PIK3R2;PSMB4;PSMD12;PSMC1;TAB2;RELA;CUL1;CHUK;NFATC3;PSMA1;PSMB1;PSMC3;BTK;LAT2;PSMA4;PSMA2;TRAF6;BCL10;PSMB8
prerank,mitotic nuclear division (GO:0140014),-0.3064885675097347,-1.1382003066135056,0.236084452975048,0.6039689567032384,1.0,29/71,32.82%,EPS8;RAB11A;SMC4;ZW10;CEP192;NDE1;NDEL1;LSM14A;KIF18A;CHMP2A;MISP;TPX2;KNSTRN;PPP2R2D;KIF18B;NSL1;NDC80;SPICE1;CDCA8;SGO1;KIFC2;CHMP7;TUBG2;KIF11;PLK1;BCCIP;RHOA;CHMP4B;ESPL1
prerank,negative regulation of phosphorylation (GO:0042326),0.3052247521717074,1.1381143566973513,0.23717948717948717,0.6759199829853083,1.0,17/85,10.46%,PID1;PTPN13;NTRK3;FBLN1;PPARA;STAP1;LYN;ACTN3;DYNLL1;PRKN;IRS2;PLPP3;IBTK;MEN1;PPP1R15B;PTEN;ANKLE2
prerank,regulation of cell communication (GO:0010646),-0.34874486883176903,-1.137880292375137,0.26459143968871596,0.6041801070573295,1.0,16/35,23.07%,CXADR;IGFBP7;CAMK2D;ANXA1;MGLL;SOCS2;CRK;NCLN;GRK5;CASQ2;SRI;YWHAG;TSPYL2;VEPH1;PTPN1;GJA5
prerank,regulation of neurotransmitter receptor activity (GO:0099601),0.32694323992849816,1.1375325993180991,0.25,0.6762979418879503,1.0,16/57,14.41%,GRIA4;DLG2;SHISA9;DLGAP1;DAPK1;NLGN2;CACNG4;CAMK2B;NLGN1;MAPK8IP2;LRRC7;GRIA3;ACTN2;DLG4;GRIN2A;GRIA1
prerank,protein localization to cell surface (GO:0034394),-0.3702256301203883,-1.1374927175752423,0.2806026365348399,0.6045360959616973,1.0,11/26,21.91%,MESD;JAM3;RIC3;VCL;EMP2;WNT11;SMURF1;USP4;PTPRK;FGF10;PTPRU
prerank,toll-like receptor 3 signaling pathway (GO:0034138),-0.47548286225794134,-1.1374734222541958,0.3001841620626151,0.6040108746811743,1.0,4/11,7.38%,SCARA3;CASP8;TLR3;RIPK1
prerank,regulation of anatomical structure morphogenesis (GO:0022603),0.28579991870150856,1.1372980115415625,0.2231578947368421,0.6757709977192304,1.0,14/118,5.49%,SH3D19;HECW2;PID1;ADGRB3;LRRC4C;FGFR2;PHLDB2;GDNF;KIF13B;RAP2A;PHIP;SFRP1;ZMYM6;HECW1
prerank,nuclear migration (GO:0007097),0.448377927139178,1.1370264038071705,0.332579185520362,0.6753715151245552,1.0,3/13,7.84%,CLMN;SYNE2;DOCK7
prerank,melanosome transport (GO:0032402),-0.4154702601656476,-1.136959890712484,0.2889733840304182,0.6041286540860126,1.0,6/18,13.87%,RAB11A;RAB27A;MREG;MLPH;RAB11B;ARL6
prerank,pigment granule transport (GO:0051904),-0.4154702601656476,-1.136959890712484,0.2889733840304182,0.6041286540860126,1.0,6/18,13.87%,RAB11A;RAB27A;MREG;MLPH;RAB11B;ARL6
prerank,nitric oxide mediated signal transduction (GO:0007263),-0.4224218938795839,-1.1366016891805952,0.3105263157894737,0.6044953844031875,1.0,4/16,12.33%,NOS3;GUCY1B1;GUCY1A1;APOE
prerank,regulation of heart contraction (GO:0008016),0.301095734921228,1.1364197447410107,0.23868312757201646,0.675751268176879,1.0,12/90,6.07%,CELF2;ATP1A2;SLC8A1;ITPR1;ANK2;PRKACA;DMPK;CORIN;P2RX4;ATP2A2;FXYD1;ASPH
prerank,positive regulation of cell-cell adhesion (GO:0022409),-0.3399662818027924,-1.135885265417284,0.2878787878787879,0.6057298035328534,1.0,7/41,9.23%,PODXL;PIEZO1;SMAD7;CD44;ADAM19;DENND6A;FLOT1
prerank,regulation of toll-like receptor 4 signaling pathway (GO:0034143),-0.39636980033724173,-1.1357727699937543,0.30275229357798167,0.605430227716352,1.0,7/22,17.52%,LBP;DAB2IP;MFHAS1;FLOT1;TIRAP;TNFAIP3;NINJ1
prerank,nucleobase-containing small molecule catabolic process (GO:0034656),-0.4459856393403441,-1.1357611399639265,0.3058161350844278,0.6048809329129992,1.0,5/14,21.92%,ENTPD1;ENTPD7;ENTPD6;ENTPD2;NUDT18
prerank,dermatan sulfate biosynthetic process (GO:0030208),0.46555503989645725,1.1354949133166967,0.30995475113122173,0.6770262128024925,1.0,7/12,23.38%,UST;DCN;DSE;VCAN;CHST14;DSEL;BCAN
prerank,negative regulation of DNA recombination (GO:0045910),0.3475354921879462,1.1354948899397863,0.2642706131078224,0.6759145113036378,1.0,14/43,21.74%,SHLD2;UBQLN4;POLR2G;RADX;BLM;SMCHD1;DAXX;RIF1;PARP3;POLR2D;RTEL1;POLR2K;ZRANB3;FBH1
prerank,response to estradiol (GO:0032355),-0.3617156168286827,-1.1351472728947911,0.2782931354359926,0.6058701295171873,1.0,11/31,20.25%,ESR1;ANXA1;SOCS2;TGFB1;NRIP1;GGT5;LCOR;EGFR;STRN3;FAM210B;GGT1
prerank,positive regulation of calcium ion-dependent exocytosis (GO:0045956),0.4615177101693702,1.1351327385923635,0.31788079470198677,0.675764464135451,1.0,5/13,13.22%,HYAL3;CACNA1I;SYT1;CACNA1G;SCAMP5
prerank,regulation of cellular amino acid metabolic process (GO:0006521),-0.3225992928586463,-1.1348736832185304,0.2421875,0.6059694527317848,1.0,19/53,25.25%,PSMA6;PSMB5;PSMC4;PSMC5;PSMD14;OAZ2;PSMD8;PSMD11;PSMB4;PSMD12;PSMC1;NQO1;PSMA1;PSMB1;PSMC3;PSMA4;PSMA2;BCKDK;PSMB8
prerank,regulation of interleukin-17 production (GO:0032660),-0.36174672772264027,-1.134780532634807,0.26824817518248173,0.6056326459877855,1.0,6/31,17.36%,IL15;SLC7A5;TGFB1;TLR4;NOD2;VSIR
prerank,visual system development (GO:0150063),-0.3461794251544239,-1.1344885291866906,0.2857142857142857,0.6057918909339254,1.0,12/37,21.55%,SMOC1;HIPK1;TGFB2;RAB18;FREM2;SIPA1L3;SMG9;CHRDL1;ADAMTS18;C1QA;BMPR1B;C3
prerank,positive regulation of lipid storage (GO:0010884),-0.4000006529733444,-1.1336299910707106,0.2926829268292683,0.6073682069867823,1.0,6/21,24.15%,SCARB1;PLIN3;EHD1;MSR1;C3;HILPDA
prerank,establishment of protein localization to organelle (GO:0072594),-0.3005936517467844,-1.1336114241572122,0.23976608187134502,0.606840850985099,1.0,23/72,26.54%,RAB11A;HK1;NUP93;AKT1;LAMP1;PTTG1IP;E2F3;SYK;NUP188;PHB2;NUP155;TNPO3;RPAIN;TSPAN17;TSC2;NXT2;CD68;TNPO2;NEURL1B;FAM53A;SEC13;NUP107;IPO13
prerank,T cell migration (GO:0072678),-0.4563718775005878,-1.1335178157796482,0.3185840707964602,0.6065088389661939,1.0,3/13,4.35%,SLC12A2;S1PR1;MSN
prerank,ephrin receptor signaling pathway (GO:0048013),-0.2935346315852893,-1.133238459637345,0.224105461393597,0.606666648264551,1.0,27/82,19.46%,ACTB;ARHGEF28;ACTG1;SIPA1L1;ARPC1B;PTK2;RAC1;CHN1;CRK;ARPC5;AP2M1;ANKS1A;PSENEN;ITSN1;ACTR3;HRAS;WASL;APH1A;SDCBP;AP2A1;EPHA2;YES1;DNM1;EPHB6;EFNB3;RASA1;EFNB1
prerank,cellular copper ion homeostasis (GO:0006878),-0.44398418043464943,-1.1331282317515277,0.31985294117647056,0.6063646894116818,1.0,3/14,4.11%,ATOX1;MT2A;APP
prerank,protein localization to membrane (GO:0072657),-0.26257831263449566,-1.133005319116199,0.16288659793814433,0.6060968638901727,1.0,57/187,19.66%,CAV1;SHANK3;BSG;RAP1A;CDH1;TSPAN5;SPTBN1;EFR3B;RAB11A;AGRN;F11R;RAMP2;EHD4;KCNB1;RAB8B;FERMT2;PACS1;CD81;IKBKB;EZR;EHD2;JUP;ATP1B1;NDC1;CPE;FLOT1;NUP54;S100A10;EMP2;RAB8A;TSPAN14;FCHO2;CACNB3;RAB11B;SLMAP;TNFRSF1A;SMURF1;NPC1;NUP155;AP4M1;TMEM88;FLOT2;EPHA2;ITGA4;TSPAN17;PACSIN1;NRXN2;RABEP1;RAB40B;PIGW;PRAM1;RAMP1;EHD1;PLEKHF1;RAB32;FYB2;EHD3
prerank,blood vessel endothelial cell migration (GO:0043534),0.3889736499300601,1.1329124477286323,0.28509719222462204,0.6803697102747012,1.0,2/22,0.36%,ROBO1;NRP1
prerank,regulation of striated muscle contraction (GO:0006942),0.38145575728333897,1.1328207883279975,0.2907216494845361,0.6794960307158396,1.0,5/27,8.07%,ATP1A2;ANK2;PRKACA;P2RX4;TNNI1
prerank,positive regulation of multicellular organismal process (GO:0051240),-0.24730288176569534,-1.132654203263679,0.1360824742268041,0.6063876521987697,1.0,56/308,13.01%,PRKCH;LEF1;CAV1;ADIPOR2;IGF1R;RREB1;LBP;IL15;TGFBR2;BMPR2;GATM;TFRC;FERMT2;NPR1;VAMP7;SIX1;TGFB1;REST;TGFB2;PRDM16;SMO;PPARGC1B;CMKLR1;FOXD1;PPARGC1A;ADIPOR1;ZBTB16;IL33;RPS19;VEGFA;UCP2;KDM3A;TGFB3;LURAP1;RGCC;GAPDH;TRIM16;NR2C2;PDGFC;TWIST1;FLOT1;DECR1;FABP5;GRB10;ACADL;INHBA;CFL1;EBF2;S100A13;GADD45G;ACVR1;APOE;FGF2;TSKU;SYK;AGPAT1
prerank,meiosis I (GO:0007127),0.4087087475617166,1.1325756808202916,0.31601731601731603,0.679043133192599,1.0,4/23,7.98%,BCL2L11;MEIKIN;HSF2BP;ZSCAN21
prerank,chromatin remodeling at centromere (GO:0031055),-0.3584710934416617,-1.1325484317468406,0.2884250474383302,0.6060835715217259,1.0,17/31,34.42%,MIS18BP1;KNL1;CENPU;RBBP4;CENPI;CENPN;CENPA;CENPO;RUVBL1;NPM1;CENPV;SMARCA5;OIP5;ITGB3BP;CENPX;CENPW;RBBP7
prerank,positive regulation of cell population proliferation (GO:0008284),-0.23896269682850635,-1.1324068242285894,0.11513859275053305,0.605861032134937,1.0,100/423,16.40%,FN1;PRKCH;KITLG;LEF1;FOXP1;MEF2C;FLT1;IGF1R;CDK6;CLDN5;ACER2;THBS1;NOTCH1;IL15;DPP4;NAMPT;FGF1;TGFBR2;LRP5;PTK2B;LIFR;KDR;STX3;PTK2;TBX1;TBC1D8;RPS4X;RPS9;VEGFC;RPRD1B;TGFB1;CNBP;TGFB2;MAP3K3;TBX2;RPL23;RPS15A;DNAJA2;ADAM10;CD81;VEGFA;CNOT7;S100B;AQP11;RARA;SHC1;TGFB3;KRAS;EDN1;FLT4;S1PR3;TNFRSF11A;NDUFS4;NES;HDAC4;AKT1;INSR;NOP2;DHX9;PDGFC;PDGFA;LAMC2;EMP2;S100A6;DDRGK1;CD74;CDK4;KMT2D;S100A13;CIB1;VEGFD;FAM98A;GRK5;E2F1;SOX4;FXN;FGF2;HES1;RPS6;ACER3;CSF1R;HRAS;SAAL1;SDCBP;EGFR;CHTOP;ERBB2;GAB2;CLCF1;TNFSF13;NOD2;PTPN6;CDK13;CDKN1A;BMI1;CSNK2A1;ZFPM2;UFL1;STAT1;GREM1
prerank,release of cytochrome c from mitochondria (GO:0001836),-0.4302916033259022,-1.131867628192355,0.32162661737523107,0.6066009718287926,1.0,11/17,29.30%,BAX;BBC3;BCL2L1;BAK1;BAD;SFN;TIMM50;GGCT;FIS1;MFF;FZD9
prerank,liver development (GO:0001889),0.3700752346041742,1.1317087858262547,0.28820960698689957,0.6801966267994455,1.0,7/32,11.25%,TGFBR3;WNT4;CEBPB;CITED2;NPHP3;PRKCSH;ARID5B
prerank,regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),-0.2870112214475268,-1.1312867636362056,0.22762645914396887,0.6074440366668952,1.0,27/95,15.00%,CAV1;THBS1;LTBP4;TGFBR2;SMAD7;ZBTB7A;HSP90AB1;TGFB1;FKBP1A;PRDM16;UBB;UBC;RPS27A;CD109;SMAD6;GIPC1;ASPN;IL17RD;HTRA3;HTRA4;SKIL;RNF111;ENG;SMURF1;EID2;SDCBP;SMAD4
prerank,plasma membrane bounded cell projection morphogenesis (GO:0120039),0.33467894354458144,1.1312629481658645,0.25925925925925924,0.6801837782488313,1.0,8/51,7.54%,NRK;EPB41L3;CNTNAP2;GPM6A;MYO16;SRGAP2;GAS7;TNIK
prerank,B cell receptor signaling pathway (GO:0050853),-0.3527358657283583,-1.1310922201888436,0.29508196721311475,0.6073521791684844,1.0,5/32,8.37%,MEF2C;PLCG2;BMX;CD38;BAX
prerank,protein stabilization (GO:0050821),-0.2633573183596667,-1.1305665165722285,0.17324561403508773,0.6080940053203707,1.0,57/168,23.42%,NLK;SEL1L;SOX17;SMAD7;HSP90AB1;RPL11;RPL23;PPARGC1A;CHP1;HIP1R;USP7;RASSF2;HCFC1;GAPDH;ATP1B1;COA8;GLMP;PFN1;CAMLG;IFT46;FLOT1;USP9X;LAMP1;HSPD1;HIP1;BAG5;NCLN;RPS7;SOX4;CDC37L1;PHB2;CCT2;COG3;MFSD1;TMEM88;FLOT2;HYPK;CDKN1A;CRTAP;HSP90AA1;CCT3;HSPA1A;CRYAB;TBL1X;PIN1;CCT8;MSX1;UBE2B;RPL5;ATP1B2;HSPA1B;TAF9;PDCD10;BAG1;WNT10B;PPIB;PRKCD
prerank,cellular response to decreased oxygen levels (GO:0036294),0.3167603232012136,1.130506768067948,0.25806451612903225,0.681032664745752,1.0,8/65,7.16%,RORA;EPAS1;PTGIS;MDM2;SFRP1;KCND2;SIRT2;SCN2A
prerank,positive regulation of voltage-gated potassium channel activity (GO:1903818),-0.474391076353181,-1.1303992804522942,0.3392539964476021,0.6079221975733865,1.0,4/11,29.89%,AKAP6;KCNIP2;TREM2;RNF207
prerank,mitochondrial calcium ion homeostasis (GO:0051560),-0.3990671389961569,-1.1302280537727434,0.296229802513465,0.6077915046387092,1.0,11/21,24.83%,TGM2;MCUB;PDZD8;MCUR1;BCAP31;RAP1GDS1;MICU2;FIS1;SMDT1;MCU;SLC8B1
prerank,protein targeting (GO:0006605),-0.2752624101600689,-1.129815394776985,0.19222903885480572,0.6082616407266058,1.0,26/118,14.46%,RASSF9;PARD3;TRAK1;RPL11;AQP11;GABARAP;GIPC1;TRAK2;SPCS1;HACL1;ATG3;NACA;SEC63;ZDHHC9;TAOK2;TIMM17A;AKAP6;ZDHHC1;KATNB1;ICMT;TOMM22;ARL6;BCAP31;ZDHHC20;AP4M1;SDCBP
prerank,centromere complex assembly (GO:0034508),-0.34611400587079544,-1.1295628456405093,0.2538167938931298,0.6083173097165552,1.0,19/36,34.42%,POGZ;MIS18BP1;KNL1;CENPU;RBBP4;CENPI;CENPN;CENPF;CENPA;CENPO;RUVBL1;NPM1;CENPV;SMARCA5;OIP5;ITGB3BP;CENPX;CENPW;RBBP7
prerank,eye development (GO:0001654),0.3309440212614509,1.1295561251502053,0.2707509881422925,0.6823849363136767,1.0,5/54,3.95%,LAMA1;FBN1;FBN2;SH3PXD2B;PBX4
prerank,negative regulation of macromolecule metabolic process (GO:0010605),-0.2649460803058697,-1.129523604706011,0.19103313840155944,0.6078472772548658,1.0,26/182,6.75%,FOXP1;MEF2C;OCLN;CLDN5;CD34;TNRC6C;ESR1;NOTCH1;SLC7A5;RACK1;RIN3;KDR;KLF4;HSP90AB1;TGFB1;REST;APP;TGFB2;SMO;REL;WWP2;ADAM10;VEGFA;CNOT7;ANKRD13A;GATA2
prerank,positive regulation of protein localization to cell periphery (GO:1904377),0.32890198721167685,1.1293662205691521,0.2587268993839836,0.6818050376557768,1.0,6/52,3.15%,PIK3R1;LRP1;DPP10;PDPK1;EPHA3;GNAI1
prerank,protein localization to cell junction (GO:1902414),-0.38604383394676617,-1.1286873576886234,0.2994652406417112,0.6093865726258938,1.0,4/22,4.07%,HEG1;TJP2;FERMT2;JAM3
prerank,regulation of cytoplasmic transport (GO:1903649),-0.473610180343067,-1.1285655967225683,0.29831144465290804,0.609117290249886,1.0,2/11,6.77%,MAPK3;USP7
prerank,positive regulation of response to biotic stimulus (GO:0002833),0.3486997818890579,1.1284501187301543,0.27865612648221344,0.6830773019492155,1.0,2/38,2.64%,BMP6;PRKCA
prerank,positive regulation of production of molecular mediator of immune response (GO:0002702),-0.356770564941914,-1.127886775916458,0.2851782363977486,0.6102650357810793,1.0,11/34,28.61%,SLC7A5;GPI;SPHK2;PHB2;CLCF1;NOD2;XBP1;LAPTM5;PTPN22;STX4;CD86
prerank,microtubule cytoskeleton organization involved in mitosis (GO:1902850),-0.2728745112612534,-1.1277778723659775,0.21822033898305085,0.6099805057770789,1.0,56/125,33.64%,DCTN2;RPS27;MAP4;ZW10;DYNC1LI2;PLK2;RCC2;NDE1;NDEL1;RANBP2;KNL1;DYNC1LI1;CENPU;NUP37;MAD1L1;KIF18A;RANGAP1;DYNLL2;RCC1;CENPI;NUP160;NSL1;NDC80;CENPN;CENPF;RMDN1;CLIP1;SPDL1;CENPA;EFHC2;CDCA8;STMN1;TBCE;NUP43;SEH1L;CENPO;SGO1;SEC13;NUP107;SETD2;BIRC5;WDR62;NUP98;XPO1;TUBG2;KIF11;BUB3;PLK1;BCCIP;NUF2;AURKA;TACC3;ESPL1;ITGB3BP;CDC20;BUB1
prerank,embryonic appendage morphogenesis (GO:0035113),-0.46197815312663315,-1.1276797041460624,0.31643356643356646,0.6096389704918009,1.0,2/12,4.12%,MBNL1;TGFB2
prerank,regulation of fibrinolysis (GO:0051917),-0.45823218706753704,-1.1268644475806218,0.29981378026070765,0.611061918707962,1.0,3/13,2.94%,THBS1;THBD;FAP
prerank,carbohydrate transport (GO:0008643),-0.4766849876818601,-1.1267380405450373,0.3041144901610018,0.6108104097153996,1.0,8/11,43.32%,AQP11;SLC26A6;SLC2A2;SLC23A1;SLC23A2;AQP1;SLC2A5;AQP9
prerank,tRNA metabolic process (GO:0006399),-0.41800019751438094,-1.1267007911561027,0.2894248608534323,0.6103330548801896,1.0,10/17,39.35%,SARS1;FARS2;TRPT1;RPP21;ADAT1;KARS1;AARS1;THG1L;YARS2;RPP30
prerank,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),-0.42049611095746003,-1.1262803259614604,0.3140794223826715,0.6108013369511813,1.0,11/17,34.49%,PPIA;HSPB1;AKT1;BAG5;SFPQ;TREM2;SOD1;P4HB;VNN1;HTRA2;MAPK7
prerank,regulation of lymphocyte differentiation (GO:0045619),0.4103292546876385,1.1261605571979787,0.2747747747747748,0.6878429181751438,1.0,2/18,3.59%,IL4I1;TBX21
prerank,cellular response to unfolded protein (GO:0034620),-0.37965538464317405,-1.1259506329952012,0.3131115459882583,0.6110004354629617,1.0,13/26,22.97%,DAB2IP;HSPA8;RHBDD1;BAX;HSPD1;HSPA5;BAK1;HSPB8;HSPA1A;HSPA9;TMBIM6;HSPA1B;PTPN1
prerank,positive regulation of cold-induced thermogenesis (GO:0120162),-0.29158028979229894,-1.1250495598671022,0.22424242424242424,0.6127280952482148,1.0,20/90,12.88%,CAV1;ADIPOR2;IGF1R;GATM;PRDM16;PPARGC1B;CMKLR1;PPARGC1A;ADIPOR1;VEGFA;UCP2;KDM3A;PDGFC;DECR1;FABP5;GRB10;ACADL;EBF2;GADD45G;SYK
prerank,pyrimidine deoxyribonucleotide catabolic process (GO:0009223),-0.4533739216046761,-1.1248248413867963,0.3314500941619586,0.6127302643820468,1.0,6/13,31.81%,SMUG1;UPP2;NT5C;NEIL1;TDG;DCTPP1
prerank,negative regulation of NIK/NF-kappaB signaling (GO:1901223),-0.382714505174181,-1.1247674516763972,0.28776978417266186,0.6122967026474136,1.0,4/23,5.35%,TMSB4X;CCN3;HDAC7;ADIPOR1
prerank,cellular response to oxidative stress (GO:0034599),-0.27917057783127125,-1.124290567723618,0.22792607802874743,0.6129194977238859,1.0,53/118,33.91%,PXN;FOXO1;MAPK3;FOXO3;RPS3;PPIA;PRR5L;PPARGC1A;NCF2;ATF4;CHCHD2;MSRA;GPX1;AKT1;STX2;ETV5;EGFR;VKORC1L1;GSR;HSPA1A;CCS;CHUK;CYBB;PTPRK;GPX8;KEAP1;HSPA1B;PKD2;ADNP2;ERO1A;SESN2;SRXN1;PRKCD;NUDT2;AIF1;GPX3;PARK7;STX4;CAMKK2;SOD1;RAD52;ROMO1;ATP13A2;RBM11;TPM1;ABL1;MAPK9;ANKRD2;FOS;NCF1;SLC4A11;JUN;HTRA2
prerank,positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),-0.35150452572045615,-1.1241430864746456,0.28735632183908044,0.6127441372034836,1.0,11/33,17.07%,KLF4;FOXO3;ETS1;TGFB1;TGFB2;GATA2;NR3C1;FGF2;SMARCA4;SRF;RELA
prerank,actomyosin structure organization (GO:0031032),-0.3011246094037519,-1.1240100662034813,0.2523364485981308,0.6125110937864227,1.0,16/75,11.21%,FRMD5;PGM5;TMOD3;SORBS1;F11R;PDLIM1;EPB41L4A;WDR1;LMOD1;FLII;FAM171A1;TMOD1;CDC42BPB;EPB41L5;TNFAIP1;FHDC1
prerank,protein acylation (GO:0043543),-0.3398514094537443,-1.123368896436216,0.2704761904761905,0.6135713581948544,1.0,18/38,32.61%,FOXO1;ING5;ZDHHC9;ZDHHC1;ZDHHC20;ZDHHC5;ZDHHC23;CLOCK;SELENOK;ZDHHC12;ZDHHC17;HHAT;ZDHHC3;ZDHHC18;NAT9;NAA80;KAT2A;CREBBP
prerank,regulation of DNA biosynthetic process (GO:2000278),-0.3723143835901719,-1.1231171515756921,0.29304029304029305,0.6136137949493713,1.0,7/27,15.87%,DACH1;HMBOX1;BMPR2;RGCC;PDGFA;FGF2;CDKN1A
prerank,response to amino acid (GO:0043200),-0.3551579477069779,-1.1227535713009629,0.2838827838827839,0.6139664204026861,1.0,19/31,35.88%,SH3BP4;CAPN2;LAMTOR2;RRAGD;XBP1;TMBIM6;RRAGA;RRAGC;SESN2;MEAK7;NSMF;RPTOR;GRIN1;LAMTOR5;CPEB4;LAMTOR1;LAMTOR3;GLRA1;IPO5
prerank,peptidyl-tyrosine phosphorylation (GO:0018108),-0.31044697873577864,-1.1226513857219227,0.25298804780876494,0.6136805710853049,1.0,22/67,17.47%,TEK;FLT1;IGF1R;IL15;PTK2B;KDR;MAPK3;PTK2;BMX;ABI3;FLT4;INSR;ABL2;SYK;CSF1R;ABI1;JAK2;EGFR;ERBB2;PTPN6;JAK3;HCK
prerank,vesicle cytoskeletal trafficking (GO:0099518),-0.34014457364913186,-1.1225686965439265,0.2875457875457875,0.6133459051942033,1.0,10/39,14.39%,MYO1D;FNBP1L;TRAK1;ACTN4;HTT;TRAK2;NDE1;NDEL1;WASL;RAB1A
prerank,regulation of RNA splicing (GO:0043484),-0.3035709041805277,-1.1225065184820096,0.24053030303030304,0.6129300425179228,1.0,20/69,20.37%,AHNAK;AHNAK2;MBNL1;HNRNPLL;RBM20;QKI;RPS13;PTBP3;ZNF326;SRPK1;FUS;RBM22;JMJD6;CLK1;FASTK;HNRNPK;HSPA1A;RPS26;ZPR1;TMBIM6
prerank,nucleic acid-templated transcription (GO:0097659),-0.3357488513974789,-1.1219374084645963,0.26848249027237353,0.6137650817539857,1.0,20/42,32.33%,MEF2A;NR4A2;PTMA;XAB2;PPP5C;E2F1;RNPS1;EPC1;POLR3A;MED20;PWP1;RRAGC;MLF1;HOXD3;TAF1B;POLR2F;POLR2L;POLR2I;POLR2C;TERT
prerank,response to organic cyclic compound (GO:0014070),-0.3172608686987578,-1.1219149527655947,0.2560747663551402,0.6132553726223587,1.0,12/52,12.63%,ESR1;ARL6IP5;ANXA1;SOCS2;IGFBP5;TGFB1;SLC1A1;CYP1B1;TLR3;SPP1;GGT5;ABCA2
prerank,regulation of vacuole organization (GO:0044088),-0.40297815447930035,-1.121708924400996,0.30648330058939094,0.6132277461535156,1.0,7/20,23.23%,IFT20;ANXA2;TBC1D12;MTM1;LAPTM4B;ADPRH;ENO1
prerank,positive regulation of dendrite morphogenesis (GO:0050775),0.4104296752042073,1.1216548464340002,0.32142857142857145,0.6983823338505406,1.0,9/19,17.48%,PTPRD;IL1RAPL1;CUX1;CAMK2B;CDKL3;CUX2;OBSL1;CAPRIN2;CUL7
prerank,epithelial cell migration (GO:0010631),-0.3378738676283015,-1.1210395267713873,0.28544776119402987,0.6143873153195281,1.0,14/37,16.32%,NOS3;DPP4;PXN;STARD13;FAP;CYP1B1;GIPC1;KANK2;FAT2;PLXND1;PKN3;FSTL1;PIK3CA;STAT1
prerank,positive regulation of macrophage differentiation (GO:0045651),0.46437021375273924,1.1208956943214388,0.32127659574468087,0.6992314623623703,1.0,2/11,2.64%,IL34;PRKCA
prerank,positive regulation of calcium ion transport into cytosol (GO:0010524),0.35997752246619313,1.1206904954553258,0.3146997929606625,0.6986762121427713,1.0,4/32,6.91%,CEMIP;PDPK1;P2RX4;CALCR
prerank,glial cell development (GO:0021782),-0.37409672911132674,-1.1202153275551652,0.3048327137546468,0.6158339733213066,1.0,6/25,15.54%,CDK6;APP;NF1;SOX4;NRROS;EIF2B3
prerank,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),0.4002330782097341,1.1200729177311661,0.3148936170212766,0.6992618558267041,1.0,4/21,2.65%,ATP1A2;SLC8A1;ANK2;PRKACA
prerank,negative regulation of receptor internalization (GO:0002091),-0.45674900041675776,-1.1193400313334265,0.3105924596050269,0.6174313293627272,1.0,6/12,29.00%,RIN3;ANKRD13A;SDCBP;NECAB2;MTMR2;UBQLN2
prerank,cellular response to interleukin-12 (GO:0071349),-0.3217871233562696,-1.1191890049345823,0.25849056603773585,0.6172624312390885,1.0,20/48,30.96%,RAP1B;HNRNPA2B1;MSN;ANXA2;PPIA;PITPNA;TALDO1;HNRNPDL;CFL1;JAK2;HSPA9;IL12RB2;CDC42;STAT4;SOD1;GSTO1;PDCD4;P4HB;PAK2;PLCB1
prerank,sterol transport (GO:0015918),-0.40497567471997487,-1.119097765923601,0.32136105860113423,0.6169511942910416,1.0,9/19,36.08%,CAV1;NPC1;LCAT;MSR1;CD36;OSBPL2;OSBPL5;ARV1;LDLR
prerank,linoleic acid metabolic process (GO:0043651),0.4180085336492012,1.1188464772235873,0.32662192393736017,0.7013579956491364,1.0,3/17,6.08%,ALOX12;ACSL1;GSTP1
prerank,positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),0.42665091314193393,1.1187622100138261,0.34051724137931033,0.7004596282270694,1.0,7/16,16.52%,SHLD2;SETMAR;KMT5C;SMCHD1;RIF1;KMT5B;PARP3
prerank,protein ADP-ribosylation (GO:0006471),0.37466817447891315,1.11831650625143,0.2872340425531915,0.7004814728563287,1.0,14/28,24.81%,PARP16;SIRT2;PARP11;PARP12;TIPARP;SIRT6;PARP4;PARP3;PARP1;ZC3HAV1;TNKS;SIRT3;SIRT1;PARP8
prerank,"negative regulation of mRNA splicing, via spliceosome (GO:0048025)",-0.44034764615021127,-1.1182628611585683,0.3114754098360656,0.6183892137439768,1.0,5/14,13.94%,SRSF6;PCBP4;RNPS1;SRSF4;SFSWAP
prerank,positive regulation of epithelial to mesenchymal transition (GO:0010718),0.33669257918134826,1.1182602312711898,0.29718004338394793,0.6994873746918023,1.0,7/40,7.96%,TCF7L2;BMP2;SMAD3;OLFM1;AXIN2;LOXL2;TGFBR1
prerank,protein peptidyl-prolyl isomerization (GO:0000413),-0.3910230841086866,-1.1181190634393308,0.3170731707317073,0.6181689786695861,1.0,9/20,25.21%,FKBP5;FKBP1A;PPIA;PPIC;PPIG;PIN1;FKBP4;PPIB;PPID
prerank,positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),0.30451362009854094,1.117634871029865,0.2822085889570552,0.6999898726612902,1.0,13/72,9.40%,IGF1;PIK3R1;NTRK3;KIT;DCN;PDGFRA;LYN;IRS2;PDGFRB;PDGFD;ERBB3;IL18;MYDGF
prerank,negative regulation of protein kinase activity (GO:0006469),-0.2906687558892555,-1.1175162313203275,0.23484848484848486,0.6190944746152964,1.0,33/88,24.29%,PTPRB;CAV1;LRP5;DAB2IP;CDKN1B;ADAR;PPIA;CHP1;DBNDD2;HSPB1;PPM1F;TRIB2;AKT1;WARS1;TRIB1;RB1;NF1;DUSP3;SRCIN1;YWHAG;CDKN1A;UBASH3B;TSC2;CDK5RAP3;GADD45A;DTNBP1;SFN;TRIB3;PTPRO;PTPRQ;PTPN1;CDKN1C;DBNDD1
prerank,organelle assembly (GO:0070925),-0.2376818863767758,-1.1175089050102862,0.15,0.6185492818681008,1.0,93/384,19.96%,ABLIM1;ABCC4;PGM5;EXOC4;CD34;TMOD3;NOTCH1;EXOC6;FNBP1L;RAB11A;RPS23;CDC14A;NCOR1;EHD4;NEK7;RPS3;RAB8B;MAP1LC3B;IFT20;CEP164;GORASP2;ABLIM3;ATXN2L;PKD1;CHMP2B;GABARAP;EHD2;LMOD1;CEP162;FLII;CDS2;RC3H1;CDS1;TMOD1;BBIP1;INPP5E;NUDCD3;DISC1;TMEM237;CPLANE2;IFT46;ATG3;SYNPO;ATG7;RAB8A;CEP290;DHX37;EXOC1;FHDC1;LIMD1;STK36;YTHDF2;RAB7A;DBNL;CIRBP;PCM1;VMP1;CC2D2A;ACTR3;POC1B;CDC14B;HAUS1;VPS36;MAP1LC3A;POGZ;ARL6;RFX2;RAB11FIP3;RAB1A;TSG101;GOLGA8B;CCDC28B;KIF24;SNF8;DNAH5;HPS1;EMC6;AMBRA1;CEP41;TMEM67;IST1;LSM14A;MAPRE2;CHMP2A;E2F4;EHD1;SPAG16;RAB32;TMEM231;EHD3;DYNLL2;WIPI2;RCC1
prerank,regulation of transferase activity (GO:0051338),-0.41036736391494694,-1.1173978286014297,0.314878892733564,0.6182766394255154,1.0,9/17,17.07%,HMBOX1;NLRC5;SPTSSB;EMP2;PPP1R3F;BAG5;FEM1A;LDB1;JMJD8
prerank,regulation of cellular macromolecule biosynthetic process (GO:2000112),-0.23881275374031882,-1.1169716528691676,0.14112903225806453,0.6187563048038874,1.0,81/366,17.62%,BNC2;MEF2C;APBB2;RREB1;RPS6KA5;ESR1;NOTCH1;RPL6;JMJD1C;NLK;RPL10;FOXO3;SOX17;VSX1;SIX1;CNBP;REST;APP;TRRAP;NFYA;ZNF431;ASCC2;PPARGC1B;PFDN5;PRDM2;PPARGC1A;BHLHE40;SOX13;SLC39A8;PPP2R1A;ATF4;FOXN3;NR3C1;HCFC1;NR2C2;ATXN1L;SPIN1;INSR;FZD7;FUS;SOX7;PDGFA;SOX18;RB1;ESRRA;PRRX2;MYBL1;WTIP;SP3;SOX12;KMT2D;SFPQ;LIMD1;TEAD2;E2F1;ZNF423;SOX4;HINT1;ENG;PHF12;HCFC2;MLX;RNF20;NR5A2;RBM4B;LDB1;ZFHX3;SOX6;DRAP1;CELSR2;SMARCA2;LIN54;SAP30L;TCF3;ANKRD17;PCIF1;RELA;ZNF22;CCAR2;BRCA2;SP1
prerank,regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),-0.3401649446664212,-1.1159666223892344,0.2840909090909091,0.6207446114017613,1.0,13/38,19.49%,THBS1;NOS3;TNFSF10;CASP8;RIPK1;FAIM;GPX1;FAS;BCL2L1;MADD;TNFAIP3;ARHGEF2;FAIM2
prerank,protein localization to condensed chromosome (GO:1903083),-0.45227760754865387,-1.1156383203281433,0.33513513513513515,0.6209224433564143,1.0,6/12,31.36%,ZW10;KNL1;MTBP;SPDL1;BUB3;CDK1
prerank,positive regulation of Rho protein signal transduction (GO:0035025),0.35853760077518443,1.1156368322897627,0.3037475345167653,0.7040642807690979,1.0,5/30,7.24%,ROBO1;LPAR1;GPR55;GPR174;LPAR4
prerank,peptidyl-serine dephosphorylation (GO:0070262),-0.43859469717163735,-1.115551174930809,0.30490018148820325,0.620550531048652,1.0,7/14,27.92%,PPM1F;PPP5C;PPP2R2A;NCK1;PPP2R2D;PPP1CA;DUSP1
prerank,regulation of endothelial cell proliferation (GO:0001936),-0.28916293804584475,-1.1151704591888194,0.2624254473161034,0.620971726187173,1.0,23/88,14.08%,TEK;CAV1;THBS1;NRP2;TIE1;BMPR2;KDR;CAV2;F3;VEGFC;PPP1R16B;PTPRM;VEGFA;ATP5F1A;RGCC;FLT4;AKT1;NF1;VEGFD;APOE;FGF2;EMC10;STAT5A
prerank,cellular response to organic cyclic compound (GO:0071407),-0.26898033900839957,-1.115012230522588,0.2024793388429752,0.6208282662870405,1.0,24/141,7.34%,MEF2C;ACTB;RAP1A;CDH1;ESR1;RAP1B;TGM2;ARL6IP5;CTNNA1;RAPGEF1;ATP1A1;IGFBP5;TGFB1;MSN;PDE2A;SLC1A1;KCNQ1;CYP1B1;DIAPH1;NRIP1;CASP7;EZR;NR3C1;JUP
prerank,cardiac muscle cell development (GO:0055013),0.39188149880972534,1.1145265888367917,0.3211845102505695,0.7058874148839223,1.0,9/20,14.84%,SLC8A1;PDGFRA;CSRP3;FHOD3;PDGFRB;ALPK3;OBSL1;PDLIM5;MYLK3
prerank,brain development (GO:0007420),0.2729836610413472,1.1145120836781572,0.2169811320754717,0.7048142204808096,1.0,25/136,14.11%,EPHA7;ARNT2;ROBO2;ATXN1;CNTN4;ZIC1;AFF2;CNTNAP2;PBX4;CTNNA2;SPEF2;HES5;CDK5R1;BBS2;PTEN;EML1;EEF1AKMT4-ECE2;PLXNB2;CTNS;PHF8;NKX2-1;TUBGCP2;CXCR4;GRIN2A;AMIGO1
prerank,regulation of granulocyte chemotaxis (GO:0071622),0.42088383148790465,1.1144067970055915,0.32112068965517243,0.7039586839968648,1.0,2/19,0.65%,CAMK1D;IL34
prerank,cardiac muscle cell action potential (GO:0086001),0.36829125085482173,1.1142533838637367,0.29446640316205536,0.703270915146154,1.0,5/30,3.32%,ATP1A2;SLC8A1;SCN3B;ANK2;CACNA2D1
prerank,positive regulation of intracellular signal transduction (GO:1902533),-0.22969241047199376,-1.1140737270902499,0.12210526315789473,0.6225997581691107,1.0,118/509,17.11%,FN1;KITLG;TEK;VWF;CAV1;FLT1;IGF1R;NR3C2;THBS1;PTPRJ;GAB1;ESR1;PLCG2;FGF1;NOD1;RACK1;TGM2;ACTN4;KDR;CAV2;F3;IQGAP1;RPS15;TFRC;PTK2;MID2;TBX1;RPS3;DAB2IP;FERMT2;RICTOR;TRIM25;TNFAIP8L3;HSP90AB1;TGFB1;APP;TGFB2;ATP2C1;FKBP1A;MAP3K3;RPL23;MFHAS1;RAC1;REL;LIMS1;TNFSF10;VEGFA;S100B;IKBKB;BRD4;MYOC;SHC1;LURAP1;CASP8;TLR3;RIPK1;EEF1D;GAPDH;FLT4;PLK2;BAX;INSR;PDGFC;PDGFA;TRIM14;RPS20;HIP1;JCAD;TIRAP;TCIM;WNT11;DHX58;CD74;S100A13;PIK3AP1;BBC3;PPP5C;TRIM62;BCL2L1;MAVS;TLR4;MIB2;FGF2;EDA2R;SPHK2;ENG;TNFRSF1A;USP15;HRAS;PHB2;TRIM68;BCAP31;LAMTOR2;JAK2;TRIM5;EGFR;ERBB2;STRN;GAB2;PIK3CA;GPR37L1;NOD2;PTPN6;BCAR3;TMEM101;CX3CR1;MET;LGALS1;PIK3R2;RRAGD;HSP90AA1;ANKRD17;MIER1;TAB2;JMJD8;RELA;BAD;GPR89A
prerank,positive regulation of peptidyl-serine phosphorylation (GO:0033138),-0.2905287869729129,-1.1136332674726939,0.2625482625482625,0.6230982359494779,1.0,27/73,29.98%,CAV1;TFRC;NGF;CD44;HSP90AB1;FNIP2;TGFB1;APP;VEGFA;AKT1;CAMK1;MTCP1;EGFR;BCAR3;HSP90AA1;RAPGEF3;HCLS1;PRKD2;PDCD10;EIF4G1;RPTOR;PARK7;TXN;TNKS1BP1;SH2D3C;TERF2IP;IRGM
prerank,cellular respiration (GO:0045333),-0.33217664724365337,-1.1135227453157626,0.27599243856332706,0.6227959504893498,1.0,15/41,22.14%,ATP5F1D;PPARGC1A;NDUFS4;COX15;MTFR1;SURF1;ETFDH;ETFB;UQCRB;COX10;UQCRH;LYRM7;SDHB;SDHAF4;MTFR2
prerank,ear morphogenesis (GO:0042471),0.39514489344216425,1.1132909404074784,0.30752688172043013,0.704663222214316,1.0,3/20,2.66%,FGFR2;ZIC1;CHD7
prerank,DNA-dependent DNA replication maintenance of fidelity (GO:0045005),0.3433255559119268,1.1126268975220894,0.3025210084033613,0.7052599960211571,1.0,18/40,23.90%,GEN1;SETMAR;BLM;MCM9;FANCM;THOC1;CENPS;CDK9;ETAA1;SMARCAL1;POLD1;RTEL1;DONSON;PCNA;ZRANB3;FBH1;RFWD3;TIMELESS
prerank,protein neddylation (GO:0045116),-0.4336522959711864,-1.112386751111664,0.3301526717557252,0.6250940073041529,1.0,4/13,14.34%,DCUN1D5;DCUN1D1;UBE2F;RBX1
prerank,protein kinase B signaling (GO:0043491),0.377069597857819,1.1123413850372155,0.3168724279835391,0.7049664083655511,1.0,1/23,0.08%,IGF1
prerank,genitalia development (GO:0048806),0.45762420465395126,1.112272837198441,0.3407079646017699,0.704077970046143,1.0,2/12,2.66%,TBX3;CHD7
prerank,positive regulation of MAPK cascade (GO:0043410),0.25573900079327655,1.1117439780492921,0.2220039292730845,0.7042981358390091,1.0,35/245,10.09%,IGF1;ROBO1;NRP1;BMP2;IL34;KSR1;LPAR1;NTRK3;FGFR2;PELI2;KIT;PLA2G5;PDGFRA;GPR55;ROCK2;PRKCA;SLC30A10;RIT2;WWC1;MAP3K12;IAPP;PDGFRB;CALCR;THPO;SOX2;PDGFD;IGF2;RYK;KLHDC10;FGFR4;EPHA8;MYDGF;ERBB4;CCL25;ADRA1D
prerank,protein autoubiquitination (GO:0051865),0.3160840718977172,1.1116106049515697,0.2917547568710359,0.7035443350733,1.0,7/61,7.72%,RNF220;SH3RF3;SH3RF1;DDB2;MDM2;PRKN;RNF181
prerank,regulation of posttranscriptional gene silencing (GO:0060147),-0.31282243968207096,-1.1113142748296976,0.31346153846153846,0.6267637381729744,1.0,25/50,34.81%,NUP93;NDC1;NUP54;H3-3A;NUP188;FMR1;NUP155;RANBP2;NUP37;PUM2;NUP160;EIF4G1;NUP43;SEH1L;SEC13;NUP107;NUP42;NUP98;POLR2F;POLR2L;POLR2I;RAE1;POLR2C;NUP88;NUP214
prerank,regulation of gene silencing by RNA (GO:0060966),-0.31282243968207096,-1.1113142748296976,0.31346153846153846,0.6267637381729744,1.0,25/50,34.81%,NUP93;NDC1;NUP54;H3-3A;NUP188;FMR1;NUP155;RANBP2;NUP37;PUM2;NUP160;EIF4G1;NUP43;SEH1L;SEC13;NUP107;NUP42;NUP98;POLR2F;POLR2L;POLR2I;RAE1;POLR2C;NUP88;NUP214
prerank,positive regulation of cholesterol transport (GO:0032376),-0.3684664484814379,-1.1112159442891036,0.2998102466793169,0.626466422622362,1.0,4/27,4.05%,CAV1;PLTP;NFKBIA;LPCAT3
prerank,regulation of cytokine production involved in immune response (GO:0002718),-0.3860969103357681,-1.1112104985993,0.32086614173228345,0.6259239984083815,1.0,8/22,30.30%,SLC7A5;TNFRSF1B;SPHK2;NOD2;LAPTM5;BTK;LILRB1;TRPM4
prerank,regulation of DNA damage checkpoint (GO:2000001),0.4823119691639343,1.11107656991282,0.34146341463414637,0.703831259017243,1.0,6/10,22.71%,CRY1;RPA2;THOC1;ETAA1;WDR76;RFWD3
prerank,regulation of cellular respiration (GO:0043457),-0.40983698979755984,-1.1109969645981768,0.32234432234432236,0.6258887259632739,1.0,5/17,10.41%,CBFA2T3;PRDM16;IDE;IFNAR1;VCP
prerank,myeloid cell development (GO:0061515),-0.3985783217243074,-1.1106028361746532,0.33070866141732286,0.6263091835612805,1.0,3/18,4.62%,FOXP1;APP;ANXA2
prerank,dendrite morphogenesis (GO:0048813),0.3543740237964552,1.1102014862897098,0.31210191082802546,0.7049623425378537,1.0,12/35,14.58%,PTN;LRP4;DOCK10;CTNNA2;CTNND2;EPHB1;MAPK8IP2;FARP1;PTEN;CHRNA7;DLG4;MAP6
prerank,regulation of extracellular matrix disassembly (GO:0010715),0.4247096604654445,1.1098835605021293,0.34096109839816935,0.7046654470053532,1.0,4/15,8.80%,DDR2;LRP1;DDR1;FGFR4
prerank,epidermal growth factor receptor signaling pathway (GO:0007173),-0.3317224671702909,-1.1098818759905478,0.2827324478178368,0.6275699987895459,1.0,12/45,10.94%,PLCE1;RPS6KA5;GAB1;PTK2B;IQGAP1;PTK2;TGFB1;REPS2;SHC1;AKT1;PIK3C2A;KIF16B
prerank,regulation of ERAD pathway (GO:1904292),-0.4588223095176932,-1.1098414866492403,0.3284671532846715,0.6271203123085896,1.0,4/11,11.64%,TMEM259;AQP11;RNF185;UBXN1
prerank,positive regulation of secretion by cell (GO:1903532),0.3083346597489129,1.109818820945845,0.27655310621242485,0.7037363516904481,1.0,5/70,4.15%,IGF1;BMP6;BMP2;P2RX4;CADPS
prerank,inorganic anion transmembrane transport (GO:0098661),0.3110668305982797,1.109570962629062,0.27897838899803534,0.7032540632872026,1.0,20/63,15.96%,SLC1A3;ANO7;GABRA2;GABRR3;GLRB;SLC20A2;GABRB3;ANO3;GABRR2;SLC25A10;GABRA5;CLCN1;SLC6A1;SLC12A3;GLRA3;ANO5;GABRB1;GABRG1;SLC25A30;GABRG3
prerank,regulation of protein kinase activity (GO:0045859),-0.2775020660787641,-1.109061667684478,0.27360308285163776,0.6284688431024763,1.0,42/106,27.63%,PLCE1;RAP1A;PTK2B;IQGAP1;PTK2;PPIA;CHP1;DBNDD2;RASSF2;HSPB1;PPM1F;TRIB2;AKT1;WARS1;TRIB1;RB1;NF1;SMG8;LCP2;MMD;PRKAG1;YWHAG;CDKN1A;TAB2;UBASH3B;AGAP2;TSC2;ECT2;DTNBP1;TSPYL2;SFN;RAPGEF2;TRIB3;DBNDD1;MRNIP;SPDYA;PARK7;MMD2;CAMKK2;SOD1;RTRAF;ADCYAP1
prerank,chondroitin sulfate metabolic process (GO:0030204),-0.35518923789184054,-1.1085337873590584,0.2958801498127341,0.6292397820132073,1.0,4/30,4.40%,CHST11;CSGALNACT1;CSPG4;HEXA
prerank,positive regulation of nitric oxide metabolic process (GO:1904407),-0.3655655450024743,-1.1082985224925008,0.3290441176470588,0.6292810840153352,1.0,13/26,29.22%,KLF2;KLF4;HSP90AB1;EDN1;AKT1;INSR;TLR4;HSP90AA1;DDAH1;PKD2;TMEM106A;CD36;TLR6
prerank,negative regulation of interleukin-12 production (GO:0032695),-0.4310858068397145,-1.1082145992918206,0.3400735294117647,0.6289534225697031,1.0,2/14,4.89%,THBS1;CMKLR1
prerank,defense response to tumor cell (GO:0002357),0.4787570206369502,1.1081829309919964,0.3169642857142857,0.7058344670283483,1.0,3/10,5.99%,RBMS3;DLEC1;DAPK1
prerank,photoreceptor cell development (GO:0042461),-0.43371966377918086,-1.1081200594080294,0.32884615384615384,0.6286375116738888,1.0,7/14,25.80%,RP1;VEGFA;MFSD2A;CEP290;CDHR1;ARL3;MYO7A
prerank,regulation of cytokine production (GO:0001817),-0.2685785798286854,-1.1080427179973231,0.228,0.6282643393161154,1.0,25/126,14.93%,FOXP1;AFAP1L2;RPS6KA5;IL15;SRGN;IFIH1;ANXA1;HDAC9;IL33;N4BP1;LURAP1;CASP8;TNFRSF1B;RGCC;GAPDH;BCL6;FLOT1;ACE2;S100A13;TRIM56;PLD3;AGPAT1;BTN3A3;BCL6B;NLRP4
prerank,extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),-0.3580922303617684,-1.1079997599484823,0.3273092369477912,0.6277894627655054,1.0,6/28,8.37%,DAB2IP;NGF;CRADD;GABARAP;CASP8;BAX
prerank,RNA metabolic process (GO:0016070),0.2765190895615762,1.1079331393304819,0.2428842504743833,0.7053918351702855,1.0,46/127,25.34%,CELF2;ATXN1;NOVA1;RBMS1;ADARB2;HNRNPUL1;AGO4;DHX8;MPHOSPH10;RBM5;POLR2G;PCBP3;FTO;BICD1;PABPN1;PNPT1;RNASE4;HNRNPD;NOL9;THOC1;PARN;METTL3;DROSHA;RNASEL;POLR2D;RNASEH1;PAPOLA;AGO3;HNRNPF;AGO1;POLR2K;AGO2;RNASE3;DDX24;TENT2;MRPL44;RNASEH2B;ATXN2;DICER1;SETX;POLR2B;RBM39;WTAP;FASTKD1;CLP1;RNGTT
prerank,establishment of melanosome localization (GO:0032401),-0.39939242627551186,-1.107696598652213,0.3428030303030303,0.6279857855361806,1.0,6/19,13.87%,RAB11A;RAB27A;MREG;MLPH;RAB11B;ARL6
prerank,positive regulation of coagulation (GO:0050820),-0.47332705022689414,-1.1076961373879166,0.34774774774774775,0.6268783215145436,1.0,3/10,9.15%,ST3GAL4;THBS1;ENPP4
prerank,positive regulation of hemostasis (GO:1900048),-0.47332705022689414,-1.1076961373879166,0.34774774774774775,0.6268783215145436,1.0,3/10,9.15%,ST3GAL4;THBS1;ENPP4
prerank,artery morphogenesis (GO:0048844),-0.356971565883228,-1.1074647600477998,0.31390977443609025,0.6268719305737959,1.0,11/30,13.24%,NOTCH1;BMPR2;TBX1;SMAD7;TGFB2;TBX2;STRA6;VEGFA;NF1;HES1;ENG
prerank,regulation of long-term synaptic potentiation (GO:1900271),0.37444471361051007,1.1073290099376791,0.31896551724137934,0.7059286284737891,1.0,6/28,13.18%,ADCY1;PTN;CYP46A1;ADCY8;CHRNA7;ZDHHC2
prerank,negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),-0.42089319372815653,-1.1072716771218176,0.3660245183887916,0.6268362884504103,1.0,3/16,6.13%,CAV1;ADIPOR1;PPP2R1A
prerank,regulation of vasculogenesis (GO:2001212),-0.43764523412066714,-1.1069898472854,0.3546099290780142,0.6269993168400012,1.0,6/14,14.51%,RAP1A;CD34;KDR;EMP2;TMEM100;HEY1
prerank,"protein localization to chromosome, centromeric region (GO:0071459)",-0.4145052959819295,-1.1068979034595512,0.3460837887067395,0.6267007271850649,1.0,9/17,31.36%,ZW10;RB1;KNL1;MTBP;BOD1;SPDL1;CENPA;BUB3;CDK1
prerank,positive regulation of telomere maintenance via telomerase (GO:0032212),-0.3510176936949025,-1.1068478167250955,0.3132530120481928,0.6262778713844129,1.0,9/32,19.52%,HMBOX1;MAPK3;NEK7;FBXO4;PNKP;CCT2;CCT3;HNRNPA1;CCT8
prerank,cellular response to cytokine stimulus (GO:0071345),-0.23378410395238364,-1.106770923300837,0.17118997912317327,0.6259301664390177,1.0,113/416,20.73%,FN1;LEF1;ST3GAL6;PTPN14;SLC12A2;LBP;PTPRJ;VIM;LIFR;LRCH1;MAOA;F3;FOXO1;MT1X;WNK1;STX3;RAPGEF1;LAMA5;FOXO3;RPS3;S1PR1;IRAK2;ANXA1;GBP5;DAB2IP;SOCS2;CDKN1B;MT2A;TGFB1;UBB;PDE2A;HSPA8;INPP5D;UBC;RPS27A;IL1R1;CRK;VEGFA;GBP7;STX1A;IKBKB;SHC1;TNFRSF21;TNFRSF1B;RIPK1;GAPDH;NPNT;YBX3;RC3H1;IL20RB;IFITM2;AKT1;NDUFA13;BCL6;CCL15;DHX9;ASAH2;TWIST1;IFNAR1;IFIT1;JUNB;RPL13A;UBE2G2;LRP8;GRB10;ABL2;AKAP6;CIB1;YWHAZ;BCL2L1;TLR4;POU2F1;FGF2;SYK;IL18BP;CSF1R;TNFRSF1A;AIM2;STAT5A;PTPN12;JAK2;F13A1;SIGIRR;GAB2;PIK3CA;CLCF1;PTPN6;NDN;CDKN1A;STAT1;HSP90AA1;RELA;XBP1;IFNGR1;JAK3;HCK;CHUK;SLA;IRF8;AQP4;ARHGEF2;IRAK4;IL3RA;CCND1;SOX9;SYNCRIP;MCL1;CASP1;HAS2;LGALS9;MAPK11;CSF2RB;IL10RB
prerank,2-oxoglutarate metabolic process (GO:0006103),0.43971311009649805,1.106578634489647,0.32407407407407407,0.7068314258392625,1.0,6/13,21.85%,ADHFE1;PHYH;D2HGDH;GPT2;GOT1;GOT2
prerank,fatty acid oxidation (GO:0019395),-0.3087260960092748,-1.1064570434524723,0.26499032882011603,0.6261607273768302,1.0,15/57,18.03%,ADIPOR2;PPARD;ACAD11;PPARGC1A;ADIPOR1;ACAA2;ECHS1;HACL1;DECR1;ACADL;ACADVL;CROT;ECI1;MECR;HSD17B10
prerank,mesonephros development (GO:0001823),-0.44880340567428195,-1.1063889452794164,0.3333333333333333,0.6257836237728642,1.0,2/11,5.53%,FGF1;ZBTB16
prerank,positive regulation of mesenchymal cell proliferation (GO:0002053),-0.47252629174827254,-1.1062873931012631,0.32608695652173914,0.6254723673006795,1.0,6/10,19.37%,TGFBR2;LRP5;TBX1;PDGFA;STAT1;SOX9
prerank,positive regulation of phosphatase activity (GO:0010922),-0.3855574582190422,-1.1060456828082021,0.3273381294964029,0.625541405179832,1.0,4/21,3.86%,MEF2C;ITGA1;HSP90AB1;CALM1
prerank,protein deubiquitination (GO:0016579),-0.2471880601900324,-1.1057977023973746,0.1868583162217659,0.6256073188572688,1.0,65/242,21.45%,ACTB;ESR1;IFIH1;NFKBIA;MINDY2;SMAD7;MINDY1;TRRAP;EIF3F;UBB;USP1;USP46;FOXK1;UBC;RPS27A;IL33;BRCC3;USP7;PSMA6;HCFC1;RIPK1;OTUD5;USP8;UIMC1;PSMB5;YY1;USP3;ENY2;BABAM1;RHOT1;USP9X;OTUB1;UCHL1;VCP;PSMC4;TADA2B;USP5;PSMC5;PSMD14;COPS5;USP15;PSMD8;SMAD4;PSMD11;TNFAIP3;UCHL3;PSMB4;PSMD12;PSMC1;BABAM2;WDR48;USP22;RCE1;MCRS1;SMAD2;USP4;USP49;SNX3;USP38;KEAP1;JOSD1;PSMA1;TADA3;PSMB1;PSMC3
prerank,ventricular cardiac muscle cell action potential (GO:0086005),0.41484434424258776,1.1053053777126416,0.345707656612529,0.7092333051227727,1.0,3/17,4.33%,SCN3B;ANK2;GPD1L
prerank,"negative regulation of transcription, DNA-templated (GO:0045892)",-0.22334502216270063,-1.1052971487388037,0.1013215859030837,0.6263352644273346,1.0,155/807,14.63%,KLF12;MECOM;LEF1;FOXP1;ELK3;MEF2C;CAV1;PRDM6;DACH1;WWP1;RREB1;ATP8B1;RPS6KA5;ESR1;NOTCH1;DDX5;RPS14;CBFA2T3;ID1;ZHX3;NEDD4L;HMBOX1;ID3;MAP2K5;PPARD;NCOR1;MEF2A;KLF2;FOXO1;KLF4;RPL10;FOXO3;DAB2IP;SMAD7;ZBTB7A;IRF2BPL;CDKN1B;KLF7;FNIP2;TGFB1;CNBP;REST;KDM5C;PRDM16;TBX2;RPL23;UBB;PDE2A;ZNF431;HDAC9;HSPA8;WWP2;NR4A2;LIMS1;PFDN5;SARS1;KCTD1;FOXD1;RLIM;PRDM2;CTBP1;PHC2;BHLHE40;SOX13;FOXK1;CD38;UBC;RPS27A;HEYL;ZBTB16;LRRFIP1;DPF2;IL33;VEGFA;CNOT7;MPHOSPH8;DPF3;NRIP1;RBFOX2;RARA;NOTCH4;EZR;GATA6;ATF4;SHC1;FOXN3;CBFB;KLF8;NR3C1;MXD4;HCFC1;CBX5;PPM1F;CIC;EDN1;UIMC1;IRF2BP2;MOSPD1;HDGF;NR2C2;YY1;HDAC4;ZMYND11;NDUFA13;BCL6;KANK2;SOX7;TWIST1;MAF1;TRIM28;USP9X;HHEX;HSBP1;SOX18;RB1;MXD1;ZC3H8;FOXP2;MTA2;WNT11;SKIL;FOXC2;ZBTB18;CCDC85B;MTA1;SP3;SFPQ;FRK;LIMD1;TCF25;PHC1;IMPACT;HIVEP1;CIPC;E2F1;ZNF423;COMMD7;POU2F1;MIER2;HES1;CIART;MTERF3;LCOR;PHF12;EPC1;HCFC2;MLX;PHB2;SMARCA4;EID2;BCL6B;SDCBP;HEY1;SMYD2;ETV5
prerank,negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),-0.3057357886183453,-1.104999998090074,0.288135593220339,0.6265352809285865,1.0,24/62,25.92%,ACKR3;TPT1;PPIA;HSPB1;YBX3;AKT1;NDUFA13;DNAJA1;PTTG1IP;BAG5;BCL2L1;NDUFS3;OPA1;HSPA1A;XBP1;CCAR2;ARHGEF2;MCL1;TMBIM6;ENO1;SNAI2;HYOU1;PLAUR;PARK7
prerank,response to cytokine (GO:0034097),-0.2648983551543708,-1.1046433267910136,0.25101214574898784,0.626878728496954,1.0,47/141,21.46%,LEF1;PTPN14;MAP4K3;LIFR;COL3A1;IRAK2;ANXA1;GCH1;MAPKAPK3;APP;ADAR;REL;ADAM10;IL1R1;IFITM1;IFITM3;CASP8;RIPK1;TNFRSF11A;HDAC4;IFITM2;ASAH2;RELB;CD74;GGT5;AKAP6;TRIM56;BCL2L1;IL18BP;CSF1R;PTPN12;JAK2;SIGIRR;SRF;TIMP2;PTPN6;STAT1;IGBP1;RELA;JAK3;MCL1;CASP1;GGT1;LGALS9;HCLS1;IL6ST;TAF9
prerank,negative regulation of insulin secretion (GO:0046676),-0.4126199102402065,-1.1045571961834721,0.3259668508287293,0.6265232538704004,1.0,6/17,13.84%,CCN3;KCNB1;KLF7;REST;PIM3;INHBB
prerank,MyD88-independent toll-like receptor signaling pathway (GO:0002756),-0.3568947148234365,-1.1040593891616313,0.32053742802303264,0.6271770941523073,1.0,7/30,7.38%,UBB;UBC;RPS27A;IKBKB;CASP8;TLR3;RIPK1
prerank,nitrogen compound transport (GO:0071705),0.26952528020730976,1.1040548111052173,0.23694779116465864,0.7114683331985756,1.0,14/141,6.25%,SLC7A11;SLC6A12;SLC43A1;TXNIP;SLC7A2;SLC6A13;SLC22A4;SLC35F3;LRP1B;ABCC2;SLC22A3;SLC38A1;SLC36A2;SLC7A9
prerank,toxin transport (GO:1901998),0.4732710844553968,1.1039063595867968,0.3405639913232104,0.7107944544312563,1.0,3/10,6.60%,ANTXR1;SLC22A3;RAB29
prerank,regulation of macrophage activation (GO:0043030),-0.3559160876186183,-1.1036139327743009,0.30740037950664134,0.62768041543542,1.0,8/30,12.43%,LBP;THBS1;MFHAS1;IL33;GPR137B;HSPD1;CD74;TLR4
prerank,attachment of mitotic spindle microtubules to kinetochore (GO:0051315),-0.4385877585966906,-1.103337827260139,0.3271375464684015,0.6278117258749335,1.0,7/12,37.33%,MAD1L1;BOD1;NDC80;RMDN1;SEH1L;NUF2;KIF2C
prerank,regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),0.4564217622517779,1.103193278552114,0.3406113537117904,0.7115214400362002,1.0,3/11,8.22%,CACNA2D1;CACNB2;CACNB1
prerank,positive regulation of binding (GO:0051099),-0.28580841064625573,-1.1024196381581006,0.2785571142284569,0.6295354107562527,1.0,18/84,9.23%,CAV1;CLDN5;B2M;HMBOX1;NGF;RPL11;APP;FKBP1A;RALB;PKD1;HIP1R;RARA;IDE;NMD3;DPH3;DHX9;ADD1;FLOT1
prerank,stabilization of membrane potential (GO:0030322),0.4216713626619225,1.10232763605381,0.3401639344262295,0.7128197170088733,1.0,1/16,0.14%,KCNK2
prerank,positive regulation of actin cytoskeleton reorganization (GO:2000251),0.4003305544593545,1.1021935286715865,0.33029612756264237,0.7120778380804587,1.0,3/17,4.01%,NRP1;NTRK3;STAP1
prerank,response to UV-A (GO:0070141),-0.43164895983615376,-1.1021660243120033,0.3553113553113553,0.6295715139750601,1.0,8/14,35.91%,AKT1;EGFR;OPN3;CCND1;PPID;MMP3;MMP1;CERS1
prerank,"regulation of phagocytosis, engulfment (GO:0060099)",-0.4673271287572034,-1.1019605400504555,0.34629629629629627,0.6295241922292262,1.0,1/10,0.23%,ANO6
prerank,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),0.38944458936126114,1.1019141897418736,0.33755274261603374,0.7106862348760734,1.0,4/21,6.54%,EYA2;GDNF;BCL2;EYA1
prerank,negative regulation of signal transduction in absence of ligand (GO:1901099),0.38944458936126114,1.1019141897418736,0.33755274261603374,0.7106862348760734,1.0,4/21,6.54%,EYA2;GDNF;BCL2;EYA1
prerank,regulation of cell cycle process (GO:0010564),-0.2779560137858024,-1.1019072324971186,0.276,0.6290833082335693,1.0,42/104,31.40%,RAB11A;CAV2;CALM1;RPRD1B;ZFYVE26;PLK2;YTHDF2;CALM3;BCL2L1;RAB11FIP3;CETN2;CDK13;CSNK2A1;CSNK2A2;MAD1L1;L3MBTL1;KLHL9;ECT2;CHEK1;KLHL21;SOX9;PIN1;PRPF40A;RCC1;KNSTRN;MKI67;KIF13A;PLK3;CDC42;CDKN2B;DCUN1D3;PLK5;TTL;MYO19;SETD2;RACGAP1;CTNNB1;ENTR1;KIF11;PLK1;AURKA;PIK3R4
prerank,regulation of phosphate metabolic process (GO:0019220),0.41329852098096487,1.101899286390669,0.32450331125827814,0.709637974217144,1.0,3/16,7.11%,SRPX2;IL4;SIRT2
prerank,sensory perception of sound (GO:0007605),0.2944008748572567,1.1014942896696451,0.25313807531380755,0.7096804031161,1.0,9/88,6.54%,ADGRV1;CEMIP;ATP6V0A4;KIT;OTOS;ALDH7A1;COL4A3;PCDH15;EYA1
prerank,positive regulation of reactive oxygen species metabolic process (GO:2000379),-0.32068099800783567,-1.101345232125046,0.30654205607476637,0.6299657571022577,1.0,23/47,31.22%,THBS1;PLCG2;TGFBR2;TGFB1;RNF41;RAB27A;RIPK1;ACE2;TLR4;SYK;CDKN1A;CBR1;GADD45A;PRKCD;DCXR;GRIN1;SOD1;CD36;TLR6;XDH;ROMO1;DHRS4;TYROBP
prerank,positive regulation of lymphocyte migration (GO:2000403),-0.44709268742859226,-1.1009150331763626,0.3441441441441441,0.6305071660675207,1.0,2/12,4.11%,JAM2;APP
prerank,carnitine shuttle (GO:0006853),0.45758975130684,1.1006200061649525,0.3609341825902335,0.7109024350068444,1.0,4/11,16.75%,PRKAG2;CPT2;ACACA;PRKAB2
prerank,negative regulation of transcription by RNA polymerase II (GO:0000122),0.23259985876477654,1.1006173620533113,0.1846435100548446,0.7098332726910399,1.0,77/572,9.65%,BMP6;TCF7L2;FHL2;LDB2;BMP2;SALL1;AR;ATXN1;TBX3;GLIS3;MXI1;FGFR2;NR2F2;BCOR;ZEB1;TBL1XR1;VDR;RARB;TRPS1;PPARA;ZHX2;GLI2;MITF;PRDM5;SMAD3;TFEC;KDM1B;NKX6-1;TBX21;MDM2;GLI3;WWC1;TENM2;ZEB2;UXT;FNIP1;AEBP1;FOSB;ZMYM5;CEBPB;IL4;RNF2;JAZF1;PRKN;SUMO1;LIN37;HDAC10;ZHX1;LOXL2;SMURF2;SIRT2;CUX1;MEN1;MBD2;NFIX;CRY1;BCL11A;RARG;SOX2;TRIM27;CITED2;RBPJ;NSD1;IGF2;FOXD3;HES5;MIER3;CPEB3;ATN1;BRMS1L;BRMS1;GLIS1;GATA3;CTCF;KCNIP3;CUX2;HDAC8
prerank,regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),-0.48021935681296374,-1.1002829196354404,0.35940409683426444,0.631541136475727,1.0,3/10,11.37%,ESR1;PSMC4;PSMC5
prerank,cellular response to ATP (GO:0071318),0.42302525906933025,1.099833723432328,0.35173824130879344,0.7107427958608641,1.0,5/14,24.01%,P2RX4;HSP90B1;P2RY1;TAF1;RYR3
prerank,C21-steroid hormone biosynthetic process (GO:0006700),0.4496547198187571,1.0998147116210006,0.33940774487471526,0.7097250855211596,1.0,1/12,0.69%,AKR1B1
prerank,adherens junction organization (GO:0034332),-0.3180757439231473,-1.099450805999982,0.290448343079922,0.6330940585025732,1.0,12/48,10.88%,ACTB;CDH1;CTNNA1;RAMP2;FERMT2;SMAD7;JAM3;CDH4;JUP;PVR;VCL;CDH6
prerank,Golgi to plasma membrane transport (GO:0006893),-0.32123838981645986,-1.0993111228767645,0.30727272727272725,0.6328928883053528,1.0,5/47,1.44%,STXBP6;EXOC4;SPTBN1;EXOC6;EXOC6B
prerank,negative regulation of mitochondrion organization (GO:0010823),0.3439125402534581,1.099036919221594,0.34710743801652894,0.7107228159472724,1.0,4/33,6.76%,IGF1;OMA1;PRKN;IAPP
prerank,epithelial structure maintenance (GO:0010669),-0.46377668974717773,-1.0989850160038357,0.3456561922365989,0.6331803403424432,1.0,5/11,36.09%,CXADR;NOD2;MUC13;PIWIL4;MUC6
prerank,regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),-0.24952229215212837,-1.09895093588509,0.21868365180467092,0.632706441390963,1.0,61/208,21.16%,ESR1;PLCG2;NOD1;TFRC;MID2;DAB2IP;TRIM25;ATP2C1;FKBP1A;MAP3K3;REL;TNFSF10;S100B;IKBKB;BRD4;LURAP1;CASP8;HSPB1;RIPK1;EEF1D;GAPDH;PLK2;ZMYND11;CARD19;TRIM14;TIRAP;MAPKBP1;CD74;S100A13;PPP5C;TRIM62;MAVS;MIB2;EDA2R;SPHK2;TRAF1;TNFRSF1A;TRIM68;TRIM5;NOD2;TNFAIP3;TMEM101;LGALS1;UFL1;STAT1;ANKRD17;MIER1;TAB2;JMJD8;RELA;GPR89A;CHUK;PELI1;ECT2;IRAK4;CCDC22;CASP1;LTBR;LGALS9;TSPAN6;CANT1
prerank,organic substance transport (GO:0071702),-0.2734894985723753,-1.0985392843503794,0.2868369351669941,0.6332141350160965,1.0,21/121,12.95%,ABCG2;SLC47A1;SLCO2A1;PLTP;ATP8A1;SLCO2B1;ARL6IP5;RAMP2;CUBN;CHMP2B;MFSD2A;ABCG1;SPNS2;NDC1;CHKA;ARRDC1;CEP290;RUFY1;RAB7A;ABCA2;MFSD2B
prerank,apoptotic cell clearance (GO:0043277),0.35944652363506996,1.0984865042028038,0.33958333333333335,0.7110527985617782,1.0,7/30,8.10%,LRP1;XKR4;MEGF10;RHOH;XKR6;RHOBTB1;TXNDC5
prerank,positive regulation of peptidyl-threonine phosphorylation (GO:0010800),0.3804989556878751,1.098435526106413,0.3490364025695932,0.710124689859094,1.0,2/23,2.08%,CEMIP;PRKAG2
prerank,regulation of cartilage development (GO:0061035),0.3989778108607541,1.0982778905715733,0.33814432989690724,0.7094529176564299,1.0,4/18,9.57%,BMP2;TRPS1;SCIN;SOX5
prerank,skeletal muscle tissue development (GO:0007519),-0.34179225506841027,-1.0981787503350458,0.3230769230769231,0.6335763262705747,1.0,5/32,3.90%,MEF2C;CAV1;MYL6;CAV2;SIX1
prerank,positive regulation of mRNA metabolic process (GO:1903313),-0.4338253402671722,-1.0980205522251236,0.3709981167608286,0.633417876205627,1.0,3/13,7.75%,PRR5L;CNOT7;RC3H1
prerank,fatty acid beta-oxidation (GO:0006635),-0.3115666045503926,-1.0979913148467761,0.30956848030018763,0.632956205652898,1.0,15/51,18.03%,PPARD;ACAD11;ACAA2;ACOX3;ECHS1;DECR1;ACADL;ACADVL;CROT;ETFDH;ETFB;ECI1;ACOT8;MECR;HSD17B10
prerank,lipid droplet organization (GO:0034389),-0.37662615998497934,-1.097751041621667,0.3301158301158301,0.6330066027220456,1.0,5/22,12.75%,PPIA;RAB18;CDS2;CDS1;FAF2
prerank,morphogenesis of an epithelium (GO:0002009),-0.3718873999576386,-1.0977186056228612,0.3302238805970149,0.6325499987485538,1.0,5/25,9.38%,ACTB;ACTG1;LAMA5;LAMA3;VCL
prerank,response to estrogen (GO:0043627),-0.34809151772189106,-1.09766592964352,0.32222222222222224,0.6321402209578926,1.0,11/31,12.06%,CAV1;ESR1;TRIM25;RBBP5;BCAS3;RARA;PELP1;KMT2D;NCOA4;WBP2;SERPINB9
prerank,neural crest cell migration (GO:0001755),0.3447589742753352,1.0974319286917114,0.3094736842105263,0.7105177746088561,1.0,6/36,4.77%,NRP1;SEMA5A;GDNF;SEMA3A;RADIL;SEMA3D
prerank,aminoglycan metabolic process (GO:0006022),0.4657887980233126,1.0973304948452642,0.33726415094339623,0.7097272826600958,1.0,4/10,21.65%,GAL3ST3;B4GALT7;B3GAT1;B3GALT6
prerank,Wnt signaling pathway (GO:0016055),-0.28127184997270704,-1.0971944787453567,0.25430210325047803,0.6327628142997201,1.0,19/92,10.46%,LEF1;NXN;PLCG2;LRP5;FZD6;FZD4;FERMT2;UBB;NR4A2;CSNK1G2;UBC;RPS27A;WNT9A;CSNK1G3;FZD3;FZD7;CPE;DIXDC1;WNT11
prerank,positive regulation of organelle organization (GO:0010638),-0.3393928497755739,-1.0971284950632347,0.318359375,0.6323809388680321,1.0,12/32,26.71%,SORBS3;ANXA1;ANXA2;PPARGC1A;ATL3;SURF4;SHCBP1L;SYNJ1;RAB3GAP2;DOC2B;TREM2;LIG4
prerank,regulation of calcium ion transmembrane transport (GO:1903169),0.3859471309404766,1.097042667022912,0.3471933471933472,0.7093502672429952,1.0,4/23,8.22%,ATP1A2;ANK2;CACNA2D1;CACNB1
prerank,regulation of release of cytochrome c from mitochondria (GO:0090199),0.3432711226675686,1.0967876052365861,0.3227176220806794,0.7089643937037158,1.0,3/40,5.39%,IGF1;BCL2L11;PRKN
prerank,antigen receptor-mediated signaling pathway (GO:0050851),-0.25558789517147945,-1.0962012586686676,0.24165029469548133,0.6341474706869646,1.0,48/163,23.09%,MEF2C;PTPRJ;PLCG2;WNK1;PDE4D;BMX;INPP5D;CD38;IKBKB;DENND1B;TNFRSF21;PSMA6;NFKBIZ;RC3H1;PSMB5;PSMC4;PSMC5;PSMD14;SYK;BTN3A3;LCP2;PSMD8;PIK3CA;EIF2B3;PSMD11;PIK3R2;PSMB4;PSMD12;PSMC1;TAB2;RELA;CUL1;SPG21;CHUK;PRAM1;TXK;FYB2;NCK1;PSMA1;PSMB1;PSMC3;PRKD2;BTK;LAT2;PTPN22;CSK;PSMA4;PSMA2
prerank,glucose transmembrane transport (GO:1904659),-0.39838098698227226,-1.0960042973077238,0.33457943925233646,0.6340960327176114,1.0,9/18,28.76%,SLC2A1;PPARD;RAB4B;SLC2A8;SLC2A3;SLC2A4;SLC2A9;SLC2A10;SLC2A2
prerank,regulation of lamellipodium assembly (GO:0010591),0.3474458057151817,1.0959954734594204,0.3117154811715481,0.7100398355835517,1.0,2/34,0.26%,AUTS2;PIK3R1
prerank,negative regulation of anoikis (GO:2000811),-0.42834685161893415,-1.0955776034440363,0.35648994515539306,0.634630941719544,1.0,3/14,2.88%,CAV1;NOTCH1;PTK2
prerank,negative regulation of voltage-gated calcium channel activity (GO:1901386),-0.467817460796691,-1.09543832925599,0.35500878734622143,0.6344300591741062,1.0,3/10,13.09%,CALM1;CALM3;FMR1
prerank,actin filament-based transport (GO:0099515),-0.3868083851811186,-1.0954129820987961,0.3388581952117864,0.6339587993692088,1.0,3/21,2.18%,MYO1D;FNBP1L;ACTN4
prerank,regulation of epithelial cell differentiation (GO:0030856),-0.41342920759967716,-1.0953710316579994,0.35804701627486435,0.6335243420536925,1.0,3/17,6.91%,CAV1;KLF7;APOLD1
prerank,positive regulation of macromolecule biosynthetic process (GO:0010557),0.2793001850835498,1.0953296912493085,0.2938775510204082,0.7106928450608759,1.0,24/122,11.59%,IGF1;PRR16;AR;SAMD4A;SLC6A9;GLI2;LARP6;STN1;IL4;IRS2;NLRP12;PDGFRB;ATAD5;BRPF3;IGF2;CPEB3;FGFR4;EIF3C;PLD1;PLXNB2;HNRNPD;PIWIL2;FXR2;HSPH1
prerank,"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",-0.3808283845002417,-1.094787968740991,0.34057971014492755,0.6344574734459302,1.0,10/22,28.29%,NOP14;RPS21;ERI1;PES1;URB1;EXOSC8;WDR12;ABT1;FTSJ3;EXOSC9
prerank,relaxation of cardiac muscle (GO:0055119),0.4489101156721743,1.0947642827287103,0.34375,0.7111079027565408,1.0,3/13,3.79%,ATP1A2;SLC8A1;P2RX4
prerank,negative regulation of BMP signaling pathway (GO:0030514),0.321315007078398,1.0945662924289983,0.33401639344262296,0.7105269787415228,1.0,3/51,0.54%,GREM2;FBN1;BMP2
prerank,Golgi to lysosome transport (GO:0090160),-0.45512559923906465,-1.09429580811039,0.37213403880070545,0.6351481296432058,1.0,5/11,19.66%,LAMP1;CCDC91;AP4M1;LAPTM5;EHD3
prerank,acylglycerol biosynthetic process (GO:0046463),0.3835752655006327,1.0942770776606305,0.3511777301927195,0.7102512069702547,1.0,8/23,16.50%,AGMO;PLA2G4A;MOGAT3;LPIN3;ANG;MOGAT2;DGAT2;LPIN1
prerank,Golgi organization (GO:0007030),-0.26626609941286633,-1.094196545675243,0.23883495145631067,0.6348389642067362,1.0,52/112,31.50%,SYNE1;ATP8B1;PI4K2A;ZW10;BCAS3;HTT;GORASP2;FAM174B;PLEKHM2;ATL3;TRIP11;STK25;ATL2;TRAPPC11;BAG5;FHDC1;SURF4;VRK1;VMP1;YWHAZ;RAB1A;COG3;GOLGA5;GOLGA8B;LMAN2;GCC2;VTI1B;TMED1;TMED5;ATP8B2;COG2;PDCD10;STX5;PLK3;LMAN2L;RAB43;CDC42;GOLPH3;GOLPH3L;PLK5;TMED3;GOLGB1;SEC16B;DNAJC28;STX16;ATP8B4;SPTBN5;DYM;VAMP4;TRAPPC12;CDK1;HACE1
prerank,mitotic DNA replication (GO:1902969),0.467446762916058,1.0936498617099728,0.32589285714285715,0.7107479349732889,1.0,2/10,10.38%,MCM3;MCM2
prerank,negative regulation of protein exit from endoplasmic reticulum (GO:0070862),-0.46523676002108927,-1.0932319281735345,0.35507246376811596,0.6367150150927898,1.0,7/10,40.10%,SVIP;UBE2G2;DERL2;ERLEC1;INSIG1;OS9;UBAC2
prerank,chromatin remodeling (GO:0006338),-0.28135737230505276,-1.0931932119725323,0.2813765182186235,0.6362984712524095,1.0,38/100,32.40%,ACTB;ESR1;ZBTB7A;KDM5C;HCFC1;HDAC4;BAZ1A;CHD1L;RB1;ARID1A;MTA2;TADA2B;MBD3;GATAD1;SATB2;HCFC2;SMARCA4;GATAD2B;SMARCA2;RBBP4;KDM6A;CHD4;SOX9;SMARCC1;POLE3;EZH1;HDAC5;RUVBL1;NPM1;CHRAC1;SMARCD2;SMARCA5;MYC;MYSM1;SMARCD3;NPM3;KAT2A;HNRNPC
prerank,positive regulation of protein-containing complex disassembly (GO:0043243),-0.44204067532514923,-1.0930219477711507,0.375,0.6361769167131183,1.0,2/12,8.53%,IGF1R;INSR
prerank,regulation of cellular amine metabolic process (GO:0033238),-0.3144341390274267,-1.0925512683384675,0.29922779922779924,0.6368216061973072,1.0,18/50,25.25%,PSMA6;PSMB5;PSMC4;PSMC5;PSMD14;OAZ2;PSMD8;PSMD11;PSMB4;PSMD12;PSMC1;NQO1;PSMA1;PSMB1;PSMC3;PSMA4;PSMA2;PSMB8
prerank,positive regulation of macrophage migration (GO:1905523),-0.39335301314648685,-1.0925352081205513,0.3408662900188324,0.6363277499733162,1.0,4/19,4.89%,THBS1;MAPK3;PTK2;CMKLR1
prerank,negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),0.32911451272959313,1.0925337797466548,0.3036093418259023,0.7125990638959563,1.0,5/43,7.92%,IGF1;IL4;GSTP1;CD274;TRIM27
prerank,inorganic cation import across plasma membrane (GO:0098659),-0.289404718931973,-1.0925203362639024,0.2937853107344633,0.6358241065164233,1.0,14/75,12.17%,SLC12A7;SLC9A2;SLC12A2;SLC39A10;KCNJ2;ABCC9;ATP1A1;SLC39A8;KCNJ10;ATP1B1;TRPV4;KCNJ8;KCNK9;KCNJ15
prerank,steroid metabolic process (GO:0008202),0.2962383104809101,1.092498073175689,0.2965931863727455,0.711644524216589,1.0,7/72,5.87%,CYP7B1;CYP27B1;VDR;CYP27A1;BAAT;CYP2A6;MSMO1
prerank,positive regulation of cell cycle (GO:0045787),-0.30913396222693174,-1.0924220460412666,0.30628803245436104,0.6355239151008694,1.0,26/62,26.08%,CCND3;CCNY;CDKN1B;APP;TGFB2;RPS15A;PKD1;RARA;HCFC1;RGCC;AKT1;TAL1;CDK4;DUSP3;EGFR;ANKRD17;USP22;ASNS;CHEK1;CCND1;PKD2;EIF4EBP1;RAD23A;EIF4E;SPDYA;TTL
prerank,release of sequestered calcium ion into cytosol (GO:0051209),-0.359263505046041,-1.0920918630482859,0.33269961977186313,0.6358517665750768,1.0,12/26,31.48%,ITPR2;PLCG2;ITPR3;FGF2;HTR2A;CHERP;PKD2;ERO1A;SLC8B1;HTR2B;LETM1;HTR2C
prerank,aortic valve development (GO:0003176),0.3508263502771432,1.0919319082930095,0.3297644539614561,0.7121283932443002,1.0,4/34,2.62%,ROBO1;BMP2;ROBO2;ROCK2
prerank,negative regulation of sequestering of calcium ion (GO:0051283),-0.36438915490620777,-1.0913472213039008,0.3359073359073359,0.6371354695387501,1.0,8/24,22.57%,ITPR2;PLCG2;ITPR3;FGF2;HTR2A;CHERP;PKD2;ERO1A
prerank,regulation of platelet aggregation (GO:0090330),0.4148376281701923,1.0909980350339796,0.3448275862068966,0.7135525699997524,1.0,4/17,4.13%,SERPINE2;ALOX12;PRKCA;LYN
prerank,CENP-A containing nucleosome assembly (GO:0034080),-0.35274642718922883,-1.0909008406655798,0.3187022900763359,0.6371925843344859,1.0,16/29,34.42%,MIS18BP1;KNL1;CENPU;RBBP4;CENPI;CENPN;CENPA;CENPO;RUVBL1;NPM1;SMARCA5;OIP5;ITGB3BP;CENPX;CENPW;RBBP7
prerank,CENP-A containing chromatin organization (GO:0061641),-0.35274642718922883,-1.0909008406655798,0.3187022900763359,0.6371925843344859,1.0,16/29,34.42%,MIS18BP1;KNL1;CENPU;RBBP4;CENPI;CENPN;CENPA;CENPO;RUVBL1;NPM1;SMARCA5;OIP5;ITGB3BP;CENPX;CENPW;RBBP7
prerank,positive regulation of TOR signaling (GO:0032008),-0.3238872745000587,-1.0908774382572286,0.30724070450097846,0.636704203554219,1.0,18/40,32.32%,RICTOR;GPR137B;PIP4P1;LAMTOR2;PIK3CA;RRAGD;RRAGA;RRAGC;GOLPH3;RPTOR;SEH1L;TREM2;SIK3;SEC13;LAMTOR5;HDAC3;LAMTOR1;LAMTOR3
prerank,positive regulation of lamellipodium organization (GO:1902745),0.3498190133034793,1.0907951022074058,0.32762312633832974,0.7129948933327495,1.0,2/32,0.26%,AUTS2;PIK3R1
prerank,regulation of mRNA catabolic process (GO:0061013),-0.2669821769335838,-1.0906416652942788,0.25773195876288657,0.6367551530577097,1.0,42/121,25.93%,VIM;UBB;HSPA8;PRR5L;UBC;RPS27A;CNOT7;ANP32A;PSMA6;HSPB1;RC3H1;PSMB5;AKT1;PCBP4;PSMC4;PSMC5;YTHDF2;PSMD14;YWHAZ;FMR1;PSMD8;TNFSF13;PSMD11;PSMB4;PSMD12;PSMC1;HSPA1A;EXOSC8;PUM2;SERBP1;PSMA1;YTHDF1;PSMB1;PSMC3;EIF4G1;PSMA4;PSMA2;PRKCD;YWHAB;PSMB8;PABPC1;DIS3
prerank,lymphocyte differentiation (GO:0030098),-0.3003587077677444,-1.0901442071207113,0.28698752228163993,0.6374524544337061,1.0,25/68,25.77%,PTPRJ;PLCG2;TPD52;ZBTB7A;HDAC9;JAG2;HDAC4;HHEX;RELB;LFNG;SOX4;CLCF1;ITGA4;TCF3;KLF6;GPR89B;GPR89A;JAK3;DLL4;ADGRG3;PTPN22;DCAF1;TOX;NFAM1;HDAC5
prerank,icosanoid secretion (GO:0032309),-0.4412224141242945,-1.0900936300533877,0.3593155893536122,0.6370340816791449,1.0,2/12,3.46%,ABCC4;ANXA1
prerank,positive regulation of interferon-gamma production (GO:0032729),-0.31538504756729946,-1.0900105898992958,0.31688804554079697,0.6366977971595404,1.0,24/48,38.45%,SLC7A5;PDE4D;CYRIB;IL1R1;TLR3;HSPD1;TLR4;TXK;LGALS9;FZD5;PTPN22;ZFPM1;IL12RB2;RASGRP1;LILRB1;SCRIB;CD14;SLAMF6;SLC11A1;TLR8;CD226;IL12A;CRTAM;IL12RB1
prerank,heart trabecula morphogenesis (GO:0061384),-0.39937706604300693,-1.0897460186628647,0.34851138353765326,0.6368404244970176,1.0,6/18,4.23%,TEK;ADGRG6;NOTCH1;S1PR1;TGFB2;FKBP1A
prerank,negative regulation of wound healing (GO:0061045),-0.35993189739163595,-1.0897262863272004,0.3392857142857143,0.6363509646429362,1.0,8/28,12.82%,SLC12A2;CD34;THBD;CD109;CRK;EDN1;APOE;FGF2
prerank,pentose-phosphate shunt (GO:0006098),-0.44688662142199365,-1.0892678326062195,0.34317343173431736,0.636999846202657,1.0,5/11,26.41%,PGLS;TALDO1;RPIA;PGM2;SHPK
prerank,positive regulation of macroautophagy (GO:0016239),-0.30839308302065466,-1.0892563968874236,0.3102766798418972,0.6364881671475691,1.0,12/48,18.97%,SPTLC2;VPS13D;KDR;HTT;RALB;SPTLC1;SCOC;EPM2A;HSPB8;BNIP3L;TSC2;RAB3GAP2
prerank,receptor signaling pathway via STAT (GO:0097696),0.36595764208908255,1.0884787114383132,0.33403361344537813,0.717815256341137,1.0,4/25,7.59%,IL31RA;STAT5B;GHR;THPO
prerank,negative regulation of complement activation (GO:0045916),-0.4716974915608808,-1.0881643332273985,0.36396396396396397,0.6386547876360044,1.0,1/10,1.66%,CD55
prerank,"chemical synaptic transmission, postsynaptic (GO:0099565)",0.3678531328748817,1.0876849930527757,0.3311546840958606,0.7187891218909134,1.0,9/25,18.84%,GRID2;MPP2;NLGN3;MAPK8IP2;CHRNA4;GRIN2A;DRD2;GRIN2B;RAB3GAP1
prerank,defense response to bacterium (GO:0042742),-0.2725200499413362,-1.0870701320819594,0.289272030651341,0.6408540001399698,1.0,21/105,16.68%,LBP;NOD1;RPL30;RPL39;STAB1;LYST;RPS19;GBP7;SHC1;TLR3;FCER1G;PGLYRP1;TIRAP;MAVS;TLR4;SYK;RAB1A;CFP;NOD2;OAS2;ANKRD17
prerank,positive regulation of protein dephosphorylation (GO:0035307),-0.3360035258315539,-1.0870435859582392,0.31891891891891894,0.6403718034094776,1.0,15/32,26.21%,ITGA1;PPP1R16B;HSP90AB1;CALM1;TGFB1;PPIA;PPP2R5A;CALM3;CDCA2;PIN1;CNEP1R1;CDH5;PRKCD;NSMF;SMPD1
prerank,regulation of homotypic cell-cell adhesion (GO:0034110),0.4511713039577032,1.08682943622041,0.3627906976744186,0.7199178119528227,1.0,2/11,4.13%,PRKCA;LYN
prerank,protein K63-linked deubiquitination (GO:0070536),-0.3549161900584136,-1.0862386494723826,0.3269961977186312,0.6418383163260498,1.0,9/31,17.16%,BRCC3;USP7;OTUD5;USP8;UIMC1;BABAM1;PSMD14;TNFAIP3;BABAM2
prerank,branching morphogenesis of an epithelial tube (GO:0048754),0.3334804991359566,1.0859747382554852,0.3482905982905983,0.7212213971055061,1.0,5/39,2.15%,NRP1;BMP2;SALL1;GDNF;GLI2
prerank,histone H3 acetylation (GO:0043966),-0.3289453594683033,-1.0858387929733657,0.31048387096774194,0.6422788792845116,1.0,15/40,28.48%,LEF1;JADE2;ING5;TRIM16;NAA60;LDB1;BRCA2;TADA3;BRPF1;TAF9;POLE3;KAT6B;SPI1;TAF10;TAF5
prerank,cell cycle G1/S phase transition (GO:0044843),-0.29977790916004576,-1.085794047471601,0.3156862745098039,0.6418698156806586,1.0,21/61,25.43%,CDK6;CDKN1B;CUL4A;PLK2;MAP3K11;RB1;INHBA;E2F3;CDK4;CRLF3;ACVR1;E2F1;CDKN1A;CUL1;CDKN2C;CCND1;RCC1;EIF4EBP1;PLK3;EIF4E;SPDYA
prerank,negative regulation of cell population proliferation (GO:0008285),-0.23346113129430415,-1.0856815692172521,0.2435344827586207,0.6416217712361967,1.0,76/351,16.41%,ZBTB7C;PTPN14;CDK6;ITGA1;B2M;IGFBP7;NOS3;PTPRJ;IGFBP6;NOTCH1;CBFA2T3;PTK2B;BMPR2;SH3BP4;KLF4;CCN3;FAP;ETS1;DAB2IP;NGF;IGFBP5;CDKN1B;TGFB1;REST;APP;TGFB2;RNF41;COL18A1;TES;PLPP1;CYP1B1;ING5;CTBP1;IGFBP3;SMAD6;CNOT7;AQP11;WNT9A;IFITM1;GATA6;GATA2;TGFB3;RGCC;ADGRG1;KANK2;SOX7;WARS1;TRIB1;CSNK2B;DIS3L2;CTNNBIP1;INHBA;E2F3;GAS8;NF1;FRK;CIB1;FTH1;TMEM115;E2F1;CDK10;SOX4;HES1;RPS6KA2;ABI1;HRAS;P3H2;JAK2;SMYD2;STRN;PTPN6;TNFAIP3;CDKN1A;SMARCA2;GREM1;RBBP4
prerank,regulation of release of sequestered calcium ion into cytosol (GO:0051279),-0.3164383251044047,-1.0854259924448488,0.29549902152641877,0.6417135121089927,1.0,14/48,14.62%,DMD;PTK2B;PDE4D;CAMK2D;CALM1;FKBP1A;DIAPH1;JPH2;JPH4;AKAP6;GSTM2;CALM3;CASQ2;SRI
prerank,negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),-0.40522473851872054,-1.0853185595782475,0.354014598540146,0.6414593778659047,1.0,4/17,6.78%,MEF2C;PRKG1;CDKN1B;TGFB3
prerank,copper ion transport (GO:0006825),0.4464014457847633,1.085174946669177,0.35185185185185186,0.7222713591359633,1.0,2/11,6.74%,STEAP3;SLC31A2
prerank,regulation of response to endoplasmic reticulum stress (GO:1905897),-0.4306080794424914,-1.085127494888593,0.3634651600753296,0.6413618207846903,1.0,4/13,16.28%,LPCAT3;AQP11;MBTPS2;NR1H2
prerank,negative regulation of cell cycle G2/M phase transition (GO:1902750),-0.30849260990998884,-1.0848396249725407,0.333984375,0.6415641865286805,1.0,20/55,23.09%,FHL1;PSMA6;PSMB5;PSMC4;PSMC5;PSMD14;AVEN;FBXL7;RBX1;PSMD8;PSMD11;PSMB4;PSMD12;PSMC1;CUL1;PSMA1;PSMB1;PSMC3;PSMA4;PSMA2
prerank,regulation of cyclin-dependent protein kinase activity (GO:1904029),-0.31379153849099367,-1.0848008183179638,0.3019230769230769,0.6411227829818242,1.0,12/50,19.30%,ACTB;CCND3;HSP90AB1;CDKN1B;CCNG2;CCNF;CDKN1A;CCNK;CDKN2C;CDK5RAP3;GADD45A;CCND1
prerank,neuromuscular process (GO:0050905),0.4114984583158443,1.0846002972368027,0.35665914221218964,0.7226148993633272,1.0,3/16,2.31%,MYCBP2;NRXN1;CHRNA1
prerank,membrane lipid metabolic process (GO:0006643),-0.3797240558965993,-1.0842012827032372,0.36823104693140796,0.6420915869727151,1.0,6/22,13.77%,ST3GAL6;CYP1B1;SPTLC1;B4GALT4;SPHK2;CERKL
prerank,mitotic spindle organization (GO:0007052),-0.2546542131846007,-1.0841895928316274,0.27896995708154504,0.6415872769697749,1.0,60/153,31.12%,RAB11A;DCTN2;RPS27;MAP4;ZW10;DYNC1LI2;CEP192;PLK2;KIF23;VCP;RCC2;NDE1;NDEL1;RANBP2;KNL1;DYNC1LI1;CENPU;NUP37;LSM14A;MAD1L1;KIF18A;MISP;RANGAP1;DYNLL2;TPX2;RCC1;CENPI;NUP160;NSL1;NDC80;CENPN;CENPF;RMDN1;SPICE1;CLIP1;SPDL1;CENPA;EFHC2;CDCA8;STMN1;TBCE;NUP43;SEH1L;CENPO;SGO1;SEC13;NUP107;KIFC2;BIRC5;WDR62;NUP98;XPO1;TUBG2;KIF11;BUB3;PLK1;BCCIP;NUF2;AURKA;RHOA
prerank,regulation of cell adhesion (GO:0030155),-0.2630982243841313,-1.0838682553618622,0.27944111776447106,0.6418528796193401,1.0,24/129,11.53%,PKP4;PODXL;FRMD5;PTPRJ;PTK2B;TGM2;STX3;PTK2;PLXNA4;ARHGDIA;ADAM10;ARHGDIB;MINK1;TGFBI;VEGFA;PPP2R1A;GPR4;ADGRG1;SIPA1;PPP1CB;PLXNA1;PLXND1;ABL2;YTHDF2
prerank,catecholamine metabolic process (GO:0006584),0.4361167638585056,1.08380555579691,0.35650224215246634,0.7235723013013837,1.0,3/14,14.15%,PRKN;COMT;DRD2
prerank,"nucleotide-excision repair, DNA incision (GO:0033683)",-0.3228095420108979,-1.0837244468578753,0.33528265107212474,0.6416641332327717,1.0,15/39,24.24%,UBB;UBC;RPS27A;ERCC1;CUL4A;GTF2H3;CHD1L;RBX1;RPA3;GTF2H4;POLK;ERCC4;RFC3;RFC2;FAN1
prerank,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),-0.3502651504363776,-1.083537502575758,0.3612167300380228,0.6415951981846537,1.0,11/30,19.49%,NOS3;TNFSF10;CASP8;RIPK1;FAIM;GPX1;FAS;BCL2L1;TNFAIP3;ARHGEF2;FAIM2
prerank,sulfur compound biosynthetic process (GO:0044272),-0.27153498628816136,-1.0834717508269707,0.283495145631068,0.641233981733401,1.0,30/104,21.87%,ST3GAL6;ST3GAL4;CHST11;CSGALNACT1;SLC26A2;CSPG4;TPK1;MAT2A;GGTA1;CDO1;SLC10A7;GSTA4;B4GALT4;GGT5;GSTM2;GSTA3;SLC35B3;SLC35D2;GSTM1;GSTO2;CTH;GCLM;MGST3;CNDP2;GCLC;GGT1;B3GNT3;GSTK1;GGCT;CHPF
prerank,negative regulation of lymphocyte proliferation (GO:0050672),0.3534552282905442,1.0834564304939418,0.35789473684210527,0.7233802886466364,1.0,5/31,7.73%,IL4I1;LYN;CEBPB;GLMN;CD274
prerank,negative regulation of microtubule depolymerization (GO:0007026),-0.3862190567648297,-1.0834048070413522,0.3333333333333333,0.6408742983035968,1.0,8/21,22.33%,STMN2;SPEF1;CIB1;KATNB1;ARHGEF2;TPX2;APC2;CAMSAP3
prerank,regulation of BMP signaling pathway (GO:0030510),-0.2826171830780202,-1.083276211209929,0.3073852295409182,0.6406578776039341,1.0,21/73,21.17%,CRIM1;BMPER;NOTCH1;BMPR2;SMAD9;SMAD7;FOXD1;SMAD6;HTRA3;SKIL;ZNF423;FSTL1;ENG;SMURF1;SMAD4;GREM1;SMAD2;SKI;BMPR1B;BAMBI;CDH5
prerank,negative regulation of protein serine/threonine kinase activity (GO:0071901),-0.29093202944316693,-1.083073246138769,0.3104125736738703,0.6406040621692916,1.0,14/75,12.33%,HEG1;PTPRJ;LRP5;RASIP1;DAB2IP;CDKN1B;PRKAR2B;AKT1;HHEX;RB1;UCHL1;NF1;STK38;APOE
prerank,regulation of lipid biosynthetic process (GO:0046890),0.3505182754173346,1.0828152840380747,0.31965442764578833,0.7239412472544271,1.0,5/32,6.61%,ZBTB20;PPARA;PRKAG2;PDK4;ASXL3
prerank,negative regulation of cellular protein localization (GO:1903828),0.34671175526074094,1.0826303841545708,0.33766233766233766,0.7234092834030598,1.0,9/34,13.81%,ROCK2;LEPROT;SNX33;UBXN2B;TAX1BP3;LZTFL1;ACTN2;LEPROTL1;MAPT
prerank,positive regulation of nucleic acid-templated transcription (GO:1903508),-0.22718737056772006,-1.0826151111100222,0.1898989898989899,0.6412306649152401,1.0,111/476,18.21%,MECOM;LEF1;MEF2C;MAP3K5;AFAP1L2;RREB1;CDH1;MLLT3;ESR1;NOTCH1;FLI1;LRP5;PPARD;KLF2;FOXO1;KLF4;ELF1;TBX1;FZD4;FOXO3;ETS1;SOX17;SIX1;TGFB1;CNBP;REST;PRDM16;NFYA;PPARGC1A;ING5;FOXK1;CD38;ZBTB16;ACTA2;IKBKB;RARA;NOTCH4;BRD4;GATA6;ATF4;SHC1;KDM3A;TGFB3;HCFC1;TRIM16;MED24;HDAC4;AKT1;SPIN1;FZD7;ENY2;TAL1;SPP1;MAP3K2;TRIM28;NFATC1;HHEX;SOX18;FOXF2;ARID1A;JMJD6;CEP290;ZIC3;WNT11;MYBL1;CD74;FOXC2;INHBA;SP3;ILF2;CRLF3;PSMC5;WBP2;TEAD2;ACVR1;TRIM56;E2F1;ZNF423;APOE;PPP3CB;SOX4;FGF2;HES1;RNF111;EPC1;SMARCA4;RNF20;NR5A2;HEY1;EGFR;SMAD4;ZFHX3;RAI1;SMARCA2;NR1H2;STAT1;YWHAH;TCF3;KLF6;ETS2;ZBTB48;RELA;MED14;USP22;BRCA2;FOXL2;SP1;RET;CHUK;GLI1;SMAD2
prerank,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002824),-0.44169480594799565,-1.0824661927795685,0.36936936936936937,0.6410622367296683,1.0,10/12,52.61%,SLC11A1;IL12RB1;ZBTB1;CARD9;IL23A;IL23R;IL12B;CCR2;CLEC6A;IL1B
prerank,lung epithelium development (GO:0060428),0.4486440801528111,1.0820938281682737,0.3927765237020316,0.7237861547545343,1.0,1/10,0.46%,ERRFI1
prerank,mitochondrial translational elongation (GO:0070125),-0.2777248118807176,-1.0820167107331333,0.32082551594746717,0.6416668566830963,1.0,36/88,29.61%,MRPL52;PTCD3;MRPL51;MRPL38;MRPL28;MRPL43;TSFM;MRPL32;MRPL14;MRPS30;ERAL1;MRPL24;MRPS17;MRPL50;MRPL16;MRPL47;MRPL54;MRPS18C;MRPS18A;MRPL35;MRPS6;MRPL58;MRPL48;MRPL49;TUFM;MRPL13;MRPL11;MRPL21;MRPL30;MRPS24;MRPL2;MRPL42;MRPL15;MRPL19;MRPS14;MRPS2
prerank,positive regulation of fat cell differentiation (GO:0045600),-0.32019260984805614,-1.0819334305552972,0.32270916334661354,0.6413347581619093,1.0,9/47,8.42%,RREB1;LRP5;PPARD;SIX1;CMKLR1;SOX13;ZBTB16;CDS1;AKT1
prerank,regulation of synapse organization (GO:0050807),0.36562909267285015,1.081809047044391,0.33978494623655914,0.7234489684774117,1.0,10/26,17.95%,CTNNA2;SLITRK4;ARHGAP22;IL1RAPL1;CAMK2B;SETD5;PDLIM5;NEDD4;CLN3;ABHD17C
prerank,regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),-0.36818074574819093,-1.0815706017047868,0.332703213610586,0.641684111037042,1.0,11/24,29.30%,DAB2IP;HHEX;GRB10;EPN2;TMEM204;ITGB3;CADM4;PRKD2;PTPN1;PDCD6;ITGA5
prerank,positive regulation of developmental process (GO:0051094),0.2612970306206302,1.0814222135420894,0.3003875968992248,0.7233910257072973,1.0,25/164,10.29%,BMP2;AR;PTN;BMP5;PHLDB2;GJA1;NRXN1;GDNF;GRIP1;DCN;SHLD2;CEBPB;PRKN;RTN4;FOXA2;SMURF2;CAMK2B;NLGN1;KMT5C;CPEB3;DVL3;BMPR1A;SOX5;ALK;PAXIP1
prerank,pulmonary valve morphogenesis (GO:0003184),-0.39843209265525714,-1.0813667958212891,0.3563636363636364,0.6416651856585527,1.0,8/17,9.30%,NOS3;NOTCH1;SLIT2;TGFB2;STRA6;HEYL;SMAD6;NFATC1
prerank,endoplasmic reticulum to cytosol transport (GO:1903513),-0.4116903973385487,-1.0809440153486345,0.36363636363636365,0.642082704665479,1.0,10/15,35.38%,SEL1L;VCP;FAF2;SEC61B;DERL2;TMEM129;DERL1;SYVN1;OS9;AUP1
prerank,oligosaccharide biosynthetic process (GO:0009312),0.38977038002403186,1.0808719198232737,0.3548387096774194,0.7237975746360619,1.0,7/20,12.73%,B3GALT1;ST6GALNAC5;FUT4;ST6GALNAC6;FUT9;B3GALT2;B3GALT5
prerank,mitochondrial translation (GO:0032543),-0.2737618063981009,-1.0803986468974216,0.2964426877470356,0.6429067167836828,1.0,42/104,30.43%,QRSL1;MRPL52;PTCD3;MRPL51;MRPL38;LARS2;MRPL28;MRPL43;TSFM;GATC;MRPL32;MRPL14;MRPS30;ERAL1;MRPL24;MRPS17;MRPL50;MRPL16;MRPL47;MRPL54;MRPS18C;MRPS18A;MRPL35;MRPS6;MRPL58;MRPL48;MRPL49;TUFM;MRPL13;MRPL11;GATB;NDUFA7;MRPL21;MRPL30;MRPS24;MRPL2;MRPL42;MRPL15;MRPL19;MRPS14;MRPS2;IARS2
prerank,negative regulation of protein modification process (GO:0031400),-0.28287282762124705,-1.0802701294607113,0.32234432234432236,0.6426792315385091,1.0,19/79,12.51%,OCLN;DMD;NIBAN1;PPP1R16B;DAB2IP;SLIT2;TGFB1;MFHAS1;PPIA;PRR5L;CHP1;IGFBP3;PRKDC;WARS1;DBI;PPP1R8;IMPACT;CIB1;PNKP
prerank,icosanoid biosynthetic process (GO:0046456),0.45913490998044587,1.080007861954682,0.3696581196581197,0.725011357308803,1.0,2/10,2.58%,PLA2G5;PLA2G4A
prerank,positive regulation of viral genome replication (GO:0045070),-0.350222207751113,-1.0792395563710353,0.34990439770554493,0.6446986249461655,1.0,8/29,15.00%,ADAR;PPIA;CNOT7;SRPK1;IFIT1;STAU1;NR5A2;TOP2A
prerank,action potential (GO:0001508),0.32524878185302425,1.0789966911765805,0.35555555555555557,0.726597095662542,1.0,10/44,11.73%,SCN7A;SCN3B;CHRNA1;SCN3A;CACNA1I;KCND2;SCN2A;CACNA1G;CHRNA4;GNA15
prerank,regulation of interleukin-1 production (GO:0032652),-0.4056275087746109,-1.078726622113437,0.3615819209039548,0.6454618025417217,1.0,2/15,3.46%,FOXP1;ANXA1
prerank,aortic valve morphogenesis (GO:0003180),-0.3480329491858299,-1.078598007017402,0.3462246777163904,0.6452337247897876,1.0,10/30,9.65%,NOS3;TIE1;NOTCH1;SLIT2;TGFB1;HEYL;SMAD6;TWIST1;NFATC1;RB1
prerank,cellular response to topologically incorrect protein (GO:0035967),-0.34516459236235886,-1.0784291601777922,0.3295238095238095,0.6450988139011152,1.0,13/31,22.97%,DAB2IP;HSPA8;RHBDD1;DNAJB12;BAX;HSPA5;BAK1;HSPB8;HSPA1A;HSPA9;TMBIM6;HSPA1B;PTPN1
prerank,COPII-coated vesicle budding (GO:0090114),0.2978733751626984,1.07819090648773,0.33613445378151263,0.7277722588266644,1.0,17/68,17.90%,AREG;SEC24D;TGFA;TRAPPC6B;SCFD1;GOLGA2;TMED10;SCAP;SEC24A;TRAPPC3;SEC31A;SEC23A;GRIA1;SAR1B;TBC1D20;GOSR2;MIA3
prerank,organic hydroxy compound biosynthetic process (GO:1901617),0.3269247897612358,1.078168522749551,0.3378119001919386,0.7267852099847533,1.0,8/44,9.74%,CYP7B1;PRKAG2;ALOX12;CYP27A1;BAAT;MSMO1;INSIG2;CYP46A1
prerank,DNA integrity checkpoint signaling (GO:0031570),-0.3302421305734945,-1.078094440245083,0.3215613382899628,0.6454323646450076,1.0,17/36,31.42%,MAP3K20;RAD1;E2F1;RAD9B;HUS1;RAD9A;RAD17;CHEK1;CLOCK;RHNO1;FBXO6;CEP63;DNA2;ATRIP;PRPF19;CDC5L;CDC6
prerank,regulation of transcription by RNA polymerase III (GO:0006359),0.39163351661985213,1.0779352559200477,0.3462414578587699,0.7263599260507293,1.0,5/19,15.93%,AR;NAB2;ICE1;TENM1;ICE2
prerank,inositol phosphate biosynthetic process (GO:0032958),-0.4528795807090135,-1.0778929535656196,0.3825136612021858,0.6453818194890368,1.0,4/11,14.12%,ITPKB;IPMK;FGF2;IP6K1
prerank,positive regulation of defense response to virus by host (GO:0002230),-0.37040398311445455,-1.0777025513893292,0.3634651600753296,0.6453276533399569,1.0,13/24,31.99%,ZDHHC1;MAVS;AIM2;STAT1;HSP90AA1;CGAS;PTPN22;DTX3L;LILRB1;PARP9;PQBP1;TRAF3IP2;TRIM44
prerank,regulation of phosphoprotein phosphatase activity (GO:0043666),-0.3359296590397892,-1.0771715174700414,0.3339382940108893,0.6460440689717729,1.0,10/35,18.62%,ITGA1;HSP90AB1;CALM1;FKBP1A;HTT;CSNK2B;CALM3;NUAK1;BOD1;PPP6R3
prerank,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),0.2878395796613625,1.0769659197082722,0.3326612903225806,0.7277939770445039,1.0,12/86,9.35%,BMP6;BMP2;SULF1;BMP5;ZEB2;UBE2O;MEN1;CITED2;TGFBR1;RBPJ;HES5;BMPR1A
prerank,regulation of signal transduction by p53 class mediator (GO:1901796),-0.25377322641087074,-1.0764691019733594,0.27459016393442626,0.6472186612457143,1.0,55/148,28.92%,PPP1R13B;HIPK1;RPS15;RICTOR;PHF20;RPL11;RPL23;ING5;USP7;RAD1;DYRK2;AKT1;NOP2;PIP4P1;MAPKAP1;CSNK2B;RPS20;MTA2;MBD3;NUAK1;RAD9B;SMYD2;PRKAG1;HUS1;RPA3;RAD9A;CSNK2A1;CSNK2A2;RBBP4;RAD17;L3MBTL1;CHD4;CHEK1;CDK5RAP3;PIN1;TPX2;MAPK11;RPL5;BRPF1;TAF9;RHNO1;PLK3;RFC3;RFC2;EXO1;KMT5A;RPF2;DNA2;BARD1;ATRIP;TAF4;TAF10;TAF5;RPL37;MRE11
prerank,carnitine metabolic process (GO:0009437),0.44314543074241575,1.076435783112729,0.38478747203579416,0.7281437681936563,1.0,3/12,6.82%,BBOX1;CPT1C;CPT2
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),-0.44113225894333336,-1.0763417096182113,0.3683241252302026,0.6470135407155636,1.0,6/12,22.03%,RPL26;CD44;CD74;KDM1A;TAF9;TRIAP1
prerank,neutral amino acid transport (GO:0015804),0.35232151422223346,1.0759828953565682,0.3542116630669546,0.7282071466911285,1.0,9/28,13.29%,SLC6A9;SLC43A1;SLC38A1;SLC36A2;SLC7A9;SLC1A5;SLC38A3;CTNS;SLC38A6
prerank,endoplasmic reticulum organization (GO:0007029),-0.28509966989519975,-1.0759717980747678,0.30708661417322836,0.6473909897104164,1.0,25/72,27.69%,CAV2;LPCAT3;APP;SHTN1;RAB18;STX1A;ATL3;SPTSSB;ATL2;SEC61B;DOP1B;SGTA;LMAN2;REEP4;RTN3;TOR1AIP2;TMEM33;TLE6;STX5;LMAN2L;RNF112;UBE2J2;SEC16B;TRAM1;SEC61A1
prerank,regulation of ERK1 and ERK2 cascade (GO:0070372),-0.24571103889910742,-1.0759267856459775,0.27505330490405117,0.6469795377058448,1.0,47/214,15.56%,FN1;TEK;BMPER;SEMA6A;RAP1A;ACKR3;NOTCH1;SEMA7A;PTK2B;KDR;MAPK3;DAB2IP;FERMT2;TNFAIP8L3;CD44;TGFB1;APP;MFHAS1;PRKCZ;EZR;SHC1;PDE8A;NPNT;FLT4;CCL15;PDGFC;PDGFA;TIRAP;CD74;CIB1;DUSP3;YWHAZ;APOE;TLR4;FGF2;SYK;STYX;CSF1R;ARHGEF5;HRAS;PHB2;EGFR;ERBB2;SMAD4;EPHA2;NOD2;PTPN6
prerank,regulation of cellular response to stress (GO:0080135),-0.26537012802125765,-1.0756247825909917,0.30019880715705766,0.6471712373137116,1.0,44/115,27.54%,MAPK3;CAMK2D;HSP90AB1;HSPA8;ATF4;CHCHD2;NUP93;MBTPS2;NDC1;HSBP1;NUP54;BAG5;NUP188;NUAK1;HSPB8;NUP155;RANBP2;RPA3;NUP37;HSP90AA1;HSPA1A;CCAR2;CRYAB;AMFR;MCL1;FKBP4;HSPA1B;NUP160;EIF4G1;DNAJB1;BAG1;ATF3;RSL1D1;SMG1;RPTOR;NUP43;SEH1L;YWHAE;SEC13;NUP107;NUP42;CAMK2G;NPM1;NUP98
prerank,tricarboxylic acid metabolic process (GO:0072350),-0.44222407235675987,-1.0756088861115738,0.38847583643122674,0.6466952696957594,1.0,4/12,22.83%,ACLY;ACO1;IDH3A;ACO2
prerank,negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747),-0.4542201689851939,-1.0753540821084424,0.38691588785046727,0.6468022721856556,1.0,2/10,3.51%,SEMA6A;DAB2IP
prerank,negative regulation of smooth muscle cell proliferation (GO:0048662),-0.3458748026951596,-1.0753058139291065,0.3493282149712092,0.6463907783942209,1.0,7/33,9.62%,MEF2C;PRKG1;IGFBP5;CDKN1B;IGFBP3;TGFB3;TRIB1
prerank,regulation of cytoplasmic translation (GO:2000765),-0.4222500797286828,-1.075078764829557,0.3763440860215054,0.6464418386994587,1.0,5/14,13.09%,CNBP;PKM;YBX3;DHX9;FMR1
prerank,regulation of DNA-dependent DNA replication (GO:0090329),0.4344360829178519,1.0749948750589358,0.3541666666666667,0.7296954157778608,1.0,4/12,18.38%,BLM;NUGGC;NBN;WRNIP1
prerank,negative regulation of intracellular signal transduction (GO:1902532),-0.2501052831724151,-1.0748706223780875,0.28512396694214875,0.6464460225321218,1.0,45/190,17.07%,CAV1;TMSB4X;THBS1;PTPRJ;ESR1;RACK1;SH3BP4;CCN3;PDE4D;CYRIB;DAB2IP;CD2AP;SLIT2;PDE2A;HDAC7;ADIPOR1;PEBP1;ARHGAP25;PIK3IP1;CASP8;RIPK1;ZMYND11;AKT1;NDUFA13;TWIST1;CARD19;PRDM15;TNFAIP8L1;MAPKBP1;WTIP;EPM2A;NF1;LIMD1;CIB1;DUSP3;BCL2L1;NDUFS3;EPHA2;PHLPP2;TNFAIP3;PIK3R2;STAT1;PHLDA3;DDIT4;RELA
prerank,MAPK cascade (GO:0000165),-0.23567530701127143,-1.0748073237891291,0.2616033755274262,0.6460788941604498,1.0,86/295,21.45%,KITLG;TEK;MEF2C;SHANK3;MAP3K5;RASAL2;RASGRP3;SPTBN1;FGF1;RASGRF2;KDR;MEF2A;MAPK3;PTK2;RGL1;SHOC2;DAB2IP;MAP3K20;CALM1;TGFB1;MAP3K3;UBB;MINK1;UBC;RPS27A;PEBP1;TAOK3;IKBKB;SHC1;PSMA6;NEFL;MAP3K8;KRAS;PSMB5;SPTAN1;PDGFA;IL17RD;PPP1CB;PSMC4;ZDHHC9;TAOK2;NF1;PSMC5;PPP5C;PSMD14;BCL2L1;ICMT;FGF2;HRAS;LYPLA1;LAMTOR2;RBX1;JAK2;EGFR;PSMD8;ERBB2;PIK3CA;RGL2;PSMD11;MET;PIK3R2;PSMB4;PSMD12;PSMC1;RCE1;JAK3;CUL1;RGL3;RET;CHUK;MAPK12;FGF9;PTGER4;RASA1;ARL2;IL3RA;SOX9;RASGRP4;LGALS9;MAPK11;CSF2RB;PSMA1;FGF10;RAPGEF2;PSMB1;PSMC3
prerank,postreplication repair (GO:0006301),-0.31221487341344606,-1.0746209640388338,0.3229571984435798,0.6460119087216761,1.0,16/45,25.72%,TRIM25;UBB;UBC;RPS27A;UBE2L6;VCP;SPRTN;USP43;RAD18;RPA3;POLK;UBE2B;DTL;RFC3;RFC2;NSMCE1
prerank,regulation of cell death (GO:0010941),-0.274452327095952,-1.0746084801394704,0.31417624521072796,0.6455331295124631,1.0,30/94,22.04%,ACER2;CCN3;FERMT2;CDKN1B;CTSZ;UBB;CHP1;PDE8A;TNFRSF1B;DUS2;SRSF6;SPEF1;WNT11;IMPACT;SOX4;CCN5;FGF2;ACER3;DHCR24;TMEM109;BNIP3L;RAD18;HSPA1A;CHMP2A;CRYAB;NCK1;HSPA1B;ADNP2;SNCG;EIF4G1
prerank,monocarboxylic acid metabolic process (GO:0032787),0.2769090203667876,1.074410857669211,0.2952755905511811,0.73023076755611,1.0,13/117,8.24%,IGF1;ALDH1A2;PPARA;ALDH4A1;ALOX12;ABAT;PCCA;ACADSB;BAAT;CPT1C;MSMO1;ACOT11;PDZD11
prerank,cell projection organization (GO:0030030),-0.3428772639633988,-1.07430330268725,0.36580882352941174,0.645810578725574,1.0,10/30,25.35%,PARVB;RHOJ;RAC1;PDGFA;NCKAP1;CAPG;PACSIN2;ATP1B2;CDC42;KIF17
prerank,translesion synthesis (GO:0019985),-0.31909995932704477,-1.073499539583714,0.3333333333333333,0.6472811015495777,1.0,15/42,24.17%,TRIM25;UBB;UBC;RPS27A;UBE2L6;VCP;SPRTN;REV3L;USP43;RPA3;POLDIP2;POLK;DTL;RFC3;RFC2
prerank,protein deacylation (GO:0035601),0.3777237826120904,1.073398536794108,0.37360178970917224,0.7319428831309688,1.0,7/23,17.95%,NOTUM;HDAC10;SIRT2;ABHD10;SIRT6;HDAC1;ABHD17C
prerank,pyrimidine-containing compound metabolic process (GO:0072527),-0.45087979427307934,-1.0733802693014516,0.3837638376383764,0.6470608751227113,1.0,3/11,8.34%,TPK1;CTPS2;SLC19A3
prerank,cellular iron ion homeostasis (GO:0006879),0.31219472966537537,1.0732182485411508,0.32040816326530613,0.7314009965763207,1.0,3/55,1.49%,BMP6;CP;HEPH
prerank,regulation of macromolecule metabolic process (GO:0060255),0.26003475245793534,1.073163060511028,0.30177514792899407,0.7305004766976153,1.0,22/170,9.44%,IGF1;NELL1;NOVA1;SLC8A1;C1D;GDNF;TRIM38;AFF2;PRDM5;ROCK2;AFF1;ZNF462;ZNF513;PRDM9;IGF2BP2;SOX2;TRIM27;STX1B;PCBP3;FUBP1;NPAT;CTCF
prerank,digestive tract morphogenesis (GO:0048546),0.41634907889345085,1.0731321546868033,0.38197424892703863,0.7295777303877339,1.0,2/14,2.19%,FGFR2;PDGFRA
prerank,negative regulation of mRNA catabolic process (GO:1902373),0.3515083512691908,1.0729220922787275,0.3624733475479744,0.7291580329593264,1.0,7/29,14.52%,GDNF;TENT5A;AXIN2;DHX34;TENT5B;NBAS;RBM24
prerank,Fc receptor signaling pathway (GO:0038093),-0.2646707118752165,-1.072895706913875,0.32170542635658916,0.6477743992942555,1.0,40/110,25.25%,PLCG2;MAPK3;MAP3K1;CALM1;RAC1;IKBKB;SHC1;PSMA6;PSMB5;NFATC1;FCER1G;PSMC4;PSMC5;PSMD14;PPP3CB;SYK;LCP2;PSMD8;GAB2;PIK3CA;PSMD11;PIK3R2;PSMB4;PSMD12;PSMC1;TAB2;RELA;CUL1;CHUK;NFATC3;PSMA1;PSMB1;PSMC3;BTK;LAT2;PSMA4;PSMA2;TRAF6;BCL10;PSMB8
prerank,regulation of autophagosome maturation (GO:1901096),0.4330051685474132,1.0724711238853324,0.35714285714285715,0.7293192248833099,1.0,4/13,16.40%,PHF23;UBQLN4;CLEC16A;CLN3
prerank,melanosome localization (GO:0032400),-0.37583967208829244,-1.0724245998395237,0.3701657458563536,0.648472198493273,1.0,7/21,16.80%,RAB11A;RAB27A;MREG;MLPH;RAB11B;ARL6;VPS33A
prerank,endoderm development (GO:0007492),-0.4304955907386336,-1.072382650729833,0.38922155688622756,0.6480748232755456,1.0,8/13,38.74%,SOX17;SOX7;KIF16B;DUSP4;DUSP1;TBX20;DUSP5;DUSP2
prerank,positive regulation of B cell proliferation (GO:0030890),-0.34717909744535475,-1.0722878030523293,0.3428030303030303,0.6478027829112283,1.0,8/29,17.77%,MEF2C;TFRC;CD38;CD81;TIRAP;CD74;CLCF1;CD320
prerank,vitamin transport (GO:0051180),-0.34174447455792456,-1.0719066861227784,0.3567362428842505,0.648194208253181,1.0,7/29,17.77%,ABCG2;SLC5A6;CUBN;SLC52A3;SLC2A8;SLC52A2;CD320
prerank,aminoglycan catabolic process (GO:0006026),0.3557371421046432,1.0717097925160135,0.35860655737704916,0.7302913603597445,1.0,4/28,4.99%,GPC6;GPC4;GPC2;GNS
prerank,negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),0.3264218161710932,1.0714849139202944,0.34439834024896265,0.7297997263395836,1.0,6/43,7.40%,ERRFI1;AREG;CBLB;TGFA;VPS25;ZFYVE28
prerank,positive regulation of sodium ion transmembrane transport (GO:1902307),-0.432668047495981,-1.0714469825655235,0.3892988929889299,0.6488131168650886,1.0,5/12,20.94%,DMD;WNK1;ATP1B1;GLRX;ATP1B2
prerank,cellular response to UV (GO:0034644),-0.282098666388038,-1.0713696127623167,0.33527131782945735,0.6485093560325357,1.0,31/76,30.92%,RPL26;CRIP1;RHBDD1;ATF4;N4BP1;ERCC1;YY1;IMPACT;BAK1;FMR1;OPN3;CDKN1A;KDM1A;POLK;CHEK1;ERCC4;COPS9;PTPRK;RHNO1;TRIAP1;HYAL1;PRKCD;CARD16;PPID;SMPD1;XPC;NPM1;MMP3;MYC;HYAL2;AQP1
prerank,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),0.3760891092649047,1.0712161692469082,0.36423841059602646,0.7294593490482322,1.0,6/21,16.03%,BCL2L11;CREB3L1;PRKN;CREB3;TXNDC12;DDIT3
prerank,vasoconstriction (GO:0042310),-0.44173209978647643,-1.0709371428820773,0.3713768115942029,0.6490553519088634,1.0,4/11,9.34%,EDNRA;ACTA2;EDN1;PIK3C2A
prerank,negative regulation of peptidyl-lysine acetylation (GO:2000757),0.4582199331425362,1.0709362702315715,0.36971046770601335,0.7291433088122202,1.0,7/10,25.80%,KLF15;NOC2L;THAP7;SET;TAF7;SIRT1;SNCA
prerank,neural crest cell development (GO:0014032),0.31997740772891126,1.0709012356326066,0.35639412997903563,0.728211613411084,1.0,6/44,4.77%,SEMA5A;NRG1;GDNF;SEMA3A;RADIL;SEMA3D
prerank,regulation of sodium ion transport (GO:0002028),0.3402156498675931,1.0706577408559095,0.36616702355460384,0.7278585453688611,1.0,15/34,24.31%,SCN3B;NKAIN2;P2RX4;GPD1L;NKAIN3;DRD2;WNK3;NEDD4;FGF12;PER1;ATP2B4;DLG1;SCN5A;RANGRF;CNKSR3
prerank,regulation of protein secretion (GO:0050708),-0.2619539439057098,-1.0702840486765883,0.3240556660039761,0.6501181647214683,1.0,19/119,8.64%,ITPR2;SLC2A1;RAP1A;SLC12A2;DPP4;UNC13B;KCNB1;CD2AP;ITPR3;TGFB1;TGFB2;PPIA;MYOM1;STX1A;UQCC2;EZR;TGFB3;DPH3;ABCG1
prerank,cardiac ventricle morphogenesis (GO:0003208),-0.31961689970889023,-1.0700643196125124,0.3675373134328358,0.6501664895613212,1.0,12/41,14.51%,MEF2C;NOTCH1;TGFBR2;SMAD7;TGFB1;TGFB2;FKBP1A;HEYL;CPE;SOX4;ENG;HEY1
prerank,myoblast fusion (GO:0007520),0.4283299489698058,1.0700036418387415,0.3758099352051836,0.7285893840977962,1.0,3/12,5.49%,ADGRB3;ADAMTS5;ADAM12
prerank,B cell mediated immunity (GO:0019724),-0.4608947107474023,-1.0699840823588005,0.394990366088632,0.6498671451512825,1.0,8/10,52.32%,FCER1G;CD74;TLR8;FCGR2B;CARD9;SLA2;MSH2;CD19
prerank,ion transport (GO:0006811),0.27833009265689074,1.0698252883636497,0.3169734151329243,0.7280437443555212,1.0,24/111,13.15%,SLC1A3;SLC24A3;SLC8A1;SLC24A5;SLC17A1;CNGB3;VDAC2;TRPM3;CHRNB4;GLRB;SLC20A2;SLC26A1;SLC36A2;SLC9A7;TRPA1;SLC25A10;SLC24A4;SLC24A2;CHRNA4;CHRNA7;CTNS;SLC12A3;CHRNB1;SLC1A2
prerank,cellular response to calcium ion (GO:0071277),-0.2902387138288088,-1.0697771921872805,0.3288201160541586,0.6498522789910296,1.0,9/67,6.89%,MEF2C;ITPKB;CLIC4;PLCG2;MEF2A;IQGAP1;CAMK2D;CARF;CPNE8
prerank,positive regulation of metabolic process (GO:0009893),-0.2672704772476972,-1.0697657454663267,0.3102766798418972,0.6493611557309644,1.0,23/103,13.01%,CAV1;ADIPOR2;IGF1R;GATM;PRDM16;PPARGC1B;CMKLR1;PPARGC1A;ADIPOR1;VEGFA;UCP2;ACLY;KDM3A;INSR;PDGFC;DECR1;FABP5;GRB10;ACADL;EBF2;GADD45G;SYK;AGPAT1
prerank,striated muscle cell differentiation (GO:0051146),0.42188786860900696,1.0696880760209062,0.38839285714285715,0.727374208029982,1.0,2/16,1.40%,BMP2;NRG1
prerank,peptidyl-serine modification (GO:0018209),-0.25212673474276237,-1.069620032534484,0.312,0.6492103530284432,1.0,39/166,16.57%,PRKCH;RPS6KA5;TGFBR2;HIPK1;WNK1;RPS6KA3;CAMK2D;RICTOR;MAPKAPK3;CSNK1G2;PRKCZ;PKD1;IKBKB;PRKDC;CSNK1G3;PLK2;DYRK2;AKT1;VRK3;STK32B;LMTK2;CAMK1;ULK3;RPS6KB2;VRK1;STK38;HPF1;POGLUT1;PKN3;PRKCE;RPS6KA2;MAST4;UHMK1;PARP2;CAB39;STK38L;CSNK2A1;CSNK2A2;POGLUT3
prerank,response to purine-containing compound (GO:0014074),-0.3923863289262109,-1.0694158493921544,0.35452793834296725,0.6491879194670857,1.0,3/17,8.10%,TRPC3;ABCC9;NDUFS4
prerank,cilium assembly (GO:0060271),-0.23299216775379286,-1.0688873949912885,0.2613168724279835,0.6499291934568452,1.0,70/296,19.74%,ABLIM1;ABCC4;EXOC4;NOTCH1;EXOC6;FNBP1L;RAB11A;CDC14A;DCTN2;EHD4;RAB8B;TUBA1A;IFT20;CEP164;RP1;ABLIM3;PKD1;PPP2R1A;PRKAR2B;CEP192;EHD2;CEP57;CEP162;TRIP11;CEP70;BBIP1;INPP5E;NUDCD3;DISC1;TMEM237;CPLANE2;IFT46;DCTN3;RAB8A;CEP290;CNTRL;DCTN1;EXOC1;GAS8;FHDC1;STK36;PCM1;TUBB4B;CC2D2A;ACTR3;POC1B;CDC14B;HAUS1;ARL6;NDE1;RFX2;RAB11FIP3;RAB1A;CETN2;CEP72;CCDC28B;KIF24;YWHAG;DNAH5;HSP90AA1;CEP41;TMEM67;E2F4;EHD1;RPGRIP1;SPAG16;TMEM231;EHD3;IFT27;DYNLL2
prerank,cellular response to estrogen stimulus (GO:0071391),0.42167319191739755,1.0688386129229472,0.3888888888888889,0.7284841881903111,1.0,3/14,4.24%,AR;OCSTAMP;SFRP1
prerank,sulfate transport (GO:0008272),-0.40737218185692436,-1.0684725411066596,0.3981981981981982,0.6504368645059673,1.0,2/14,1.09%,SLC26A7;SLC26A2
prerank,mesoderm formation (GO:0001707),-0.40376952027674307,-1.0683343197253115,0.3892988929889299,0.6502631847538607,1.0,4/17,19.70%,BMPR2;ITGB4;SMAD2;ITGB3
prerank,snRNA metabolic process (GO:0016073),-0.3875423676444042,-1.068127556556591,0.3670886075949367,0.6502579832826108,1.0,9/17,31.56%,MTREX;INTS8;INTS1;RBM7;MEPCE;INTS12;INTS2;INTS3;ZCCHC8
prerank,oligosaccharide metabolic process (GO:0009311),0.31994038227586474,1.0679427516118392,0.33916849015317285,0.7298331183779591,1.0,15/46,14.75%,B3GALT1;ST6GALNAC5;GAL3ST3;AMY1A;AMY1C;AMY1B;ST8SIA1;FUT4;ST6GALNAC6;FUT9;ST8SIA2;B3GALT2;B3GALT5;GLA;ST8SIA5
prerank,proton transmembrane transport (GO:1902600),0.33144346006906894,1.0673484143110876,0.3508771929824561,0.7302427999445308,1.0,7/36,12.34%,ATP1A2;ATP6V0A4;SLC36A2;DMAC2L;ATP6V1H;SLC46A1;ATP1A3
prerank,regulation of cellular localization (GO:0060341),0.3218455953174234,1.067310250619771,0.3619631901840491,0.7293291071680743,1.0,14/46,17.74%,ADCY5;WWC1;STXBP4;LYN;PRKN;FOXA2;DVL3;EPHA5;BRSK1;PARD6G;CDK16;TRIM46;NUMA1;PARP1
prerank,regulation of cytoskeleton organization (GO:0051493),-0.26409282893371555,-1.0671629254750166,0.324853228962818,0.6520153068819764,1.0,20/108,11.10%,CLIC4;SORBS3;F11R;MAPK3;IQGAP1;PTK2;ARHGAP17;CAPN2;RICTOR;RAC1;DIAPH1;CRK;HIP1R;EZR;PHLDB1;PDGFA;FAM107A;SPEF1;RHOB;TAOK2
prerank,"positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",-0.4350861737752305,-1.0670960220365002,0.37389770723104054,0.6516755500081229,1.0,2/13,1.71%,DDX5;RPL26
prerank,folic acid-containing compound metabolic process (GO:0006760),0.3844555913401432,1.0670151404031052,0.3852813852813853,0.7290348976166637,1.0,8/19,24.32%,ALDH1L1;FPGS;SLC46A1;MTHFD1;MTHFD1L;SLC19A1;MTHFR;MTHFD2L
prerank,positive regulation of autophagy (GO:0010508),-0.2785908366987333,-1.0669613099284239,0.32323232323232326,0.651485290552641,1.0,24/81,22.81%,SH3BP4;KDR;FOXO1;MID2;FOXO3;HTT;SVIP;PLK2;SCOC;TRIM14;PIK3C2A;EPM2A;PHB2;TRIM68;BNIP3L;TRIM5;UFL1;BAD;TSC2;PLEKHF1;TMEM59;TFEB;PLK3;SESN2
prerank,nucleoside salvage (GO:0043174),-0.46353364894166804,-1.0669536749227648,0.4060721062618596,0.6509940484364489,1.0,9/10,51.45%,UPP2;TK2;UPP1;DCK;UCK2;TK1;UCKL1;UCK1;HPRT1
prerank,cellular response to corticosteroid stimulus (GO:0071384),-0.4058359509441259,-1.0666573688483332,0.3747747747747748,0.6511719678544975,1.0,4/15,9.68%,ANXA1;REST;NR3C1;FAM107A
prerank,cellular response to sterol (GO:0036315),0.4320965571307702,1.0662660244294835,0.38146551724137934,0.7299311224851143,1.0,3/13,9.54%,RORA;INSIG2;GRAMD1B
prerank,regulation of cell cycle G2/M phase transition (GO:1902749),-0.2836689142741244,-1.0656918772090989,0.3431952662721893,0.653014802678818,1.0,29/82,26.11%,DCTN2;TUBA1A;CEP164;PPP2R1A;PRKAR2B;CEP192;CEP57;CEP70;DCTN3;CEP290;CNTRL;DCTN1;PCM1;TUBB4B;HAUS1;NDE1;CETN2;CEP72;YWHAG;HSP90AA1;CEP41;TPX2;TUBA4A;CENPF;HAUS4;YWHAE;CEP63;NEDD1;NEK10
prerank,intrinsic apoptotic signaling pathway (GO:0097193),-0.27487824892412055,-1.0655720242510658,0.31650485436893205,0.6527945701376865,1.0,20/94,12.65%,PPP1R13B;MAP3K5;DDX5;ARL6IP5;DAB2IP;FNIP2;CRIP1;CYP1B1;ATP2A3;ATF4;PRKDC;TNFRSF1B;PPM1F;CUL4A;BAX;BBC3;BCL2L1;E2F1;HINT1;BAK1
prerank,spinal cord development (GO:0021510),-0.44174799385895364,-1.0652494780799575,0.3996212121212121,0.6530457491905073,1.0,7/12,21.50%,VIT;PKD1;SOX12;NF1;SOX4;ZPR1;PKD2
prerank,protein sumoylation (GO:0016925),-0.300918560394074,-1.06515790654014,0.35195530726256985,0.6527534900308933,1.0,25/49,34.81%,IFIH1;STX1A;NUP93;NDC1;TRIM28;NUP54;SAE1;NUP188;SUMO3;NUP155;RANBP2;NUP37;UBA2;RANGAP1;NUP160;NUP43;SEH1L;NUP107;NUP42;NUP98;TRPM4;UBE2I;RAE1;NUP88;NUP214
prerank,RNA interference (GO:0016246),0.39844189809381025,1.0650212080116142,0.39094650205761317,0.7321531809721715,1.0,9/17,25.23%,HENMT1;AGO4;DROSHA;AGO3;AGO1;AGO2;MRPL44;DICER1;CLP1
prerank,relaxation of muscle (GO:0090075),0.4407172384707395,1.0646053467937897,0.39330543933054396,0.7321721353290674,1.0,3/13,3.79%,ATP1A2;SLC8A1;P2RX4
prerank,negative regulation of epithelial cell migration (GO:0010633),-0.33935595293848514,-1.063856705405961,0.38113207547169814,0.6554104083859286,1.0,6/33,5.35%,PTPRG;THBS1;DAB2IP;SLIT2;PTPRM;ADIPOR1
prerank,negative regulation of macromolecule biosynthetic process (GO:0010558),0.4208814462503242,1.0636834278921603,0.37264150943396224,0.7335868014725306,1.0,2/12,6.08%,AR;GSTP1
prerank,negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),-0.42466797074540696,-1.0635579180062218,0.3830570902394107,0.6556268553587031,1.0,6/13,20.61%,PPARD;REST;SRF;RELA;SOX9;NFATC3
prerank,positive regulation of non-canonical Wnt signaling pathway (GO:2000052),-0.44648640882519414,-1.0634383708354405,0.3868092691622103,0.6553671288030829,1.0,2/11,2.04%,MLLT3;RSPO3
prerank,"regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",-0.3530148711537242,-1.0632021898500528,0.3902877697841727,0.6554639607624547,1.0,13/27,30.15%,DDX5;CD44;TWIST1;PTTG1IP;CD74;SMYD2;KDM1A;MSX1;SPRED3;SNAI2;KMT5A;PMAIP1;SPRED1
prerank,intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),-0.44526603633988565,-1.062512117521782,0.3787313432835821,0.6566051404006503,1.0,4/11,7.87%,MAP3K5;ARL6IP5;CYP1B1;STK25
prerank,positive regulation of mitochondrion organization (GO:0010822),-0.3014182362061788,-1.0624393756088526,0.34705882352941175,0.6562608040048995,1.0,24/57,28.77%,KDR;HTT;TNFSF10;PPARGC1A;MIEF1;HIP1R;BAX;MIEF2;BBC3;BAK1;CHCHD10;ADCK1;BAD;BIK;FIS1;MCU;PLAUR;TREM2;PARK7;CAMKK2;HRK;MFF;MUL1;PMAIP1
prerank,cytoplasmic translational initiation (GO:0002183),-0.3925018686098852,-1.0622917226296718,0.3715277777777778,0.6561186489426918,1.0,9/17,25.69%,EIF3D;EIF3I;EIF4A1;EIF2B3;EIF5;EIF4G1;EIF4A2;EIF4B;EIF4H
prerank,lymphocyte mediated immunity (GO:0002449),-0.4211921046626118,-1.0622338748610964,0.39814814814814814,0.6557565849274083,1.0,2/12,13.51%,CD55;BTN3A3
prerank,"regulation of transcription, DNA-templated (GO:0006355)",-0.20461529706035034,-1.061947990013111,0.12378640776699029,0.6559644924595672,1.0,337/1646,18.51%,BNC2;KLF12;MECOM;LEF1;FOXP1;ELK3;ERG;ZBTB7C;MEF2C;DACH1;MAP3K5;APBB2;AFAP1L2;WWP1;RREB1;TBX15;NR3C2;CDH1;ATP8B1;MLLT3;RPS6KA5;ESR1;KLF3;NOTCH1;DDX5;CBFA2T3;ID1;RPL6;ZHX3;FLI1;DACH2;CDK17;LRP5;TEAD4;HMBOX1;TRAK1;ID3;JUND;PPARD;JMJD1C;NCOR1;MEF2A;KLF2;FOXO1;KLF4;NLK;ELF1;ZBTB46;TBX1;SMAD9;FZD4;ZSCAN29;RPS6KA3;CAMK2D;FOXO3;ETS1;SOX17;DAB2IP;BRD3;SMAD7;ZBTB7A;PHF20;IRF2BPL;VSX1;DDX17;SIX1;CDKN1B;KLF7;TGFB1;LHX6;CNBP;REST;KDM5C;PRDM16;TRRAP;TBX2;ARID3B;NFYA;ZNF431;REL;HDAC9;HSPA8;WWP2;NR4A2;CARF;ASCC2;PPARGC1B;LIMS1;PFDN5;KCTD1;FOXD1;RLIM;CTDSP1;TFCP2L1;BRWD3;PRDM2;PPARGC1A;ING5;CTBP1;PHC2;BHLHE40;SOX13;FOXK1;CD38;SLC39A8;HEYL;ZBTB16;LRRFIP1;DPF2;BRD9;CRK;SMAD6;VEGFA;CNOT7;ACTA2;MPHOSPH8;DPF3;AEBP2;USF2;PPP2R1A;IKBKB;RBFOX2;RARA;NOTCH4;BRD4;GATA6;ATF4;SHC1;FOXN3;KDM3A;ZNF326;CBFB;GATA2;TGFB3;KLF8;SAFB;NR3C1;MXD4;HCFC1;ZNF276;TOX3;CBX5;ANXA4;FOXQ1;CC2D1B;PPM1F;CIC;UIMC1;IRF2BP2;HDGF;TRIM16;MED24;NR2C2;YY1;HDAC4;ATXN1L;ZMYND11;AKT1;PLAGL1;SPIN1;INSR;FZD7;NDUFA13;ENY2;BCL6;FUS;TAL1;NOP2;SOX7;MKX;DHX9;SPP1;TWIST1;MED27;MAP3K2;TRIM28;NFATC1;BAZ1A;HHEX;PRDM15;RELB;SOX18;FOXF2;RB1;SP110;ESRRA;MXD1;ARID1A;JMJD6;ZC3H8;HSPD1;CEP290;JUNB;ZIC3;FOXP2;ZFP14;PRRX2;TCIM;WNT11;MYBL1;GABPA;WTIP;CD74;MED6;FOXC2;ZBTB18;INHBA;TADA2B;E2F3;CCDC85B;EBF2;SP3;ILF2;CRLF3;SOX12;KMT2D;SFPQ;PSMC5;LIMD1;HTATIP2;PHC1;WBP2;TEAD2;HIVEP1;ZNF83;OLIG1;IFRD1;ACVR1;TRIM56;CIPC;TOX2;MED29;ZFHX2;E2F1;ZNF423;APOE;PPP3CB;COMMD7;SOX4;HINT1;ZNF471;ABCA2;TSFM;POU2F1;FGF2;HES1;RNF111;SATB2;ZMIZ2;PLAGL2;GRHL1;ZNF367;TOX4;ENG;CIART;MTERF3;LCOR;ZNF569;PHF12;EPC1;HCFC2;MLX;PHB2;SMARCA4;STAT5A;MRGBP;EID2;RFX2;RNF20;FOXD2;BCL6B;NR5A2;HEY1;ETV5;EGFR;SRF;ERBB2;PURG;IRF9;HNRNPK;LDB1;SMAD4;ETV4;SNF8;ZFHX3;SOX6;RFX5;CDKN1A;RAI1;DRAP1;ZFPM2;CELSR2;SMARCA2;POU2F2;LIN54;NR1H2;STAT1;SAP30L;ZNF76;YWHAH;TCF3;GMEB2;CCNK;KLF6;ZNF319;ETS2;ZNF32;ZBTB2;ZBTB48;HOXB4;RELA;ZNF22;CCAR2;KDM1A;MED14;USP22;BRCA2;FOXL2;NR6A1;SP1;MED20;SCML2;DRGX;RET;ARID4B;CHUK;FOXP4;GLI1;E2F4;SMAD2;MED8;CRYAB;ZNF568;L3MBTL1;CHD4;PHF5A;IRF8
prerank,"positive regulation of transcription, DNA-templated (GO:0045893)",0.2132330156986605,1.0619299878134534,0.20722433460076045,0.7372092098608127,1.0,119/1082,9.65%,IGF1;AUTS2;BMP6;TCF7L2;TCF4;RORA;PIK3R1;WNT4;IL31RA;ARNT2;LDB2;BMP2;SALL1;PID1;AR;CDK8;TBX3;GLIS3;EPAS1;HLF;FGFR2;NFIA;NR2F2;BMP5;TBL1XR1;GDNF;VDR;RARB;NCOA2;ZIC1;TEAD1;PPARA;HOXC4;GLI2;DCN;MITF;NFAT5;IL4I1;SMAD3;CREB5;TFEC;KDM1B;STAT5B;NKX6-1;HOXB3;PIM2;TBX21;ZNF462;CSRP3;KLF15;AKAP8L;GLI3;TFCP2;ZEB2;PBX4;PHIP;SFRP1;SP7;TFDP1;PHOX2A;CEBPB;MAP3K12;IL4;CAMK4;PRKN;ZNF513;MLLT10;HNF4G;SERPINE1;MAML3;BCL2L12;TAF6L;ATF5;ZNF318;GABPB1;GABPB2;FOXA2;TRIP4;ASXL3;ZNF296;PCGF5;SIRT2;LHX4;MEN1;TP53INP2;SIX4;KMT2A;NFIX;RARG;SOX2;CITED2;TGFBR1;ZSCAN21;RBPJ;NSD1;IGF2;IL18;SENP1;RGMA;KAT8;FOXD3;NCOA1;HES5;CXXC1;ATOH8;BLM;CREB3L4;CREB3;GLIS1;GATA3;DVL3;BMPR1A;NPAT;MLXIP;MYDGF;CTCF;AHI1;HOXC10;HDAC8
prerank,protein complex oligomerization (GO:0051259),-0.2786883540300456,-1.0617710497245707,0.32386363636363635,0.6558831622518988,1.0,29/85,26.10%,LRRC8C;LRRC8D;EHD4;MAT2A;AQP11;ATL3;FUS;ATL2;KCNC3;PRMT8;JMJD6;HOMER1;OPA1;NINJ1;CHMP2A;POLQ;EHD1;TRMT61B;ECT2;EHD3;PKD2;UPB1;LRRC8A;CLDN1;BCL10;ALAD;MCU;RNF112;ZNHIT6
prerank,positive regulation of cardiac muscle cell proliferation (GO:0060045),0.4225959668678751,1.0615687816431523,0.3974358974358974,0.7371445477900522,1.0,5/13,9.82%,TGFBR3;FGFR2;RBPJ;BMPR1A;ERBB4
prerank,regulation of cilium movement (GO:0003352),0.46279189304392365,1.0615464243054211,0.38443935926773454,0.7361971455030984,1.0,3/10,11.52%,CFAP43;CCDC65;DNAH11
prerank,receptor-mediated endocytosis (GO:0006898),-0.2577966588141052,-1.0615400127329575,0.3387096774193548,0.6559728705578495,1.0,23/132,12.88%,CAV1;DNM3;ACKR3;FNBP1L;SCARB1;SCARF1;CAV2;RAMP2;TFRC;ARHGAP27;CUBN;STAB1;IGF2R;CD81;HIP1R;CD9;AP2M1;INSR;FCER1G;FCHO2;SGIP1;APOE;SYK
prerank,vasodilation (GO:0042311),-0.4180417157784586,-1.0612813837553223,0.3867403314917127,0.6561376540885815,1.0,2/13,2.57%,NOS3;KLF2
prerank,interleukin-2-mediated signaling pathway (GO:0038110),-0.4487755755409239,-1.0605632757179404,0.4,0.6568587328685692,1.0,5/11,17.47%,PTK2B;SHC1;SYK;STAT5A;JAK3
prerank,cellular response to interleukin-2 (GO:0071352),-0.4487755755409239,-1.0605632757179404,0.4,0.6568587328685692,1.0,5/11,17.47%,PTK2B;SHC1;SYK;STAT5A;JAK3
prerank,response to reactive oxygen species (GO:0000302),-0.30018599356830805,-1.0603013698345356,0.3236434108527132,0.6569915518356604,1.0,26/54,33.74%,PXN;MAPK3;RPS3;STK25;COA8;GPX1;AKT1;APOE;EGFR;STK26;CHUK;PTPRK;PKD2;PDCD10;PLK3;HYAL1;CAMKK2;SOD1;ROMO1;HYAL2;TPM1;MAPK9;HP;FOS;NCF1;JUN
prerank,chromatin organization (GO:0006325),-0.2552685386254478,-1.0602843803559483,0.3186372745490982,0.6565243102362621,1.0,48/132,31.95%,MECOM;ESR1;ZBTB7A;KDM5C;PRDM16;SAFB;HCFC1;HDAC4;BAZ1A;CHD1L;RB1;ARID1A;MTA2;TADA2B;HMGN1;GATAD1;SATB2;CDAN1;HCFC2;SMARCA4;HMGN2;SMARCA2;RBBP4;PWWP3A;KDM6A;L3MBTL1;SOX9;SETDB1;SMARCC1;EZH1;PHF19;HDAC5;FAM50A;SETD2;CHD1;RUVBL1;NPM1;CHRAC1;SPI1;SMARCD2;HMGB2;SMARCA5;HDAC3;MYC;MYSM1;SMARCD3;NPM3;KAT2A
prerank,positive regulation of endocytosis (GO:0045807),-0.3111215983361498,-1.0602687279637375,0.3591682419659735,0.6560648408163564,1.0,9/45,12.33%,ANO6;B2M;GPC3;NEDD4L;CD151;FLOT1;HIP1;SGIP1;APOE
prerank,COPII vesicle coating (GO:0048208),0.29858484556995896,1.0598542659424666,0.3510204081632653,0.7375713176883671,1.0,14/61,15.55%,AREG;SEC24D;TGFA;TRAPPC6B;SCFD1;GOLGA2;TMED10;SEC24A;TRAPPC3;SEC31A;SEC23A;GRIA1;SAR1B;TBC1D20
prerank,"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",0.29858484556995896,1.0598542659424666,0.3510204081632653,0.7375713176883671,1.0,14/61,15.55%,AREG;SEC24D;TGFA;TRAPPC6B;SCFD1;GOLGA2;TMED10;SEC24A;TRAPPC3;SEC31A;SEC23A;GRIA1;SAR1B;TBC1D20
prerank,vesicle coating (GO:0006901),0.29858484556995896,1.0598542659424666,0.3510204081632653,0.7375713176883671,1.0,14/61,15.55%,AREG;SEC24D;TGFA;TRAPPC6B;SCFD1;GOLGA2;TMED10;SEC24A;TRAPPC3;SEC31A;SEC23A;GRIA1;SAR1B;TBC1D20
prerank,cellular response to glucose starvation (GO:0042149),-0.31591044062801416,-1.0597814888903874,0.3493282149712092,0.656760783719636,1.0,18/41,33.29%,FOXO3;ATF4;HSPA5;IMPACT;NUAK1;NUAK2;PRKAG1;XBP1;HNRNPA1;ASNS;SESN2;BRSK2;SIK1;SESN1;PMAIP1;CPEB4;PIK3R4;ATG14
prerank,positive regulation of cell cycle process (GO:0090068),0.28033681554502726,1.0596352714455568,0.36666666666666664,0.7371703482394906,1.0,17/91,15.14%,IGF1;SVIL;TGFA;PHIP;UBXN2B;PDGFRB;GEN1;SIRT2;IGF2;MAP10;CDC25B;AURKC;BTC;DRD2;SPAST;RANBP1;USP19
prerank,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),0.30089835401803594,1.0594832510289662,0.3726315789473684,0.7365447085973157,1.0,9/59,7.85%,ROBO1;ROBO2;SDK2;TENM3;CNTN4;PTPRT;KIRREL3;NPTN;TRO
prerank,anaphase-promoting complex-dependent catabolic process (GO:0031145),-0.27506994555298653,-1.0593891929549262,0.3422562141491396,0.6572497109426323,1.0,38/84,34.73%,UBB;UBC;RPS27A;ANAPC15;PSMA6;ANAPC11;PSMB5;RB1;PSMC4;PSMC5;PSMD14;PSMD8;PSMD11;ANAPC7;CDC27;PSMB4;PSMD12;PSMC1;FZR1;PSMA1;ANAPC2;PSMB1;PSMC3;PSMA4;PSMA2;PSMB8;BUB3;PSMC6;PLK1;AURKA;CDK1;PSMD6;PSMA8;ANAPC10;CDC20;CUL3;PSMD2;UBE2C
prerank,endoplasmic reticulum calcium ion homeostasis (GO:0032469),-0.3710357075356713,-1.0592957123567668,0.38446969696969696,0.6569842176239801,1.0,8/20,22.16%,TGM2;CAMK2D;BAX;BAK1;BCAP31;RAP1GDS1;FIS1;SELENOK
prerank,negative regulation of cellular component organization (GO:0051129),0.2876119338950751,1.0590573517002675,0.3486973947895792,0.7366877498916788,1.0,5/74,3.69%,BMP6;AR;EPHA3;SNX33;DNAJB8
prerank,negative regulation of ATP metabolic process (GO:1903579),0.4013899528288815,1.058675794604441,0.3841059602649007,0.7366652215982261,1.0,3/17,4.89%,PID1;PPARA;ACTN3
prerank,negative regulation of mRNA processing (GO:0050686),-0.4058099480193579,-1.0583282373893683,0.4007220216606498,0.6588395570279062,1.0,5/15,13.94%,SRSF6;PCBP4;RNPS1;SRSF4;SFSWAP
prerank,cellular biogenic amine metabolic process (GO:0006576),-0.4402384891713736,-1.0581381794790867,0.41788321167883213,0.6587708174232556,1.0,6/12,20.02%,MAOA;AMD1;OAZ2;DDC;SMS;SRM
prerank,regulation of transcription by RNA polymerase II (GO:0006357),0.2077654014702813,1.058132007104146,0.18135593220338983,0.7370969592360811,1.0,194/1668,9.68%,IGF1;AUTS2;BMP6;TCF7L2;TCF4;RORA;PIK3R1;ARNT2;FHL2;ZBTB20;LDB2;BMP2;MAF;SALL1;PID1;AR;CDK8;ATXN1;TBX3;GLIS3;EPAS1;HLF;MXI1;FGFR2;NFIA;NR2F2;BCOR;BMP5;ZEB1;TBL1XR1;HIVEP2;GDNF;VDR;RBAK;RARB;TRPS1;NCOA2;ZIC1;TEAD1;PRRX1;PPARA;KIT;HOXC4;ZHX2;GLI2;DCN;MITF;TBX18;DLX3;NFAT5;PRDM5;IKZF4;IL4I1;SMAD3;CREB5;TFEC;KDM1B;ZKSCAN2;STAT5B;NKX6-1;HOXB3;HOXC5;TGFA;TBX21;ZNF462;CSRP3;KLF15;AKAP8L;MDM2;GLI3;WWC1;VRTN;TENM2;TFCP2;ZEB2;PBX4;CREB3L1;UXT;PHIP;FNIP1;SP7;TFDP1;KDM7A;PHOX2A;AEBP1;HDX;HOXC8;FOSB;ZNF35;CAMTA1;ZMYM5;CEBPB;HOXB8;ZNF112;PKNOX2;EBF1;IL4;GTF2H2;RNF2;SOX21;JAZF1;PRKN;ZNF292;ZNF513;HES3;SUMO1;ZKSCAN7;MNAT1;MLLT10;HNF4G;LIN37;MED12L;SERPINE1;MAML3;AGO4;HOXC9;BCL2L12;TAF6L;ATF5;HDAC10;BBX;GABPB1;GABPB2;ZNF394;BAZ1B;FOXA2;ASXL3;ZHX1;ZNF296;LOXL2;DMRTA2;SMURF2;SP5;PCGF5;SIRT2;CUX1;LHX4;MEN1;MBD2;DMTF1;ZNF697;SIX4;KMT2A;NFIX;KTI12;CRY1;BCL11A;HTATSF1;TNRC6A;RFX7;RARG;SOX2;TRIM27;CITED2;ZSCAN21;RBPJ;NSD1;IGF2;PPM1D;SAFB2;IL18;SENP1;RGMA;KAT8;FOXD3;NCOA1;HES5;MIER3;ZBTB45;CPEB3;ATN1;ATOH8;CREB3L4;CREB3;BRMS1L;BRMS1;GLIS1;GATA3;PRKCB;DVL3;BMPR1A;NPAT;MLXIP;MYDGF;CTCF;KCNIP3;CUX2;SOX5;AHI1;HOXC10;BRWD1;VGLL3;HDAC8;PCGF6
prerank,positive regulation of endothelial cell chemotaxis (GO:2001028),-0.40252699928078983,-1.0580760803409326,0.37163375224416517,0.6584100086171419,1.0,6/15,15.81%,TMSB4X;KDR;VEGFA;HSPB1;FGF2;MET
prerank,regulation of neuron migration (GO:2001222),-0.35014240196489227,-1.0577589531556633,0.38235294117647056,0.6587116833531097,1.0,11/26,20.92%,SEMA6A;COL3A1;DAB2IP;SHTN1;ADGRG1;PLAA;ULK4;NEXMIF;ARHGEF2;NIPBL;RAPGEF2
prerank,positive regulation of vasculogenesis (GO:2001214),-0.4616642106703567,-1.05730065196678,0.4262589928057554,0.659306374799916,1.0,3/10,2.36%,RAP1A;CD34;KDR
prerank,cognition (GO:0050890),-0.31019711535025457,-1.0569892735263786,0.38202247191011235,0.6595307426208112,1.0,9/42,11.33%,ST3GAL4;SHROOM4;APP;DGCR2;STRA6;CHMP2B;MFSD2A;FAM107A;NF1
prerank,regulation of sodium ion transmembrane transporter activity (GO:2000649),-0.32755068869022896,-1.0569032527304916,0.3747680890538033,0.6592413086427428,1.0,6/39,3.29%,UTRN;DMD;NEDD4L;FXYD5;WNK1;CAMK2D
prerank,respiratory system development (GO:0060541),0.3475849766769449,1.0568371646648944,0.34838709677419355,0.739433300722703,1.0,8/32,13.61%,FGFR2;GLI2;CHD7;SPEF2;LOXL3;NPHP3;SMCHD1;NKX2-1
prerank,negative regulation of cellular amide metabolic process (GO:0034249),0.28193392865329553,1.0565653042660839,0.35394456289978676,0.7391040530118294,1.0,11/84,11.38%,IGF1;SAMD4A;DAPK1;RTN4;IGF2BP2;NANOS3;CPEB3;DDX6;RIDA;CHRNA7;FXR2
prerank,cell differentiation in spinal cord (GO:0021515),-0.44709991422638606,-1.056540548110873,0.42230347349177333,0.6596122231273794,1.0,3/10,15.70%,SOX13;SOX4;SOX6
prerank,cardiac muscle cell differentiation (GO:0055007),0.371647504716188,1.0565327285961776,0.38626609442060084,0.7382029088086758,1.0,3/21,1.40%,BMP2;SLC8A1;NRG1
prerank,regulation of organelle assembly (GO:1902115),-0.28146280610009067,-1.056406280368851,0.35812133072407043,0.6594559228589383,1.0,29/72,29.03%,TBC1D8;IFT20;MSN;ATXN2L;TBC1D1;TBC1D12;EZR;TBC1D22A;PLK2;KIF9;ATG3;TBC1D9B;TSG101;VPS11;HCK;TBC1D2;RABEP2;ADPRH;DCDC2;TBC1D15;SPICE1;ODAD3;TBC1D17;RDX;CDKL5;NPM1;TBC1D5;UBQLN2;STAM
prerank,positive regulation of protein transport (GO:0051222),-0.29031633772145965,-1.0562000135590128,0.362,0.6594665494246982,1.0,19/67,13.54%,RACK1;UNC13B;CD2AP;TGFB1;TGFB2;ATP2C1;BCAS3;PPIA;PRR5L;CHP1;MYOM1;EZR;TGFB3;ABCG1;CEP290;EXOC1;PCM1;OAZ2;ARHGEF5
prerank,G protein-coupled glutamate receptor signaling pathway (GO:0007216),0.40682857838418757,1.0557806209667648,0.38961038961038963,0.7392225054629769,1.0,8/15,25.72%,TRPM1;GRM1;GRM4;HOMER2;GRIK3;DAGLA;GRM5;GRM8
prerank,stem cell differentiation (GO:0048863),0.32693267680179433,1.054759123540915,0.38526315789473686,0.7408240820617732,1.0,6/39,5.29%,FGFR2;KIT;GPM6A;SFRP1;SP7;SOX21
prerank,"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",0.3022787910185041,1.0546341685167078,0.3574380165289256,0.7401439288339281,1.0,7/52,8.30%,CELF2;RBFOX1;NOVA1;SRSF12;KHDRBS1;CELF4;RBM5
prerank,negative regulation of cellular component movement (GO:0051271),0.41287227985826713,1.0544073080298852,0.416135881104034,0.7397073608179703,1.0,4/15,9.13%,TGFBR3;FBLN1;SPOCK3;GATA3
prerank,membrane fusion (GO:0061025),-0.3325853019571412,-1.0543066332190585,0.37707948243992606,0.6636533949929979,1.0,11/33,20.37%,DNM3;MYOF;CHP1;NAPA;DYSF;OPA1;RABEP1;VTI1B;NSF;DNM1;DNM2
prerank,mitotic metaphase plate congression (GO:0007080),-0.3004391846565136,-1.054196070352798,0.3735408560311284,0.6634028767656417,1.0,22/51,32.17%,RAB11A;DCTN2;ZW10;CHMP2B;MAD1L1;KIF18A;CHMP2A;BOD1;NDC80;RMDN1;KIF22;SPDL1;CDCA8;CEP55;VPS4A;SEH1L;EML3;CHMP7;NUF2;PSRC1;CHMP4B;CHMP4A
prerank,response to sterol (GO:0036314),0.4299057530152629,1.0541149474691704,0.40829694323144106,0.7394798685062952,1.0,1/11,0.19%,RORA
prerank,"positive regulation of synaptic transmission, glutamatergic (GO:0051968)",0.39271126062930695,1.0539137537194039,0.38329764453961457,0.7390308381187153,1.0,5/18,7.71%,NRXN1;NLGN2;NLGN3;CACNG4;NLGN1
prerank,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),-0.2289658643147271,-1.053891021689955,0.2920168067226891,0.6636560157844815,1.0,89/314,23.28%,WWP1;NEDD4L;SEL1L;TRIM25;UBB;ZNRF1;WWP2;UBC;RPS27A;FBXO17;ANAPC15;PSMA6;ANAPC11;CUL4A;DNAJB12;PSMB5;FBXO4;NHLRC3;KCTD5;MAN1B1;PLAA;RB1;ERLIN2;RNF185;UCHL1;UBE2G2;VCP;TNFAIP1;PSMC4;MTA1;MAEA;HSPA5;PSMC5;FBXL14;UBXN1;PSMD14;FBXW5;UBXN8;ITCH;FAF2;RNF5;FBXL7;SMURF1;FBXL2;SEC61B;FEM1A;RBX1;UBE2G1;SGTA;PSMD8;PSMD11;CCNF;RNF121;ANAPC7;KCTD10;CDC27;PSMB4;PSMD12;PSMC1;TMEM67;FBXL3;FZR1;FBXL16;CUL1;DMAC2;DERL2;PELI1;ZSWIM8;TBL1X;AMFR;KCTD2;TMEM129;UBE2B;PSMA1;ZFAND2B;TMUB2;ANAPC2;CLOCK;PSMB1;PSMC3;BFAR;LTN1;SGTB;PSMA4;PCNP;FBXL19;PSMA2;FBXL18;TMUB1
prerank,nucleotide-excision repair (GO:0006289),-0.2667113185940025,-1.053537279267773,0.35363457760314343,0.6640270971878033,1.0,48/101,34.22%,UBB;UBC;RPS27A;USP7;ISY1;ERCC1;CUL4A;GTF2H3;CHD1L;COPS6;XAB2;HMGN1;PNKP;SLX4;COPS5;RNF111;RBX1;XRCC1;CETN2;HUS1;RPA3;BRCA2;TCEA1;GTF2H4;POLK;ERCC4;COPS7A;RFC3;RAD23A;COPS4;RFC2;COPS7B;FAN1;POLL;XPC;GPS1;LIG4;RAD23B;POLR2F;AQR;POLB;PRPF19;POLR2L;POLR2I;POLR2C;POLE;SLC30A9;POLA1
prerank,copper ion homeostasis (GO:0055070),-0.3919200119543953,-1.0534103092756442,0.3838951310861423,0.6638264218060037,1.0,3/17,4.11%,ATOX1;MT2A;APP
prerank,cellular response to DNA damage stimulus (GO:0006974),-0.22782093975219062,-1.0533286436825378,0.2891304347826087,0.6635122472224703,1.0,106/336,27.25%,FOXP1;ACER2;FOXO1;MAPK3;PAXX;DCUN1D5;RPS3;FNIP2;RBBP5;TRRAP;CRIP1;MTREX;TAOK3;SUSD6;CBX1;PRKDC;TNFRSF1B;CBX5;ERCC1;RAD1;CUL4A;YY1;USP3;BAX;DYRK2;BCL6;GTF2H3;TRIM28;OTUB1;CHD1L;FAM111A;HERC2;VCP;TAOK2;CIB1;HPF1;BCL2L1;E2F1;PNKP;SPRTN;BAK1;SLX4;FMR1;SAMHD1;RAD9B;CDKN2AIP;SLF1;RAD18;TOP2A;PARP2;HUS1;EPHA2;NSMCE4A;RAD9A;RPAIN;CDKN1A;UFL1;CCNK;RAD17;PWWP3A;BABAM2;WDR48;GTF2H4;POLQ;POLK;TRAIP;MAPK12;CGAS;ZBTB40;CHEK1;ERCC4;GADD45A;CCND1;BRAT1;MCL1;UBE2B;SFN;UBA1;CHCHD6;NIPBL;TAF9;PLK3;CCDC13;DTL;EID3;RFC3;POLE3;NUPR2;DTX3L;ASH2L;RFC2;FAN1;EXO1;MRNIP;FBXO6;ALKBH7;XIAP;SPDYA;CEP63;PARK7;PLK5;XPC;RAD51AP1;KIN;SLF2;NPM1
prerank,cellular potassium ion homeostasis (GO:0030007),-0.41424649318121165,-1.0532318217814625,0.39416058394160586,0.663249766144622,1.0,4/13,7.63%,SLC12A2;KCNJ2;ATP1A1;ATP1B1
prerank,positive regulation of stress fiber assembly (GO:0051496),0.3110932283326433,1.0531733978016031,0.3684210526315789,0.7398996044488588,1.0,5/44,4.24%,PPM1E;NRP1;LPAR1;ROCK2;SFRP1
prerank,regulation of antigen receptor-mediated signaling pathway (GO:0050854),-0.4241846988591505,-1.0531547102871759,0.4081272084805654,0.662935638412855,1.0,3/12,7.75%,ELF1;CBFB;RC3H1
prerank,epithelium development (GO:0060429),0.26733353735539056,1.0531479993147537,0.3381742738589212,0.7389691355398801,1.0,7/107,2.41%,WNT4;ERRFI1;BMP2;ALDH1A2;SALL1;FGFR2;DLX3
prerank,metal ion export (GO:0070839),0.35200474874961185,1.0530236176169705,0.38063063063063063,0.7382735162562536,1.0,2/31,0.47%,KCNT2;ATP1A2
prerank,lysine catabolic process (GO:0006554),-0.4351470104315994,-1.0525905060761211,0.41560798548094374,0.6632424683995972,1.0,5/12,19.23%,DLD;HYKK;OGDH;DLST;AASS
prerank,lysine metabolic process (GO:0006553),-0.4351470104315994,-1.0525905060761211,0.41560798548094374,0.6632424683995972,1.0,5/12,19.23%,DLD;HYKK;OGDH;DLST;AASS
prerank,phospholipid catabolic process (GO:0009395),-0.3589717802084631,-1.052469705082863,0.3926605504587156,0.6630277204254227,1.0,8/24,28.84%,GPCPD1;SMPDL3A;ENPP6;GDE1;PLA2G4F;ENPP2;SMPD1;PLA2G4B
prerank,positive regulation of fibroblast proliferation (GO:0048146),0.35937104705924594,1.0518556851526413,0.38054968287526425,0.7403579206149612,1.0,3/27,2.19%,IGF1;DDR2;PDGFRA
prerank,negative regulation of axon extension involved in axon guidance (GO:0048843),-0.377271288024573,-1.0513972591668572,0.4215328467153285,0.6651906088299941,1.0,3/20,1.47%,SEMA6A;SEMA3C;SEMA7A
prerank,neuron projection development (GO:0031175),0.2533179726250287,1.0513368997179082,0.3260437375745527,0.7407013554874067,1.0,33/168,13.81%,ADGRV1;NRK;EPB41L3;GDNF;CNTN4;CNTNAP2;GPM6A;DOCK10;GPRIN2;LYN;GPRIN1;MYO16;SRGAP2;CTNND2;TBC1D24;EPHB1;GAS7;TNIK;PPP1R9A;NLGN1;DOCK7;RYK;CDK5R1;EPHA8;CAMSAP1;PTEN;LRP12;RASGRF1;SNAPIN;ATXN10;DLG4;CDK16;MAPT
prerank,response to interferon-gamma (GO:0034341),-0.28590820397953987,-1.0513348141075682,0.3537037037037037,0.6648416357678866,1.0,17/67,20.27%,GBP5;GCH1;GBP7;IFITM1;IFITM3;GAPDH;IFITM2;CCL15;RPL13A;CD74;TLR4;STAT1;IRF8;AQP4;SYNCRIP;CASP1;LGALS9
prerank,regulation of protein localization to plasma membrane (GO:1903076),0.28576771401278755,1.0508157658025878,0.34615384615384615,0.7410427743564171,1.0,7/78,2.58%,PIK3R1;PID1;AR;LRP1;DPP10;PDPK1;EPHA3
prerank,cellular response to hormone stimulus (GO:0032870),0.2909282746107152,1.0507560334294248,0.373046875,0.7401899359347179,1.0,8/69,4.95%,ATP1A2;ROBO2;AR;OCSTAMP;NCOA2;STAT5B;SFRP1;GHR
prerank,regulation of potassium ion transmembrane transport (GO:1901379),-0.2978159696677485,-1.049998582326093,0.37667304015296366,0.6675585617672262,1.0,12/54,15.37%,CAV1;KCNJ2;NEDD4L;FHL1;WWP2;KCNQ1;KCNJ10;AKAP6;KCNJ15;GNB1;CACNA1D;CAB39
prerank,zinc ion transmembrane transport (GO:0071577),-0.3692876847475842,-1.0498772467217328,0.3783783783783784,0.6673412046598661,1.0,6/22,14.06%,SLC39A10;SLC39A8;SLC30A6;SLC39A1;SLC39A11;SLC39A7
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),-0.27491215706283306,-1.0497543282286041,0.32879377431906615,0.666633505748035,1.0,29/78,27.31%,KLC1;DCTN2;DYNC1LI2;OSBPL1A;AP2M1;CTSD;KIF23;DCTN3;CTSF;FCER1G;DCTN1;CD74;RAB7A;KIF26A;DYNC1LI1;AP2A1;KIF18A;DYNLL2;SEC24B;DNM2;CLTA;KIF22;AP1S2;CTSS;ACTR1B;SEC13;DCTN4;RACGAP1;AP2A2
prerank,antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),-0.27491215706283306,-1.0497543282286041,0.32879377431906615,0.666633505748035,1.0,29/78,27.31%,KLC1;DCTN2;DYNC1LI2;OSBPL1A;AP2M1;CTSD;KIF23;DCTN3;CTSF;FCER1G;DCTN1;CD74;RAB7A;KIF26A;DYNC1LI1;AP2A1;KIF18A;DYNLL2;SEC24B;DNM2;CLTA;KIF22;AP1S2;CTSS;ACTR1B;SEC13;DCTN4;RACGAP1;AP2A2
prerank,cellular response to catecholamine stimulus (GO:0071870),-0.3552472444052637,-1.0494360112323828,0.39090909090909093,0.6668977096129151,1.0,6/23,13.50%,TGM2;MAPK3;KCNQ1;ATF4;GABPA;GNB1
prerank,regulation of insulin secretion (GO:0050796),0.2725028431654423,1.04897209774324,0.3752535496957404,0.7437806369468103,1.0,15/101,7.62%,TCF7L2;ADCY5;RAPGEF4;CACNA1E;ITPR1;PRKCA;STXBP4;SFRP1;FAM3D;PRKN;IRS2;NLGN2;FOXA2;SNAP25;TM7SF3
prerank,glycoprotein metabolic process (GO:0009100),-0.29674108278611466,-1.0486912792950447,0.3558648111332008,0.6682505751857782,1.0,9/53,9.28%,ST3GAL4;ST6GALNAC3;ST8SIA4;MANBA;GANC;ST8SIA6;FBXO17;MAN1B1;FUT8
prerank,negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),0.45077008872293944,1.0486684368057237,0.38666666666666666,0.7436235777724489,1.0,2/10,6.13%,BMP6;PLG
prerank,positive regulation of TORC1 signaling (GO:1904263),-0.3996471573744944,-1.0485865995112993,0.41040462427745666,0.6680378128476814,1.0,7/16,26.83%,GPR137B;PIP4P1;RRAGD;RRAGA;SEH1L;SIK3;LAMTOR5
prerank,cellular glucan metabolic process (GO:0006073),0.443994708365933,1.0485581865395428,0.4194915254237288,0.7429183266902496,1.0,2/11,2.55%,PRKAG2;PHKA1
prerank,negative regulation of cation transmembrane transport (GO:1904063),-0.380828270661266,-1.0484876784018744,0.4059590316573557,0.6677618083712302,1.0,4/18,7.38%,CAV1;NEDD4L;CAMK2D;SLC43A2
prerank,female gonad development (GO:0008585),0.38145160239068376,1.0484821863736038,0.3794642857142857,0.7421500191033131,1.0,5/19,11.50%,NR2F2;KIT;CEBPB;ANG;EIF2B5
prerank,production of siRNA involved in RNA interference (GO:0030422),0.4571645221981813,1.0483177166105162,0.4065934065934066,0.7415880910198539,1.0,5/10,23.08%,HENMT1;DROSHA;AGO2;MRPL44;DICER1
prerank,glycine transport (GO:0015816),0.4378907807446746,1.0480017502471095,0.41797752808988764,0.7414424098069454,1.0,2/10,5.51%,SLC6A9;SLC36A2
prerank,regulation of signal transduction (GO:0009966),0.24474524204253417,1.047872782811518,0.3383458646616541,0.7408072653290803,1.0,22/190,8.27%,RORA;IGFBP2;GRK3;FGFR2;SEMA5A;GPHB5;SULF1;GDNF;IFT81;ZIC1;DHRS3;KCTD8;RGS20;TSPAN15;SENP2;NLRP12;DTX1;YJEFN3;FRMPD1;TULP3;MAPK8IP2;ERBB3
prerank,lipoprotein localization (GO:0044872),0.4266106134440895,1.0472335602356222,0.41646489104116224,0.7414805150188845,1.0,5/11,18.82%,LRP1;PRKCB;MIA3;UNC119B;PPARG
prerank,antigen processing and presentation of exogenous peptide antigen (GO:0002478),-0.27394839662432846,-1.0469284264227696,0.32608695652173914,0.6710524504498799,1.0,29/79,27.31%,KLC1;DCTN2;DYNC1LI2;OSBPL1A;AP2M1;CTSD;KIF23;DCTN3;CTSF;FCER1G;DCTN1;CD74;RAB7A;KIF26A;DYNC1LI1;AP2A1;KIF18A;DYNLL2;SEC24B;DNM2;CLTA;KIF22;AP1S2;CTSS;ACTR1B;SEC13;DCTN4;RACGAP1;AP2A2
prerank,branching involved in blood vessel morphogenesis (GO:0001569),-0.4147046590122383,-1.0468332037829637,0.38155515370705245,0.670788321021108,1.0,5/13,6.44%,TGFBR2;KDR;COL4A1;VEGFA;NOTCH4
prerank,positive regulation of potassium ion transmembrane transport (GO:1901381),-0.31124507165202286,-1.0466511278285178,0.36627906976744184,0.670743125685249,1.0,9/44,13.50%,ANO6;KCNJ2;WNK1;KCNQ1;KCNJ10;ATP1B1;AKAP6;KCNJ15;GNB1
prerank,positive regulation of transcription of Notch receptor target (GO:0007221),-0.3903488900296197,-1.0464658301622114,0.41404805914972276,0.6706945725770084,1.0,5/17,10.56%,NOTCH3;NOTCH1;HEYL;NOTCH4;PLXND1
prerank,negative regulation of developmental process (GO:0051093),-0.28205371513285277,-1.0463781121271643,0.3405088062622309,0.6703816718327715,1.0,13/69,8.73%,CDK6;NOS3;NOTCH1;TFRC;TBX1;ARHGEF15;KLF7;TGFB1;TBX2;VAT1;NOTCH4;RC3H1;CST3
prerank,N-acetylneuraminate metabolic process (GO:0006054),-0.4414854118654358,-1.0462869297912896,0.4139194139194139,0.6701102834319193,1.0,5/10,30.78%,ST6GAL1;AMDHD2;RENBP;GNPDA1;GNE
prerank,protein autophosphorylation (GO:0046777),0.2521275386023613,1.0460909953772892,0.350187265917603,0.743462499557503,1.0,35/157,13.17%,DDR2;FGFR2;DAPK2;STK17B;KIT;PDGFRA;PDPK1;PIM2;LYN;DDR1;AAK1;MAPKAPK5;MAP3K12;CAMK4;DAPK1;PDGFRB;EPHB1;CAMK2B;TNIK;MAK;FGFR4;STK33;EPHA8;ERBB4;ALK;MEX3B;MAP3K10;MUSK;EEF2K;ITK;FGFR1;TEC;EPHA1;ULK2;ATM
prerank,glutathione derivative biosynthetic process (GO:1901687),-0.369644771974199,-1.046037875553151,0.4307116104868914,0.6697070402454959,1.0,14/20,38.99%,GSTA4;GSTM2;GSTA3;GSTM1;GSTO2;MGST3;GSTK1;GSTM5;GSTO1;MGST2;ESD;MGST1;HPGDS;GSTM4
prerank,glutathione derivative metabolic process (GO:1901685),-0.369644771974199,-1.046037875553151,0.4307116104868914,0.6697070402454959,1.0,14/20,38.99%,GSTA4;GSTM2;GSTA3;GSTM1;GSTO2;MGST3;GSTK1;GSTM5;GSTO1;MGST2;ESD;MGST1;HPGDS;GSTM4
prerank,negative regulation of neuron death (GO:1901215),-0.26685219165399204,-1.0459385572665214,0.38524590163934425,0.6694461478095642,1.0,13/93,8.42%,MEF2C;CD34;PTK2B;NGF;SIX1;REST;PPARGC1A;ATF4;TGFB3;TOX3;TNFRSF1B;FOXQ1;AKT1
prerank,"nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",-0.31591056922097555,-1.0458788876587979,0.3722772277227723,0.6690799296943104,1.0,12/37,19.11%,UBB;UBC;RPS27A;ERCC1;CUL4A;GTF2H3;CHD1L;RBX1;RPA3;GTF2H4;POLK;ERCC4
prerank,signal transduction in response to DNA damage (GO:0042770),-0.30390922267197684,-1.0456643636320508,0.38113207547169814,0.6690873909948407,1.0,23/49,35.65%,ACER2;MAP3K20;RAD1;E2F1;HUS1;RAD9A;RAD17;CHEK1;GADD45A;E2F7;CLOCK;RHNO1;TRIAP1;SESN2;FBXO6;CEP63;ATRIP;PRPF19;CDC5L;ABL1;CLSPN;MAD2L2;BATF
prerank,nucleotide biosynthetic process (GO:0009165),-0.3819056946655052,-1.0455946344782752,0.4148936170212766,0.6687688051759862,1.0,5/18,13.47%,ME1;PRPS2;PRPS1;PRPS1L1;RRM1
prerank,membrane lipid catabolic process (GO:0046466),-0.44236208352429707,-1.045530293988366,0.40293040293040294,0.66844303772308,1.0,8/10,36.20%,CYP1B1;SGPL1;ENPP2;NAGA;MGST2;SMPD2;FUCA1;PDXDC1
prerank,endomembrane system organization (GO:0010256),-0.23963774681835937,-1.0455038556896061,0.34591194968553457,0.6680140543017452,1.0,45/178,20.30%,SYNE1;ATP8B1;SPTBN1;SRGN;CAV2;MYOF;PI4K2A;ZW10;BCAS3;HTT;GORASP2;DYSF;FAM174B;CHMP2B;PLEKHM2;A4GALT;NUP93;USP8;ATL3;TRIP11;SPTSSB;ATL2;TRAPPC11;BAG5;SURF4;VMP1;ALS2CL;NUP155;RAB1A;DOP1B;COG3;GOLGA5;GOLGA8B;VPS11;LMAN2;WASHC5;LAPTM4B;REEP4;DNM1;TMED1;PLEKHF1;TOR1AIP2;TMED5;ATP8B2;COG2
prerank,protein polyglutamylation (GO:0018095),0.4290156028397139,1.045351915825013,0.39420935412026725,0.744372858858181,1.0,2/11,5.52%,TTLL11;TTLL9
prerank,calcium ion transmembrane transport (GO:0070588),0.2805357967531971,1.0448112321909204,0.35912698412698413,0.7448556921550975,1.0,16/86,9.83%,NALCN;SLC24A3;SLC8A1;SLC24A5;CACNA2D1;TRPM3;P2RX4;ATP2A2;TRPM1;TRPM5;TRPA1;MICU3;CACNA1G;SLC24A4;SLC24A2;PARL
prerank,cellular response to hexose stimulus (GO:0071331),-0.3556994046928422,-1.044665026188904,0.3923809523809524,0.669638639505285,1.0,4/23,3.44%,IGF1R;RACK1;UNC13B;KCNB1
prerank,determination of bilateral symmetry (GO:0009855),-0.35506418610490464,-1.0444940807494418,0.42003853564547206,0.6695302295455624,1.0,9/24,24.81%,NOTCH1;TBX1;ZIC3;ARL6;DNAH5;PKD2;ODAD2;ODAD3;MKKS
prerank,sterol metabolic process (GO:0016125),0.2972299700887479,1.0440538764393965,0.3793103448275862,0.7457716706345392,1.0,10/60,9.74%,CYP7B1;ABCA1;PRKAG2;CYP27A1;IL4;MSMO1;ABCA5;INSIG2;SCAP;CYP46A1
prerank,protein polymerization (GO:0051258),-0.29236425064976773,-1.0439949953539693,0.3830227743271222,0.6701734071536637,1.0,21/55,24.74%,COBL;RAC1;DIAPH1;TTC17;FAM107A;WASHC3;TRPV4;PREX1;ARL6;WASL;JAK2;CASQ2;WASHC5;GPX4;CHMP2A;PIN1;MSRB2;MICALL2;CORO7;AIF1;CASQ1
prerank,purine ribonucleotide metabolic process (GO:0009150),0.29377142841162374,1.043830528680899,0.35550935550935553,0.7453881088835678,1.0,7/68,7.30%,ENPP1;AMPD3;TPST1;ACSM5;BAAT;SULT6B1;ACOT11
prerank,regulation of translational initiation (GO:0006446),-0.28681815253260184,-1.0437303780782865,0.362962962962963,0.6703291761137182,1.0,33/63,33.70%,EIF4G3;EIF5B;ATF4;HSPB1;RPS6KB2;IMPACT;YTHDF2;FMR1;UHMK1;EIF5;PAIP2B;EIF1;NCK1;YTHDF1;PAIP1;EIF4G1;EIF4A2;EIF4EBP1;NCBP2;ATF3;NCK2;EIF4B;EIF4H;PAIP2;NPM1;BOLL;RPS6KB1;GLE1;YTHDF3;MIF4GD;MTIF2;CTIF;CCL5
prerank,cell projection assembly (GO:0030031),-0.3601446220089614,-1.04366813790242,0.4088291746641075,0.6699901510064225,1.0,4/22,8.93%,PARVB;RHOJ;RAC1;PDGFA
prerank,regulation of sequestering of triglyceride (GO:0010889),0.4083409722140702,1.0433321446720658,0.41309255079006774,0.7457613284613998,1.0,2/15,3.10%,PPARA;OSBPL8
prerank,L-alpha-amino acid transmembrane transport (GO:1902475),0.35620952626117824,1.0431676542770956,0.39019189765458423,0.7452323671905482,1.0,5/27,7.15%,SLC1A3;SLC6A9;SLC7A2;SLC38A1;SLC25A13
prerank,sensory perception of mechanical stimulus (GO:0050954),0.2792437330457127,1.0429071622468409,0.34591194968553457,0.7449289742184153,1.0,9/85,6.54%,ADGRV1;CEMIP;ATP6V0A4;OTOS;P2RX4;ALDH7A1;COL4A3;PCDH15;EYA1
prerank,regulation of potassium ion transmembrane transporter activity (GO:1901016),-0.353684226736942,-1.0420344223108706,0.40037950664136623,0.6734765789233924,1.0,7/26,15.37%,NEDD4L;FHL1;WWP2;ATP1B1;CASQ2;CACNA1D;CAB39
prerank,negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),-0.41245165008439266,-1.041075740624137,0.3886792452830189,0.6753046970640957,1.0,6/13,25.97%,DAB2IP;HHEX;EPN2;CADM4;PTPN1;PDCD6
prerank,sensory perception of pain (GO:0019233),0.3685254191584193,1.040884851427081,0.39601769911504425,0.7491911013256967,1.0,6/21,17.41%,P2RX4;OPRK1;TRPA1;CHRNA4;PTGES;SCN9A
prerank,regulation of telomerase activity (GO:0051972),-0.30064527185150375,-1.0407596612124566,0.3824130879345603,0.6755601451822374,1.0,24/45,37.80%,HMBOX1;KLF4;MAPK3;NEK7;HSP90AB1;PNKP;DKC1;CCT2;GREM1;HSP90AA1;ERCC4;CTNNB1;SRC;MYC;PKIB;SMG6;PIF1;WRAP53;CCT4;MAP2K7;CERS1;MAPK15;NVL;GRHL2
prerank,positive regulation of natural killer cell activation (GO:0032816),0.4074108492048853,1.040738449310753,0.40497737556561086,0.7486403168182152,1.0,3/13,8.31%,TICAM1;AXL;IL18
prerank,positive regulation of phosphoprotein phosphatase activity (GO:0032516),-0.38471151630140427,-1.0406047398305587,0.43031358885017423,0.6754411675197366,1.0,3/17,3.86%,ITGA1;HSP90AB1;CALM1
prerank,"retrograde protein transport, ER to cytosol (GO:0030970)",-0.3835766740133262,-1.0404177327571036,0.41523809523809524,0.67539408252318,1.0,7/17,19.84%,SEL1L;RHBDD1;VCP;FAF2;SEC61B;DERL2;TMEM129
prerank,neurogenesis (GO:0022008),-0.30632271253177445,-1.0404039559522849,0.3844731977818854,0.6749255130648385,1.0,7/43,7.22%,CDK6;TRAK1;ANXA1;SIX1;TGFB2;TRAK2;BTBD3
prerank,positive regulation of cellular biosynthetic process (GO:0031328),-0.2439080101615149,-1.0404024968577439,0.33811475409836067,0.6744281471745919,1.0,46/166,18.30%,THBS1;SORBS1;VIM;RPL26;SCARB1;KLF2;KLF4;EEF2;NIBAN1;RPS4X;HSP90AB1;PPARGC1A;CHP1;GIPC1;MFSD2A;PRKDC;RGCC;EDN1;NMD3;DYRK2;AKT1;INSR;DHX9;ELOVL5;RPS27L;EIF3D;LARP4B;CIRBP;UPF3A;TLR4;SOX4;FGF2;FMR1;PAOX;EGFR;ERBB2;LDB1;OPN3;STAR;BCAR3;NR1H2;HSP90AA1;PCIF1;SP1;GLI1;ZCCHC4
prerank,cellular response to nitrogen compound (GO:1901699),0.3706533074401841,1.0403557578227107,0.3986784140969163,0.748617456600425,1.0,7/20,23.90%,ROCK2;BLM;DAXX;EPG5;ATP2B4;HSF1;TIMELESS
prerank,cellular response to pH (GO:0071467),-0.3924779574616809,-1.0403024021263616,0.4141791044776119,0.6741815480216673,1.0,5/17,26.90%,CHP1;IMPACT;RAB11B;HYAL1;RAB11FIP5
prerank,glucose homeostasis (GO:0042593),-0.27553347509126713,-1.0401608000714533,0.3796477495107632,0.6740211189399283,1.0,11/83,5.37%,ADIPOR2;IGF1R;LRRC8D;FOXO1;HK1;KCNB1;BACE2;KLF7;PPARGC1A;ADIPOR1;FOXK1
prerank,negative regulation of interleukin-10 production (GO:0032693),-0.3839643237192307,-1.0399661432883083,0.41263940520446096,0.6740130794673262,1.0,13/16,47.78%,TNFRSF21;TRIB2;VSIR;JAK3;LILRB1;DLL1;TYROBP;FCGR2B;PDCD1LG2;IL23A;FOXP3;IL23R;IL12B
prerank,regulation of cytosolic calcium ion concentration (GO:0051480),0.2528918579915216,1.0399574111153012,0.36015325670498083,0.7487024066859007,1.0,29/142,15.37%,ATP1A2;LPAR1;PTGFR;SLC8A1;ADCY5;PDGFRA;PRKACA;SMAD3;CCR6;ACKR4;ACKR2;CCR10;PTGDR;NPTN;IAPP;CALCR;CCR9;ADRA1D;C3AR1;ADCY8;ADRA1B;PTGIR;DLG4;P2RY1;CXCR4;DRD2;HCRTR1;TRPC1;ADRA1A
prerank,androgen receptor signaling pathway (GO:0030521),-0.4312416017939798,-1.0397428495117913,0.4194107452339688,0.6740445322991779,1.0,5/11,9.87%,DDX5;DDX17;PLPP1;KDM3A;ARID1A
prerank,cardiac muscle cell action potential involved in contraction (GO:0086002),0.34025711192489316,1.0396232956956848,0.4069264069264069,0.7485482376128682,1.0,6/30,7.51%,GJA1;SCN3B;ANK2;CACNA2D1;GPD1L;CACNA1G
prerank,glycerophospholipid metabolic process (GO:0006650),-0.2768815844896967,-1.0395593211181384,0.3862745098039216,0.6739869632140691,1.0,27/75,32.52%,GPCPD1;DGKH;PLCB3;PIGL;PIGF;CSF1R;FAR1;PLA1A;PIGC;ENPP6;SYNJ1;PIGW;LCAT;GDE1;CPNE3;PLA2G4F;ACP6;PIP5K1A;PLA2G4B;PLEK;PLA2G7;PLCB1;PIGM;CPNE7;SERINC5;ABHD6;PLCB2
prerank,positive regulation of axon extension (GO:0045773),0.359121344885121,1.039478894481847,0.3835920177383592,0.747931247876069,1.0,2/22,1.18%,NRP1;SEMA5A
prerank,generation of neurons (GO:0048699),0.24340201237254994,1.0393701020773354,0.3481624758220503,0.7472482178338804,1.0,32/190,14.24%,AUTS2;WNT4;NRP1;SEMA3A;GPM6A;ARTN;PTPRD;SH3RF1;ASTN2;HES3;CASP3;IL1RAPL1;LHX4;SIX4;DOCK7;NRCAM;HES5;RYK;ATOH8;CDK5R1;FUT9;EML1;PLXNB2;BRSK1;LRP12;FZD10;FGFR1;YAP1;MAPT;TUBGCP2;TAFA1;WNT6
prerank,positive regulation of actin filament bundle assembly (GO:0032233),-0.2941593148433452,-1.039255395208995,0.38910505836575876,0.6742297610709223,1.0,14/51,10.46%,SORBS3;PXN;LIMCH1;ARHGEF15;FERMT2;RAC1;MYOC;TGFB3;RGCC;PPM1F;PFN1;SYNPO;S100A10;WNT11
prerank,positive regulation of heart rate (GO:0010460),0.37906008134488367,1.0389135496687727,0.417910447761194,0.7474867094499725,1.0,5/17,10.73%,SCN3B;ATP2A2;ADM;ADRA1D;ADRA1B
prerank,cellular response to lectin (GO:1990858),-0.26082218879497726,-1.0387329417039444,0.35943775100401604,0.6745451046706277,1.0,48/104,36.47%,RPS6KA5;PLCG2;IKBKB;PSMA6;KRAS;PSMB5;RELB;FCER1G;PSMC4;ICAM2;PSMC5;PSMD14;SYK;HRAS;PSMD8;PSMD11;PSMB4;PSMD12;PSMC1;TAB2;RELA;CUL1;CHUK;PSMA1;PSMB1;PSMC3;PSMA4;NRAS;PSMA2;PRKCD;TRAF6;BCL10;PSMB8;CARD11;SRC;PSMC6;PAK2;TYROBP;PSMD6;PSMA8;CREBBP;MUC1;IKBKG;PSMD2;MUC13;PSMB2;MUC6;FYN
prerank,stimulatory C-type lectin receptor signaling pathway (GO:0002223),-0.26082218879497726,-1.0387329417039444,0.35943775100401604,0.6745451046706277,1.0,48/104,36.47%,RPS6KA5;PLCG2;IKBKB;PSMA6;KRAS;PSMB5;RELB;FCER1G;PSMC4;ICAM2;PSMC5;PSMD14;SYK;HRAS;PSMD8;PSMD11;PSMB4;PSMD12;PSMC1;TAB2;RELA;CUL1;CHUK;PSMA1;PSMB1;PSMC3;PSMA4;NRAS;PSMA2;PRKCD;TRAF6;BCL10;PSMB8;CARD11;SRC;PSMC6;PAK2;TYROBP;PSMD6;PSMA8;CREBBP;MUC1;IKBKG;PSMD2;MUC13;PSMB2;MUC6;FYN
prerank,negative regulation of cell activation (GO:0050866),-0.4017208925753828,-1.038657807303046,0.4275491949910555,0.6742471371583367,1.0,4/14,12.33%,NOS3;THBD;PDGFA;APOE
prerank,thyroid hormone generation (GO:0006590),0.4593155777378734,1.0381697158933236,0.43015521064301554,0.7484172855724897,1.0,2/10,5.83%,DIO2;CPQ
prerank,C21-steroid hormone metabolic process (GO:0008207),0.36917360825359613,1.0380340173431066,0.3969631236442516,0.7477961302022593,1.0,2/20,9.74%,AKR1B1;CYP46A1
prerank,regulation of receptor signaling pathway via JAK-STAT (GO:0046425),-0.3272414520106807,-1.0380057092373127,0.4003623188405797,0.675355465363535,1.0,9/35,14.41%,CAV1;NOTCH1;NLK;CYP1B1;ADIPOR1;CRLF3;OCIAD1;HES1;JAK2
prerank,positive regulation of protein import into nucleus (GO:0042307),0.35208849621786364,1.0374938562277047,0.42316258351893093,0.7482615396590598,1.0,3/28,2.77%,PIK3R1;ZIC1;SMAD3
prerank,connective tissue development (GO:0061448),-0.317707032101214,-1.0372425751029057,0.39807692307692305,0.676717065406961,1.0,9/35,9.90%,SPTLC2;NAMPT;LRP5;CD44;PKD1;ZBTB16;PGRMC2;TRIP11;DDRGK1
prerank,regulation of coagulation (GO:0050818),-0.42853296321439804,-1.0371803668357944,0.4225092250922509,0.6763688933248965,1.0,1/11,0.34%,CAV1
prerank,phosphate ion transport (GO:0006817),0.3855896792784058,1.0368858576732227,0.40380549682875266,0.7488366828505056,1.0,3/16,7.31%,SLC17A1;SLC20A2;SLC25A10
prerank,regulation of T cell differentiation (GO:0045580),0.3329013126250734,1.036290558171453,0.39501039501039503,0.7493847983335145,1.0,7/33,15.77%,TBX21;RHOH;IL4;CAMK4;GATA3;CLPTM1;METTL3
prerank,negative regulation of phosphatase activity (GO:0010923),-0.35406660021376685,-1.0360196069635992,0.40850277264325324,0.6786724109790848,1.0,4/25,6.52%,TGFB2;FKBP1A;CHP1;SH3RF2
prerank,apoptotic mitochondrial changes (GO:0008637),-0.329956667259933,-1.036009823104325,0.4245810055865922,0.6781924008876384,1.0,13/32,21.54%,BAX;ATG3;HSPD1;BBC3;BCL2L1;BAK1;BAD;CCAR2;BIK;SFN;TIMM50;GGCT;FIS1
prerank,regulation of ATP biosynthetic process (GO:2001169),0.38690619494858186,1.035924546478925,0.3851063829787234,0.7493464181372645,1.0,3/16,5.08%,PID1;PPARA;IL4
prerank,cellular response to leucine starvation (GO:1990253),-0.4451945710833012,-1.035897678060994,0.4583333333333333,0.6779755723510698,1.0,7/10,45.47%,IMPACT;RRAGD;SESN2;SESN1;GCN1;SESN3;LARS1
prerank,positive regulation of interleukin-1 beta production (GO:0032731),-0.3006925123160393,-1.035885860644367,0.4070450097847358,0.6775167530532283,1.0,18/45,32.07%,GBP5;APP;CASP8;HSPB1;TRIM16;TLR4;AIM2;JAK2;NOD2;CASP1;LGALS9;FZD5;TMEM106A;CD36;TLR6;EGR1;TYROBP;NLRP3
prerank,RNA splicing (GO:0008380),-0.2645006055897706,-1.0357190720934089,0.39235412474849096,0.6774197168423928,1.0,27/95,19.99%,MBNL1;IVNS1ABP;PPARGC1A;PRPF8;SRSF2;PPP2R1A;SNRNP48;SRPK1;DHX15;FUS;SNRPD3;U2AF1;SFPQ;RNPS1;ZRSR2;SRSF4;MAGOH;DDX23;SF3A3;DDX39B;CCAR2;SCAF11;PPIG;SNRPG;PDCD7;LSM1;SYNCRIP
prerank,regulation of protein sumoylation (GO:0033233),-0.3834605875897096,-1.0355447913252147,0.42613636363636365,0.6773278105207381,1.0,9/17,32.73%,HDAC4;SAE1;UBA2;PARK7;CTNNB1;MUL1;CAPN3;EGR1;RASD2
prerank,extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),0.3825909693512263,1.035462201435742,0.3967280163599182,0.7495131926730352,1.0,5/20,9.76%,BCL2;IL4;CASP3;ERBB3;DCC
prerank,negative regulation of cilium assembly (GO:1902018),-0.421380717657193,-1.0353052277499497,0.44804088586030666,0.6773963924791053,1.0,3/12,12.34%,LIMK2;MAP4;CDK10
prerank,regulation of peptide hormone secretion (GO:0090276),-0.2791322781156574,-1.0352096352113598,0.3835616438356164,0.6771336050911726,1.0,8/67,6.37%,ITPR2;SLC2A1;RAP1A;DPP4;KCNB1;ITPR3;STX1A;UQCC2
prerank,transepithelial transport (GO:0070633),-0.40044866297922643,-1.0351472769215007,0.40641711229946526,0.6767915529510937,1.0,4/15,4.60%,ABCG2;CXADR;SLC12A2;SLC1A1
prerank,cellular monovalent inorganic cation homeostasis (GO:0030004),-0.3677781330087384,-1.035056222596208,0.42857142857142855,0.6764980815564103,1.0,5/20,7.63%,SLC12A2;KCNJ2;NEDD4L;ATP1A1;ATP1B1
prerank,cellular sodium ion homeostasis (GO:0006883),0.4001856536511601,1.034373951370297,0.42105263157894735,0.7512882123172849,1.0,2/15,1.17%,ATP1A2;SLC8A1
prerank,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),0.26755602569941306,1.0342609532586888,0.3856858846918489,0.750606399552849,1.0,17/100,10.91%,IGF1;PIK3R1;PTPN13;NTRK3;KIT;DCN;PDGFRA;PIP4K2A;LYN;IRS2;PDGFRB;PDGFD;ERBB3;IL18;MYDGF;PTEN;PIP4K2B
prerank,protein modification by small protein removal (GO:0070646),-0.2301962365946884,-1.0341482076193553,0.36270491803278687,0.6780814635722885,1.0,100/252,32.48%,ACTB;ESR1;IFIH1;NFKBIA;SMAD7;TRRAP;EIF3F;UBB;USP1;USP46;FOXK1;UBC;RPS27A;IL33;BRCC3;USP7;PSMA6;HCFC1;RIPK1;OTUD5;USP8;UIMC1;PSMB5;YY1;USP3;BABAM1;RHOT1;USP9X;OTUB1;COPS6;UCHL1;VCP;PSMC4;TADA2B;USP5;PSMC5;PSMD14;COPS5;USP15;PSMD8;SMAD4;PSMD11;TNFAIP3;UCHL3;PSMB4;PSMD12;PSMC1;BABAM2;WDR48;USP22;RCE1;MCRS1;SMAD2;USPL1;USP4;USP49;SNX3;USP38;KEAP1;JOSD1;PSMA1;TADA3;COPS7A;PSMB1;PSMC3;PSMA4;PSMA2;INO80D;RAD23A;COPS4;COPS7B;TRAF6;SENP5;TFPT;SMAD1;PSMB8;GPS1;RUVBL1;RAD23B;BARD1;USP14;TAF10;STAM2;JOSD2;FOXO4;STAM;POLB;USP35;PSMC6;MYC;MYSM1;FOXK2;RHOA;CDK1;PSMD6;KAT2A;NLRP3;PSMA8;USP12;TNIP2
prerank,DNA replication-independent nucleosome assembly (GO:0006336),-0.31867476869474254,-1.0335670441449512,0.4015444015444015,0.6790656761149719,1.0,18/38,34.42%,H3-3A;MIS18BP1;KNL1;CENPU;RBBP4;CENPI;CENPN;CENPA;CENPO;RUVBL1;NPM1;ASF1B;SMARCA5;OIP5;ITGB3BP;CENPX;CENPW;RBBP7
prerank,positive regulation of lipid metabolic process (GO:0045834),0.3591056086908102,1.0334660685855415,0.4129032258064516,0.7517097881046986,1.0,2/22,2.05%,ZBTB20;PPARA
prerank,sarcomere organization (GO:0045214),0.340351528683466,1.0334229408659912,0.40618101545253865,0.750863198976594,1.0,8/27,14.84%,CSRP3;FHOD3;SIX4;CSRP2;ACTN2;SYNPO2L;TNNT3;MYLK3
prerank,phosphatidylinositol metabolic process (GO:0046488),-0.2542424485553795,-1.0333545467189726,0.38461538461538464,0.6791318755758395,1.0,31/109,17.68%,PLCG2;PIP5K1B;BMX;PLCB3;PI4K2A;INPP5D;PIK3R6;CDS1;MTMR14;MTMR12;CDIPT;INPP5E;PIP4P1;PIK3C2A;PLAAT3;PITPNM2;MBOAT7;RUFY1;PITPNM3;RAB4A;FGF2;CSF1R;PIK3R3;PITPNM1;PIK3CA;MTM1;SYNJ1;PIK3R2;FIG4;PIK3C2B;PIGW
prerank,positive regulation of B cell activation (GO:0050871),-0.2959833832938702,-1.0333525418955791,0.3832684824902724,0.6786466050796909,1.0,13/50,17.77%,MEF2C;TFRC;CD38;CD81;MMP14;PPP2R3C;TIRAP;CD74;SYK;CLCF1;NOD2;XBP1;CD320
prerank,positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),0.27438386744977666,1.0329438922969758,0.3739495798319328,0.7510850768330997,1.0,6/80,3.90%,AUTS2;PIK3R1;NRP1;DOCK11;GPM6A;TENM2
prerank,spermatid development (GO:0007286),-0.3252761019536494,-1.032545483863984,0.4050880626223092,0.6801569483370324,1.0,11/32,28.45%,JAM2;CEP57;CIB1;TDRD5;RFX2;NECTIN2;IQCG;SYCP3;MKKS;CDYL;RNF8
prerank,negative regulation of double-strand break repair (GO:2000780),0.3433457658801423,1.0323037271461548,0.4073275862068966,0.7518357268911179,1.0,7/30,14.46%,SHLD2;UBQLN4;TRIP12;RADX;OTUB2;SMCHD1;RIF1
prerank,negative regulation of protein catabolic process (GO:0042177),0.3216094844694184,1.0316309802322046,0.4054621848739496,0.7526666317294395,1.0,13/40,21.66%,NELL1;TIMP3;SIRT2;TIMP4;FMN2;PRKCG;SF3B3;CYP51A1;SNRNP70;IRAK3;AZIN2;RGP1;TIMP1
prerank,transcription-coupled nucleotide-excision repair (GO:0006283),-0.27852952178977153,-1.0315667931788841,0.4024390243902439,0.6821017759160121,1.0,24/72,24.21%,UBB;UBC;RPS27A;USP7;ISY1;ERCC1;CUL4A;GTF2H3;COPS6;XAB2;HMGN1;COPS5;RBX1;XRCC1;RPA3;TCEA1;GTF2H4;POLK;ERCC4;COPS7A;RFC3;COPS4;RFC2;COPS7B
prerank,regulation of acrosome reaction (GO:0060046),-0.4408505675798249,-1.031506027191286,0.4343807763401109,0.6817564638465645,1.0,7/10,54.41%,CACNA1H;PLCB1;GLRA1;SERPINA10;FAM170B;PRSS37;PLA2G10
prerank,central nervous system development (GO:0007417),0.23345505574539802,1.0312508575492803,0.3879472693032015,0.7527223795125968,1.0,45/250,14.11%,EPHA7;ARNT2;ROBO2;ATXN1;TBX3;CHST8;CNTN4;ZIC1;AFF2;CNTNAP2;CHD7;PBX4;PRKN;GSTP1;ASIC2;LOXL3;GRIK1;ADGRA2;SCIN;NRCAM;HES5;ATN1;CDK5R1;AHI1;PTEN;ZIC4;ANKLE2;EML1;EEF1AKMT4-ECE2;RPS6KA6;PLXNB2;CTNS;EIF2B5;PHF8;COX7B;PAX8;GBA2;VCAN;NKX2-1;CNTN6;POU6F2;TUBGCP2;CXCR4;GRIN2A;AMIGO1
prerank,exit from mitosis (GO:0010458),-0.4207570761445091,-1.0302288238194108,0.4116575591985428,0.6843822972437278,1.0,7/12,36.63%,EPS8;CHMP2A;PPP2R2D;CHMP7;CHMP4B;UBE2C;SIRT7
prerank,post-translational protein modification (GO:0043687),-0.2226006802855188,-1.0300469887773194,0.37687366167023556,0.6843274189565093,1.0,101/332,25.25%,FN1;IGFBP7;GPC3;RAB11A;LMO7;SOCS2;IGFBP5;APP;RBBP5;SUMF2;KLHL5;MSLN;ADAM10;SPARCL1;IGFBP3;DCAF6;ZBTB16;RHBDD1;PTP4A2;KLHL2;FBXO17;NUCB1;PSMA6;DCUN1D1;WSB2;QSOX1;MFGE8;CUL4A;PSMB5;FBXO4;CST3;SPP1;PNPLA2;RAB8A;ASB8;COPS6;UBE2F;PSMC4;WDTC1;PSMC5;FBXL14;RAB11B;CHRDL1;PSMD14;FBXW5;FBXW10;APOE;ICMT;FSTL1;COPS5;KLHL3;FBXL7;SUMF1;FUCA2;CISH;FEM1A;RBX1;RAB1A;PSMD8;WSB1;PSMD11;CCNF;UCHL3;LGALS1;PSMB4;PSMD12;PSMC1;FBXL3;FBXL16;F5;GAN;CUL1;FBXW2;KLHL9;KLHL21;ELOB;PRSS23;CCDC22;KEAP1;KCTD7;PSMA1;COPS7A;VWA1;PSMB1;PSMC3;C3;PSMA4;FBXO40;DTL;FBXL19;PSMA2;FBXL18;COPS4;COPS7B;COP1;FBXO6;EVA1A;TULP4;KCTD6;DCUN1D3;PSMB8
prerank,innate immune response activating cell surface receptor signaling pathway (GO:0002220),-0.2586154970306688,-1.0300217220689682,0.3709677419354839,0.6838841272596513,1.0,48/105,36.47%,RPS6KA5;PLCG2;IKBKB;PSMA6;KRAS;PSMB5;RELB;FCER1G;PSMC4;ICAM2;PSMC5;PSMD14;SYK;HRAS;PSMD8;PSMD11;PSMB4;PSMD12;PSMC1;TAB2;RELA;CUL1;CHUK;PSMA1;PSMB1;PSMC3;PSMA4;NRAS;PSMA2;PRKCD;TRAF6;BCL10;PSMB8;CARD11;SRC;PSMC6;PAK2;TYROBP;PSMD6;PSMA8;CREBBP;MUC1;IKBKG;PSMD2;MUC13;PSMB2;MUC6;FYN
prerank,erythrocyte differentiation (GO:0030218),-0.30629677367755814,-1.029743747155756,0.403921568627451,0.6840542247445577,1.0,21/44,27.17%,RPS14;MFHAS1;RPS19;VEGFA;SLC25A38;TAL1;INHBA;JAK2;ATP5IF1;UFL1;JAK3;HSPA9;CDK5RAP3;UBA5;ALAS2;HCLS1;ZFPM1;DMTN;ACIN1;INHA;PTPN2
prerank,actin filament polymerization (GO:0030041),-0.32689759634657595,-1.0297302283874101,0.4166666666666667,0.6835953289453264,1.0,14/29,23.82%,COBL;RAC1;DIAPH1;TTC17;FAM107A;WASHC3;PREX1;WASL;JAK2;WASHC5;MSRB2;MICALL2;CORO7;AIF1
prerank,triglyceride homeostasis (GO:0070328),0.3519526931346993,1.0296475543438544,0.41228070175438597,0.7558369716138399,1.0,5/26,17.54%,RORA;IL18;PLA2G12B;DGAT2;MLXIPL
prerank,positive regulation of keratinocyte migration (GO:0051549),-0.44420980055946907,-1.0293909788710134,0.44760213143872113,0.6839091175856961,1.0,4/10,28.39%,MAPRE2;IQSEC1;FGF10;EPB41L4B
prerank,positive regulation of cytoskeleton organization (GO:0051495),-0.2698529128426055,-1.0292950983103415,0.3834296724470135,0.6836528803880748,1.0,23/76,24.27%,TEK;SORBS3;BAIAP2L1;PTK2B;BCAS3;WDR1;LMOD1;EDN1;NES;PFN1;SYNPO;PRKCE;HRAS;LIMK1;NCKAP1;HCK;CDC42EP3;CTTN;NCK1;HCLS1;CARMIL1;NCK2;CDC42
prerank,regulation of monocyte chemotaxis (GO:0090025),-0.35308038155949295,-1.028974820195077,0.41742286751361163,0.6839440341703864,1.0,3/24,3.59%,ANO6;CCN3;SLIT2
prerank,regulation of p38MAPK cascade (GO:1900744),-0.321040163910008,-1.028913005819894,0.4166666666666667,0.6835897948607716,1.0,17/35,30.10%,DAB2IP;MFHAS1;MINK1;VEGFA;EZR;ULK4;GADD45G;EMC10;GADD45A;LGALS9;PTPN22;TREM2;DUSP1;SPI1;RASGRP1;XDH;PJA2
prerank,regulation of mitotic cell cycle (GO:0007346),-0.24072361279175447,-1.0287480624948788,0.36472945891783565,0.6835210576574174,1.0,53/171,24.00%,AFAP1L2;TTC28;CAV2;IQGAP1;NEK7;CDKN1B;TGFB1;APP;ANAPC15;PSMA6;ANAPC11;PSMB5;TAL1;ASAH2;PIM3;RB1;PSMC4;MAEA;PSMC5;DUSP3;PSMD14;CDK10;RNF20;SDCBP;PSMD8;PSMD11;CDK13;ANAPC7;CDC27;PSMB4;PSMD12;PSMC1;FZR1;USP22;CUL1;L3MBTL1;ASNS;CDK5RAP3;TTLL12;SRA1;PIN1;RCC1;PSMA1;MKI67;ANAPC2;PSMB1;PSMC3;EIF4EBP1;PSMA4;PSMA2;BTG3;SIK1;CDKN1C
prerank,cardiolipin metabolic process (GO:0032048),0.41046390750275086,1.0286043350900886,0.4279475982532751,0.7575515237766967,1.0,2/13,2.58%,PLA2G5;PLA2G4A
prerank,regulation of B cell proliferation (GO:0030888),-0.30141705669854,-1.0285661425186456,0.4029574861367837,0.6835015206877264,1.0,8/44,10.73%,MEF2C;TFRC;CD38;CD81;TNFRSF21;RC3H1;TIRAP;CD74
prerank,negative regulation of response to endoplasmic reticulum stress (GO:1903573),-0.35713652841143956,-1.0285177998258357,0.437137330754352,0.6831311847351961,1.0,10/24,20.37%,RACK1;LPCAT3;AQP11;UBXN1;BCL2L1;OPA1;NR1H2;HSPA1A;XBP1;TMBIM6
prerank,protein localization to centrosome (GO:0071539),-0.3784070466586106,-1.0283954798964698,0.43413729128014844,0.6829329889213204,1.0,4/17,11.72%,DCTN2;CEP192;NUDCD3;PCM1
prerank,negative regulation of response to wounding (GO:1903035),-0.36696447468653853,-1.0282275141352548,0.44525547445255476,0.6828551179353581,1.0,10/19,37.68%,CD109;CRK;FGF2;RTN4RL1;RTN4R;CERS2;ALOX5;PTPRS;KLK8;INPP5F
prerank,replicative senescence (GO:0090399),0.4072956001727577,1.0281410888732017,0.4117647058823529,0.7577099244574924,1.0,4/12,17.96%,PLA2R1;SERPINE1;ATM;TP53
prerank,negative regulation of cellular protein catabolic process (GO:1903363),0.44350109455790715,1.0278831398183679,0.43013100436681223,0.7574241978450161,1.0,1/10,0.35%,NELL1
prerank,positive regulation of alpha-beta T cell differentiation (GO:0046638),-0.4041366061361161,-1.0275481569813516,0.4257602862254025,0.6839916066867894,1.0,2/13,6.72%,TGFBR2;CBFB
prerank,chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),-0.342028862183407,-1.0272088005602051,0.4307116104868914,0.6842987972992369,1.0,3/27,3.48%,CHST11;CSGALNACT1;CSPG4
prerank,dicarboxylic acid catabolic process (GO:0043649),0.4058369526916674,1.0266053365773167,0.4341801385681293,0.759674911492495,1.0,3/13,8.62%,ASPA;DDO;GLUL
prerank,steroid biosynthetic process (GO:0006694),0.299038609604378,1.0263142893218185,0.41851106639839036,0.7594417314716583,1.0,10/56,12.65%,CYP7B1;PRKAG2;HSD11B2;CYP27A1;BAAT;MSMO1;INSIG2;CYP46A1;OSBP;PRLR
prerank,positive regulation of mRNA catabolic process (GO:0061014),0.3092345111515776,1.025376311283889,0.4045643153526971,0.7608210323540142,1.0,14/44,16.37%,ROCK2;NANOS3;TNRC6A;CPEB3;POLR2G;FTO;RIDA;PNPT1;KHSRP;TNRC6B;METTL16;RBM24;METTL3;TOB1
prerank,negative regulation of fatty acid biosynthetic process (GO:0045717),-0.42373388547010876,-1.0251565810053476,0.43161634103019536,0.6888379536532219,1.0,6/12,25.17%,ERLIN2;ACADL;WDTC1;ACADVL;TRIB3;APOC1
prerank,positive regulation of cellular amide metabolic process (GO:0034250),-0.2685734594018796,-1.0246515181313727,0.4015748031496063,0.6896078393715152,1.0,25/80,18.30%,THBS1;VIM;RPL26;RACK1;EEF2;NIBAN1;RPS4X;PRKDC;ABCG1;RPS27L;EIF3D;LARP4B;CIRBP;UPF3A;SOX4;ABCA2;SPHK2;FMR1;TNFRSF1A;ERBB2;PCIF1;RELA;IFNGR1;SP1;ZCCHC4
prerank,response to glucocorticoid (GO:0051384),-0.34057275433964596,-1.0244897304550158,0.42201834862385323,0.6895035247137168,1.0,5/26,9.68%,ANXA1;SLIT2;REST;NR3C1;FAM107A
prerank,cellular component disassembly (GO:0022411),-0.29081895900454513,-1.02422922036335,0.4113345521023766,0.6896611847940602,1.0,9/53,9.23%,TLL1;BSG;CAPN2;CD44;ADAM15;ADAM10;KIF9;MMP14;FLOT1
prerank,regulation of mitochondrial translation (GO:0070129),-0.3526337748829801,-1.0234590237343941,0.4106813996316759,0.6910902574567649,1.0,6/21,16.80%,UQCC2;TSFM;COA3;TRMT10C;RPUSD4;FASTKD3
prerank,positive regulation of striated muscle cell differentiation (GO:0051155),0.3636875596058698,1.0234571736700016,0.4260089686098655,0.7646586048836457,1.0,2/23,1.40%,IGF1;NRG1
prerank,negative regulation of tumor necrosis factor production (GO:0032720),0.30981507486604787,1.0234067101745319,0.4173728813559322,0.7638366428263968,1.0,4/41,7.92%,IGF1;IL4;GSTP1;TRIM27
prerank,peptidyl-tyrosine dephosphorylation (GO:0035335),-0.32043007418464814,-1.0231961474498736,0.4158607350096712,0.6912717377269569,1.0,14/34,27.92%,PTPRB;PTPRJ;DUSP3;PTPN12;PTPN6;UBASH3B;PTPRO;PTPRQ;PTPN22;PTPN1;DUSP4;DUSP6;PTPN2;DUSP1
prerank,glycosaminoglycan biosynthetic process (GO:0006024),0.26733729138166495,1.0229026696307484,0.3969957081545064,0.7641084418703727,1.0,24/95,16.24%,CEMIP;GPC6;FMOD;UST;DCN;GPC4;GPC2;B3GNT7;PXYLP1;OMD;LUM;OGN;GPC5;DSE;CHST1;HS2ST1;HS6ST2;VCAN;CHSY3;HS3ST6;HS3ST5;HSPG2;CHSY1;ST3GAL1
prerank,positive regulation of T-helper 17 type immune response (GO:2000318),-0.4190591238295755,-1.0226967989365527,0.43133802816901406,0.6919892918551255,1.0,7/11,50.05%,NFKBIZ;IL12RB1;CARD9;IL23A;IL23R;IL12B;CLEC6A
prerank,"nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",-0.3266136869163354,-1.0222290033264245,0.416988416988417,0.6925663673799495,1.0,12/31,21.06%,CNOT7;DCPS;HBS1L;DIS3L2;EDC4;NT5C3B;EXOSC8;DCP1B;LSM2;LSM1;LSM7;LSM3
prerank,phosphatidylglycerol metabolic process (GO:0046471),0.35325330632528196,1.0221450473192106,0.423728813559322,0.7651078630407794,1.0,2/24,2.58%,PLA2G5;PLA2G4A
prerank,alanine transport (GO:0032328),-0.4472852464553534,-1.0220945803067356,0.4731182795698925,0.692412595147465,1.0,1/10,0.38%,SLC6A6
prerank,cation transmembrane transport (GO:0098655),0.312634431058405,1.0218943522650579,0.4192872117400419,0.7647484582091635,1.0,8/44,7.08%,ATP1A2;SLC6A9;SLC7A2;TRPM3;TRPM1;MFSD12;TRPM5;ASIC2
prerank,regulation of histone acetylation (GO:0035065),-0.31424999126247166,-1.0218073552906097,0.43047619047619046,0.6926557790783198,1.0,6/33,10.90%,RPS6KA5;MAPK3;PPARGC1A;CTBP1;CAMK1;TADA2B
prerank,sodium ion export across plasma membrane (GO:0036376),0.41529779623012997,1.021776746021037,0.44243792325056436,0.7640867180945086,1.0,3/13,14.06%,ATP1A2;ATP1A3;ATP1B3
prerank,regulation of dendrite extension (GO:1903859),-0.37056338038633807,-1.021752575535305,0.46254681647940077,0.6923006960439104,1.0,5/18,13.59%,NEDD4L;ITSN2;PLAA;SYT2;SMURF1
prerank,regulation of tau-protein kinase activity (GO:1902947),-0.4313065111750127,-1.021695155687585,0.4268292682926829,0.6919436896739054,1.0,3/10,16.67%,HSP90AB1;RB1;HSP90AA1
prerank,cardiac muscle cell contraction (GO:0086003),-0.36864063247509093,-1.0210768187750758,0.44045368620037806,0.6929413179699934,1.0,8/19,19.15%,KCNJ2;ATP1A1;CAMK2D;SCN1A;CACNA1D;PIK3CA;SCN2B;CACNA1C
prerank,positive regulation of phosphate metabolic process (GO:0045937),0.3422392608825755,1.0210561806064322,0.4582441113490364,0.7649677331632986,1.0,3/25,5.41%,NRP1;AR;GLMN
prerank,regulation of cation channel activity (GO:2001257),0.2715106088240644,1.021019022602631,0.39068825910931176,0.7641174037718295,1.0,23/89,15.10%,FGF14;GRIA4;ANK2;PRKACA;DLG2;SHISA9;DAPK1;NLGN2;CACNG4;CAMK2B;CACNB4;CACNB2;NLGN1;MAPK8IP2;CACNB1;LRRC7;GRIA3;ACTN2;DLG4;GRIN2A;GRIA1;JPH1;KCNS1
prerank,secretion (GO:0046903),0.4028284097003907,1.0207310361496578,0.4314159292035398,0.7639290535972018,1.0,6/14,18.69%,SLC22A4;RIMS1;PRKCI;FBLN5;GUCA1B;SLC22A2
prerank,negative regulation of chemokine production (GO:0032682),-0.39356176973109613,-1.020510523631724,0.44216417910447764,0.6937865565824252,1.0,2/14,2.59%,MAP2K5;KLF4
prerank,negative regulation of microtubule polymerization or depolymerization (GO:0031111),-0.3230008974060789,-1.0202260744377942,0.4424131627056673,0.6940093560900639,1.0,11/32,25.21%,STMN2;SPEF1;CIB1;KATNB1;ARHGEF2;TPX2;FKBP4;CDH5;APC2;CAMSAP3;STMN1
prerank,toll-like receptor 9 signaling pathway (GO:0034162),-0.40121262230867294,-1.020117494589687,0.4332129963898917,0.6938053381992548,1.0,6/13,32.48%,IRAK2;PIK3AP1;IRAK4;TRAF6;PIK3R4;TNIP2
prerank,cellular response to peptide (GO:1901653),0.2974921112633414,1.0198973678105796,0.4125,0.7650768196850818,1.0,5/56,3.85%,IGF1;LRP1;GJA1;CACNA2D1;MDM2
prerank,mitotic intra-S DNA damage checkpoint signaling (GO:0031573),-0.3940118614946094,-1.0198504695014863,0.44014732965009207,0.6939520769067068,1.0,7/15,28.92%,RAD9B;HUS1;EME2;RAD9A;RAD17;FANCD2;MRE11
prerank,protein localization to Golgi apparatus (GO:0034067),-0.3367187235480399,-1.0197061457811472,0.4430379746835443,0.6937701246344712,1.0,4/27,3.87%,VPS13D;VPS13A;GBP5;IFT20
prerank,extracellular matrix disassembly (GO:0022617),-0.29098565599428533,-1.01907118595594,0.42452830188679247,0.6947823687998564,1.0,9/53,9.23%,TLL1;BSG;CAPN2;CD44;ADAM15;ADAM10;KIF9;MMP14;FLOT1
prerank,negative regulation of autophagosome assembly (GO:1902902),0.4037497342036651,1.0187973003532422,0.4048140043763676,0.7668553442995811,1.0,2/13,4.38%,PHF23;SCFD1
prerank,regulation of anoikis (GO:2000209),-0.36683384910391437,-1.018690059466088,0.42857142857142855,0.695214326388181,1.0,3/19,2.88%,CAV1;NOTCH1;PTK2
prerank,cellular response to glucocorticoid stimulus (GO:0071385),-0.3709493710316496,-1.0181995506951966,0.4385026737967914,0.6959429390284744,1.0,4/18,9.68%,ANXA1;REST;NR3C1;FAM107A
prerank,negative regulation of platelet activation (GO:0010544),-0.38141757817349786,-1.0180746834490986,0.43884892086330934,0.6957962278980806,1.0,7/16,16.44%,NOS3;PRKG1;THBD;CD9;PDGFA;APOE;ADAMTS18
prerank,SNARE complex assembly (GO:0035493),-0.4353448968394954,-1.0179825075271545,0.44423791821561337,0.6955245664287442,1.0,1/10,1.02%,STXBP6
prerank,positive regulation of mitochondrial translation (GO:0070131),-0.39458524982688875,-1.0179542705538802,0.43413729128014844,0.695115389952731,1.0,5/14,16.80%,UQCC2;COA3;TRMT10C;RPUSD4;FASTKD3
prerank,Rho protein signal transduction (GO:0007266),-0.29106184578522926,-1.0177138449808443,0.4272030651340996,0.6952547798579296,1.0,16/53,15.29%,ARHGEF3;RHOJ;EPS8;EPS8L2;ARHGAP1;ARHGDIA;SHTN1;ARHGDIB;ADGRG1;PHACTR4;RHOB;CFL1;RTKN;NTN1;CELSR1;LIMK1
prerank,exonucleolytic catabolism of deadenylated mRNA (GO:0043928),-0.3301977152404878,-1.017615187570025,0.4226415094339623,0.6950144910020817,1.0,11/29,21.06%,CNOT7;DCPS;HBS1L;EDC4;NT5C3B;EXOSC8;DCP1B;LSM2;LSM1;LSM7;LSM3
prerank,regulation of mRNA metabolic process (GO:1903311),-0.4285683459960228,-1.0173247881351843,0.4532627865961199,0.6952481609036283,1.0,3/11,8.77%,SAFB;SRPK1;DHX9
prerank,histone H3-K4 methylation (GO:0051568),0.3413464022933669,1.0171349578483435,0.43722943722943725,0.7700019433890118,1.0,9/26,15.53%,WDR5B;PRDM9;SETMAR;MEN1;KMT2A;CXXC1;PAXIP1;DYDC2;WDR82
prerank,positive regulation of reproductive process (GO:2000243),0.33171463690655933,1.0167972939927286,0.42342342342342343,0.7699735196054486,1.0,5/31,7.11%,HYAL3;PRDM9;CFAP69;SMURF2;SIRT2
prerank,positive regulation of dendrite extension (GO:1903861),-0.3772227524538774,-1.01670203481885,0.4373831775700935,0.6962266179205037,1.0,5/17,13.59%,NEDD4L;ITSN2;PLAA;SYT2;SMURF1
prerank,RNA transport (GO:0050658),-0.27201447538516443,-1.0166985355917468,0.41762452107279696,0.6957528691079845,1.0,22/71,22.45%,TGFBR2;HNRNPA2B1;SRSF2;SRSF5;SRSF6;FLOT1;U2AF1;ZC3H11A;RNPS1;NUP188;FMR1;SRSF4;MAGOH;NUP155;CHTOP;ALYREF;DDX39B;HNRNPA1;CASC3;THOC6;DDX39A;NCBP2
prerank,protein insertion into mitochondrial inner membrane (GO:0045039),-0.4163951928317263,-1.016520207395268,0.43838028169014087,0.6956965268528718,1.0,7/11,30.55%,NDUFA13;TIMM29;TIMM13;TIMM10;TIMM8B;TIMM10B;ROMO1
prerank,regulation of neutrophil chemotaxis (GO:0090022),-0.3474678470466398,-1.0164905222685254,0.44029850746268656,0.6953003984115502,1.0,7/23,10.73%,DPP4;SLIT2;JAM3;RAC1;TIRAP;MOSPD2;CD74
prerank,DNA damage checkpoint signaling (GO:0000077),-0.3331903178089718,-1.0163737741652008,0.42314990512333966,0.6950985538109308,1.0,14/28,31.04%,MAP3K20;RAD1;E2F1;HUS1;RAD9A;RAD17;CHEK1;CLOCK;RHNO1;FBXO6;CEP63;ATRIP;PRPF19;CDC5L
prerank,positive regulation of vasoconstriction (GO:0045907),-0.39573163090063,-1.0163185984213232,0.4148148148148148,0.6947408387336095,1.0,1/13,0.34%,CAV1
prerank,regulation of potassium ion transport (GO:0043266),0.32348645822077077,1.0162720653838961,0.41870824053452116,0.7703622426888855,1.0,7/31,14.15%,KCNIP4;DPP10;ANK2;KCNIP3;ACTN2;DPP6;DRD2
prerank,nucleobase-containing compound biosynthetic process (GO:0034654),0.37103003901541004,1.0158968995054203,0.407158836689038,0.770390764338061,1.0,8/19,23.43%,AMPD3;GMPR;APRT;POLD1;POLD3;POLD2;AMPD2;DGUOK
prerank,"regulation of mRNA splicing, via spliceosome (GO:0048024)",-0.26288983373180697,-1.015877627848614,0.4319852941176471,0.6954082515016932,1.0,20/84,14.96%,DDX5;NOVA2;MBNL1;ZBTB7A;DDX17;REST;QKI;RBFOX2;SRPK1;SRSF6;NCL;PCBP4;JMJD6;CIRBP;RNPS1;FMR1;SRSF4;SFSWAP;MAGOH;HNRNPK
prerank,regulation of postsynapse organization (GO:0099175),-0.34266919845298316,-1.0157890361950352,0.45036764705882354,0.6951343550906909,1.0,6/28,12.62%,SHANK3;SIPA1L1;ABI3;CFL1;SRCIN1;HOMER1
prerank,Notch signaling pathway (GO:0007219),-0.28131829547635595,-1.0157853281196036,0.4549019607843137,0.6946596968438989,1.0,17/59,16.32%,SORBS2;NOTCH3;NOTCH1;ADAM10;HEYL;JAG2;NOTCH4;DTX3;PSENEN;PLXND1;ZNF423;ITCH;HES1;APH1A;HEY1;DTX2;STAT1
prerank,regulation of non-canonical Wnt signaling pathway (GO:2000050),0.39424015469034035,1.015780546260602,0.4343220338983051,0.7697424819050201,1.0,4/15,8.90%,DAAM2;ZNRF3;SFRP1;NPHP3
prerank,regulation of fibroblast proliferation (GO:0048145),-0.29803884121637236,-1.0155371607587607,0.42,0.6947942686415541,1.0,13/45,12.22%,FN1;CDK6;DAB2IP;NDUFS4;DHX9;PDGFC;PDGFA;S100A6;CD74;CDK4;NF1;FTH1;E2F1
prerank,negative regulation of myoblast differentiation (GO:0045662),0.40455444173802235,1.015175981617145,0.44835164835164837,0.7702842372141949,1.0,2/13,1.64%,TBX3;PRICKLE1
prerank,phospholipid homeostasis (GO:0055091),0.4145115636449428,1.0148627515471718,0.4407894736842105,0.7701118555219324,1.0,2/11,11.06%,ABCA1;TLCD2
prerank,regulation of T-helper 17 cell differentiation (GO:2000319),-0.4278456790708598,-1.0148166255617235,0.4492753623188406,0.6960552352771932,1.0,3/10,7.75%,SMAD7;NFKBIZ;RC3H1
prerank,protein depolymerization (GO:0051261),0.344446127993603,1.0147342499865084,0.4331065759637188,0.7694785007073093,1.0,2/27,3.06%,MICAL3;NCKAP5
prerank,monocyte differentiation (GO:0030224),0.42694891178528527,1.01458099036146,0.44731182795698926,0.7689575695312033,1.0,1/10,0.34%,IL31RA
prerank,lung development (GO:0030324),0.32108468570236853,1.0145130176512696,0.4036885245901639,0.768169664381091,1.0,5/33,8.90%,ERRFI1;FGFR2;GLI2;LOXL3;NPHP3
prerank,positive regulation of intracellular transport (GO:0032388),-0.31356916957083725,-1.0143169389150462,0.4269230769230769,0.6967686093915901,1.0,12/38,22.40%,BCAS3;PRR5L;EHD2;CEP290;PCM1;OAZ2;CAPN10;MLC1;EHD1;RIPOR1;PDCD10;PLK3
prerank,"negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",-0.40228732985975724,-1.014309107105249,0.45714285714285713,0.6963060268671916,1.0,5/13,17.32%,CD44;TWIST1;PTTG1IP;CD74;KDM1A
prerank,regulation of DNA binding (GO:0051101),-0.3003635379840739,-1.0143061717219735,0.4068441064638783,0.6958322013435163,1.0,15/44,19.98%,LEF1;NFKBIA;ZBTB7A;NGF;TGFB1;SMO;CSNK2B;E2F1;HES1;SUMO3;JAK2;KDM1A;MDFI;SKI;EDF1
prerank,"mRNA splicing, via spliceosome (GO:0000398)",-0.22371578771627176,-1.0142823188056749,0.423728813559322,0.6954009936340142,1.0,108/264,34.99%,DDX5;NOVA2;HNRNPA2B1;DDX17;CTNNBL1;HSPA8;PRPF8;SRSF2;MTREX;DNAJC8;SRSF5;SNRNP48;SNRPA;SNRPC;DCPS;SRPK1;ISY1;DDX41;SRSF6;DHX15;FUS;RBM22;DHX9;SNRPD3;U2AF1;XAB2;SFPQ;RNPS1;RBM6;ZRSR2;SRSF4;MAGOH;RBM4B;DDX23;HNRNPK;ALYREF;SMN1;CDK13;EFTUD2;SF3A3;DDX20;DDX39B;PCBP1;GTF2F1;HNRNPA1;SCAF11;PHF5A;SNRPG;PNN;PDCD7;UBL5;LSM2;CASC3;TGS1;USP49;CHERP;PRPF40A;SYNCRIP;LSM7;CD2BP2;RBM19;CPSF4;LSM3;SRRM2;DDX39A;NCBP2;RBM17;RBM14;CSTF2T;SNRPB;SF3A1;PABPC1;SF3A2;CLNS1A;GTF2F2;SNRPB2;HNRNPR;WBP11;POLR2F;AQR;SRSF9;LSM6;PRPF19;HNRNPA3;CDC5L;HNRNPH3;PQBP1;POLR2L;ESS2;ZCCHC8;U2AF1L4;POLR2I;SNRNP25;POLR2C;HNRNPC;SF3B5;SRSF1;PCF11;UPF3B;WBP4;RBM15B;TRA2B;RSRC1;SNUPN;HNRNPM;HNRNPH1;SMNDC1;PUF60
prerank,defense response to fungus (GO:0050832),-0.37781559723920366,-1.0140424695116674,0.453382084095064,0.6954577492482715,1.0,5/17,24.55%,PLCG2;GAPDH;CX3CR1;FAM3A;BCL10
prerank,dopamine metabolic process (GO:0042417),-0.37180325725287844,-1.0138530750820562,0.4277456647398844,0.695418759862895,1.0,3/18,4.12%,MAOA;GCH1;TGFB2
prerank,positive regulation of leukocyte chemotaxis (GO:0002690),-0.2899139212170938,-1.0135688224286514,0.43190661478599224,0.695589987199055,1.0,7/51,5.68%,ANO6;THBS1;MAPK3;PTK2;VEGFC;CMKLR1;VEGFA
prerank,cellular response to organic substance (GO:0071310),0.25636517575377643,1.013144122253546,0.4437869822485207,0.7706980807352165,1.0,19/116,9.35%,ROBO2;PID1;PTPN13;CLEC3B;NCOA2;NFAT5;SMAD3;STAT5B;SFRP1;GHR;NLRP12;IL1RAPL1;DPYSL3;TGFBR1;IL18;IL1RL2;NCOA1;PTPN4;BMPR1A
prerank,cholesterol biosynthetic process (GO:0006695),-0.3171213234497093,-1.0130765037292266,0.4499054820415879,0.6962560197347625,1.0,14/31,31.77%,LBR;ACAA2;ACLY;DHCR24;TM7SF2;SC5D;FDPS;LSS;PLPP6;IDI1;ACAT2;INSIG1;EBP;HMGCR
prerank,negative regulation of gene expression (GO:0010629),-0.2216468264434061,-1.0125785723390097,0.416015625,0.6969700506799595,1.0,73/302,20.37%,FOXP1;MEF2C;OCLN;CLDN5;RPS6KA5;CD34;TNRC6C;ESR1;NOTCH1;SRGN;SLC7A5;RACK1;KDR;NCOR1;KLF4;RPS3;IGFBP5;TGFB1;REST;APP;TGFB2;SMO;REL;HDAC9;WWP2;ADAM10;RPS13;VEGFA;CNOT7;MPHOSPH8;AEBP2;PTBP3;N4BP1;GATA2;RGCC;GAPDH;YY1;NCL;RB1;DDRGK1;H3-3A;RPL13A;CAPRIN1;DIS3L2;YTHDF2;APOE;FGF2;FMR1;ENG;HRAS;EPC1;FLOT2;BMI1;TASOR;ATP2B1;RBBP4;RNH1;HSPA1A;PCIF1;LSM14A;GIGYF2;CNPY2;DLL4;RPS26;PTGER4;MSR1;LSM2;TYMS;PAIP2B;PTRH2;SYNCRIP;LGALS9;TMBIM6
prerank,cellular response to gamma radiation (GO:0071480),-0.3721534004836461,-1.012149379023486,0.42857142857142855,0.6975190989109755,1.0,6/17,18.35%,RPL26;MAP3K20;HRAS;TMEM109;KDM1A;CRYAB
prerank,positive regulation of myeloid leukocyte differentiation (GO:0002763),0.32596093940298543,1.0118184496931406,0.42516268980477223,0.7731565185779793,1.0,3/33,2.64%,IL34;OCSTAMP;PRKCA
prerank,cilium organization (GO:0044782),-0.22984419284021496,-1.0115486910552385,0.39344262295081966,0.6984771024057532,1.0,49/209,19.78%,ABLIM1;ABCC4;EXOC4;NOTCH1;EXOC6;FNBP1L;RAB11A;CDC14A;EHD4;RAB8B;IFT20;CEP164;ABLIM3;PKD1;TTC17;EHD2;CEP162;BBIP1;INPP5E;NUDCD3;DISC1;TMEM237;CPLANE2;IFT46;RAB8A;CEP290;EXOC1;FHDC1;STK36;PCM1;CC2D2A;ACTR3;POC1B;CDC14B;ARL6;RFX2;RAB11FIP3;RAB1A;CCDC28B;KIF24;DNAH5;CEP41;TMEM67;EHD1;SPAG16;TMEM231;EHD3;DYNLL2;IQCG
prerank,epithelial cell-cell adhesion (GO:0090136),-0.4264980568148834,-1.011342357453799,0.46296296296296297,0.6985133564740881,1.0,6/11,22.33%,CCN3;JUP;VCL;DSP;THBS4;CAMSAP3
prerank,antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),-0.33975755454736956,-1.0109167793993505,0.4519056261343013,0.6990680771700154,1.0,9/24,20.01%,B2M;TAPBP;ERAP1;IDE;FCER1G;ACE;BCAP31;TAP2;SEC24B
prerank,carbohydrate biosynthetic process (GO:0016051),0.36172135458500587,1.0104814025194166,0.45161290322580644,0.7755654791337743,1.0,7/21,12.73%,B3GALT1;ST6GALNAC5;FUT4;ST6GALNAC6;FUT9;B3GALT2;B3GALT5
prerank,regulation of proteasomal protein catabolic process (GO:0061136),-0.2885108602755979,-1.0104660635632392,0.4365904365904366,0.6996975179222299,1.0,24/53,30.21%,OPHN1;DAB2IP;HSP90AB1;UBB;PKD1;GPX1;FOXF2;DDRGK1;PSMC5;PSMD14;APOE;FMR1;UFL1;OSBPL7;PSMC3;RAD23A;ALAD;TREM2;F8A1;RAD23B;USP14;XPO1;PSMC6;ECSCR
prerank,negative regulation of cation channel activity (GO:2001258),-0.3364587644385758,-1.0101975126380582,0.444636678200692,0.6998892210683294,1.0,7/26,14.62%,CALM1;FKBP1A;GSTM2;CALM3;FMR1;CASQ2;SRI
prerank,regulation of leukocyte cell-cell adhesion (GO:1903037),0.4111599130395508,1.0099053910599682,0.45368171021377673,0.7761273241573965,1.0,5/12,17.90%,PPARA;FUT4;FUT9;ASS1;MIA3
prerank,regulation of epidermal growth factor receptor signaling pathway (GO:0042058),-0.2785943482772255,-1.0097319819277721,0.4518664047151277,0.7005525673243989,1.0,27/65,30.03%,ITGA1;AFAP1L2;PTPRJ;DAB2IP;EPN1;MVB12B;HIP1R;AKT1;HIP1;DUSP3;SHKBP1;PTPN12;TSG101;EGFR;BCAR3;NEU3;SPRY1;RHBDF2;CDC42;CCDC88A;PLAUR;EPS15;PTPN2;STAM2;STAM;MVP;ARAP1
prerank,DNA strand elongation (GO:0022616),0.3645552572008835,1.009513517432636,0.4240506329113924,0.7761949696999174,1.0,8/18,23.13%,MCM3;GINS2;NBN;POLD3;MCMDC2;POLD2;DCLRE1B;MCM7
prerank,positive regulation of phagocytosis (GO:0050766),0.29879206712105216,1.0082621781738468,0.43333333333333335,0.7784917001483159,1.0,5/47,4.01%,CAMK1D;PLA2G5;AHSG;C4B;STAP1
prerank,regulation of neuron apoptotic process (GO:0043523),-0.25816586822935234,-1.0081737083646358,0.4170124481327801,0.7038083147058181,1.0,16/96,8.37%,MEF2C;PTK2B;EGLN3;FOXO3;KCNB1;NGF;SIX1;TGFB2;PPARGC1A;BACE1;ATF4;TGFB3;TOX3;EGLN2;FOXQ1;BAX
prerank,chromosome condensation (GO:0030261),-0.3044009303165302,-1.0079946012184144,0.450281425891182,0.7037356903108081,1.0,19/36,31.91%,SMC4;CSNK2B;RB1;TOP2A;CSNK2A1;CSNK2A2;SMC2;NCAPH;NCAPG;DFFB;ACIN1;KMT5A;BANF2;NCAPH2;TTN;PLK1;CDK1;BANF1;NCAPD2
prerank,second-messenger-mediated signaling (GO:0019932),0.2696211938867647,1.0077489537995714,0.43121149897330596,0.7788807512543439,1.0,12/82,8.81%,RCAN2;PDPK1;DGKD;P2RX4;CCR6;ACKR4;ACKR2;CCR10;CHRM3;HRH1;PPP1R9A;CCR9
prerank,ubiquinone biosynthetic process (GO:0006744),-0.3742877852772425,-1.0077443074893273,0.44320297951582865,0.7038614131135212,1.0,6/15,22.20%,PDSS2;COQ6;NDUFA9;COQ8A;COQ7;UBIAD1
prerank,G2/M transition of mitotic cell cycle (GO:0000086),-0.24734201340672285,-1.0073886797192906,0.4260355029585799,0.7042265772447964,1.0,43/128,25.79%,CCNY;DCTN2;TPD52L1;TUBA1A;CEP164;PPP2R1A;PRKAR2B;CEP192;CEP57;NES;CEP70;DCTN3;PPP1CB;CEP290;CNTRL;DCTN1;PPP1R12B;PCM1;TUBB4B;PPP2R2A;FBXL7;HAUS1;NDE1;CETN2;CEP72;YWHAG;CDKN1A;HSP90AA1;CEP41;FBXL3;CUL1;LCMT1;DNM2;TUBA4A;PLK3;ARPP19;PPP1R12A;BRSK2;CDKN2B;HAUS4;YWHAE;CEP63;NEDD1
prerank,regulation of cation transmembrane transport (GO:1904062),0.3217218932630655,1.00729279609996,0.44567627494456763,0.7790947798920892,1.0,12/29,23.04%,KCNIP4;DPP10;KCNIP3;DPP6;WNK3;FGF12;ATP2B4;DLG1;PDZK1;KCNAB2;SCN5A;RANGRF
prerank,ether lipid biosynthetic process (GO:0008611),0.43838008522593785,1.007055642618546,0.46578366445916114,0.7787615329562759,1.0,2/10,2.58%,CHPT1;PLA2G4A
prerank,regulation of phospholipase C activity (GO:1900274),0.39030831024954604,1.0069463690533915,0.46325167037861914,0.7781118617718218,1.0,6/15,12.51%,NTRK3;KIT;PDGFRA;PDGFRB;BICD1;FGFR1
prerank,positive regulation of lipid catabolic process (GO:0050996),0.36930627377881814,1.006864065360078,0.4337606837606838,0.7773684931040468,1.0,3/19,6.04%,PPARA;IRS2;ABCD2
prerank,catecholamine biosynthetic process (GO:0042423),-0.42806064662463483,-1.0068514735370597,0.46223021582733814,0.7050294498113433,1.0,3/11,12.38%,GCH1;TGFB2;DDC
prerank,acetyl-CoA metabolic process (GO:0006084),-0.3772985227270722,-1.0062381486328529,0.4519056261343013,0.7060142072874305,1.0,2/15,6.27%,HMGCS2;ACLY
prerank,positive regulation of dendrite development (GO:1900006),0.43986545691459816,1.0061329501865877,0.4444444444444444,0.7783013605342528,1.0,2/10,1.32%,PTN;BMP5
prerank,protein dephosphorylation (GO:0006470),-0.24372075535848328,-1.0060806759144572,0.4271047227926078,0.7059114098397757,1.0,46/135,27.17%,PTPRB;PTPRG;PTPN14;CTTNBP2NL;PTPRJ;RPRD1B;CTDSP1;PTPRM;SSH2;PPP3CC;PPP2R1A;PPP2R5A;PPM1F;PPP1CB;PPP2R1B;DUSP3;PPP5C;PPP3CB;PPP2R2A;CDC14B;PTPN12;MTM1;PTPN6;PPP2R5E;UBASH3B;UBLCP1;DUSP11;PTPRK;NCK1;PPP2R2D;TIMM50;PPP1CA;PTPRO;PTPRU;PTPN22;PPP1R12A;PPM1M;PTPN1;DUSP4;PPEF2;MTMR2;PPP2R5B;PDP1;RPRD1A;DUSP6;PTPN2
prerank,regulation of synaptic vesicle exocytosis (GO:2000300),-0.3699429297806798,-1.0058273488269684,0.4573502722323049,0.7060781672377597,1.0,6/18,19.51%,RAP1A;RAP1B;SLC4A8;FMR1;RIMS4;DTNBP1
prerank,cellular response to arsenic-containing substance (GO:0071243),-0.38281602302979545,-1.0056740492863292,0.46511627906976744,0.7059567373901983,1.0,6/15,27.77%,VCP;GSTO2;HNRNPA1;ATF3;MKNK2;GSTO1
prerank,nucleoside phosphate catabolic process (GO:1901292),0.397303281484062,1.005491492437791,0.46017699115044247,0.7789829308091264,1.0,1/13,0.21%,ENPP1
prerank,regulation of macrophage differentiation (GO:0045649),0.3969579387053459,1.0053559467368958,0.42283298097251587,0.7784350053803225,1.0,2/15,2.64%,IL34;PRKCA
prerank,regulation of toll-like receptor 2 signaling pathway (GO:0034135),-0.4176592004253877,-1.0053445307465014,0.4528985507246377,0.7063197575549907,1.0,7/11,30.82%,MFHAS1;TIRAP;TNFAIP3;TREM2;TLR6;PJA2;TLR1
prerank,purine nucleoside monophosphate biosynthetic process (GO:0009127),-0.4158269907627605,-1.0051726466233826,0.4716636197440585,0.7062201493754507,1.0,3/12,8.25%,PAICS;ADSS2;IMPDH1
prerank,negative regulation of axonogenesis (GO:0050771),0.34227132236234636,1.004648907839371,0.46593406593406594,0.7793083821056084,1.0,9/27,15.70%,LRP4;MCF2;RTN4;CDKL3;DCC;PTEN;NGFR;ULK2;TRIM46
prerank,negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),-0.4266647996649948,-1.0044763156553609,0.4810126582278481,0.7074111211866015,1.0,3/10,10.60%,SEC14L1;RNF125;DHX58
prerank,cellular response to radiation (GO:0071478),-0.3002362023299231,-1.004318734772754,0.4490566037735849,0.7072945623702476,1.0,21/40,32.43%,NET1;EEF1D;RAD1;RHOB;RAD9B;OPN3;HUS1;RAD9A;CDKN1A;ECT2;GADD45A;CLOCK;RHNO1;RAD51AP1;LIG4;TNKS1BP1;SWI5;RRH;OPN1MW3;OPN1MW;FIGNL1
prerank,import into nucleus (GO:0051170),-0.265900847271193,-1.0039195459838846,0.4584139264990329,0.7077598996487863,1.0,24/73,26.54%,NUP93;AKT1;SNRPD3;PTTG1IP;E2F3;HTATIP2;SYK;NUP188;PHB2;NUP155;TNPO3;SMN1;RPAIN;DDX20;HNRNPA1;TSC2;SNRPG;NXT2;TNPO2;SNRPB;FAM53A;SEC13;NUP107;IPO13
prerank,regulation of transport (GO:0051049),0.31694048147576914,1.0036894602586535,0.44,0.7807198913122564,1.0,5/36,5.39%,NRP1;LEPR;WWC1;SCFD1;PRKN
prerank,positive regulation of protein import (GO:1904591),0.3363538071406268,1.0031437830110477,0.4645308924485126,0.7811275503230743,1.0,3/30,2.77%,PIK3R1;ZIC1;SMAD3
prerank,regulation of MAP kinase activity (GO:0043405),-0.2573553944664917,-1.0030599931794895,0.4387755102040816,0.709310345998248,1.0,40/92,28.62%,FLT1;PTPRJ;FGF1;TPD52L1;DAB2IP;TGFB1;PIK3R6;VEGFA;EDN1;TRIB2;PDGFC;PDGFA;TRIB1;UCHL1;NF1;STK38;APOE;FGF2;HRAS;TSG101;EGFR;ERBB2;SNF8;NOD2;SPRY1;CDK5RAP3;TRIB3;PDCD10;PTPN1;PIK3CG;PRKCD;PIK3R5;PPEF2;FGF18;NEK10;SMPD1;SPRY4;DUSP1;RASGRP1;CD24
prerank,N-glycan processing (GO:0006491),-0.37009832213793004,-1.0030182443255027,0.46408839779005523,0.7089263376308876,1.0,5/18,9.28%,ST8SIA4;GANC;ST8SIA6;MAN1B1;FUT8
prerank,regulation of receptor internalization (GO:0002090),-0.3129088942253071,-1.0030175296874764,0.43875685557586835,0.7084458331614847,1.0,8/35,16.40%,RIN3;VEGFA;ANKRD13A;INSR;FLOT1;FMR1;SDCBP;GREM1
prerank,regulation of SMAD protein signal transduction (GO:0060390),0.3625774394912525,1.002849776324865,0.4365256124721604,0.7809853689011887,1.0,3/21,9.35%,BMP6;TGFBR1;BMPR1A
prerank,regulation of protein localization to centrosome (GO:1904779),0.43359946766163876,1.0028168103510462,0.43953488372093025,0.7801224949719219,1.0,4/10,20.12%,UBXN2B;BICD1;NUP62;APC
prerank,rRNA 3'-end processing (GO:0031125),-0.4332882264173854,-1.002532738938862,0.46545454545454545,0.7091061324121962,1.0,3/10,17.09%,RPS21;ERI1;EXOSC8
prerank,lipoprotein catabolic process (GO:0042159),0.42086448248046426,1.002469140175702,0.4469026548672566,0.7800790550733692,1.0,1/11,0.50%,NOTUM
prerank,mammary gland epithelium development (GO:0061180),0.4005214861726874,1.002394008225147,0.4490238611713666,0.7793431464318996,1.0,1/14,0.32%,WNT4
prerank,establishment of epithelial cell apical/basal polarity (GO:0045198),-0.42790921297054296,-1.0023099206991124,0.46368715083798884,0.7091384904787844,1.0,3/10,6.47%,OPHN1;MSN;EZR
prerank,"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",-0.2638357852316936,-1.0015690081017712,0.47058823529411764,0.7104403125821174,1.0,31/80,27.62%,KLC1;ZW10;KDELR1;HTT;NAPA;TAPBP;ARF5;RAB6B;ATP9B;ERGIC1;KIF23;COPG1;SURF4;KIF26A;TMEM115;COPB2;RAB1A;COG3;LMAN2;NSF;KIF18A;KIF1C;USE1;KIF22;COPZ2;GOLPH3;GOLPH3L;TMED3;ARF3;RACGAP1;DNAJC28
prerank,negative regulation of T cell differentiation (GO:0045581),0.4218025558180645,1.0014109911134574,0.4574712643678161,0.7809237272728847,1.0,2/10,11.80%,GLI3;LAG3
prerank,nuclear transport (GO:0051169),-0.37520166345527023,-1.0011572668939908,0.46382189239332094,0.7109175694456565,1.0,11/16,39.92%,ANP32A;NXT2;PSIP1;NPM1;NUP98;XPO1;BANF1;RBM15B;RSRC1;HMGA1;NXT1
prerank,positive regulation of lipid localization (GO:1905954),0.42433619968674596,1.0011156502301122,0.4463157894736842,0.7807430872631347,1.0,1/11,1.51%,LRP1
prerank,regulation of endocytic recycling (GO:2001135),-0.41733314474915917,-1.0007938810279362,0.4646271510516252,0.7113500901771613,1.0,4/11,18.42%,ARHGAP1;EHD2;RAB11B;EHD1
prerank,regulation of neurotransmitter secretion (GO:0046928),0.32175653927150993,1.0007016868918515,0.4270833333333333,0.780830431096447,1.0,9/32,16.20%,RIMS1;CHRNB4;CPLX2;STX1B;MCTP2;BAIAP3;SNAPIN;SYT11;HCRT
prerank,T cell receptor signaling pathway (GO:0050852),-0.24114720439162093,-1.0004361938585458,0.4536489151873767,0.7117464684240962,1.0,41/138,23.09%,PTPRJ;PLCG2;WNK1;PDE4D;INPP5D;IKBKB;DENND1B;TNFRSF21;PSMA6;NFKBIZ;RC3H1;PSMB5;PSMC4;PSMC5;PSMD14;BTN3A3;LCP2;PSMD8;PIK3CA;EIF2B3;PSMD11;PIK3R2;PSMB4;PSMD12;PSMC1;TAB2;RELA;CUL1;CHUK;PRAM1;TXK;FYB2;NCK1;PSMA1;PSMB1;PSMC3;PRKD2;PTPN22;CSK;PSMA4;PSMA2
prerank,negative regulation of nucleocytoplasmic transport (GO:0046823),-0.3949665114757056,-1.0003520718429781,0.44545454545454544,0.7114795325761718,1.0,6/13,27.90%,CHP1;UFM1;RANGAP1;RAB23;PARK7;BARD1
prerank,positive regulation by host of viral transcription (GO:0043923),-0.3840784168776178,-1.0000127925467694,0.4835164835164835,0.7118212518137095,1.0,1/15,0.14%,LEF1
prerank,response to ATP (GO:0033198),-0.3656594989734265,-0.999825551206064,0.4701348747591522,0.7117814251582334,1.0,2/18,2.17%,TRPC3;ABCC9
prerank,establishment of apical/basal cell polarity (GO:0035089),-0.37807141127585764,-0.9998031103794018,0.44716981132075473,0.7113484899465429,1.0,8/14,31.12%,OPHN1;MSN;EZR;CAMSAP3;FSCN1;CDC42;SCRIB;RHOA
prerank,RNA processing (GO:0006396),0.236993039570697,0.9997982200994581,0.42585551330798477,0.7822094063885096,1.0,23/176,11.07%,CELF2;ATXN1;NOVA1;RBMS1;TUT4;AURKAIP1;PRKACA;SNRPN;ADARB2;AKAP8L;SNRPA1;RNPC3;HNRNPUL1;LIN28B;DHX8;MPHOSPH10;RBM5;SLU7;BICD1;PABPN1;HNRNPD;KHSRP;PIWIL2
prerank,positive regulation of vascular permeability (GO:0043117),-0.40076705754316166,-0.9992778227085876,0.4691780821917808,0.7121341199377983,1.0,6/12,10.66%,OCLN;TJP2;TGFB1;PDE2A;VEGFA;TRPV4
prerank,endosome organization (GO:0007032),-0.30180583716616116,-0.9992102350274016,0.42661448140900193,0.7118031528945182,1.0,16/41,25.16%,PI4K2A;RAB27A;EEA1;CHMP2B;USP8;CLCN3;ALS2CL;VPS11;WASHC5;LAPTM4B;DNM1;PLEKHF1;SNX3;ANXA8L1;ANXA8;PHETA2
prerank,hexose transmembrane transport (GO:0008645),-0.3481571605673825,-0.9987591263388836,0.4809437386569873,0.7124004674795726,1.0,8/21,28.76%,SLC2A1;PPARD;SLC2A8;SLC2A3;SLC2A4;SLC2A9;SLC2A10;SLC2A2
prerank,regulation of peptidase activity (GO:0052547),-0.35891734099069084,-0.9978823176749602,0.46379310344827585,0.7139880040115517,1.0,3/19,8.73%,CAV1;NDUFA13;CST3
prerank,protein localization to phagophore assembly site (GO:0034497),0.4173493148666139,0.9975784922147622,0.4537037037037037,0.7868621492571423,1.0,4/11,21.67%,WDR45B;WIPI1;ATG9A;WDR45
prerank,macromolecule catabolic process (GO:0009057),-0.3382279723841729,-0.9974186466519578,0.48073394495412847,0.7146253048202164,1.0,6/26,16.02%,TPP1;TGFB1;IDE;KIF16B;SMURF1;UCHL3
prerank,positive regulation of interleukin-1 production (GO:0032732),-0.2824292379506349,-0.9970562855117977,0.437125748502994,0.715013750216974,1.0,19/51,32.07%,GBP5;APP;CASP8;HSPB1;TRIM16;S100A13;TLR4;AIM2;JAK2;NOD2;CASP1;LGALS9;FZD5;TMEM106A;CD36;TLR6;EGR1;TYROBP;NLRP3
prerank,telomere organization (GO:0032200),0.3066266934477264,0.9969027637543514,0.44539614561027835,0.7876503434781869,1.0,18/43,21.96%,STN1;BLM;RPA2;NBN;ATM;RIF1;RPA1;PARP3;PARP1;SP100;POLD4;POLD1;RTEL1;PCNA;POLD3;DOT1L;POLD2;DCLRE1B
prerank,mitochondrial translational termination (GO:0070126),-0.25855244097626623,-0.9968266778482321,0.46942800788954636,0.7151108733098893,1.0,34/88,29.61%,MRPL52;PTCD3;MRPL51;MRPL38;MRPL28;MRPL43;MRPL32;MRPL14;MRPS30;ERAL1;MRPL24;MRPS17;MRPL50;MRPL16;MRPL47;MRPL54;MRPS18C;MRPS18A;MRPL35;MRPS6;MRPL58;MRPL48;MRPL49;MRPL13;MRPL11;MRPL21;MRPL30;MRPS24;MRPL2;MRPL42;MRPL15;MRPL19;MRPS14;MRPS2
prerank,regulation of heart rate by cardiac conduction (GO:0086091),-0.3026861839324715,-0.996759369041936,0.4796116504854369,0.7147953438166393,1.0,12/38,19.15%,CAV1;KCNJ2;CAMK2D;KCNQ1;JUP;CTNNA3;CACNA1D;DSG2;KCND3;DSP;SCN2B;CACNA1C
prerank,positive regulation of protein depolymerization (GO:1901881),-0.41755329560202414,-0.9966402958514463,0.49272727272727274,0.7145936431978116,1.0,5/11,12.53%,WDR1;STMN2;NES;TRPV4;KATNB1
prerank,negative regulation of nervous system development (GO:0051961),-0.3716226575692354,-0.9961891612660163,0.462406015037594,0.7151518297645042,1.0,3/17,4.11%,B2M;NOTCH1;REST
prerank,organelle disassembly (GO:1903008),-0.3131260230564734,-0.995831865405829,0.4646098003629764,0.7155600491677423,1.0,19/33,37.46%,KLC1;UFM1;KIF9;DDRGK1;VCP;VRK1;UFL1;UFC1;UBA5;STX5;PLK3;PLK5;KIF5B;CDK1;MTIF2;MCTS1;DYRK3;ULK1;PELO
prerank,canonical Wnt signaling pathway (GO:0060070),0.27640159475838133,0.9957792188390415,0.475,0.7895952471218708,1.0,16/68,15.79%,TCF7L2;WNT4;SFRP1;FRAT1;PLPP3;RARG;RYK;GATA3;DVL3;PTEN;FRZB;FZD10;WNT6;WNT5B;TCF7L1;PORCN
prerank,negative regulation of autophagy (GO:0010507),-0.2803815504332505,-0.9951999249343172,0.46153846153846156,0.7166215568000706,1.0,19/54,25.40%,RASIP1;DAPL1;EIF4G3;FOXK1;QSOX1;AKT1;ATG7;PIK3CA;MET;TAB2;MCL1;RRAGA;EIF4G1;PTPN22;WDR6;SMG1;RUBCN;EIF4E;TREM2
prerank,positive regulation of RNA splicing (GO:0033120),0.32612883675562937,0.9950192425604668,0.44933920704845814,0.7905746913828885,1.0,4/29,7.63%,PIK3R1;DAZAP1;TRA2A;CELF4
prerank,"nucleotide-excision repair, preincision complex assembly (GO:0006294)",-0.32295759767388516,-0.9949006283501887,0.45866141732283466,0.7168494234969428,1.0,10/29,17.81%,UBB;UBC;RPS27A;CUL4A;GTF2H3;CHD1L;RBX1;CETN2;RPA3;GTF2H4
prerank,regulation of response to oxidative stress (GO:1902882),0.4250137221129943,0.9947278719144323,0.46255506607929514,0.7904097205372025,1.0,3/11,14.31%,PRKN;GGT7;STOX1
prerank,regulation of fatty acid beta-oxidation (GO:0031998),0.3890418622598146,0.994626619800641,0.46153846153846156,0.7897290892665776,1.0,3/14,6.04%,PPARA;IRS2;ABCD2
prerank,calcium ion homeostasis (GO:0055074),0.2634729286096434,0.9945872338059133,0.4394904458598726,0.7889268112987409,1.0,14/95,8.94%,SLC24A3;SLC8A1;CYP27B1;SLC24A5;ANK2;DMPK;ATP13A3;CSRP3;ATP2A2;TNNI3;NPTN;ATP13A4;SLC24A4;SLC24A2
prerank,protein localization to kinetochore (GO:0034501),-0.3985659813146845,-0.9943426734602494,0.4659090909090909,0.7177093267632829,1.0,7/14,31.36%,ZW10;RCC2;KNL1;MTBP;SPDL1;BUB3;CDK1
prerank,double-strand break repair via nonhomologous end joining (GO:0006303),-0.2803581528338524,-0.9929421545328349,0.4383838383838384,0.7206431875491228,1.0,26/58,34.22%,PAXX;ZBTB7A;BRCC3;PRKDC;UIMC1;ERCC1;BABAM1;HERC2;PSMD14;DCLRE1C;CYREN;BABAM2;POLQ;ERCC4;POLL;LIG4;BARD1;RNF8;HMGB2;MRE11;POLB;PRPF19;NSD2;RAD50;ATP23;POLA1
prerank,positive regulation of T cell differentiation (GO:0045582),0.30310733004395907,0.9929186159339508,0.448,0.7922304877804606,1.0,5/36,5.08%,GLI2;IL4I1;RHOH;GLI3;IL4
prerank,protein exit from endoplasmic reticulum (GO:0032527),-0.33459473600756795,-0.9927652997167664,0.47191011235955055,0.7205186088459961,1.0,12/23,35.38%,SEL1L;VCP;SURF4;FAF2;SEC61B;DERL2;TMEM129;SEC13;DERL1;SYVN1;OS9;AUP1
prerank,macroautophagy (GO:0016236),-0.24524776970171144,-0.9926595644192651,0.4645669291338583,0.7203118819453818,1.0,36/118,21.48%,PLEKHM1;MAP1LC3B;VAMP7;CHMP2B;GABARAP;LIX1L;MTMR14;TECPR1;PLAA;ATG3;CSNK2B;ATG7;VCP;ULK3;KLHL3;TOMM22;MTERF3;VPS36;MAP1LC3A;PGAM5;TSG101;PRKAG1;SNF8;CSNK2A1;CSNK2A2;VPS16;AMBRA1;VPS33A;VTI1B;CHMP2A;ARL8B;DYNLL2;WIPI2;TOMM5;RUBCNL;VPS41
prerank,midbody abscission (GO:0061952),-0.36482204310259336,-0.9923081122087151,0.4866920152091255,0.7206759151046349,1.0,8/17,32.17%,CHMP2B;MITD1;CHMP2A;CEP55;VPS4A;CHMP7;CHMP4B;CHMP4A
prerank,negative regulation of leukocyte mediated cytotoxicity (GO:0001911),-0.42163792918017007,-0.9922697999012267,0.4791288566243194,0.7202958154942093,1.0,6/10,44.29%,CX3CR1;LGALS9;LILRB1;FCGR2B;CEACAM1;KLRD1
prerank,pyrimidine nucleoside metabolic process (GO:0006213),-0.38410543945836567,-0.9921530934822814,0.4548802946593002,0.7200995378807927,1.0,5/14,14.02%,NT5E;UPP2;NT5C;NT5C1A;CAD
prerank,positive regulation of protein kinase activity (GO:0045860),-0.23798422132310468,-0.9921492960106684,0.4689507494646681,0.7196268294337995,1.0,37/148,19.85%,RAP1A;TGFBR2;PTK2B;IQGAP1;PTK2;DAB2IP;HSP90AB1;CALM1;TGFB2;RALB;NEDD9;MINK1;VEGFA;TAOK3;RASSF2;INSR;EMP2;LRP8;CAMK1;TAOK2;CIB1;MTCP1;CALM3;SRCIN1;CSF1R;ACE;LCP2;MMD;PRKAG1;CAB39;CDKN1A;HSP90AA1;TAB2;AGAP2;ECT2;ITGB3;TPX2
prerank,regulation of steroid metabolic process (GO:0019218),0.35260390097045585,0.9918967625796394,0.4638949671772429,0.7938432235597358,1.0,1/23,0.19%,RORA
prerank,regulation of protein localization (GO:0032880),-0.2759397362508489,-0.9915785868814914,0.49245283018867925,0.7204909512561112,1.0,19/58,19.70%,RACK1;TRIM25;HSP90AB1;FKBP1A;PLEKHM2;PPM1F;USP8;CTSD;TRIM14;CEP290;CAMK1;TRIM68;TRIM5;MMD;UFL1;HSP90AA1;KDM1A;TMEM231;ITGB3
prerank,regulation of cholesterol efflux (GO:0010874),-0.31602067529503236,-0.9915290868225869,0.4846743295019157,0.7201339988794839,1.0,6/30,12.63%,CAV1;PLTP;NFKBIA;NAXE;APOE;ABCA2
prerank,RNA polyadenylation (GO:0043631),0.3401554193033677,0.991472205404039,0.4519650655021834,0.7930387449836211,1.0,15/26,28.42%,PAPOLB;FIP1L1;SYMPK;PNPT1;SCAF8;PAPOLA;GRSF1;PAF1;TENT2;MTPAP;WDR33;CLP1;TENT4B;LEO1;AHCYL1
prerank,mRNA polyadenylation (GO:0006378),0.3401554193033677,0.991472205404039,0.4519650655021834,0.7930387449836211,1.0,15/26,28.42%,PAPOLB;FIP1L1;SYMPK;PNPT1;SCAF8;PAPOLA;GRSF1;PAF1;TENT2;MTPAP;WDR33;CLP1;TENT4B;LEO1;AHCYL1
prerank,regulation of cholesterol esterification (GO:0010872),-0.42790362701204854,-0.9914099832391476,0.4883303411131059,0.7199413841352577,1.0,6/10,35.25%,ABCG1;APOE;ABCA2;APOC1;LAMTOR1;STARD4
prerank,positive regulation of cellular protein localization (GO:1903829),-0.26497282836212144,-0.9913326826200349,0.4667931688804554,0.7196595659652008,1.0,30/69,31.49%,LIMK2;STX3;TFRC;FERMT2;HSP90AB1;TGFB1;RIC3;GPR137B;AKT1;DDRGK1;GAS8;CDK5RAP3;MAP1A;NDC80;SESN2;MEAK7;DTX3L;NECAB2;CCDC88A;PARK7;CARD10;STX4;LAMTOR5;ENTR1;PLK1;PARP9;TRAPPC12;TYROBP;CDK1;PARD6A
prerank,regulation of systemic arterial blood pressure by hormone (GO:0001990),-0.3830502466629976,-0.9912976305181086,0.4753521126760563,0.719270538742719,1.0,4/14,13.71%,NOS3;EDN1;ACE2;ACE
prerank,axon development (GO:0061564),0.27315612920146326,0.9912419724793186,0.468,0.7927312567845977,1.0,18/78,14.15%,FGFR2;SEMA5A;CNTN4;CTNNA2;SLITRK4;NREP;RTN4;DOCK7;NRCAM;RYK;RAB10;CDK5R1;DCC;BRSK1;LLGL1;MAPT;AMIGO1;DRD2
prerank,positive regulation of T cell receptor signaling pathway (GO:0050862),-0.39383671239182905,-0.9907204323382333,0.48336252189141854,0.7201820052397344,1.0,10/14,37.20%,RPS3;CD81;NECTIN2;RELA;PRKD2;BCL10;CARD11;IKBKG;CD226;TESPA1
prerank,protein deneddylation (GO:0000338),-0.4199863155421229,-0.9904577594522187,0.5008880994671403,0.7203137023752997,1.0,6/10,26.57%,COPS6;COPS5;COPS7A;COPS4;COPS7B;GPS1
prerank,regulation of cardiac muscle cell differentiation (GO:2000725),-0.40887222042861776,-0.9903070311614839,0.4955116696588869,0.7202093157114078,1.0,5/11,16.40%,MEF2C;TGFB1;FZD7;SOX6;GREM1
prerank,phosphate-containing compound metabolic process (GO:0006796),-0.22495309956582,-0.9898699217257888,0.4830508474576271,0.7207344991216842,1.0,42/198,16.68%,PTPRB;PLCE1;ITPKB;PLCG2;LIMK2;GPI;MAPK3;PLCB3;HK1;TNFAIP8L3;CALM1;TGFB1;PLPP1;INPP5D;IPMK;PFKP;NT5C;AKT1;PLAA;PIP4P1;PLAAT3;TOLLIP;INPP5A;LIMD1;ISYNA1;DUSP3;PPP3CB;NUDT4;PNKP;GFPT1;SPHK2;AGPAT1;CERKL;IP6K1;PIK3CA;COQ8A;GPX4;PGK1;MINPP1;SYNJ1;DUSP23;IMPA2
prerank,negative regulation of purine nucleotide metabolic process (GO:1900543),-0.4179451537024568,-0.9897134623912995,0.4854014598540146,0.7201482720818985,1.0,3/10,8.30%,CBFA2T3;NCOR1;HDAC4
prerank,negative regulation of glycolytic process (GO:0045820),-0.4179451537024568,-0.9897134623912995,0.4854014598540146,0.7201482720818985,1.0,3/10,8.30%,CBFA2T3;NCOR1;HDAC4
prerank,cellular metal ion homeostasis (GO:0006875),0.25690134391945374,0.9896634820181167,0.4757085020242915,0.7958015640552607,1.0,15/102,9.00%,ATP1A2;SLC24A3;SLC8A1;SLC24A5;ANK2;DMPK;ATP13A3;CSRP3;ATP2A2;TNNI3;NPTN;ATP13A4;SLC24A4;SLC24A2;SLC41A1
prerank,negative regulation of cell division (GO:0051782),0.4123741735035461,0.9891482235428194,0.4778761061946903,0.7961852355161679,1.0,2/11,8.95%,TXNIP;BLM
prerank,protein glycosylation (GO:0006486),-0.24116492699208236,-0.989115620046947,0.4796905222437137,0.721112865747057,1.0,44/125,27.54%,ST3GAL6;ST3GAL4;EOGT;ST8SIA4;TRAK1;PLOD2;TMEM165;SLC39A8;AQP11;ST8SIA6;MGAT1;C1GALT1C1;GALNT10;FUT8;KRTCAP2;DAD1;POGLUT1;PLOD3;GFPT1;ST6GALNAC2;SERP2;NPC1;COG3;TMEM258;POMK;OGA;ALG9;NUS1;B3GNT3;B3GNT8;ALG12;MGAT5;ALG1;PGM3;LARGE1;MPI;GCNT4;POMGNT2;RPN2;ALG2;GALNT6;GALNT9;ALG3;STT3B
prerank,positive regulation of RNA metabolic process (GO:0051254),-0.2906992054551054,-0.988859732778007,0.49230769230769234,0.7212524719182739,1.0,13/45,19.21%,DDX5;HNRNPLL;TGFB1;RBM20;RIPK1;NMD3;RBM22;ZC3H18;HRAS;EGFR;HSPA1A;RELA;ZPR1
prerank,dermatan sulfate metabolic process (GO:0030205),0.39844980624770515,0.9879941880488063,0.4634703196347032,0.7981223187082298,1.0,7/13,23.38%,UST;DCN;DSE;VCAN;CHST14;DSEL;BCAN
prerank,eye photoreceptor cell differentiation (GO:0001754),-0.4021909012058283,-0.9876934377051436,0.49165120593692024,0.7235157260688293,1.0,4/12,12.26%,PROM1;VEGFA;CEP290;AGTPBP1
prerank,regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),0.37356068913453455,0.9871866585279249,0.45555555555555555,0.7992873826563197,1.0,2/17,3.32%,ANK2;CACNA2D1
prerank,DNA synthesis involved in DNA repair (GO:0000731),-0.2904514181453067,-0.9871466665718247,0.4839319470699433,0.7243535181081557,1.0,13/42,24.17%,TRIM25;UBB;UBC;RPS27A;UBE2L6;VCP;SPRTN;USP43;RPA3;POLK;DTL;RFC3;RFC2
prerank,cellular calcium ion homeostasis (GO:0006874),-0.23903638291190532,-0.9865061606324177,0.4708333333333333,0.7253722258924857,1.0,22/133,11.62%,ATP13A5;CAV1;TPT1;TRPC3;CAV2;MCUB;CAMK2D;TMEM165;ATP2C1;SLC35G1;ATP2A3;PDZD8;ATP1B1;EDN1;BAX;STIM2;CCL15;SLC10A7;TRPC6;TRPV4;TRPC4;ATP2B3
prerank,positive regulation of response to external stimulus (GO:0032103),-0.24071655088425997,-0.9863195537583654,0.47474747474747475,0.7253530737439774,1.0,28/128,17.52%,THBS1;IL15;NFKBIA;SCARF1;STX3;THBD;ETS1;GBP5;TGFB1;APP;PDE2A;IL33;GPR4;TLR3;NFKBIZ;RIPK1;PPM1F;DHX9;DHX58;TLR4;TNFRSF1A;USP15;FEM1A;AKIRIN2;IL17RA;SLC15A4;ANKRD17;NINJ1
prerank,peptidyl-threonine modification (GO:0018210),-0.27282254422379526,-0.9862560456051697,0.4819047619047619,0.725028227669553,1.0,16/66,16.04%,TGFBR2;HIPK1;NLK;WNK1;CAMK2D;PRKDC;DYRK2;AKT1;CDC42BPB;CSNK2B;LMTK2;ACVR1;CDK10;CAD;CSNK2A1;CSNK2A2
prerank,tyrosine metabolic process (GO:0006570),0.40250447945178325,0.986253731358574,0.46238938053097345,0.800780393647706,1.0,2/11,14.42%,IL4I1;GSTZ1
prerank,substrate-dependent cell migration (GO:0006929),0.3704130260396745,0.9861499928226637,0.48325358851674644,0.8001484013981813,1.0,2/14,1.80%,NRP1;ITGA11
prerank,negative regulation of DNA replication (GO:0008156),-0.3849335782049439,-0.986037618021138,0.4783427495291902,0.7250746339044656,1.0,4/13,19.59%,CDAN1;RAD17;WAPL;TSPYL2
prerank,protein maturation (GO:0051604),-0.2510453265908664,-0.9859978728636359,0.4876190476190476,0.7246858824958933,1.0,18/95,17.24%,TSPAN5;NNAT;SRGN;F3;ADAM10;BACE1;ADAM19;MMP14;PSENEN;CPE;HSPD1;TSPAN14;LMF2;NAA60;APH1A;TSPAN17;PHEX;CCS
prerank,iron ion homeostasis (GO:0055072),0.2824905635165982,0.9855261280612864,0.4669421487603306,0.800737055754016,1.0,3/58,1.49%,BMP6;CP;HEPH
prerank,protein-containing complex assembly (GO:0065003),-0.21817445033991528,-0.9854668509761267,0.4767932489451477,0.7254498912242064,1.0,62/259,20.01%,FN1;LEF1;ANO6;OCLN;SLC2A1;DMD;PARD3;PTK2B;TLE4;FERMT2;CD2AP;RBBP5;TRRAP;ZW10;CTSZ;ADAM10;PPARGC1A;NAPA;PYGO2;PPP2R1A;TAPBP;REPS2;TLE3;CTSC;CASP8;RIPK1;AP2M1;DNAJB12;DHX9;FAS;CSNK2B;CD74;KMT2D;TEAD2;DBNL;HES1;TRAF1;FBXL7;TNFRSF1A;AIM2;PEF1;SMARCA4;WASL;RBX1;RAB1A;MCFD2;MDN1;CHCHD10;SKAP2;TRAPPC5;OPA1;BAD;F5;NSF;CUL1;WIPF1;PPP6R3;CAPG;ELOB;SOX9;SHANK1;SEC24B
prerank,regulation of microtubule polymerization or depolymerization (GO:0031110),-0.3225886502789122,-0.9849395675297749,0.4602272727272727,0.726206905161524,1.0,11/28,26.04%,STMN2;PRUNE1;GAS2L1;MAP1B;MAPRE2;ARL2;MAP1A;FKBP4;CAMSAP3;STMN1;SKA3
prerank,microtubule polymerization or depolymerization (GO:0031109),-0.3285067085898605,-0.9849371206123622,0.45132743362831856,0.7257373171644325,1.0,10/24,26.61%,STMN2;TRPV4;KATNB1;KIF24;KIF18A;PIN1;KIF18B;NCKAP5L;STMN1;MAP7D3
prerank,maintenance of protein location in nucleus (GO:0051457),-0.34727246005016066,-0.984722107221076,0.48623853211009177,0.7257644024074091,1.0,8/20,31.63%,SYNE1;ARL2BP;CHCHD10;ARL2;RANGAP1;PARK7;BARD1;TAF3
prerank,negative regulation of heart contraction (GO:0045822),0.423243684522219,0.9846484678686445,0.4817204301075269,0.8020363370522334,1.0,1/11,0.47%,ATP1A2
prerank,cytoskeleton organization (GO:0007010),0.25554792758700373,0.9846352704971686,0.4911242603550296,0.8011481378255306,1.0,19/114,10.68%,MICAL3;SH3D19;EPB41L3;RHOH;PHIP;FGD4;RHOBTB1;ZMYM6;ANK1;FMNL3;TNIK;FGD1;AJUBA;RHOBTB3;BRWD1;CAMSAP1;PRKCI;CECR2;MICAL1
prerank,response to peptide hormone (GO:0043434),0.3030194499536028,0.9844529925584057,0.4673913043478261,0.8006829955857827,1.0,4/43,3.15%,TGFBR3;ROCK2;STAT5B;GNAI1
prerank,positive regulation of cytokine production involved in inflammatory response (GO:1900017),-0.3746256629561177,-0.9844467037864637,0.4812734082397004,0.7259178158317936,1.0,4/15,15.55%,GBP5;TLR4;NOD2;IL17RA
prerank,neuromuscular process controlling balance (GO:0050885),0.39425425206958703,0.9842608224940098,0.4634703196347032,0.8002275613095071,1.0,4/12,16.40%,NRXN1;PCDH15;CLRN1;CLN3
prerank,protein-DNA complex disassembly (GO:0032986),-0.3768775858559852,-0.9842576199194687,0.4834558823529412,0.7258984197482509,1.0,9/16,37.58%,RPL23;ARID1A;SMARCA4;SMARCC1;SMARCD2;MYC;SMARCD3;NFE2;HMGA1
prerank,potassium ion export across plasma membrane (GO:0097623),0.3905451282104418,0.9841931805214077,0.4660633484162896,0.7994701185009455,1.0,1/13,0.43%,KCNT2
prerank,mitotic cytokinesis (GO:0000281),-0.2838434507458513,-0.9837278775848761,0.4868913857677903,0.7266474412769379,1.0,24/47,33.49%,SPTBN1;USP8;KIF23;RHOB;RTKN;MITD1;SNX18;ECT2;RASA1;ANLN;CNTROB;CENPA;EFHC2;CIT;CEP55;STMN1;ARL3;RACGAP1;TRIM36;PLK1;CHMP4B;ESPL1;UNC119;STAMBP
prerank,regulation of myoblast differentiation (GO:0045661),-0.31381646822193476,-0.9834767000508621,0.4703703703703704,0.7267850528977001,1.0,5/32,5.28%,MEF2C;NOTCH1;BOC;TGFB1;IGFBP3
prerank,dolichol-linked oligosaccharide biosynthetic process (GO:0006488),-0.3621849035876086,-0.9834732167047386,0.49818840579710144,0.7263228917850503,1.0,9/17,35.13%,ALG9;NUS1;ALG12;ALG1;DHDDS;ALG2;ALG3;MPDU1;ALG6
prerank,regulation of protein-containing complex disassembly (GO:0043244),-0.3666697384699527,-0.9834569698838199,0.4853801169590643,0.7258844368017591,1.0,2/16,8.53%,IGF1R;INSR
prerank,positive regulation of myeloid cell differentiation (GO:0045639),-0.3095416910119717,-0.9833775139323319,0.48007590132827327,0.7256163654455986,1.0,10/33,21.43%,FOXO3;ETS1;PRKDC;TAL1;INHBA;STAT1;HSPA1A;FAM210B;MAPK11;HSPA1B
prerank,plasma membrane tubulation (GO:0097320),-0.38901565365972096,-0.9833156412356537,0.5028248587570622,0.7252883543449616,1.0,6/13,19.95%,FNBP1L;CAVIN2;EHD2;PACSIN1;PACSIN3;PACSIN2
prerank,regulation of phosphorylation (GO:0042325),0.24681878614853411,0.983085747664195,0.4816414686825054,0.8013113510967799,1.0,18/120,10.74%,NRP1;SRPX2;LDB2;AR;PRKAG2;STAP1;PHIP;LYN;FNIP1;IL4;DYNLL1;GLMN;SIRT2;NUP205;ANKLE2;ANG;NUP35;PLXNB2
prerank,error-free translesion synthesis (GO:0070987),-0.34413116504855906,-0.9830474982436754,0.48794063079777367,0.7254435104520193,1.0,9/22,24.17%,UBB;UBC;RPS27A;VCP;SPRTN;RPA3;POLDIP2;RFC3;RFC2
prerank,negative regulation of kinase activity (GO:0033673),0.27625212226734536,0.9829431620086175,0.48868778280542985,0.8007141920757807,1.0,9/62,7.92%,PPM1E;PRKAG2;PDPK1;DEPTOR;CEP85;IRS2;GSTP1;CEP43;TRIM27
prerank,positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),-0.3352759045886471,-0.982882661358261,0.4928571428571429,0.7253524198409176,1.0,6/24,11.03%,NOTCH1;KLF2;VEGFA;ATF4;MBTPS2;HSPA5
prerank,negative regulation of cell-matrix adhesion (GO:0001953),0.31567797862941,0.9828634230237345,0.45964125560538116,0.80001326495469,1.0,4/32,5.80%,ARHGAP6;PHLDB2;DLC1;SERPINE1
prerank,myofibril assembly (GO:0030239),0.2968387017723624,0.9822050956508863,0.4845814977973568,0.8007086812851874,1.0,13/42,14.84%,PDGFRA;CSRP3;CFLAR;KLHL41;FHOD3;PDGFRB;SIX4;CSRP2;ACTN2;OBSL1;SYNPO2L;TNNT3;MYLK3
prerank,regulation of execution phase of apoptosis (GO:1900117),0.3997289585203304,0.9821135329241756,0.48322147651006714,0.8000360568667042,1.0,3/11,7.11%,PTGIS;DLC1;SIRT2
prerank,sodium ion homeostasis (GO:0055078),0.3544677722762992,0.9819284915179852,0.49430523917995445,0.7995545061574231,1.0,2/21,1.17%,ATP1A2;SLC8A1
prerank,vascular endothelial growth factor signaling pathway (GO:0038084),-0.3840289997660632,-0.9818119163108701,0.47680890538033394,0.7274276134594675,1.0,9/14,20.07%,GAB1;KDR;VEGFC;VEGFA;FLT4;VEGFD;PIK3CA;PGF;NUS1
prerank,monocarboxylic acid biosynthetic process (GO:0072330),0.2809459034674409,0.9818016078207995,0.46449136276391556,0.7989674934822246,1.0,10/59,14.23%,ALDH1A2;CYP7B1;CYP27A1;ACSM5;BAAT;CYP46A1;NDUFAB1;OSBP;MCAT;ACACA
prerank,positive regulation of intracellular protein transport (GO:0090316),-0.2366728748017758,-0.9817653359223859,0.500998003992016,0.7270725527777762,1.0,49/144,23.42%,PPP1R13B;CDH1;KCNB1;TGFB1;BCAS3;PRR5L;ABLIM3;CHP1;MIEF1;CD81;PPP3CC;CASP8;JUP;RBM22;TRIM28;CEP290;MIEF2;CAMK1;CIB1;PCM1;SAE1;BBC3;YWHAZ;OAZ2;E2F1;MAVS;HRAS;VPS11;ERBB2;YWHAG;CSNK2A2;PIK3R2;YWHAH;RAPGEF3;BAD;TMEM30A;ECT2;UBL5;ZPR1;SFN;FZD5;RIPOR1;HCLS1;FIS1;PDCD10;NPEPPS;PLK3;MICALL2;PRKCD
prerank,negative regulation of receptor signaling pathway via STAT (GO:1904893),-0.41256205520460115,-0.981451404821778,0.4886164623467601,0.7273122076936457,1.0,2/11,5.35%,CAV1;ADIPOR1
prerank,multivesicular body organization (GO:0036257),-0.31424348521624684,-0.9812951567534314,0.49706457925636005,0.7272030890790387,1.0,15/31,32.17%,RAB11A;RAB27A;CHMP2B;VPS36;TSG101;SNF8;IST1;CHMP2A;VPS4A;STAM2;CHMP7;STAM;VPS37C;CHMP4B;CHMP4A
prerank,peptidyl-tyrosine modification (GO:0018212),-0.2810074919974379,-0.9812189720474269,0.5029239766081871,0.7269059158113799,1.0,18/56,17.47%,TEK;FLT1;PTK2B;KDR;PTK2;ABI3;FLT4;INSR;ABL2;SYK;CSF1R;ABI1;JAK2;EGFR;ERBB2;PTPN6;JAK3;HCK
prerank,establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),0.31711893742331476,0.9794423893153469,0.470954356846473,0.8039696745359988,1.0,7/31,10.17%,PARD3B;DLG2;RAP2A;ANK1;PDZD11;LRRC7;PRKCI
prerank,heparan sulfate proteoglycan metabolic process (GO:0030201),0.345949692490596,0.9791905681510137,0.44539614561027835,0.8036760989216322,1.0,7/21,17.44%,SULF1;SULF2;HS6ST3;HS2ST1;HS6ST2;HS3ST5;HPSE
prerank,negative regulation of sodium ion transmembrane transport (GO:1902306),0.4197977847891581,0.9789644455218285,0.5032537960954447,0.8033585359925162,1.0,2/10,5.49%,HECW2;HECW1
prerank,RNA stabilization (GO:0043489),0.3117869071246998,0.9786383530942901,0.4879120879120879,0.8032860411286482,1.0,7/33,14.52%,GDNF;TENT5A;AXIN2;PHAX;TENT5B;PARN;RBM24
prerank,regulation of long-term neuronal synaptic plasticity (GO:0048169),-0.4215343288093353,-0.9786084070087194,0.49725776965265084,0.7325445715699622,1.0,2/10,4.11%,SHANK3;APP
prerank,positive regulation of exocytosis (GO:0045921),-0.3062434583154361,-0.9783035133453419,0.5019305019305019,0.7328311222148727,1.0,14/35,33.07%,RAB27A;RAB7A;SDCBP;TSG101;SNF8;CHMP2A;RAB2B;RAB3D;ATP6AP1;VPS4A;STAM;ATP13A2;RAB3A;RAB15
prerank,negative regulation of cellular response to growth factor stimulus (GO:0090288),-0.2534056958035539,-0.9777865727625239,0.5077821011673151,0.7335728290603807,1.0,21/79,19.31%,CRIM1;BMPER;THBS1;NOTCH1;BMPR2;SMAD9;DAB2IP;SMAD7;SLIT2;SMAD6;HHEX;HTRA3;SKIL;FGF2;SMURF1;EPN2;SMAD4;GREM1;SPRY1;SKI;BMPR1B
prerank,wound healing (GO:0042060),0.27615438548262206,0.977633781184035,0.4768611670020121,0.8049524972475369,1.0,6/62,4.25%,IGF1;NRG1;PDGFRA;SMAD3;PPL;CFLAR
prerank,dephosphorylation (GO:0016311),-0.23306851777446122,-0.9774425547036311,0.49471458773784355,0.7339108145400969,1.0,51/147,28.27%,PTPRB;PTPRG;PTPN14;CTTNBP2NL;PTPRJ;PLPP1;CTDSP1;PTPRM;SSH2;PPP3CC;PPP2R1A;PPP2R5A;PPM1F;NT5C;PPP1CB;PPP2R1B;DUSP3;PPP5C;PPP3CB;PNKP;PPP2R2A;CDC14B;PTPN12;MTM1;PTPN6;DUSP23;PPP2R5E;UBLCP1;DUSP11;PTPRK;PLPP2;TIMM50;PPP1CA;PTPRO;PTPRU;PTPN22;PPP1R12A;PPM1M;PTPN1;DUSP4;ACP6;PPEF2;SGPP1;MTMR2;THNSL2;PPP2R5B;PDP1;DUSP6;PLPP6;DUSP1;PPP4R1
prerank,low-density lipoprotein particle remodeling (GO:0034374),0.41114639957972204,0.9771275900559117,0.4792626728110599,0.80536123824355,1.0,1/11,2.09%,PLA2G5
prerank,glutamine family amino acid catabolic process (GO:0009065),0.39522446930545346,0.9761578864743239,0.49107142857142855,0.8068960601497316,1.0,4/13,8.69%,ALDH4A1;PRODH;GLUL;GLS2
prerank,positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),0.32084880945266986,0.9756317261525967,0.5052410901467506,0.8073648611549689,1.0,2/32,2.25%,CEMIP;PDPK1
prerank,regulation of cholesterol transport (GO:0032374),0.3569006669868394,0.9752700703452041,0.4853932584269663,0.8073767933566203,1.0,4/20,8.12%,LRP1;YJEFN3;ABCB4;ABCA5
prerank,cellular response to purine-containing compound (GO:0071415),0.4227735640486752,0.9752600706365875,0.48596112311015116,0.8064987903240989,1.0,1/10,1.17%,SLC8A1
prerank,leukotriene biosynthetic process (GO:0019370),0.3873367792786549,0.9745333159605728,0.4796573875802998,0.8073470173134865,1.0,3/14,6.00%,PLA2G5;PLA2G4A;GGT7
prerank,regulation of dendritic spine development (GO:0060998),-0.3509183454876823,-0.9743851257773732,0.5018248175182481,0.7406115921510984,1.0,5/19,13.09%,MEF2C;SHANK3;CAMK1;APOE;FMR1
prerank,protein modification by small protein conjugation (GO:0032446),-0.2083117986883367,-0.974276631237763,0.5583864118895966,0.7403659585042025,1.0,92/361,20.48%,WWP1;NEDD4L;RACK1;IFIH1;LMO7;MSL2;DCUN1D5;RNF41;UBB;WWP2;RLIM;UBC;RPS27A;UFM1;KLHL2;STX1A;UBE2Q2;USP7;PRKDC;RNF38;DCUN1D1;NUP93;ANAPC11;TRIM47;CUL4A;FBXO4;DTX3;NDC1;TRIM28;TRIM14;USP9X;NUP54;ATG3;ARRDC1;HERC2;ATG7;DDRGK1;UBE2G2;VCP;UBE2F;TNFAIP1;USP5;SAE1;TRIM62;FBXW5;MIB2;ITCH;RNF111;NUP188;KLHL3;FBXL7;URM1;SMURF1;FBXL2;TRIM68;SUMO3;RNF20;NUP155;RBX1;UBE2G1;RAD18;TRIM5;RANBP2;VPS11;DTX2;CCNF;TSPAN17;ANAPC7;UCHL3;KCTD10;CDC27;UFL1;NUP37;FBXL3;UFC1;UBA2;GAN;CUL1;TRAIP;KLHL9;CDK5RAP3;ZSWIM8;KLHL21;UBA5;AMFR;RANGAP1;ELOB;TMEM129;CCDC22;KEAP1;UBE2B;UBA1
prerank,B cell homeostasis (GO:0001782),0.4131205348539831,0.9742255151885548,0.45434298440979953,0.8071984292388388,1.0,3/10,4.13%,DOCK11;DOCK10;LYN
prerank,regulation of cellular protein catabolic process (GO:1903362),-0.34867679675996177,-0.9740952674769955,0.5293040293040293,0.7403183141431045,1.0,8/18,18.77%,DAB2IP;MSN;EZR;PTTG1IP;VPS11;HSP90AA1;ATRAID;CDK5RAP3
prerank,regulation of establishment of planar polarity (GO:0090175),-0.24843476876625076,-0.974074198291313,0.5067961165048543,0.7398962804557303,1.0,45/88,35.76%,FZD6;FZD4;RAC1;PSMA6;AP2M1;PSMB5;FZD3;FZD7;PFN1;SPEF1;WNT11;PSMC4;PSMC5;PSMD14;SMURF1;CELSR1;PSMD8;AP2A1;PSMD11;CELSR2;PSMB4;PSMD12;PSMC1;PSMA1;FZD5;PSMB1;PSMC3;PSMA4;PSMA2;CDC42;PSMB8;VANGL2;AP2A2;PSMC6;WNT7A;RHOA;PARD6A;PSMD6;PSMA8;AP2B1;PKHD1;ROR2;PSMD2;PSMB2;CELSR3
prerank,pyrimidine-containing compound catabolic process (GO:0072529),-0.3667163400626691,-0.9739873126997565,0.5027829313543599,0.7396346399570484,1.0,4/16,11.45%,NT5E;UPP2;NT5C;NT5C1A
prerank,epithelial cell differentiation (GO:0030855),-0.25235652858745117,-0.9737503381290756,0.5019230769230769,0.7397252201851939,1.0,28/88,23.58%,KDR;TBX1;TPP1;ANXA1;SIX1;VEGFA;GATA6;ANXA4;AKT1;FZD7;TDRD7;TOLLIP;ACADVL;CTSB;CPT1A;FSTL1;TAGLN2;PGK1;CBR1;TAGLN;GLI1;E2F4;EDF1;GSTK1;E2F7;CNN3;CASP6;ANXA7
prerank,positive regulation of protein localization to membrane (GO:1905477),0.2550613935535978,0.9733923423703771,0.48770491803278687,0.8084143038247037,1.0,10/98,5.39%,CEMIP;PIK3R1;LRP1;DPP10;PDPK1;EPHA3;SLC5A3;BCL2;TFDP1;PRKN
prerank,IRE1-mediated unfolded protein response (GO:0036498),-0.2767711201320968,-0.9729443649650432,0.48007590132827327,0.7411877360138484,1.0,22/52,31.68%,EXTL3;PDIA5;TPP1;SHC1;HDGF;ADD1;DCTN1;HSPA5;ACADVL;GFPT1;XBP1;KLHDC3;TSPYL2;YIF1A;HYOU1;ATP6V0D1;PPP2R5B;PLA2G4B;ERN1;EDEM1;SYVN1;SRPRA
prerank,mitotic cytokinetic process (GO:1902410),-0.3463735016287026,-0.9727569623103116,0.5078125,0.7411823586546256,1.0,10/20,32.17%,CHMP2B;MITD1;CHMP2A;CNTROB;CEP55;VPS4A;CHMP7;RHOA;CHMP4B;CHMP4A
prerank,regulation of androgen receptor signaling pathway (GO:0060765),-0.31850480310149554,-0.9724535135407522,0.5213523131672598,0.7413996141857778,1.0,8/30,13.97%,FOXP1;DDX5;NCOR1;ZBTB7A;HEYL;H3-3A;TRIM68;SMARCA4
prerank,aerobic respiration (GO:0009060),-0.35133062810195076,-0.9722408538995962,0.5148698884758365,0.7414286182163833,1.0,7/20,22.14%,ATP5F1D;MTFR1;SURF1;UQCRB;UQCRH;SDHB;MTFR2
prerank,phosphatidylethanolamine acyl-chain remodeling (GO:0036152),0.3398719071346593,0.9722272055269155,0.5021367521367521,0.810404751338985,1.0,2/23,2.58%,PLA2G5;PLA2G4A
prerank,positive regulation of fatty acid metabolic process (GO:0045923),-0.3724375121367762,-0.9722200667256317,0.5174418604651163,0.740993825929479,1.0,4/15,16.28%,PPARD;PPARGC1A;ELOVL5;NR1H2
prerank,negative regulation of protein secretion (GO:0050709),-0.29180815246295316,-0.9719383421977078,0.5156537753222836,0.7411814513118936,1.0,10/38,19.17%,CCN3;KCNB1;REST;RAB11FIP1;DPH3;APOE;INHBB;RAB11FIP3;RSAD2;CD200
prerank,nuclear export (GO:0051168),-0.2502458813807704,-0.97177711030974,0.5095057034220533,0.7411006111250183,1.0,24/80,22.45%,TGFB1;PKD1;CHP1;SRSF2;SRSF5;SRSF6;U2AF1;ZC3H11A;RNPS1;NUP188;SMURF1;SRSF4;MAGOH;NUP155;CHTOP;ALYREF;RITA1;DDX39B;HNRNPA1;CCHCR1;CASC3;THOC6;DDX39A;NCBP2
prerank,regulation of ceramide biosynthetic process (GO:2000303),-0.3649494399995144,-0.9715800566737661,0.5241779497098646,0.7410660148170642,1.0,6/15,30.56%,RACK1;SPHK2;TNFRSF1A;PRKCD;ORMDL1;SMPD2
prerank,outer dynein arm assembly (GO:0036158),-0.3851522560373161,-0.9715714207546192,0.49714285714285716,0.7406208574247445,1.0,8/14,34.95%,ODAD1;DNAH8;DNAH5;ODAD2;ODAD3;DNAH17;DNAAF4;CCDC63
prerank,ncRNA metabolic process (GO:0034660),0.30777660238791243,0.9715573153072292,0.49700598802395207,0.8112148887281079,1.0,11/37,20.54%,TUT4;HENMT1;KHSRP;PIWIL2;XPO5;PARN;MAPT;BCDIN3D;DROSHA;NIFK;AGO2
prerank,positive regulation of leukocyte cell-cell adhesion (GO:1903039),-0.323426501295538,-0.9707642208885381,0.499054820415879,0.7420546297197413,1.0,8/27,24.36%,CYRIB;ETS1;CD44;HSPD1;RELA;HAS2;TRAF6;CCL2
prerank,sodium ion import across plasma membrane (GO:0098719),-0.3593383549130824,-0.9707363386409139,0.488929889298893,0.7416459585230097,1.0,2/17,0.97%,SLC9A2;SLC12A2
prerank,tRNA processing (GO:0008033),-0.26972778498120703,-0.9704817658649088,0.5144508670520231,0.7418134545162247,1.0,24/61,29.51%,SARS1;THUMPD1;TRMT9B;QTRT2;URM1;TRMT10C;FARS2;TRDMT1;TRPT1;QTRT1;TSEN54;RPP21;CPSF4;TRMT6;AARS2;ANKRD16;RTCB;METTL1;ADAT1;ADAT2;RTRAF;CTU2;TSEN2;KARS1
prerank,positive regulation of stem cell proliferation (GO:2000648),0.37466800424165925,0.9700390974049579,0.5218390804597701,0.8141060114256827,1.0,4/17,13.62%,GJA1;THPO;LTBP3;N4BP2L2
prerank,positive regulation of endothelial cell proliferation (GO:0001938),0.2635928414573037,0.9695991629740712,0.4927536231884058,0.8143725976959335,1.0,7/75,3.08%,NRP1;BMP2;SEMA5A;PDPK1;PRKCA;VEGFB;AKT3
prerank,epidermal cell differentiation (GO:0009913),-0.2934118843760481,-0.9694898685917016,0.5269016697588126,0.7437795733432,1.0,13/41,27.73%,CLIC4;ANXA1;GATA6;BCR;OPN3;EPHA2;DSP;GLI1;EVPL;SCEL;CERS3;PIP5K1A;CTNNB1
prerank,positive regulation of immunoglobulin mediated immune response (GO:0002891),0.3891132885889864,0.9693870430843587,0.47757847533632286,0.8139840972995269,1.0,5/14,15.92%,SHLD2;KMT5C;PAXIP1;RIF1;KMT5B
prerank,regulation of interferon-gamma-mediated signaling pathway (GO:0060334),-0.34182025837513935,-0.9692590449018346,0.5296296296296297,0.7438550258599315,1.0,11/23,31.09%,HSP90AB1;NLRC5;JAK2;NR1H2;STAT1;IFNGR1;TXK;PTPN2;PARP14;IRGM;PARP9
prerank,activation of GTPase activity (GO:0090630),-0.2510843315062239,-0.9691618852456335,0.5070422535211268,0.7436525888643126,1.0,32/89,22.60%,ARHGAP42;SIPA1L1;SGSM2;RALGAPA2;TBC1D8;ARHGEF15;GRTP1;BCAS3;TBC1D1;ARHGAP25;CCDC125;TBC1D12;BCR;TBC1D22A;RALGAPB;SIPA1;SIPA1L3;GMIP;ABR;TBC1D9B;ARHGEF5;TBCK;EPHA2;TBC1D25;TBC1D2;ECT2;RANGAP1;APC2;ADPRH;RAP1GAP;TBC1D15;ARHGAP45
prerank,folic acid metabolic process (GO:0046655),0.35421059213234224,0.9691066401818407,0.48451327433628316,0.8137892380301067,1.0,8/18,24.32%,ALDH1L1;FPGS;SLC46A1;MTHFD1;MTHFD1L;SLC19A1;MTHFR;MTHFD2L
prerank,positive regulation of organelle assembly (GO:1902117),0.2937886548132862,0.9690502924794947,0.46311475409836067,0.8130171238733921,1.0,13/44,24.31%,ASAP1;PIP4K2A;STX18;PIP4K2B;FUZ;LRSAM1;NUMA1;RAB3GAP1;NUP62;BBS4;G3BP1;PDCD6IP;CNOT2
prerank,fatty acid elongation (GO:0030497),-0.39405019389665885,-0.9689888918105817,0.5156537753222836,0.7435939542596812,1.0,5/13,26.94%,ELOVL7;ELOVL5;ELOVL1;HACD4;HACD2
prerank,regulation of AMPA receptor activity (GO:2000311),-0.3167817981782803,-0.9685160754971304,0.5262135922330097,0.7442249878059657,1.0,3/25,5.31%,MEF2C;SHANK3;MINK1
prerank,intracellular protein transport (GO:0006886),-0.21194970891103573,-0.9680275171082248,0.532520325203252,0.7448741388201792,1.0,99/304,27.42%,RASSF9;TRAK1;SGSM2;STX3;TBC1D8;GRTP1;RPL11;TGFB1;AP3B1;PKD1;CHP1;SYNRG;NAPA;TBC1D1;RAB18;FAM91A1;TBC1D12;STX1A;GABARAP;GIPC1;TRAK2;TBC1D22A;NUP93;ARF5;AKT1;RAB6B;PTTG1IP;HERC2;CD74;E2F3;STX2;SURF4;AKAP6;RAB24;RAB7A;COPB2;KATNB1;ARL4A;SYK;NUP188;TBC1D9B;VPS36;TBCK;SMURF1;ARL6;PHB2;NUP155;RAB1A;AP4M1;TNPO3;AP2A1;SNF8;RPAIN;YWHAH;VPS33A;NSF;TBC1D25;CCHCR1;TSC2;TBC1D2;EHD1;ARHGEF2;VPS29;TMED1;RAB3GAP2;RAB32;CTTN;LAPTM5;IFT27;TMED5;ARL4C;RAB23;ADPRH;STX5;NXT2;CAMSAP3;KIF13A;TBC1D15;CACNG3;TNPO2;COPZ2;RAB43;STXBP2;TBC1D30;TBC1D17;FAM53A;SEC13;RAB5C;PDCD6;RTN2;NUP107;TMED3;NUP42;BCS1L;IPO13;STX4;ARF3;NPM1;TBC1D5
prerank,activation of NF-kappaB-inducing kinase activity (GO:0007250),-0.37401864563752907,-0.9679048830580941,0.5036231884057971,0.7446853865986243,1.0,7/14,33.91%,CARD14;TLR3;TIRAP;TRAF6;CARD10;TLR6;TNFSF15
prerank,respiratory chain complex IV assembly (GO:0008535),-0.3425547949795382,-0.9676847410539875,0.4795539033457249,0.7447468930861365,1.0,12/21,32.70%,COA8;COX15;TIMM21;COA3;SURF1;FASTKD3;COX10;SCO1;PET100;BCS1L;COA6;SCO2
prerank,cell cycle G2/M phase transition (GO:0044839),-0.2376616499916276,-0.9674920215684586,0.5206286836935167,0.7447131712933308,1.0,43/129,25.79%,CCNY;DCTN2;TPD52L1;TUBA1A;CEP164;PPP2R1A;PRKAR2B;CEP192;CEP57;NES;CEP70;DCTN3;PPP1CB;CEP290;CNTRL;DCTN1;PPP1R12B;PCM1;TUBB4B;PPP2R2A;FBXL7;HAUS1;NDE1;CETN2;CEP72;YWHAG;CDKN1A;HSP90AA1;CEP41;FBXL3;CUL1;LCMT1;DNM2;TUBA4A;PLK3;ARPP19;PPP1R12A;BRSK2;CDKN2B;HAUS4;YWHAE;CEP63;NEDD1
prerank,regulation of dendritic cell apoptotic process (GO:2000668),0.41474811690530317,0.967044950984745,0.49213483146067416,0.8172524415192771,1.0,2/10,5.75%,LYN;AXL
prerank,protein polyubiquitination (GO:0000209),-0.21232613313519022,-0.9668952466328482,0.5644820295983086,0.7456565209908441,1.0,84/297,23.16%,WWP1;NEDD4L;LMO7;RNF144B;HERC6;RNF41;UBB;ZNRF1;WWP2;RLIM;UBC;RPS27A;RNF125;UBE2Q2;CBFB;FBXO17;PSMA6;RNF114;ANAPC11;RC3H1;PSMB5;FBXO4;NHLRC3;UBE2L6;TRIM14;UBE2G2;PSMC4;PSMC5;FBXL14;TRIM56;PSMD14;TRIM62;FBXW5;UBE2Q1;FBXW10;MIB2;ITCH;RNF5;TRAF1;KLHL3;FBXL7;LNPEP;SMURF1;TRIM68;RNF20;RBX1;UBE2G1;TRIM5;PSMD8;WSB1;PSMD11;TNFAIP3;CCNF;ANAPC7;HECTD1;CDC27;PSMB4;PSMD12;PSMC1;FBXL3;FZR1;FBXL16;CUL1;ZNRF2;FBXW2;PELI1;RNF19A;AMFR;TMEM129;UBE2B;PSMA1;UBE3A;BLMH;ANAPC2;PSMB1;PSMC3;BFAR;NPEPPS;PSMA4;FBXO40;DTL;FBXL19;PSMA2;FBXL18
prerank,DNA double-strand break processing (GO:0000729),0.35243795429505875,0.966362699332926,0.5,0.8180524129034153,1.0,7/18,18.13%,RNF138;SETMAR;BLM;NBN;ATM;KAT5;UBE2N
prerank,regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),-0.39448618780619155,-0.9658192482442349,0.5063520871143375,0.7476236850828342,1.0,4/12,21.38%,MPHOSPH8;TRIM28;TASOR;SETDB1
prerank,histone H4 deacetylation (GO:0070933),-0.4200861830529103,-0.9657283822951404,0.5298372513562387,0.7473438933520858,1.0,3/10,8.30%,REST;HDAC9;HDAC4
prerank,cartilage development (GO:0051216),0.2868764664952291,0.9655598051333231,0.4970178926441352,0.8191408147282109,1.0,4/49,1.48%,BMP2;SULF1;HYAL3;SULF2
prerank,regulation of lipid metabolic process (GO:0019216),0.2552397381110534,0.9650617519300694,0.504,0.8194571878144252,1.0,6/88,2.08%,RORA;TBL1XR1;CHD9;NCOA2;PPARA;PRKAG2
prerank,spindle assembly (GO:0051225),-0.2618476420412059,-0.964548817495596,0.5166994106090373,0.7497255289098902,1.0,22/67,31.12%,RAB11A;NCOR1;NEK7;RPS3;CEP192;HAUS1;GOLGA8B;LSM14A;MAPRE2;MISP;TPX2;RCC1;SPICE1;HAUS4;CEP63;KIFC2;SAC3D1;TUBGCP6;KIF11;HDAC3;BCCIP;RHOA
prerank,anterograde axonal transport (GO:0008089),-0.2933763076183471,-0.9644604604785545,0.4839357429718876,0.7494802382528921,1.0,7/37,9.75%,TRAK1;AP3M1;AP3B1;NEFL;TRAK2;HSPB1;KIF1B
prerank,regulation of blood circulation (GO:1903522),0.3036474592743912,0.9643863608343504,0.5295315682281059,0.8202557716349838,1.0,3/34,5.75%,CELF2;DMPK;FXYD1
prerank,protein localization to nucleus (GO:0034504),-0.24619281027909215,-0.964329939244174,0.5502958579881657,0.7493206403661188,1.0,30/102,26.54%,ZBTB7A;RPL11;SIX1;NUP93;AKT1;HHEX;PTTG1IP;ARL2BP;E2F3;TOR1AIP1;SYK;NUP188;PHB2;NUP155;TNPO3;CHCHD10;RPAIN;TSC2;TOR1AIP2;ARL2;MSX1;CNEP1R1;NXT2;TNPO2;YWHAE;FAM53A;SEC13;RPF2;NUP107;IPO13
prerank,positive regulation of mononuclear cell migration (GO:0071677),-0.31357301462378445,-0.9640067757543431,0.5091911764705882,0.7496074099919245,1.0,2/29,1.00%,ANO6;JAM2
prerank,"nucleotide-excision repair, preincision complex stabilization (GO:0006293)",-0.33380122652765726,-0.963908742536814,0.5098425196850394,0.748885666776842,1.0,8/21,19.11%,ERCC1;CUL4A;GTF2H3;CHD1L;RBX1;RPA3;GTF2H4;ERCC4
prerank,"nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",-0.33380122652765726,-0.963908742536814,0.5098425196850394,0.748885666776842,1.0,8/21,19.11%,ERCC1;CUL4A;GTF2H3;CHD1L;RBX1;RPA3;GTF2H4;ERCC4
prerank,regulation of water loss via skin (GO:0033561),-0.37165964938855306,-0.9638533541743177,0.5152671755725191,0.7480726978084569,1.0,7/15,30.21%,LSR;HRNR;MET;SFN;CLDN1;STMN1;ALOXE3
prerank,establishment of skin barrier (GO:0061436),-0.37165964938855306,-0.9638533541743177,0.5152671755725191,0.7480726978084569,1.0,7/15,30.21%,LSR;HRNR;MET;SFN;CLDN1;STMN1;ALOXE3
prerank,establishment or maintenance of apical/basal cell polarity (GO:0035088),0.3444455061396771,0.9636859196133352,0.4734607218683652,0.8210886322299216,1.0,4/19,10.17%,PARD3B;DLG2;LRRC7;PRKCI
prerank,cholesterol transport (GO:0030301),-0.2816195922181886,-0.963466098922917,0.5077519379844961,0.7485395605266432,1.0,18/45,33.06%,CAV1;SCARB1;ABCG1;STARD5;APOE;TSKU;NPC1;STAR;LCAT;MSR1;SERAC1;APOC1;VPS4A;CD36;SOAT2;OSBPL2;OSBPL5;LIMA1
prerank,negative regulation of cellular metabolic process (GO:0031324),-0.2927116942771784,-0.9633299784196726,0.5390625,0.7483711739216145,1.0,7/37,14.46%,RIN3;NCOR1;ANKRD13A;EDN1;APOE;ABCA2;SDCBP
prerank,monoacylglycerol metabolic process (GO:0046462),0.38566114658959955,0.9633109446106629,0.4782608695652174,0.8211165812234847,1.0,4/13,14.55%,PLA2G4A;MOGAT3;MOGAT2;DGAT2
prerank,cellular response to glucose stimulus (GO:0071333),-0.3068018285920811,-0.9632110572552876,0.5158102766798419,0.7481562037209859,1.0,4/30,3.44%,IGF1R;RACK1;UNC13B;KCNB1
prerank,macrophage differentiation (GO:0030225),0.38391307924007123,0.9630217716258569,0.4967032967032967,0.8209425379080398,1.0,1/13,0.34%,IL31RA
prerank,response to alcohol (GO:0097305),0.3232739386873131,0.9630013665157655,0.524008350730689,0.8200808577765027,1.0,2/27,2.71%,TGFBR3;GRIN3A
prerank,regulation of cell size (GO:0008361),0.33303974262866565,0.9627039781310321,0.5159090909090909,0.8199368561143441,1.0,4/23,10.35%,PRR16;DEPTOR;RARG;PTEN
prerank,negative regulation of cell projection organization (GO:0031345),0.2790047662554769,0.9624165858831859,0.5204301075268817,0.8197610048292475,1.0,11/48,17.49%,LPAR1;SEMA3A;RAB29;DPYSL3;STX1B;DCC;PTEN;CBFA2T2;DENND5A;PTPN9;GRIN2B
prerank,gene silencing by miRNA (GO:0035195),-0.2997574978710042,-0.9623648169919714,0.503731343283582,0.7496236490400631,1.0,6/32,11.40%,TNRC6C;ADAR;CNOT7;NOTCH4;WTIP;LIMD1
prerank,endoplasmic reticulum tubular network organization (GO:0071786),-0.3676591357136983,-0.9619466784591403,0.5,0.7501854305726783,1.0,6/15,25.01%,RAB18;ATL2;REEP4;RTN3;TMEM33;ZFYVE27
prerank,peptidyl-arginine modification (GO:0018195),-0.36517993201441146,-0.9616512182990619,0.5160142348754448,0.7504023080669334,1.0,3/15,10.12%,PRMT8;ART3;KRTCAP2
prerank,positive regulation of cartilage development (GO:0061036),0.3617956769902716,0.9614980315951054,0.5221987315010571,0.8211222947731542,1.0,3/17,9.57%,BMP2;LOXL2;SOX5
prerank,protein import into nucleus (GO:0006606),-0.2615063003520507,-0.9614669046405713,0.574,0.7503977307567316,1.0,22/66,26.54%,RPL23;NUP93;KPNA1;AKT1;NUP54;PTTG1IP;E2F3;SYK;NUP188;PHB2;NUP155;RANBP2;TNPO3;RPAIN;TSC2;KPNA4;NXT2;TNPO2;FAM53A;SEC13;NUP107;IPO13
prerank,synaptic vesicle endocytosis (GO:0048488),0.310075260161698,0.9613906097021563,0.5087336244541485,0.8204677688243218,1.0,7/33,7.71%,DNAJC6;STON1;SNAP91;NLGN2;NLGN3;SYT1;NLGN1
prerank,positive regulation of ceramide biosynthetic process (GO:2000304),-0.40062265465670704,-0.9613069928799037,0.5096899224806202,0.749823421276847,1.0,3/10,13.25%,RACK1;SPHK2;TNFRSF1A
prerank,positive regulation of sphingolipid biosynthetic process (GO:0090154),-0.40062265465670704,-0.9613069928799037,0.5096899224806202,0.749823421276847,1.0,3/10,13.25%,RACK1;SPHK2;TNFRSF1A
prerank,positive regulation of bone resorption (GO:0045780),-0.40837010850313893,-0.9612212929560746,0.5355191256830601,0.7495898479005697,1.0,4/11,12.88%,PLEKHM1;TNFRSF11A;SPP1;SYK
prerank,chondrocyte differentiation (GO:0002062),0.31442405526985584,0.9611530231698737,0.5123456790123457,0.8201563450786633,1.0,3/32,1.48%,BMP2;SULF1;SULF2
prerank,negative regulation of mononuclear cell migration (GO:0071676),-0.3876193946109123,-0.9608581143810029,0.5109489051094891,0.7500105716619297,1.0,5/12,16.40%,CCN3;SLIT2;AKT1;WASL;GREM1
prerank,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),-0.3163221864252015,-0.9608324804319891,0.532803180914513,0.7495939093195151,1.0,11/28,23.34%,MAP3K5;DAB2IP;ATP2A3;ATF4;BAX;BBC3;BAK1;TRIB3;SELENOK;ERO1A;BRSK2
prerank,non-motile cilium assembly (GO:1905515),0.31806734926346764,0.9604896967582943,0.5011286681715575,0.8208804718019943,1.0,15/30,26.71%,TMEM17;TTC8;IFT122;C2CD3;FUZ;PIBF1;ARL13B;IFT88;IFT57;BBS4;TMEM107;TMEM80;CSNK1D;CEP250;CEP89
prerank,energy derivation by oxidation of organic compounds (GO:0015980),0.32919718155742733,0.960335000077246,0.49166666666666664,0.820386476412351,1.0,4/24,8.46%,PID1;LEPR;SLC25A13;NDUFS1
prerank,cellular response to oxygen-containing compound (GO:1901701),-0.21203509964272219,-0.9602181939334102,0.5846153846153846,0.7505749996541733,1.0,39/291,11.49%,MEF2C;ACTB;RAP1A;LBP;ESR1;MTR;VIM;PXN;RAP1B;PTK2B;TGM2;SH3BP4;FOXO1;MAPK3;RAPGEF1;TBX1;FZD4;CAPN2;RPS3;DAB2IP;SLIT2;IGFBP5;PDE2A;GUCY1B1;KCNQ1;NRIP1;WNT9A;EZR;TNFRSF1B;AKT1;FZD7;NDUFA13;PLAA;TIRAP;VCP;WNT11;ABL2;AKAP6;IMPACT
prerank,cellular response to interleukin-15 (GO:0071350),-0.3830399702104493,-0.9602160655394636,0.5440140845070423,0.7496403535739815,1.0,4/13,17.47%,IL15;SHC1;STAT5A;JAK3
prerank,interleukin-15-mediated signaling pathway (GO:0035723),-0.3830399702104493,-0.9602160655394636,0.5440140845070423,0.7496403535739815,1.0,4/13,17.47%,IL15;SHC1;STAT5A;JAK3
prerank,glutamate metabolic process (GO:0006536),0.35318179981168096,0.9599964432817225,0.5249457700650759,0.8203482367032798,1.0,5/19,11.18%,ALDH18A1;PRODH;GLUL;GLS2;FPGS
prerank,cortical actin cytoskeleton organization (GO:0030866),0.3398164054421541,0.9597229236766629,0.5103734439834025,0.8201231174351176,1.0,5/20,15.56%,ROCK2;FHOD3;FMNL3;LLGL1;RHOQ
prerank,regulation of voltage-gated calcium channel activity (GO:1901385),-0.333263127168061,-0.9596839650478425,0.5152671755725191,0.7504774730772046,1.0,5/22,14.62%,AHNAK;DMD;CACNB3;FMR1;SRI
prerank,"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",0.2772388970948817,0.9589213833009638,0.498960498960499,0.8212631984486327,1.0,9/53,12.43%,HTR7;CHRM2;MC5R;CHRM3;HRH1;HRH2;HTR4;PTGIR;HTR5A
prerank,positive regulation of protein localization to plasma membrane (GO:1903078),0.2772542796735531,0.9588701831109002,0.5155925155925156,0.8204879151045695,1.0,5/52,2.58%,PIK3R1;LRP1;DPP10;PDPK1;EPHA3
prerank,chemical homeostasis (GO:0048878),-0.2652592922906779,-0.958234174989173,0.5096153846153846,0.7534123680886762,1.0,14/61,19.63%,SLC4A10;NEDD4L;WNK1;AQP11;USF2;SLC4A8;ACOX3;PNPLA2;SLC4A2;KLHL3;TLCD3A;ADCK1;AQP4;ABHD8
prerank,inorganic ion transmembrane transport (GO:0098660),-0.39415056587192343,-0.9582288303879206,0.5203703703703704,0.7529609097238105,1.0,7/12,32.72%,ABCC9;KCNJ8;CACNA1H;PKD2;ABCC8;TRPM4;P2RX3
prerank,regulation of mitochondrial depolarization (GO:0051900),-0.4098596501705163,-0.9580936954581553,0.5221238938053098,0.7528043808486412,1.0,3/10,6.57%,RACK1;KDR;MYOC
prerank,cellular response to virus (GO:0098586),-0.3094980551981421,-0.9578516579768495,0.516728624535316,0.7528781224809252,1.0,16/30,37.52%,IFIH1;BAX;FMR1;POU2F2;HSP90AA1;CHUK;LGALS9;MAPK11;VWCE;IRGM;RIOK3;CCL5;IRF3;EIF5A;POU2AF1;IL12A
prerank,response to retinoic acid (GO:0032526),-0.27034966691611406,-0.9577981894038415,0.5092402464065708,0.752526789243426,1.0,12/59,11.08%,ACER2;PTK2B;TBX1;FZD4;WNT9A;RARA;GATA6;TRIM16;FZD7;NDUFA13;WNT11;ABL2
prerank,3'-UTR-mediated mRNA stabilization (GO:0070935),-0.3711443003392463,-0.9571977756612478,0.5277777777777778,0.7534763715906867,1.0,6/14,36.29%,YBX3;TIRAP;BOLL;HNRNPC;ANGEL2;DAZL
prerank,protein hydroxylation (GO:0018126),-0.37229891197674186,-0.9565285767223268,0.53125,0.7546167371900614,1.0,7/15,29.08%,EGLN3;PLOD2;PLOD3;P3H2;HIF1AN;VPS33B;P3H1
prerank,mRNA metabolic process (GO:0016071),-0.24645191626894408,-0.9563941894137591,0.5277246653919694,0.7544433232746818,1.0,37/90,33.10%,DDX5;HNRNPA2B1;PPARGC1A;PRPF8;SRSF2;SRSF5;DHX15;SNRPD3;U2AF1;LSM11;DIS3L2;SFPQ;YTHDF2;SRSF4;SF3A3;RNH1;HSPA1A;SCAF11;SNRPG;LSM2;LSM3;TBRG4;HSPA1B;NCBP2;LSM10;SNRPB;SF3A1;SF3A2;KIN;HNRNPR;ERN1;SRSF9;LSM6;SRSF1;ZC3H12D;PCF11;DCP2
prerank,error-prone translesion synthesis (GO:0042276),-0.33808955229566745,-0.956175767662291,0.5351851851851852,0.7544916746626184,1.0,8/21,24.17%,UBB;UBC;RPS27A;REV3L;RPA3;POLK;RFC3;RFC2
prerank,hydrogen peroxide catabolic process (GO:0042744),-0.4061027593165999,-0.9559936272301247,0.5427509293680297,0.7544782260392539,1.0,3/11,26.34%,GPX1;GPX3;PRDX4
prerank,positive regulation of histone modification (GO:0031058),-0.30095472180021,-0.9556630601539017,0.5281553398058253,0.754810890906594,1.0,8/33,17.32%,RPS6KA5;MAPK3;PPARGC1A;CTBP1;TADA2B;FMR1;CHTOP;KDM1A
prerank,positive regulation of small molecule metabolic process (GO:0062013),0.36828684691385527,0.9554418557530382,0.5307855626326964,0.8281211474935842,1.0,3/15,5.95%,PPARA;IRS2;ADM
prerank,positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),-0.35554303176624646,-0.9553428506035981,0.5384615384615384,0.7550977816892742,1.0,2/16,3.35%,ST3GAL4;ETS1
prerank,vacuolar acidification (GO:0007035),0.33568583191368173,0.9548201337515867,0.512396694214876,0.8287757463975537,1.0,5/21,17.07%,ATP6V0A4;ATP6V1H;DMXL1;CLN3;DMXL2
prerank,positive regulation of long-term synaptic potentiation (GO:1900273),0.38344231877735485,0.9544398993245395,0.5062240663900415,0.8288021390885725,1.0,4/13,13.18%,ADCY1;ADCY8;CHRNA7;ZDHHC2
prerank,positive regulation of lipid biosynthetic process (GO:0046889),-0.3092520284459423,-0.9544077812750342,0.5380116959064327,0.7567393636142703,1.0,7/29,12.33%,SORBS1;SCARB1;CHP1;MFSD2A;AKT1;ELOVL5;APOE
prerank,plasma membrane organization (GO:0007009),-0.2633358157419734,-0.9542867773310996,0.5423387096774194,0.7565574927706333,1.0,9/61,7.53%,ANO6;SPTBN1;FNBP1L;AHNAK2;CAVIN2;MYOF;DYSF;EHD2;A4GALT
prerank,positive regulation of Notch signaling pathway (GO:0045747),-0.28876733216131817,-0.9541395988645911,0.5219047619047619,0.7564416407279365,1.0,13/39,15.49%,NOS3;TSPAN5;NOTCH1;CCN3;TGFB2;NEPRO;JAG2;NOTCH4;TSPAN14;TM2D3;POGLUT1;EPN2;NOD2
prerank,cellular response to insulin stimulus (GO:0032869),-0.2335982931907947,-0.9541229807069764,0.5693877551020409,0.7560134283559462,1.0,22/124,10.84%,IGF1R;GAB1;SORBS1;NAMPT;GRB14;CAV2;FOXO1;RAB8B;ATP6V0B;HDAC9;ATP6V0A2;PKM;SHC1;PRKDC;IDE;AKT1;INSR;PIK3C2A;ATP6V0C;RAB8A;GRB10;FOXC2
prerank,regulation of neutrophil migration (GO:1902622),-0.41242547954482817,-0.9538939403835809,0.5256410256410257,0.7560987258567591,1.0,2/10,4.56%,JAM3;RAC1
prerank,phagosome-lysosome fusion (GO:0090385),0.40961922746631313,0.9537510558024972,0.5203836930455635,0.8295306958217266,1.0,4/10,19.24%,PLA2G5;RAB20;CLN3;RAB7B
prerank,long-chain fatty acid metabolic process (GO:0001676),-0.2623276228659611,-0.9536679457090558,0.5386138613861386,0.7561796810967916,1.0,18/64,19.79%,MGLL;EPHX1;CYP1B1;LTA4H;GPX1;HACL1;ASAH2;ELOVL5;ACADL;GSTM2;CPT1A;ACSL5;FAAH;GPX4;ACOT8;ELOVL1;DAGLB;ACOT2
prerank,regulation of protein polymerization (GO:0032271),-0.29558109468248167,-0.9535913969697973,0.5361010830324909,0.7558836859334502,1.0,13/35,23.65%,ESAM;PFN1;PRUNE1;DBNL;DBN1;HSP90AA1;RASA1;ARL2;CTTN;HCLS1;PLEKHG2;CAMSAP3;ARHGAP18
prerank,membrane repolarization (GO:0086009),-0.36893679366118226,-0.9533863860203625,0.5466417910447762,0.7558708720931601,1.0,7/15,21.60%,KCNJ2;ATP1A1;KCNQ1;ATP1B1;KCND3;ATP1B2;KCNIP2
prerank,cardiac myofibril assembly (GO:0055003),0.37174910095493735,0.9525546578327055,0.5188916876574308,0.8316850393507386,1.0,6/15,14.84%,PDGFRA;CSRP3;FHOD3;PDGFRB;OBSL1;MYLK3
prerank,synaptic vesicle localization (GO:0097479),0.3730692658346503,0.9518725312073576,0.508235294117647,0.832477623491047,1.0,5/13,16.29%,KIF5C;SYNDIG1;NLGN1;SNAPIN;TMEM230
prerank,diacylglycerol metabolic process (GO:0046339),-0.3308107036953713,-0.9511295754436214,0.548689138576779,0.7606446580692918,1.0,2/23,1.69%,PLCE1;DGKH
prerank,branched-chain amino acid catabolic process (GO:0009083),0.3420517944535974,0.9499151873628596,0.5010706638115632,0.8356581457357168,1.0,10/20,20.96%,ACADSB;ALDH6A1;BCKDHB;HIBADH;DBT;ACAD8;IVD;MCCC2;BCAT2;BCAT1
prerank,branched-chain amino acid metabolic process (GO:0009081),0.3420517944535974,0.9499151873628596,0.5010706638115632,0.8356581457357168,1.0,10/20,20.96%,ACADSB;ALDH6A1;BCKDHB;HIBADH;DBT;ACAD8;IVD;MCCC2;BCAT2;BCAT1
prerank,positive regulation of osteoclast differentiation (GO:0045672),0.3770344364983129,0.9498646083587144,0.5172413793103449,0.8348811866163831,1.0,1/14,1.34%,OCSTAMP
prerank,long-chain fatty acid import into cell (GO:0044539),-0.4055335379698242,-0.949836183431969,0.543233082706767,0.7631168956714972,1.0,6/10,30.00%,SLC2A1;SPX;SLC27A2;SLC27A1;CD36;RPS6KB1
prerank,fibrinolysis (GO:0042730),0.3773123484623362,0.9498152535398795,0.5063025210084033,0.8341203023141148,1.0,2/13,6.13%,SERPINE1;PLG
prerank,peptide hormone secretion (GO:0030072),-0.30771096928110203,-0.9493223417583311,0.5393258426966292,0.7638289688899154,1.0,16/26,45.49%,LTBP4;ANXA1;EDN1;RAB1A;PARK7;CAMK2G;ADCYAP1;SNX19;EXOC3L1;VIP;EDN3;SLC30A8;FAM3B;NEUROD1;IL6;GAL
prerank,phosphatidic acid metabolic process (GO:0046473),0.280524996063412,0.948924062574582,0.5207100591715976,0.8353547543529121,1.0,12/48,20.28%,PLA2G5;PLA2G4A;DGKD;GPD1L;PLD1;GNPAT;DDHD2;PLD2;ABHD5;LCLAT1;PLA2G6;PLA2G12A
prerank,cytosolic transport (GO:0016482),-0.23490309961781808,-0.948882436385468,0.5787476280834914,0.7643720194004444,1.0,40/108,29.97%,MYO1D;VPS13A;VPS53;EEA1;RAB6B;TMEM87B;HEATR5A;GOSR1;LAMP1;EMP2;LMTK2;DCTN1;KIF16B;RAB7A;CCDC91;DOP1B;AP4M1;SPAG9;AP2A1;SNF8;GCC2;VTI1B;TBC1D23;VPS29;LAPTM5;EHD3;STX5;VPS54;CORO7;PHETA2;TBC1D17;EPS15;SNX2;TBC1D5;PREPL;ERC1;STX16;HEATR5B;RAB6A;AP1G1
prerank,regulation of phospholipid metabolic process (GO:1903725),-0.4039505568561517,-0.9487422926967413,0.5227272727272727,0.764238011705712,1.0,6/10,40.16%,MFSD2A;PHB2;MTMR2;GNB3;ABCA3;MTMR3
prerank,"phagocytosis, engulfment (GO:0006911)",-0.2932321634652352,-0.9478107351561248,0.5470249520153551,0.7659838276135106,1.0,5/36,5.70%,THBS1;DOCK1;VAMP7;RAC1;ARHGAP25
prerank,regulation of cell-cell adhesion mediated by cadherin (GO:2000047),0.3485974270776635,0.9476485123297004,0.5076923076923077,0.8376115338767699,1.0,3/19,6.59%,BMP6;PLG;FOXA2
prerank,negative regulation of T cell proliferation (GO:0042130),0.3180978338542163,0.9472057301611719,0.5222672064777328,0.8378363589142831,1.0,4/28,7.73%,IL4I1;CEBPB;GLMN;CD274
prerank,regulation of intrinsic apoptotic signaling pathway (GO:2001242),-0.2756312245230939,-0.9470729288548192,0.5423728813559322,0.7672239894098444,1.0,13/49,21.54%,SGMS1;CAV1;RACK1;BAX;NDUFA13;BBC3;BCL2L1;NDUFS3;BCAP31;BAD;PTPMT1;MCL1;FIS1
prerank,secondary palate development (GO:0062009),0.3770523029066913,0.9466983480186538,0.5298969072164949,0.838243566217039,1.0,3/14,5.04%,TGFBR3;CHD7;LRRC32
prerank,positive regulation of calcium ion transport (GO:0051928),-0.28827648535769856,-0.9466223643586207,0.5607142857142857,0.7677790622468593,1.0,8/36,16.26%,CAV1;TRPC3;STIM2;TRPC6;ORAI1;SPHK2;CACNA1D;ATP2B1
prerank,protein targeting to membrane (GO:0006612),-0.24437661360319546,-0.9464336179641554,0.5626168224299065,0.7677716462739653,1.0,34/83,32.23%,PARD3;RAB8B;AQP11;ATG3;NACA;SEC63;ZDHHC9;TAOK2;ZDHHC1;ICMT;ARL6;ZDHHC20;SDCBP;SGTA;SRP19;SSR2;ZDHHC23;FIS1;SGTB;ZDHHC12;ZDHHC3;ZDHHC18;TRAM1;SEC61A1;PEX14;GOLGA7B;NACAD;ZDHHC24;ABCD3;SRPRA;VPS37C;CHMP4B;CHMP4A;CHM
prerank,steroid hormone biosynthetic process (GO:0120178),0.3102655670567588,0.9463670561077535,0.5218340611353712,0.8381851733178659,1.0,1/29,0.69%,AKR1B1
prerank,positive regulation of small GTPase mediated signal transduction (GO:0051057),0.31623835355961116,0.9463348214671923,0.5223880597014925,0.8373719680625966,1.0,3/29,5.54%,IGF1;LYN;IRS2
prerank,regulation of phagocytosis (GO:0050764),0.2735235699569766,0.9462286319171409,0.5094339622641509,0.8367552860733367,1.0,4/53,2.10%,CAMK1D;PRTN3;PLA2G5;AHSG
prerank,secondary alcohol biosynthetic process (GO:1902653),-0.29898163139974465,-0.9462184177386522,0.550185873605948,0.7677929784642592,1.0,13/30,31.77%,LBR;ACAA2;ACLY;DHCR24;TM7SF2;FDPS;LSS;PLPP6;IDI1;ACAT2;INSIG1;EBP;HMGCR
prerank,ganglioside metabolic process (GO:0001573),-0.3431448041291844,-0.9460600612938551,0.5652173913043478,0.7676769819243764,1.0,4/20,6.49%,ST6GALNAC3;ST8SIA4;HEXA;ST8SIA6
prerank,vasculature development (GO:0001944),0.35523486012830296,0.945815233687559,0.5138248847926268,0.8369289491471512,1.0,3/16,6.77%,ERRFI1;PDGFRA;PDGFRB
prerank,autophagy of nucleus (GO:0044804),0.3614689447104964,0.9457715006446894,0.5460674157303371,0.8361401870266347,1.0,7/16,21.67%,WDR45B;ATG12;WIPI1;ULK2;ATG9A;ATG5;WDR45
prerank,positive regulation of protein ubiquitination (GO:0031398),-0.2542086285393586,-0.9453298014337805,0.5670731707317073,0.7688997079957264,1.0,32/80,30.24%,CAV1;DCUN1D5;SMAD7;FKBP1A;UBB;DCUN1D1;FBXO4;FAM107A;PTTG1IP;MTA1;SPRTN;PEF1;RBX1;BMI1;KDM1A;CDK5RAP3;PIN1;LAPTM5;UBE3A;TRIB3;TRAF6;BCL10;DCUN1D3;XIAP;PDCD6;TSPYL5;NDFIP2;MAGEC2;DERL1;RPS2;HDAC3;PLK1
prerank,excitatory postsynaptic potential (GO:0060079),0.3390801494830323,0.9451412059033628,0.5235042735042735,0.8367737201648549,1.0,7/19,18.84%,GRID2;MPP2;MAPK8IP2;GRIN2A;DRD2;GRIN2B;RAB3GAP1
prerank,peptidyl-threonine dephosphorylation (GO:0035970),0.3408113987965504,0.9450566382527132,0.5268817204301075,0.8360962353047227,1.0,1/22,0.29%,PPM1E
prerank,regulation of ERBB signaling pathway (GO:1901184),-0.36339732033989686,-0.9448111888211096,0.5572916666666666,0.7696556595901036,1.0,4/15,14.83%,MVB12B;PTPN12;EGFR;ERBB2
prerank,histone modification (GO:0016570),0.2394322656638152,0.9447541738790648,0.5523613963039015,0.8359570107379454,1.0,23/109,15.47%,EYA2;TBL1XR1;PRDM5;MAP3K12;TAF6L;HDAC10;BAZ1B;EYA1;SIRT2;ATXN7;NSD1;KAT8;MIER3;BRMS1L;BRMS1;EHMT2;NEK11;AURKC;NSD3;EP300;EZH2;KAT5;PADI1
prerank,peptide metabolic process (GO:0006518),-0.24845785319791966,-0.9443820675555028,0.5670731707317073,0.7702267868677347,1.0,18/75,15.05%,DMD;TPP1;BACE2;BACE1;LTA4H;ERAP1;IDE;SPCS1;GPX1;GSTA4;CPE;CARNMT1;GSTM2;SEC11A;GSTA3;LNPEP;ACE;GSTM1
prerank,proteasomal ubiquitin-independent protein catabolic process (GO:0010499),-0.3254667277615455,-0.9443361555032243,0.5307971014492754,0.7698559180191907,1.0,8/22,25.25%,PSMA6;PSMB5;PSMB4;PSMA1;PSMB1;PSMA4;PSMA2;PSMB8
prerank,regulation of high voltage-gated calcium channel activity (GO:1901841),-0.3969972153637581,-0.9441999495669383,0.5355191256830601,0.7697026996251395,1.0,5/10,15.15%,CALM1;CACNB3;CALM3;SRI;NIPSNAP2
prerank,sulfur amino acid catabolic process (GO:0000098),-0.40484058828457825,-0.944112126137803,0.5287769784172662,0.769421244151677,1.0,4/10,24.95%,TXN2;CTH;BLMH;MTRR
prerank,DNA replication checkpoint signaling (GO:0000076),-0.35556119394061036,-0.9435579428004824,0.5185185185185185,0.7702310714605756,1.0,8/16,34.13%,RAD9B;HUS1;RAD9A;RAD17;DNA2;CDC6;TICRR;CLSPN
prerank,positive regulation of ion transport (GO:0043270),0.2781669052909772,0.9433581950581426,0.5491452991452992,0.8385330823308809,1.0,7/48,7.60%,GDNF;SCN3B;ANK2;P2RX4;GPD1L;MYLK;CACNB2
prerank,pharyngeal system development (GO:0060037),0.36737635930218265,0.9430293898746558,0.5346756152125279,0.838438576759087,1.0,5/15,9.35%,BMP5;SIX4;TGFBR1;GATA3;BMPR1A
prerank,establishment of spindle localization (GO:0051293),-0.3624436309641687,-0.9430283489504577,0.5327102803738317,0.770940922091994,1.0,5/14,36.29%,MAP4;CFL1;TLE6;ESPL1;NLRP5
prerank,"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",-0.20994989473023193,-0.9429604088930805,0.6303418803418803,0.7706209091309841,1.0,98/241,34.99%,DDX5;NOVA2;HNRNPA2B1;CTNNBL1;HSPA8;PRPF8;SRSF2;MTREX;DNAJC8;SRSF5;SNRNP48;SNRPA;SNRPC;ISY1;DDX41;SRSF6;DHX15;FUS;RBM22;DHX9;SNRPD3;U2AF1;XAB2;SFPQ;RNPS1;RBM6;ZRSR2;SRSF4;MAGOH;RBM4B;DDX23;HNRNPK;ALYREF;EFTUD2;SF3A3;DDX39B;PCBP1;GTF2F1;HNRNPA1;PHF5A;SNRPG;PNN;PDCD7;UBL5;LSM2;CASC3;USP49;CHERP;PRPF40A;SYNCRIP;LSM7;CD2BP2;RBM19;CPSF4;LSM3;SRRM2;DDX39A;NCBP2;RBM17;RBM14;CSTF2T;SNRPB;SF3A1;PABPC1;SF3A2;GTF2F2;SNRPB2;HNRNPR;WBP11;POLR2F;AQR;SRSF9;LSM6;PRPF19;HNRNPA3;CDC5L;HNRNPH3;PQBP1;POLR2L;ESS2;ZCCHC8;U2AF1L4;POLR2I;SNRNP25;POLR2C;HNRNPC;SF3B5;SRSF1;PCF11;UPF3B;WBP4;RBM15B;TRA2B;RSRC1;HNRNPM;HNRNPH1;SMNDC1;PUF60
prerank,DNA methylation (GO:0006306),0.3277404805753438,0.9427940195696258,0.5167364016736402,0.8381334135622803,1.0,7/23,22.69%,PPM1D;DNMT1;EHMT2;TEX15;DNMT3B;ATF7IP;ZFP57
prerank,protein localization to chromatin (GO:0071168),-0.345161329531649,-0.9424974280561543,0.5417439703153989,0.7712370555312338,1.0,8/18,30.24%,ESR1;TASOR;WAPL;RAD21;NIPBL;MRNIP;CHMP7;PLK1
prerank,regulation of calcium ion transport (GO:0051924),0.2689962535234157,0.9423422348239526,0.5318681318681319,0.8383669876471033,1.0,8/54,8.79%,ANK2;CACNA2D1;BCL2;P2RX4;MYLK;CAMK2B;CACNB2;SARAF
prerank,regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),-0.2480682747992032,-0.9415891897004706,0.5561904761904762,0.7728836769358131,1.0,17/78,19.30%,ACTB;CCND3;CCNY;CDKN1B;PKD1;RGCC;AKT1;HHEX;CCNG2;EGFR;CCNF;CDKN1A;CCNK;CDKN2C;CDK5RAP3;GADD45A;CCND1
prerank,positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),-0.32493955549757014,-0.9410141769064425,0.5384615384615384,0.7732644767089362,1.0,6/23,15.00%,THBS1;HSP90AB1;GIPC1;RNF111;SDCBP;SMAD4
prerank,positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),-0.32493955549757014,-0.9410141769064425,0.5384615384615384,0.7732644767089362,1.0,6/23,15.00%,THBS1;HSP90AB1;GIPC1;RNF111;SDCBP;SMAD4
prerank,positive regulation of transmembrane transport (GO:0034764),-0.3794500279938797,-0.9407767486307824,0.5393053016453382,0.7733670143665164,1.0,1/13,0.23%,ANO6
prerank,positive regulation of peptide hormone secretion (GO:0090277),0.2907371694217668,0.9407094476711262,0.5521472392638037,0.841483070853643,1.0,5/39,9.93%,TCF7L2;IRS2;NLGN2;TM7SF3;AIMP1
prerank,adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),0.3459509605867568,0.9400821865840088,0.5305263157894737,0.8421091543784402,1.0,5/17,15.86%,ADRA1D;ADRA1B;DRD2;ADRA1A;ADRB3
prerank,regulation of platelet activation (GO:0010543),0.33287507843288633,0.9394082905773552,0.5201793721973094,0.842928007324096,1.0,4/21,4.13%,PDGFRA;PLA2G4A;PRKCA;LYN
prerank,regulation of melanin biosynthetic process (GO:0048021),0.40236242892820473,0.9389836036809374,0.5108695652173914,0.843075353287198,1.0,3/10,11.47%,ZEB2;MFSD12;CTNS
prerank,fat cell differentiation (GO:0045444),0.26958536262347615,0.9388765436992695,0.5535714285714286,0.8424626328031715,1.0,5/57,6.13%,TCF7L2;PID1;OSBPL8;SENP2;ATF5
prerank,DNA duplex unwinding (GO:0032508),-0.2662463277435726,-0.938794331352039,0.5584677419354839,0.7774343746816961,1.0,12/50,17.81%,ANXA1;UBB;UBC;RPS27A;CUL4A;GTF2H3;DHX9;CHD1L;RBX1;CETN2;ASCC3;GTF2H4
prerank,T cell activation (GO:0042110),-0.25610101887037373,-0.9387804336949926,0.5545286506469501,0.777000091521585,1.0,22/69,23.65%,CXADR;DPP4;CTPS1;CD44;FKBP1A;MSN;JAG2;CASP8;HSPD1;CD74;LFNG;PPP3CB;SOX4;JAML;GPR89B;GPR89A;DLL4;NCK1;PTPN22;ADA;PIK3CG;NCK2
prerank,DNA strand elongation involved in DNA replication (GO:0006271),0.3459648758074843,0.938566122264658,0.5066371681415929,0.8423384104546356,1.0,7/18,23.13%,MCM3;GINS2;PCNA;POLD3;MCMDC2;POLD2;MCM7
prerank,T cell differentiation (GO:0030217),0.2919692673794379,0.9385410054848852,0.558891454965358,0.8415265682252662,1.0,5/40,3.86%,KIT;CHD7;LEPR;RHOH;GLI3
prerank,nucleobase-containing compound catabolic process (GO:0034655),-0.28676267376511655,-0.9384838672717045,0.5531531531531532,0.7771764404188575,1.0,10/37,23.55%,ENTPD1;MTREX;PPP1R8;ENTPD7;ENTPD6;DNASE1L2;ENTPD2;RNASEH2C;NUDT18;DFFB
prerank,neural tube closure (GO:0001843),0.3026468518704136,0.9383244753914265,0.5198329853862212,0.8411569823566645,1.0,9/34,12.32%,PRICKLE1;LMO4;DLC1;IFT122;DVL3;PLXNB2;FUZ;GRHL3;MTHFD1
prerank,hippo signaling (GO:0035329),0.3206998933924077,0.9382786157271997,0.5144628099173554,0.8404041849012073,1.0,4/26,6.63%,TEAD1;DCHS1;WWC1;CASP3
prerank,O-glycan processing (GO:0016266),-0.261168127843799,-0.9382314364416944,0.5825049701789264,0.7772832874265366,1.0,20/54,36.09%,ST3GAL4;ST6GAL1;C1GALT1C1;GALNT10;GXYLT1;ST6GALNAC2;B3GNT3;B3GNT8;GALNT5;GCNT4;GALNT6;GALNT9;GALNT1;B4GALT5;ST3GAL2;MUC1;ST6GALNAC4;MUC13;B3GNT2;MUC6
prerank,negative regulation of cellular senescence (GO:2000773),-0.3747025564527617,-0.9381031456580403,0.565587734241908,0.777103325873974,1.0,3/13,8.99%,CDK6;MAP3K3;TWIST1
prerank,triglyceride metabolic process (GO:0006641),0.2762758291598895,0.9379687089777076,0.534516765285996,0.840273002113261,1.0,9/48,16.50%,AGMO;APOH;APOBR;MOGAT3;LPIN3;MOGAT2;DGAT2;FABP4;LPIN1
prerank,neuron development (GO:0048666),0.2315826280543862,0.9379053750533372,0.6083499005964215,0.8395559457983794,1.0,30/141,13.81%,TENM3;GDNF;CNTN4;GLI2;CNTNAP2;GPM6A;GPRIN2;TENM2;PBX4;LYN;GPRIN1;TBC1D24;PPP1R9A;NLGN1;DOCK7;RYK;CDK5R1;EPHA8;CAMSAP1;EPHA5;ALK;ATP8A2;LRP12;RASGRF1;SNAPIN;ATXN10;GBA2;TENM1;CDK16;MAPT
prerank,negative regulation of striated muscle cell differentiation (GO:0051154),-0.340650519658227,-0.9378192105960704,0.5676691729323309,0.7773138941592449,1.0,6/18,17.15%,NOTCH1;CCN3;HDAC4;FZD7;SOX6;XBP1
prerank,negative regulation of macrophage derived foam cell differentiation (GO:0010745),0.39071483095608794,0.937647875345978,0.5021645021645021,0.8393035715338111,1.0,3/12,8.12%,ABCA1;PPARA;ABCA5
prerank,protein K48-linked ubiquitination (GO:0070936),-0.26755111239498347,-0.9373609597697156,0.5778688524590164,0.7778776274534731,1.0,26/54,35.80%,NEDD4L;ZNRF1;UBE2Q2;UBE2G2;ITCH;RNF5;KLHL3;RBX1;UBE2G1;TNFAIP3;PELI1;AMFR;UBE2B;UBE3A;BFAR;DTX3L;RNF187;FBXO38;RNF8;SYVN1;HACE1;UBE2T;CUL3;UBE2R2;UBE2C;RNF152
prerank,negative regulation of T-helper cell differentiation (GO:0045623),-0.39299446448342035,-0.9373402751975993,0.5430711610486891,0.7774598582223806,1.0,3/11,7.75%,ANXA1;SMAD7;RC3H1
prerank,arachidonic acid metabolic process (GO:0019369),-0.2899578553790875,-0.9370480024469969,0.5269230769230769,0.7776332176195411,1.0,10/35,18.31%,PTGDS;MGLL;EPHX1;CYP1B1;GPX1;PTGS1;FAAH;GPX4;CBR1;DAGLB
prerank,Arp2/3 complex-mediated actin nucleation (GO:0034314),-0.3547292248728293,-0.9366690392251092,0.5284697508896797,0.7780341900404457,1.0,3/15,12.70%,ARPC1B;ARPC5;ACTR3
prerank,negative regulation of chondrocyte differentiation (GO:0032331),0.373316513279025,0.9366571798658379,0.5221052631578947,0.840808245443166,1.0,2/14,7.96%,ADAMTS12;TGFBR1
prerank,pore complex assembly (GO:0046931),-0.33439762584246624,-0.9363329342712443,0.5706422018348624,0.7783373949374571,1.0,4/19,9.18%,ANO6;ADAM10;NUP93;NDC1
prerank,defense response to Gram-positive bacterium (GO:0050830),-0.2815002510065936,-0.9355369966853609,0.5418994413407822,0.7797172926276822,1.0,5/40,10.31%,LBP;RPL39;GBP7;PGLYRP1;TIRAP
prerank,translational termination (GO:0006415),-0.23854279350583535,-0.9353995722053612,0.5904572564612326,0.7795539597925566,1.0,34/95,29.61%,MRPL52;PTCD3;MRPL51;MRPL38;MRPL28;MRPL43;MRPL32;MRPL14;MRPS30;ERAL1;MRPL24;MRPS17;MRPL50;MRPL16;MRPL47;MRPL54;MRPS18C;MRPS18A;MRPL35;MRPS6;MRPL58;MRPL48;MRPL49;MRPL13;MRPL11;MRPL21;MRPL30;MRPS24;MRPL2;MRPL42;MRPL15;MRPL19;MRPS14;MRPS2
prerank,glutathione metabolic process (GO:0006749),-0.28287294050407114,-0.9353607813602983,0.55765595463138,0.7791752583435525,1.0,16/38,27.08%,GPX1;GSTA4;GGT5;GSTM2;GSTA3;GSTM1;GSR;GCLM;CNDP2;GCLC;GGT1;GSTK1;GGCT;GSTM5;PARK7;SOD1
prerank,central nervous system neuron axonogenesis (GO:0021955),0.38077091958978815,0.9353019973776915,0.5300925925925926,0.843238585372919,1.0,3/12,10.35%,MYCBP2;EPHB1;PTEN
prerank,negative regulation of secretion (GO:0051048),0.4009271190205746,0.935185772615041,0.5315904139433552,0.8426381693370909,1.0,2/10,8.27%,NRG1;ERBB3
prerank,positive regulation of telomere maintenance (GO:0032206),-0.30601019848689426,-0.9351132474045147,0.5452755905511811,0.7792657402258756,1.0,6/31,12.81%,MAPK3;NEK7;HNRNPA2B1;ERCC1;PNKP;SLX4
prerank,peptidyl-lysine dimethylation (GO:0018027),0.33748234536543226,0.9340653065473962,0.54,0.844629885447348,1.0,5/18,11.57%,PRDM9;SETMAR;KMT2A;SETD7;EHMT2
prerank,regulation of nucleobase-containing compound metabolic process (GO:0019219),0.38499565159845917,0.9339630493158564,0.5597345132743363,0.8440049285227772,1.0,3/11,9.11%,NOVA1;IGF2BP2;PCBP3
prerank,DNA methylation or demethylation (GO:0044728),0.34337362359282114,0.933885032695769,0.5492341356673961,0.8424188033073722,1.0,6/19,21.62%,PPM1D;DNMT1;EHMT2;TEX15;DNMT3B;ATF7IP
prerank,DNA alkylation (GO:0006305),0.34337362359282114,0.933885032695769,0.5492341356673961,0.8424188033073722,1.0,6/19,21.62%,PPM1D;DNMT1;EHMT2;TEX15;DNMT3B;ATF7IP
prerank,cytosolic calcium ion transport (GO:0060401),-0.30540423340668466,-0.9338255096401078,0.5749063670411985,0.7818056488492758,1.0,15/28,24.61%,MCUB;ITPR3;SLC35G1;ATP2A3;MCUR1;JPH2;JPH4;CACNB3;ATP2B3;ATP2B1;MICU2;CACNA1C;JPH3;SMDT1;MCU
prerank,chemokine-mediated signaling pathway (GO:0070098),-0.2793007006486836,-0.9334765534625549,0.5614366729678639,0.7821446774391493,1.0,5/42,11.58%,ACKR3;PTK2B;WNK1;CCL15;CIB1
prerank,endoplasmic reticulum membrane organization (GO:0090158),0.3881156054510567,0.9334682643146706,0.5191011235955056,0.8425867699938276,1.0,3/11,10.19%,VCPIP1;RTN4;STX18
prerank,nucleobase-containing small molecule interconversion (GO:0015949),-0.31343444534064124,-0.933306393871705,0.5477941176470589,0.7820841214451393,1.0,8/27,25.80%,CTPS1;CTPS2;RRM1;GLRX;GSR;TYMS;NME1;AK9
prerank,low-density lipoprotein particle receptor catabolic process (GO:0032802),-0.40555839628207957,-0.9332020607496238,0.5813528336380256,0.7813771896785289,1.0,5/10,32.90%,AP2M1;AP2A1;CLTA;AP2A2;AP2B1
prerank,low-density lipoprotein receptor particle metabolic process (GO:0032799),-0.40555839628207957,-0.9332020607496238,0.5813528336380256,0.7813771896785289,1.0,5/10,32.90%,AP2M1;AP2A1;CLTA;AP2A2;AP2B1
prerank,actin filament capping (GO:0051693),0.3466115048412655,0.9331673617526315,0.5580448065173116,0.8415507864963155,1.0,1/18,0.16%,SVIL
prerank,barbed-end actin filament capping (GO:0051016),0.3466115048412655,0.9331673617526315,0.5580448065173116,0.8415507864963155,1.0,1/18,0.16%,SVIL
prerank,regulation of stem cell differentiation (GO:2000736),-0.24083239703513842,-0.9331516034457905,0.5942307692307692,0.7810223024605198,1.0,24/89,17.05%,NOTCH1;LMO2;CBFB;GATA2;PRKDC;PSMA6;PSMB5;TAL1;PSMC4;PSMC5;YTHDF2;OCIAD1;PSMD14;ITCH;HES1;SETD1A;PSMD8;LDB1;PSMD11;PSMB4;PSMD12;PSMC1;TCF3;HOXB4
prerank,positive regulation of morphogenesis of an epithelium (GO:1905332),0.327245243671391,0.9325075187429598,0.5631469979296067,0.8422876496754238,1.0,7/23,16.01%,GJA1;GDNF;SIX4;PAX8;SIRT6;WNT5B;LIF
prerank,negative regulation of leukocyte migration (GO:0002686),0.39257348994645036,0.932372530311219,0.5228310502283106,0.8417550665555888,1.0,1/10,1.32%,BMP5
prerank,motor neuron axon guidance (GO:0008045),-0.36048510061623795,-0.9317826879362954,0.5631768953068592,0.7836479782146598,1.0,5/15,14.21%,SLIT2;RAC1;CHN1;LAMC2;NTN1
prerank,negative regulation of cartilage development (GO:0061037),0.3752216792221017,0.9316717436237089,0.5164609053497943,0.842618674423197,1.0,2/13,7.96%,ADAMTS12;TGFBR1
prerank,negative regulation of transposition (GO:0010529),0.3528114498970606,0.9316542062705889,0.5251046025104602,0.8417991568434008,1.0,3/16,13.86%,TUT4;PIWIL2;TEX15
prerank,cell junction maintenance (GO:0034331),0.36594829206589585,0.9315628067366098,0.5564681724845996,0.8411396486612724,1.0,3/14,10.74%,PRTN3;NLGN2;CBLN2
prerank,regulation of actin filament bundle assembly (GO:0032231),-0.30567797991563694,-0.9312839844211285,0.54,0.7843175910109226,1.0,8/26,19.90%,SHANK3;ACTG1;RAC1;PFN1;SYNPO;LIMK1;PTGER4;SHANK1
prerank,negative regulation of histone modification (GO:0031057),-0.36101078791201224,-0.9308468261104211,0.5689981096408318,0.7848001952035402,1.0,4/14,19.23%,CTBP1;TWIST1;SPHK2;AASS
prerank,protein targeting to mitochondrion (GO:0006626),-0.2608837184303994,-0.9306408624918735,0.5833333333333334,0.7848115102889024,1.0,19/52,28.18%,NDUFA13;IMMP2L;HSPD1;TIMM17A;TIMM21;TIMM29;TOMM22;CHCHD4;HSPA4;BCAP31;HSP90AA1;TIMM13;TOMM5;TIMM50;FIS1;TIMM10;TIMM8B;TIMM10B;MFF
prerank,smoothened signaling pathway (GO:0007224),0.2966534352728462,0.9305019452397185,0.5555555555555556,0.8427980570834122,1.0,11/32,19.76%,TMEM17;GLI2;GLI3;GPC2;HES5;MAP3K10;EVC2;ARL13B;SHH;DISP3;DISP2
prerank,cellular response to interleukin-6 (GO:0071354),0.31217046194607434,0.9304459303473466,0.5540838852097131,0.8420736163098692,1.0,3/26,3.92%,PID1;PTGIS;PTPRT
prerank,regulation of histone H3-K9 acetylation (GO:2000615),-0.39464491693092035,-0.9303277376624427,0.5545454545454546,0.7850443515290145,1.0,6/10,25.77%,CAMK1;SPHK2;SMAD4;RAPGEF3;CHEK1;HDAC5
prerank,ATP-dependent chromatin remodeling (GO:0043044),-0.2831936554259632,-0.9301514871768795,0.5772994129158513,0.7849912717062306,1.0,9/42,18.45%,ACTB;ARID1A;MTA2;MBD3;SMARCA4;GATAD2B;SMARCA2;RBBP4;CHD4
prerank,glycine metabolic process (GO:0006544),0.3799779001724063,0.930009212804194,0.5404255319148936,0.8422813908908228,1.0,3/12,9.75%,GLDC;BAAT;RIDA
prerank,regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),-0.2915192775031348,-0.93000762136989,0.5429616087751371,0.7848494721185721,1.0,10/33,19.01%,ESR1;DDX5;UFM1;CBFB;DDRGK1;H3-3A;TRIM68;UFL1;KDM1A;UBA5
prerank,negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),0.2975109418562299,0.9296518319103803,0.5460385438972163,0.8422607945159939,1.0,5/38,6.94%,RORA;RHOH;GSTP1;NLRP12;TLE1
prerank,negative regulation of developmental growth (GO:0048640),0.29974061018460446,0.9289382665103844,0.5592841163310962,0.8431159919125003,1.0,9/30,15.84%,WWC1;RTN4;CDKL3;DCC;BBS2;PTEN;ULK2;TRIM46;NKD1
prerank,cellular protein localization (GO:0034613),-0.20341657353200499,-0.9288340310191856,0.6809338521400778,0.7870544137488052,1.0,81/285,22.57%,OCLN;ESAM;DMD;ID1;SGSM2;STX3;TBC1D8;GRTP1;MESD;FERMT2;JAM3;AP3B1;RIC3;SYNRG;NAPA;AMOT;TBC1D1;RAB18;FAM91A1;TBC1D12;STX1A;TBC1D22A;ARF5;RAB6B;ITSN1;CPLANE2;CPE;HHEX;VCL;HERC2;EMP2;WNT11;CD74;STX2;GAS8;RAB24;COPB2;ARL4A;TBC1D9B;TBCK;SMURF1;ARL6;LAMTOR2;RAB1A;CEP68;AP4M1;CELSR1;COG3;EGFR;AP2A1;RRAGD;YWHAH;PACSIN1;VPS33A;NSF;TBC1D25;TBC1D2;EHD1;ARHGEF2;VPS29;TMED1;USP4;RAB3GAP2;RAB32;CTTN;LAPTM5;IFT27;TMED5;WIPI2;PTPRK;FGF10;RRAGA;NIPBL;ARL4C;RAB23;ADPRH;PTPRU;STX5;KIF13A;RRAGC;TBC1D15
prerank,regulation of autophagy (GO:0010506),-0.21025500386530113,-0.9286019229080306,0.6443965517241379,0.787095046044814,1.0,62/216,25.40%,ACER2;EXOC4;EEF1A1;RASIP1;SH3BP4;FOXO1;MID2;FOXO3;DAPL1;ATP6V0B;EIF4G3;FOXK1;PSAP;ATP6V0A2;GPR137B;HSPB1;GAPDH;SVIP;PLK2;AKT1;TRIM14;PIK3C2A;ATP6V0C;RAB8A;UCHL1;EXOC1;ABL2;FBXL2;TRIM68;LAMTOR2;TRIM5;PRKAG1;ATP6V1G1;MET;CSNK2A2;UFL1;PIK3R2;RRAGD;TAB2;BAD;VPS29;GFAP;PLEKHF1;OSBPL7;TMEM59;MCL1;KEAP1;FZD5;RRAGA;TFEB;TRIB3;EIF4G1;PTPN22;RRAGC;TPCN2;WDR6;RUBCN;EIF4E;RPTOR;SREBF1;ATP6V0D1;TREM2
prerank,innate immune response in mucosa (GO:0002227),0.4020639022694618,0.9283748927371732,0.5645514223194749,0.8436171048536183,1.0,2/10,5.47%,IL4;BPIFB1
prerank,thymus development (GO:0048538),-0.3684127284613315,-0.9281488396012553,0.5641952983725136,0.7876360166344797,1.0,5/13,27.08%,TBX1;SIX1;HES1;FGF10;SOD1
prerank,phasic smooth muscle contraction (GO:0014821),0.4013470215903611,0.9281363279588403,0.5227817745803357,0.8433542916817408,1.0,3/10,14.15%,GDNF;EDNRB;DRD2
prerank,glutamine family amino acid metabolic process (GO:0009064),0.29334848436405353,0.9269141081788523,0.5392561983471075,0.8454517877883319,1.0,6/33,11.18%,ALDH4A1;ALDH18A1;PRODH;GLUL;GLS2;FPGS
prerank,mitotic chromosome condensation (GO:0007076),-0.30321576495966596,-0.9263403900488908,0.5650557620817844,0.7913124563201033,1.0,14/26,31.91%,SMC4;CSNK2B;RB1;CSNK2A1;CSNK2A2;SMC2;NCAPH;NCAPG;KMT5A;NCAPH2;TTN;PLK1;CDK1;NCAPD2
prerank,non-canonical Wnt signaling pathway (GO:0035567),-0.2248153863614798,-0.9261684363966297,0.6471774193548387,0.791217020859872,1.0,30/124,16.47%,LEF1;TNRC6C;FZD6;NLK;FZD4;PLCB3;CALM1;RAC1;PSMA6;AP2M1;PSMB5;FZD3;FZD7;PFN1;NFATC1;WNT11;PSMC4;PSMC5;PSMD14;PPP3CB;GNB1;SMURF1;CELSR1;PSMD8;AP2A1;PSMD11;CELSR2;PSMB4;PSMD12;PSMC1
prerank,termination of RNA polymerase I transcription (GO:0006363),0.3084430654648466,0.9260916080955032,0.5391120507399577,0.8466327565386359,1.0,7/30,13.62%,POLR1A;GTF2H2;MNAT1;POLR1G;POLR1B;CCNH;TTF1
prerank,calcium ion-regulated exocytosis of neurotransmitter (GO:0048791),0.38243624193852943,0.9258927773360575,0.5747126436781609,0.8462620658593119,1.0,3/12,6.74%,RIMS1;UNC13C;SYT1
prerank,GTP metabolic process (GO:0046039),-0.3547816892915396,-0.9257948365008614,0.5688073394495413,0.791599415947,1.0,4/15,21.31%,IMPDH1;ENTPD7;OPA1;RAB23
prerank,regulation of endocytosis (GO:0030100),-0.2564377793433756,-0.9257377458739252,0.5858778625954199,0.7912624865368402,1.0,23/61,26.21%,GPC3;NEDD4L;OPHN1;CD151;HIP1R;FLOT1;HIP1;RAB4B;ABL2;RUFY1;RAB4A;APOE;PACSIN1;TSC2;PACSIN3;PACSIN2;PTPN1;RUBCN;ZFYVE16;CBLL1;MTMR2;RAB5C;SMPD1
prerank,regulation of interleukin-1 beta production (GO:0032651),0.2563893794085756,0.9252149868394733,0.578125,0.8470322573375741,1.0,6/66,8.44%,IGF1;ORM2;GSTP1;NLRP12;GSDMD;NLRP2B
prerank,positive regulation of response to DNA damage stimulus (GO:2001022),-0.263181320867043,-0.9245926240926436,0.5923076923076923,0.7933898676707218,1.0,21/53,30.31%,DDX5;RPS3;BRCC3;UIMC1;DHX9;BABAM1;TRIM28;FMR1;EGFR;NSMCE4A;BABAM2;CCAR2;MSX1;FGF10;PRKCD;SPRED3;NSMCE1;RNF8;PMAIP1;SPRED1;MYC
prerank,regulation of mast cell activation (GO:0033003),0.39002212732156505,0.9242009038993219,0.5533980582524272,0.848585415158433,1.0,4/10,16.36%,LYN;CD300LF;TSLP;CRLF2
prerank,positive regulation of protein localization to cell surface (GO:2000010),-0.3622395291670345,-0.9239069752050146,0.5661080074487895,0.7944903432214836,1.0,3/13,4.55%,STX3;HSP90AB1;RIC3
prerank,histone acetylation (GO:0016573),-0.25014633319137,-0.9237533293621181,0.5987903225806451,0.7943871939860722,1.0,21/69,28.86%,LEF1;PHF20;TRRAP;JADE2;ING5;TRIM16;EPC1;NAA60;MRGBP;BRCA2;EP400;TADA3;BRPF1;TAF9;POLE3;RUVBL1;KAT6B;SPI1;TAF10;TAF5;NAA50
prerank,positive regulation of embryonic development (GO:0040019),0.3414776395167279,0.9236949312369963,0.540084388185654,0.8488957124928919,1.0,2/19,6.59%,WNT4;FOXA2
prerank,regulation of reactive oxygen species biosynthetic process (GO:1903426),0.3145936153223854,0.9234463856509089,0.5569620253164557,0.8486311116232107,1.0,4/26,6.04%,PPARA;SLC5A3;SLC30A10;ABCD2
prerank,mature B cell differentiation involved in immune response (GO:0002313),0.3799653353636989,0.9233953880828433,0.5538116591928252,0.8478916563160362,1.0,2/12,3.27%,DOCK11;DOCK10
prerank,"regulation of DNA-templated transcription, initiation (GO:2000142)",0.26497339980661216,0.9233538223831727,0.5987780040733197,0.8471435378788214,1.0,9/59,11.39%,TCF7L2;CDK8;MITF;CEBPB;AGO4;TNRC6A;PPM1D;PTEN;TNRC6B
prerank,positive regulation of purine nucleotide biosynthetic process (GO:1900373),0.36725601448818535,0.9230001482594284,0.5475206611570248,0.8471901839871303,1.0,3/13,5.08%,PID1;PPARA;IL4
prerank,retinoic acid receptor signaling pathway (GO:0048384),-0.39970714200635094,-0.9226547785898582,0.571969696969697,0.7964261573969312,1.0,3/10,6.42%,ACTN4;TBX1;RARA
prerank,mRNA destabilization (GO:0061157),0.2886143760679905,0.9225875675937943,0.5772357723577236,0.8472882707288972,1.0,9/38,15.77%,TUT4;ROCK2;CPEB3;FTO;RIDA;KHSRP;METTL16;RBM24;METTL3
prerank,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),-0.326387374292223,-0.9222786838651865,0.5821428571428572,0.7968013896585188,1.0,8/20,17.15%,NOTCH1;SMAD9;CARF;VEGFA;ATF4;SMAD4;RELA;XBP1
prerank,regulation of adenylate cyclase activity (GO:0045761),0.3285263650931024,0.9208378047506587,0.5477272727272727,0.8506802163778703,1.0,1/22,0.22%,ADGRV1
prerank,regulation of protein tyrosine kinase activity (GO:0061097),-0.2808897879152895,-0.920438394307445,0.5657620041753654,0.8005144522262035,1.0,8/38,13.71%,CAV1;APP;NEDD9;SHC1;LRP8;SRCIN1;CSF1R;ACE
prerank,mRNA modification (GO:0016556),0.32666740843044445,0.9204062404144367,0.5893617021276596,0.85080831615912,1.0,7/22,18.65%,VIRMA;RPUSD2;METTL16;PUS7;METTL3;METTL8;PUS1
prerank,response to muscle stretch (GO:0035994),0.3481417476939793,0.920342895936989,0.552863436123348,0.8500829259739127,1.0,2/15,3.68%,SLC8A1;CSRP3
prerank,cytoskeleton-dependent cytokinesis (GO:0061640),-0.25801529062363304,-0.9202352276722413,0.6108949416342413,0.8005027982964705,1.0,27/56,33.49%,SPTBN1;USP8;KIF23;DCTN3;RHOB;RTKN;MITD1;SNX18;IST1;ECT2;RASA1;ANLN;CENPA;EFHC2;CIT;CEP55;VPS4A;STMN1;ARL3;RACGAP1;TRIM36;PLK1;RHOA;CHMP4B;ESPL1;UNC119;STAMBP
prerank,positive regulation of potassium ion transmembrane transporter activity (GO:1901018),0.3540604045413596,0.9198358062717265,0.5438202247191011,0.8504612750615856,1.0,3/14,14.06%,ANK2;ACTN2;ATP1B3
prerank,establishment of vesicle localization (GO:0051650),-0.3389924284806676,-0.9197393867324583,0.5769911504424778,0.8011666866993638,1.0,3/18,4.21%,RAB11A;LIMK2;RAB27A
prerank,mitochondrial outer membrane permeabilization (GO:0097345),0.38294890138123205,0.9194164796907172,0.5550660792951542,0.8505732375875985,1.0,2/13,3.42%,BCL2L11;VDAC2
prerank,long-chain fatty-acyl-CoA metabolic process (GO:0035336),-0.31861492414814874,-0.9192665649789764,0.5908256880733945,0.8017540234766685,1.0,7/23,22.39%,FAR2;ELOVL7;ELOVL5;ACSL5;FAR1;ELOVL1;ACSF3
prerank,detection of chemical stimulus involved in sensory perception of taste (GO:0050912),0.3768516193823751,0.9192330422722856,0.538961038961039,0.8501584534583775,1.0,11/11,62.34%,PKD1L3;LPO;RTP2;PKD2L1;TAS1R3;PIGR;GNAT2;GNAT3;TAS1R2;RTP3;RTP4
prerank,positive regulation of ERBB signaling pathway (GO:1901186),-0.3122489626924696,-0.9191625210027855,0.6057347670250897,0.801505704659069,1.0,7/25,17.50%,AFAP1L2;HIP1R;AKT1;HIP1;SHKBP1;BCAR3;NEU3
prerank,cellular response to nerve growth factor stimulus (GO:1990090),-0.31904323313792987,-0.9184841217906039,0.5637707948243993,0.8025597188684811,1.0,9/22,20.92%,RAP1A;RAPGEF1;NGF;STMN2;AKT1;CIB1;KIDINS220;EHD1;RAPGEF2
prerank,"positive regulation of mRNA splicing, via spliceosome (GO:0048026)",0.3391145595866929,0.9184590715051636,0.572463768115942,0.851159736104322,1.0,3/16,7.63%,DAZAP1;TRA2A;CELF4
prerank,negative regulation of neuron differentiation (GO:0045665),0.32858195567959286,0.9179238820613609,0.5866666666666667,0.8515623105341208,1.0,5/22,8.54%,CNTN4;HES3;DTX1;SOX2;HES5
prerank,cellular response to estradiol stimulus (GO:0071392),-0.33173426531569244,-0.9178619756091492,0.5855018587360595,0.803410578302747,1.0,11/18,39.03%,ESR1;NRIP1;LCOR;EGFR;FAM210B;SSTR2;POU4F1;RAMP3;GPER1;CRHBP;SSTR1
prerank,positive regulation of regulated secretory pathway (GO:1903307),-0.333110742835554,-0.9175460252260821,0.581981981981982,0.8036570865127044,1.0,4/17,7.32%,KCNB1;RAB27A;STX1A;SLC4A8
prerank,glycerophospholipid biosynthetic process (GO:0046474),-0.21163653727148876,-0.9174743219271684,0.6728395061728395,0.8033313395142169,1.0,48/172,21.70%,PLCG2;DGKH;PIP5K1B;BMX;TAMM41;PI4K2A;LPCAT3;INPP5D;PIK3R6;MFSD2A;CDS2;CDS1;MTMR14;MTMR12;CDIPT;INPP5E;CHKA;PIK3C2A;CSNK2B;PITPNM2;MBOAT7;RUFY1;CEPT1;PITPNM3;RAB4A;FGF2;AGPAT1;PIK3R3;PITPNM1;FAR1;PIK3CA;MTM1;CSNK2A1;CSNK2A2;PCYT2;SYNJ1;PIK3R2;FIG4;PIK3C2B;DGKZ;LCAT;GPD1;ABHD8;AGPAT5;CPNE3;PCYT1A;CHAT;LPCAT2
prerank,hydrogen peroxide metabolic process (GO:0042743),-0.33275389812632317,-0.9171590137632523,0.5868725868725869,0.8035385066149457,1.0,7/19,29.11%,GPX1;ACOX1;GPX3;PARK7;PRDX4;SOD1;NOX1
prerank,receptor signaling pathway via JAK-STAT (GO:0007259),0.3031630969587278,0.9167647167301192,0.5603448275862069,0.8534953713854035,1.0,3/29,4.95%,IL31RA;STAT5B;GHR
prerank,transferrin transport (GO:0033572),-0.28422338735005853,-0.9164369244101739,0.5949612403100775,0.80470476602392,1.0,8/33,11.50%,TFRC;ATP6V0B;ARHGAP1;ATP6V0A2;ATP6V0C;LMTK2;REP15;RAB11B
prerank,mRNA splice site selection (GO:0006376),0.2993641880751016,0.9160850453861733,0.5560439560439561,0.8542193284430174,1.0,4/30,9.28%,CELF2;SRSF12;CELF4;SLU7
prerank,positive regulation of leukocyte migration (GO:0002687),0.3051485448582701,0.9160758366549141,0.5604838709677419,0.8533893742020607,1.0,2/27,5.08%,PTN;IL4
prerank,eye photoreceptor cell development (GO:0042462),-0.3503453717030129,-0.9158508378726933,0.5538461538461539,0.8055451237583449,1.0,4/15,18.65%,RP1;VEGFA;CEP290;RPGRIP1
prerank,regulation of cell morphogenesis (GO:0022604),0.29926765451341253,0.9157570766898515,0.5958762886597938,0.8533089882162302,1.0,3/30,5.12%,SH3D19;PHIP;ZMYM6
prerank,protein localization to microtubule organizing center (GO:1905508),-0.346059718872957,-0.9156481689897253,0.5967741935483871,0.805529911422193,1.0,3/15,11.72%,DCTN2;CEP192;PCM1
prerank,peptide catabolic process (GO:0043171),-0.31158943032452574,-0.9153678246958189,0.5670289855072463,0.8056411474474163,1.0,7/23,13.71%,TPP1;LTA4H;ERAP1;IDE;GGT5;LNPEP;ACE
prerank,regulation of response to DNA damage stimulus (GO:2001020),0.280967335966028,0.9152477212339352,0.5799180327868853,0.8536256955626038,1.0,18/40,22.71%,CRY1;RADX;RPA2;FXR2;ANKLE1;MAPT;IER3;CDK9;FBXO5;ETAA1;UBE2N;WRNIP1;ARMT1;WDR76;NEK4;NPAS2;UBE2V2;RFWD3
prerank,actin nucleation (GO:0045010),-0.32201056402638506,-0.9149026200247994,0.5841035120147874,0.8062576772331398,1.0,4/21,12.70%,ARPC1B;LMOD1;ARPC5;ACTR3
prerank,positive regulation of positive chemotaxis (GO:0050927),-0.34794893684034933,-0.9148801637078285,0.5827205882352942,0.8058309851748502,1.0,4/15,5.68%,KDR;F3;VEGFC;VEGFA
prerank,aspartate family amino acid metabolic process (GO:0009066),0.34320591812191226,0.914285812750232,0.5616740088105727,0.8550472479556811,1.0,9/18,23.75%,ASPA;SLC25A13;FOLH1;MTHFD1;ASS1;ASPG;GOT1;GOT2;MTHFR
prerank,protein K11-linked ubiquitination (GO:0070979),0.3107076437176142,0.9141347019332928,0.5458422174840085,0.85454933598396,1.0,9/27,19.61%,PRKN;ANAPC1;UBE2E3;CDC23;CDC16;RNF26;UBE2E2;ANAPC5;CDC26
prerank,negative regulation by host of viral transcription (GO:0043922),-0.3681137654745919,-0.9137467673820339,0.574468085106383,0.8079719134608021,1.0,7/12,39.25%,REST;PSMC3;POU2F3;CCL5;JUN;CCL4;INPP5K
prerank,negative regulation of homotypic cell-cell adhesion (GO:0034111),0.39461364273014377,0.9136831166903578,0.5575620767494357,0.8547507964647113,1.0,2/10,2.55%,SERPINE2;ALOX12
prerank,positive regulation of macrophage derived foam cell differentiation (GO:0010744),-0.3563967503593527,-0.9133606395818366,0.5897920604914934,0.8083498247994052,1.0,1/15,0.12%,PRKCH
prerank,protein-containing complex subunit organization (GO:0043933),0.2305967803702074,0.9132855232899793,0.6141732283464567,0.8548613235468203,1.0,27/109,15.17%,TEAD1;MITF;RIMS1;MDM2;IL1RAP;JCHAIN;MAGI1;MNAT1;SLC7A9;GPAA1;FANCC;PPIH;TUBGCP4;KMT2A;HES5;KNTC1;NUP205;LPXN;NUP35;SNX9;LAMC1;LLGL1;DLG4;YAP1;TUBGCP2;TRAF2;GEMIN5
prerank,lipopolysaccharide-mediated signaling pathway (GO:0031663),-0.3302226765744796,-0.9130613436055279,0.596745027124774,0.8085408854105164,1.0,8/20,24.55%,LBP;TGFB1;PRKCE;TLR4;HCK;PTPN22;CCL2;BCL10
prerank,lipoprotein biosynthetic process (GO:0042158),0.36962708111129755,0.9125149380398005,0.5855855855855856,0.8558453698826579,1.0,4/11,15.79%,WDR45B;WIPI1;ATG10;PORCN
prerank,regulation of mitochondrial fission (GO:0090140),-0.31372214000813814,-0.9123414921327296,0.5922330097087378,0.8096987301305835,1.0,11/24,31.12%,KDR;CYRIB;MIEF1;MIEF2;INF2;FIS1;MCU;MYO19;MFF;MUL1;AURKA
prerank,positive regulation of endopeptidase activity (GO:0010950),0.3097927930542141,0.9119451024617874,0.5692963752665245,0.8563897875783592,1.0,3/26,4.80%,ROCK2;LYN;EFNA3
prerank,peptidyl-lysine trimethylation (GO:0018023),0.30110016725751354,0.9116875977353349,0.5615550755939525,0.8561712583114001,1.0,10/26,23.41%,PRDM9;KMT2A;KMT5C;SETD5;WDR82;KMT5B;VCPKMT;SETD4;SUV39H2;CTR9
prerank,cardiac atrium morphogenesis (GO:0003209),-0.3419711075380628,-0.9116099207463614,0.5898876404494382,0.8109221927361775,1.0,3/16,4.12%,NOTCH1;BMPR2;TGFB2
prerank,positive regulation of cytokine-mediated signaling pathway (GO:0001961),-0.2861634525150581,-0.9115996336247718,0.6036697247706422,0.8104701719224043,1.0,16/36,31.99%,NLRC5;RIPK1;EDN1;CD74;MAVS;AGPAT1;HSPA1A;TXK;LAPTM5;CASP1;HSPA1B;PARP14;C1QTNF4;IRGM;PARP9;TRIM44
prerank,positive regulation of T cell mediated cytotoxicity (GO:0001916),-0.3702667221156313,-0.9114597787056449,0.584870848708487,0.8103277400391099,1.0,4/13,20.18%,CYRIB;PVR;NECTIN2;MR1
prerank,positive regulation of neuron death (GO:1901216),-0.26376983141999955,-0.9112190606405292,0.6110056925996205,0.8104188055708373,1.0,11/46,17.02%,MAP3K5;FOXO3;REST;TGFB2;BACE1;ATF4;BAX;NF1;TLR4;C1QA;DDIT4
prerank,tRNA wobble base modification (GO:0002097),-0.3580658308467789,-0.9109323969552348,0.5745062836624776,0.8105652235090904,1.0,5/14,28.07%,DPH3;TRMT9B;URM1;ADAT2;CTU2
prerank,polarized epithelial cell differentiation (GO:0030859),-0.3580115235344454,-0.9108361532553957,0.5898876404494382,0.8103114649859627,1.0,3/13,6.47%,OPHN1;MSN;EZR
prerank,regulation of calcium-mediated signaling (GO:0050848),-0.30777916819064366,-0.9105237677929142,0.613126079447323,0.8105225123241819,1.0,4/25,4.89%,PLCG2;TMBIM4;HTT;CMKLR1
prerank,positive regulation of BMP signaling pathway (GO:0030513),-0.2997874700103727,-0.9104700562873002,0.587360594795539,0.8101563502236752,1.0,9/25,21.17%,NOTCH1;BMPR2;FOXD1;ZNF423;ENG;SMAD4;SMAD2;BMPR1B;CDH5
prerank,positive regulation of protein sumoylation (GO:0033235),-0.3887334182536162,-0.909683158883633,0.5904572564612326,0.8113991704611496,1.0,5/10,32.73%,HDAC4;SAE1;UBA2;MUL1;RASD2
prerank,epidermis development (GO:0008544),0.25516410205990964,0.9096427778112337,0.6137787056367432,0.860137650578086,1.0,3/56,3.83%,SVEP1;FGFR2;ATP2A2
prerank,regulation of protein import into nucleus (GO:0042306),0.28806223320726043,0.9091799163292877,0.5615550755939525,0.860359675199645,1.0,3/36,2.77%,PIK3R1;ZIC1;SMAD3
prerank,positive regulation of reactive oxygen species biosynthetic process (GO:1903428),-0.3612418495508738,-0.9088645513744857,0.5960854092526691,0.812706499163286,1.0,6/12,29.22%,PLCG2;RAB27A;TLR4;GRIN1;CD36;TLR6
prerank,protein palmitoylation (GO:0018345),-0.2911967508845609,-0.9086035121683232,0.5950570342205324,0.8128191125570786,1.0,13/30,31.17%,ZDHHC9;ZDHHC1;ZDHHC20;ZDHHC5;ZDHHC23;SELENOK;ZDHHC12;ZDHHC17;HHAT;ZDHHC3;ZDHHC18;GOLGA7B;ZDHHC24
prerank,glycosphingolipid biosynthetic process (GO:0006688),-0.341181838064086,-0.9083750746370973,0.5939278937381404,0.8128297800140606,1.0,4/16,7.53%,ST6GALNAC3;ST8SIA4;ST8SIA6;A4GALT
prerank,positive regulation of actin filament depolymerization (GO:0030836),0.38633266702343455,0.9081189623283412,0.5534883720930233,0.8620773749993265,1.0,2/10,11.79%,SEMA5A;ACTN2
prerank,calcium import into the mitochondrion (GO:0036444),-0.3913262851943794,-0.9079540919360792,0.5936920222634509,0.8133113041545398,1.0,5/10,24.61%,MCUB;MCUR1;MICU2;SMDT1;MCU
prerank,calcineurin-mediated signaling (GO:0097720),-0.3919709499215517,-0.9071659513376085,0.5897920604914934,0.8140786991110682,1.0,5/10,20.61%,PPP3CC;NFATC1;PPP3CB;ADGRB2;NFATC3
prerank,calcineurin-NFAT signaling cascade (GO:0033173),-0.3919709499215517,-0.9071659513376085,0.5897920604914934,0.8140786991110682,1.0,5/10,20.61%,PPP3CC;NFATC1;PPP3CB;ADGRB2;NFATC3
prerank,superoxide metabolic process (GO:0006801),-0.2865631405301411,-0.9070619768778316,0.6070726915520629,0.8138655363312916,1.0,5/29,12.83%,SH3PXD2A;NOS3;NCF2;PREX1;NRROS
prerank,DNA recombination (GO:0006310),0.2785197469055416,0.9069371663497294,0.5945945945945946,0.8640160510040817,1.0,7/37,14.57%,DMC1;HDAC10;GEN1;BLM;RAD51C;RAD51B;RPA1
prerank,posttranscriptional regulation of gene expression (GO:0010608),-0.26930176749753726,-0.9069355024692738,0.6118546845124283,0.8136924325054211,1.0,21/45,37.12%,RPL10;FOXO3;APP;RC3H1;TDRD7;RBM4B;PCIF1;PUM2;ZC3H7A;MEX3D;EIF4E;RBM3;METTL18;ZC3H10;PARP9;ATG14;NANOS1;LARP4;CYFIP1;TRIM71;EIF2A
prerank,ATP transport (GO:0015867),0.39006827602570415,0.9063044404930977,0.5779816513761468,0.864601950450997,1.0,3/10,15.52%,SLC25A42;SLC25A24;CD47
prerank,phosphatidic acid biosynthetic process (GO:0006654),0.2717186149374586,0.9060410560675005,0.6130346232179226,0.8643527617700955,1.0,11/46,20.28%,PLA2G5;PLA2G4A;DGKD;GPD1L;PLD1;GNPAT;DDHD2;PLD2;ABHD5;LCLAT1;PLA2G12A
prerank,negative regulation of ion transport (GO:0043271),-0.30541215247985626,-0.9057723929386796,0.6032315978456014,0.815780838558225,1.0,13/24,39.25%,PTK2B;WNK1;CASQ2;PACSIN3;LILRB1;NOS1;CD33;WNK4;HRH3;ADRA2A;VIP;GPM6B;INPP5K
prerank,proteasomal protein catabolic process (GO:0010498),-0.20621670474857648,-0.9056521074397735,0.7290836653386454,0.8155783266018096,1.0,56/201,24.42%,WWP1;NEDD4L;SEL1L;RNF41;ZNRF1;WWP2;RHBDD1;PSMA6;CUL4A;DNAJB12;PSMB5;NHLRC3;KCTD5;PLAA;RNF185;UCHL1;VCP;TNFAIP1;PSMC4;MTA1;MAEA;PSMC5;UBXN1;PSMD14;FBXW5;ITCH;RNF5;SMURF1;RBX1;UBE2G1;PSMD8;PSMD11;KCTD10;PSMB4;PSMD12;PSMC1;PELI1;ZSWIM8;TBL1X;ERLEC1;KCTD2;UBE2B;PSMA1;ZFAND2B;CLOCK;PSMB1;PSMC3;BFAR;PSMA4;PCNP;FBXL19;PSMA2;BRSK2;RAD23A;RNF187;COP1
prerank,regulation of G protein-coupled receptor signaling pathway (GO:0008277),-0.23839480101454896,-0.9053942915309628,0.6500994035785288,0.8156376862752028,1.0,8/75,8.48%,PLCE1;RGS3;RGS5;MGLL;CALM1;GIT2;EDN1;RGS6
prerank,triglyceride catabolic process (GO:0019433),-0.3224139312066162,-0.9049033256145664,0.5660377358490566,0.816235835873168,1.0,2/19,10.36%,PNPLA2;FABP5
prerank,regulation of cell cycle phase transition (GO:1901987),-0.23064317502350717,-0.9046292064166523,0.6666666666666666,0.8163668613331467,1.0,39/91,34.73%,CDKN1B;ANAPC15;PSMA6;ANAPC11;PSMB5;TCIM;PSMC4;PSMC5;PSMD14;PSMD8;PSMD11;CDKN1A;ANAPC7;CDC27;PSMB4;PSMD12;PSMC1;FZR1;CUL1;PSMA1;ANAPC2;PSMB1;PSMC3;PSMA4;PSMA2;PSMB8;TRIM39;NEK10;XPC;BUB3;PSMC6;PLK1;CDK1;PSMD6;PSMA8;ANAPC10;CDC20;PSMD2;UBE2C
prerank,regulation of chemotaxis (GO:0050920),0.29294010928985853,0.9043501113024162,0.5609756097560976,0.8674883423459939,1.0,6/30,8.14%,MYCBP2;PDGFRA;P2RX4;PDGFRB;ZSWIM5;ADGRA2
prerank,regulation of cellular metabolic process (GO:0031323),0.27204937218075603,0.9041599073302183,0.608786610878661,0.8670823459725381,1.0,5/45,5.80%,PID1;PPARA;PDK4;PRKN;PDK3
prerank,beta-catenin-TCF complex assembly (GO:1904837),-0.2952741094540992,-0.9037489018339222,0.62152133580705,0.8178267930347549,1.0,6/29,6.37%,LEF1;TLE4;RBBP5;TRRAP;PYGO2;TLE3
prerank,"negative regulation of gene expression, epigenetic (GO:0045814)",-0.3033950447313802,-0.9036269664847798,0.5936920222634509,0.8176534215663864,1.0,7/24,16.41%,MPHOSPH8;AEBP2;H3-3A;EPC1;BMI1;TASOR;RBBP4
prerank,negative regulation of hemostasis (GO:1900047),0.37285229257395036,0.9031246787602825,0.5714285714285714,0.86869552385385,1.0,3/12,5.80%,SERPINE2;APOH;SERPINE1
prerank,response to light stimulus (GO:0009416),0.2635104534197584,0.902967318917914,0.6152263374485597,0.8682391198910365,1.0,7/55,7.61%,GPR88;DDB2;TRPM1;GTF2H2;COPS3;MEN1;CRY1
prerank,regulation of vascular endothelial cell proliferation (GO:1905562),-0.3356073164099078,-0.9024412422809359,0.5914972273567468,0.8197561914714044,1.0,2/18,0.53%,MEF2C;FLT1
prerank,positive regulation of ATPase activity (GO:0032781),-0.26761247629057544,-0.9024163929040179,0.6162790697674418,0.8193409779484015,1.0,12/41,22.07%,ATP1B1;DHX9;PFN1;VMP1;TOR1AIP1;DNAJC9;CHTOP;TOR1AIP2;DYNLL2;FGF10;ATP1B2;DNAJB1
prerank,cilium movement (GO:0003341),-0.25981598532243927,-0.9017337804800764,0.6101010101010101,0.8203168840338104,1.0,28/47,44.25%,SPEF1;ODAD1;GAS8;DNAH5;CABYR;CFAP251;ROPN1L;ODAD2;CAMSAP3;ADCY10;SPAG17;ODAD3;ZBBX;SPA17;DNAH17;CFAP70;CFAP206;DNAAF4;CCDC63;CFAP91;TEKT5;CFAP54;DNAH1;RSPH6A;DNHD1;DNAAF1;DNAI3;RSPH4A
prerank,"negative regulation of translation, ncRNA-mediated (GO:0040033)",-0.368547108806159,-0.9013510419239001,0.5618181818181818,0.8202160299224428,1.0,2/11,6.44%,TNRC6C;NOTCH4
prerank,miRNA mediated inhibition of translation (GO:0035278),-0.368547108806159,-0.9013510419239001,0.5618181818181818,0.8202160299224428,1.0,2/11,6.44%,TNRC6C;NOTCH4
prerank,brain morphogenesis (GO:0048854),0.36825200463981556,0.9010051189726267,0.6165919282511211,0.8719140473174679,1.0,4/12,10.35%,CTNNA2;SPEF2;BBS2;PTEN
prerank,regulation of catabolic process (GO:0009894),-0.3307528727970179,-0.9009663196836644,0.5938697318007663,0.8205713608555727,1.0,2/18,2.94%,NEDD4L;FAP
prerank,regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),0.30628670275817194,0.9009580792710491,0.6,0.8711812236274163,1.0,4/26,6.54%,EYA2;GDNF;BCL2;EYA1
prerank,negative regulation of proteolysis (GO:0045861),0.2850889586004115,0.9009352418213944,0.5986547085201793,0.8703827875169691,1.0,3/34,7.28%,TIMP3;SERPINE2;TIMP4
prerank,negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),0.31755711594602243,0.9008519678072641,0.5782608695652174,0.8697182323296904,1.0,9/20,25.64%,NR2F2;MEN1;PTEN;IPO7;CDK5RAP1;APC;HEXIM1;LATS2;LATS1
prerank,endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),-0.20717335780262305,-0.9007019947634777,0.7054108216432866,0.8206965787329817,1.0,58/173,27.34%,SPTBN1;CD55;DCTN2;VAMP7;ZW10;KDELR1;CTSZ;DYNC1LI2;NAPA;NRBP1;CTSC;ATL3;TRIP11;SPTAN1;ATL2;ERGIC1;GOSR1;DCTN3;COPG1;TRAPPC11;DCTN1;TMEM115;COPB2;COG8;PEF1;BCAP31;RAB1A;MCFD2;COG3;LMAN2;DYNC1LI1;COG5;TRAPPC5;F5;VTI1B;NSF;TMED1;DYNLL2;TMED5;SEC24B;COG2;TRAPPC2L;TRAPPC2;USE1;TEX261;STX5;YIF1A;LMAN2L;COPZ2;HYOU1;CNIH2;SEC13;PDCD6;TMED3;DCTN4;GOLGB1;F8;SEC16B
prerank,bile acid biosynthetic process (GO:0006699),0.314078465779472,0.9006255755988393,0.578838174273859,0.8693756654944763,1.0,5/24,12.40%,CYP7B1;CYP27A1;BAAT;CYP46A1;OSBP
prerank,epiboly involved in wound healing (GO:0090505),-0.3353422373654483,-0.9003290108766422,0.6039076376554174,0.8210275435200304,1.0,9/16,40.93%,CD44;CD151;MRTFA;PDCD10;RHOA;TMEFF2;CEACAM1;FLNA;ARHGAP35
prerank,positive regulation of nervous system process (GO:0031646),-0.32534645466078616,-0.9001213216006784,0.6046511627906976,0.8210202135465544,1.0,3/18,7.20%,PARD3;UNC13B;TNFRSF1B
prerank,establishment of protein localization to mitochondrion (GO:0072655),-0.2612432192637643,-0.8998972898071574,0.6189555125725339,0.8210601990686945,1.0,16/46,28.18%,HK1;AKT1;HSPD1;TIMM17A;TIMM21;TOMM22;CHCHD4;BCAP31;TIMM13;TOMM5;TIMM50;FIS1;TIMM10;TIMM8B;TIMM10B;MFF
prerank,protein transport (GO:0015031),0.19865698347432603,0.8998873143340413,0.7777777777777778,0.8702916471036016,1.0,74/332,18.13%,WLS;VAMP5;STEAP3;ATP6V0A4;TBC1D4;TANGO2;RABGAP1L;TXNIP;LRP1;ABCA1;ARCN1;LRP1B;SNX33;RAB3C;SCFD1;MON1A;VPS26B;SYNDIG1;RAB5B;RAB29;SCG2;TBC1D2B;STX1B;RAB10;PRKCB;TMED10;SLU7;CHMP1A;ATP6V1H;STX7;LTBP2;BBS2;SEC31A;SNX9;TBC1D10C;EIF2D;KIF3A;HSP90B1;NGFR;DNAJC27;OPTN;STXBP3;TBC1D8B;STX12;SCAMP2;SYS1;SCAMP5;RPGR;RUNDC1;RAB38;SAR1B;ATP6V1B2;SCFD2;COPG2;TBC1D10A;ARRDC2;RAB20;ARL1;SCG5;TMED9;AFM;LRSAM1;SVBP;SNX8;TBC1D9;RAB19;RABL3;SGSM3;TRIM23;COPZ1;EVI5;MIA3;VLDLR;SNX6
prerank,replication fork processing (GO:0031297),0.2783218643974375,0.8995494656536286,0.6068548387096774,0.8702269078534411,1.0,15/38,22.71%,ZGRF1;GEN1;SETMAR;BLM;FANCM;THOC1;CENPS;CDK9;ETAA1;SMARCAL1;RTEL1;PCNA;ZRANB3;FBH1;RFWD3
prerank,synaptic vesicle exocytosis (GO:0016079),0.2761425191645034,0.8994798061296907,0.6028225806451613,0.8695455602540774,1.0,9/40,13.08%,RIMS1;UNC13C;SYT1;CPLX2;SNAP25;OTOF;STX1B;SNAPIN;SNAP47
prerank,positive regulation of receptor-mediated endocytosis (GO:0048260),-0.26664301146433583,-0.8991993162762347,0.633147113594041,0.8221422664087014,1.0,10/40,16.40%,B2M;ANXA2;VEGFA;INSR;HIP1;SGIP1;FMR1;WASL;HNRNPK;GREM1
prerank,regulation of T cell differentiation in thymus (GO:0033081),0.3550408243286331,0.8991224338011389,0.5638766519823789,0.8695190618704631,1.0,2/13,5.13%,GLI2;CAMK4
prerank,regulation of interferon-gamma production (GO:0032649),-0.2415329409260074,-0.8983797341435743,0.655511811023622,0.823465918088231,1.0,32/71,40.25%,SLC7A5;PDE4D;CYRIB;IL1R1;RARA;TLR3;HSPD1;INHBA;TLR4;VSIR;TXK;LAPTM5;LGALS9;FZD5;PTPN22;ZFPM1;IL12RB2;INHA;RASGRP1;LILRB1;SCRIB;CD14;SLAMF6;SLC11A1;TLR8;CD226;IL12A;CRTAM;PDCD1LG2;IL12RB1;ISL1;NR1H4
prerank,negative regulation of interleukin-2 production (GO:0032703),-0.3326183699189245,-0.8981962317480203,0.6007462686567164,0.823376528836891,1.0,3/18,6.47%,CD34;HDAC7;EZR
prerank,keratan sulfate metabolic process (GO:0042339),0.29151236680602727,0.8979761454589624,0.6203090507726269,0.8713319197881019,1.0,13/31,19.34%,FMOD;B3GNT7;OMD;GNS;LUM;GALNS;OGN;CHST1;GLB1;ST3GAL1;B4GAT1;CHST2;B4GALT6
prerank,cellular amide metabolic process (GO:0043603),0.23299701944169487,0.8978146032918058,0.6673228346456693,0.8708680907297773,1.0,22/102,17.00%,PCCA;ACSM5;CPZ;AEBP1;BAAT;CPXM1;DNPEP;PLPP3;ACOT11;PDZD11;ALDH1L1;NSMAF;FPGS;SLC46A1;THOP1;MTHFD1;PLAAT5;ACSL6;MTHFD1L;ST3GAL1;ACBD6;MCCC2
prerank,negative regulation of endothelial cell apoptotic process (GO:2000352),0.3125849128013614,0.8976313270851747,0.5752212389380531,0.8704643249476522,1.0,6/24,9.13%,SEMA5A;PDPK1;IL4;SERPINE1;SCG2;GATA3
prerank,maturation of 5.8S rRNA (GO:0000460),0.33312489464918826,0.8973517339430567,0.5759637188208617,0.8702864364889561,1.0,2/17,1.51%,MPHOSPH6;C1D
prerank,megakaryocyte differentiation (GO:0030219),0.3813470929888696,0.8966734280579197,0.5879629629629629,0.8710804008111229,1.0,2/11,7.59%,KIT;THPO
prerank,regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),0.2529824946187481,0.8958042376178074,0.6504065040650406,0.8722130576217605,1.0,9/60,11.39%,TCF7L2;CDK8;CEBPB;AGO4;TNRC6A;PPM1D;PAXIP1;PTEN;TNRC6B
prerank,beta-catenin destruction complex disassembly (GO:1904886),-0.3157267698327298,-0.8957374969211538,0.6189624329159212,0.8282031040505191,1.0,1/21,0.34%,CAV1
prerank,organonitrogen compound catabolic process (GO:1901565),0.25483530630982226,0.8950908694299811,0.5936842105263158,0.8730278534924166,1.0,10/57,10.89%,PLA2G5;PLA2G4A;IL4I1;CPQ;CLPX;ANPEP;ENPEP;RIDA;NAALADL1;TRHDE
prerank,negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),-0.3142881136614642,-0.8950303305585213,0.6158088235294118,0.8292274951716326,1.0,6/22,22.08%,PTPRJ;EZR;DUSP3;DGKZ;LAPTM5;PTPN22
prerank,negative regulation of epithelial cell differentiation (GO:0030857),-0.35815322870443955,-0.8946805515107813,0.5813528336380256,0.8295009843215897,1.0,7/14,30.94%,CAV1;NOTCH4;SPRY1;SPRED3;XDH;SPRED1;DLL1
prerank,regulation of neurotransmitter transport (GO:0051588),0.33724432420191486,0.8946590623205476,0.6131687242798354,0.8732071084484013,1.0,4/16,10.26%,RIMS1;CHRNB4;CPLX2;MCTP2
prerank,regulation of amyloid-beta clearance (GO:1900221),0.33238532857991754,0.8946255730221805,0.582441113490364,0.8724496757855618,1.0,2/16,5.08%,LRP1;IL4
prerank,unsaturated fatty acid metabolic process (GO:0033559),-0.266810634239719,-0.8945310241761947,0.6238003838771593,0.829333742472615,1.0,12/41,18.31%,MGLL;EPHX1;CYP1B1;GPX1;ELOVL5;GSTM2;PTGS1;FAAH;GPX4;ACOT8;ELOVL1;DAGLB
prerank,protein-DNA complex assembly (GO:0065004),0.22686463411677835,0.8936484273489027,0.6807228915662651,0.873926041653468,1.0,26/116,19.04%,TCF4;DMC1;MCM3;ORC4;DDB2;GTF2H2;MNAT1;PSMA3;PSMF1;RPA2;MCM2;CCNH;MCM8;PSME3;ORC1;DAXX;SPTY2D1;RPA1;PSMD1;PSMB9;SART3;ORC3;PARP1;PSMD13;NAP1L2;ORC5
prerank,nuclear membrane disassembly (GO:0051081),0.3490298107490132,0.8930022305732878,0.5879732739420935,0.874549474160836,1.0,3/14,9.16%,PRKCA;AKAP8L;PRKCB
prerank,establishment of spindle orientation (GO:0051294),-0.2898859271077875,-0.8928073044092729,0.6328871892925431,0.8325931843989927,1.0,10/28,24.32%,MAP4;ZW10;HTT;DCTN1;NDE1;NDEL1;MISP;NDC80;SPDL1;CENPA
prerank,sensory organ development (GO:0007423),-0.25681028975500364,-0.8927690446938635,0.645224171539961,0.8322008135317802,1.0,9/51,11.80%,SMOC1;HIPK1;TGFB2;STRA6;RAB18;FREM2;SIPA1L3;SMG9;CHRDL1
prerank,protein deacetylation (GO:0006476),0.27349509761404184,0.8925698968686161,0.623059866962306,0.874691227475764,1.0,7/41,9.09%,TBL1XR1;PRDM5;HDAC10;SIRT2;MIER3;BRMS1L;BRMS1
prerank,negative regulation of cell cycle (GO:0045786),0.24056642548338958,0.8924817756661699,0.6457925636007827,0.874069329645054,1.0,11/73,10.49%,BMP2;NR2F2;SMAD3;BRINP1;BRINP3;MEN1;NLRP2B;GATA3;CHMP1A;PTEN;HPGD
prerank,homologous chromosome segregation (GO:0045143),0.32120600643320874,0.8920328014582349,0.5872340425531914,0.8742577840244485,1.0,3/20,10.93%,MEIKIN;PRDM9;FMN2
prerank,cell-cell junction maintenance (GO:0045217),0.37272735966615556,0.8918189478098486,0.5902335456475584,0.8738954698582965,1.0,2/11,6.25%,PRTN3;NLGN2
prerank,histone methylation (GO:0016571),0.303132278936397,0.8916812501484349,0.6252771618625277,0.8733537562051731,1.0,6/26,14.59%,NSD1;SMYD1;SMYD3;EHMT2;NSD3;EZH2
prerank,bile acid metabolic process (GO:0008206),0.3004377877379135,0.891643247636569,0.5883534136546185,0.872601970928719,1.0,6/27,13.34%,CYP7B1;CYP27A1;BAAT;CYP46A1;OSBP;GBA2
prerank,transition metal ion transport (GO:0000041),0.28417273675417304,0.891564344567354,0.6017130620985011,0.8719410951961385,1.0,4/35,6.74%,CP;HEPH;SLC30A10;SLC31A2
prerank,regulation of ubiquitin protein ligase activity (GO:1904666),-0.3181276052182424,-0.891086716787995,0.5934065934065934,0.8353791106340709,1.0,7/21,20.67%,RPL11;RPL23;RPS7;CDC14B;RAB1A;FZR1;RPL5
prerank,peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),-0.30761745969298837,-0.8910362339642428,0.6064638783269962,0.8345266255768709,1.0,9/22,31.17%,ZDHHC9;ZDHHC1;ZDHHC20;ZDHHC23;ZDHHC12;ZDHHC3;ZDHHC18;GOLGA7B;ZDHHC24
prerank,peptidyl-L-cysteine S-palmitoylation (GO:0018230),-0.30761745969298837,-0.8910362339642428,0.6064638783269962,0.8345266255768709,1.0,9/22,31.17%,ZDHHC9;ZDHHC1;ZDHHC20;ZDHHC23;ZDHHC12;ZDHHC3;ZDHHC18;GOLGA7B;ZDHHC24
prerank,regulation of chromosome segregation (GO:0051983),-0.3330498515744671,-0.8909726244492857,0.6368613138686131,0.8341940467397341,1.0,11/16,42.40%,RAD18;CSNK2A1;CSNK2A2;PUM2;MKI67;CDC6;BUB1;KIF2C;IHO1;AURKB;RMI2
prerank,fatty acid catabolic process (GO:0009062),-0.2394357506684256,-0.8904990846228364,0.654510556621881,0.8347398194222906,1.0,15/67,18.03%,ABHD2;PPARD;ACAD11;ACAA2;ECHS1;HACL1;DECR1;ACADL;ACADVL;CROT;FAAH;ECI1;ACOT8;MECR;HSD17B10
prerank,primary neural tube formation (GO:0014020),0.2941277721385113,0.8903161623637961,0.6268041237113402,0.8740078605598055,1.0,8/30,12.32%,PRICKLE1;LMO4;DLC1;IFT122;PLXNB2;FUZ;GRHL3;MTHFD1
prerank,protein localization to chromosome (GO:0034502),-0.27597187280016977,-0.8892105868471902,0.6193181818181818,0.8370164628280133,1.0,13/34,30.24%,ESR1;TPP1;RB1;SLF1;WAPL;BOD1;RAD21;CENPA;MRNIP;SLF2;CHMP7;TERF2IP;PLK1
prerank,negative regulation of response to external stimulus (GO:0032102),0.22721788983582303,0.8886279727891997,0.7106690777576854,0.8768855919768408,1.0,14/105,10.35%,RORA;GRID2;PPARA;PTGIS;CTNNA2;IL4;SERPINE1;NLRP12;SMPDL3B;SIRT2;GATA3;RNF26;TNFAIP6;PTEN
prerank,regulation of sequestering of calcium ion (GO:0051282),-0.3567779068504589,-0.8885461186964176,0.6033210332103321,0.8379610570515494,1.0,4/12,17.76%,PTK2B;DIAPH1;CASQ2;UBASH3B
prerank,negative regulation of cellular catabolic process (GO:0031330),0.2510136668121265,0.8882304006266768,0.6548117154811716,0.8769665533079478,1.0,8/63,8.57%,NELL1;TIMP3;LEPR;BCL2;DAP;SIRT2;TIMP4;GOLGA2
prerank,embryonic limb morphogenesis (GO:0030326),0.2822009880940408,0.8882003292242009,0.6414253897550112,0.8762061526435733,1.0,4/34,7.78%,SALL1;TBX3;GLI3;RARG
prerank,regulation of cardiac muscle cell membrane repolarization (GO:0099623),0.31775816508109,0.8881356520309455,0.6260869565217392,0.875502852473947,1.0,2/21,3.32%,ANK2;CACNA2D1
prerank,negative regulation of cell aging (GO:0090344),-0.33632843686086045,-0.8876517881751362,0.6263157894736842,0.8393958434963802,1.0,3/16,8.99%,CDK6;MAP3K3;TWIST1
prerank,multivesicular body assembly (GO:0036258),-0.2840660002865526,-0.8873982700134417,0.637065637065637,0.8394620350026337,1.0,14/30,32.17%,RAB11A;CHMP2B;VPS36;TSG101;SNF8;IST1;CHMP2A;VPS4A;STAM2;CHMP7;STAM;VPS37C;CHMP4B;CHMP4A
prerank,positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),0.310260436961202,0.8872373401262974,0.5926724137931034,0.8767303260063082,1.0,8/23,12.65%,KIT;GHR;IL4;HES5;ERBB4;OCIAD2;PIBF1;PRLR
prerank,positive regulation of protein acetylation (GO:1901985),-0.3627554399649608,-0.8867556545750481,0.6195652173913043,0.8404172767437149,1.0,3/12,16.94%,DIP2B;CAMK1;RAPGEF3
prerank,regulation of lysosomal lumen pH (GO:0035751),-0.3549932770285085,-0.8867246749231832,0.6165137614678899,0.8400170665011567,1.0,5/12,39.15%,TMEM165;VPS33A;CCDC115;GRN;TMEM199
prerank,microtubule anchoring at microtubule organizing center (GO:0072393),0.36123278106274953,0.8864174289583179,0.6,0.877781678149421,1.0,5/12,20.74%,NINL;BICD1;KIF3A;BBS4;CCDC68
prerank,regulation of mRNA stability (GO:0043488),-0.2127911537334422,-0.8864124194181656,0.7571428571428571,0.8402100371248121,1.0,46/145,24.02%,VIM;UBB;HSPA8;UBC;RPS27A;ANP32A;PSMA6;HSPB1;RC3H1;PSMB5;AKT1;FUS;PCBP4;PSMC4;PSMC5;YTHDF2;CIRBP;PSMD14;YWHAZ;E2F1;FMR1;PSMD8;TNFSF13;PSMD11;PSMB4;PSMD12;PSMC1;FASTKD3;HSPA1A;EXOSC8;GIGYF2;TENT5D;PUM2;SERBP1;PSMA1;YTHDF1;TBRG4;MEX3D;PSMB1;PSMC3;PAIP1;EIF4G1;PSMA4;PSMA2;PRKCD;YWHAB
prerank,spliceosomal tri-snRNP complex assembly (GO:0000244),-0.3491504949215869,-0.8863629355624784,0.5985533453887885,0.8398415430353302,1.0,5/13,20.44%,PRPF8;DDX20;USP4;LSM2;CD2BP2
prerank,acute-phase response (GO:0006953),0.3604514445098151,0.8861002175670095,0.5697940503432495,0.8777123554682101,1.0,3/12,11.20%,AHSG;CEBPB;IL6R
prerank,determination of left/right symmetry (GO:0007368),-0.27654066318486215,-0.8859928378165972,0.6422764227642277,0.8401841910852468,1.0,10/36,24.81%,NOTCH1;TBX1;SMO;ZIC3;ARL6;DNAH5;PKD2;ODAD2;ODAD3;MKKS
prerank,chromosome organization (GO:0051276),-0.22470252817339387,-0.8859140939685358,0.701171875,0.8398692739110977,1.0,42/99,30.77%,ZBTB7A;UBB;UBC;RPS27A;SAFB;CUL4A;HHEX;H3-3A;COPS6;HMGN1;GATAD1;COPS5;CDAN1;SMARCA4;NUP155;RBX1;CETN2;LDB1;TOP2A;HMGN2;PWWP3A;L3MBTL1;COPS7A;NDC80;POLE3;COPS4;COPS7B;EZH1;CDCA8;PHF19;HDAC5;FAM50A;XPC;GPS1;LIG4;CENPV;RAD23B;TOP2B;HMGB2;HDAC3;MYC;NUF2
prerank,axonal transport (GO:0098930),-0.2748954711678282,-0.8855864256225937,0.6461232604373758,0.8400340382908327,1.0,17/36,38.38%,AP3M1;AP3B1;NEFL;KIF1B;DCTN1;OPA1;DTNBP1;AP3M2;SOD1;DST;BLOC1S2;BLOC1S6;AP3D1;AP3S1;BLOC1S1;AP3B2;BLOC1S4
prerank,cellular response to retinoic acid (GO:0071300),0.26855993935773315,0.8855044632614142,0.6465863453815262,0.8782879173006286,1.0,11/42,14.80%,PTK7;EPHA3;LYN;ZNF35;BRINP1;BRINP3;FZD10;BRINP2;ATM;WNT6;WNT5B
prerank,regulation of T cell proliferation (GO:0042129),-0.24543160947182502,-0.8852884032107783,0.672514619883041,0.840174016040685,1.0,6/61,7.20%,IL15;SLC7A1;TFRC;ANXA1;TNFRSF21;TNFRSF1B
prerank,glycosaminoglycan metabolic process (GO:0030203),-0.25341955379527337,-0.8852401552984295,0.6629422718808193,0.839786527956478,1.0,14/54,16.48%,GPC3;AGRN;HS3ST3A1;HEXA;NDST1;HS3ST1;IDUA;HAS1;SDC3;SGSH;HS3ST3B1;SLC35D2;GUSB;XYLT2
prerank,histone deacetylation (GO:0016575),0.2682867572478348,0.885065483523916,0.6351648351648351,0.8784706819634684,1.0,8/43,9.65%,TBL1XR1;PRDM5;HDAC10;SIRT2;MIER3;BRMS1L;BRMS1;HDAC8
prerank,vesicle transport along microtubule (GO:0047496),-0.2992452018617191,-0.885000564715195,0.6336996336996337,0.8398430711831345,1.0,8/23,22.37%,TRAK1;HTT;TRAK2;NDE1;NDEL1;RAB1A;KIF1C;KIF13A
prerank,cellular response to superoxide (GO:0071451),-0.3755301025458354,-0.8847996748755775,0.6290630975143403,0.8398207053657573,1.0,1/10,1.10%,NOS3
prerank,negative regulation of peptide hormone secretion (GO:0090278),-0.3196517035813268,-0.8844500125810743,0.6273408239700374,0.8400664159465601,1.0,3/18,4.11%,CCN3;KCNB1;REST
prerank,limb morphogenesis (GO:0035108),0.31477454191694676,0.884099530634045,0.6393088552915767,0.8797733595195902,1.0,2/20,3.86%,TBX3;GLI3
prerank,methylguanosine-cap decapping (GO:0110156),-0.3784637556893333,-0.8835578582838145,0.6277777777777778,0.8414589764950958,1.0,5/10,19.91%,DCPS;PNRC2;EDC4;DCP1B;LSM1
prerank,polyol biosynthetic process (GO:0046173),-0.3355488585830948,-0.8832314061600862,0.6273764258555133,0.8416912268489815,1.0,6/16,14.12%,ITPKB;IPMK;ISYNA1;FGF2;ACER3;IP6K1
prerank,"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",-0.22727838434894795,-0.8829944201799579,0.7051039697542533,0.8417400882047811,1.0,28/85,23.09%,FZD6;FZD4;RAC1;PSMA6;AP2M1;PSMB5;FZD3;FZD7;PFN1;WNT11;PSMC4;PSMC5;PSMD14;SMURF1;CELSR1;PSMD8;AP2A1;PSMD11;CELSR2;PSMB4;PSMD12;PSMC1;PSMA1;FZD5;PSMB1;PSMC3;PSMA4;PSMA2
prerank,regulation of urine volume (GO:0035809),-0.3718145155271901,-0.8828671044613957,0.6228239845261122,0.8415433590458998,1.0,6/10,39.25%,NPR1;NPR3;HAS2;HYAL2;TFAP2B;INPP5K
prerank,negative regulation of blood coagulation (GO:0030195),-0.27396865033913753,-0.8828146506060283,0.6550387596899225,0.8411703717503554,1.0,6/38,8.93%,NOS3;CD34;F3;THBD;EDN1;PDGFA
prerank,transcription initiation from RNA polymerase II promoter (GO:0006367),0.2174663546493962,0.8827284117218053,0.7568093385214008,0.8820292838264967,1.0,15/138,8.77%,RORA;AR;TBL1XR1;VDR;RARB;TEAD1;PPARA;GTF2H2;MNAT1;HNF4G;MAML3;HDAC10;RARG;RBPJ;POLR2G
prerank,regulation of actin filament-based process (GO:0032970),0.24110707027018866,0.8823211120853974,0.668,0.8821890671953091,1.0,16/70,15.56%,LRP1;ARHGEF19;EPHA3;ROCK2;RHOH;RHOBTB1;DLC1;PDGFRB;RHOBTB3;EPHA5;GRHL3;RHOF;FZD10;RND1;PAK1;RHOQ
prerank,positive regulation of cytoplasmic transport (GO:1903651),-0.36992195684293794,-0.882044604090546,0.6488413547237076,0.8422809450697829,1.0,5/11,25.89%,MSN;EZR;VPS11;RDX;MTMR2
prerank,ganglioside biosynthetic process (GO:0001574),-0.33869818552140885,-0.8818038214118661,0.6131528046421664,0.8423210008722632,1.0,3/15,6.49%,ST6GALNAC3;ST8SIA4;ST8SIA6
prerank,dendritic spine organization (GO:0097061),-0.2926623867490051,-0.8812445554323813,0.625,0.8430284457345607,1.0,2/26,0.55%,SHANK3;IGF1R
prerank,regulation of reactive oxygen species metabolic process (GO:2000377),-0.2495132185812804,-0.8803928906256735,0.6943907156673114,0.8443931572699502,1.0,13/55,19.26%,THBS1;TGFBR2;RNF41;RAC1;CYP1B1;RIPK1;ACE2;SPHK2;CDKN1A;COQ7;CBR1;SLC25A33;GADD45A
prerank,maintenance of gastrointestinal epithelium (GO:0030277),-0.3549830120473863,-0.8803269080762753,0.617059891107078,0.8440459500645563,1.0,5/12,36.09%,TLR4;NOD2;SOX9;MUC13;MUC6
prerank,tube closure (GO:0060606),0.2892441393309166,0.8802022660076997,0.6322314049586777,0.8861286931052663,1.0,8/31,12.32%,PRICKLE1;LMO4;DLC1;IFT122;PLXNB2;FUZ;GRHL3;MTHFD1
prerank,quinone biosynthetic process (GO:1901663),-0.3324713637068507,-0.880117052297988,0.6383763837638377,0.8439963403376416,1.0,5/14,22.20%,PDSS2;COQ6;COQ8A;COQ7;UBIAD1
prerank,positive regulation of viral life cycle (GO:1903902),-0.30581861379388825,-0.8800159659420438,0.6451016635859519,0.8437376387757889,1.0,9/22,27.99%,CHMP2B;CD74;FMR1;TSG101;LGALS1;CHMP2A;LGALS9;VPS4A;P4HB
prerank,lipid biosynthetic process (GO:0008610),0.241994416259384,0.8796305602516886,0.694,0.8865804605496603,1.0,15/77,17.28%,PAM;ACSM5;ACSL1;SCD5;NDUFAB1;PRLR;GNPAT;MCAT;ACSL6;ACACA;FADS1;SCD;OLAH;ACSS2;CYP51A1
prerank,DNA conformation change (GO:0071103),0.32863277894509535,0.8793230953796415,0.6271929824561403,0.886429423852434,1.0,3/17,8.02%,TOP1;TOP3A;TOP1MT
prerank,positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),0.2812551198512959,0.8790442875677653,0.6666666666666666,0.8862204971442641,1.0,3/33,3.55%,AREG;DGKD;TGFA
prerank,regulation of mRNA processing (GO:0050684),-0.2788838913838693,-0.8788546028118723,0.6383763837638377,0.8456477555586907,1.0,8/32,20.74%,QKI;SAFB;SRPK1;DHX9;JMJD6;HNRNPK;PTCD2;CPSF4
prerank,smooth muscle contraction (GO:0006939),0.3415029123784549,0.878731973023202,0.5977272727272728,0.8860975702468694,1.0,3/14,6.27%,SLC8A1;ROCK2;MYLK
prerank,regulation of myelination (GO:0031641),-0.29518930191008813,-0.8786927299732142,0.6629422718808193,0.8455447827035574,1.0,4/25,7.20%,JAM2;PARD3;TNFRSF21;TNFRSF1B
prerank,positive regulation of leukocyte mediated cytotoxicity (GO:0001912),-0.2844500539986328,-0.8783877155299739,0.6280373831775701,0.8456968356845295,1.0,20/29,45.89%,CYRIB;PVR;LAMP1;NECTIN2;SPI1;RASGRP1;AP1G1;NOS2;TYROBP;CADM1;SLAMF6;CD226;IL12A;CRTAM;IL12RB1;IL23A;KLRD1;CD160;KLRK1;IL23R
prerank,proteolysis (GO:0006508),-0.19491145619326464,-0.8783558845920718,0.8183632734530938,0.8452898936918932,1.0,43/252,13.71%,DPP4;SRGN;F3;FAP;TPP1;CAPN2;BACE2;CTSZ;ADAM10;CTSO;BACE1;CASP7;ADAM19;CTSC;CASP8;PSMA6;ERAP1;IDE;SPCS1;PRCP;CAPN15;PSMB5;LACTB;MMP14;CTSD;PSENEN;CPE;CTSF;HTRA3;CAPN5;FAM111A;HTRA4;LRP8;PSMC4;GGT5;CTSB;MMP15;DPP8;SPRTN;CAPN10;LNPEP;FBXL2;ACE
prerank,regulation of vasoconstriction (GO:0019229),-0.2916746881028486,-0.8783358837653261,0.6303571428571428,0.844859096200864,1.0,5/27,16.26%,CAV1;BMPR2;ACE2;ACE;ATP2B1
prerank,neurotrophin signaling pathway (GO:0038179),-0.3079866228297321,-0.8782213358830194,0.6319569120287253,0.8446014196433226,1.0,3/21,3.71%,RAP1A;RAPGEF1;NGF
prerank,detection of calcium ion (GO:0005513),-0.3537616525547751,-0.8781462577435986,0.616871704745167,0.8442814045958319,1.0,4/13,21.60%,CALM1;CALM3;CASQ2;KCNIP2
prerank,icosanoid metabolic process (GO:0006690),-0.2621340840510214,-0.8779183184506015,0.6693227091633466,0.8442536282073657,1.0,12/40,20.25%,MGLL;EPHX1;CYP1B1;LTA4H;GPX1;PON3;GGT5;PTGS1;FAAH;GPX4;DAGLB;GGT1
prerank,regulation of peptidyl-threonine phosphorylation (GO:0010799),-0.26598311950345405,-0.8778560950354258,0.6958174904942965,0.8439175680522936,1.0,18/37,30.24%,PARD3;SMAD7;CALM1;TGFB1;APP;CALM3;CAB39;DDIT4;CADM4;EIF4G1;DMTN;SPRED3;PPEF2;RPTOR;TNKS1BP1;IRGM;SPRED1;PLK1
prerank,regulation of macrophage derived foam cell differentiation (GO:0010743),0.3030922844785773,0.8775638630810799,0.6140724946695096,0.8879278846488856,1.0,5/27,8.31%,ABCA1;PPARA;PLA2G5;ABCA5;IL18
prerank,protein modification by small protein conjugation or removal (GO:0070647),-0.3511165059957575,-0.8773310816718266,0.6420664206642066,0.8445069491420951,1.0,5/13,20.48%,ATG7;SAE1;UBA2;UBA5;UBA1
prerank,positive regulation of insulin secretion (GO:0032024),0.27853439127488805,0.8772378009211136,0.6646216768916156,0.887843569303685,1.0,6/36,10.92%,TCF7L2;IRS2;NLGN2;TM7SF3;ADCY8;BAIAP3
prerank,negative regulation of protein depolymerization (GO:1901880),0.30302906121482964,0.8768961876439797,0.6238938053097345,0.8877946552017316,1.0,4/24,13.50%,PLEKHH2;ATXN7;CAMSAP1;NAV3
prerank,positive regulation of telomerase RNA localization to Cajal body (GO:1904874),-0.3365111116616232,-0.8767691968274298,0.6431297709923665,0.8451709120687406,1.0,9/15,35.68%,DKC1;CCT2;CCT3;CCT8;CCT7;RUVBL1;CCT4;CCT6A;NOP10
prerank,positive regulation of cellular respiration (GO:1901857),-0.36558893443677043,-0.8767476777512674,0.6497175141242938,0.8447444108881139,1.0,5/11,27.00%,IFNAR1;VCP;IL10RB;PARK7;IFNLR1
prerank,positive regulation of mRNA 3'-end processing (GO:0031442),0.3771353288713401,0.8762517414430507,0.625,0.8884101384115245,1.0,5/10,23.01%,CPEB3;CPEB1;PAF1;HSF1;NUDT21
prerank,negative regulation of cell cycle process (GO:0010948),0.24697413676353686,0.8762344818630641,0.6680327868852459,0.8876181466715483,1.0,18/61,20.86%,AURKAIP1;UXT;TFDP1;L3MBTL2;RNF2;APAF1;TOM1L2;PCGF6;EHMT2;TOM1L1;PPP1R10;EZH2;FBXO5;ZFYVE19;YAF2;CDC7;MGA;PCGF2
prerank,body fluid secretion (GO:0007589),0.34094200645344386,0.8759774269243179,0.6271551724137931,0.887340747598789,1.0,5/15,18.69%,SLC22A4;ERBB4;PRLR;GUCA1B;SLC22A2
prerank,gluconeogenesis (GO:0006094),-0.2659460875831635,-0.8759515451608251,0.6653919694072657,0.8459157562461119,1.0,8/39,16.11%,GPI;PGM1;PPARGC1A;ATF4;GAPDH;SLC25A12;SLC25A1;PGK1
prerank,mRNA 3'-end processing (GO:0031124),-0.2314919392151336,-0.8759050844344065,0.718052738336714,0.8455516977546932,1.0,24/78,26.91%,RPRD1B;APP;SRSF2;SRSF5;SRSF6;U2AF1;LSM11;ZC3H11A;RNPS1;SRSF4;MAGOH;CHTOP;ALYREF;DDX39B;CASC3;PAPOLG;THOC6;CPSF4;DDX39A;NCBP2;CSTF2T;PABPC1;THOC7;RPRD1A
prerank,negative regulation of response to biotic stimulus (GO:0002832),-0.2878189667546366,-0.8756985992183993,0.6370808678500987,0.8455131434443319,1.0,6/26,15.59%,TRIB1;DHX58;MAPKBP1;ITCH;SIGIRR;TNFAIP3
prerank,post-transcriptional gene silencing by RNA (GO:0035194),0.30428259798348584,0.8755583992195228,0.6077235772357723,0.8874828701398976,1.0,9/20,20.54%,AGO4;HELZ;TNRC6A;AJUBA;TNRC6B;AGO3;CNOT8;AGO1;AGO2
prerank,regulation of protein targeting to membrane (GO:0090313),-0.28384642842875685,-0.8752041610650356,0.6360225140712945,0.846065970399234,1.0,8/28,14.83%,KCNB1;CHP1;MIEF1;GDI1;MIEF2;CIB1;HRAS;ERBB2
prerank,cellular response to osmotic stress (GO:0071470),-0.31638851097389914,-0.8749269535071863,0.6551094890510949,0.8461199552490878,1.0,10/21,33.54%,LRRC8D;YBX3;TRPV4;CAB39;ARHGEF2;PKD2;CAPN3;LRRC8E;AQP1;SLC4A11
prerank,protein K48-linked deubiquitination (GO:0071108),-0.30901426165219015,-0.8746817101703691,0.634011090573013,0.8461624475737717,1.0,6/23,10.91%,MINDY2;MINDY1;OTUD5;USP8;OTUB1;USP5
prerank,regulation of primary metabolic process (GO:0080090),-0.213059548138015,-0.8743503973733524,0.7425149700598802,0.8464029467423526,1.0,43/126,28.06%,PPARD;NCOR1;TNFAIP8L3;NFYA;PLPP1;ADIPOR1;PSAP;PSMA6;PSMB5;LACTB;PSMC4;PSMC5;PSMD14;OAZ2;APOE;PSMD8;TM7SF2;PSMD11;SC5D;PSMB4;PSMD12;PSMC1;NQO1;SP1;TBL1X;TGS1;EDF1;HELZ2;PSMA1;RUBCNL;OPA3;PSMB1;PSMC3;FDPS;PSMA4;PSMA2;SREBF1;PSMB8;LSS;SIN3B;IDI1;NFYB;CERS2
prerank,blood circulation (GO:0008015),0.2545174857938352,0.8739959846907391,0.6929824561403509,0.8901473281745377,1.0,6/49,5.85%,SGCZ;HTR7;SGCD;ROCK2;TNNI3;COL4A3
prerank,proteasome assembly (GO:0043248),-0.36725943316112897,-0.8739468702895643,0.6261180679785331,0.8467497642834759,1.0,3/11,24.05%,POMP;PSMD11;PSMG2
prerank,dendritic spine morphogenesis (GO:0060997),0.33600636008217954,0.8737065741411219,0.5978947368421053,0.8899766061493563,1.0,5/15,13.19%,DOCK10;CTNND2;EPHB1;PTEN;DLG4
prerank,monovalent inorganic cation homeostasis (GO:0055067),-0.29940146633994347,-0.8735864291041628,0.671559633027523,0.8470201069831549,1.0,2/23,0.97%,SLC12A7;SLC12A2
prerank,negative regulation of axon extension (GO:0030517),-0.281024758385502,-0.87351009783216,0.6857142857142857,0.846717255402062,1.0,5/30,9.74%,SEMA6A;SEMA3C;SEMA7A;DIP2B;SEMA3G
prerank,cellular response to low-density lipoprotein particle stimulus (GO:0071404),-0.3466506077935637,-0.8733432263592387,0.6432532347504621,0.8465984201208375,1.0,4/13,12.88%,CD81;CD9;FCER1G;SYK
prerank,"DNA catabolic process, endonucleolytic (GO:0000737)",0.29717273940314587,0.8731472554156784,0.6059907834101382,0.8903353051868361,1.0,4/23,10.31%,CASP3;SETMAR;EXOG;CECR2
prerank,"synaptic transmission, cholinergic (GO:0007271)",0.3206286037765032,0.8724710427570351,0.6204545454545455,0.8910167245626309,1.0,6/19,16.91%,CHRNB4;CHRNA4;CHRNA7;CHRFAM7A;CHRNB1;ACHE
prerank,phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),0.2365830902652696,0.87225552229012,0.705050505050505,0.8906359756168949,1.0,16/76,14.15%,LPAR1;GPR55;GPR174;GRM1;CHRM2;OPRK1;HRH1;LPAR4;NMBR;ADRA1D;C3AR1;ADRA1B;GNA15;ACTN2;P2RY1;DRD2
prerank,positive regulation of tissue remodeling (GO:0034105),0.35940107424790413,0.8721066603527676,0.5875831485587583,0.8901193686729532,1.0,2/10,8.31%,ROCK2;IL18
prerank,fatty-acyl-CoA metabolic process (GO:0035337),-0.30719827236036146,-0.8719278328622003,0.6529411764705882,0.8490593182487913,1.0,5/20,16.01%,FAR2;ACLY;PPT2;FAR1;SLC25A1
prerank,glucose metabolic process (GO:0006006),-0.24123899807733284,-0.871570473115604,0.7176470588235294,0.849297415720811,1.0,11/58,16.93%,LRP5;PPARD;GPI;PGM1;PPARGC1A;ATF4;GAPDH;SLC25A12;SLC25A1;PGK1;GALM
prerank,positive regulation of isotype switching (GO:0045830),0.34445155917022174,0.8711125588148377,0.6053811659192825,0.8914525987900804,1.0,6/15,15.92%,SHLD2;IL4;KMT5C;PAXIP1;RIF1;KMT5B
prerank,positive regulation of neuron apoptotic process (GO:0043525),0.30159455658147866,0.8706657352394255,0.6543478260869565,0.8915999342299458,1.0,1/24,0.15%,EPHA7
prerank,regulation of lipid storage (GO:0010883),-0.3007548394649213,-0.8697460023120527,0.6320754716981132,0.8525483063729794,1.0,13/22,44.33%,NFKBIA;ITGB3;C3;HILPDA;ALKBH7;PTPN2;MEST;IKBKE;ITGAV;PLIN5;TNF;IL6;LPL
prerank,regulation of axon extension (GO:0030516),-0.2716865638852738,-0.8690422595473877,0.66,0.8535122544009588,1.0,22/37,37.62%,SEMA7A;SHTN1;DIP2B;SEMA3G;DBNL;DBN1;APOE;NTN1;LIMK1;CTTN;DNM2;RTN4R;ZFYVE27;CDKL5;ISLR2;PTPRS;ABL1;MAP3K13;MAG;RNF6;L1CAM;TWF2
prerank,DNA replication (GO:0006260),0.2235053881565164,0.8690047646569482,0.7563559322033898,0.8942749332452898,1.0,29/105,21.08%,RBMS1;MCM3;ORC4;TOP1;TOP3A;TOP1MT;BLM;RPA2;RFC5;MCM2;MCM9;MCM8;ORC1;NBN;ATM;RPA1;KAT5;BRIP1;ORC3;POLD4;WRNIP1;ORC5;POLD1;DONSON;SET;CDC7;DUT;RFC1;NT5M
prerank,"nucleotide-excision repair, DNA gap filling (GO:0006297)",-0.29366214073119495,-0.8683010997927391,0.6551724137931034,0.8545054556364305,1.0,10/24,29.93%,UBB;UBC;RPS27A;XRCC1;RPA3;POLK;RFC3;RFC2;LIG4;POLB
prerank,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),-0.3194319241522068,-0.8677273366161591,0.630188679245283,0.8551920188622726,1.0,4/18,11.00%,PPIA;HSPB1;AKT1;BAG5
prerank,regulation of TORC1 signaling (GO:1903432),-0.26986327910180896,-0.8675717720186514,0.6622137404580153,0.8550273239266803,1.0,11/33,27.35%,GPR137B;PIP4P1;RRAGD;RRAGA;RRAGC;SESN2;CASTOR2;SEH1L;SIK3;LAMTOR5;SESN1
prerank,myelination (GO:0042552),-0.24853393777394406,-0.8674271204586976,0.6775431861804223,0.8548451542377847,1.0,11/46,16.04%,ADGRG6;PARD3;CMTM8;MYOC;TNFRSF21;MAL;NF1;PLLP;ACER3;MALL;MARVELD1
prerank,heterocycle biosynthetic process (GO:0018130),0.33536156817024804,0.8670645277252735,0.6244541484716157,0.897712645328062,1.0,1/14,2.11%,MOCS2
prerank,lipid droplet formation (GO:0140042),-0.37045049854284506,-0.8670283985067087,0.647495361781076,0.8552455265668046,1.0,2/10,7.82%,CDS2;CDS1
prerank,positive regulation of phospholipid transport (GO:2001140),-0.3773580967208786,-0.8669731349004852,0.6552346570397112,0.8549002953345748,1.0,4/10,22.03%,DBI;APOE;TMEM30A;TRIAP1
prerank,polyamine metabolic process (GO:0006595),-0.34431016332752296,-0.8664854125300574,0.6557377049180327,0.8554386963190579,1.0,6/13,23.30%,AMD1;OAZ2;PAOX;SMS;SRM;DHPS
prerank,keratinocyte differentiation (GO:0030216),-0.28485068319565926,-0.866357210685198,0.6635338345864662,0.8552365669009122,1.0,10/29,27.46%,CLIC4;ANXA1;BCR;OPN3;EPHA2;DSP;EVPL;SCEL;CERS3;PIP5K1A
prerank,calcium-mediated signaling using intracellular calcium source (GO:0035584),0.31502272327271175,0.8663285272616527,0.621900826446281,0.8984570044584897,1.0,2/19,2.65%,PTGFR;PRKACA
prerank,negative regulation of lipid storage (GO:0010888),0.3206165603488465,0.8661591360030545,0.6076233183856502,0.8980047219206787,1.0,3/19,3.10%,ABCA1;PPARA;OSBPL8
prerank,protein localization to organelle (GO:0033365),-0.20929892740171963,-0.8657581733513713,0.7524366471734892,0.8560005775875899,1.0,33/133,22.42%,RAB11A;GBP5;ZBTB7A;IFT20;RPL11;SIX1;APP;STX1A;DHX9;DNAJA1;HHEX;LAMP1;DDRGK1;TOLLIP;TULP2;ZNF423;TOR1AIP1;SEC61B;TUB;ARL6;CEP68;COG3;SGTA;TSPAN17;GCC2;TMEM30A;EHD1;PACSIN2;MSX1;RIPOR1;CNEP1R1;STX5;CD68
prerank,regulation of cellular protein localization (GO:1903827),0.2580339686374787,0.8653205734858064,0.6625514403292181,0.8990172664133104,1.0,7/45,10.07%,GPC6;GPC4;GPC2;VCPIP1;GBF1;DVL3;GPC5
prerank,regulation of amyloid fibril formation (GO:1905906),-0.3333573724525756,-0.8652774585881003,0.6477272727272727,0.8565085744058155,1.0,7/15,25.40%,APP;PFDN5;APOE;CRYAB;PFDN6;PFDN4;TREM2
prerank,regulation of branching involved in ureteric bud morphogenesis (GO:0090189),-0.32551697803864954,-0.8652174159218118,0.6405959031657356,0.8561585723355192,1.0,3/15,5.68%,SIX1;SMO;VEGFA
prerank,receptor recycling (GO:0001881),-0.36549568224187795,-0.8647144626122554,0.636697247706422,0.8566979431108199,1.0,5/10,25.16%,LMTK2;REP15;RAB11B;EHD3;PHETA2
prerank,"endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",-0.3461536761172572,-0.8642950522924866,0.6368715083798883,0.8570409505205558,1.0,2/13,2.97%,NOP14;RPS21
prerank,positive regulation of heterochromatin assembly (GO:0031453),-0.3614613274497064,-0.8640580623748049,0.6602112676056338,0.8570486953094443,1.0,4/11,21.38%,MPHOSPH8;TRIM28;TASOR;SETDB1
prerank,regulation of nervous system development (GO:0051960),0.26928365838806234,0.8640279350893756,0.663135593220339,0.9009398880649169,1.0,6/37,8.90%,PTN;HES3;SIRT2;DOCK7;HES5;NPHP3
prerank,regulation of centriole replication (GO:0046599),0.32128961898094593,0.8640207209300247,0.6401869158878505,0.90012182196842,1.0,8/17,23.01%,MDM1;CEP295NL;ALMS1;NUP62;TRIM37;CEP295;CEP76;KAT2B
prerank,respiratory electron transport chain (GO:0022904),-0.34379638472528246,-0.8633088068514563,0.6487985212569316,0.8581276056349639,1.0,7/14,26.95%,PPARGC1A;SLC25A12;ETFDH;ETFB;SDHB;SLC25A22;ETFRF1
prerank,carboxylic acid metabolic process (GO:0019752),-0.275193674179772,-0.8626785102228046,0.7182835820895522,0.8589240617376852,1.0,5/33,10.82%,SLC2A1;CSGALNACT1;ST6GAL1;PON3;CARNMT1
prerank,glycerol metabolic process (GO:0006071),0.36918517071342083,0.8619853256182218,0.6420824295010846,0.90368975428814,1.0,7/10,29.59%,GOT1;COQ3;GK;PDXP;ANGPTL3;COQ2;TKFC
prerank,regulation of trophoblast cell migration (GO:1901163),0.33742918218390383,0.8610840338950615,0.6426966292134831,0.9047809307796636,1.0,5/14,21.66%,GJA1;SMURF2;SYDE1;AGO2;TIMP1
prerank,modulation by host of symbiont process (GO:0051851),-0.2747648027031029,-0.860766737172164,0.6783088235294118,0.8622334273158654,1.0,14/31,36.84%,LEF1;REST;SMARCA4;CX3CR1;SP1;NAPEPLD;CHD1;POU2F3;AQP1;CCL5;JUN;SAP30;HPN;CCL4
prerank,positive regulation of chromatin organization (GO:1905269),-0.3518273842010488,-0.8604115897538557,0.6767485822306238,0.8625180255101202,1.0,3/12,16.98%,TAL1;H3-3A;MIER1
prerank,double-strand break repair (GO:0006302),-0.20391544021790153,-0.86010584462339,0.8347457627118644,0.8626547149583846,1.0,57/158,30.52%,PAXX;BRCC3;PRKDC;ZFYVE26;UIMC1;ERCC1;YY1;BABAM1;HERC2;VCP;MTA1;SFPQ;CIB1;UBXN1;HPF1;PPP5C;PSMD14;SLX4;DCLRE1C;REV3L;SAMHD1;XRCC1;PARP2;HUS1;MMS22L;EME2;RPA3;CYREN;BABAM2;BRCA2;AP5Z1;HELQ;POLQ;RAD21;ERCC4;SFR1;DTX3L;FAN1;POLL;NSMCE1;DNA2;RAD51AP1;LIG4;TNKS1BP1;BARD1;RNF8;HMGB2;MRE11;SWI5;EXD2;POLB;SMARCA5;MEIOB;RMI1;RAD52;PRPF19;RECQL
prerank,response to tumor necrosis factor (GO:0034612),0.22611050458164733,0.8600707925359526,0.7661795407098121,0.9061225801761654,1.0,11/91,10.34%,ADAMTS12;PID1;HYAL3;OCSTAMP;SFRP1;GGT7;CXCL16;CASP3;GATA3;CCL25;YTHDC2
prerank,response to gamma radiation (GO:0010332),-0.29503755984747276,-0.8589660256481411,0.6500956022944551,0.8645227006100741,1.0,11/24,30.31%,RPL26;MAP3K20;HRAS;TMEM109;KDM1A;CRYAB;DCUN1D3;FANCD2;LIG4;TSPYL5;MYC
prerank,neuron apoptotic process (GO:0051402),0.31451975026669654,0.8582880922326934,0.6417910447761194,0.9091921986387984,1.0,6/19,12.56%,BCL2;SCN2A;ERBB3;ATN1;NGFR;DIABLO
prerank,motile cilium assembly (GO:0044458),0.35169986000015896,0.858229829391094,0.639821029082774,0.9084806274870401,1.0,4/12,22.14%,DNAAF3;BBOF1;RSPH9;CCDC39
prerank,synaptic vesicle recycling (GO:0036465),0.2762497024115619,0.8579579722191549,0.6595289079229122,0.9082609090194208,1.0,6/31,7.71%,STON1;NLGN2;TBC1D24;NLGN3;SYT1;NLGN1
prerank,post-Golgi vesicle-mediated transport (GO:0006892),0.23145307140770396,0.8579094707363404,0.7447698744769874,0.9075316086272703,1.0,16/88,13.18%,SH3D19;DNAJC6;SORCS1;AP4B1;MYO5A;SCFD1;ACBD3;GBF1;ARFGEF2;TXNDC5;RAB10;CCDC93;SCAMP2;VPS35L;SYS1;LLGL1
prerank,negative regulation of coagulation (GO:0050819),0.33738954128697685,0.8576594051106534,0.6443965517241379,0.9072207257113853,1.0,3/14,5.80%,SERPINE2;APOH;SERPINE1
prerank,P-body assembly (GO:0033962),-0.3475447186132079,-0.8576402197937738,0.6428571428571429,0.8666678986422289,1.0,4/12,21.06%,RC3H1;LIMD1;LSM14A;LSM3
prerank,positive regulation of lymphocyte differentiation (GO:0045621),0.31385413081919783,0.8567453170887946,0.6373390557939914,0.9083696452849195,1.0,4/19,9.13%,RHOH;IL4;AXL;GATA3
prerank,positive regulation of monocyte chemotaxis (GO:0090026),-0.32364276097495065,-0.8564492596352841,0.6595744680851063,0.8685909689438617,1.0,1/17,0.23%,ANO6
prerank,positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),0.32643369742675676,0.856304145464772,0.6477024070021882,0.90848099234462,1.0,3/16,18.27%,PRKCA;PDE6G;MRAP2
prerank,aspartate family amino acid catabolic process (GO:0009068),0.316710980405478,0.8561254616003325,0.6371681415929203,0.9080497282698734,1.0,3/19,7.44%,ASPA;ALDH7A1;DDO
prerank,regulation of axon regeneration (GO:0048679),0.34874755413165864,0.8560612566024939,0.6291390728476821,0.907355140664671,1.0,1/12,0.72%,PTN
prerank,protein alkylation (GO:0008213),-0.29366271842815284,-0.8559938188261867,0.6492146596858639,0.8690042421447075,1.0,6/22,19.46%,PRMT8;SNRPD3;FAM98A;EEF2KMT;PRMT3;LCMT1
prerank,negative regulation of bone remodeling (GO:0046851),-0.3560851731603107,-0.8559658334984295,0.6793478260869565,0.8685950191194436,1.0,4/11,17.76%,GPR137B;TNFAIP3;GREM1;UBASH3B
prerank,RNA phosphodiester bond hydrolysis (GO:0090501),0.29140487559688333,0.8552537875270503,0.6830265848670757,0.9082708758806166,1.0,27/27,70.91%,NYNRIN;RNASE4;PARN;RNASEH1;NHP2;DICER1;ZC3H12B;TOE1;XRN1;LACTB2;POP1;CPSF3;ZC3H12A;POP7;RNASE1;ZC3H12C;SLFN14;RNASE6;TRIR;KHNYN;NUDT16;RPP30;CSTF3;PDE12;PCF11;ZC3H12D;ERN1
prerank,cellular response to light stimulus (GO:0071482),-0.2313625899957829,-0.8552326718169014,0.747104247104247,0.8695707394011706,1.0,25/66,32.61%,RPL26;RHBDD1;ATF4;N4BP1;YY1;BAK1;FMR1;GNB1;OPN3;KDM1A;POLK;ERCC4;COPS9;PTPRK;RHNO1;TRIAP1;PRKCD;SMPD1;NPM1;MYC;AQP1;RRH;OPN1MW3;OPN1MW;CREBBP
prerank,regulation of protein localization to cell periphery (GO:1904375),-0.3123876858140784,-0.8550762963737232,0.6803571428571429,0.8693822051692128,1.0,6/18,19.19%,ACTB;SPTBN1;MMP14;ABCA2;VTI1B;MISP
prerank,regulation of hormone secretion (GO:0046883),-0.3169599500297209,-0.8549356276235953,0.656084656084656,0.86918640406256,1.0,2/15,7.67%,ANXA1;EDN1
prerank,regulation of tissue remodeling (GO:0034103),0.31774532424347857,0.8547308622034044,0.6543778801843319,0.9085619657888598,1.0,3/18,8.31%,DDR2;LEPR;IL18
prerank,negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),0.3441761055370651,0.8545075152176046,0.6598639455782312,0.9073626939249665,1.0,1/12,1.08%,FBLN1
prerank,negative regulation of cell morphogenesis involved in differentiation (GO:0010771),0.3441761055370651,0.8545075152176046,0.6598639455782312,0.9073626939249665,1.0,1/12,1.08%,FBLN1
prerank,negative regulation of cellular protein metabolic process (GO:0032269),-0.22183299500400144,-0.8543585405699224,0.775894538606403,0.86985214645917,1.0,22/88,19.99%,RACK1;RPS3;DAB2IP;IGFBP5;CNOT7;GAPDH;EDN1;AKT1;CST3;NCL;RPL13A;CAPRIN1;APOE;FMR1;PCIF1;LSM14A;GIGYF2;ATRAID;CDK5RAP3;TYMS;PAIP2B;SYNCRIP
prerank,Golgi localization (GO:0051645),-0.35965515853290686,-0.8539276239707044,0.6717267552182163,0.8702385039991156,1.0,6/11,24.27%,STK25;COPG1;YWHAZ;RIPOR1;PDCD10;CDC42
prerank,phagolysosome assembly (GO:0001845),0.34703039590451246,0.8539088385435081,0.6232227488151659,0.9078167151593772,1.0,4/12,19.24%,PLA2G5;RAB20;CLN3;RAB7B
prerank,myeloid dendritic cell activation (GO:0001773),0.3526429940622846,0.8531378455935789,0.6355140186915887,0.9086045041244606,1.0,3/12,12.83%,IL4;CAMK4;DOCK2
prerank,negative regulation of hormone secretion (GO:0046888),0.36294177434285674,0.8530759948163271,0.6519721577726219,0.9079259083882864,1.0,1/10,1.53%,GJA1
prerank,negative regulation of locomotion (GO:0040013),-0.34365733879789223,-0.8529698886779601,0.6482504604051565,0.8716290627748857,1.0,4/12,11.89%,FRMD5;CRK;CCDC125;DUSP3
prerank,fatty acid transport (GO:0015908),-0.311260480538988,-0.8529404127576413,0.6586270871985158,0.8712112713701337,1.0,4/17,12.33%,PPARD;MFSD2A;FABP5;APOE
prerank,phosphatidylcholine biosynthetic process (GO:0006656),-0.26477576600032593,-0.8529295688325664,0.6967370441458733,0.8707566740614103,1.0,13/32,28.36%,LPCAT3;MFSD2A;CHKA;CSNK2B;CEPT1;CSNK2A1;CSNK2A2;LCAT;PCYT1A;CHAT;PEMT;LPIN2;SLC27A1
prerank,negative regulation of ERK1 and ERK2 cascade (GO:0070373),0.256077764999767,0.8528516862180514,0.7052845528455285,0.907561364941109,1.0,6/46,10.71%,FBLN1;TIMP3;LYN;GSTP1;PTEN;RPS6KA6
prerank,neuron differentiation (GO:0030182),0.20335987917074821,0.8527363846635605,0.8154158215010142,0.9069974197275739,1.0,20/165,10.85%,WNT4;TENM3;GLI2;PTPRD;TENM2;PBX4;PHOX2A;FOXA2;CASP3;IL1RAPL1;LHX4;TGFBR1;RYK;ATOH8;CDK5R1;EPHA5;ALK;FUT9;ATP8A2;BRSK1
prerank,placenta development (GO:0001890),-0.34268566272525824,-0.8526411567727074,0.6598513011152416,0.8708648875562329,1.0,2/12,6.61%,PTK2;ADAM19
prerank,ovarian follicle development (GO:0001541),0.34200016407870626,0.8523330640625193,0.6449438202247191,0.9070016943222781,1.0,5/13,15.91%,KIT;CEBPB;ANG;EIF2B5;EIF2B2
prerank,phosphatidylinositol phosphate biosynthetic process (GO:0046854),0.26303695865965604,0.8520827256824941,0.7142857142857143,0.9066969928787127,1.0,4/39,4.69%,PIK3R1;PIP4K2A;ITPKC;EFR3A
prerank,G1/S transition of mitotic cell cycle (GO:0000082),-0.22115178263938454,-0.8519699852250407,0.7470355731225297,0.871649135045298,1.0,22/83,22.69%,CDK6;CDK17;CDKN1B;BRD4;CUL4A;PLK2;RB1;INHBA;E2F3;CDK4;CRLF3;ACVR1;E2F1;CDKN1A;CUL1;CDKN2C;CCND1;TYMS;RCC1;EIF4EBP1;PLK3;CDK15
prerank,negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),-0.36914431200884523,-0.8516008108250447,0.6765217391304348,0.8719105037210926,1.0,8/10,43.57%,PPP2R1A;PTPN2;PARP14;NF2;PPP2CA;INPP5F;SOCS3;SH2B3
prerank,poly(A)+ mRNA export from nucleus (GO:0016973),-0.30126730099810295,-0.85135320273548,0.674812030075188,0.8718840714828967,1.0,4/18,12.01%,NUP93;ENY2;HHEX;ZC3H11A
prerank,calcium ion transport into cytosol (GO:0060402),0.3076374284387487,0.8510388986557139,0.6554621848739496,0.9080537448977754,1.0,7/21,17.49%,SLC8A1;CACNA2D1;TRPM1;GRIN2A;JPH1;ADRA1A;GRIN2B
prerank,"DNA-templated transcription, initiation (GO:0006352)",0.20551176030017484,0.8508559044529236,0.8356435643564356,0.9076124926277016,1.0,18/166,9.27%,RORA;AR;TBL1XR1;VDR;RARB;TEAD1;PPARA;POLR1A;GTF2H2;MNAT1;HNF4G;MAML3;HDAC10;POLR1G;RARG;RBPJ;POLR2G;POLR1B
prerank,regulation of viral transcription (GO:0046782),-0.2554993361180946,-0.8505572577613064,0.7001972386587771,0.8729643825385776,1.0,6/39,12.16%,MID2;IFITM3;DHX9;TRIM14;NELFE;TRIM62
prerank,positive regulation of keratinocyte differentiation (GO:0045618),0.36645778383889127,0.8505561750753031,0.6305309734513275,0.9073787093332523,1.0,2/10,1.77%,CYP27B1;VDR
prerank,protein localization to endoplasmic reticulum (GO:0070972),0.3197580166078624,0.8500540551754835,0.648471615720524,0.9075853598270291,1.0,2/16,6.07%,ANK2;GBF1
prerank,dicarboxylic acid metabolic process (GO:0043648),0.25068318283552965,0.850029132579689,0.7029478458049887,0.9068276264714937,1.0,17/52,21.85%,ALDH18A1;ADHFE1;PHYH;D2HGDH;ALDH1L1;FPGS;MDH2;SLC46A1;SDHA;MTHFD1;ASS1;MTHFD1L;GPT2;ALDH5A1;GOT1;SLC19A1;GOT2
prerank,nucleotide metabolic process (GO:0009117),-0.29595219513954474,-0.8491234420264059,0.704331450094162,0.8753223343932868,1.0,12/23,45.03%,ME1;CTPS2;NMNAT3;PARK7;NMNAT2;FHIT;CMPK2;DCK;ENPP3;DCTD;AK7;NUDT5
prerank,positive regulation of transcription by RNA polymerase I (GO:0045943),-0.29485448864596,-0.8486221884547204,0.6818181818181818,0.8757797344133782,1.0,6/22,25.84%,ATF4;NCL;SMARCA4;ERBB2;PWP1;UTP15
prerank,keratan sulfate biosynthetic process (GO:0018146),-0.2751064022583205,-0.8485753744380259,0.676056338028169,0.8753938838790547,1.0,2/26,0.35%,ST3GAL6;ST3GAL4
prerank,"RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",0.32533902561526845,0.8484242441160387,0.6339285714285714,0.9093084847709119,1.0,15/15,67.50%,NYNRIN;RNASEH1;DICER1;ZC3H12B;LACTB2;POP1;ZC3H12A;POP7;ZC3H12C;SLFN14;KHNYN;NUDT16;RPP30;ZC3H12D;RPP40
prerank,DNA metabolic process (GO:0006259),0.19191757198907386,0.8481190444634706,0.8871595330739299,0.9091324322380834,1.0,69/270,21.97%,TCF7L2;DMC1;MCM3;ORC4;DDB2;MPG;STN1;AXIN2;SUMO1;MNAT1;TOP1;TOP3A;GEN1;FANCC;SETMAR;MEN1;KMT5C;TOP1MT;DNMT1;BLM;RPA2;RFC5;CHRNA4;MCM2;RAD51C;MCM8;RAD51B;ORC1;NBN;POLE4;ATM;CENPS;RIF1;RPA1;SMARCB1;KAT5;ENDOV;KMT5B;PDS5A;PARP4;NUDT1;PARP3;BACH1;POLI;INIP;ORC3;PARP1;SP100;UBE2N;POLD4;RNASEH1;ORC5;SMARCAL1;PDS5B;POLD1;RTEL1;CDC7;PCNA;POLD3;DOT1L;RFC1;PRIM1;ZRANB3;GLRX2;TOP3B;POLD2;PRIM2;DCLRE1B;UBE2V2
prerank,cellular response to hypoxia (GO:0071456),-0.2068677308061821,-0.8479537112427074,0.8073929961089494,0.8761288395967841,1.0,41/126,25.45%,EGLN3;UBB;UBC;RPS27A;VEGFA;ACAA2;GATA6;PSMA6;RGCC;EGLN2;PSMB5;TWIST1;PSMC4;EGLN1;PSMC5;LIMD1;PSMD14;RBX1;BNIP3L;PSMD8;PSMD11;PGK1;PSMB4;PSMD12;PSMC1;BAD;ELOB;HIGD1A;PSMA1;PSMB1;PSMC3;NPEPPS;PLK3;PSMA4;PSMA2;HILPDA;HYOU1;HIF1AN;CARD16;PSMB8;ANGPT4
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",0.36754463196352827,0.8475614472354684,0.6673684210526316,0.909481178213147,1.0,4/10,17.96%,RPS6KA6;KAT5;SP100;TP53
prerank,metanephros development (GO:0001656),0.2879327167195101,0.8475197160983661,0.702355460385439,0.9087573494866517,1.0,2/26,1.69%,ROBO2;GDNF
prerank,response to organonitrogen compound (GO:0010243),-0.25393406183519585,-0.8474222749934301,0.7354596622889306,0.876664120671646,1.0,10/38,23.87%,SEL1L;RHBDD1;DNAJB12;RNF185;VCP;RNF5;ERLEC1;RRAGC;BRSK2;MEAK7
prerank,nucleotide-sugar biosynthetic process (GO:0009226),-0.30142650154333417,-0.8471903796155784,0.6990291262135923,0.876633369667854,1.0,8/19,29.27%,UAP1L1;GFPT1;AMDHD2;RENBP;PGM3;MPI;UAP1;GNPDA1
prerank,negative regulation of ERBB signaling pathway (GO:1901185),0.2627971298287747,0.8468544607295958,0.6995967741935484,0.9093313592477199,1.0,3/39,3.55%,ERRFI1;AREG;TGFA
prerank,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),0.3317959921942424,0.8466288354894511,0.6666666666666666,0.9089641422948249,1.0,4/14,12.53%,CREB3L1;PRKN;CREB3;TXNDC12
prerank,mRNA processing (GO:0006397),-0.18439626386861438,-0.8465257351749996,0.9225806451612903,0.8774590127990264,1.0,111/287,34.99%,DDX5;NOVA2;HNRNPA2B1;RPRD1B;CTNNBL1;HSPA8;PPARGC1A;PRPF8;SRSF2;MTREX;DNAJC8;SRSF5;SNRNP48;SNRPA;SNRPC;ISY1;DDX41;SRSF6;DHX15;FUS;RBM22;GTF2H3;DHX9;SNRPD3;U2AF1;XAB2;SFPQ;ZC3H11A;RNPS1;RBM6;ZRSR2;SRSF4;MAGOH;RBM4B;DDX23;CHTOP;HNRNPK;ALYREF;EFTUD2;SF3A3;DDX39B;PCBP1;GTF2F1;HNRNPA1;GTF2H4;SCAF11;PHF5A;SNRPG;PNN;PDCD7;UBL5;LSM2;CASC3;USP49;CHERP;PRPF40A;SYNCRIP;LSM7;CD2BP2;THOC6;RBM19;CPSF4;LSM3;TBRG4;SRRM2;DDX39A;NCBP2;RBM17;RBM14;CSTF2T;SNRPB;SF3A1;PABPC1;SF3A2;THOC7;RPRD1A;KIN;GTF2F2;SNRPB2;HNRNPR;WBP11;ERN1;POLR2F;AQR;SRSF9;LSM6;PRPF19;HNRNPA3;CDC5L;HNRNPH3;PQBP1;POLR2L;ESS2;ZCCHC8;U2AF1L4;POLR2I;SNRNP25;POLR2C;HNRNPC;SF3B5;SRSF1;PCF11;UPF3B;WBP4;RBM15B;TRA2B;RSRC1;HNRNPM;HNRNPH1;SMNDC1;PUF60
prerank,resolution of meiotic recombination intermediates (GO:0000712),-0.320144463968886,-0.8463386420475187,0.6784386617100372,0.8773470861262131,1.0,11/16,38.50%,SLX4;TOP2A;EME2;ERCC4;TOP2B;MEIOB;RMI1;MSH4;CENPX;EME1;SHOC1
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),-0.35298205994923454,-0.8459255909951771,0.6751824817518248,0.8776685457370601,1.0,5/11,22.03%,CD44;CD74;KDM1A;TAF9;TRIAP1
prerank,microglial cell activation (GO:0001774),-0.2954540452405496,-0.8457697878566304,0.6837121212121212,0.8774907171897697,1.0,14/21,46.27%,APP;JAK2;CX3CR1;C1QA;IFNGR1;AIF1;TREM2;TYROBP;GRN;ITGB2;C5AR1;TNF;CX3CL1;CLU
prerank,prostanoid biosynthetic process (GO:0046457),-0.32702069318839594,-0.8456936572411186,0.6762589928057554,0.8771542435554599,1.0,5/15,18.31%,PTGDS;EDN1;CD74;PTGS1;DAGLB
prerank,sterol biosynthetic process (GO:0016126),-0.26160213133244875,-0.845394327277348,0.6996197718631179,0.8772580819235812,1.0,15/33,31.77%,LBR;ACAA2;ACLY;DHCR24;TM7SF2;SC5D;CH25H;FDPS;LSS;PLPP6;IDI1;ACAT2;INSIG1;EBP;HMGCR
prerank,regulation of RNA export from nucleus (GO:0046831),0.35271002712729327,0.8452665496233224,0.6610576923076923,0.9109855081085589,1.0,2/11,7.13%,AKAP8L;KHDRBS1
prerank,pyroptosis (GO:0070269),-0.3180547372336095,-0.8448301154861603,0.6853526220614828,0.8778076715657829,1.0,5/15,25.40%,CASP8;DHX9;AIM2;CASP1;TREM2
prerank,positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),-0.3099777973965197,-0.8447805847354279,0.6765217391304348,0.8774340764047559,1.0,6/18,22.92%,RAB11A;BRD4;CDK4;RCC2;CCND1;DTL
prerank,regulation of actomyosin structure organization (GO:0110020),0.33586180116638154,0.8443883053222742,0.6808510638297872,0.911944823272518,1.0,3/13,9.17%,ROCK2;ASAP3;ALMS1
prerank,regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),0.2921662693685044,0.8443260880634708,0.6898047722342733,0.9112636970476102,1.0,7/26,13.77%,ADCY5;STXBP4;FOXA2;EPHA5;ADCY8;BAIAP3;CDK16
prerank,regulation of cellular biosynthetic process (GO:0031326),0.2784336859053281,0.8439258643408847,0.6746203904555315,0.9113027862333178,1.0,6/28,11.47%,PRKAG2;MITF;PDK4;MFSD12;FGFR4;CTNS
prerank,regulation of protein neddylation (GO:2000434),-0.3606406474812694,-0.8433487595552196,0.6837121212121212,0.8797153703302527,1.0,6/10,25.13%,DCUN1D5;RPL11;DCUN1D1;COPS9;RPL5;DCUN1D3
prerank,positive regulation of leukocyte degranulation (GO:0043302),-0.3341446531261254,-0.8432581007823357,0.6685393258426966,0.8794283388577363,1.0,4/13,14.89%,LAMP1;SPHK2;SYK;GAB2
prerank,positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),-0.3264393706051061,-0.8429572722823335,0.6945454545454546,0.8795417238111841,1.0,5/15,18.42%,EHD2;FLOT1;CAMK1;RAPGEF3;EHD1
prerank,neurotrophin TRK receptor signaling pathway (GO:0048011),0.32613083291477607,0.8414060590308164,0.6704545454545454,0.915620810653507,1.0,7/15,23.94%,CASP3;NGFR;BCAR1;FRS2;SORT1;NTRK2;BDNF
prerank,peptidyl-glutamic acid modification (GO:0018200),0.28764223093257646,0.8413400651651058,0.665938864628821,0.9149397215287748,1.0,3/24,5.52%,TTLL11;AGBL4;TTLL9
prerank,negative regulation of protein processing (GO:0010955),-0.34343107064168854,-0.8407827233217768,0.6757246376811594,0.883252803168778,1.0,2/12,4.45%,THBS1;CTSZ
prerank,negative regulation of neuron apoptotic process (GO:0043524),-0.2262173968716672,-0.8406814527442148,0.7588235294117647,0.8829759837559858,1.0,8/69,7.54%,MEF2C;PTK2B;NGF;SIX1;PPARGC1A;TGFB3;TOX3;FOXQ1
prerank,positive regulation of cell death (GO:0010942),-0.23298696823806986,-0.8406258134626486,0.7590822179732314,0.8826081722547552,1.0,4/59,3.91%,SLC6A6;MAP3K5;ACER2;CDKN1B
prerank,ubiquinone metabolic process (GO:0006743),-0.30858567887456767,-0.8403205051166522,0.6814814814814815,0.8826963418719287,1.0,5/15,22.20%,PDSS2;COQ6;COQ8A;COQ7;UBIAD1
prerank,DNA geometric change (GO:0032392),-0.2876242358632721,-0.8401744763761986,0.676950998185118,0.8825175761729429,1.0,11/24,35.58%,HNRNPA2B1;ANXA1;DHX9;ASCC3;DNA2;HMGB2;MRE11;RECQL;PIF1;RAD50;HMGB3
prerank,negative regulation of calcium ion transmembrane transporter activity (GO:1901020),-0.280257527562075,-0.840166029073108,0.6970260223048327,0.8820625165375425,1.0,7/26,14.62%,CALM1;FKBP1A;GSTM2;CALM3;FMR1;CASQ2;SRI
prerank,synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629),-0.33750706344740355,-0.840010629459952,0.6548507462686567,0.8818928400982025,1.0,3/12,11.05%,STX3;STX1A;STX2
prerank,protein trimerization (GO:0070206),0.32600260756367266,0.8399216252829506,0.6571428571428571,0.9162091691844974,1.0,6/14,23.65%,SLC1A5;PNPT1;SLC1A2;MIF;STEAP4;SCARA5
prerank,protein homotrimerization (GO:0070207),0.32600260756367266,0.8399216252829506,0.6571428571428571,0.9162091691844974,1.0,6/14,23.65%,SLC1A5;PNPT1;SLC1A2;MIF;STEAP4;SCARA5
prerank,glycoprotein catabolic process (GO:0006516),0.30401236079076,0.8397522565842865,0.6133333333333333,0.9157247938756592,1.0,1/17,0.44%,ADAMTS12
prerank,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),0.3223899057922323,0.8396407941755739,0.6986301369863014,0.9151325529390568,1.0,3/15,5.39%,BCL2;MDM2;PRKN
prerank,protein insertion into mitochondrial membrane (GO:0051204),-0.29142213272366674,-0.8395285757831681,0.6698113207547169,0.8823264406490392,1.0,13/23,30.55%,BAX;NDUFA13;TIMM29;TOMM22;HSPA4;HSP90AA1;BAD;TIMM13;TIMM10;TIMM8B;TIMM10B;PMAIP1;ROMO1
prerank,glycerophospholipid catabolic process (GO:0046475),-0.2731381298435699,-0.8393308703651815,0.717948717948718,0.8821983329673864,1.0,1/27,0.10%,GPCPD1
prerank,neuron fate commitment (GO:0048663),0.3265606768381203,0.8385845776870984,0.6616379310344828,0.9165150893595747,1.0,5/14,19.69%,TGFBR1;MYT1L;PAX6;SHH;POU3F2
prerank,zinc ion transport (GO:0006829),-0.29470741799890854,-0.8378058798414494,0.6879562043795621,0.8845857654752652,1.0,5/21,14.06%,SLC39A8;SLC30A6;SLC39A1;SLC39A11;SLC39A7
prerank,intestinal lipid absorption (GO:0098856),-0.34739518928821894,-0.8370822304890412,0.6606498194945848,0.8854943025563271,1.0,7/11,52.95%,CD36;SOAT2;LIMA1;LDLR;AKR1C1;ABCG5;NPC1L1
prerank,regulation of double-strand break repair via nonhomologous end joining (GO:2001032),0.2810239319074667,0.8370527044380002,0.6985446985446986,0.9187700694457029,1.0,7/28,16.52%,SHLD2;SETMAR;KMT5C;SMCHD1;RIF1;KMT5B;PARP3
prerank,endochondral bone morphogenesis (GO:0060350),-0.3509801254230279,-0.8369619086495211,0.6648351648351648,0.8852391047924697,1.0,2/11,2.11%,MEF2C;BMPR2
prerank,response to interleukin-1 (GO:0070555),0.22776557963115554,0.8368439801358919,0.7835671342685371,0.9183788260004601,1.0,5/73,4.24%,ADAMTS12;HYAL3;PRKCA;PTGIS;SFRP1
prerank,neural tube development (GO:0021915),0.31318979172011385,0.8365244036559436,0.65,0.9181953675854179,1.0,1/15,0.56%,ALDH1A2
prerank,positive regulation of protein modification by small protein conjugation or removal (GO:1903322),-0.22327863265525896,-0.8360601963389316,0.7873684210526316,0.8864406703198471,1.0,26/76,30.06%,CAV1;DCUN1D5;SMAD7;FKBP1A;UBB;DCUN1D1;FBXO4;HDAC4;FAM107A;PTTG1IP;SAE1;SPRTN;UBA2;WDR48;CDK5RAP3;LAPTM5;UBE3A;TRAF6;BCL10;DCUN1D3;XIAP;TSPYL5;NDFIP2;MUL1;DERL1;HDAC3
prerank,regulation of neural precursor cell proliferation (GO:2000177),-0.28896111721311474,-0.835797880216818,0.6988636363636364,0.8864715106497174,1.0,10/22,38.63%,GATA2;NES;KDM1A;DLL4;SHCBP1;TOX;FZD9;RASSF10;TRIM71;PROX1
prerank,clathrin-dependent endocytosis (GO:0072583),-0.2776586017550928,-0.8356971445714548,0.7294332723948812,0.8861888059349454,1.0,7/26,15.15%,FNBP1L;ITSN2;AP2M1;ITSN1;FCHO2;SGIP1;AP2A1
prerank,peptidyl-lysine modification (GO:0018205),-0.2110715411320841,-0.8355481574398744,0.8239845261121856,0.8859903665150524,1.0,31/99,26.55%,NNAT;IFIH1;PLOD2;HDAC9;STX1A;NUP93;HDAC4;NDC1;TRIM28;NUP54;SAE1;PLOD3;NUP188;LOX;SUMO3;NUP155;RANBP2;NUP37;UBA2;CTH;USPL1;RANGAP1;NUP160;SENP5;ATPSCKMT;NUP43;SEH1L;PARK7;NUP107;NUP42;EEF1AKMT3
prerank,histone H2A acetylation (GO:0043968),-0.31586505612326565,-0.8355441941592116,0.7018181818181818,0.885526392410738,1.0,4/16,18.10%,TRRAP;SPHK2;EPC1;EP400
prerank,regulation of muscle contraction (GO:0006937),-0.2769349942356109,-0.8353906370944937,0.722753346080306,0.8853485732359144,1.0,2/26,0.34%,PLCE1;CAV1
prerank,histone exchange (GO:0043486),-0.2574520187569012,-0.8347261111808321,0.7495145631067961,0.8860936864567742,1.0,17/37,34.42%,MIS18BP1;KNL1;CENPU;RBBP4;CENPI;CENPN;CENPA;CENPO;RUVBL1;NPM1;RNF8;SMARCA5;OIP5;ITGB3BP;CENPX;CENPW;RBBP7
prerank,regulation of B cell differentiation (GO:0045577),-0.30561945968853366,-0.8340454255289327,0.6837294332723949,0.886925437159529,1.0,7/17,26.70%,MMP14;PPP2R3C;INHBA;SYK;XBP1;BTK;INHA
prerank,embryo development ending in birth or egg hatching (GO:0009792),-0.32088350618069905,-0.8336625107052803,0.7158469945355191,0.88719984837018,1.0,3/15,4.12%,STOX2;RICTOR;TGFB2
prerank,cellular response to molecule of bacterial origin (GO:0071219),-0.21543382242887243,-0.833578409468797,0.7936210131332082,0.8868959730687079,1.0,33/95,32.48%,MEF2C;LBP;VIM;CYRIB;DAB2IP;TNFRSF1B;PLAA;TIRAP;TLR4;NOD2;TNFAIP3;CX3CR1;RELA;XBP1;CASP1;FZD5;CD68;TRAF6;CCL2;CARD16;BCL10;SHPK;PDCD4;LILRB1;HMGB2;CD86;IRGM;UPF1;RHOA;CD14;LY96;NLRP3;TNIP2
prerank,positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),-0.33572747533407177,-0.8334871331775594,0.7055449330783938,0.8865815087826107,1.0,2/12,12.38%,ANO1;PPP3CB
prerank,regulation of cholesterol storage (GO:0010885),-0.3166061716231008,-0.833328251950477,0.6972972972972973,0.8864024841442344,1.0,6/15,19.06%,SCARB1;PPARD;ABCG1;NR1H2;EHD1;MSR1
prerank,positive regulation of epidermal cell differentiation (GO:0045606),0.322199457247376,0.8332412110062241,0.6703296703296703,0.923925114622044,1.0,2/15,1.77%,CYP27B1;VDR
prerank,mitochondrion disassembly (GO:0061726),0.2652093833912474,0.8331059133718807,0.7301927194860813,0.9233824965598446,1.0,12/34,21.67%,WDR45B;PRKN;ATG12;WIPI1;FBXO7;ULK2;FUNDC1;FUNDC2;ATG9A;ATG5;USP30;WDR45
prerank,regulation of humoral immune response (GO:0002920),-0.245449620589433,-0.8326321934286499,0.7430830039525692,0.887208858146346,1.0,8/44,16.97%,CD55;CD81;GATA6;C1QB;C1QC;PHB2;CFP;C1QA
prerank,organic cation transport (GO:0015695),0.3062258789620518,0.8325366155952169,0.693304535637149,0.9236765900348449,1.0,4/20,9.41%,SLC22A4;SLC22A3;SLC25A42;SLC44A1
prerank,pyrimidine nucleobase metabolic process (GO:0006206),-0.33869685135523403,-0.8325136265762837,0.6424581005586593,0.8869661432003342,1.0,2/12,4.90%,CTPS1;CTPS2
prerank,steroid catabolic process (GO:0006706),0.3604533996188583,0.8324740655872551,0.6503496503496503,0.922992666151084,1.0,1/10,1.76%,CYP27B1
prerank,peptidyl-lysine methylation (GO:0018022),0.27752230696300184,0.8324706935371661,0.6886363636363636,0.9221896031928589,1.0,5/26,11.57%,METTL21A;SMYD1;SETD7;SMYD3;EHMT2
prerank,regulation of protein export from nucleus (GO:0046825),0.28993536849442736,0.8324109209614861,0.692144373673036,0.9214986485381113,1.0,1/23,0.18%,TCF7L2
prerank,metal ion transport (GO:0030001),-0.2133561004032002,-0.8322766444837912,0.8180076628352491,0.8869208813226849,1.0,12/86,11.23%,CAV1;TPT1;TRPC3;TRPM7;RAMP2;ATP2C1;SLC39A8;ATP2A3;TRPV4;TRPC4;CACNB3;NIPAL3
prerank,regulation of cellular ketone metabolic process (GO:0010565),-0.23043980293493554,-0.8317681017149869,0.7562862669245648,0.8873750475218425,1.0,18/61,23.09%,CAV1;PSMA6;PSMB5;PSMC4;PSMC5;PSMD14;OAZ2;PSMD8;PSMD11;PSMB4;PSMD12;PSMC1;NQO1;PSMA1;PSMB1;PSMC3;PSMA4;PSMA2
prerank,DNA repair (GO:0006281),-0.18232327602340578,-0.831736886800068,0.945031712473573,0.8869531652703126,1.0,105/284,34.25%,TRRAP;UBB;USP1;ASCC2;UBC;RPS27A;BRCC3;SMUG1;PRKDC;UIMC1;ERCC1;RAD1;USP3;GTF2H3;BABAM1;TRIM28;CHD1L;FAM111A;HERC2;VCP;MTA1;CIB1;UBXN1;HPF1;PPP5C;PNKP;SPRTN;SLX4;DCLRE1C;RAD9B;RAD18;XRCC1;CETN2;PARP2;HUS1;EME2;RPA3;NSMCE4A;RAD9A;RPAIN;ASCC3;RAD17;PWWP3A;BABAM2;WDR48;BRCA2;GTF2H4;NEIL1;POLQ;POLK;TRAIP;CHEK1;RAD21;ERCC4;GADD45A;UBE2B;APEX2;RHNO1;EID3;RFC3;DTX3L;RAD23A;RFC2;FAN1;POLL;EXO1;FBXO6;NSMCE1;PARK7;DNA2;SETD2;TDG;XPC;FANCD2;RAD51AP1;LIG4;TNKS1BP1;NPM1;RAD23B;BARD1;ATRIP;RNF8;MRE11;EXD2;POLB;SMARCA5;RAD52;FAAP24;RECQL;UPF1;INTS3;PARP9;CDK1;NSD2;TICRR;UBE2T;ABL1;RAD50;NEIL3;POLE;SLC30A9;CENPX;MAD2L2;POLA1;FANCF
prerank,histone ubiquitination (GO:0016574),-0.29076554134873606,-0.8316049708014998,0.7126654064272212,0.8867261967097572,1.0,8/21,29.67%,PHC1;RNF20;USP22;UBE2B;DTX3L;RNF40;RNF8;UHRF1
prerank,negative regulation of transport (GO:0051051),0.24457828638861703,0.8314162024262133,0.7366167023554604,0.9226576917239645,1.0,12/51,16.74%,NRG1;PRTN3;EPHA3;SNX33;PRKN;ERBB3;YRDC;PTEN;SCAMP5;SYT11;LRSAM1;TRAT1
prerank,protein ubiquitination (GO:0016567),0.178104857675421,0.8313210609191622,0.9640933572710951,0.922046574951032,1.0,90/471,18.13%,RNF220;HECW2;SH3RF3;PDZRN3;MYCBP2;EPAS1;PELI2;TRIM38;FBXO24;DTX4;SPSB1;BCL2;SH3RF1;DDB2;MDM2;ZNRF3;DZIP3;TRIP12;RNF43;PRKN;KLHL41;HECW1;UBE2O;RNF138;VCPIP1;CUL9;DTX1;KLHL42;ASB2;SMURF2;FBXO25;UBE2E3;PSMA3;RNF181;KLHL25;TRIM27;CDC23;PSMF1;CUL2;CDC16;MGRN1;AKTIP;RNF26;TOPORS;UBR3;SPOP;MIB1;PPIL2;SIAH2;UNKL;FBXO7;THOP1;BTRC;RNF146;RNF217;PSME3;RNF122;TRIM63;SASH1;BIRC2;ARIH2;FBXO44;ASB1;RNF34;UBA6;UBE3C;PSMD1;TRAF2;UBE2E2;FBXO28;PSMB9;LRSAM1;HECTD2;SKP1;NEDD4;SKP2;KLHL22;FBXO31;HLTF;TRIM35;RNFT1;SPSB2;NFE2L2;CUL7;FBXO21;TRIM23;RNF13;PSMD13;PEX10;UBE2N
prerank,positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190),-0.3354687809191255,-0.8310513002170854,0.7099811676082862,0.8872678746825504,1.0,3/12,5.68%,SIX1;SMO;VEGFA
prerank,tRNA modification (GO:0006400),-0.2298884629156216,-0.8310333311684637,0.7903846153846154,0.8868334442659472,1.0,21/62,28.53%,DUS2;THUMPD1;TRMT9B;QTRT2;URM1;TYW1;TRDMT1;QTRT1;TRMT61B;TRMT6;AARS2;TRMT44;TYW3;ANKRD16;PUSL1;WDR6;METTL1;ADAT2;CTU2;METTL2A;METTL2B
prerank,interleukin-27-mediated signaling pathway (GO:0070106),-0.3306654296052761,-0.830595693956408,0.6844036697247706,0.8871483759683652,1.0,6/13,32.79%,JAK2;OAS2;STAT1;IL6ST;IL27RA;CANX
prerank,negative regulation of neurogenesis (GO:0050768),-0.2572806003227624,-0.8305899021400169,0.7174721189591078,0.8866945786413434,1.0,7/34,11.72%,B2M;NOTCH1;REST;ARHGDIA;GDI1;NF1;PCM1
prerank,Golgi ribbon formation (GO:0090161),-0.32488377052737966,-0.8304729381269983,0.692167577413479,0.8864460574064037,1.0,7/13,30.46%,TRIP11;FHDC1;GCC2;TMED5;GOLPH3;STX16;VAMP4
prerank,peripheral nervous system development (GO:0007422),0.29669361800016425,0.8304343373203467,0.6954545454545454,0.9229376879307126,1.0,5/23,10.56%,GDNF;ARTN;ASIC2;ERBB3;NFASC
prerank,regulation of activin receptor signaling pathway (GO:0032925),-0.31756888757098495,-0.8303116498136281,0.7119856887298748,0.8862850922017537,1.0,4/15,11.97%,SMAD7;FKBP1A;CSNK2B;ACVR1
prerank,sensory perception of light stimulus (GO:0050953),0.22425052500247647,0.8301607438079773,0.7723577235772358,0.9226663760658745,1.0,19/87,18.99%,ADGRV1;DHRS3;TRPM1;PCDH15;CRYBA1;ATXN7;GUCY2F;BBS2;ATF6;POU6F2;RPGR;RP2;CLRN1;COL11A1;MYO9A;ZIC2;PAX6;TULP1;COL1A1
prerank,regulation of alcohol biosynthetic process (GO:1902930),-0.33403223821041667,-0.8299963308941123,0.6880570409982175,0.8863547524124419,1.0,3/12,12.63%,LPCAT3;MBTPS2;ABCA2
prerank,regulation of multicellular organismal development (GO:2000026),0.2850849895543609,0.8295835873466728,0.702819956616052,0.9230225465093316,1.0,3/25,9.13%,PTN;TRIP12;GATA3
prerank,RNA modification (GO:0009451),-0.23311600457477288,-0.8289854665411511,0.7551789077212806,0.887708921645497,1.0,19/54,28.07%,ADAR;THUMPD1;NOP2;TRMT9B;JMJD6;QTRT2;URM1;TRDMT1;QTRT1;MEPCE;TRMT6;AARS2;ANKRD16;MRM2;METTL1;NSUN5;FTSJ3;ADAT2;CTU2
prerank,tRNA aminoacylation for protein translation (GO:0006418),-0.2462712387374442,-0.8288074694836938,0.7495291902071564,0.887571589563554,1.0,16/42,30.43%,SARS1;WARS2;CARS1;LARS2;WARS1;SARS2;TARS1;CARS2;FARS2;FARSB;AARS2;IARS1;GARS1;KARS1;NARS1;IARS2
prerank,oligosaccharide-lipid intermediate biosynthetic process (GO:0006490),-0.3274782655303589,-0.8285128827391517,0.7032374100719424,0.8876458707988397,1.0,7/13,35.13%,ALG9;ALG12;ALG1;ALG2;ALG3;MPDU1;ALG6
prerank,negative regulation of defense response (GO:0031348),0.22735468891897684,0.8283542532743599,0.8051948051948052,0.924685719558001,1.0,10/77,10.16%,RORA;PPARA;PTGIS;IL4;NLRP12;SMPDL3B;SIRT2;GATA3;RNF26;TNFAIP6
prerank,regulation of NLRP3 inflammasome complex assembly (GO:1900225),-0.3148653867752322,-0.8280997518259499,0.6881918819188192,0.8878954050089315,1.0,6/15,32.30%,GBP5;TLR4;TREM2;CD36;TLR6;NLRC3
prerank,phospholipid dephosphorylation (GO:0046839),0.2587401372585114,0.8280749537138783,0.7349397590361446,0.9244303538790322,1.0,9/37,17.92%,MTMR7;PLPP3;PLPPR1;PTEN;PLPP4;MTMR10;PLPPR5;OCRL;MTMR9
prerank,regulation of vesicle-mediated transport (GO:0060627),-0.2122486069787149,-0.8276987119225638,0.8140900195694716,0.8881098695014167,1.0,23/91,19.95%,RAB11A;OPHN1;SCARB1;MAPK3;RAB8B;HIP1R;USP7;CPLANE2;RAB8A;HIP1;RAB4B;ABL2;RAB11B;RUFY1;RAB4A;SYK;PACSIN1;LGI3;NSF;HCK;TSC2;PACSIN3;PACSIN2
prerank,cholesterol homeostasis (GO:0042632),0.2353713191642125,0.8276046335999899,0.7668067226890757,0.924546725109531,1.0,8/64,11.15%,RORA;CYP7B1;ABCA1;ABCA5;IL18;FGFR4;GRAMD1B;PLA2G12B
prerank,photoperiodism (GO:0009648),-0.2700715519266899,-0.8275792835162802,0.7220216606498195,0.8878784437526415,1.0,9/28,27.43%,BHLHE40;PPP1CB;MTA1;RBM4B;FBXL3;PPP1CA;CLOCK;SIK1;FBXL8
prerank,ESCRT complex disassembly (GO:1904896),-0.35940671194299106,-0.8274979534207373,0.686456400742115,0.8870951542588156,1.0,5/10,28.55%,CHMP2B;IST1;CHMP2A;VPS4A;CHMP7
prerank,ESCRT III complex disassembly (GO:1904903),-0.35940671194299106,-0.8274979534207373,0.686456400742115,0.8870951542588156,1.0,5/10,28.55%,CHMP2B;IST1;CHMP2A;VPS4A;CHMP7
prerank,macrophage chemotaxis (GO:0048246),0.34752636880870685,0.8272644991097292,0.63718820861678,0.9244133984784279,1.0,3/10,19.88%,EDNRB;CKLF;TAFA4
prerank,regulation of chromatin organization (GO:1902275),-0.3208284111317169,-0.8267824838037203,0.6877323420074349,0.8879030746472275,1.0,4/14,21.07%,MLLT3;HPF1;SETD1A;MKI67
prerank,transcription by RNA polymerase II (GO:0006366),0.18417855526279678,0.8261022495580911,0.9521988527724665,0.9258660961601451,1.0,61/305,18.88%,RORA;MAF;AR;GLIS3;TBL1XR1;VDR;RARB;TEAD1;PRRX1;PPARA;TFCP2;TFDP1;PMF1;GTF2H2;MNAT1;HNF4G;MAML3;HSF2BP;HDAC10;DTX1;RPAP1;NFIX;FIP1L1;RARG;RBPJ;SNAPC3;POLR2G;SYMPK;SOX5;PHAX;PABPN1;CCNH;SNAPC1;MAML1;INTS7;ICE1;SCAF8;PGR;TAF5L;YAP1;INTS9;CPSF7;CCNT1;NRBF2;ICE2;PAX5;CDK9;HDAC1;PARP1;ESRRG;GTF2E2;MED4;POLR2D;GTF2B;TAF15;PAPOLA;ELOA;E2F2;PPARG;ELL2;TAF1C
prerank,regulation of receptor-mediated endocytosis (GO:0048259),0.262670788718631,0.825897259788472,0.7100213219616205,0.9254798891045501,1.0,6/35,9.57%,TNK2;AAK1;IL4;SERPINE1;SNAP91;BICD1
prerank,smooth muscle tissue development (GO:0048745),-0.35777048991706034,-0.8258309998204703,0.7058823529411765,0.8891608665393484,1.0,4/10,13.24%,SMO;STRA6;NF1;ENG
prerank,"wound healing, spreading of cells (GO:0044319)",-0.2745494638457731,-0.825421319420078,0.7184801381692574,0.8894170694169409,1.0,12/24,40.93%,CD44;CD151;MRTFA;PDCD10;ACVRL1;ITGA5;WNT7A;RHOA;TMEFF2;CEACAM1;FLNA;ARHGAP35
prerank,regulation of transcription by RNA polymerase I (GO:0006356),-0.3015867467956508,-0.8251082013745573,0.6994106090373281,0.8895025924551744,1.0,9/18,42.85%,ATF4;MAF1;ERBB2;UTP15;POLR2L;LYAR;SIRT7;FLNA;RASL11A
prerank,androgen metabolic process (GO:0008209),-0.3002715592552454,-0.8249469693864407,0.7,0.8893304502522026,1.0,12/18,53.04%,SPP1;HSD17B10;HSD17B7;SRD5A2;SRD5A3;HSD3B2;CYP19A1;DHRS9;SRD5A1;HSD17B6;HSD17B3;AKR1D1
prerank,regulation of neuron projection arborization (GO:0150011),0.31870789681665235,0.8247159885694958,0.6884875846501128,0.9269465569825056,1.0,4/15,16.77%,GRIP1;DVL3;DLG4;MYO9A
prerank,regulation of telomere maintenance via telomerase (GO:0032210),-0.23491315824535972,-0.8246335990870101,0.7859848484848485,0.8894416135745026,1.0,20/51,35.15%,HMBOX1;MAPK3;NEK7;FBXO4;PNKP;CCT2;CCT3;HNRNPA1;CCT8;CCT7;CTNNB1;SRC;PKIB;SMG6;PIF1;HNRNPC;DCP2;CCT4;MAP2K7;CCT6A
prerank,pyrimidine nucleoside biosynthetic process (GO:0046134),-0.33799983033907033,-0.8242152629636598,0.6990654205607477,0.8897311636744837,1.0,8/12,40.56%,UPP2;TK2;CAD;UMPS;UPP1;DCK;UCK2;TK1
prerank,sterol homeostasis (GO:0055092),0.2330212031067691,0.8239790410674813,0.7807933194154488,0.9275973771481476,1.0,8/65,11.15%,RORA;CYP7B1;ABCA1;ABCA5;IL18;FGFR4;GRAMD1B;PLA2G12B
prerank,chondroitin sulfate catabolic process (GO:0030207),-0.3233328962124692,-0.8228350260625562,0.6981818181818182,0.8917114253107816,1.0,3/13,9.35%,CSPG4;HEXA;IDUA
prerank,prostaglandin biosynthetic process (GO:0001516),-0.2982450142328056,-0.8225421296315956,0.7095652173913043,0.8917800226420282,1.0,6/18,18.31%,PTGDS;EDN1;CD74;PTGS1;CBR1;DAGLB
prerank,positive regulation of smoothened signaling pathway (GO:0045880),-0.28965109783966503,-0.8222980942689475,0.7186932849364791,0.8917329116784208,1.0,7/21,22.00%,SMO;GAS8;ULK3;STK36;TUBD1;GLI1;DCDC2
prerank,Golgi to endosome transport (GO:0006895),-0.31102686334950225,-0.8222866722527948,0.7012522361359571,0.8912890768609814,1.0,5/16,15.15%,VPS13A;KIF16B;DOP1B;AP4M1;AP2A1
prerank,negative regulation of cyclin-dependent protein kinase activity (GO:1904030),0.281160488121623,0.8221568786032094,0.702819956616052,0.9303220372970983,1.0,9/22,25.64%,NR2F2;MEN1;PTEN;IPO7;CDK5RAP1;APC;HEXIM1;LATS2;LATS1
prerank,mitochondrial cytochrome c oxidase assembly (GO:0033617),-0.2985843053389384,-0.8217663269932031,0.7178571428571429,0.8917513760583141,1.0,8/18,26.50%,COA8;TIMM21;COA3;SURF1;FASTKD3;SCO1;PET100;BCS1L
prerank,pre-replicative complex assembly (GO:0036388),-0.22567154326402772,-0.8211928070598403,0.7713717693836978,0.8922846101362543,1.0,20/64,25.25%,UBB;UBC;RPS27A;PSMA6;PSMB5;PSMC4;PSMC5;PSMD14;PSMD8;PSMD11;PSMB4;PSMD12;PSMC1;PSMA1;PSMB1;PSMC3;PSMA4;PSMA2;MCM5;PSMB8
prerank,reverse cholesterol transport (GO:0043691),-0.32448124731507355,-0.8210674894364735,0.6880570409982175,0.8920309303114814,1.0,4/13,18.26%,SCARB1;ABCG1;APOE;LCAT
prerank,NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),0.33152260810726764,0.820504402894185,0.6743697478991597,0.9326201168574357,1.0,2/13,3.63%,PARP16;PTGIS
prerank,microtubule depolymerization (GO:0007019),-0.3066800343734128,-0.8203826994900661,0.7124060150375939,0.8928030543635925,1.0,7/17,25.21%,STMN2;KATNB1;KIF24;KIF18A;KIF18B;NCKAP5L;STMN1
prerank,regulation of ion transport (GO:0043269),0.2212840631925444,0.8202990486453721,0.7955465587044535,0.9322152849637928,1.0,23/76,18.77%,GDNF;NKAIN2;P2RX4;PRKN;KCNJ16;SYT1;KCNJ3;NKAIN3;KCNJ5;CHRNA4;KCNJ14;SYT13;DRD2;KCNJ6;SYT11;SYT12;NEDD4;KCNJ9;VAMP3;PER1;SYT6;SNX6;HTR1A
prerank,negative regulation of myeloid leukocyte differentiation (GO:0002762),-0.2751866505365332,-0.8202484205445053,0.7367458866544789,0.892573731263163,1.0,15/26,30.83%,CDK6;RARA;GPR137B;TLR3;C1QC;INHBA;TLR4;TCTA;ZFPM1;INHA;PTPN2;LILRB3;CARTPT;MYC;LRRC17
prerank,protein tetramerization (GO:0051262),-0.22432325395726882,-0.8199320728737931,0.8018867924528302,0.8926997975954651,1.0,16/67,22.31%,B2M;KCNJ2;GBP5;PKD1;KCNC3;GLS;HOMER1;SAMHD1;ALDH1A3;CTH;HSD17B10;AQP4;FARSB;PKD2;ACOT13;UPB1
prerank,negative regulation of DNA biosynthetic process (GO:2000279),-0.2665633101767504,-0.8196421616983126,0.7188081936685289,0.8927432240178435,1.0,2/30,2.11%,DACH1;BMPR2
prerank,autophagosome assembly (GO:0000045),0.23837164221887994,0.8193608837503948,0.7734204793028322,0.9331764342557443,1.0,11/52,12.91%,ATP2A2;WDR45B;UBXN2B;ATG12;WIPI1;UBXN2A;TP53INP2;TMEM41B;ATG16L2;STX12;ULK2
prerank,negative regulation of amyloid fibril formation (GO:1905907),-0.3355704287723827,-0.8191184383587001,0.7203703703703703,0.89315918639506,1.0,6/12,25.40%,PFDN5;APOE;CRYAB;PFDN6;PFDN4;TREM2
prerank,regulation of actin polymerization or depolymerization (GO:0008064),-0.26385754515786214,-0.8190116505870075,0.7275985663082437,0.892897540773547,1.0,10/28,23.65%,ESAM;WDR1;PFN1;DBNL;DBN1;RASA1;CTTN;HCLS1;PLEKHG2;ARHGAP18
prerank,negative regulation of protein localization to membrane (GO:1905476),-0.28052729617388095,-0.8189200901309864,0.7357512953367875,0.8926118670903588,1.0,6/24,12.16%,TGFB1;ABI3;PPP2R5A;AP2M1;GDI1;BCL2L1
prerank,regulation of macroautophagy (GO:0016241),-0.20720457999559636,-0.8185745990440201,0.8523908523908524,0.8927446953827207,1.0,37/105,32.32%,EXOC4;KDR;ATP6V0B;ATP6V0A2;GAPDH;QSOX1;AKT1;SCOC;ATP6V0C;UCHL1;EXOC1;EPM2A;LAMTOR2;BNIP3L;PIK3CA;PRKAG1;ATP6V1G1;RRAGD;TBC1D25;TSC2;RRAGA;RRAGC;SESN2;SMG1;RPTOR;ATP6V0D1;ATG13;LAMTOR5;SESN1;UBQLN2;ERN1;ATG101;ATP13A2;ATP6V0E2;ATP6V1C1;LAMTOR1;LAMTOR3
prerank,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),0.33417326607897524,0.8183482638307604,0.6985138004246284,0.9342788326977961,1.0,5/11,17.96%,CREB3L1;CEBPB;ATF6;DDIT3;TP53
prerank,positive regulation of potassium ion transport (GO:0043268),-0.24789534199149615,-0.8175561604543132,0.7427466150870407,0.8940283369888525,1.0,7/38,13.50%,KCNJ2;FHL1;KCNQ1;KCNJ10;AKAP6;KCNJ15;GNB1
prerank,cellular response to oxidised low-density lipoprotein particle stimulus (GO:0140052),-0.3461989542881013,-0.8168483709192419,0.7039586919104991,0.8947928716029987,1.0,6/10,29.22%,AKT1;TLR4;CD68;TREM2;CD36;TLR6
prerank,cholesterol efflux (GO:0033344),-0.292732345818888,-0.8161998305125288,0.7410881801125704,0.895475587854664,1.0,5/20,13.92%,SCARB1;ABCG1;APOE;TSKU;NPC1
prerank,hexose biosynthetic process (GO:0019319),0.24560911782500533,0.8158614239608729,0.7318087318087318,0.938285475305872,1.0,7/42,11.75%,AKR1B1;SLC25A13;SLC25A10;CRY1;ALDOB;MDH2;ENO2
prerank,regulation of telomerase RNA localization to Cajal body (GO:1904872),-0.29528430914641196,-0.8157746257414094,0.750465549348231,0.895738483702736,1.0,10/18,35.68%,DKC1;CCT2;CCT3;CCT8;CCT7;RUVBL1;DCP2;CCT4;CCT6A;NOP10
prerank,regulation of sister chromatid cohesion (GO:0007063),0.3305018105127044,0.8155016592386498,0.6636363636363637,0.9381891408838734,1.0,3/12,9.65%,AXIN2;CTCF;HDAC8
prerank,protein insertion into ER membrane (GO:0045048),-0.2528446085617836,-0.8153874621753393,0.7808988764044944,0.8959420249194228,1.0,13/37,29.07%,APP;STX1A;CAMLG;EMC10;SEC61B;SGTA;EMC6;EMC9;STX5;UBE2J2;EMC1;TRAM1;VAMP2
prerank,transcription by RNA polymerase III (GO:0006383),0.27439364257382753,0.8145697923804462,0.7304526748971193,0.9390727386514209,1.0,11/27,20.36%,SNAPC3;GTF3C3;GTF3C2;SNAPC1;GTF3C6;ICE1;GTF3C4;ICE2;POLR3H;POLR2K;POLR3GL
prerank,positive regulation of dephosphorylation (GO:0035306),-0.26612285773692784,-0.8144688863575741,0.7448405253283302,0.8970146069937939,1.0,13/27,26.21%,PPP1R16B;CALM1;TGFB1;PPIA;PPP2R5A;CALM3;CDCA2;PIN1;CNEP1R1;CDH5;PRKCD;NSMF;SMPD1
prerank,carbohydrate homeostasis (GO:0033500),-0.2216986047711201,-0.8143489815077329,0.8015267175572519,0.8967710736719227,1.0,6/67,5.35%,ADIPOR2;IGF1R;KCNB1;BACE2;KLF7;ADIPOR1
prerank,transcription initiation from RNA polymerase I promoter (GO:0006361),0.2633717844667756,0.8139871880329381,0.7327935222672065,0.9393923500290938,1.0,6/32,10.75%,POLR1A;GTF2H2;MNAT1;POLR1G;POLR1B;CCNH
prerank,negative regulation of protein metabolic process (GO:0051248),-0.23988517105949575,-0.8137296671615721,0.7903846153846154,0.8973684197629191,1.0,16/48,25.40%,HSP90AB1;PFDN5;EDN1;APOE;INHBB;EGFR;FLOT2;CD84;AGAP2;CRYAB;PIN1;ITGB3;SNX3;PFDN6;PFDN4;TREM2
prerank,positive regulation of protein targeting to membrane (GO:0090314),0.279928230121462,0.8135362045816356,0.7167381974248928,0.9394167656539053,1.0,1/24,0.26%,CEMIP
prerank,DNA unwinding involved in DNA replication (GO:0006268),0.3053933571921894,0.8133080894296207,0.6849015317286652,0.9390275512186717,1.0,16/16,69.49%,BLM;MCM2;RPA1;MCMDC2;MCM7;MCM6;MCM4;RECQL5;SSBP1;WRN;RECQL4;HMGA1;PURA;RAD51;TWNK;RECQL
prerank,positive regulation of secretion (GO:0051047),-0.3376454456846756,-0.8132542412622679,0.7210526315789474,0.8977340225126481,1.0,2/11,17.15%,NPR1;XBP1
prerank,positive regulation of lipid transport (GO:0032370),0.33233513587514674,0.8129389581228,0.6839622641509434,0.9388764697559219,1.0,2/12,8.09%,LRP1;ABCB4
prerank,apoptotic DNA fragmentation (GO:0006309),0.2997838651565006,0.8129219505144555,0.6779661016949152,0.9381056102160563,1.0,3/16,10.31%,CASP3;EXOG;CECR2
prerank,cellular response to alkaloid (GO:0071312),0.3033198992640771,0.8129015773984162,0.7108167770419426,0.9373367857043616,1.0,3/17,8.95%,SLC8A1;CASP3;BLM
prerank,regulation of proteolysis (GO:0030162),-0.23759465783584494,-0.8125418784245776,0.8123861566484517,0.8984652075576947,1.0,10/48,17.09%,CAV1;LTBP4;CASP8;AKT1;PERP;CST3;ITCH;BAK1;IST1;BAD
prerank,mitochondrial transcription (GO:0006390),-0.3467828815491293,-0.8123923916044749,0.6928838951310862,0.898271493988401,1.0,2/10,18.64%,FOXO3;SLC25A33
prerank,long-chain fatty acid transport (GO:0015909),0.26624446711942884,0.8122147793543146,0.7236580516898609,0.9378780716365702,1.0,9/30,18.82%,PRKAG2;ACSL1;ABCD2;CPT2;ACACA;FABP4;PRKAB2;SLC27A4;PPARG
prerank,serine family amino acid metabolic process (GO:0009069),-0.30778769040667303,-0.8118958800573822,0.7324478178368121,0.8986572601102916,1.0,9/16,36.02%,SARS1;CDO1;SEPHS2;CTH;GCLC;THNSL2;SRR;SHMT2;DAO
prerank,positive regulation of telomere capping (GO:1904355),-0.30242299988918636,-0.8115818557200684,0.7260536398467433,0.8986942984818738,1.0,2/17,3.11%,MAPK3;NEK7
prerank,protein O-linked glycosylation (GO:0006493),0.20930799163858768,0.8114103799801001,0.8133874239350912,0.9384913599351681,1.0,9/96,7.81%,TMTC1;GALNTL6;GXYLT2;B3GNT7;B3GLCT;TMTC3;TMTC4;POGLUT2;CRPPA
prerank,phosphorylated carbohydrate dephosphorylation (GO:0046838),-0.3352119414373502,-0.8113032440904163,0.740608228980322,0.8982204394178644,1.0,4/11,24.67%,INPP5A;SYNJ1;IMPA2;INPP5B
prerank,inositol phosphate dephosphorylation (GO:0046855),-0.3352119414373502,-0.8113032440904163,0.740608228980322,0.8982204394178644,1.0,4/11,24.67%,INPP5A;SYNJ1;IMPA2;INPP5B
prerank,regulation of Golgi organization (GO:1903358),-0.2956726116119917,-0.8111441468216515,0.746588693957115,0.8980056122466045,1.0,6/17,22.33%,MAPK3;ARMH3;EHD3;PDCD10;STX5;CAMSAP3
prerank,regulation of defense response to virus (GO:0050688),-0.31510282649020427,-0.8110008901707475,0.7116788321167883,0.8977851338746966,1.0,3/14,15.59%,DHX9;ITCH;TNFAIP3
prerank,regulation of B cell activation (GO:0050864),0.27667598584345804,0.810837582496662,0.7189542483660131,0.9387714246904328,1.0,3/25,11.53%,IL4I1;IL4;AHR
prerank,cholesterol metabolic process (GO:0008203),-0.216874224737724,-0.8105027562449474,0.8374485596707819,0.8981282925608366,1.0,14/68,18.26%,PPARD;SCARF1;LBR;OSBPL1A;ACAA2;ACLY;ABCG1;PIP4P1;APOE;TSKU;DHCR24;TM7SF2;CH25H;LCAT
prerank,negative regulation of T cell activation (GO:0050868),0.25840340858344085,0.8102639609707017,0.7433628318584071,0.9390067594215411,1.0,4/35,7.73%,IL4I1;CEBPB;GLMN;CD274
prerank,spliceosomal snRNP assembly (GO:0000387),-0.24851797398640968,-0.8102450856761194,0.7801556420233463,0.8980945115271227,1.0,19/38,40.09%,PRPF8;SNRPC;SNRPD3;SMN1;DDX20;SNRPG;USP4;LSM2;TGS1;CD2BP2;SNRPB;CLNS1A;PRPF19;SNUPN;SRSF10;SNRPE;SNRPF;GEMIN2;PRPF6
prerank,inner dynein arm assembly (GO:0036159),0.34858469842465334,0.8102056276666291,0.7039473684210527,0.9382960667870274,1.0,10/10,65.16%,CCDC39;CFAP73;CCDC40;DNAAF5;CFAP100;ZMYND10;DNAI3;DNAAF1;DNAH1;DNAAF4
prerank,regulation of establishment of protein localization (GO:0070201),-0.3249452007372793,-0.8099413821344421,0.717391304347826,0.898146948918803,1.0,3/13,10.06%,CTSD;DNAJA1;CEP290
prerank,fibroblast growth factor receptor signaling pathway (GO:0008543),0.22186920015438905,0.8098549194330531,0.795131845841785,0.9381444988983864,1.0,4/72,3.04%,FLRT2;FGFR2;KL;FLRT1
prerank,histone mRNA catabolic process (GO:0071044),0.3121336364743891,0.8097687376970323,0.6775599128540305,0.9375055172105478,1.0,7/15,26.89%,TUT4;ATM;TENT2;MTPAP;SSB;TENT4B;XRN1
prerank,positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),-0.3215928816657424,-0.809446901580672,0.7153153153153153,0.898531585314488,1.0,4/14,12.36%,SEMA7A;PLCG2;CD74;MAVS
prerank,regulation of peptidyl-lysine acetylation (GO:2000756),0.34309113156365983,0.809114279519125,0.6854663774403471,0.9378805472887684,1.0,2/10,12.95%,KLF15;SETD5
prerank,autophagosome organization (GO:1905037),0.2361388097064706,0.8087001410352365,0.8170212765957446,0.9378420119822861,1.0,11/50,12.91%,ATP2A2;WDR45B;UBXN2B;ATG12;WIPI1;UBXN2A;TP53INP2;TMEM41B;ATG16L2;STX12;ULK2
prerank,organophosphate biosynthetic process (GO:0090407),-0.24928516058410227,-0.8081002608924129,0.7745664739884393,0.9003050688876482,1.0,7/37,16.18%,ITPKB;TPK1;IPMK;FGF2;IP6K1;MBOAT1;PCYT2
prerank,"regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",-0.3112567165238366,-0.8076804319902914,0.7377938517179023,0.9001002972692499,1.0,2/15,5.85%,TNRC6C;CNOT7
prerank,"positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",-0.3112567165238366,-0.8076804319902914,0.7377938517179023,0.9001002972692499,1.0,2/15,5.85%,TNRC6C;CNOT7
prerank,antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),-0.25912367426068644,-0.8068546880823733,0.7589453860640302,0.9010498039596678,1.0,5/32,10.03%,RPL30;RPL39;RPS19;GAPDH;PGLYRP1
prerank,protein maturation by iron-sulfur cluster transfer (GO:0097428),-0.3171156907777062,-0.8066728710571348,0.7377938517179023,0.9008714511860523,1.0,5/13,29.66%,GLRX5;ISCA2;NFU1;ISCA1;CISD3
prerank,regulation of gastrulation (GO:0010470),0.3130372740458759,0.8066273191938828,0.682648401826484,0.9408194122187556,1.0,2/14,6.59%,PHLDB2;FOXA2
prerank,stem cell development (GO:0048864),0.30261666991090286,0.8061189844575162,0.7015590200445434,0.9409707304924262,1.0,1/16,1.40%,NRG1
prerank,negative regulation of cytokine-mediated signaling pathway (GO:0001960),0.24104521762687733,0.8041324599261326,0.7736625514403292,0.9438206326806531,1.0,4/48,8.44%,ROBO1;STAP1;GSTP1;NLRP2B
prerank,negative regulation of G0 to G1 transition (GO:0070317),0.2531473983240974,0.8038236541880036,0.7658227848101266,0.943576749058361,1.0,12/36,20.86%,UXT;TFDP1;L3MBTL2;RNF2;APAF1;PCGF6;EHMT2;EZH2;YAF2;CDC7;MGA;PCGF2
prerank,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),-0.3164453359572698,-0.8035774476096152,0.7238805970149254,0.9055069825802476,1.0,2/13,5.85%,TNRC6C;CNOT7
prerank,regulation of B cell apoptotic process (GO:0002902),0.32533445456615573,0.8032017760354752,0.6738197424892703,0.9438683115724773,1.0,3/12,5.54%,LYN;FNIP1;IRS2
prerank,bone morphogenesis (GO:0060349),-0.3120479517647561,-0.8024467309457529,0.7333333333333333,0.9069024513662147,1.0,2/14,2.11%,LRP5;BMPR2
prerank,presynaptic endocytosis (GO:0140238),0.27794959756266835,0.8023312404854063,0.7363834422657952,0.9446140590754621,1.0,5/24,7.71%,STON1;NLGN2;NLGN3;SYT1;NLGN1
prerank,mucosal immune response (GO:0002385),0.31049934572712135,0.8023190640216035,0.7008547008547008,0.9438359925100015,1.0,2/15,5.47%,IL4;BPIFB1
prerank,cell surface receptor signaling pathway involved in heart development (GO:0061311),-0.2975372666503423,-0.8021297806052189,0.7441441441441441,0.9069466501659774,1.0,6/17,17.87%,NOTCH1;TGFB1;HEYL;ACVR1;HEY1;DLL4
prerank,positive regulation of viral process (GO:0048524),-0.22403063949095015,-0.801764617063485,0.8557312252964426,0.9071103789215932,1.0,21/60,32.29%,ADAR;PPIA;CNOT7;SRPK1;DHX9;IFIT1;RAB7A;NELFE;STAU1;NR5A2;GTF2F1;RAD23A;VPS4A;PPID;PABPC1;GTF2F2;POLR2F;POLR2L;KPNA6;POLR2I;POLR2C
prerank,microtubule-based transport (GO:0099111),-0.32658481610561374,-0.8017512594557414,0.7272727272727273,0.9066705403366322,1.0,6/12,27.29%,HTT;CABYR;ROPN1L;ADCY10;SPAG17;SPA17
prerank,negative regulation of ion transmembrane transporter activity (GO:0032413),0.2951832183344646,0.8016739188011864,0.7368421052631579,0.9442070745503711,1.0,2/20,5.49%,HECW2;HECW1
prerank,chondroitin sulfate proteoglycan metabolic process (GO:0050654),-0.3469029505460343,-0.8014355992125028,0.7366482504604052,0.9067293572147024,1.0,1/10,0.70%,CSGALNACT1
prerank,respiratory tube development (GO:0030323),0.2671092411840385,0.8004526179379408,0.7457983193277311,0.9456143690999133,1.0,4/28,8.90%,FGFR2;GLI2;LOXL3;NPHP3
prerank,positive regulation of neuroinflammatory response (GO:0150078),0.32015350168095075,0.8004481036745351,0.7004608294930875,0.9448282637420246,1.0,2/12,8.31%,STAP1;IL18
prerank,glycogen catabolic process (GO:0005980),0.30806718649327935,0.8001883107218792,0.7287784679089027,0.944476530087002,1.0,3/15,11.58%,PHKA1;STBD1;PYGM
prerank,regulation of store-operated calcium entry (GO:2001256),-0.34755161046435223,-0.8001314258891308,0.7223230490018149,0.9084351456897287,1.0,5/10,29.12%,HOMER1;CD84;CASQ1;SLC8B1;GRAMD2A
prerank,protein processing (GO:0016485),-0.20214580654055314,-0.799639772229748,0.875968992248062,0.9087607724929772,1.0,25/102,24.34%,SRGN;F3;ADAM10;BACE1;ADAM19;SPCS1;MMP14;PSENEN;CPE;FAM111A;SEC11A;SPRTN;FXN;APH1A;PHEX;VSIR;RCE1;TMEM208;PRSS12;CASP1;GGT1;SEC11C;CTSS;PTCH1;MYRF
prerank,actin-myosin filament sliding (GO:0033275),-0.24582784493563348,-0.7980988292403624,0.794392523364486,0.9103199368595569,1.0,3/38,1.74%,DMD;VIM;MYL6
prerank,muscle filament sliding (GO:0030049),-0.24582784493563348,-0.7980988292403624,0.794392523364486,0.9103199368595569,1.0,3/38,1.74%,DMD;VIM;MYL6
prerank,rRNA methylation (GO:0031167),-0.2755724658740799,-0.7979625438894425,0.7676190476190476,0.9100704474618282,1.0,8/22,28.38%,NOP2;EMG1;MRM3;ZCCHC4;MRM2;NSUN5;FTSJ3;MRM1
prerank,establishment of mitotic spindle orientation (GO:0000132),-0.2738528493889018,-0.7977559477844264,0.7784090909090909,0.9099188064809969,1.0,9/23,24.32%,ZW10;HTT;DCTN1;NDE1;NDEL1;MISP;NDC80;SPDL1;CENPA
prerank,embryonic cranial skeleton morphogenesis (GO:0048701),0.3080757919325762,0.7944483072760307,0.7340425531914894,0.9536092908794864,1.0,5/15,15.51%,FGFR2;PDGFRA;TGFBR1;MTHFD1;MTHFD1L
prerank,negative regulation of mitotic cell cycle (GO:0045930),0.23421025554474004,0.7942951428149378,0.7770833333333333,0.9530820639546804,1.0,13/45,19.15%,AURKAIP1;SMAD3;BRINP1;BRINP3;TOM1L2;WEE2;TOM1L1;PRCC;BRINP2;ZWINT;TRIM35;FOXC1;ZWILCH
prerank,lipid catabolic process (GO:0016042),-0.28805128544752034,-0.7941796713377828,0.7728119180633147,0.9152060509123601,1.0,6/18,33.37%,PLAAT3;ACADL;PLA1A;LIPH;HSD11B1;LIPE
prerank,mitotic G1/S transition checkpoint signaling (GO:0044819),-0.3238005621511171,-0.7940618008983118,0.7547169811320755,0.9149364708922607,1.0,5/12,26.02%,PRKDC;RPS27L;CCND1;PLK3;PLK5
prerank,negative regulation of macroautophagy (GO:0016242),0.2648850589398294,0.7938755584454086,0.7370689655172413,0.9530530018629949,1.0,3/26,4.38%,PHF23;UBQLN4;SCFD1
prerank,regulation of protein localization to cell surface (GO:2000008),0.25449638388489326,0.7936207920511865,0.7795918367346939,0.9527116944109023,1.0,5/33,6.07%,LEPROT;SNX33;GPD1L;TAX1BP3;GBF1
prerank,positive regulation of double-strand break repair via homologous recombination (GO:1905168),-0.31229579075965896,-0.7934784271028402,0.7385159010600707,0.9153736502714829,1.0,6/14,38.17%,FUS;WDR48;MRNIP;RAD51AP1;WRAP53;FANCB
prerank,response to axon injury (GO:0048678),0.2905496944636979,0.7930946985691412,0.7668067226890757,0.9528120113832861,1.0,5/18,17.42%,P2RX4;NREP;DPYSL3;SARM1;FLRT3
prerank,positive regulation of DNA recombination (GO:0045911),0.26437426755405163,0.7928864808708478,0.7883369330453563,0.9523986133912554,1.0,7/27,17.74%,SHLD2;PRDM9;KMT5C;PAXIP1;RIF1;KMT5B;PARP1
prerank,positive regulation of DNA repair (GO:0045739),-0.22900376386646878,-0.7918962442465368,0.8033395176252319,0.9174087391190611,1.0,10/46,17.16%,RPS3;BRCC3;UIMC1;DHX9;BABAM1;TRIM28;SLF1;XRCC1;EGFR;BABAM2
prerank,transcription by RNA polymerase I (GO:0006360),0.2545311122799657,0.7914300637433284,0.7674897119341564,0.954107679819338,1.0,10/34,20.08%,POLR1A;GTF2H2;MNAT1;POLR1G;POLR1B;CCNH;TTF1;TAF1C;TAF1;POLR2K
prerank,serine family amino acid biosynthetic process (GO:0009070),-0.31393759195330695,-0.791355880411725,0.7563636363636363,0.9177428185935462,1.0,7/12,34.80%,SEPHS2;CTH;GGT1;SERINC3;SERINC5;SRR;PSAT1
prerank,transport along microtubule (GO:0010970),-0.3197431956008059,-0.7911931959888191,0.7400379506641366,0.9175292570456015,1.0,3/13,9.41%,APP;BORCS5;COPG1
prerank,C-terminal protein amino acid modification (GO:0018410),0.32967646490200375,0.7910217149955044,0.7313084112149533,0.9539953484628698,1.0,3/11,10.82%,AGBL4;ATG12;FOLH1
prerank,regulation of stress-activated protein kinase signaling cascade (GO:0070302),-0.33217523018714545,-0.7908779350270764,0.7472324723247232,0.9175764000613287,1.0,3/10,16.40%,MAPK3;FAS;GREM1
prerank,regulation of cellular catabolic process (GO:0031329),0.22447747573974713,0.7905937465051219,0.8138075313807531,0.9539300279543137,1.0,11/62,13.81%,DAPK2;ITPR1;PIP4K2A;PRKN;DAPK1;KAT8;RAB39B;PIP4K2B;ATM;EP300;MAPT
prerank,Golgi to plasma membrane protein transport (GO:0043001),0.2533076969626646,0.7901057677106219,0.7429805615550756,0.9540289104659755,1.0,5/30,13.16%,VAMP5;RAB10;BBS2;OPTN;SYS1
prerank,epithelial cell development (GO:0002064),-0.277883350092589,-0.7900201908771449,0.7589453860640302,0.9184676289031057,1.0,11/20,40.75%,ACTA2;SIPA1L3;WNT7A;RILPL1;PKHD1;POF1B;GRHL2;RILPL2;WNT7B;RAB25;ROS1
prerank,neural crest cell differentiation (GO:0014033),-0.2831345524202362,-0.7898229590399705,0.7590579710144928,0.9182835169447167,1.0,1/18,0.31%,MEF2C
prerank,positive regulation of chondrocyte differentiation (GO:0032332),-0.3370902799226875,-0.7897522368934465,0.726078799249531,0.9179302415602486,1.0,4/10,19.37%,ZBTB16;SOX6;BMPR1B;SOX9
prerank,regulation of attachment of spindle microtubules to kinetochore (GO:0051988),-0.33888666000628476,-0.7889469554965777,0.7406716417910447,0.9187506174297843,1.0,5/10,27.12%,RCC2;ECT2;KNSTRN;CDC42;RACGAP1
prerank,camera-type eye morphogenesis (GO:0048593),0.3365110767676357,0.7886536427874198,0.7015250544662309,0.9556374308699266,1.0,2/10,6.38%,TENM3;IFT122
prerank,midbrain dopaminergic neuron differentiation (GO:1904948),-0.32562974624286833,-0.7881032847063232,0.7512864493996569,0.9196030765001687,1.0,5/11,35.23%,NR4A2;LMX1A;WNT2;CTNNB1;LRP6
prerank,AMP metabolic process (GO:0046033),-0.3095164370658054,-0.7880337548439111,0.7409420289855072,0.9192312024948962,1.0,7/13,30.09%,NT5E;ADSS2;NT5C1A;ADSS1;NUDT2;AK9;XDH
prerank,"mRNA cis splicing, via spliceosome (GO:0045292)",-0.297489640347569,-0.7872576978578976,0.7363636363636363,0.9199648879224569,1.0,10/16,33.39%,SNRPC;DCPS;RBM22;SFSWAP;DDX23;NCBP2;PSIP1;WBP11;SRSF1;WBP4
prerank,cellular response to lipopolysaccharide (GO:0071222),-0.20093453076507148,-0.786861988345236,0.9053803339517625,0.920098244686772,1.0,34/101,32.48%,MEF2C;LBP;VIM;DAB2IP;TGFB1;TNFRSF1B;PLAA;PRKCE;TLR4;NOD2;TNFAIP3;CX3CR1;RELA;XBP1;HCK;CASP1;PTPN22;CD68;TRAF6;CCL2;CARD16;BCL10;SHPK;PDCD4;LILRB1;HMGB2;CD86;IRGM;UPF1;RHOA;CD14;LY96;NLRP3;TNIP2
prerank,response to UV-B (GO:0010224),0.3081501276304476,0.7864105823161537,0.7177242888402626,0.9586730448081693,1.0,1/12,1.32%,HYAL3
prerank,positive regulation of calcium ion import (GO:0090280),0.3142875748544195,0.7863406308383694,0.7214285714285714,0.9579855315917057,1.0,2/12,6.91%,PDGFRB;CALCR
prerank,positive regulation of epithelial cell differentiation (GO:0030858),0.29601248171694927,0.7863308975806673,0.7429193899782135,0.9572024242073305,1.0,3/17,9.58%,NKX6-1;ATOH8;AHI1
prerank,GPI anchor biosynthetic process (GO:0006506),0.26030059467352507,0.7856908537169643,0.7639751552795031,0.9575005316252437,1.0,11/30,22.22%,GPAA1;PIGU;PIGH;PIGP;PIGX;PGAP3;DPM1;PIGN;MPPE1;PGAP1;PIGB
prerank,positive regulation of ubiquitin-protein transferase activity (GO:0051443),-0.2514822617882507,-0.7856463519251811,0.7861271676300579,0.9215032220693518,1.0,14/31,34.73%,DCUN1D5;DCUN1D1;CDC14B;RAB1A;BMI1;FZR1;PIN1;TRIB3;DCUN1D3;MAGEC2;RPS2;PLK1;CDC20;UBE2C
prerank,sulfation (GO:0051923),0.32615398014070995,0.7856160078324111,0.7463312368972747,0.956835852176034,1.0,2/11,7.11%,UST;SULT6B1
prerank,regulation of telomere capping (GO:1904353),-0.27168062429159806,-0.7855088350914629,0.749003984063745,0.9212261713857465,1.0,4/23,12.51%,MAPK3;NEK7;USP7;PNKP
prerank,mitotic DNA integrity checkpoint signaling (GO:0044774),0.3233668427855377,0.7848862381889278,0.7006651884700665,0.9573114893976886,1.0,4/12,17.07%,SETMAR;STK33;ORC1;NAE1
prerank,inositol phosphate catabolic process (GO:0071545),-0.31507504069282566,-0.7847966339203912,0.764808362369338,0.9218946280024115,1.0,4/12,24.67%,INPP5A;SYNJ1;IMPA2;INPP5B
prerank,positive regulation of ion transmembrane transporter activity (GO:0032414),-0.2666172588413484,-0.7845283887408598,0.7699619771863118,0.9218409015891478,1.0,5/25,9.05%,DMD;WNK1;ATP1B1;COA8;TRPC6
prerank,positive regulation of cell division (GO:0051781),0.24490609284902562,0.783632924402036,0.7791411042944786,0.9586110817399798,1.0,2/38,1.11%,SVIL;FGFR2
prerank,Rac protein signal transduction (GO:0016601),-0.2791080713605092,-0.7835053303892698,0.7872727272727272,0.9229678634687103,1.0,4/18,16.41%,EPS8;RAC1;DBNL;NCKAP1
prerank,regulation of lymphocyte activation (GO:0051249),0.3126608499152597,0.7825961934778566,0.7616822429906542,0.9595793140744943,1.0,12/12,68.76%,PAG1;LCK;IKZF3;SIT1;CD4;CD19;THEMIS2;CRTAM;CCL5;DCAF15;KAT2A;LAT
prerank,positive regulation of protein targeting to mitochondrion (GO:1903955),-0.24790890053888082,-0.7824457108425309,0.8216318785578748,0.9240867946925849,1.0,10/30,25.82%,ABLIM3;SAE1;VPS11;CSNK2A2;UBL5;FZD5;NPEPPS;MICALL2;UBE2J2;ATG13
prerank,regulation of lipase activity (GO:0060191),0.31136220966729455,0.7823846569185469,0.7315010570824524,0.9591207859109732,1.0,13/13,68.89%,PCSK6;SNCA;ANGPTL3;LIPC;LMF1;RHOC;APOA2;ANGPTL8;PCSK5;LPL;PLIN5;FURIN;RHOA
prerank,cobalamin metabolic process (GO:0009235),-0.28966120782693633,-0.7818650474778157,0.7942238267148014,0.9244956688583311,1.0,4/17,17.77%,MTR;CUBN;MMADHC;CD320
prerank,negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),-0.3129360829993954,-0.7818242560838046,0.7676579925650557,0.9240893268218553,1.0,3/12,28.45%,NELFE;EAPP;RNF8
prerank,regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),-0.31309820150981565,-0.7817961524022641,0.7733333333333333,0.9236633054616149,1.0,8/13,41.23%,ANAPC15;DYNC1LI1;LCMT1;NDC80;DUSP1;CCNB1;CDK5RAP2;PCID2
prerank,regulation of TOR signaling (GO:0032006),-0.21240979910109856,-0.7808049774787793,0.8663967611336032,0.9246890077188347,1.0,26/67,35.32%,SH3BP4;RICTOR;TNFAIP8L1;EPM2A;TBCK;LAMTOR2;PIK3CA;RRAGD;DDIT4;TSC2;RRAGA;RRAGC;GOLPH3;RPTOR;SEH1L;TREM2;SEC13;PDCD6;LAMTOR5;FAM83D;HDAC3;LAMTOR1;LAMTOR3;PKHD1;DYRK3;TTI1
prerank,positive regulation of mRNA processing (GO:0050685),0.26989220439501654,0.7804782237818264,0.7769423558897243,0.9614570074671064,1.0,3/21,7.63%,DAZAP1;TRA2A;CELF4
prerank,phosphatidylcholine metabolic process (GO:0046470),-0.20877787897510922,-0.7804572772610691,0.8732394366197183,0.9247619249323782,1.0,22/70,28.84%,LPCAT3;MFSD2A;CHKA;DBI;CSNK2B;PLAAT3;MBOAT7;CEPT1;MBOAT1;CSNK2A1;CSNK2A2;NR1H2;LCAT;PCYT1A;CHAT;LPCAT2;PLA2G4F;ENPP2;PEMT;LPIN2;SLC27A1;PLA2G4B
prerank,Golgi inheritance (GO:0048313),-0.3206969301635359,-0.7800905657641081,0.7580645161290323,0.924836488225207,1.0,7/11,26.02%,STK25;VRK1;YWHAZ;PDCD10;STX5;PLK3;PLK5
prerank,negative regulation of cAMP-mediated signaling (GO:0043951),-0.33579113159438223,-0.7798076063123428,0.7692307692307693,0.9247912673224155,1.0,2/10,4.53%,PDE4D;PDE2A
prerank,glycosphingolipid metabolic process (GO:0006687),-0.22945457280624462,-0.7795763875498617,0.8261682242990654,0.9246945679838575,1.0,6/42,7.53%,ST6GALNAC3;ESYT2;SUMF2;HEXA;PSAP;A4GALT
prerank,cellular response to leucine (GO:0071233),-0.33167543205768407,-0.7793151304508238,0.7584905660377359,0.9241348632805327,1.0,4/10,27.35%,RRAGD;SESN2;RPTOR;SESN1
prerank,response to leucine (GO:0043201),-0.33167543205768407,-0.7793151304508238,0.7584905660377359,0.9241348632805327,1.0,4/10,27.35%,RRAGD;SESN2;RPTOR;SESN1
prerank,regulation of exocytosis (GO:0017157),-0.22860963451966437,-0.7793089288841462,0.8326693227091634,0.9236796553740945,1.0,6/46,9.84%,STXBP6;ANXA1;RAB8B;RAB27A;CPLANE2;RAB8A
prerank,carbohydrate derivative biosynthetic process (GO:1901137),-0.2568031412070147,-0.7791337746447506,0.7887323943661971,0.9234797207256112,1.0,11/26,35.13%,ST3GAL4;ST8SIA6;RRM1;SCCPDH;LARGE1;GOLPH3;ALG2;B4GALT5;ST3GAL2;TPI1;ALG6
prerank,visual perception (GO:0007601),0.2089479968808913,0.7791188461169277,0.8709677419354839,0.9629334752974656,1.0,17/84,18.99%,ADGRV1;DHRS3;TRPM1;CRYBA1;ATXN7;GUCY2F;BBS2;ATF6;POU6F2;RPGR;RP2;COL11A1;MYO9A;ZIC2;PAX6;TULP1;COL1A1
prerank,positive regulation of cell cycle phase transition (GO:1901989),-0.30321083018627937,-0.7789659363172038,0.774074074074074,0.9232731331395119,1.0,10/15,35.80%,PLCG2;DDRGK1;PHB2;GLI1;NPM1;FAM83D;CUL3;KLHL18;DYRK3;CDC73
prerank,dermatan sulfate proteoglycan biosynthetic process (GO:0050651),0.3015740623796094,0.7789108384012743,0.7522123893805309,0.9624643344674357,1.0,4/15,13.46%,UST;DCN;DSE;VCAN
prerank,regulation of DNA repair (GO:0006282),-0.22812670007183644,-0.7788024969461194,0.8365384615384616,0.923041637910056,1.0,7/44,9.21%,RPS3;USP1;BRCC3;UIMC1;DHX9;BABAM1;TRIM28
prerank,prostaglandin metabolic process (GO:0006693),-0.2580785866684491,-0.778474978980176,0.7940630797773655,0.9230853480274196,1.0,7/26,18.31%,PTGDS;EDN1;PLAA;CD74;PTGS1;GSTM1;DAGLB
prerank,nucleic acid phosphodiester bond hydrolysis (GO:0090305),0.21257946820415846,0.7783030206345309,0.8664047151277013,0.9626585720212466,1.0,8/72,10.64%,ENPP1;DCP1A;DDB2;GTF2H2;SETMAR;RPA2;RFC5;RNASE4
prerank,protein heterooligomerization (GO:0051291),-0.2844242997743869,-0.7780170515261032,0.7664233576642335,0.9232898113937923,1.0,8/17,36.06%,PKD1;MAT2A;FARSB;PKD2;GRIN1;KRT10;TMEM120B;TMEM120A
prerank,regulation of feeding behavior (GO:0060259),0.32607918033805317,0.7775391656813012,0.7596371882086168,0.9631117960439631,1.0,1/11,2.85%,LEPR
prerank,plasma membrane invagination (GO:0099024),-0.2494178638540152,-0.7774921256918312,0.807909604519774,0.9236080543779798,1.0,8/29,24.27%,DOCK1;VAMP7;ARHGAP25;SNX18;MSR1;MYH9;AIF1;CDC42
prerank,purine ribonucleoside triphosphate metabolic process (GO:0009205),-0.3090734852289495,-0.7769923157869407,0.7689393939393939,0.923911169761182,1.0,3/13,21.31%,ENTPD7;OPA1;RAB23
prerank,endodermal cell fate commitment (GO:0001711),-0.33909850889539916,-0.7767998169766043,0.7623239436619719,0.9237459777821075,1.0,1/10,3.46%,SOX17
prerank,dosage compensation by inactivation of X chromosome (GO:0009048),0.3148946164486097,0.7767897180635206,0.7333333333333333,0.9634540216597922,1.0,4/12,15.77%,PCGF5;SMCHD1;LRIF1;METTL3
prerank,microtubule anchoring at centrosome (GO:0034454),0.32883830556599225,0.7766549627785977,0.7251082251082251,0.9628889159850443,1.0,4/10,20.74%,NINL;KIF3A;BBS4;CCDC68
prerank,"regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)",0.33731422440292597,0.7760429724830878,0.7146118721461188,0.9630512087318923,1.0,1/10,3.70%,SH3RF1
prerank,hematopoietic stem cell differentiation (GO:0060218),-0.3318784108478686,-0.7759003327891834,0.7696428571428572,0.9246456733056748,1.0,4/10,17.05%,MLLT3;ACE;UFL1;HOXB4
prerank,maintenance of protein localization in endoplasmic reticulum (GO:0035437),0.3213127706091285,0.7755115977555386,0.7217573221757322,0.9630963803865095,1.0,3/12,10.17%,GPAA1;INSIG2;KDELR3
prerank,"transcription, DNA-templated (GO:0006351)",-0.1790211449442586,-0.7754450443785781,0.9730848861283644,0.9248238253153681,1.0,35/207,17.81%,RREB1;MLLT3;DDX5;MEF2A;FOXO3;AFF4;IVNS1ABP;NFYA;NR4A2;PTMA;GTF3C5;GTF2E1;ATF4;CBFB;TRIP11;PIR;GTF2H3;XAB2;NELFE;PPP5C;E2F1;RNPS1;BTF3;EPC1;POLR3A;IRF9;SMN1;DRAP1;GMEB2;CCNK;XBP1;GTF2F1;TCEA1;MED20;GTF2H4
prerank,negative regulation of DNA recombination at telomere (GO:0048239),0.2903165033911077,0.7751640984723012,0.7558386411889597,0.9620960452729681,1.0,19/19,71.00%,POLR2G;DAXX;POLR2D;POLR2K;POLR2B;TINF2;POLR2H;ATRX;ACD;POLR2E;POLR2J;TERF2;TERF1;POLR2A;POLR2C;POLR2I;POLR2L;POLR2F;TERF2IP
prerank,regulation of DNA recombination at telomere (GO:0072695),0.2903165033911077,0.7751640984723012,0.7558386411889597,0.9620960452729681,1.0,19/19,71.00%,POLR2G;DAXX;POLR2D;POLR2K;POLR2B;TINF2;POLR2H;ATRX;ACD;POLR2E;POLR2J;TERF2;TERF1;POLR2A;POLR2C;POLR2I;POLR2L;POLR2F;TERF2IP
prerank,inflammatory response (GO:0006954),0.1806977893587071,0.7747932267418373,0.9551656920077972,0.9619032677121819,1.0,20/195,10.66%,ADCY1;BMP2;PTGFR;HYAL3;SCUBE1;KIT;TPST1;CEBPB;IL4;PTGDR;ADM;PPBP;HRH1;SCG2;LOXL3;IL18;CCL25;TNFAIP6;C3AR1;ADCY8
prerank,activin receptor signaling pathway (GO:0032924),0.30880591448882344,0.7745261481660592,0.7546296296296297,0.9615265056947084,1.0,2/15,7.96%,SMAD3;TGFBR1
prerank,negative regulation of cellular biosynthetic process (GO:0031327),0.23075719545995665,0.7740172791521905,0.8306772908366534,0.9615960147374963,1.0,8/47,14.51%,WNT4;ROCK2;PTGIS;CRY1;KHSRP;ERLIN1;EP300;GLA
prerank,secretory granule organization (GO:0033363),-0.3346357154790688,-0.7740109229620619,0.7775735294117647,0.9264366950265315,1.0,2/10,5.21%,SRGN;LYST
prerank,regulation of neuroblast proliferation (GO:1902692),-0.2978801172503861,-0.7738595053841237,0.7685512367491166,0.9262075040546204,1.0,6/15,17.32%,VEGFA;FZD3;DISC1;NF1;CX3CR1;KDM1A
prerank,negative regulation of protein localization to plasma membrane (GO:1903077),-0.27829195230132775,-0.7738180361678656,0.764808362369338,0.9258075922022518,1.0,8/20,23.71%,TGFB1;ABI3;PPP2R5A;AP2M1;BCL2L1;TMEM59;CSK;NUMB
prerank,positive regulation of interleukin-13 production (GO:0032736),0.3377896432930963,0.7737206590933922,0.7214611872146118,0.9612673160924079,1.0,4/10,13.71%,IL4;IL18;GATA3;TSLP
prerank,regulation of short-term neuronal synaptic plasticity (GO:0048172),-0.3091798850064398,-0.773308019367505,0.7637362637362637,0.926104020704069,1.0,1/13,0.21%,SLC4A10
prerank,negative regulation of cellular carbohydrate metabolic process (GO:0010677),-0.2633315583012574,-0.773119674447935,0.7954110898661568,0.9259093783670258,1.0,3/23,8.30%,CBFA2T3;NCOR1;HDAC4
prerank,ribosomal subunit export from nucleus (GO:0000054),-0.30528593876517507,-0.7720113740084956,0.767097966728281,0.9270606345925309,1.0,2/13,8.14%,RPS15;NMD3
prerank,activation of cysteine-type endopeptidase activity (GO:0097202),-0.3011594580402093,-0.7719900336903082,0.7657142857142857,0.9266384204837705,1.0,4/13,17.09%,CASP8;PERP;BAK1;BAD
prerank,regulation of carbohydrate biosynthetic process (GO:0043255),-0.33027608859256463,-0.771239496285419,0.7996357012750456,0.9272443072410393,1.0,6/10,52.89%,USP7;GNMT;SIRT7;DGKQ;PDK2;FBP1
prerank,cellular response to UV-A (GO:0071492),-0.3206529275338682,-0.7706690306881042,0.7617328519855595,0.9276242272101691,1.0,8/11,50.00%,OPN3;PPID;MMP3;MMP1;CERS1;OPN5;MMP9;OPN1SW
prerank,regulation of actin filament-based movement (GO:1903115),0.32659048077706854,0.7703897934955641,0.728448275862069,0.9657554412166839,1.0,2/10,10.22%,ANK2;PDE4B
prerank,plasma membrane bounded cell projection organization (GO:0120036),-0.19128237126072842,-0.7701522917670209,0.9270833333333334,0.9279228376790079,1.0,11/124,6.57%,FRY;FRYL;RAB11A;OPHN1;STX3;MAP4;APP;RAC1;PTPRM;TTC17;MYOC
prerank,early endosome to Golgi transport (GO:0034498),-0.32136032906815537,-0.769938123273823,0.7644859813084112,0.9277765223574408,1.0,5/11,29.68%,SURF4;EHD3;STX5;SNX2;RAB6A
prerank,negative regulation of signal transduction by p53 class mediator (GO:1901797),-0.28465997102513496,-0.7696805905475544,0.7916666666666666,0.9277100742331496,1.0,4/17,10.73%,CD44;TWIST1;PTTG1IP;CD74
prerank,regulation of histone deacetylation (GO:0031063),-0.30190506587175653,-0.7690159068809672,0.7582417582417582,0.928198082493826,1.0,5/13,25.67%,CAMK2D;CTBP1;SPHK2;NIPBL;APLNR
prerank,modification-dependent protein catabolic process (GO:0019941),-0.17801707575168896,-0.7689938605117134,0.9571428571428572,0.9277733775380586,1.0,45/193,21.56%,NEDD4L;RNF144B;TRIM25;UBB;RLIM;UBC;RPS27A;RNF125;ANAPC15;RNF114;ANAPC11;RC3H1;UBE2L6;ARRDC1;RNF185;UBE2G2;TOLLIP;FBXL14;PCYOX1;PSMD14;ITCH;RNF5;RNF111;KLHL3;FBXL7;SMURF1;FEM1A;RNF20;RBX1;UBE2G1;UBL7;PSMD11;ANAPC7;KCTD10;CDC27;FZR1;XBP1;RNF19A;AMFR;PCYOX1L;KEAP1;UBE2B;UBA1;ANAPC2;BFAR
prerank,phosphatidylethanolamine metabolic process (GO:0046337),-0.25150806019399574,-0.7686476476172487,0.7956777996070727,0.9277917149047522,1.0,8/27,28.36%,CHKA;PLAAT3;CEPT1;PCYT2;NAPEPLD;SELENOI;LPIN2;SLC27A1
prerank,regulation of T cell migration (GO:2000404),-0.2773185264749317,-0.767651823737857,0.7878260869565218,0.92873095759239,1.0,2/18,4.11%,LRCH1;APP
prerank,regulation of exosomal secretion (GO:1903541),-0.27855650806184423,-0.7674145836213369,0.797752808988764,0.9285931368860282,1.0,8/19,30.80%,RAB7A;SDCBP;TSG101;SNF8;CHMP2A;VPS4A;STAM;ATP13A2
prerank,double-strand break repair via homologous recombination (GO:0000724),0.19827925694651824,0.7670037917158983,0.8891170431211499,0.9702799500247126,1.0,23/95,18.39%,MCM3;RNF138;GEN1;POLN;GINS2;SWSAP1;BLM;RPA2;MCM2;MCM9;RAD51C;MCM8;RAD51B;FANCM;NBN;RPA1;SMC6;PARP1;SEM1;SMC5;UBE2N;NSMCE2;PALB2
prerank,regulation of mitotic metaphase/anaphase transition (GO:0030071),0.2617365995678246,0.7669651600462424,0.8039647577092511,0.9695478568961461,1.0,7/26,18.37%,HECW2;CDC23;CDC16;DLGAP5;FBXO5;ANAPC5;NSMCE2
prerank,regulation of DNA replication (GO:0006275),0.22382338112603864,0.7663611517947787,0.8422131147540983,0.9697557705391497,1.0,12/49,20.33%,GLI2;STN1;USP37;ATAD5;BRPF3;BLM;EHMT2;PDS5A;FBXO5;ORC3;ORC5;PCNA
prerank,phosphatidylethanolamine biosynthetic process (GO:0006646),-0.2923823434039141,-0.7660921361524871,0.7862595419847328,0.9299961393408899,1.0,6/14,28.36%,CHKA;CEPT1;PCYT2;SELENOI;LPIN2;SLC27A1
prerank,late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),0.2929697536382495,0.7659821096002335,0.7729257641921398,0.9695375785191767,1.0,2/16,5.09%,LEPROT;VPS25
prerank,lymphocyte migration (GO:0072676),0.24295700036515855,0.7659329684693976,0.7928870292887029,0.9688303367751695,1.0,5/32,10.73%,TBX21;CCR6;GATA3;CCL25;MYO1G
prerank,regulation of cilium assembly (GO:1902017),-0.20912842719458838,-0.7657882008236526,0.8913443830570903,0.9299457302239408,1.0,19/62,27.42%,LIMK2;TBC1D8;IFT20;HTT;TBC1D1;TBC1D22A;ATG3;CDK10;TBC1D9B;TBC1D2;RABEP2;DCDC2;TBC1D15;ODAD3;CCDC88A;TBC1D30;TBC1D17;CDKL5;TBC1D5
prerank,negative regulation of interferon-gamma production (GO:0032689),-0.2641655018029915,-0.7657802092620994,0.8060836501901141,0.9294977661083655,1.0,8/23,28.50%,RARA;INHBA;TLR4;VSIR;LAPTM5;LGALS9;INHA;LILRB1
prerank,regulation of response to interferon-gamma (GO:0060330),-0.3009028157050674,-0.7656414492533068,0.7660311958405546,0.9292399411329911,1.0,4/14,17.22%,HSP90AB1;JAK2;STAT1;IFNGR1
prerank,cell cycle checkpoint signaling (GO:0000075),-0.3089655824417433,-0.765546124680732,0.7833935018050542,0.9289199185364123,1.0,2/12,8.12%,ZW10;PLK2
prerank,nucleus organization (GO:0006997),-0.22490994894408362,-0.764861478822045,0.8598326359832636,0.9294611660952314,1.0,14/47,28.55%,SYNE1;RPS19;CHMP2B;NUP93;NDC1;NUP54;NUP155;REEP4;CHMP2A;CEP55;VPS4A;SEH1L;NUP98;CHMP7
prerank,regulation of histone H3-K9 methylation (GO:0051570),0.33445661362136714,0.7643275491568868,0.7626728110599078,0.9705243908087943,1.0,4/10,23.59%,DNMT1;RIF1;DNMT3B;SIRT1
prerank,regulation of oxidative stress-induced cell death (GO:1903201),-0.31919042754086135,-0.7642203488847407,0.7689320388349514,0.9298990223001761,1.0,5/11,28.99%,REST;STK26;PARK7;P4HB;MMP3
prerank,phosphatidylcholine acyl-chain remodeling (GO:0036151),0.2505612160389144,0.7638119424109117,0.817047817047817,0.970513374726854,1.0,2/29,2.58%,PLA2G5;PLA2G4A
prerank,morphogenesis of an epithelial sheet (GO:0002011),-0.3266948590389443,-0.7637981248736609,0.7517857142857143,0.9300291459449241,1.0,3/10,17.87%,NOTCH1;PHACTR4;DLL4
prerank,regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),0.2961042093578281,0.7634957650285787,0.7808510638297872,0.9701859542549077,1.0,7/15,21.86%,TNRC6A;CPEB3;POLR2G;TNRC6B;TOB1;AGO2;TENT4A
prerank,"RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",-0.2936461586961915,-0.763084317405859,0.8028933092224232,0.9305864582926066,1.0,7/15,29.10%,TRPT1;TSEN54;CPSF4;RTCB;RTRAF;TSEN2;ERN1
prerank,nucleosome assembly (GO:0006334),-0.24268374173359875,-0.7629650334728942,0.812962962962963,0.9303080922530473,1.0,10/31,30.02%,H3-3A;NAA60;RBBP4;SOX9;NPM1;KAT6B;HMGB2;ANP32B;ASF1B;SMARCA5
prerank,pseudouridine synthesis (GO:0001522),0.3073618431062217,0.7624489367671102,0.7692307692307693,0.9710239930859287,1.0,5/13,22.80%,RPUSD2;PUS7;PUS1;NHP2;PUS10
prerank,positive regulation of cytokinesis (GO:0032467),-0.23811365458976147,-0.7616759135111536,0.8610567514677103,0.9316338088881058,1.0,6/32,13.18%,PKP4;CDC14A;GIPC1;KIF23;PRKCE;CDC14B
prerank,cochlea morphogenesis (GO:0090103),0.33050073993848056,0.7616437353995034,0.7417218543046358,0.9714559576640607,1.0,1/10,2.25%,TBX18
prerank,positive regulation of protein deacetylation (GO:0090312),0.2970820789135345,0.7611014315083737,0.7516778523489933,0.9714699635836166,1.0,3/14,11.01%,AKAP8L;BRMS1;SAP30BP
prerank,regulation of autophagy of mitochondrion (GO:1903146),-0.2754705788972658,-0.7610320921403653,0.7996146435452793,0.9320392483933758,1.0,8/19,33.91%,HTT;CSNK2A2;FZD5;SREBF1;PARK7;CAMKK2;ATP13A2;HTRA2
prerank,peptidyl-lysine acetylation (GO:0018394),0.31958827590535377,0.7608679077205692,0.7435294117647059,0.9710372443179079,1.0,10/10,68.06%,EP300;KAT5;KAT2B;SIRT1;ESCO1;KAT7;BAG6;BLOC1S1;CREBBP;KAT2A
prerank,chromatin disassembly (GO:0031498),-0.30148587265149873,-0.7608093805362189,0.7814814814814814,0.9313992824712701,1.0,7/14,37.58%,ARID1A;SMARCA4;SMARCC1;SMARCD2;SMARCD3;NFE2;HMGA1
prerank,nucleosome disassembly (GO:0006337),-0.30148587265149873,-0.7608093805362189,0.7814814814814814,0.9313992824712701,1.0,7/14,37.58%,ARID1A;SMARCA4;SMARCC1;SMARCD2;SMARCD3;NFE2;HMGA1
prerank,intracellular protein transmembrane transport (GO:0065002),-0.22518966011774078,-0.7606278051248471,0.867816091954023,0.9311822257920718,1.0,14/42,30.55%,HSPD1;SEC63;HSPA5;TIMM17A;TIMM21;CHCHD4;SEC61B;TIMM50;ZFAND2B;RTN2;SEC61A1;PEX14;PEX6;ROMO1
prerank,autophagy of peroxisome (GO:0030242),-0.30740921187072656,-0.7598987472627036,0.781786941580756,0.9317090844068623,1.0,1/12,3.68%,MAP1LC3B
prerank,"DNA damage response, signal transduction resulting in transcription (GO:0042772)",0.3205168783782347,0.7598841541355308,0.7600849256900213,0.9716940273868384,1.0,4/11,17.96%,RPS6KA6;KAT5;SP100;TP53
prerank,regulation of myoblast fusion (GO:1901739),0.32215987076052766,0.7594283154153673,0.7555555555555555,0.9716280711659423,1.0,2/11,5.08%,CFLAR;IL4
prerank,"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",0.2205247600252529,0.7582487673740358,0.8542094455852156,0.9726107829447466,1.0,3/52,2.63%,SAMD4A;TUT4;DCP1A
prerank,positive regulation of DNA metabolic process (GO:0051054),-0.21101397814779932,-0.7581683113698965,0.8951612903225806,0.9335817155965087,1.0,9/61,9.33%,RPS3;BRCC3;USP7;RGCC;UIMC1;DHX9;BABAM1;TRIM28;USP9X
prerank,cellular senescence (GO:0090398),0.24922804810270915,0.756769581235294,0.8142548596112311,0.973994671356184,1.0,2/27,4.65%,TBX3;MAPKAPK5
prerank,fatty-acyl-CoA biosynthetic process (GO:0046949),-0.24681667758874495,-0.7565156853563405,0.8544423440453687,0.935366421891665,1.0,10/29,27.61%,ELOVL7;ACLY;ELOVL5;ACSL5;PPT2;SLC25A1;ELOVL1;ACSF3;HACD2;GCDH
prerank,regulation of mitochondrion organization (GO:0010821),0.224054107086271,0.7549243953764339,0.8562874251497006,0.9759654923278809,1.0,8/47,14.31%,PID1;OMA1;PRKN;IAPP;PARL;EP300;MAPT;STOX1
prerank,water-soluble vitamin metabolic process (GO:0006767),-0.20238845163222693,-0.7547131047177499,0.8899803536345776,0.9373164574113145,1.0,25/68,29.81%,SLC2A1;MTR;SLC5A6;RFK;CUBN;TPK1;SLC19A3;SLC52A3;MMADHC;SLC2A3;SLC52A2;GSTO2;CD320;NNMT;MTHFS;MCCC1;CYB5R3;MTRR;AOX1;SLC25A19;GSTO1;PANK2;VNN1;SLC23A1;SLC23A2
prerank,intracellular pH reduction (GO:0051452),-0.23593910006303176,-0.75440272910456,0.839622641509434,0.9372696174670272,1.0,8/33,17.11%,ATP6V0B;ATP6V0A2;CLCN3;ATP6V0C;RAB7A;ATP6V1G1;GPR89B;GPR89A
prerank,establishment of mitotic spindle localization (GO:0040001),-0.2476955279952188,-0.7539594819362642,0.8474903474903475,0.9373880592235169,1.0,9/28,24.32%,ZW10;HTT;DCTN1;NDE1;NDEL1;MISP;NDC80;SPDL1;CENPA
prerank,entrainment of circadian clock by photoperiod (GO:0043153),-0.24696651287349697,-0.7537556963738432,0.8102836879432624,0.9372168056098295,1.0,8/27,27.43%,BHLHE40;PPP1CB;MTA1;RBM4B;FBXL3;PPP1CA;SIK1;FBXL8
prerank,C4-dicarboxylate transport (GO:0015740),-0.2921571285628417,-0.7531924502407658,0.8066202090592335,0.937495770848292,1.0,3/14,10.97%,LRRC8D;SLC1A1;SLC25A12
prerank,atrial septum development (GO:0003283),-0.29624185495560784,-0.7525440637738554,0.7851985559566786,0.9378865040847033,1.0,2/13,4.12%,BMPR2;TGFB2
prerank,regulation of G0 to G1 transition (GO:0070316),0.23208684793601775,0.7524136184791895,0.8495934959349594,0.9788431150189142,1.0,7/38,11.57%,UXT;TFDP1;L3MBTL2;RNF2;APAF1;PCGF6;EHMT2
prerank,alcohol catabolic process (GO:0046164),0.3266724417381681,0.751950142492592,0.7721238938053098,0.9786895693876693,1.0,2/10,9.74%,CYP27A1;CYP46A1
prerank,mesenchymal cell development (GO:0014031),-0.27008837193564694,-0.7517115426446997,0.8317929759704251,0.9384579274520306,1.0,7/18,30.11%,NOTCH1;HEYL;PEF1;SNAI2;SOX8;PDCD6;TBX20
prerank,glucan catabolic process (GO:0009251),0.2895804573585542,0.7512123967272201,0.8164948453608247,0.9790043116056357,1.0,3/15,11.58%,PHKA1;STBD1;PYGM
prerank,positive regulation of receptor signaling pathway via STAT (GO:1904894),0.2637989608376451,0.7510682754767685,0.8067940552016986,0.9784262212393985,1.0,7/22,16.36%,KIT;GHR;HES5;ERBB4;OCIAD2;TSLP;CRLF2
prerank,response to peptide (GO:1901652),0.24399424992222563,0.7509575064310674,0.8288100208768268,0.9778000462496931,1.0,5/33,11.50%,STAT5B;GNAI1;CALCR;CHRNA7;EIF2B5
prerank,neurotransmitter biosynthetic process (GO:0042136),0.2972361553528512,0.7508373660757077,0.7447795823665894,0.9771674953245765,1.0,4/14,23.29%,MOXD1;ACHE;SLC22A2;DAGLA
prerank,cyclooxygenase pathway (GO:0019371),-0.3204283345469312,-0.7507994696582687,0.7802197802197802,0.9391975257711215,1.0,3/10,16.72%,PTGDS;PTGS1;CBR1
prerank,negative regulation of protein kinase B signaling (GO:0051898),-0.23036887111095614,-0.7500449029082084,0.862934362934363,0.9397532828883853,1.0,15/38,30.65%,PTPRJ;RACK1;AKT1;CIB1;EPHA2;PHLPP2;PHLDA3;TSC2;TRIB3;BANK1;PDCD6;PPP2R5B;MUL1;XDH;HYAL2
prerank,"retrograde transport, endosome to Golgi (GO:0042147)",0.20086689615617176,0.749628551362718,0.9079497907949791,0.9781574597676631,1.0,23/80,19.24%,RAB9B;VPS26B;UBE2O;GBF1;RAB29;TRIM27;RHOBTB3;BAIAP3;TBC1D10C;PHETA1;VPS50;TBC1D10A;ARL1;TMED9;DENND5A;SNX8;SNX32;GOSR2;EVI5;VAMP3;SNX6;DENND2A;RAB7B
prerank,base conversion or substitution editing (GO:0016553),0.3090360790217949,0.7495420270357039,0.7726269315673289,0.977500183236111,1.0,1/11,3.36%,ADARB2
prerank,protein homotetramerization (GO:0051289),-0.21875681907076577,-0.7490530384208863,0.8776290630975143,0.9405671916790931,1.0,12/49,22.31%,B2M;KCNJ2;GBP5;GLS;SAMHD1;ALDH1A3;CTH;HSD17B10;AQP4;PKD2;ACOT13;UPB1
prerank,cellular response to misfolded protein (GO:0071218),-0.2671127869928674,-0.7487493555385069,0.818348623853211,0.9404850561701219,1.0,4/20,12.80%,DNAJB12;RNF185;VCP;RNF5
prerank,ubiquitin-dependent protein catabolic process (GO:0006511),-0.16107106384976688,-0.7482802890315389,0.9978586723768736,0.9406175343667178,1.0,80/341,23.09%,WWP1;NEDD4L;RNF144B;TRIM25;ZNRF1;WWP2;MVB12B;RLIM;RNF125;ANAPC15;PSMA6;RNF114;ANAPC11;RC3H1;CUL4A;PSMB5;NHLRC3;UBE2L6;KCTD5;PLAA;USP9X;ARRDC1;RNF185;UCHL1;UBE2G2;VCP;TOLLIP;TNFAIP1;PSMC4;MTA1;MAEA;PSMC5;FBXL14;UBXN1;PSMD14;FBXW5;ITCH;RNF5;RNF111;KLHL3;FBXL7;SMURF1;FEM1A;RNF20;RBX1;UBE2G1;TSG101;UBL7;PSMD8;PSMD11;TNFAIP3;ANAPC7;KCTD10;CDC27;PSMB4;PSMD12;PSMC1;FZR1;XBP1;PELI1;RNF19A;ZSWIM8;TBL1X;AMFR;KCTD2;KEAP1;UBE2B;UBA1;PSMA1;ZFAND2B;ANAPC2;CLOCK;PSMB1;PSMC3;BFAR;PSMA4;DTL;PCNP;FBXL19;PSMA2
prerank,glycolipid biosynthetic process (GO:0009247),0.23699071321440257,0.7476492882521056,0.8496868475991649,0.9793509593286424,1.0,12/38,20.47%,ST6GALNAC5;ST3GAL5;ST8SIA1;PIGU;PIGH;PIGP;ST8SIA5;PGAP3;DPM1;PIGN;B4GALT6;MPPE1
prerank,mitotic nuclear membrane disassembly (GO:0007077),0.30722818699127963,0.7473182456042665,0.7876106194690266,0.9790448538840011,1.0,4/12,20.13%,PRKCA;PRKCB;LPIN1;CCNB2
prerank,positive regulation of lymphocyte activation (GO:0051251),-0.24410326897145282,-0.7472759944509074,0.8405253283302064,0.9414659453659641,1.0,13/28,44.21%,CYRIB;PRKDC;HSPD1;NOD2;FGF10;CCL2;TYROBP;TNIP2;IL12A;CCDC88B;TNFSF11;IL23A;IL6
prerank,mitochondrial calcium ion transmembrane transport (GO:0006851),-0.2667689253143226,-0.7470453433444392,0.8285163776493256,0.9412940982137602,1.0,7/20,24.83%,MCUB;MCUR1;PHB2;MICU2;SMDT1;MCU;SLC8B1
prerank,snRNA transcription (GO:0009301),-0.2000472745923205,-0.7464323554701522,0.9119850187265918,0.941599143805441,1.0,25/70,33.24%,RPRD1B;GTF2E1;ZC3H8;INTS8;POU2F1;INTS1;POU2F2;CCNK;GTF2F1;SP1;USPL1;TAF9;NCBP2;ELL;RPRD1A;GTF2F2;INTS12;TAF5;INTS2;POLR2F;INTS3;POLR2L;POLR2I;POLR2C;INTS14
prerank,regulation of chromosome organization (GO:0033044),-0.25855387356826415,-0.745809925553172,0.8220183486238533,0.9419682395650293,1.0,12/22,33.64%,RB1;SHCBP1L;WAPL;SMG1;LIG4;CENPV;TERF2IP;MYC;UPF1;SMG6;PIF1;BUB1
prerank,protein lipidation (GO:0006497),0.21382801213563077,0.7448110136372564,0.91792656587473,0.9817921489467554,1.0,19/59,22.22%,WDR45B;ATG12;WIPI1;PIGU;GLUL;PIGH;PIGP;ATG10;ZDHHC2;PGAP3;PORCN;ZDHHC15;DPM1;PIGN;ZDHHC6;MPPE1;ATG5;WDR45;PIGB
prerank,antibacterial humoral response (GO:0019731),0.28456814421777277,0.7446362992671343,0.7945823927765236,0.9812442322058974,1.0,5/16,22.39%,JCHAIN;ANG;PLA2G6;RNASE3;SLPI
prerank,positive regulation of p38MAPK cascade (GO:1900745),0.2588801223399177,0.744468977643585,0.8126315789473684,0.9807038597853598,1.0,1/22,0.54%,BMP2
prerank,regulation of receptor signaling pathway via STAT (GO:1904892),0.29488503778894465,0.7437789347871029,0.7923627684964201,0.9808975896594578,1.0,4/13,16.36%,PTPRT;PIGU;TSLP;CRLF2
prerank,DNA dealkylation (GO:0035510),0.31599967522248784,0.743757100555748,0.757847533632287,0.9793727412659651,1.0,2/10,9.31%,MPG;FTO
prerank,DNA dealkylation involved in DNA repair (GO:0006307),0.31599967522248784,0.743757100555748,0.757847533632287,0.9793727412659651,1.0,2/10,9.31%,MPG;FTO
prerank,negative regulation of leukocyte cell-cell adhesion (GO:1903038),0.27002309891023957,0.7437235292481449,0.7938388625592417,0.9786447185675022,1.0,2/18,2.69%,PPARA;IL4I1
prerank,regulation of calcium ion-dependent exocytosis (GO:0017158),0.2435055770297134,0.7432404485452497,0.8240343347639485,0.9785125497324956,1.0,10/31,18.84%,CACNA1I;SYT1;CACNA1G;SYT13;STXBP3;SCAMP5;SYT11;SYT12;SYT6;RAB3GAP1
prerank,negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),-0.24542841258072023,-0.7426867922720811,0.8258426966292135,0.9454268685287949,1.0,4/25,12.34%,LIMK2;SLIT2;ABI3;CDK10
prerank,"regulation of gene expression, epigenetic (GO:0040029)",0.2007877415747542,0.7423175377272438,0.9103313840155945,0.9790352357632788,1.0,16/73,15.83%,KDM1B;POLR1A;GLMN;BAZ1B;POLR1G;TRIM27;IGF2;PPM1D;DNMT1;POLR1B;CTCF;EP300;MYBBP1A;EZH2;MYO1C;MTF2
prerank,neuron projection organization (GO:0106027),-0.28360744785830494,-0.7421531132189068,0.7954144620811288,0.9456347040500204,1.0,3/15,10.22%,APP;INSR;DCTN1
prerank,long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),-0.2731716577607526,-0.7413170045749,0.8231046931407943,0.9461984973133877,1.0,6/18,26.94%,ELOVL7;ELOVL5;ACSL5;ELOVL1;ACSF3;HACD2
prerank,mRNA methylation (GO:0080009),0.28141406271110087,0.7413065572048427,0.7806451612903226,0.9796665568087385,1.0,4/15,16.82%,VIRMA;METTL16;METTL3;METTL8
prerank,protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),0.2561582392513557,0.7412924213253651,0.8204545454545454,0.9789048111627239,1.0,5/25,12.49%,OMA1;ATXN3;UFD1;UGGT2;POMT2
prerank,RNA-dependent DNA biosynthetic process (GO:0006278),-0.24340079110465845,-0.7410801967252055,0.8473282442748091,0.9460431276040784,1.0,13/29,35.68%,HSP90AB1;PPIA;DKC1;HSP90AA1;PPP6R3;TNKS1BP1;MRE11;TERF2IP;PIF1;TERT;WRAP53;RAD50;NOP10
prerank,central nervous system neuron development (GO:0021954),-0.27944082073094045,-0.7409327859099565,0.8014981273408239,0.9457728081686059,1.0,2/15,4.08%,HSP90AB1;LHX6
prerank,dendrite self-avoidance (GO:0070593),-0.2825100631521232,-0.7394525152383524,0.8229755178907722,0.9471991027976397,1.0,2/16,4.96%,BSG;ROBO4
prerank,response to X-ray (GO:0010165),-0.2850692223879095,-0.7394143734320336,0.8025594149908593,0.9467897252670946,1.0,5/14,26.71%,ANXA1;BRCC3;IKBIP;NIPBL;LIG4
prerank,cardiac right ventricle morphogenesis (GO:0003215),-0.3057476719613905,-0.7383283446976387,0.8115384615384615,0.9476538501206291,1.0,3/11,16.10%,TGFB2;SOX4;ZFPM2
prerank,negative regulation of translation (GO:0017148),0.1961361046781595,0.7379106172662391,0.9382978723404255,0.9826748446615715,1.0,16/87,16.67%,SAMD4A;ROCK2;DAPK1;IGF2BP2;NANOS3;CPEB3;FTO;DDX6;RIDA;FXR2;METTL16;PUS7;RBM24;METTL3;TOB1;CPEB1
prerank,melanosome organization (GO:0032438),-0.24427565863526077,-0.7373825557549059,0.8404669260700389,0.9484011577607433,1.0,15/26,38.38%,AP3B1;LYST;HPS1;RAB32;DTNBP1;KIF13A;ABCB6;AP1G1;BLOC1S2;BLOC1S6;AP3D1;SHROOM2;BLOC1S1;GPR143;BLOC1S4
prerank,nucleoside phosphate biosynthetic process (GO:1901293),-0.2879838388813043,-0.7371389975743763,0.8130671506352087,0.9482418624273907,1.0,1/14,2.58%,ME1
prerank,positive regulation of histone deacetylation (GO:0031065),-0.29999469999187334,-0.7370637865979591,0.7970749542961609,0.9478741542093547,1.0,5/12,25.67%,CTBP1;VEGFA;NIPBL;PRKD2;APLNR
prerank,protein homooligomerization (GO:0051260),-0.18554150343688905,-0.7368694421703943,0.9663366336633663,0.9476606685375476,1.0,27/114,22.31%,B2M;KCNJ2;EHD4;GBP5;AQP11;ATL3;FUS;ATL2;PRMT8;JMJD6;GLS;SAMHD1;ALDH1A3;MLKL;CTH;NINJ1;HSD17B10;CHMP2A;POLQ;EHD1;AQP4;TRMT61B;ECT2;EHD3;PKD2;ACOT13;UPB1
prerank,tetrapyrrole metabolic process (GO:0033013),-0.269603852762849,-0.7368186815880238,0.8586956521739131,0.9472588675498412,1.0,2/18,4.06%,MTR;CUBN
prerank,regulation of secretion by cell (GO:1903530),0.21256870987715332,0.7363402383696359,0.8823529411764706,0.984006651995858,1.0,14/54,19.63%,RIMS1;RAB3C;CHRNB4;SYT1;CPLX2;RAB10;MCTP2;LLGL1;SCG5;HCRT;VAMP3;HTR1A;RIMS2;STXBP5
prerank,purine-containing compound biosynthetic process (GO:0072522),0.2502092934497084,0.7362182554386546,0.8429203539823009,0.9833834826992741,1.0,3/25,6.90%,AMPD3;PRPSAP2;GMPR
prerank,regulation of supramolecular fiber organization (GO:1902903),0.2580516036509995,0.7357745710000444,0.8303030303030303,0.9832106385470992,1.0,6/22,13.81%,EFEMP2;AEBP1;CAMSAP1;CHRNA7;GBA2;MAPT
prerank,carboxylic acid catabolic process (GO:0046395),-0.2950939734867584,-0.7344741832247923,0.818342151675485,0.9496001619892687,1.0,6/12,29.27%,PON3;ACOT8;AMDHD2;RENBP;BCKDK;GNPDA1
prerank,peptidyl-lysine monomethylation (GO:0018026),-0.31925964126717826,-0.7341807550620385,0.8214285714285714,0.9494874823011318,1.0,5/10,30.37%,SMYD2;KMT5A;SETD2;METTL18;EEF1AKMT2
prerank,recombinational repair (GO:0000725),-0.19039690307313,-0.7339235864724217,0.9441233140655106,0.949340233688948,1.0,29/77,30.52%,ZFYVE26;YY1;SFPQ;PSMD14;SLX4;REV3L;SAMHD1;XRCC1;HUS1;MMS22L;RPA3;BRCA2;AP5Z1;HELQ;POLQ;ERCC4;SFR1;RHNO1;FAN1;POLL;NSMCE1;RAD51AP1;MRE11;SWI5;EXD2;MEIOB;RMI1;RAD52;RECQL
prerank,regulation of complement activation (GO:0030449),-0.22314234508614333,-0.7337971608484819,0.90234375,0.9490236742988611,1.0,7/40,16.97%,CD55;CD81;C1QB;C1QC;PHB2;CFP;C1QA
prerank,mitochondrial membrane organization (GO:0007006),-0.23335569898423508,-0.7335808959203434,0.8754646840148699,0.9488283987196721,1.0,12/32,28.77%,CHCHD3;BCL2L1;BAK1;OPA1;BAD;HSPA9;CHCHD6;TIMM50;SLC25A4;APOO;MICOS13;PMAIP1
prerank,protein import (GO:0017038),-0.18863915700536957,-0.7331362101465764,0.9347408829174664,0.9488888941762137,1.0,23/84,26.54%,RAB8B;NUP93;AKT1;PTTG1IP;E2F3;APOE;SYK;NUP188;TOMM22;HSPA4;PHB2;NUP155;TNPO3;RPAIN;HSP90AA1;TSC2;FIS1;NXT2;TNPO2;FAM53A;SEC13;NUP107;IPO13
prerank,regulation of mitotic spindle organization (GO:0060236),0.23390930088062137,0.7328531799102724,0.874251497005988,0.9863519878464941,1.0,9/35,19.01%,GNAI1;MAP9;BORA;CHMP1A;FSD1;PARP3;NUMA1;DRG1;NUP62
prerank,muscle cell migration (GO:0014812),-0.3175209237947008,-0.7321995794607296,0.7981651376146789,0.9495552946745954,1.0,2/10,3.90%,CCN3;SIX1
prerank,positive regulation of mitochondrial fission (GO:0090141),-0.2670263753627046,-0.7318569915829217,0.8192307692307692,0.9494962252664187,1.0,8/18,31.12%,KDR;MIEF1;MIEF2;FIS1;MCU;MFF;MUL1;AURKA
prerank,purine nucleotide biosynthetic process (GO:0006164),-0.304966707647088,-0.7314392530546661,0.8283185840707965,0.9495277727962516,1.0,3/12,11.38%,PRPS2;PRPS1;PRPS1L1
prerank,negative regulation of transferase activity (GO:0051348),-0.23906900828807093,-0.7294221561733053,0.8643410852713178,0.9514200953512845,1.0,12/28,32.96%,SMAD7;CDKN1B;BAG5;LIMK1;ERCC4;EIF4A2;DTX3L;CDKN1C;PARK7;SRC;PIF1;ABL1
prerank,phospholipid metabolic process (GO:0006644),0.20312754560439478,0.7292640356338285,0.919917864476386,0.9903031834292975,1.0,11/71,14.65%,PLA2G5;PIP4K2A;PLA2G4A;PLPP3;PLPPR1;PLBD2;LGALS13;PIP4K2B;GNPAT;FADS1;PLPPR5
prerank,negative regulation of gluconeogenesis (GO:0045721),0.3166315326294941,0.7289955853894247,0.7956989247311828,0.9898418278010267,1.0,2/11,13.45%,CRY1;EP300
prerank,regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),0.23607477733760546,0.7283536135876422,0.8402625820568927,0.9898969732761296,1.0,7/32,16.63%,CDK14;TFDP1;NPAT;ORC1;CDK16;BACH1;FBXO5
prerank,PERK-mediated unfolded protein response (GO:0036499),-0.3162669987607187,-0.7283049549177725,0.8153310104529616,0.9522967528408252,1.0,2/10,11.03%,ATF4;HSPA5
prerank,nuclear envelope organization (GO:0006998),-0.25524945262385756,-0.7282311642669553,0.8481973434535104,0.9519268283014262,1.0,5/20,17.34%,NUP93;TOR1AIP1;TMEM43;NUP155;REEP4
prerank,nuclear membrane organization (GO:0071763),0.2636513786802473,0.7277304518467703,0.8222698072805139,0.9898927941540374,1.0,5/19,16.30%,AKAP8L;UBXN2B;UBXN2A;SPAST;EMD
prerank,regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),0.27062878839582694,0.7277226361264285,0.8134490238611713,0.9891224223733761,1.0,6/17,22.17%,CTNNA2;GMFB;BRK1;FCHSD2;WASF1;ABI2
prerank,secondary alcohol metabolic process (GO:1902652),0.2273490648300241,0.7275728039346481,0.8734439834024896,0.9885352948121582,1.0,5/42,9.35%,ABCA1;CYP27A1;IL4;ABCA5;SCAP
prerank,tRNA wobble uridine modification (GO:0002098),-0.2853328808272044,-0.7273651288591554,0.8348457350272233,0.9524572902020123,1.0,3/14,13.54%,DPH3;TRMT9B;URM1
prerank,regulation of phosphatase activity (GO:0010921),0.2500362105043968,0.7271839459408468,0.8408602150537634,0.9882281645193562,1.0,1/24,0.54%,BMP2
prerank,rRNA transcription (GO:0009303),0.278284793766585,0.7269649392406115,0.8108108108108109,0.98772992406652,1.0,6/17,14.66%,POLR1G;GTF3C3;ANG;GTF3C2;GTF3C6;GTF3C4
prerank,regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836),-0.30787420053213416,-0.7267426300895352,0.839572192513369,0.9526855519166828,1.0,3/11,20.79%,NCL;SMARCA4;PWP1
prerank,positive regulation of oxidoreductase activity (GO:0051353),0.268843677703248,0.7260500654059197,0.8264840182648402,0.9881090300945418,1.0,2/18,3.41%,GDNF;POR
prerank,nuclear pore complex assembly (GO:0051292),0.3099187056946435,0.7258742916572852,0.7910112359550562,0.9875402557375274,1.0,4/10,17.19%,RTN4;NUP205;AHCTF1;TMEM170A
prerank,synaptic vesicle membrane organization (GO:0048499),-0.2612026341897754,-0.7252845719248533,0.8435754189944135,0.9539134636555773,1.0,3/17,11.05%,STX3;STX1A;STX2
prerank,regulation of nuclear division (GO:0051783),-0.25939458375071645,-0.7238684481526118,0.8520599250936329,0.9550346271245462,1.0,6/20,21.07%,CAV2;CDK13;L3MBTL1;PIN1;RCC1;MKI67
prerank,histone H3-K4 trimethylation (GO:0080182),0.296205700359624,0.7227104698730502,0.8013100436681223,0.9908279438411141,1.0,3/11,15.53%,PRDM9;KMT2A;WDR82
prerank,regulation of mitochondrial membrane potential (GO:0051881),-0.21826419070257946,-0.7222959848830063,0.8973384030418251,0.9563597494640039,1.0,11/40,18.64%,ARL6IP5;UBB;BAX;AKT1;VCP;BCL2L1;BAK1;ATP5IF1;TUSC2;BAD;SLC25A33
prerank,cellular response to fibroblast growth factor stimulus (GO:0044344),0.19173830667751282,0.7220529652680246,0.9496981891348089,0.9908740821509511,1.0,5/87,4.24%,FLRT2;FGFR2;KL;FLRT1;SFRP1
prerank,G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),0.26899524690364573,0.7213585098134513,0.8354430379746836,0.9909861594439531,1.0,4/18,11.73%,CHRM2;CHRM3;CDK5R1;GNA15
prerank,ER-associated misfolded protein catabolic process (GO:0071712),-0.30378530533332854,-0.7213537937002614,0.8326996197718631,0.9569196138604579,1.0,3/11,12.80%,RNF185;VCP;RNF5
prerank,tRNA 5'-end processing (GO:0099116),-0.2732357263807431,-0.7204091763232342,0.8568872987477638,0.9575242801536322,1.0,5/15,25.51%,RPP38;TRMT10C;HSD17B10;RPP21;RPP25L
prerank,fatty acid transmembrane transport (GO:1902001),0.25928271065184394,0.7199085407419168,0.8160676532769556,0.9920130054320356,1.0,3/19,6.82%,PRKAG2;ABCD2;CPT2
prerank,regulation of amyloid precursor protein catabolic process (GO:1902991),0.2905633944754696,0.7186836964101634,0.815068493150685,0.9927204561411551,1.0,3/12,11.12%,ROCK2;TMED10;CHRNA7
prerank,kinetochore organization (GO:0051383),-0.285463273056762,-0.7185990095892489,0.8436363636363636,0.9590750751243688,1.0,6/13,34.33%,POGZ;NDC80;CENPF;CENPA;NUF2;CENPW
prerank,mitotic cell cycle checkpoint signaling (GO:0007093),-0.24597809203984053,-0.7184896778871322,0.8660377358490566,0.9587307895866828,1.0,8/23,26.02%,ZW10;PLK2;PABIR1;CHEK1;CDK5RAP3;PLK3;VPS4A;PLK5
prerank,negative regulation of endocytosis (GO:0045806),-0.24428313513809513,-0.7183732210471476,0.8614232209737828,0.9583917415770876,1.0,2/24,4.56%,CAV1;RAC1
prerank,arachidonate transport (GO:1903963),0.30481419936431103,0.7179701835584417,0.8043010752688172,0.9920836126449939,1.0,1/10,2.09%,PLA2G5
prerank,arachidonic acid secretion (GO:0050482),0.30481419936431103,0.7179701835584417,0.8043010752688172,0.9920836126449939,1.0,1/10,2.09%,PLA2G5
prerank,cytoplasmic microtubule organization (GO:0031122),-0.20219930480178394,-0.7178831351606724,0.9415094339622642,0.9584493668625194,1.0,9/54,11.72%,RAB11A;LIMK2;CHP1;EZR;SLAIN2;DCTN1;TRPV4;CIB1;PCM1
prerank,retinol metabolic process (GO:0042572),0.2879872343040557,0.717622384401424,0.790948275862069,0.9917346841164679,1.0,1/14,2.06%,DHRS3
prerank,RNA 3'-end processing (GO:0031123),-0.19255015349635435,-0.7168716711124913,0.9435483870967742,0.9591090801559647,1.0,20/69,26.91%,RPRD1B;SRSF2;SRSF5;SRSF6;U2AF1;ZC3H11A;RNPS1;SRSF4;MAGOH;CHTOP;ALYREF;DDX39B;CASC3;THOC6;CPSF4;DDX39A;NCBP2;CSTF2T;THOC7;RPRD1A
prerank,cellular polysaccharide catabolic process (GO:0044247),0.27114834729711895,0.7161957101401556,0.843298969072165,0.992688653815448,1.0,3/16,11.58%,PHKA1;STBD1;PYGM
prerank,tail-anchored membrane protein insertion into ER membrane (GO:0071816),-0.26548431229957453,-0.7160410887858161,0.8234234234234235,0.9595742637105296,1.0,6/17,26.39%,CAMLG;EMC10;SGTA;EMC6;EMC9;EMC1
prerank,protein autoprocessing (GO:0016540),-0.26689143753589417,-0.7157693515205593,0.8537477148080439,0.9594042259485639,1.0,7/17,33.91%,FAM111A;SPRTN;FXN;CASP1;MYRF;PIDD1;HTRA2
prerank,negative regulation of protein-containing complex assembly (GO:0031333),-0.2062497258735284,-0.7145872664376937,0.9147727272727273,0.9602404790442688,1.0,8/49,11.49%,JAM3;PRKCZ;SMAD6;AIDA;SVIP;RPL13A;HSPA5;IMPACT
prerank,positive regulation of calcium-mediated signaling (GO:0050850),-0.2978652518078624,-0.7138751740156419,0.8333333333333334,0.9605064849211559,1.0,1/11,1.59%,PLCG2
prerank,regulation of protein modification by small protein conjugation or removal (GO:1903320),0.2553050310536592,0.7133551714040504,0.8459869848156182,0.9952804986894243,1.0,3/20,7.96%,EPAS1;PRKN;TGFBR1
prerank,oligodendrocyte differentiation (GO:0048709),-0.25430397948986244,-0.7133032546667478,0.8555347091932458,0.9606613372704041,1.0,7/19,25.38%,SOX13;EIF2B3;SOX6;SOX9;MYRF;SOX8;NSUN5
prerank,protein acetylation (GO:0006473),-0.22954272719770774,-0.7129618372527738,0.8946459412780656,0.960568808267059,1.0,11/30,36.55%,FOXO1;ING5;NAA60;CLOCK;DSCC1;NAT9;NAA50;NAA80;CREBBP;ESCO2;BLOC1S1
prerank,regulation of plasma membrane bounded cell projection organization (GO:0120035),-0.23815533553420326,-0.7125540338725637,0.8838095238095238,0.9605426270406494,1.0,11/27,27.05%,AKT1;DISC1;ULK4;HOMER1;NDEL1;MBOAT1;BRSK2;EFHC2;CCDC88A;TREM2;CAMK2G
prerank,regulation of autophagosome assembly (GO:2000785),0.22579496400565002,0.7123468527033889,0.8688524590163934,0.9956885392832413,1.0,3/33,4.38%,PIP4K2A;PHF23;SCFD1
prerank,regulation of retinoic acid receptor signaling pathway (GO:0048385),-0.2959878478923617,-0.7122965605864795,0.8327205882352942,0.9603346140029088,1.0,2/12,7.90%,KLF2;TRIM16
prerank,regulation of immune effector process (GO:0002697),-0.21378639465067453,-0.7120082247257062,0.9089147286821705,0.960160982095067,1.0,7/41,16.97%,CD55;CD81;C1QB;C1QC;PHB2;CFP;C1QA
prerank,glycogen metabolic process (GO:0005977),0.24199781473495396,0.7119519969244553,0.8784648187633263,0.9954164289551573,1.0,4/27,11.58%,PRKAG2;PHKA1;STBD1;PYGM
prerank,fatty acid metabolic process (GO:0006631),0.1826135484505962,0.7119110370688515,0.9523809523809523,0.9946875392932102,1.0,19/115,15.12%,PPARA;ALOX12;ACSM5;ACADSB;ACSL1;BAAT;CPT1C;MSMO1;ABCD2;CPT2;ACOT11;HPGD;LPIN3;NDUFAB1;GNPAT;MCAT;ACSL6;ACACA;NUDT19
prerank,N-acetylglucosamine metabolic process (GO:0006044),-0.27359987490808324,-0.7116878160757542,0.855072463768116,0.960035783245881,1.0,7/15,29.27%,AMDHD2;OGA;RENBP;LARGE1;CHST5;CHST3;GNPDA1
prerank,regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),0.28091750249055425,0.7111624049456722,0.827433628318584,0.9947957107755578,1.0,2/13,10.21%,NFAT5;FUT9
prerank,regulation of leukocyte activation (GO:0002694),-0.27660200634648985,-0.7107622792262209,0.8342059336823735,0.9605563246291805,1.0,8/14,36.97%,MFHAS1;GPR137B;CD74;CD200;SHPK;PJA2;CD33;GPER1
prerank,negative regulation of ATPase activity (GO:0032780),0.2694601612421384,0.7105775932627659,0.8506787330316742,0.9947437802707335,1.0,6/16,23.59%,TNNI3;TP53;PAM16;VCPKMT;PXK;SIRT1
prerank,dendritic cell chemotaxis (GO:0002407),0.278759793949372,0.710485165604698,0.8013100436681223,0.9940863301797571,1.0,2/14,13.93%,CCR6;CXCR4
prerank,neuron remodeling (GO:0016322),-0.306873339442696,-0.7103632918695916,0.8352059925093633,0.9605090801212337,1.0,3/10,8.12%,SCARF1;APP;ANKS1A
prerank,regulation of DNA recombination (GO:0000018),0.2312476719561481,0.7097696621684466,0.8814317673378076,0.994146227168487,1.0,6/32,14.73%,SHLD2;IL4;BLM;RPA2;THOC1;SIRT6
prerank,negative regulation of T cell mediated immunity (GO:0002710),0.3005505359958178,0.7097095659050205,0.8004434589800443,0.9934463240615746,1.0,2/11,11.53%,IL4I1;AHR
prerank,central nervous system myelination (GO:0022010),0.2931753851022545,0.7093389414421309,0.8231441048034934,0.993102531729392,1.0,4/11,19.34%,HES5;PTEN;TENM4;B4GALT6
prerank,negative regulation of translational initiation (GO:0045947),-0.28429215189697793,-0.7092223818516714,0.8445229681978799,0.9612655702046324,1.0,4/13,26.81%,FMR1;PAIP2B;EIF4EBP1;PAIP2
prerank,positive regulation of cation transmembrane transport (GO:1904064),-0.21568861911533,-0.7089824382288606,0.9285714285714286,0.9610529339885107,1.0,7/41,13.50%,KCNJ2;KCNQ1;KCNJ10;ACE2;AKAP6;KCNJ15;GNB1
prerank,metallo-sulfur cluster assembly (GO:0031163),-0.24650018078993613,-0.7088588547882791,0.8892857142857142,0.960721466418085,1.0,9/22,27.36%,FXN;GLRX5;ISCA2;HSPA9;CIAO3;NFU1;ISCA1;CIAPIN1;IBA57
prerank,regulation of gluconeogenesis (GO:0006111),-0.23177721462220768,-0.7086607174429476,0.8665413533834586,0.9604546678093349,1.0,12/27,43.02%,PPARGC1A;USP7;NNMT;ARPP19;SIK1;PTPN2;GNMT;SIRT7;DDB1;CLK2;C1QTNF3;ERFE
prerank,negative regulation of protein localization to cell periphery (GO:1904376),0.25360733275909353,0.7085401095783246,0.8524590163934426,0.9932320647694705,1.0,6/20,18.27%,PID1;LZTFL1;SAPCD2;RHOQ;DAB2;MRAP2
prerank,autophagy of mitochondrion (GO:0000422),0.2204875851019545,0.7082536257085362,0.9177489177489178,0.9928000232166394,1.0,9/38,16.55%,WDR45B;PRKN;ATG12;WIPI1;FBXO7;ULK2;FUNDC1;FUNDC2;ATG9A
prerank,lipid homeostasis (GO:0055088),0.20472629794580327,0.7063397621936576,0.9422680412371134,0.9941905851295538,1.0,11/57,20.42%,ZBTB20;ABCA1;IRS2;ABCB4;TLCD2;DGAT2;ABHD5;MLXIPL;PPARG;POLD1;NR1D2
prerank,microtubule polymerization (GO:0046785),-0.23168653338825987,-0.7058467602406469,0.9020408163265307,0.9628784175468468,1.0,9/28,29.62%,SLAIN2;TRPV4;NDE1;NDEL1;PIN1;TPX2;MAP7D3;TUBG2;TUBGCP6
prerank,fatty acid biosynthetic process (GO:0006633),-0.1947063985366061,-0.7057808001278363,0.9491869918699187,0.9624936087701447,1.0,10/63,17.96%,ABHD2;ELOVL7;LTA4H;ACLY;ASAH2;ELOVL5;TECRL;GPX4;XBP1;ELOVL1
prerank,regulation of mRNA 3'-end processing (GO:0031440),0.28527516887695636,0.7050240254355528,0.8274231678486997,0.9948872176498879,1.0,6/11,28.42%,ZC3H3;PAPOLA;PAF1;ZFP36L1;LEO1;AHCYL1
prerank,microtubule bundle formation (GO:0001578),-0.2074689170442153,-0.7039015061361749,0.9216867469879518,0.9639474428444271,1.0,13/42,32.27%,NAV1;RP1;CHP1;SPEF1;GAS8;GAS2L1;SPAG16;CLIP1;NCKAP5L;CAPN6;PLK1;PSRC1;CFAP206
prerank,regulation of cellular amide metabolic process (GO:0034248),-0.22237569471401214,-0.703658069614316,0.9131274131274131,0.9637228073867801,1.0,3/32,4.11%,RPL10;FOXO3;APP
prerank,stress granule assembly (GO:0034063),-0.24829652295345983,-0.7036336682638825,0.8787878787878788,0.9632955224206785,1.0,6/20,20.99%,RPS23;ATXN2L;YTHDF2;CIRBP;LSM14A;YTHDF1
prerank,calcium ion transmembrane import into cytosol (GO:0097553),0.2170789337105452,0.703489375171209,0.886,0.9958303477454808,1.0,5/41,8.94%,SLC8A1;ITPR1;CACNA2D1;IBTK;SLC24A2
prerank,purine ribonucleoside monophosphate metabolic process (GO:0009167),-0.251345889581821,-0.7025231808838297,0.8654205607476636,0.963988166836583,1.0,3/20,8.25%,PAICS;ADSS2;IMPDH1
prerank,cellular response to interleukin-7 (GO:0098761),0.2647242034298002,0.702441705170179,0.8414096916299559,0.9954824403111778,1.0,5/17,16.36%,STAT5B;IRS2;BRWD1;TSLP;CRLF2
prerank,interleukin-7-mediated signaling pathway (GO:0038111),0.2647242034298002,0.702441705170179,0.8414096916299559,0.9954824403111778,1.0,5/17,16.36%,STAT5B;IRS2;BRWD1;TSLP;CRLF2
prerank,nuclear pore organization (GO:0006999),0.2735614061466583,0.702436017362259,0.8013100436681223,0.9947292418379741,1.0,5/14,17.19%,RTN4;NUP205;NUP35;AHCTF1;TMEM170A
prerank,cellular lipid catabolic process (GO:0044242),-0.22969881781782805,-0.7017600675107881,0.8785714285714286,0.964306619621336,1.0,9/27,29.73%,PPARD;CYP1B1;ACADL;FAAH;ACOT8;ENPP2;ACOX1;LPIN2;MGST2
prerank,regulation of mast cell degranulation (GO:0043304),-0.2707521766879313,-0.7015376004367464,0.8665480427046264,0.9640800832910462,1.0,6/14,24.01%,SPHK2;SYK;GAB2;CD84;LGALS9;STXBP2
prerank,histone mRNA metabolic process (GO:0008334),-0.2305145340816588,-0.701457231624955,0.8951310861423221,0.963701362379486,1.0,8/27,24.84%,ERI1;SNRPD3;LSM11;SNRPG;LSM1;NCBP2;LSM10;SNRPB
prerank,snRNA transcription by RNA polymerase II (GO:0042795),-0.18963552350519028,-0.7013286215616148,0.9694656488549618,0.9633757470957304,1.0,24/69,33.24%,RPRD1B;GTF2E1;ZC3H8;INTS8;POU2F1;INTS1;POU2F2;CCNK;GTF2F1;SP1;TAF9;NCBP2;ELL;RPRD1A;GTF2F2;INTS12;TAF5;INTS2;POLR2F;INTS3;POLR2L;POLR2I;POLR2C;INTS14
prerank,"negative regulation of DNA-templated transcription, elongation (GO:0032785)",-0.27068649941059175,-0.7008260862064322,0.8511029411764706,0.9634012155621835,1.0,3/13,28.45%,NELFE;EAPP;RNF8
prerank,chromatin assembly or disassembly (GO:0006333),-0.2943087657131034,-0.7005080469467068,0.8388998035363457,0.9632352214546687,1.0,3/11,16.41%,MTA2;CDAN1;RBBP4
prerank,"DNA-templated transcription, termination (GO:0006353)",0.19668966207832778,0.700356576745438,0.9507186858316222,0.9962856662537969,1.0,12/68,14.53%,POLR1A;GTF2H2;MNAT1;FIP1L1;POLR1G;SYMPK;POLR1B;PABPN1;CCNH;SCAF8;TTF1;CPSF7
prerank,protein kinase A signaling (GO:0010737),-0.2848651497002592,-0.7000717059973177,0.8465909090909091,0.9632268697867006,1.0,2/12,6.47%,MYOM1;EZR
prerank,regulation of cell projection organization (GO:0031344),-0.2777094504079734,-0.6998750506680514,0.8553571428571428,0.962959574593718,1.0,10/13,57.33%,MFSD2A;TREM2;ERMN;NTNG1;MOV10;SEMA4D;NTNG2;FAM110C;MACF1;CCL19
prerank,covalent chromatin modification (GO:0016569),0.2711762381614976,0.6998129084892727,0.8547008547008547,0.996112724308582,1.0,4/14,17.00%,MBD2;AURKC;SETD5;HDAC1
prerank,regulation of mitochondrial membrane permeability (GO:0046902),-0.25643871368456506,-0.6994571956265538,0.8616822429906542,0.9629116228972724,1.0,10/18,39.61%,BCL2L1;BAK1;BAD;SLC25A4;ALKBH7;MUL1;PMAIP1;HEBP2;SLC25A31;PPIF
prerank,mRNA stabilization (GO:0048255),0.2122851631814673,0.6991690773212672,0.921443736730361,0.9960565419466685,1.0,3/40,5.19%,GDNF;TENT5A;AXIN2
prerank,"tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",-0.2728784084237295,-0.6983714040058171,0.8576449912126538,0.9635067296212065,1.0,6/14,28.14%,TRPT1;TSEN54;CPSF4;RTCB;RTRAF;TSEN2
prerank,peptidyl-asparagine modification (GO:0018196),-0.22338329048942085,-0.6981149750556949,0.9051094890510949,0.9633147876022234,1.0,14/31,35.82%,ST6GAL1;MGAT1;FUT8;DAD1;OST4;MCFD2;MGAT5;HIF1AN;RPN2;STT3B;OSTC;NUDT14;RPN1;UGGT1
prerank,regulation of lipid catabolic process (GO:0050994),0.2518839487565937,0.6978372932386899,0.8680089485458613,0.9967244660975201,1.0,19/19,74.84%,PDE3B;ALK;RARRES2;ANGPTL3;APOC3;SCT;LONP2;APOA2;IL1B;PRKAA1;HCAR2;ABCB11;TNF;ABCD1;CIDEA;ADRA2A;TYSND1;BSCL2;APOC1
prerank,regulation of nervous system process (GO:0031644),-0.25673195881291294,-0.6967303237866115,0.8596153846153847,0.9641708299132198,1.0,2/18,4.11%,NOS3;APP
prerank,regulation of hippo signaling (GO:0035330),-0.2551835931708606,-0.6964123587436204,0.8784530386740331,0.9640194913180399,1.0,7/17,30.86%,MOB3B;WTIP;LIMD1;CIT;WWC2;MARK3;NF2
prerank,regulation of cAMP-mediated signaling (GO:0043949),-0.23444773227201468,-0.695231496362807,0.9063097514340345,0.9646676081793305,1.0,7/24,20.92%,PDE4D;PDE2A;PRKAR2B;PRKAR2A;CGAS;UBE2B;RAPGEF2
prerank,protein methylation (GO:0006479),-0.2084095702211217,-0.6946771711538057,0.933456561922366,0.9647084167302157,1.0,13/40,30.37%,PRMT8;SNRPD3;FAM98A;EEF2KMT;ICMT;PRMT3;LCMT1;NTMT1;SNRPB;ATPSCKMT;EEF1AKMT3;RAB6A;EEF1AKMT2
prerank,transcription elongation from RNA polymerase II promoter (GO:0006368),-0.18792515862957068,-0.6940723750344664,0.9620493358633776,0.9648423173287406,1.0,18/62,32.29%,MLLT3;AFF4;GTF2H3;NELFE;CDK13;CCNK;GTF2F1;TCEA1;GTF2H4;ELOB;NCBP2;ELL;SETD2;GTF2F2;POLR2F;POLR2L;POLR2I;POLR2C
prerank,long-term synaptic potentiation (GO:0060291),-0.24245992346505285,-0.6939690558650008,0.8558052434456929,0.9644807002900554,1.0,3/21,8.12%,PTK2B;PRKCZ;PLK2
prerank,negative regulation of phagocytosis (GO:0050765),0.26325870684905417,0.693802104683295,0.8789808917197452,1.0,1.0,4/17,15.94%,PRTN3;CD300LF;CD47;SYT11
prerank,positive regulation of vacuole organization (GO:0044090),0.29682387632053936,0.6936037525340525,0.8152866242038217,0.999658912733289,1.0,4/10,18.84%,PIP4K2A;PIP4K2B;LRSAM1;RAB3GAP1
prerank,embryonic axis specification (GO:0000578),0.2713758326471697,0.6931599840466414,0.8369565217391305,0.9993360122283014,1.0,2/15,7.51%,TBX3;CXXC4
prerank,regulation of synapse maturation (GO:0090128),-0.29077534287168866,-0.6928344918491458,0.8532608695652174,0.965077658911379,1.0,3/10,12.13%,ARHGEF15;DAB2IP;YWHAZ
prerank,regulation of mitotic spindle assembly (GO:1901673),-0.2569085261335444,-0.6927160080302585,0.8654205607476636,0.964741390558954,1.0,7/19,32.16%,CHMP2B;HSPA1A;CHMP2A;HSPA1B;EML3;PLK1;CHMP4B
prerank,peroxisome organization (GO:0007031),-0.23321544148776446,-0.6924319926675625,0.9035916824196597,0.9645662399873747,1.0,11/25,33.99%,PLAAT3;ACOT8;FIS1;PEX11G;PEX11A;SEC16B;PEX14;MFF;PEX6;ABCD3;PEX7
prerank,phosphate ion transmembrane transport (GO:0035435),0.27156873953544586,0.6922582376283953,0.8559498956158664,0.9995224448725303,1.0,3/12,15.24%,SLC20A2;SLC25A10;SLC25A30
prerank,regulation of regulated secretory pathway (GO:1903305),0.22242625243186917,0.6917509855038867,0.9175946547884187,0.9992638557481154,1.0,9/34,20.30%,RIMS1;SYT1;SYT13;SNAPIN;SYT11;SYT12;SYT6;RIMS2;UNC13D
prerank,histone H3-K9 demethylation (GO:0033169),-0.2924385261482678,-0.6916329963920973,0.8576642335766423,0.9648526129703225,1.0,2/11,6.71%,JMJD1C;KDM3A
prerank,"negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)",-0.29180868408277577,-0.691324143334346,0.8645038167938931,0.9646717029601474,1.0,3/11,20.27%,CBFB;VSIR;LGALS9
prerank,negative regulation of TOR signaling (GO:0032007),0.21623550823110285,0.6910819872184222,0.9195652173913044,0.9991839291764111,1.0,3/36,4.65%,DEPTOR;FNIP1;MAPKAPK5
prerank,negative regulation of phosphoprotein phosphatase activity (GO:0032515),-0.24032205607610785,-0.690590964361664,0.8833922261484098,0.9649177482370922,1.0,10/22,37.76%,FKBP1A;IKBKB;BOD1;MGAT5;STYXL1;PPP1R1B;CRY2;FKBP1B;PTPA;ROCK1
prerank,DNA biosynthetic process (GO:0071897),-0.25838720095537016,-0.6898090435515778,0.8966165413533834,0.9651886260032452,1.0,9/16,42.41%,PPIA;TYMS;RFC3;POLL;TERT;POLE;POLA1;POLH;WRN
prerank,monosaccharide transmembrane transport (GO:0015749),0.2526238682764408,0.6891402706139702,0.8688888888888889,1.0,1.0,1/16,2.70%,SLC5A3
prerank,RNA catabolic process (GO:0006401),-0.20367771510598967,-0.6888058922895871,0.9344569288389513,0.9656543239473909,1.0,18/46,33.10%,MTREX;PPP1R8;DIS3L2;YTHDF2;RNH1;HSPA1A;LSM2;ZPR1;RNASEH2C;HSPA1B;DNA2;ERN1;XRN2;LSM6;ISG20;SIDT2;ZC3H12D;DCP2
prerank,positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),-0.277192770180382,-0.6887874878674877,0.8479020979020979,0.9643258698914184,1.0,4/12,16.23%,ANAPC11;RB1;ANAPC7;CDC27
prerank,positive regulation of mitotic metaphase/anaphase transition (GO:0045842),-0.277192770180382,-0.6887874878674877,0.8479020979020979,0.9643258698914184,1.0,4/12,16.23%,ANAPC11;RB1;ANAPC7;CDC27
prerank,positive regulation of mitotic sister chromatid separation (GO:1901970),-0.277192770180382,-0.6887874878674877,0.8479020979020979,0.9643258698914184,1.0,4/12,16.23%,ANAPC11;RB1;ANAPC7;CDC27
prerank,regulation of neuronal synaptic plasticity (GO:0048168),0.23181094971760866,0.6875066186485499,0.8867102396514162,1.0,1.0,8/29,16.40%,SHISA9;GRIK2;CAMK2B;SYP;ZDHHC2;DLG4;DRD2;CLN3
prerank,ether lipid metabolic process (GO:0046485),0.26874939902368783,0.6874932714104575,0.8526785714285714,1.0,1.0,1/14,1.30%,AGMO
prerank,histone H2B ubiquitination (GO:0033523),-0.28873677882979976,-0.6868455151537887,0.8703374777975134,0.9656476121477531,1.0,5/10,35.80%,RNF20;DTX3L;RNF40;RNF8;CDC73
prerank,sensory perception of taste (GO:0050909),0.2892110713613255,0.6855554947235133,0.8214285714285714,1.0,1.0,10/10,71.10%,ASIC2;TAS1R1;PKD1L3;PKD2L1;TAS1R3;GNAT3;ASIC1;TAS1R2;ASIC3;CD36
prerank,protein N-linked glycosylation via asparagine (GO:0018279),-0.2217592319980416,-0.684129670555984,0.9227941176470589,0.9676455694583804,1.0,6/30,14.58%,ST6GAL1;MGAT1;FUT8;DAD1;OST4;MCFD2
prerank,protein import into peroxisome matrix (GO:0016558),0.27958069173309913,0.6841242563035106,0.8516949152542372,1.0,1.0,12/12,72.06%,PEX5L;PEX10;PEX2;PEX16;PEX5;PEX12;PEX1;PEX26;PEX13;PEX7;PEX6;PEX14
prerank,negative regulation of leukocyte apoptotic process (GO:2000107),0.28785868350086474,0.6839101958579228,0.8422273781902552,1.0,1.0,3/11,18.42%,AXL;MERTK;CXCL12
prerank,regulation of T cell mediated immunity (GO:0002709),-0.29275461528956565,-0.6838213137668632,0.8558875219683656,0.9674630549503916,1.0,1/10,7.20%,TNFRSF1B
prerank,iron-sulfur cluster assembly (GO:0016226),-0.23117962399552452,-0.6837931945860004,0.9090909090909091,0.9670395216794189,1.0,9/24,27.36%,FXN;GLRX5;ISCA2;HSPA9;CIAO3;NFU1;ISCA1;CIAPIN1;IBA57
prerank,regulation of protein acetylation (GO:1901983),-0.2803104342892871,-0.6834916704056385,0.8665511265164645,0.9668420590548414,1.0,4/12,29.01%,CAMK1;RAPGEF3;PARK7;TERF2IP
prerank,positive regulation of double-strand break repair (GO:2000781),0.2155848094180393,0.6829155845368886,0.936542669584245,1.0,1.0,9/39,17.74%,SHLD2;SETMAR;KMT5C;FMN2;SMCHD1;RIF1;KMT5B;PARP3;PARP1
prerank,mitochondrial transport (GO:0006839),0.2004420253326261,0.6827592289340465,0.9409368635437881,1.0,1.0,10/53,15.83%,AIP;BCL2;SLC25A13;MTX2;TOMM70;FBXO7;COX18;TIMM22;SLC25A24;MAIP1
prerank,regulation of microtubule cytoskeleton organization (GO:0070507),0.210181884779367,0.6825942467306817,0.9408033826638478,1.0,1.0,2/37,2.58%,PHLDB2;EPHA3
prerank,negative regulation of interleukin-17 production (GO:0032700),-0.29458159765554054,-0.6822647520145398,0.8771593090211133,0.9674849707684251,1.0,2/10,17.36%,TLR4;VSIR
prerank,pre-mRNA cleavage required for polyadenylation (GO:0098789),0.27488717547424535,0.6822233242372966,0.8325688073394495,1.0,1.0,5/13,23.01%,FIP1L1;CPSF4L;CPSF7;CPSF6;NUDT21
prerank,B cell activation involved in immune response (GO:0002312),0.26716886377903326,0.6815577676350458,0.8363636363636363,1.0,1.0,13/13,73.30%,CD180;EXOSC3;RNF168;GPR183;CD40LG;GAPT;CD19;MSH2;BATF;MSH6;FCGR2B;RNF8;LIG4
prerank,dorsal/ventral pattern formation (GO:0009953),0.24583458574472172,0.6810113811648085,0.8600823045267489,1.0,1.0,3/20,9.35%,GLI2;SFRP1;BMPR1A
prerank,fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),-0.26728021964278215,-0.68089984109011,0.8849056603773585,0.9682116372822072,1.0,3/14,16.01%,ACOX3;CROT;ACOT8
prerank,primary miRNA processing (GO:0031053),0.2947394263502144,0.6801936188608758,0.8571428571428571,1.0,1.0,5/10,22.80%,SMAD3;METTL3;DROSHA;MRPL44;PUS10
prerank,axoneme assembly (GO:0035082),0.21947251591172245,0.6800300990641857,0.923679060665362,0.9996203808284215,1.0,3/30,6.91%,CFAP74;DNAAF3;CCDC65
prerank,intracellular lipid transport (GO:0032365),0.24332519032536126,0.6799743676969399,0.8877118644067796,0.998921034673451,1.0,3/21,6.82%,PRKAG2;ABCD2;CPT2
prerank,positive regulation of cell cycle G2/M phase transition (GO:1902751),-0.24198864457675495,-0.6798623111996511,0.8985765124555161,0.9686756781429284,1.0,4/21,12.21%,RAB11A;BRD4;CDK4;RCC2
prerank,purine ribonucleoside monophosphate biosynthetic process (GO:0009168),-0.2562736321159009,-0.6798409483305903,0.875,0.9682451441692933,1.0,3/16,8.25%,PAICS;ADSS2;IMPDH1
prerank,protein insertion into ER membrane by stop-transfer membrane-anchor sequence (GO:0045050),-0.28912733206812785,-0.6791467611700663,0.8509874326750448,0.9683982913553103,1.0,5/10,33.66%,EMC10;EMC6;EMC9;EMC1;EMC4
prerank,epithelial cilium movement involved in extracellular fluid movement (GO:0003351),-0.24597935833698265,-0.678678502117639,0.8758992805755396,0.9683484868724508,1.0,7/18,27.29%,CABYR;AQP4;ROPN1L;ADCY10;SPAG17;NEK10;SPA17
prerank,GPI anchor metabolic process (GO:0006505),0.23419265595026,0.6777902919712441,0.8936170212765957,1.0,1.0,9/26,22.22%,PIGU;PIGH;PIGP;PGAP3;DPM1;PIGN;MPPE1;PGAP1;PIGB
prerank,mitochondrial genome maintenance (GO:0000002),0.28240826004865816,0.6771590633980612,0.8612334801762115,1.0,1.0,4/11,17.74%,AKT3;TOP3A;SLC25A36;PARP1
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),-0.2805408807766244,-0.6770162961987449,0.8631386861313869,0.9692847852526522,1.0,5/11,33.91%,FAS;LGALS9;PLAUR;PARK7;HTRA2
prerank,cell differentiation in hindbrain (GO:0021533),0.27637980860783307,0.676391963287572,0.8687782805429864,1.0,1.0,1/11,1.54%,GRID2
prerank,negative regulation of telomere maintenance via telomerase (GO:0032211),0.24568897233847822,0.6761644960976306,0.8802660753880266,0.999486188450672,1.0,2/19,8.92%,STN1;PINX1
prerank,nuclear body organization (GO:0030575),-0.27642651931091977,-0.6760367909792891,0.8802946593001841,0.969661551456858,1.0,4/12,19.88%,ETS1;USPL1;ZPR1;SERBP1
prerank,regulation of microglial cell activation (GO:1903978),0.25612870829518963,0.675470859165172,0.8681818181818182,0.999391614296519,1.0,14/15,63.93%,STAP1;SYT11;TTBK1;SPHK1;MMP8;PTPRC;NR1D1;CCL3;CX3CL1;IL6;TAFA3;CST7;GRN;LDLR
prerank,modulation by host of viral genome replication (GO:0044827),0.26792398778107723,0.6751866544434121,0.8635394456289979,0.9989287007586242,1.0,4/13,18.26%,PRKN;YTHDC2;TBC1D20;IFI27
prerank,regulation of embryonic development (GO:0045995),0.21679328763211936,0.6748230343675506,0.9154334038054969,0.9985153232547854,1.0,5/34,10.71%,PHLDB2;TRIP12;FOXA2;NPHP3;RPS6KA6
prerank,chromatin assembly (GO:0031497),-0.20532015656494196,-0.6747892745429045,0.9406130268199234,0.9702653508589085,1.0,13/38,30.02%,H3-3A;CDAN1;NAA60;LIN54;RBBP4;SOX9;POLE3;EZH1;NPM1;KAT6B;HMGB2;ANP32B;SMARCA5
prerank,cellular defense response (GO:0006968),-0.2046781054011233,-0.6747738132067999,0.9424860853432282,0.9698315763636477,1.0,3/40,5.78%,LBP;PTK2B;NCF2
prerank,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),0.2384810302482133,0.6746897287470539,0.8694690265486725,0.9979029552810017,1.0,6/22,16.09%,VPS25;VPS37D;UBAP1;TOM1L1;VPS37A;NEDD4
prerank,phosphatidylinositol dephosphorylation (GO:0046856),0.23812447387342542,0.6744157182681084,0.8978723404255319,0.9974046748039791,1.0,5/23,17.92%,MTMR7;PTEN;MTMR10;OCRL;MTMR9
prerank,glial cell differentiation (GO:0010001),-0.2214605213801459,-0.674125183408103,0.9134615384615384,0.9698948104161302,1.0,7/28,24.59%,ADGRG6;SOX4;SOX9;FGF10;METRN;MYRF;SOX8
prerank,establishment of protein localization to plasma membrane (GO:0061951),0.209195956649206,0.6738537414921129,0.9372197309417041,0.997189546567305,1.0,6/36,13.16%,VAMP5;RAB10;BBS2;AFDN;OPTN;SYS1
prerank,NAD biosynthetic process (GO:0009435),0.2458699547719646,0.6732656336457387,0.8804347826086957,0.9969541362309712,1.0,3/20,10.07%,PARP16;PTGIS;KYNU
prerank,preassembly of GPI anchor in ER membrane (GO:0016254),-0.25085922080615997,-0.6713883203727593,0.8940754039497307,0.971705871228448,1.0,4/16,17.68%,PIGL;PIGF;PIGC;PIGW
prerank,very long-chain fatty acid metabolic process (GO:0000038),-0.21997520114139837,-0.6704834151152697,0.9316888045540797,0.9719909208439853,1.0,12/30,31.29%,ELOVL7;ELOVL5;TECRL;ELOVL1;ACOT2;HACD4;SLC27A2;ACOX1;HACD2;SLC27A6;ACOT1;ABCD3
prerank,regulation of cellular response to growth factor stimulus (GO:0090287),0.24301322246505136,0.6694846672801552,0.8725274725274725,0.9996381481146615,1.0,4/17,16.47%,SULF1;FSTL3;PCSK6;TWSG1
prerank,interstrand cross-link repair (GO:0036297),-0.19058587137832,-0.6693864064560038,0.9539347408829175,0.9724165698006677,1.0,27/53,39.24%,UBB;USP1;UBC;RPS27A;ERCC1;VCP;SLX4;DCLRE1C;RPA3;WDR48;ERCC4;FAN1;FANCD2;RAD51AP1;ATRIP;RNF8;FAAP24;UBE2T;NEIL3;CENPX;FANCF;MSH6;RAD51;UBA52;EME1;FANCB;XPA
prerank,positive regulation of translational initiation (GO:0045948),0.25066942231228423,0.6692216676410615,0.8854625550660793,0.9991088895933152,1.0,6/18,18.33%,KHDRBS1;POLR2G;EIF2B5;HABP4;CDC123;POLR2D
prerank,ncRNA transcription (GO:0098781),-0.259053074825097,-0.6684977607843201,0.8932384341637011,0.9727136845928679,1.0,4/13,20.05%,CAVIN1;SPIN1;USPL1;GTF3C1
prerank,histone H3 deacetylation (GO:0070932),-0.26007192474606144,-0.6684214707145406,0.9074733096085409,0.9723332171457733,1.0,3/15,11.34%,HDAC9;HDAC4;SFPQ
prerank,sno(s)RNA 3'-end processing (GO:0031126),0.2789617590069628,0.6679776668512184,0.8628318584070797,0.9994712201905931,1.0,4/11,26.29%,PARN;EXOSC3;EXOSC2;TENT4B
prerank,integrated stress response signaling (GO:0140467),-0.26805588939167657,-0.6679649729707734,0.8656987295825771,0.9722159961414747,1.0,3/14,11.49%,ATF4;HSPA5;IMPACT
prerank,protein export from nucleus (GO:0006611),-0.21980899138082888,-0.6673574992558898,0.9347014925373134,0.9722537042836114,1.0,5/27,13.59%,TGFB1;PKD1;CHP1;STYX;SMURF1
prerank,coenzyme A metabolic process (GO:0015936),-0.25899994796159526,-0.6671375248250418,0.8803921568627451,0.9719639817034181,1.0,4/14,29.03%,ACLY;CROT;SLC25A16;PANK2
prerank,"protein localization to chromosome, telomeric region (GO:0070198)",-0.2614011707086604,-0.6665824213161677,0.8828996282527881,0.9719638906259176,1.0,4/14,32.33%,TPP1;BRCA2;TERF2IP;TERT
prerank,regulation of microtubule nucleation (GO:0010968),-0.2822434675508115,-0.6665323836755626,0.8822495606326889,0.9715541423083458,1.0,3/10,21.43%,DCTN1;HSPA1A;HSPA1B
prerank,regulation of DNA metabolic process (GO:0051052),0.19895531116140402,0.6655583657418609,0.9643605870020965,1.0,1.0,12/44,19.44%,KDM1B;RADX;HDAC8;HNRNPD;TOM1L1;THOC1;NBN;STOX1;CDK9;UBE2N;WRNIP1;SMG5
prerank,regulation of protein targeting to mitochondrion (GO:1903214),-0.19871948525349342,-0.6652620622070071,0.9584905660377359,0.9721224502249257,1.0,12/38,25.82%,ABLIM3;SAE1;VPS11;ATP5IF1;CSNK2A2;UBL5;FZD5;NPEPPS;MICALL2;SREBF1;UBE2J2;ATG13
prerank,"positive regulation of gene expression, epigenetic (GO:0045815)",-0.19070634981470866,-0.665156020446169,0.963855421686747,0.9717476815554509,1.0,16/48,31.95%,ACTB;SERTAD2;ARID1A;WBP2;SPHK2;ZMIZ2;CDCA4;CHEK1;POLR1F;TAF1B;POLR1C;POLR2F;SMARCA5;POLR1H;POLR2L;KAT2A
prerank,lymphocyte chemotaxis (GO:0048247),0.21283370851628666,0.665018012752827,0.9178947368421052,1.0,1.0,3/34,9.85%,CYP7B1;CXCL16;CCL25
prerank,regulation of keratinocyte migration (GO:0051547),-0.27152550614496945,-0.6649704227389793,0.8809523809523809,0.9714457280522538,1.0,4/12,28.39%,MAPRE2;IQSEC1;FGF10;EPB41L4B
prerank,dopaminergic neuron differentiation (GO:0071542),0.2420398793927594,0.6645721420279879,0.9027431421446384,1.0,1.0,3/19,8.57%,PHOX2A;FOXA2;RYK
prerank,negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),-0.2861043568818212,-0.6641980017429374,0.875,0.9715860261301855,1.0,5/10,24.31%,IMPACT;HSPA1A;NCK1;DNAJB1;HIF1AN
prerank,magnesium ion transport (GO:0015693),0.26757230330069387,0.6635649992322397,0.8542094455852156,1.0,1.0,4/12,20.76%,MAGT1;SLC41A1;TUSC3;NIPAL1
prerank,positive regulation of immunoglobulin production (GO:0002639),0.21816219109229243,0.6632669436608919,0.9256900212314225,0.9998740552103945,1.0,8/31,18.33%,SHLD2;KMT5C;PAXIP1;TNFRSF4;RIF1;KMT5B;VAMP3;RBP4
prerank,zymogen activation (GO:0031638),-0.19882644331227084,-0.6632313145779682,0.9466911764705882,0.9718405733221694,1.0,10/39,20.25%,CASP8;MMP14;PERP;BAK1;PGK1;BAD;VSIR;PLAU;PRSS12;GGT1
prerank,regulation of double-strand break repair via homologous recombination (GO:0010569),0.2027582800271133,0.6631847785131536,0.9619450317124736,0.9992096886130523,1.0,14/42,26.08%,SHLD2;UBQLN4;RADX;RPA2;SMCHD1;RIF1;SIRT6;PARP1;RTEL1;FBH1;WAS;TIMELESS;ARID2;PPP4C
prerank,positive regulation of release of cytochrome c from mitochondria (GO:0090200),-0.22398572713020623,-0.6630336010913886,0.9217557251908397,0.9715395171689463,1.0,9/25,28.77%,TNFSF10;BAX;BBC3;BAD;BIK;PLAUR;HRK;MFF;PMAIP1
prerank,positive regulation of ubiquitin protein ligase activity (GO:1904668),0.2689524153461253,0.6626166355833008,0.8702127659574468,0.9989472582114549,1.0,4/12,16.04%,GOLGA2;PTEN;BTRC;SKP1
prerank,regulation of calcium ion import (GO:0090279),0.237615386416021,0.6626100900269317,0.8830275229357798,0.9982121074088666,1.0,5/21,18.42%,PDGFRB;TRIM27;PLPP4;WNK3;CXCL12
prerank,negative regulation of centrosome duplication (GO:0010826),-0.2752683715873243,-0.6623080703079685,0.8805704099821747,0.9716360716512893,1.0,7/11,38.29%,CCNF;TMEM67;RBM14;NPM1;KAT2A;CDK5RAP2;BRCA1
prerank,positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),-0.29048846153609764,-0.6622573823263975,0.894927536231884,0.9712379308659455,1.0,4/10,29.30%,GRB10;ITGB3;PRKD2;ITGA5
prerank,NLS-bearing protein import into nucleus (GO:0006607),0.25870019534380095,0.66200621066731,0.8776824034334764,0.9979724600463145,1.0,2/13,10.67%,CBLB;NUP35
prerank,long-term memory (GO:0007616),0.24532562265457816,0.6619822013592259,0.8764044943820225,0.9972496268140768,1.0,3/19,12.41%,CAMK4;CPEB3;RASGRF1
prerank,phagosome acidification (GO:0090383),0.22500090911008544,0.6618842381493671,0.9260869565217391,0.9965982989365215,1.0,5/26,15.46%,ATP6V0A4;ATP6V1H;RAB38;ATP6V1B2;RAB20
prerank,regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645),-0.25840455107479354,-0.6618500649275678,0.8917975567190227,0.9710946768524474,1.0,10/14,52.61%,PAEP;CD84;RASGRP1;ISL1;CARD9;IL23A;IL23R;IL12B;IL17F;IL1B
prerank,neuron maturation (GO:0042551),-0.24358326295195326,-0.6615303289082016,0.9264990328820116,0.9709044419003028,1.0,3/18,8.12%,SCARF1;APP;ANKS1A
prerank,positive regulation of actin nucleation (GO:0051127),-0.27480340451676266,-0.6597058658287863,0.8698010849909584,0.9718215325123862,1.0,1/11,1.61%,WASF2
prerank,DNA replication-independent nucleosome organization (GO:0034724),-0.2765488493434993,-0.6593867199395511,0.8812949640287769,0.9716259092126848,1.0,2/11,16.41%,H3-3A;RBBP4
prerank,negative regulation of histone acetylation (GO:0035067),0.27038160516632104,0.6586903581943968,0.8848614072494669,0.9985763116775518,1.0,6/11,25.80%,NOC2L;THAP7;SET;TAF7;SIRT1;SNCA
prerank,acetylcholine receptor signaling pathway (GO:0095500),0.24293601426660474,0.6576356505064459,0.8962472406181016,0.9986980300214204,1.0,4/20,11.12%,CHRM2;CHRM3;CDK5R1;CHRNA7
prerank,7-methylguanosine RNA capping (GO:0009452),0.21819494207921922,0.6575729150574076,0.9372384937238494,0.9972824892406513,1.0,12/31,26.43%,GTF2H2;MNAT1;POLR2G;CCNH;POLR2D;POLR2K;RNMT;POLR2B;ERCC2;RNGTT;RAMAC;ERCC3
prerank,7-methylguanosine mRNA capping (GO:0006370),0.21819494207921922,0.6575729150574076,0.9372384937238494,0.9972824892406513,1.0,12/31,26.43%,GTF2H2;MNAT1;POLR2G;CCNH;POLR2D;POLR2K;RNMT;POLR2B;ERCC2;RNGTT;RAMAC;ERCC3
prerank,interleukin-6-mediated signaling pathway (GO:0070102),-0.23945812547481818,-0.6571651209145699,0.9,0.972807910999638,1.0,7/18,33.75%,JAK2;SMAD4;STAT1;IL6ST;SPI1;SRC;CBL
prerank,insulin secretion (GO:0030073),-0.23431585624276638,-0.6570905393257152,0.9083969465648855,0.9724139840098913,1.0,7/19,30.97%,ANXA1;RAB11B;PARK7;RAB11FIP5;CAMK2G;ADCYAP1;SNX19
prerank,L-serine metabolic process (GO:0006563),0.2811774304901778,0.6564052313409071,0.8903803131991052,0.9974664513732017,1.0,10/10,71.90%,PSPH;PHGDH;CBS;SHMT1;SDS;SHMT2;PSAT1;SRR;SERINC5;SERINC3
prerank,protein heterotetramerization (GO:0051290),-0.259443942093314,-0.6563582794248982,0.8833034111310593,0.9725197093132057,1.0,5/13,31.76%,PKD1;FARSB;PKD2;GRIN1;KRT10
prerank,glucosamine-containing compound metabolic process (GO:1901071),-0.26086659594687833,-0.6553576733792316,0.9141323792486583,0.9727798600926372,1.0,6/13,28.59%,OGA;RENBP;PGM3;LARGE1;CHST5;CHST3
prerank,protein N-linked glycosylation (GO:0006487),-0.1799331309270638,-0.6553029880350784,0.9752851711026616,0.9723718750080782,1.0,20/66,27.54%,TMEM165;ST6GAL1;SLC39A8;MGAT1;FUT8;KRTCAP2;DAD1;GFPT1;OST4;MCFD2;TMEM258;ALG9;ALG12;MGAT5;ALG1;PGM3;RPN2;ALG2;ALG3;STT3B
prerank,mRNA catabolic process (GO:0006402),0.19672334578982814,0.6546947746136669,0.9593679458239278,0.998087519890411,1.0,9/44,15.77%,TUT4;AGO4;DHX34;RIDA;PNPT1;METTL16;NBAS;NBDY;METTL3
prerank,epithelial cell morphogenesis (GO:0003382),0.2503910738236644,0.6544572014841714,0.8730512249443207,0.9975532595374828,1.0,2/17,9.02%,COL22A1;CNMD
prerank,positive regulation of alpha-beta T cell activation (GO:0046635),-0.24703158870379305,-0.6543413343812894,0.926873857404022,0.9725948252786235,1.0,2/15,12.88%,CD55;SYK
prerank,long-chain fatty acid biosynthetic process (GO:0042759),0.22987970126900584,0.6541000341213196,0.9243353783231084,0.9970904223970918,1.0,6/23,19.07%,ALOX12;GSTP1;HPGD;FADS1;ELOVL6;PTGS2
prerank,spliceosomal complex assembly (GO:0000245),0.19686878597471172,0.6539390619637517,0.9627329192546584,0.9964834061256188,1.0,4/46,10.06%,CELF2;CELF4;RBM5;GCFC2
prerank,negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),0.2802815680494052,0.6533062478033397,0.8789144050104384,0.9962446785830122,1.0,1/10,1.51%,LRP1
prerank,positive regulation of cellular carbohydrate metabolic process (GO:0010676),-0.27610400795267614,-0.652189933200913,0.8926553672316384,0.9736704513226419,1.0,2/10,12.33%,AKT1;PRKCE
prerank,regulation of T cell mediated cytotoxicity (GO:0001914),-0.24603445544099622,-0.6504728043063608,0.9186691312384473,0.9743532430864648,1.0,12/16,50.33%,CYRIB;LILRB1;IL12A;CEACAM1;IL12RB1;IL23A;KLRD1;IL23R;IL12B;RIPK3;XCL1;KLRC1
prerank,"DNA-templated transcription, elongation (GO:0006354)",-0.175685441991694,-0.6489490516752412,0.97265625,0.9749156184267762,1.0,18/64,32.29%,MLLT3;AFF4;GTF2H3;NELFE;CDK13;CCNK;GTF2F1;TCEA1;GTF2H4;ELOB;NCBP2;ELL;SETD2;GTF2F2;POLR2F;POLR2L;POLR2I;POLR2C
prerank,phagosome maturation (GO:0090382),-0.20369360605787565,-0.6481855725070048,0.9621212121212122,0.9749943577704563,1.0,12/35,31.20%,ATP6V0B;ATP6V0A2;MREG;ATP6V0C;RAB7A;ATP6V1G1;RAB32;RAB43;ATP6V0D1;CORO1A;ATP6V0E2;ATP6V1C1
prerank,regulation of regulatory T cell differentiation (GO:0045589),-0.22761786523215588,-0.6480450242443142,0.9210019267822736,0.9746520456226627,1.0,4/22,17.36%,CBFB;BCL6;SOX12;VSIR
prerank,dendritic cell migration (GO:0036336),-0.2481919778297541,-0.647968847659372,0.914018691588785,0.9742585516998286,1.0,1/16,1.78%,EPS8
prerank,regulation of double-strand break repair (GO:2000779),0.19972167818227723,0.6467305374420494,0.9430379746835443,1.0,1.0,5/39,10.93%,SHLD2;TRIP12;OTUB2;RPA2;FMN2
prerank,tRNA methylation (GO:0030488),0.20707047494644873,0.646477660692069,0.9623893805309734,1.0,1.0,11/34,23.45%,DALRD3;FTSJ1;NSUN6;METTL6;BCDIN3D;TARBP1;TRMT1L;TRMT12;PRORP;TRMT5;THUMPD2
prerank,negative regulation of catabolic process (GO:0009895),0.1924886828991294,0.644703879224414,0.9590163934426229,1.0,1.0,12/47,20.27%,PPARA;ACTN3;SIRT2;PDE3B;ALK;FMN2;PRKCG;SF3B3;CYP51A1;NUPR1;IRAK3;AZIN2
prerank,negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),0.2588780646007372,0.6446646706743809,0.8717948717948718,1.0,1.0,2/14,8.44%,GSTP1;NLRP2B
prerank,"base-excision repair, gap-filling (GO:0006287)",0.20021097106272562,0.6446385086788863,0.9503105590062112,0.9993426357563611,1.0,11/35,21.92%,MPG;RPA2;RFC5;RPA1;PARP1;POLD4;POLD1;PCNA;POLD3;RFC1;POLD2
prerank,hexose metabolic process (GO:0019318),-0.19175609630514237,-0.6443477089006204,0.9574074074074074,0.9762870973645623,1.0,15/39,36.94%,PPARD;HK1;PGM1;FUCA2;GALM;GALT;BRAT1;DCXR;FUCA1;ALDOA;HECTD4;ADPGK;GDPGP1;APOD;TFAP2B
prerank,retrograde axonal transport (GO:0008090),0.24643407754326535,0.6431771970311942,0.8900862068965517,0.9997074309702272,1.0,5/16,20.67%,DLG2;KIF1A;ACTR10;FBXW11;TMEM108
prerank,histone lysine demethylation (GO:0070076),0.22416263712352966,0.6417009702637808,0.9309576837416481,1.0,1.0,7/25,18.72%,KDM1B;KDM7A;KDM2A;PHF8;HR;KDM4C;KDM5B
prerank,RNA methylation (GO:0001510),0.1841103920271367,0.6410371106972063,0.9791231732776617,0.9997957673287305,1.0,20/60,25.21%,VIRMA;FTSJ1;HENMT1;DIMT1;METTL16;NSUN6;MTERF4;METTL6;METTL3;BCDIN3D;METTL8;TFB1M;TARBP1;TRMT12;TRMT5;THUMPD2;RBM15;WTAP;BUD23;THUMPD3
prerank,urogenital system development (GO:0001655),-0.2636265572567834,-0.6408999414788991,0.9020715630885122,0.9780809907688028,1.0,1/11,3.46%,ANXA1
prerank,ribonucleoside bisphosphate metabolic process (GO:0033875),0.2097639113870779,0.6397421342993181,0.9395248380129589,0.99926764627365,1.0,3/29,7.30%,ACSM5;BAAT;ACOT11
prerank,purine nucleoside bisphosphate metabolic process (GO:0034032),0.2097639113870779,0.6397421342993181,0.9395248380129589,0.99926764627365,1.0,3/29,7.30%,ACSM5;BAAT;ACOT11
prerank,lipid modification (GO:0030258),0.19635937575690532,0.6385880650101744,0.9538152610441767,0.9993652772470227,1.0,8/37,17.59%,ALOX12;DGKD;PLPP3;PLPPR1;PLPP4;PLPPR5;PORCN;DGKI
prerank,calcium-ion regulated exocytosis (GO:0017156),0.218852937632743,0.6383341621467787,0.941304347826087,0.9988182765246164,1.0,8/27,18.77%,RIMS1;SYT1;SCIN;SYT13;SYT11;SYT12;SYT6;RIMS2
prerank,somite development (GO:0061053),0.26457837047381055,0.6377559225412706,0.8833693304535637,0.998510236405575,1.0,4/11,18.67%,LOXL3;MTHFD1;PPP2R3A;SHH
prerank,RNA biosynthetic process (GO:0032774),0.20676487785968553,0.6366506538452962,0.9445628997867804,0.9985802763635415,1.0,30/31,71.57%,TTF1;GTF2B;TCEA2;TAF7;PRIM1;PRIM2;SETX;BRF1;BRF2;TBPL1;RSF1;TAF13;TBPL2;ELL3;TAF6;PRMT5;POLA2;TTF2;POLR2A;TAF12;NAT14;NCOA6;TBP;POLA1;HELB;TERT;SMARCA5;TAF5;TAF10;TAF4
prerank,protein localization to cilium (GO:0061512),-0.20297610640215974,-0.6358551333984708,0.9559118236472945,0.9808606808327668,1.0,7/32,18.42%,IFT20;TULP2;ZNF423;TUB;ARL6;RABEP1;EHD1
prerank,positive regulation of glucose metabolic process (GO:0010907),0.24901809698361912,0.6355622404613496,0.9050772626931567,0.9986192737480525,1.0,2/14,5.54%,ACTN3;IRS2
prerank,eosinophil migration (GO:0072677),0.24370644736016056,0.6354806243447132,0.8939051918735892,0.9972237702881173,1.0,14/14,75.65%,SCG2;CCL13;CCL8;CCL24;CCL26;LGALS3;CCL3;CCL1;CX3CL1;CCL7;CCL4;CCL11;CCL5;CCL2
prerank,eosinophil chemotaxis (GO:0048245),0.24370644736016056,0.6354806243447132,0.8939051918735892,0.9972237702881173,1.0,14/14,75.65%,SCG2;CCL13;CCL8;CCL24;CCL26;LGALS3;CCL3;CCL1;CX3CL1;CCL7;CCL4;CCL11;CCL5;CCL2
prerank,telomere maintenance via recombination (GO:0000722),0.2562075253776249,0.6354146688119783,0.8702460850111857,0.9965565899537294,1.0,4/11,18.37%,TEP1;SMC6;SMC5;NSMCE2
prerank,negative regulation of hippo signaling (GO:0035331),0.26134426855605497,0.6343988018333299,0.9002320185614849,0.9965443075598777,1.0,2/12,8.59%,WWC1;AJUBA
prerank,superoxide anion generation (GO:0042554),0.2547161100470132,0.633990754499331,0.9016393442622951,0.9961215891907669,1.0,1/13,2.55%,ALOX12
prerank,negative regulation of JUN kinase activity (GO:0043508),-0.274626246204693,-0.6337598998760525,0.918625678119349,0.9817100974062601,1.0,4/10,27.86%,AIDA;DNAJA1;PTPN22;PDCD4
prerank,DNA-dependent DNA replication (GO:0006261),-0.1548313897641568,-0.633726618615593,0.9979035639412998,0.9812857502999542,1.0,49/128,37.58%,UBB;UBC;RPS27A;PSMA6;PSMB5;BAZ1A;PSMC4;PSMC5;PSMD14;PNKP;REV3L;DDX23;PSMD8;RPA3;PSMD11;RPAIN;PSMB4;PSMD12;PSMC1;GINS3;PSMA1;PSMB1;PSMC3;PSMA4;RFC3;PSMA2;POLE3;MCM5;RFC2;PSMB8;DNA2;POLB;PSMC6;RECQL;TWNK;CDC6;PSMD6;PSMA8;HELB;POLE;POLA1;PSMD2;GINS4;PSMB2;RAD51;SIRT7;UBA52;PURA;HMGA1
prerank,Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904953),0.27308102679972385,0.6327678136644581,0.8969555035128806,0.996233470924054,1.0,10/10,72.71%,RYK;WNT3;WNT5A;FZD1;WNT3A;WNT1;WNT9B;LRP6;CTNNB1;WNT2
prerank,adrenergic receptor signaling pathway (GO:0071875),0.22796915812168583,0.6317864622571513,0.9224137931034483,0.9961689326225495,1.0,8/20,25.55%,ADRA1D;ADRA1B;DRD2;ADRA1A;ADRB3;LMBRD2;ADCY9;DRD3
prerank,regulation of catecholamine secretion (GO:0050433),0.20987207925794432,0.6311272591881361,0.9451476793248945,0.9959108630639156,1.0,8/29,18.08%,PRKN;SYT1;CHRNA4;SYT13;DRD2;SYT11;SYT12;SYT6
prerank,regulation of centrosome cycle (GO:0046605),0.22842851851263363,0.6310326237699401,0.9217002237136466,0.9952571540404442,1.0,3/21,9.48%,ATF5;GEN1;CHMP1A
prerank,regulation of lymphocyte proliferation (GO:0050670),-0.23019723645565882,-0.6298721109546048,0.9222797927461139,0.9831482966643116,1.0,12/16,51.84%,TNFRSF1B;FGF10;PTPN22;LST1;TNFSF8;IL12A;CD22;TNFSF9;IL12B;LGALS3;TNFSF18;SOX11
prerank,lipid phosphorylation (GO:0046834),-0.2761263768423944,-0.6296757237047108,0.8882882882882883,0.9828159721170152,1.0,1/10,1.69%,DGKH
prerank,negative regulation of B cell proliferation (GO:0030889),-0.26659383168842643,-0.6283575658739656,0.9276672694394213,0.9831063642259796,1.0,2/11,7.75%,TNFRSF21;RC3H1
prerank,negative regulation of microtubule polymerization (GO:0031115),-0.2532319588910085,-0.6283435596733276,0.9197207678883071,0.9826660951628974,1.0,5/12,39.71%,STMN2;CDH5;STMN1;DYRK1A;MAP2
prerank,protein import into peroxisome membrane (GO:0045046),0.21682674911421249,0.6278595601225205,0.9299363057324841,0.9966558974544011,1.0,6/22,20.07%,ABCD2;PXMP4;PEX11B;PXMP2;PEX19;PEX2
prerank,lysosome organization (GO:0007040),-0.1936027363202143,-0.62778669068769,0.9625,0.982558120701513,1.0,12/36,33.32%,TPP1;TMEM165;HPS1;VPS33A;TFEB;TPCN2;GNPTAB;MYO7A;ATP10B;CORO1A;LAMTOR1;MBTPS1
prerank,protein K63-linked ubiquitination (GO:0070534),-0.1878982017920466,-0.6262418909401889,0.9730250481695568,0.9830081561889273,1.0,11/41,21.56%,WWP2;TRIM56;ITCH;RNF5;TRAF1;UBE2G1;TRIM5;HECTD1;PELI1;UBE2B;BFAR
prerank,regulation of histone methylation (GO:0031060),-0.24901023824621285,-0.6240662468443973,0.9269662921348315,0.9838240395961927,1.0,4/13,22.14%,CHTOP;AASS;TTLL12;NNMT
prerank,UV-damage excision repair (GO:0070914),0.25046544566887424,0.6226418241459208,0.9166666666666666,0.9993087739577446,1.0,1/12,3.73%,DDB2
prerank,negative regulation of lipid metabolic process (GO:0045833),-0.21404086387433754,-0.6211655541249587,0.9538188277087034,0.9850119965048764,1.0,11/22,42.86%,NCOR1;PPP2R5A;CCDC3;APOC1;BSCL2;APOD;GPER1;ADRA2A;CEACAM1;CIDEA;TNF
prerank,intracellular sterol transport (GO:0032366),0.2485277743932651,0.6210094699834068,0.9018264840182648,0.9996548580563543,1.0,3/13,14.38%,ABCA1;OSBP;RELCH
prerank,protein insertion into membrane (GO:0051205),-0.19696329526796139,-0.6209435110567838,0.9517625231910947,0.984694352649081,1.0,13/32,38.30%,APP;STX1A;SEC61B;EGFR;SGTA;STX5;UBE2J2;TRAM1;VAMP2;CCDC47;RTP4;RTP3;VAPA
prerank,monocarboxylic acid catabolic process (GO:0072329),-0.2155180707164305,-0.6201607265120644,0.9469026548672567,0.9846797283364916,1.0,6/21,28.23%,PPARD;FAAH;ACOT8;LDHD;ACOX1;LPIN2
prerank,heterochromatin assembly (GO:0031507),0.21930886398140087,0.6192729709674595,0.9409090909090909,1.0,1.0,4/20,17.00%,SIRT2;MBD2;SMCHD1;HDAC1
prerank,regulation of lipoprotein lipase activity (GO:0051004),0.23335396779998982,0.6179742075548229,0.9267782426778243,1.0,1.0,1/17,1.91%,APOH
prerank,regulation of immunoglobulin production (GO:0002637),-0.2142628284792844,-0.6175125592510753,0.9485294117647058,0.9856901215651463,1.0,4/23,17.15%,GPI;PHB2;CLCF1;XBP1
prerank,cell proliferation in forebrain (GO:0021846),-0.26540120637790127,-0.6173273579461135,0.9169741697416974,0.9853411171225727,1.0,4/10,31.10%,PCM1;NUMB;AKNA;WNT7A
prerank,t-circle formation (GO:0090656),-0.2644507357430457,-0.6170017957870347,0.9303904923599321,0.9841738318416634,1.0,4/10,26.27%,ERCC1;SLX4;EXO1;DNA2
prerank,telomere maintenance via telomere trimming (GO:0090737),-0.2644507357430457,-0.6170017957870347,0.9303904923599321,0.9841738318416634,1.0,4/10,26.27%,ERCC1;SLX4;EXO1;DNA2
prerank,formation of extrachromosomal circular DNA (GO:0001325),-0.2644507357430457,-0.6170017957870347,0.9303904923599321,0.9841738318416634,1.0,4/10,26.27%,ERCC1;SLX4;EXO1;DNA2
prerank,internal peptidyl-lysine acetylation (GO:0018393),0.20672591786298367,0.6169829211891555,0.9256198347107438,1.0,1.0,5/27,15.01%,NAT8;TAF6L;KAT8;EP300;KAT5
prerank,nucleocytoplasmic transport (GO:0006913),-0.1906515979882362,-0.6160594271984806,0.9770554493307839,0.9842285199804169,1.0,22/40,40.17%,ANP32A;SNRPD3;HTATIP2;SMN1;RITA1;DDX20;HNRNPA1;SNRPG;NXT2;NCBP2;SNRPB;NPM1;NUP98;XPO1;RBM15B;RSRC1;SNUPN;SNRPE;SNRPF;GEMIN2;NXT1;NCBP1
prerank,protein oxidation (GO:0018158),0.25834808052773084,0.615570201985592,0.9117647058823529,1.0,1.0,2/11,7.66%,LOXL2;LOXL3
prerank,regulation of telomere maintenance (GO:0032204),-0.21037826199640278,-0.6154983128199056,0.9459962756052142,0.9840802569789838,1.0,11/26,33.31%,USP7;ERCC1;ERCC4;SMG1;MRE11;TERF2IP;MYC;UPF1;SMG6;PIF1;RAD50
prerank,detection of visible light (GO:0009584),0.23777243365317252,0.6154307177207169,0.9270833333333334,0.9995229980769919,1.0,1/16,3.53%,ABCA4
prerank,defense response to Gram-negative bacterium (GO:0050829),-0.18467178927296057,-0.6142104354020529,0.9809885931558935,0.9843140701336336,1.0,3/42,5.67%,LBP;RPL30;RPS19
prerank,mitochondrial RNA metabolic process (GO:0000959),0.2390476489988379,0.6141397119693324,0.9324894514767933,0.9995650111462877,1.0,2/14,10.47%,EARS2;PNPT1
prerank,protein prenylation (GO:0018342),-0.2557722938526169,-0.6136073826284116,0.9245283018867925,0.9841777359451875,1.0,6/10,48.15%,RCE1;RABGGTB;CHM;RABGGTA;FNTB;AIPL1
prerank,telomere maintenance via telomerase (GO:0007004),-0.20268328307123765,-0.6130485247772492,0.952561669829222,0.9840173530482219,1.0,12/28,35.68%,HSP90AB1;DKC1;HSP90AA1;PPP6R3;TNKS1BP1;MRE11;TERF2IP;PIF1;TERT;WRAP53;RAD50;NOP10
prerank,central nervous system neuron differentiation (GO:0021953),-0.1940889162475105,-0.6124006869935208,0.9777777777777777,0.9839059494295057,1.0,18/33,39.97%,OPHN1;NR4A2;AGTPBP1;SOX4;FAIM2;TOX;CEND1;LMX1A;WNT2;CTNNB1;DRAXIN;LRP6;SPOCK1;NPY;PROX1;KNDC1;MAP2;ISL1
prerank,axonemal dynein complex assembly (GO:0070286),0.20394710341111918,0.6095089391519384,0.954,1.0,1.0,3/27,8.19%,DNAAF3;CCDC65;DNAL1
prerank,male meiosis I (GO:0007141),0.23503007873383297,0.6082092296105557,0.9313304721030042,1.0,1.0,3/16,15.06%,HSF2BP;ZSCAN21;BRDT
prerank,ncRNA catabolic process (GO:0034661),0.2021604144966135,0.6074744210526358,0.9623430962343096,1.0,1.0,2/28,6.12%,TUT4;LIN28B
prerank,positive regulation of mitotic cell cycle (GO:0045931),-0.20592646679050142,-0.6068346810984236,0.9607476635514018,0.9862681855985234,1.0,9/26,26.08%,APP;TAL1;DUSP3;HES1;USP22;ASNS;EIF4EBP1;EIF4E;TTL
prerank,positive regulation of cell development (GO:0010720),-0.19487135022041413,-0.6060157076220958,0.9689213893967094,0.9862139067324245,1.0,8/31,26.71%,TGM2;FAIM;CX3CR1;BAD;NUMB;ATP6AP1;LRP2;LIG4
prerank,regulation of centrosome duplication (GO:0010824),-0.1976616443357378,-0.6060040725253201,0.9568480300187617,0.9857772229172793,1.0,6/29,18.15%,CHMP2B;PLK2;FBXW5;CCNF;TMEM67;CHMP2A
prerank,cytoskeleton-dependent intracellular transport (GO:0030705),0.20928509835935363,0.60537888879644,0.9517543859649122,1.0,1.0,5/23,14.58%,KIF5C;DYNC1I1;CCDC186;KIF1A;MAP6
prerank,regulation of intracellular transport (GO:0032386),0.18762687632834008,0.6048242747071572,0.9610655737704918,1.0,1.0,5/38,13.05%,WWC1;SCFD1;ATP9A;DYNLT2B;RINT1
prerank,negative regulation of organelle assembly (GO:1902116),0.18885055400303696,0.6037575220943021,0.9684684684684685,1.0,1.0,11/35,23.78%,PHF23;SCFD1;MDM1;YAP1;TCHP;NBDY;NUPR1;TRIM37;FEZ1;KAT2B;TESK1
prerank,"phototransduction, visible light (GO:0007603)",-0.2335006858204324,-0.6029133066904402,0.9496268656716418,0.9867915503193743,1.0,3/14,21.19%,RP1;GNB1;GNA11
prerank,retinal metabolic process (GO:0042574),-0.24053950740196717,-0.6027787015469519,0.9546279491833031,0.9864114181803537,1.0,3/12,17.17%,CYP1B1;ALDH1A3;DHRS13
prerank,receptor catabolic process (GO:0032801),-0.20432704459388465,-0.6011030062297033,0.9606003752345216,0.9867355229388014,1.0,5/24,15.15%,TGFB1;AP2M1;KIF16B;SMURF1;AP2A1
prerank,3'-UTR-mediated mRNA destabilization (GO:0061158),0.2274675617572654,0.6005453225525368,0.9285714285714286,1.0,1.0,5/16,22.29%,CPEB3;KHSRP;RBM24;TARDBP;ZFP36L2
prerank,negative regulation by host of viral process (GO:0044793),0.25329458968633994,0.6001852790657857,0.91792656587473,1.0,1.0,1/10,5.39%,PRKN
prerank,snRNA 3'-end processing (GO:0034472),-0.2139495115079973,-0.5994343909784445,0.9441340782122905,0.9870424266223372,1.0,8/19,36.70%,INTS8;INTS1;EXOSC8;INTS12;EXOSC9;INTS2;INTS14;USB1
prerank,mRNA cleavage involved in mRNA processing (GO:0098787),0.23591863684674796,0.5991989499144678,0.91324200913242,1.0,1.0,5/14,23.01%,FIP1L1;CPSF4L;CPSF7;CPSF6;NUDT21
prerank,tetrahydrofolate metabolic process (GO:0046653),0.24904089533835183,0.5985698478406282,0.9074889867841409,1.0,1.0,4/10,24.32%,MTHFD1;MTHFD1L;MTHFR;MTHFD2L
prerank,mismatch repair (GO:0006298),0.19665878827189928,0.5984181124234179,0.9740820734341252,1.0,1.0,11/27,23.98%,RPA2;MCM9;PMS2;RPA1;POLD4;POLD1;PCNA;POLD3;POLD2;PMS1;MUTYH
prerank,positive regulation of T-helper 1 type immune response (GO:0002827),-0.24452015874881985,-0.5968492934982191,0.9405204460966543,0.9877762389957127,1.0,10/12,53.99%,IL1R1;SLC11A1;IL12RB1;IL23A;IL23R;IL12B;XCL1;CCR2;IL1B;IL18R1
prerank,regulation of pseudopodium assembly (GO:0031272),-0.25064997778900555,-0.5944713844063757,0.9293478260869565,0.9879174784493849,1.0,4/10,37.25%,CDC42EP3;CDC42;CDC42EP2;WASHC1
prerank,positive regulation of pseudopodium assembly (GO:0031274),-0.25064997778900555,-0.5944713844063757,0.9293478260869565,0.9879174784493849,1.0,4/10,37.25%,CDC42EP3;CDC42;CDC42EP2;WASHC1
prerank,positive regulation of rRNA processing (GO:2000234),0.25475428356241764,0.5942912483986876,0.928416485900217,1.0,1.0,10/10,74.54%,DIMT1;HEATR1;BUD23;WDR75;WDR43;TRMT112;SIRT7;RIOK1;UTP15;RIOK2
prerank,intracellular cholesterol transport (GO:0032367),0.2251180066657124,0.5941172511083714,0.9250535331905781,1.0,1.0,4/15,18.17%,ABCA1;OSBP;RELCH;LDLRAP1
prerank,negative regulation of lipid catabolic process (GO:0050995),-0.21915533153874764,-0.5928891704425464,0.9599271402550091,0.9881583405876461,1.0,2/17,8.42%,MFSD2A;AKT1
prerank,gas transport (GO:0015669),-0.2554703739003197,-0.5900328311566501,0.9180035650623886,0.9889603884985838,1.0,5/10,41.43%,CYGB;MYC;AQP1;MB;NGB
prerank,ncRNA 3'-end processing (GO:0043628),0.23119284574172902,0.5897590654839375,0.9321266968325792,1.0,1.0,7/14,26.40%,INTS6L;PTCD1;INTS7;TRNT1;SSB;INTS5;TOE1
prerank,negative regulation of interleukin-6 production (GO:0032715),-0.1916295284517106,-0.589414561403739,0.9803149606299213,0.9887768955333969,1.0,5/27,22.08%,TLR4;PTPN6;TNFAIP3;CD200;PTPN22
prerank,peroxisomal membrane transport (GO:0015919),0.19587265094345857,0.5882974160876787,0.9762931034482759,1.0,1.0,7/27,20.07%,ABCD2;PXMP4;PEX11B;PXMP2;PEX10;PEX19;PEX2
prerank,microtubule anchoring (GO:0034453),0.24447818327968251,0.5880296654270117,0.929384965831435,1.0,1.0,3/12,15.98%,SAXO2;BICD1;DAG1
prerank,lipoxygenase pathway (GO:0019372),0.2356030353078964,0.5875373200505081,0.9358974358974359,1.0,1.0,2/14,10.49%,ALOX12;HPGD
prerank,microtubule nucleation (GO:0007020),-0.21214942088454142,-0.5870022499149778,0.9496981891348089,0.989308738969647,1.0,6/19,29.62%,SLAIN2;NDE1;NDEL1;TPX2;TUBG2;TUBGCP6
prerank,negative regulation of immune system process (GO:0002683),-0.22125617351978283,-0.5863999824961936,0.9488117001828154,0.9891032981281066,1.0,3/16,19.37%,COL3A1;CD200;SOX9
prerank,negative regulation of cholesterol transport (GO:0032375),-0.2542171921943439,-0.5863578469666669,0.9253731343283582,0.9886821494093055,1.0,2/10,25.17%,ABCA2;APOC1
prerank,negative regulation of signaling (GO:0023057),0.19901221667338276,0.5860323275729451,0.9593147751605996,1.0,1.0,7/25,19.85%,NLRP12;ERBB3;OPTN;LIF;HHIP;TRAT1;SOCS5
prerank,negative regulation of inclusion body assembly (GO:0090084),0.247998001442054,0.5856418375487726,0.9360189573459715,1.0,1.0,1/10,3.69%,DNAJB8
prerank,"RNA splicing, via transesterification reactions (GO:0000375)",-0.1934608364003233,-0.5855815695210875,0.9742173112338858,0.9885383899489723,1.0,6/25,19.91%,PRPF8;SRSF4;DDX23;SF3A3;SCAF11;LSM1
prerank,establishment of protein localization to endoplasmic reticulum (GO:0072599),-0.22366811777305262,-0.5850526185587203,0.9611307420494699,0.9882983827076643,1.0,6/15,31.68%,SPCS1;RAB3GAP2;ZFAND2B;SEC61A1;EDEM1;SRPRA
prerank,negative regulation of phosphate metabolic process (GO:0045936),-0.20027885664947764,-0.5846651881317811,0.964349376114082,0.9880173038766349,1.0,8/22,29.76%,CDKN1B;INHBA;CDKN1A;CDKN2C;CDKN1C;CDKN2B;INHA;PLEK
prerank,rRNA pseudouridine synthesis (GO:0031118),-0.24917734437154282,-0.5835559870831452,0.945750452079566,0.9879952871184389,1.0,3/10,18.00%,DKC1;RPUSD4;RPUSD1
prerank,positive regulation of receptor internalization (GO:0002092),0.20358737548495043,0.5825973256076985,0.9682875264270613,1.0,1.0,2/22,9.58%,MAGI2;AHI1
prerank,regulation of microtubule-based movement (GO:0060632),0.23904624450429685,0.5823429852783513,0.9420935412026726,1.0,1.0,2/11,11.66%,CCDC65;DYNLT2B
prerank,nucleic acid metabolic process (GO:0090304),0.15874651940565387,0.5793124247620601,0.9921722113502935,1.0,1.0,1/69,0.21%,ENPP1
prerank,regulation of oxidative phosphorylation (GO:0002082),-0.21623310086286857,-0.5791232302789199,0.9467889908256881,0.9892010787836517,1.0,9/16,41.34%,UQCC2;VCP;SLC25A33;COX7A2L;SHMT2;PDE12;PPIF;COX7A2;ABCD1
prerank,rRNA modification (GO:0000154),-0.1992144604819044,-0.5777887167566643,0.9663551401869159,0.9892538892205851,1.0,5/21,25.97%,THUMPD1;DKC1;ZCCHC4;MRM2;FTSJ3
prerank,organophosphate catabolic process (GO:0046434),0.23518704494099915,0.5771734454160312,0.9258426966292135,1.0,1.0,11/11,76.50%,PLBD2;PLBD1;PDXP;ANGPTL3;PNLIPRP2;ABHD12;APOA2;LIPG;PON1;NUDT15;ENPP2
prerank,negative regulation of lymphocyte activation (GO:0051250),-0.20410992364451375,-0.576297071451358,0.9551166965888689,0.9893483735442808,1.0,8/21,27.85%,DUSP3;TNFAIP3;JAK3;LAPTM5;PTPN22;BANK1;LST1;LAX1
prerank,cilium-dependent cell motility (GO:0060285),0.20575498680346432,0.5752146624186664,0.9607438016528925,1.0,1.0,2/22,6.91%,TEKT3;CCDC65
prerank,homologous chromosome pairing at meiosis (GO:0007129),0.18951866281261762,0.5749848899873083,0.9680170575692963,1.0,1.0,29/29,81.08%,PRDM9;SYCE2;P3H4;TEX11;MEI4;SYCE3;RNF212;KASH5;SYCE1;SYCP1;TRIP13;SYCP2;BAG6;TERB2;HORMAD1;ANKRD31;RNF212B;TERB1;RAD21L1;IHO1;SIRT7;STAG3;TEX12;ZCWPW1;MEIOB;MAJIN;FANCD2;REC8;RAD21
prerank,negative regulation of telomere maintenance via telomere lengthening (GO:1904357),0.19886214091779178,0.5739849316828242,0.9592760180995475,1.0,1.0,10/24,28.23%,STN1;PINX1;PARP1;GNL3L;TNKS;TINF2;TENT4B;TNKS2;XRN1;NAT10
prerank,negative regulation of TORC1 signaling (GO:1904262),0.22818581293157555,0.571869336849565,0.9465116279069767,1.0,1.0,13/13,77.20%,ITFG2;ATM;CASTOR1;DEPDC5;KPTN;SZT2;STK11;SPAAR;SESN3;RNF152;SESN1;CASTOR2;SESN2
prerank,positive regulation of superoxide anion generation (GO:0032930),-0.22905868826083753,-0.5715765812447084,0.9530075187969925,0.9906139990845029,1.0,5/13,31.22%,TGFB1;SYK;PRKCD;SOD1;TYROBP
prerank,positive regulation of DNA-dependent DNA replication (GO:2000105),-0.24507059656241997,-0.5709130536574254,0.9509090909090909,0.9904048246345577,1.0,9/10,59.89%,E2F7;E2F8;STOML2;DBF4;SSBP1;CDT1;INO80;WIZ;ATRX
prerank,nucleosome organization (GO:0034728),0.1652123053930181,0.5700083981999386,0.9919517102615694,1.0,1.0,16/55,23.18%,PRDM9;CTCF;ANP32E;MCM3AP;DAXX;SPTY2D1;SMARCB1;BRDT;SART3;SRCAP;NAP1L2;SET;PAF1;SMARCD1;BPTF;NASP
prerank,mitotic spindle assembly (GO:0090307),0.1746862629731773,0.5681754465817712,0.9815195071868583,1.0,1.0,6/42,12.33%,STAG1;MAP9;GOLGA2;MAP10;PIBF1;AURKC
prerank,serine family amino acid catabolic process (GO:0009071),-0.2466322296493399,-0.5674937410396326,0.9471698113207547,0.9911251747540946,1.0,5/10,36.02%,DLD;AMT;THNSL2;SHMT2;DAO
prerank,acyl-CoA biosynthetic process (GO:0071616),-0.2155766605827133,-0.5660747543377544,0.9652509652509652,0.9911363821327502,1.0,3/16,16.01%,ACLY;PPT2;SLC25A1
prerank,regulation of spindle assembly (GO:0090169),-0.19401278985978465,-0.564396156217064,0.9626865671641791,0.991213575582138,1.0,7/25,32.16%,CHMP2B;HSPA1A;CHMP2A;HSPA1B;EML3;PLK1;CHMP4B
prerank,piRNA metabolic process (GO:0034587),0.2076685572557247,0.5639770996968694,0.9701789264413518,1.0,1.0,3/19,13.86%,HENMT1;PIWIL2;TEX15
prerank,homocysteine metabolic process (GO:0050667),-0.2350374872146578,-0.5625118307060483,0.9570093457943926,0.991342966455288,1.0,6/11,42.66%,CTH;BLMH;MTRR;MPST;TST;DPEP1
prerank,immune response-activating cell surface receptor signaling pathway (GO:0002429),0.20405706400488477,0.56117464097358,0.9616204690831557,1.0,1.0,3/18,12.96%,LYN;C3AR1;BCAR1
prerank,glycerolipid metabolic process (GO:0046486),-0.23236254079839316,-0.5587643071133596,0.9702276707530648,0.9920788671961704,1.0,11/11,76.79%,DGKZ;PIP5K1A;DGKB;DGKG;PGP;DGKQ;GAL3ST1;PDXP;PLA2G15;PNPLA3;DGKA
prerank,isotype switching (GO:0045190),0.23504595585064683,0.5566434840116511,0.9410377358490566,1.0,1.0,1/10,4.41%,CCR6
prerank,endosome transport via multivesicular body sorting pathway (GO:0032509),-0.19006863286622216,-0.5565702036397044,0.9790874524714829,0.9923076358981932,1.0,5/25,18.15%,LYST;CHMP2B;VCP;LAPTM4B;CHMP2A
prerank,negative regulation of B cell activation (GO:0050869),-0.19558595702305615,-0.5561490561375194,0.9801084990958409,0.9919894060099774,1.0,7/21,26.70%,TNFRSF21;RC3H1;INHBA;TNFAIP3;LAPTM5;BANK1;INHA
prerank,ribonucleoside bisphosphate biosynthetic process (GO:0034030),0.22853376851619378,0.5558189035371074,0.9502982107355865,1.0,1.0,11/11,77.16%,PANK3;PANK1;COASY;PPCDC;PANK4;ACAT1;PPCS;DCAKD;ACOT7;PANK2;SLC25A16
prerank,coenzyme A biosynthetic process (GO:0015937),0.22853376851619378,0.5558189035371074,0.9502982107355865,1.0,1.0,11/11,77.16%,PANK3;PANK1;COASY;PPCDC;PANK4;ACAT1;PPCS;DCAKD;ACOT7;PANK2;SLC25A16
prerank,purine nucleoside bisphosphate biosynthetic process (GO:0034033),0.22853376851619378,0.5558189035371074,0.9502982107355865,1.0,1.0,11/11,77.16%,PANK3;PANK1;COASY;PPCDC;PANK4;ACAT1;PPCS;DCAKD;ACOT7;PANK2;SLC25A16
prerank,protein O-linked glycosylation via serine (GO:0018242),0.23097728801172707,0.5532982988006253,0.936768149882904,1.0,1.0,2/10,14.23%,POGLUT2;MGAT5B
prerank,positive regulation of acute inflammatory response (GO:0002675),0.21382384330466447,0.5523427633471781,0.9642857142857143,1.0,1.0,14/14,78.64%,OSMR;PTGS2;C2CD4A;C2CD4B;IL1B;FFAR2;OSM;IL6;CREB3L3;TNF;ADAM8;PTGER3;PARK7;IL6ST
prerank,protein destabilization (GO:0031648),0.18138995569821656,0.5520707735060086,0.9842342342342343,1.0,1.0,8/32,20.07%,MDM2;PRKN;SENP2;BTRC;EP300;CTSH;FBXW11;PEX2
prerank,rRNA catabolic process (GO:0016075),-0.20894977937707238,-0.5516900031964003,0.957089552238806,0.9928415587812999,1.0,9/16,50.32%,EXOSC8;DIS3;EXOSC9;PELO;ERN2;TRIR;DIS3L;SLFN14;EXOSC7
prerank,alpha-linolenic acid metabolic process (GO:0036109),-0.22705937305683327,-0.5489223937784263,0.9679144385026738,0.9931755051317642,1.0,4/12,24.94%,ELOVL5;ACOT8;ELOVL1;ACOX1
prerank,small nucleolar ribonucleoprotein complex assembly (GO:0000491),-0.23566952233027968,-0.5488416229288333,0.9570661896243292,0.992752047242999,1.0,8/10,45.20%,TAF9;PIH1D2;ZNHIT6;RUVBL1;ZNHIT3;NUFIP1;NAF1;RUVBL2
prerank,apoptotic nuclear changes (GO:0030262),-0.18543443736093262,-0.5446954558590217,0.9764492753623188,0.9934560306259818,1.0,8/24,31.17%,KPNA1;TOP2A;FOXL2;CDK5RAP3;DFFB;ACIN1;HMGB2;ENDOG
prerank,negative regulation of activated T cell proliferation (GO:0046007),-0.23361585675506163,-0.5440842894706024,0.9613259668508287,0.9931845155281884,1.0,5/10,38.35%,RC3H1;LGALS9;SCRIB;CRTAM;PDCD1LG2
prerank,positive regulation of transporter activity (GO:0032411),0.21753170598581142,0.5398345728000858,0.9576837416481069,1.0,1.0,6/13,25.87%,KMT2A;WNK3;PDZK1;RXRA;NR1H3;SGK1
prerank,synaptic vesicle transport (GO:0048489),0.22280509345472582,0.5389721877942579,0.9760765550239234,1.0,1.0,3/11,16.29%,KIF5C;SNAPIN;TMEM230
prerank,oligodendrocyte development (GO:0014003),0.2047825256868714,0.5368831683702842,0.978494623655914,1.0,1.0,4/15,19.34%,HES5;EIF2B5;EIF2B2;B4GALT6
prerank,negative regulation of fibroblast proliferation (GO:0048147),0.19669280562959277,0.5363704089286615,0.9736842105263158,1.0,1.0,6/18,20.07%,SFRP1;GSTP1;EMD;TP53;B4GALT7;PEX2
prerank,regulation of postsynaptic neurotransmitter receptor activity (GO:0098962),0.2363020146864998,0.5354533053465855,0.9626373626373627,1.0,1.0,10/10,76.38%,DLGAP1;DLGAP2;DLGAP3;CACNG5;NPTX2;NPTX1;AKAP9;NPTXR;DLGAP4;BEGAIN
prerank,N-terminal protein amino acid modification (GO:0031365),-0.20903137401606695,-0.5333245045503148,0.9696969696969697,0.9953948400209781,1.0,7/14,43.61%,NAA60;METAP1D;NTMT1;NAA50;METAP2;PDF;NAA11
prerank,protein transmembrane import into intracellular organelle (GO:0044743),-0.1698035741974685,-0.5324468269783038,0.9921722113502935,0.9951570613378663,1.0,11/31,37.21%,HSPD1;TIMM17A;TIMM21;CHCHD4;TIMM50;PEX14;PEX6;ROMO1;PEX7;DNLZ;GRPEL1
prerank,positive regulation of chromosome organization (GO:2001252),0.2052593036677534,0.5286420100785314,0.9711751662971175,1.0,1.0,4/15,19.74%,PPP1R10;NBN;SIRT6;RTEL1
prerank,positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725),-0.21797182398641118,-0.5286217578650205,0.9697508896797153,0.9956092830059204,1.0,7/12,47.78%,PAEP;RASGRP1;ISL1;CARD9;IL23A;IL23R;IL12B
prerank,organic cyclic compound biosynthetic process (GO:1901362),0.17339470774343368,0.5282033115545312,0.9935064935064936,1.0,1.0,1/31,2.11%,MOCS2
prerank,regulation of inclusion body assembly (GO:0090083),-0.22234744477502716,-0.5278188252782176,0.9826388888888888,0.9953514296854432,1.0,5/11,29.24%,BAG5;HSPA1A;HSPA1B;DNAJB1;DNAJB6
prerank,"positive regulation of DNA-templated transcription, initiation (GO:2000144)",0.18790438776494142,0.5273579350213623,0.9829787234042553,1.0,1.0,4/21,18.08%,MITF;PAXIP1;MED12;MED4
prerank,negative regulation of cell communication (GO:0010648),-0.18620185077801968,-0.5265050102315154,0.9808429118773946,0.9952234669369563,1.0,5/21,22.97%,IGFBP3;KIF26A;ACVR1;UBASH3B;PTPN1
prerank,regulation of MHC class II biosynthetic process (GO:0045346),0.22231373131917972,0.5256545075738466,0.9603960396039604,1.0,1.0,4/11,24.09%,IL4;TAF7;SIRT1;CIITA
prerank,regulation of actin nucleation (GO:0051125),0.21190717084539668,0.5254013052578975,0.9683257918552036,1.0,1.0,2/12,14.27%,SCIN;ARPIN
prerank,negative regulation of telomere maintenance (GO:0032205),0.2050959951294953,0.5249382515364163,0.9689737470167065,1.0,1.0,6/15,22.88%,PINX1;NBN;ATM;PARP1;RTEL1;TNKS
prerank,base-excision repair (GO:0006284),-0.15128131524016836,-0.5242131525587642,1.0,0.9952983467619305,1.0,12/48,26.43%,SMUG1;PNKP;XRCC1;RPA3;NEIL1;POLQ;APEX2;RFC3;RFC2;POLL;DNA2;TDG
prerank,spindle assembly checkpoint signaling (GO:0071173),-0.1867768271832373,-0.5209499453603061,0.9792452830188679,0.9946296433931903,1.0,8/20,34.18%,ZW10;MAD1L1;CENPF;BUB3;PLK1;CDC20;BUB1;MAD2L2
prerank,mitotic spindle checkpoint signaling (GO:0071174),-0.1867768271832373,-0.5209499453603061,0.9792452830188679,0.9946296433931903,1.0,8/20,34.18%,ZW10;MAD1L1;CENPF;BUB3;PLK1;CDC20;BUB1;MAD2L2
prerank,mitotic spindle assembly checkpoint signaling (GO:0007094),-0.1867768271832373,-0.5209499453603061,0.9792452830188679,0.9946296433931903,1.0,8/20,34.18%,ZW10;MAD1L1;CENPF;BUB3;PLK1;CDC20;BUB1;MAD2L2
prerank,prostanoid metabolic process (GO:0006692),-0.2041638028327864,-0.5208175354679244,0.9804270462633452,0.994218354458459,1.0,3/13,15.05%,PLAA;PTGS1;GSTM1
prerank,regulation of rhodopsin mediated signaling pathway (GO:0022400),0.17858174129785553,0.5123488349814606,0.9912472647702407,1.0,1.0,4/23,15.26%,GUCY2F;METAP1;GUCA1B;PDE6G
prerank,signal peptide processing (GO:0006465),0.21522710968534614,0.5111867396074975,0.9559748427672956,1.0,1.0,3/11,15.85%,HM13;PARL;SPCS3
prerank,N-terminal protein amino acid acetylation (GO:0006474),0.18969149360413043,0.5102688293161801,0.9839449541284404,1.0,1.0,6/16,24.02%,EP300;NAA20;AANAT;NAA40;KAT2B;NAA15
prerank,"base-excision repair, AP site formation (GO:0006285)",-0.18578685279267765,-0.5097586486504799,0.9875222816399287,0.9958700151474474,1.0,6/17,37.49%,SMUG1;NEIL1;TDG;TERF2IP;NEIL3;UNG
prerank,DNA catabolic process (GO:0006308),0.20851117248305306,0.5082612434705766,0.9845474613686535,1.0,1.0,11/11,79.16%,SETMAR;FBH1;MUS81;DNASE1L3;REXO4;DNASE1;DNASE1L1;ISG20;XRN2;DFFB;DNASE1L2
prerank,regulation of telomere maintenance via telomere lengthening (GO:1904356),0.19184399093822768,0.5067107281436465,0.9697674418604652,1.0,1.0,8/16,26.63%,PINX1;ATM;PARP1;SMG5;RTEL1;TNKS;TINF2;TNKS2
prerank,acyl-CoA metabolic process (GO:0006637),0.16107341805042943,0.5041649487164364,0.9978448275862069,1.0,1.0,8/35,20.77%,ACSM5;BAAT;ACOT11;ACSL6;ACACA;ACBD6;MCEE;HMGCS1
prerank,telomere maintenance via telomere lengthening (GO:0010833),-0.15871959386487816,-0.5037103898643052,0.9980952380952381,0.9964599586451869,1.0,14/33,36.31%,HSP90AB1;DKC1;HSP90AA1;ZBTB48;PPP6R3;TNKS1BP1;MRE11;TERF2IP;PIF1;TERT;WRAP53;RAD50;NOP10;RAD51
prerank,regulation of superoxide anion generation (GO:0032928),-0.19776912618122142,-0.5013682617133687,0.9829867674858223,0.9963882666282159,1.0,5/14,31.22%,TGFB1;SYK;PRKCD;SOD1;TYROBP
prerank,negative regulation of defense response to virus (GO:0050687),-0.2146232244947361,-0.5009079504349837,0.981549815498155,0.996019642809763,1.0,3/10,28.21%,ITCH;TSPAN6;MUL1
prerank,rhodopsin mediated signaling pathway (GO:0016056),-0.21471576952186394,-0.496517261301834,0.9794392523364486,0.9962460762060937,1.0,7/10,56.71%,GNB1;PDE6B;RHO;GNAT1;PDE6A;CNGB1;SAG
prerank,lytic vacuole organization (GO:0080171),0.1609844520597153,0.4959283991189078,0.9955654101995566,1.0,1.0,4/32,16.40%,ABCA1;AKTIP;SNAPIN;CLN3
prerank,synaptonemal complex organization (GO:0070193),0.1893520843797084,0.49354263934726156,0.9839080459770115,1.0,1.0,15/15,81.08%,SYCE2;P3H4;TEX11;SYCE3;SYCE1;SYCP1;TRIP13;SYCP2;BAG6;HORMAD1;RAD21L1;STAG3;TEX12;REC8;RAD21
prerank,synaptonemal complex assembly (GO:0007130),0.1893520843797084,0.49354263934726156,0.9839080459770115,1.0,1.0,15/15,81.08%,SYCE2;P3H4;TEX11;SYCE3;SYCE1;SYCP1;TRIP13;SYCP2;BAG6;HORMAD1;RAD21L1;STAG3;TEX12;REC8;RAD21
prerank,positive regulation of viral transcription (GO:0050434),-0.16420272729369367,-0.4930653399079351,0.9961977186311787,0.9963191738984726,1.0,8/25,32.29%,DHX9;NELFE;GTF2F1;GTF2F2;POLR2F;POLR2L;POLR2I;POLR2C
prerank,neuropeptide signaling pathway (GO:0007218),0.14318831047227806,0.49240896809460394,0.9978586723768736,1.0,1.0,9/58,18.99%,SORCS1;GLRB;OPRK1;GLRA3;PNOC;HCRTR1;LTB4R2;SORT1;PDYN
prerank,protein targeting to peroxisome (GO:0006625),0.16079822383774167,0.4922411108114054,0.9978308026030369,1.0,1.0,7/29,20.07%,ABCD2;PXMP4;PEX11B;PXMP2;PEX10;PEX19;PEX2
prerank,protein monoubiquitination (GO:0006513),0.15311511421209498,0.49190013109532604,0.9934065934065934,1.0,1.0,4/36,9.95%,PRKN;UBE2O;MGRN1;TOPORS
prerank,regulation of biosynthetic process (GO:0009889),0.2055985413699113,0.4917854300450645,0.981941309255079,0.9998284436368328,1.0,1/11,6.08%,GSTP1
prerank,positive regulation of fatty acid biosynthetic process (GO:0045723),-0.2078553954516323,-0.49121038575433246,0.9853479853479854,0.9961573334165111,1.0,2/10,16.28%,ELOVL5;NR1H2
prerank,snRNA processing (GO:0016180),-0.18170164078517684,-0.4894067005795793,0.9925788497217068,0.9959680443605897,1.0,7/16,36.12%,INTS8;INTS1;INTS12;INTS2;INTS3;INTS14;INTS4
prerank,regulation of delayed rectifier potassium channel activity (GO:1902259),0.1821410711601181,0.4892129444897769,0.9891540130151844,0.9995985285348579,1.0,4/17,23.28%,SUMO1;KCNS1;KCNS2;KCNE4
prerank,regulation of T cell activation (GO:0050863),0.1463627961292468,0.4876593589030661,0.9976689976689976,0.9991604797311516,1.0,6/42,15.77%,IL4I1;TBX21;IL27;PAG1;CD47;METTL3
prerank,response to hydroxyurea (GO:0072710),0.19842886820836889,0.4831030507287447,0.9839816933638444,0.9992043075933073,1.0,1/11,8.95%,BLM
prerank,regulation of cell aging (GO:0090342),0.1977885770048361,0.47631298798282146,0.9739952718676123,0.9995128549245615,1.0,3/11,20.43%,PNPT1;MIF;NEK4
prerank,negative regulation of mitotic metaphase/anaphase transition (GO:0045841),0.16426881381483166,0.4687297878564768,0.9913978494623656,0.9998118372344545,1.0,6/21,20.12%,KNTC1;ATM;ZWINT;KLHL22;FBXO5;APC
prerank,cellular response to hydroxyurea (GO:0072711),0.198627624633658,0.46812578525729776,0.9858823529411764,0.9992097909875569,1.0,1/10,8.95%,BLM
prerank,regulation of receptor recycling (GO:0001919),-0.1705161321796918,-0.46137302663878804,1.0,0.9986515982397118,1.0,3/16,17.44%,ANXA2;KIF16B;NSF
prerank,termination of RNA polymerase II transcription (GO:0006369),-0.14090546803877985,-0.46105169080737085,0.9982174688057041,0.9982398479635954,1.0,15/33,40.17%,SNRPD3;LSM11;SNRPG;CPSF4;NCBP2;LSM10;CSTF2T;SNRPB;MAZ;PCF11;CPSF1;CSTF3;SNRPE;SNRPF;NCBP1
prerank,telomere maintenance in response to DNA damage (GO:0043247),0.20002561376097192,0.4609525287717429,0.9934924078091106,0.9993727437354434,1.0,3/10,21.96%,RIF1;RTEL1;DCLRE1B
prerank,telomere capping (GO:0016233),0.1723703153842247,0.46036945033931415,0.9802197802197802,0.9987592697986606,1.0,2/16,12.63%,STN1;NBN
prerank,transcription preinitiation complex assembly (GO:0070897),-0.18485970748854433,-0.4576367761640785,0.9928698752228164,0.9981155245750122,1.0,12/12,81.53%,BDP1;TAF1B;TBP;TAF7L;TAF12;DR1;GTF2A2;POLR1E;TAF11;TAF7;TAF1;GTF2B
prerank,positive regulation of cilium assembly (GO:0045724),-0.1668547218972887,-0.4552764374719229,0.9961904761904762,0.9978836448980815,1.0,1/18,4.88%,HTT
prerank,peptidyl-amino acid modification (GO:0018193),0.1906106822318459,0.4487258439899621,0.9892241379310345,0.9992608464769709,1.0,10/10,80.95%,METAP1;TTLL4;FKBP7;ATP7A;APOA2;APOA1;FKBP10;PDF;METAP2;METAP1D
prerank,regulation of transposition (GO:0010528),0.17554410810193954,0.44140826965941005,0.9916317991631799,0.9992309262549826,1.0,3/13,20.49%,PIWIL2;TEX15;UBR2
prerank,DNA modification (GO:0006304),0.15619174371840222,0.4357312758658685,0.995475113122172,0.9990041186486608,1.0,4/22,17.74%,MPG;PARP3;EXOSC3;PARP1
prerank,DNA packaging (GO:0006323),-0.16678708785762117,-0.435458910401489,1.0,0.998866800993303,1.0,4/16,31.43%,CDAN1;RBBP4;BANF2;BANF1
prerank,regulation of response to stress (GO:0080134),-0.17931289267585168,-0.4210568274500146,0.9981981981981982,0.999184157900581,1.0,5/10,37.66%,MLC1;EIF4G1;DYRK3;SLC38A2;CRHBP
prerank,regulation of rRNA processing (GO:2000232),0.1544768789831035,0.40418944754840364,0.9957805907172996,1.0,1.0,5/16,24.93%,SHQ1;DIMT1;HEATR1;KAT2B;BUD23
prerank,peptidyl-methionine modification (GO:0018206),-0.15770435360578383,-0.39121557906255516,0.998158379373849,0.99976629609061,1.0,2/12,19.06%,NAA60;METAP1D
prerank,protein import into mitochondrial matrix (GO:0030150),0.13975074117594477,0.38649893163333693,0.9977528089887641,1.0,1.0,5/18,20.40%,TOMM70;PAM16;GRPEL2;TOMM40;TOMM40L
prerank,tRNA 5'-leader removal (GO:0001682),-0.14982315548134184,-0.3750012614677162,1.0,0.9996250806076693,1.0,6/13,43.91%,RPP38;RPP21;RPP25L;RPP40;RPP30;RPP25
prerank,natural killer cell activation (GO:0030101),0.12334814085772376,0.3495556452250414,1.0,0.9998517525574104,1.0,3/23,17.12%,AXL;NFIL3;RABL3
